{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "58c52cdb",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/siddhigupta/Desktop/Arvia-Ai/Arvia/.venv/lib/python3.14/site-packages/langchain_tavily/tavily_research.py:97: UserWarning: Field name \"output_schema\" in \"TavilyResearch\" shadows an attribute in parent \"BaseTool\"\n",
      "  class TavilyResearch(BaseTool):  # type: ignore[override, override]\n",
      "/Users/siddhigupta/Desktop/Arvia-Ai/Arvia/.venv/lib/python3.14/site-packages/langchain_tavily/tavily_research.py:97: UserWarning: Field name \"stream\" in \"TavilyResearch\" shadows an attribute in parent \"BaseTool\"\n",
      "  class TavilyResearch(BaseTool):  # type: ignore[override, override]\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "from langchain_community.document_loaders import PyPDFLoader, PyMuPDFLoader\n",
    "from langchain_community.document_loaders import DirectoryLoader\n",
    "from langchain_community.document_loaders import TextLoader\n",
    "\n",
    "from langchain_tavily import TavilySearch\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "from tqdm import tqdm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "ce9b173e",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 2/2 [00:01<00:00,  1.22it/s]\n"
     ]
    }
   ],
   "source": [
    "all_pdf_documents = []\n",
    "dir_loader=DirectoryLoader(\n",
    "    \"../data/remedies\",\n",
    "    glob=\"**/*.pdf\", \n",
    "    loader_cls= PyMuPDFLoader, \n",
    "    use_multithreading=True,\n",
    "    show_progress=True\n",
    "\n",
    ")\n",
    "\n",
    "\n",
    "\n",
    "pdf_documents=dir_loader.lazy_load()\n",
    "\n",
    "for doc in dir_loader.lazy_load():   \n",
    "    doc.metadata[\"source_type\"] = \"Authorotative\"\n",
    "    doc.metadata[\"priority\"] = \"1\"\n",
    "    all_pdf_documents.append(doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "69f3eada",
   "metadata": {},
   "outputs": [],
   "source": [
    "def split_documents(pdf_documents,chunk_size=1000,chunk_overlap=200):\n",
    "\n",
    "    text_splitter = RecursiveCharacterTextSplitter(\n",
    "        chunk_size=chunk_size,\n",
    "        chunk_overlap=chunk_overlap,\n",
    "        length_function=len,\n",
    "        separators=[\"\\n\\n\", \"\\n\", \" \", \"\"]\n",
    "    )\n",
    "    split_docs = text_splitter.split_documents(pdf_documents)\n",
    "    print(f\"Split {len(pdf_documents)} documents into {len(split_docs)} chunks\")\n",
    "    \n",
    "    # Show example of a chunk\n",
    "    if split_docs:\n",
    "        print(f\"\\nExample chunk:\")\n",
    "        print(f\"Content: {split_docs[0].page_content[:200]}...\")\n",
    "        print(f\"Metadata: {split_docs[0].metadata}\")\n",
    "    \n",
    "    return split_docs\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "4587fc48",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Example chunk:\n",
      "Content: i\n",
      "STANDARD TREATMENT GUIDELINES\n",
      "A Manual for Medical Therapeutics\n",
      "First Edition, 2013\n",
      "Gujarat Medical Services Corporation Limited\n",
      "Health & Family Welfare Department\n",
      "Government of Gujarat...\n",
      "Metadata: {'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 0, 'source_type': 'Authorotative', 'priority': '1'}\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 0, 'source_type': 'Authorotative', 'priority': '1'}, page_content='i\\nSTANDARD TREATMENT GUIDELINES\\nA Manual for Medical Therapeutics\\nFirst Edition, 2013\\nGujarat Medical Services Corporation Limited\\nHealth & Family Welfare Department\\nGovernment of Gujarat'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 1, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ii\\nMessage\\n(Health Minister)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 2, 'source_type': 'Authorotative', 'priority': '1'}, page_content='iii\\nMessage\\n(Principal Secretary)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 3, 'source_type': 'Authorotative', 'priority': '1'}, page_content='iv\\nMessage\\n(Commissionerate)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='v\\nPREFACE TO FIRST EDITION\\nThe Rational Use of Medicines results into a more effective treatment at an affordable cost.\\nEssential Medicines List (EML) and the Standard Treatment Guidelines (STG) are an\\nimportant component of promoting rational use of medicines. Gujarat Medical Service\\nCorporation Limited under the auspices of Department of Health & Family Welfare,\\nGovernment of Gujarat finalizes EML and has undertaken the task to develop STG for the\\nState. The objective is to improve the availability of quality drugs at each health facility and\\nto achieve maximum public health improvement using available resources. B. J. Medical\\nCollege & Civil Hospital, Ahmedabad has been instrumental in the preparation of the STG.\\nAn attempt has been made in this manual to provide guidelines for the treatment of common\\ndiseases, keeping in mind the rational use of medicines. It is a blend of evidence from\\nstandard text and reference books with consensus of specialists. The guidelines are'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='diseases, keeping in mind the rational use of medicines. It is a blend of evidence from\\nstandard text and reference books with consensus of specialists. The guidelines are\\ncomprehensive, concise and seek to summarize treatment plan for patients with priority\\ndiseases. It is assumed that the patient has been fully evaluated and all co-morbidities\\nidentified. Under each clinical condition, the treatment plan has been suggested that can be\\napplied to average patient with common presentation. However, there may be great variations\\nin patient presentation, their family history, treatment preferences and tolerance for different\\nside effect. Therefore, these guidelines can be viewed as an expert consultation and weighed\\nwith respect to other information. Moreover, the recommendations do not replace clinical\\njudgment nor encroach on clinical flexibility, which must be tailored to the particular needs\\nof each clinical situation.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='judgment nor encroach on clinical flexibility, which must be tailored to the particular needs\\nof each clinical situation.\\nA large number of experienced clinicians have contributed in the preparation of these\\nguidelines. The manual begins with a brief introduction to the concept of Rational Use of\\nMedicines along with its important components. This is followed by chapters on common\\ndiseases and emergency conditions which may be general to all specialties. Remaining\\nchapters describe frequent clinical conditions in each specialty, for example ENT, Psychiatry,\\nObstetrics and Gynecology etc. The format of the guidelines includes important salient\\nfeatures, diagnostic tests followed by non-pharmacological, pharmacological treatment plan\\nand patient education, if applicable. Medicines are mentioned in generic names and choice is\\nbased on the balanced criteria of efficacy, safety, suitability and cost.\\nThis manual will be useful as ready reference for the health care providers and supply'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 4, 'source_type': 'Authorotative', 'priority': '1'}, page_content='based on the balanced criteria of efficacy, safety, suitability and cost.\\nThis manual will be useful as ready reference for the health care providers and supply\\nmanagement staff. We hope this manual will help in pursuance of the objectives of Rational\\nUse of Medicines and make the treatment more specific and effective. We thank all the\\nexperts for sharing their valuable time and expertise in developing the book.\\nDr. Mira Desai\\nDr. Samidh Shah\\nDr. Geetha Iyer'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vi\\nACKNOWLEDGEMENTS\\nThe standard treatment guidelines have been developed after several meetings and\\ndiscussions among the core committee members and expert clinicians. These guidelines\\ninclude material from the many sources, recommendations and advice from numerous\\nindividuals.\\nWe extend our sincere thanks to all those who have contributed as members, subject experts\\nand provided technical and editorial expertise. The resident doctors from various departments\\nhave immensely helped in literature search, data entry, computer processing and\\ncommunication with editors.\\nThe contribution made by resident doctors Dr. R P. Pole, Dr. Saloni Shah, Dr. Trupal\\nSolanki, Dr. Falguni Parmar, Dr. Dhaval Mistry, Dr. Mitali Desai, Dr Pinakin Patel, Dr.\\nAbhinav Jain, Dr. Roopesh Singhal, Dr. Satyam Satyarth, Dr. Ravi Varmora, Dr. Hardik\\nRughwani, Dr. Mayank Andrepa, Dr Mayur Patil, Dr. Rachel Shah, Dr. Dharmesh\\nVaghasiya, Dr. Bhavik Prajapati, Dr. Nayan Pawnikar, Dr. Shailesh Patel, Dr. Jaydeep'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 5, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Rughwani, Dr. Mayank Andrepa, Dr Mayur Patil, Dr. Rachel Shah, Dr. Dharmesh\\nVaghasiya, Dr. Bhavik Prajapati, Dr. Nayan Pawnikar, Dr. Shailesh Patel, Dr. Jaydeep\\nOdhvani, Dr. Pankaj Vyas and Dr. Dhrumil Patel are gratefully acknowledged.\\nWithout their dedication, it might have not been possible to bring out this publication. Once\\nagain we express our heartfelt gratitude to the generous support given by each and every one\\nof our team.\\nNovember, 2013\\nAhmedabad\\nEditors'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vii\\nCONTRIBUTORS TO FIRST EDITION\\nCore - Committee Members\\nShri H. K. Patel, Managing Director, GMSCL, Gandhinagar\\nDr. A. B. Solanki, General Manager, GMSCL, Gandhinagar\\nDr. B. J. Shah, Dean, B. J. Medical College, Ahmedabad\\nDr. Kamlesh Parmar, MO, Gandhinagar\\nDr. Mira Desai, Professor & Head, Department of Pharmacology, B. J. Medical College &\\nCivil Hospital, Ahmedabad Ahmedabad\\nMedicine\\nDr.  Asha Shah .Professor & Head, Department of Medicine, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nDr.B. K. Amin, Additional Professor, Department of Medicine, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. B. B. Solanki, Additional Professor, Department of Medicine, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. K. J. Upadhyay, Additional Professor, Department of Medicine, B. J. Medical College\\n& Civil Hospital, Ahmedabad\\nDr. Shivani Patel, Associate Professor, Department of Medicine, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nEmergency Medicine'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='& Civil Hospital, Ahmedabad\\nDr. Shivani Patel, Associate Professor, Department of Medicine, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nEmergency Medicine\\nDr. Samira Parikh, Professor & Head, Department of Emergency Medicine, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nDr. Nilima Shah, Professor & Head, Department of Emergency Medicine, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nDr. Shruti Sangani, Professor & Head, Department of Emergency Medicine, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nSurgery\\nDr. P. N. Kantharia, Professor, Department of Surgery, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nDr. Subham Negi, Assistant Professor Department of Surgery, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nPharmacology\\nDr. Mira Desai, Professor & Head, Department of Pharmacology, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Samidh Shah, Assistant Professor, Department of Pharmacology, B. J. Medical College\\n& Civil Hospital, Ahmedabad'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 6, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Civil Hospital, Ahmedabad\\nDr. Samidh Shah, Assistant Professor, Department of Pharmacology, B. J. Medical College\\n& Civil Hospital, Ahmedabad\\nDr. Geetha Iyer, Assistant Professor, Department of Pharmacology, B. J. Medical College &\\nCivil Hospital, Ahmedabad'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='viii\\nObstetrics and Gynecology\\nDr. Malini R. Desai Professor & Head, Department of OB & Gy, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Tejal L. Patel, Associate Professor, Department of OB & Gy, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Dhaval Swaminarayan, Assistant Professor, Department of OB & Gy, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nDr. Pallavi Ninama, Assistant Professor, Department of OB & Gy, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Shirish Toshniwal, Assistant Professor, Department of OB & Gy, B. J. Medical College\\n& Civil Hospital, Ahmedabad\\nDermatology\\nDr. Kirti Parmar, Associate Professor, Department of Dermatology, B. J. Medical College\\n& Civil Hospital, Ahmedabad\\nDr. Rima Joshi, Assistant Professor, Department of Dermatology, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Brijesh Parmar, Assistant Professor, Department of Dermatology, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nOphthalmology'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Civil Hospital, Ahmedabad\\nDr. Brijesh Parmar, Assistant Professor, Department of Dermatology, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nOphthalmology\\nDr. Mariam Mansuri, Professor and Head of Unit- Glaucoma, M & J Institute of\\nOphthalmology, Civil Hospital, Ahmedabad.\\nDr. Purvi Bhagat, Associate Professor, M & J Institute of Ophthalmology, Civil Hospital,\\nAhmedabad.\\nDr. Rupal Bhatt, Assistant Professor, M & J Institute of Ophthalmology, Civil Hospital,\\nAhmedabad.\\nDr. Pooja Negi, Tutor, M & J Institute of Ophthalmology, Civil Hospital, Ahmedabad.\\nDr. Kalpit Shah, Assistant Professor, M & J Institute of Ophthalmology, Civil Hospital,\\nAhmedabad.\\nPsychiatry\\nDr. G.K. Vankar, Professor & Head, Department of Psychiatry, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Minakshi Parikh, Professor, Department of Psychiatry, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nOrthopedics\\nDr. M.M. Prabhakar, Professor & Head, Department of Orthopedics, Superintendent'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 7, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Dr. Minakshi Parikh, Professor, Department of Psychiatry, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nOrthopedics\\nDr. M.M. Prabhakar, Professor & Head, Department of Orthopedics, Superintendent\\nDirector, paraplegia, B. J. Medical College & Civil Hospital, Ahmedabad\\nDr. G D Tharadara, Additional Professor, Department of Orthopedics, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ix\\nENT\\nDr. Rajesh Vishwakarma, Professor, Department of ENT, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nDr Kalpesh Patel, Assistant Professor, Department of ENT, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nDr. Dipesh Darji, Assistant Professor, Department of ENT, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nTB and Chest Diseases\\nDr. Rajesh N. Solanki, Additional Professor ,Department of Pulmonary Medicine, B J\\nMedical College and Civil Hospital, Ahmedabad\\nDr. Amit R. Dedun, Assistant Professor, Department of Pulmonary Medicine, B J Medical\\nCollege and Civil Hospital, Ahmedabad\\nDr. (Mrs.) Purvi Nayak, Medical Officer (Drug Resistance TB), State TB Training and\\nDemonstration Center, Ahmedabad\\nPaediatrics\\nDr. Bela Shah, Additional Professor, Department of Paediatrics, B. J. Medical College and\\nCivil Hospital, Ahmedabad.\\nDr. Gargi Pathak, Additional Professor, Department of Paediatrics, B. J. Medical College\\nand Civil Hospital, Ahmedabad.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 8, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Civil Hospital, Ahmedabad.\\nDr. Gargi Pathak, Additional Professor, Department of Paediatrics, B. J. Medical College\\nand Civil Hospital, Ahmedabad.\\nDr. Bharat Parmar, Professor, Department of Paediatrics, B. J. Medical College and Civil\\nHospital, Ahmedabad.\\nDental\\nDr. Piyush Limdiwala, Assistant Professor, Oral Medicine & Radiology Department,\\nGovernment Dental College & Hospital, Ahmedabad\\nDr. Janki Shah, Assistant Professor, Department of Preventive & Community Medicine,\\nGovernment Dental College & Hospital,  Ahmedabad.\\nDr. Girish Parmar, Dean, Government Dental College & Hospital, Ahmedabad'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 9, 'source_type': 'Authorotative', 'priority': '1'}, page_content='x\\nLIST OF ABBREVIATIONS\\nAED: Automated External Defibrillator\\nAHA: American Heart Association\\nAPACHE: Acute Physiology and Chronic Health Evaluation\\nAPTT: Activated Partial Thromboplastin Time\\nBERA: Brainstem Evoked Response Audiometry\\nBPS: Bio Physical Profile Scoring\\nCIN: Cervical Intraepithelial Neoplasia\\nCRP: C - reactive protein\\nCRT: Corneal Refractive Therapy\\nCT-IVP: Computed Tomography Intravenous Pyelogram\\nDMPA: Depot Medroxy Progesterone Acetate\\nDMSA: Dimercapto Succinic Acid\\nELISA: Enzyme-Linked Immunosorbent Assay\\nFDP: Fibrin Degradation Product\\nFML: Flurometholone Ophthalmic Suspension\\nFTA-ABS: Fluorescent Treponemal Antibody-Absorption\\nHPV: Human Papilloma Virus\\nLNG IUCD:Levonornestrel Intra Uterine Contraceptive Device\\nLR SHUNT: Left to Right Shunt\\nLSD:Lysergic Acid Diethylamine\\nMHA-TP: Microhemagglutination Assay Treponema Pallidum\\nNCHS:National Center For Health Statistics\\nNET-EN: Norethisterone Enanthate\\nNLEP:National Leprosy Eradication Programme'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 9, 'source_type': 'Authorotative', 'priority': '1'}, page_content='MHA-TP: Microhemagglutination Assay Treponema Pallidum\\nNCHS:National Center For Health Statistics\\nNET-EN: Norethisterone Enanthate\\nNLEP:National Leprosy Eradication Programme\\nNPSP: National Polio Surveillance Project\\nNST: Non Stress Test\\nPAIR: Puncture, Aspiration, Injection (Of A Scolicidal Agent), Reaspiration\\nPC: Product Code\\nPDA: Patent Ductus Arteriosus\\nPEA: Pulseless Electrical Activity\\nPET: Positron Emission Tomography\\nPWB: Patient Wise Box'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 10, 'source_type': 'Authorotative', 'priority': '1'}, page_content='xi\\nRDA: Recommended Daily Allowance\\nRPR:  Rapid Plasma Regain\\nS.PSA: Serum Prostate Specific Antigen\\nSLE: Systemic Lupus Erythematosus\\nTAPP: Trans Abdominal Preperitoneal Meshplasty\\nTEP: Totally Extra Peritoneal Meshplasty\\nTMJ: Temporo Mandibular Joint\\nTMT: Trabecular Meatel Technology\\nTPHA: Treponema Pallidum Haemagglutination Assays\\nTT: Tetanus Toxoid\\nUSAID: Us Agency For International Development\\nUSG-Kub: Ultrasonogram Kidney Ureter Bladder\\nVDRL: Venereal Disease Research Laboratory,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 11, 'source_type': 'Authorotative', 'priority': '1'}, page_content='xii\\nINDEX\\nTopic\\nPage\\nNo.\\n1. Introduction to Rational Use of Medicines\\nConcept of essential medicines, Standard treatment guidelines, Drug formulary,\\nRational approach to therapeutics, Adverse drug effects and drug interactions,\\nPrescription writing\\n1\\n2. Common Conditions\\nAcute fever, Fever of unknown origin, Acute rheumatic fever, Anaemia, Typhoid\\nfever, Malaria, Dengue, Chikungunya, Tuberculosis and RNTCP, Epilepsy, Status\\nepilepticus, Urinary tract infection\\n11\\n3. Emergency Conditions\\nCardiopulmonary resuscitation, Anaphylaxis, Acute airway obstruction, Stridor,\\nShock, Fluid and electrolyte imbalance, Septicemia, Organophosphorus poisoning,\\nKerosene and petrol poisoning, Datura poisoning, Abdominal injury, Foreign body in\\near, Chemical injuries of the eye, Corneal and conjunctival foreign bodies, Traumatic\\nhyphema, Animal bites- Dog bite, Snake bite, Insect and Arachnid bites, Scorpion bite\\n47\\n4. Cardiovascular Diseases'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 11, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hyphema, Animal bites- Dog bite, Snake bite, Insect and Arachnid bites, Scorpion bite\\n47\\n4. Cardiovascular Diseases\\nInfective endocarditis, Acute pericarditis, Cardiomyopathy, Hypertension, Angina\\npectoris, Myocardial infarction, Congestive heart failure, Arrhythmias, Ventricular\\ntachycardia, Atrial fibrillation, bradyarrhythmias\\n80\\n5. Central Nervous System Diseases\\nMigraine, Tension headache, Cluster headache, Stroke, Facial palsy, Parkinson’s\\ndisease, Dementia, Guillain- Barre Syndrome, Acute bacterial meningitis, Viral\\nencephalitis, Neurocysticercosis, Paraplegia and quadriplegia, Vertigo\\n91\\n6. Genitourinary Diseases\\nNephrotic syndrome, Chronic kidney disease, Acute renal failure, Hypokalemia,\\nHyperkalemia\\n107\\n7. Endocrine Diseases\\nHypothyroidism, \\nHyperthyroidism, \\nHypocalcemia, \\nHypercalcemia, \\nDiabetes\\nmellitus, Diabetes ketoacidosis\\n112'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 12, 'source_type': 'Authorotative', 'priority': '1'}, page_content='xiii\\nTopic\\nPage\\nNo.\\n8. Gastrointestinal Diseases\\nAphthous ulcers, Dyspepsia, Peptic ulcer disease, Vomiting, Irritable bowel\\nsyndrome, Acute gastroenteritis, Ulcerative colitis, Gastroesophageal reflux\\ndisorder, Upper gastrointestinal bleeding, Acute pancreatitis, Chronic pancreatitis,\\nConstipation, Amoebic liver abscess, Pyogenic liver abscess\\n125\\n9. Infections\\nTetanus, Leptospirosis, Cholera, Influenza infection, HIV and AIDS, Opportunistic\\ninfections, Amoebiasis, Giardiasis, Hookworm  infestation, Roundworm  infestation,\\nEnterobiasis, Filariasis\\n138\\n10. ENT Diseases\\nEar wax, Keratosis obturans, Furuncle, Otomycosis, Malignant otitis externa, Acute\\nsuppurative otitis media, Chronic suppurative otitis media, Serous otitis media, Acute\\nsinusitis, Epistaxis, Allergic rhinitis, Common cold, Furunculosis of nose, Acute\\ntonsillitis, Chronic tonsillitis, Acute parotitis, Bacterial parotitis\\n156\\n11. Eye Diseases'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 12, 'source_type': 'Authorotative', 'priority': '1'}, page_content='sinusitis, Epistaxis, Allergic rhinitis, Common cold, Furunculosis of nose, Acute\\ntonsillitis, Chronic tonsillitis, Acute parotitis, Bacterial parotitis\\n156\\n11. Eye Diseases\\nStye, Chalazion, Viral conjunctivitis, Allergic conjunctivitis, Atopic conjunctivitis,\\nNon gonococcal conjunctivitis, Gonococcal conjunctivitis, Trachoma, Corneal Ulcer,\\nBacterial keratitis, Fungal keratitis, Viral keratitis, Glaucoma, Primary open angle\\nglaucoma,  Primary angle closure glaucoma, Lens induced glaucoma,  Anterior\\nUveitis, Orbital cellulitis, Endophthalmitis, Optic neuritis, Diabetic retinopathy,\\nRetinal detachment, Vitamin A deficiency, Senile cataract, Refractive errors,\\nStrabismus, Computer vision syndrome\\n169\\n12. Skin Diseases\\nBacterial skin infections, Leprosy, Cutaneous tuberculosis, Scabies, Pediculosis,\\nMyiasis, \\nPityrosporum \\ninfections, \\nPityriasis, \\nTinea \\ncorporis,\\nCapitis,\\nOnychomycosis, Candidiasis, Diaper dermatitis, Herpes labialis, Chickenpox, Herpes'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 12, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Myiasis, \\nPityrosporum \\ninfections, \\nPityriasis, \\nTinea \\ncorporis,\\nCapitis,\\nOnychomycosis, Candidiasis, Diaper dermatitis, Herpes labialis, Chickenpox, Herpes\\nzoster, Molluscum contagiosum, Wart, Acne vulgaris, Miliaria,  Eczema, Contact\\ndermatitis, Pityriasis alba, Vitiligo, Albinism, Melasma, Urticaria, Psoriasis, Lichen\\nplanus, Alopecia areata, Pemphigus vulgaris, Cutaneous  reactions to drugs, Herpes\\ngenitalis, Syphilis, Chancroid, Lymphogranuloma venerum, Urethral discharge,\\nDermatological emergencies\\n196'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='xiv\\nTopic\\nPage\\nNo.\\n13. Obstetrics and Gynecology\\nNormal Pregnancy, Nausea and vomiting in pregnancy, First trimester bleeding,\\nAnaemia in pregnancy, Pregnancy induced hypertension, Pregnancy with diabetes,\\nPregnancy with heart disease, Antepartum haemorrhage, Premature rupture of\\nmembranes, Preterm labour, Normal labour, Fetal distress in labour, Meconium\\nstained liquor, Induction and augmentation of  labour, Postpartum haemorrhage,\\nPrevention of maternal to child transmission, Vaginal discharge, Pelvic inflammatory\\ndisease, Pre-Menstrual syndrome, Dysfunctional uterine bleeding , Menopause,\\nPostmenopausal bleeding, Screening guidelines for early detection of cancer,\\nContraception\\n229\\n14. Psychiatry Disorders\\nSchizophrenia and other psychotic disorders, Major depressive disorders, Bipolar\\nmood disorder, Insomnia, Generalized anxiety disorders, Panic disorder,  Obsessive\\ncompulsive disorder, Phobic disorder, Post-traumatic stress disorder, Conversion'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mood disorder, Insomnia, Generalized anxiety disorders, Panic disorder,  Obsessive\\ncompulsive disorder, Phobic disorder, Post-traumatic stress disorder, Conversion\\ndisorder, Dissociative disorder, Alcohol use disorder, Opioid use disorder, Cannabis\\nuse disorder,  Autistic disorder, Attention deficit hyperactivity disorder, Mental\\nretardation, Suicidal patient, Psychotropic drugs in special population, Management\\nof wandering mentally ill patient, Personality disorder.\\n284\\n15. Orthopedic Conditions\\nOsteoarthritis, Rheumatoid arthritis, Cervical and lumbar spondylosis, Sprains, Acute\\npyogenic osteomyelitis, Acute septic arthritis.\\n308\\n16. Surgery\\nPre-operative assessment and preparations, Post-operative care, Surgical site\\ninfection, Wound care, Sterilization and disinfection, Suturing of primary wound,\\nAcute appendicitis, Hernia, Hydrocele, Cholelithiasis, Hydatid disease of liver,\\nObstructive jaundice, Intestinal obstruction, Typhoid perforation, Small bowel'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 13, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Acute appendicitis, Hernia, Hydrocele, Cholelithiasis, Hydatid disease of liver,\\nObstructive jaundice, Intestinal obstruction, Typhoid perforation, Small bowel\\ntuberculosis, Anal fissure, Fistula in ano, Hemorrhoids, Diabetic foot, Varicose veins,\\nDeep vein thrombosis, Cervical lymphadenopathy, Thyroid nodule, Benign breast\\ndiseases, Breast abscess, Carcinoma breast, Renal stones, Urinary retention\\n317'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 14, 'source_type': 'Authorotative', 'priority': '1'}, page_content='xv\\nTopic\\nPage\\nNo.\\n17. Respiratory Diseases\\nCommunity acquired pneumonia, Hospital acquired pneumonia, Bronchial asthma,\\nChronic obstructive pulmonary diseases, Bronchiectasis\\n348\\n18. Pediatrics\\nNewborn care, Low birth weight baby, Neonatal jaundice, Management of common\\nclinical problems in new born, Immunization schedule, Fluid and electrolyte therapy\\nin children, Iron deficiency anemia, Megaloblastic anemia, Protein energy\\nmalnutrition, Nutritional rickets, Pica, Primary nocturnal enuresis, Wheezy child,\\nAcute bronchiolitis, Pneumonia, Thrush (oral candidiasis), Constipation, Acute\\ndiarrhea, Acute viral hepatitis, Chicken pox(varicella), Measles, Mumps,  Acute\\nflaccid paralysis, Pertusis,  Cardiac failure, Diabetes mellitus, Hypothyroidism,\\nUrinary tract infection, Post streptococcal acute glomerulonephritis, Nephrotic\\nsyndrome, Febrile seizure, Acute pyogenic meningitis, Tubercular meningitis, Status\\nepilepticus,\\nHypovolemic shock,\\nDiphtheria,\\nSevere malaria,\\nHypertensive'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 14, 'source_type': 'Authorotative', 'priority': '1'}, page_content='syndrome, Febrile seizure, Acute pyogenic meningitis, Tubercular meningitis, Status\\nepilepticus,\\nHypovolemic shock,\\nDiphtheria,\\nSevere malaria,\\nHypertensive\\nencephalopathy, Acute severe asthma\\n365\\n19. Dental Conditions\\nTooth avulsion, Toothache, Tooth/maxillary fracture, Dental caries, Dental abscess,\\nAdult type periodontitis, Juvenile periodontitis, Inflammatory gingival enlargement,\\nDental fluorosis, Trigeminal neuralgia, Oral submucous fibrosis, Cyst of tumor of\\njaw, Oral hygiene, Antibiotic prophylaxis in dental procedure\\n416'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1\\nChapter 1\\nINTRODUCTION TO RATIONAL USE OF MEDICINES\\nRational Use of Medicines requires that patients receive medications appropriate to their\\nclinical needs, in doses that meet their own individual requirements, for an adequate period of\\ntime, and at affordable cost to them and the community (WHO, 1985). In other words,\\nrational use means ‘prescribing right medicines, in adequate dose for the sufficient duration\\nand appropriate to the clinical needs of the patient at lowest cost’. Medicine use is a complex\\ncyclical process and in the clinical context, rational drug use implies correct drug, appropriate\\nindication and selection with respect to efficacy, safety, suitability for the patient and cost.\\nThe concept of Rational Use of Medicines is age old; however, it has attained more\\nsignificance and momentum in terms of medical and socioeconomic aspects recently. Three\\ntools have been identified to implement Rational Use of Medicines effectively. These include'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='significance and momentum in terms of medical and socioeconomic aspects recently. Three\\ntools have been identified to implement Rational Use of Medicines effectively. These include\\nEssential Medicines List, Standard Treatment Guidelines and Drug Formulary. To be\\nmeaningful, all three tools should work in concert and subject for periodic review and update.\\nI.\\nThe concept of Essential Medicines\\nEssential Medicines (EM) are those that satisfy the health care needs of the majority of\\nthe population and therefore should be available at all times in appropriate amounts and in\\nappropriate dosage forms. Following the concept of EM, WHO published the first\\nEssential Medicine List (EML) in 1977, which has been updated successively every 5\\nyear in view of changing world scenario about the medical needs and availability of new\\nand better drugs. The selection of these medicines is based on public health relevance,\\nevidence of efficacy and safety and comparative cost-effectiveness. These priority'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and better drugs. The selection of these medicines is based on public health relevance,\\nevidence of efficacy and safety and comparative cost-effectiveness. These priority\\nmedicines should be available at each functioning health care facility with assured quality\\nand adequate information at a price the individual and the community can afford.\\nThe selection of essential medicines depends upon level of health care facility, adequate\\ndata on the efficacy, safety, suitability and comparative cost effectiveness of available\\ntreatments. In addition, stability of the product, need for special diagnostic or treatment\\nfacilities and pharmacokinetic properties are also considered. Most essential medicines\\nare formulated as single compound. However, fixed dose combinations are selected only\\nwhen it has proven pharmacokinetic and/or pharmacodynamic advantages over single\\ncompound administered separately. While comparing the cost of medicines among the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 16, 'source_type': 'Authorotative', 'priority': '1'}, page_content='when it has proven pharmacokinetic and/or pharmacodynamic advantages over single\\ncompound administered separately. While comparing the cost of medicines among the\\nalternative treatments, the cost of total treatment and not the unit cost is considered. Other\\nfactors taken into account include pattern of diseases, treatment facilities, training and\\nexperience of the available personnel, financial resources etc.\\nAdvantages of Essential Medicines\\nThe implementation of the concept of EM has several logistic and prescribing advantages.\\nFor example better management of medicines i.e. easier procurement, storage,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 17, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n2\\ndistribution, more manageable stock, better quality assurance, easier dispensing, less\\nfragmentation of budget  with improve drug availability. Moreover, prescribing improves\\ndue to focused training and drug information, better recognition of adverse drug reactions,\\ndrug interactions and focused education efforts. The list of EM closely relates to\\ntreatment guidelines for clinical diseases and is also used for the procurement and supply\\nof medicines in public sector, schemes for reimburses medicines costs and local medicine\\nproduction.\\nIts implementation is intended to be flexible and adaptable to different situations; which\\nmedicines are regarded as essential remains a national responsibility.\\nII. Standard Treatment Guidelines\\nStandard Treatment Guidelines (STGs), treatment protocols, and prescribing policies are\\ndefined as systematically developed statements designed to assist prescribers in making'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 17, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Standard Treatment Guidelines (STGs), treatment protocols, and prescribing policies are\\ndefined as systematically developed statements designed to assist prescribers in making\\ndecisions about the appropriate treatment and health care for specific clinical problem.\\nThese guidelines usually reflect the consensus on the optimal treatment options within a\\nhealth facility or system. In fact, they represent one of the approaches to promote\\ntherapeutically effective and economically efficient use of medicines.\\nSTGs list the preferred pharmacological and non-pharmacological treatment for common\\nhealth problems experienced by people in a specific health system. The pharmacological\\ntreatment should include the name, dosage form, strength, average dose (pediatric and\\nadult), number of doses per day, and duration of treatment. Other information on\\ndiagnosis and advice to the patient may also be included. The most common diseases and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 17, 'source_type': 'Authorotative', 'priority': '1'}, page_content='adult), number of doses per day, and duration of treatment. Other information on\\ndiagnosis and advice to the patient may also be included. The most common diseases and\\nserious medical conditions that have high morbidity and mortality rate are selected.\\nTreatment guidelines must have the most up-to-date and evidence based information to\\ndetermine appropriate treatment options by expert authors and reviewers. Effective\\nimplementation, however, is perhaps the greatest challenge in introducing STGs. When\\nimplemented effectively, it offers several advantages to patients, health care providers,\\nsupply management personnel and policy makers as follows:\\nPatients,\\n\\uf0b7\\nMost cost-effective optimal therapy is provided.\\n\\uf0b7\\nBetter compliance through consistency among prescribers.\\n\\uf0b7\\nImprovement in availability of drugs.\\n\\uf0b7\\nOverall better quality of care.\\nHealth care providers,\\n\\uf0b7\\nProvides standardized guidance to practitioners\\n\\uf0b7\\nQuality of care standard- based on expert consensus and basis for monitoring'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 17, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nOverall better quality of care.\\nHealth care providers,\\n\\uf0b7\\nProvides standardized guidance to practitioners\\n\\uf0b7\\nQuality of care standard- based on expert consensus and basis for monitoring\\n\\uf0b7\\nUtilizes only formulary or essential medicines, so the health care system needs to\\nprovide only the medicines in the STGs.\\nSupply managers,\\n\\uf0b7\\nIdentification of medicines to be available for the most commonly treated problems.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 18, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n3\\n\\uf0b7\\nFacilitation of prepackaging of course-of-therapy quantities of commonly prescribed\\nitems.\\n\\uf0b7\\nMedicine demand more predictable, so forecasting more reliable\\nHealth care policy makers,\\n\\uf0b7\\nProvides focus therapeutic integration of special programs (diarrhea disease control,\\nacute respiratory infection)\\n\\uf0b7\\nProvides a system for controlling cost by using funds more efficiently\\nSTGs also have certain drawbacks. Establishing, developing and implementation of STGs\\nis a difficult, lengthy and time consuming process. Moreover, it needs to be updated\\nregularly to reflect changes in treatment strategies. If a regular schedule for updating the\\nSTGs is not followed, they lose credibility and become obsolete. The extent of\\ninformation to be provided in each medical condition is often a difficult decision.\\nHowever, the STG manual should be concise and small enough to carry it easily.\\nKey features of a successful STG manual'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 18, 'source_type': 'Authorotative', 'priority': '1'}, page_content='However, the STG manual should be concise and small enough to carry it easily.\\nKey features of a successful STG manual\\nSimplicity- The number of health problem is limited to commonly observed conditions.\\nEach clinical condition list a few salient features with clear and concise information on\\npharmacological and non- pharmacological treatment.\\nCredibility- Guidelines developed by the most respected experienced clinicians in the\\ncountry and revision is based on actual experience.\\nTreatment standards for all levels of health care facility- Health care providers use the\\nsame standard treatment; however, the referral criterion differs. While the first choice\\ntreatment for a patient depends upon the patient’s diagnosis and condition and not on the\\nprescriber.\\nMedicine supply based on standards- The supply of medicines must match with the\\nstandard treatment and list of essential medicines.\\nRegular updating- Any change in the therapeutic options, bacterial resistance pattern'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 18, 'source_type': 'Authorotative', 'priority': '1'}, page_content='standard treatment and list of essential medicines.\\nRegular updating- Any change in the therapeutic options, bacterial resistance pattern\\nshould be incorporated in the revised version to reflect current recommendations.\\nUser friendly- The STGs should be published as small, durable pocket manual which\\nmake it convenient to carry and use.\\nIII.Drug Formulary\\nA formulary is a compendium of practical drug information for clinical practice adapted\\nfor use at a particular health care facility. It is a ready reference to key information on the\\nselection, prescribing, dispensing and administration of medicines. Although the concept\\nof formulary is old, a drug formulary is considered an essential element in achieving\\nrational prescribing in addition to controlling the costs. The task of development of a\\nformulary in a hospital is usually undertaken by Drugs and Therapeutics Committee with\\na multidisciplinary membership of doctors, pharmacists, nurses and administrative staff.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 19, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n4\\nThe consultants place a request for inclusion of medicines along with its dosage\\nformulations to Drugs and Therapeutics Committee. The committee may accept the\\nrequest and include it in formulary or reject and suggest an alternative with information to\\nthe prescriber. The committee then monitors the impact, cost and benefits of various\\nmedicines in the health care facility. Depending on the outcome, the use of medicine is\\nextended or curtailed. Formularies have significant advantages for patients care.\\nHowever, the introduction of formularies may cause friction since it may be viewed as a\\nmajor threat to their clinical freedom. Effective multidisciplinary working methods and\\nconsultation is needed to overcome this attitude. Potential advantages and disadvantages\\nof drug formularies are as follows:\\nAdvantages\\n\\uf0b7\\nReduces range of products to be purchased / stored / distributed\\n\\uf0b7\\nEncourages generic prescribing\\n\\uf0b7\\nLowers drug costs\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 19, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of drug formularies are as follows:\\nAdvantages\\n\\uf0b7\\nReduces range of products to be purchased / stored / distributed\\n\\uf0b7\\nEncourages generic prescribing\\n\\uf0b7\\nLowers drug costs\\n\\uf0b7\\nImproved knowledge of a limited number of medicines\\n\\uf0b7\\nImproves drug safety\\n\\uf0b7\\nImproves patient care\\n\\uf0b7\\nProvides opportunity for  multidisciplinary work\\nDisadvantages\\n\\uf0b7\\nRestricts prescribing choice\\n\\uf0b7\\nReduces treatment options\\n\\uf0b7\\nInhibits introduction of new products\\n\\uf0b7\\nRestricts research efforts\\nIV.Rational Approach To Therapeutics\\nMedicines should only be prescribed when necessary, and the benefit of administering the\\nmedicine should be considered in relation to the risks involved. Bad prescribing habits\\nlead to ineffective and unsafe treatment, exacerbation or prolongation of illness, distress\\nand harm to the patient, and higher cost. The Guide to Good Prescribing; WHO; 1994,\\nprovides medical undergraduates with important tools for training in the process of\\nrational prescribing.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 19, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and harm to the patient, and higher cost. The Guide to Good Prescribing; WHO; 1994,\\nprovides medical undergraduates with important tools for training in the process of\\nrational prescribing.\\nThe following steps will help to remind prescribers of the rational approach to\\ntherapeutics.\\n1. Define the patient’s problem\\nWhenever possible, making the right diagnosis is based on integrating many pieces of\\ninformation: the complaint as described by the patient; a detailed history; physical\\nexamination; laboratory tests; X-rays and other investigations. This will help in rational\\nprescribing, always bearing in mind that disease are evolutionary process.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n5\\n2. Specify the therapeutic objective\\nDoctors must clearly state their therapeutic objectives based on the pathophysiology\\nunderlying the clinical situation. Very often physicians must select more than one\\ntherapeutic goal for each patient.\\n3. Selecting therapeutic strategies\\nThe selected strategy should be discussed with the patient. The selected treatment can be\\nnon-pharmacological and/or pharmacological; it also needs to take into account the total\\ncost of all therapeutic options.\\na. Non-pharmacological treatment\\nThe patient does not always need a medicine for treatment of the condition. Very often,\\nhealth problems can be resolved by a change in life style, dietary habits, use of\\nphysiotherapy or exercise, provision of adequate psychological support and other non-\\npharmacological treatments; they have the same importance as a prescription drug and\\ninstructions must be written, explained and monitored in the same way.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='pharmacological treatments; they have the same importance as a prescription drug and\\ninstructions must be written, explained and monitored in the same way.\\nb. Pharmacological treatment\\nSelecting the correct group of drugs\\nKnowledge about the pathophysiology involved in the clinical situation of each patient\\nand the pharmacodynamics of the chosen group of drugs, are two of the fundamental\\nprinciples for rational therapeutics.\\nSelecting the drug from the chosen group\\nThe selection process must consider benefit/risk/cost information. This step is based on\\nevidence about maximal clinical benefits of the drug for a given indication (efficacy) with\\nminimum production of adverse effects (safety).\\nIt must be remembered that each drug has adverse effects and it is estimated that up to\\n10% of hospital admissions in industrialized countries are due to adverse effects. Not all\\ndrug-induced injury can be prevented but much of it is caused by inappropriate selection\\nof drugs.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='10% of hospital admissions in industrialized countries are due to adverse effects. Not all\\ndrug-induced injury can be prevented but much of it is caused by inappropriate selection\\nof drugs.\\nIn cost comparisons between drugs, the cost of total treatment and not only the unit cost\\nof the drug must be considered.\\nVerifying the suitability of the chosen pharmaceutical treatment of each patient\\nThe prescriber must check suitability of the chosen active substance, its dosage form,\\ndosage schedule and duration of treatment are suitable for each patient. Drug treatment\\nshould be individualized to the needs of each patient.\\nPrescription writing\\nThe prescription is the link between the prescriber, the pharmacist (or dispenser) and the\\npatient so it is important for successful management of presenting medical condition. The\\nitem is covered in more detail in the following section.\\nGiving information, instructions and warnings'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 20, 'source_type': 'Authorotative', 'priority': '1'}, page_content='patient so it is important for successful management of presenting medical condition. The\\nitem is covered in more detail in the following section.\\nGiving information, instructions and warnings\\nThis step is important to ensure patient adherence and is covered in detail in the following\\nsection.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n6\\nMonitoring treatment\\nEvaluation of the follow up and the outcome of treatment provides information whether\\nthe patient’s problem is solved or to reformulate, if necessary. This step gives rise to\\nimportant information about the effects and adverse effects of medicines, contributing to\\nthe evidence of knowledge, necessary to promote the rational use of drugs.\\nV. Adverse Drug Effects and Drug Interactions\\nAdverse drug reactions\\nAn adverse drug reaction (ADR) may be defined as ‘A response to a drug which is\\nnoxious, unintended and occurs at doses normally used for prophylaxis, diagnosis or\\ntherapy of disease, or for the modification of physiological function’. ADRs are therefore\\nunwanted or unintended effects of a medicine, including idiosyncratic effects, which\\noccur during its proper use.\\nAn adverse drug event (ADE) is defined as ‘Any untoward medical occurrence that may'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='unwanted or unintended effects of a medicine, including idiosyncratic effects, which\\noccur during its proper use.\\nAn adverse drug event (ADE) is defined as ‘Any untoward medical occurrence that may\\npresent during treatment with a medicine but which does not necessarily have a causal\\nrelationship with this treatment’.\\nTwo types of ADRs and their differentiating characteristics have been identified. The\\ncommon, predictable, dose related reaction with low mortality is type ‘A’ ADR. For\\nexample, anticholinergic effect of tricyclic antidepressants and digoxin toxicity. ADRs\\nmay also be unrelated to the known pharmacological action of a drug. These are\\nuncommon, non-dose related bizarre ‘B’ type reactions, for example, anaphylaxis with\\npenicillins, malignant hyperthermia with halothane.\\nThalidomide marked the first recognized public health disaster related to the\\nintroduction of a new drug. It is now recognized that clinical trials, however through,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Thalidomide marked the first recognized public health disaster related to the\\nintroduction of a new drug. It is now recognized that clinical trials, however through,\\ncannot be guaranteed to detect all adverse effects likely to be caused by a drug. Health\\nworkers are thus encouraged to record and report to their national pharmacovigilance\\ncentre any unexpected adverse effects with any drug to achieve faster recognition of\\nserious related problems. The Central Drugs Standard Control Organization (CDSCO),\\nDirector General of Health Services under the influence of Ministry of Health & Family\\nWelfare, has initiated a nationwide Pharmacovigilance programme for protecting the\\nhealth of the patients by assuring drug safety.\\nThe specific aims and objectives of the National Pharmacovigilance Programme are:\\n\\uf0b7\\nTo monitor ADRs in Indian population.\\n\\uf0b7\\nTo create awareness amongst health care professionals about the importance of  ADR\\nreporting in India\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 21, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTo monitor ADRs in Indian population.\\n\\uf0b7\\nTo create awareness amongst health care professionals about the importance of  ADR\\nreporting in India\\n\\uf0b7\\nTo ensure that the benefits of use of medicine outweighs the risks and thus safeguard\\nthe health of the Indian population\\n\\uf0b7\\nTo generate independent, evidence based recommendations on the safety of medicines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 22, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n7\\n\\uf0b7\\nTo encourage safe, rational and cost effective use of medicines.\\nUnder the National Coordinating Center, several ADR monitoring centers operates to\\ndetect ADEs. These ADR monitoring centers are located at MCI approved medical\\ncolleges and hospitals, private hospitals, public health programmes, and autonomous\\ninstitutions such as Indian Council of Medical Research etc. The ADR monitoring centers\\nrecord and analyze the ADEs and submit them to the National Coordinating center via\\nonline reporting system known as Vigiflow.\\nSpontaneous reporting\\nSpontaneous reporting is the reporting of ADRs by healthcare professionals (and in some\\ncountries consumers) to identify and report any suspected adverse drug reaction to a\\npharmacovigilance center and/or to the manufacturer. It is one of the important methods\\nof collecting information about ADRs.\\nAll suspected adverse reactions, known or unknown, serious or otherwise should be'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 22, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of collecting information about ADRs.\\nAll suspected adverse reactions, known or unknown, serious or otherwise should be\\nreported. It is important to report even minor reactions of new drugs. For established\\ndrugs, the reporting of serious ADRs is important. An increased frequency of a known\\nADR to a drug is also important.\\nAdverse drug reactions may be reported or notified to the nearest ADR monitoring centre\\nunder the National Pharmacovigilance Program. The Department of Pharmacology, B. J.\\nMedical College is one of the approved ADR monitoring center in Gujarat state. The\\nADRs can be reported by the forms available at the department. Reporting is the process\\nof providing ADR information by filling in the ADR form appropriately giving details of\\nthe clinical case as well as the ADR ( Appendix – I).\\nMajor factors predisposing to adverse drug effects\\nIt is well known that different patients often respond differently to a given treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 22, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the clinical case as well as the ADR ( Appendix – I).\\nMajor factors predisposing to adverse drug effects\\nIt is well known that different patients often respond differently to a given treatment\\nregimen. For example, patients taking combinations of drugs known to interact, only a\\nsmall number show any clinical evidence of interactions. In addition to the\\npharmaceutical properties of drug therefore, there are characteristics of the patient which\\npredispose to ADRs.\\nExtremes of age: The very old and the very young are more susceptible to ADRs. Drugs\\nwhich commonly cause problems in the elderly include hypnotics, diuretics, non-steroidal\\nanti-inflammatory drugs, antihypertensives, psychotropics and digoxin.\\nAll children and particularly neonates, differ from adults in their response to drugs. Some\\ndrugs are likely to cause problems in neonates (for example morphine), but are generally\\ntolerated in children. Other drugs (for example valproic acid) are associated with'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 22, 'source_type': 'Authorotative', 'priority': '1'}, page_content='drugs are likely to cause problems in neonates (for example morphine), but are generally\\ntolerated in children. Other drugs (for example valproic acid) are associated with\\nincreased risk of ADRs in children of all ages. Other drugs associated with problems in\\nchildren include chloramphenicol (Grey baby syndrome), antiarrhythmics (worsening of\\narrhythmias), acetylsalicylic acid (Reye syndrome).\\nIntercurrent illness: If besides the condition being treated, the patient suffers from\\nanother disease, such as kidney, liver or heart disease, special precautions may be'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 23, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n8\\nnecessary to prevent ADRs. The genetic make-up of the individual patient may also\\npredispose to ADRs.\\nDrug interactions: May occur between drugs which compete for the same receptor or act\\non the same physiological system. They may also occur indirectly when a drug-induced\\ndisease or a change in fluid or electrolyte balance alters the response to another drug.\\nIncompatibilities between drugs and intravenous fluids\\nDrugs should not be added to blood, amino acid solutions or fat emulsions. Certain drugs,\\nwhen added to intravenous fluids, may be inactivated by pH changes, by precipitation or\\nchemical reaction. Benzylpenicillin and ampicillin lose potency after 6-8 hours if added\\nto dextrose solutions, due to the acidity of the solutions. Some drugs bind to plastic\\ncontainers and tubing, for example diazepam and insulin. Aminoglycosides are\\nincompatible with penicillins and heparin. Hydrocortisone is incompatible with heparin,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 23, 'source_type': 'Authorotative', 'priority': '1'}, page_content='containers and tubing, for example diazepam and insulin. Aminoglycosides are\\nincompatible with penicillins and heparin. Hydrocortisone is incompatible with heparin,\\ntetracycline and chloramphenicol.\\nAdverse effects caused by traditional medicines\\nPatients who have been or are taking traditional herbal remedies may develop ADRs. It is\\nnot always easy to identify the responsible plant or plant constituent. Refer to the drug\\nand toxicology information service if available or to suitable literature.\\nThe effect of food on drug absorption\\nFood delays gastric emptying and reduces the rate of absorption of many drugs; the total\\namount of drug absorbed may or may not be reduced. However, some drugs are\\npreferably taken with food, either to increase absorption or to decrease the irritant effect\\non the stomach.\\nVI.Prescription writing\\nA prescription is an instruction from a prescriber to a dispenser. Every country has its'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 23, 'source_type': 'Authorotative', 'priority': '1'}, page_content='on the stomach.\\nVI.Prescription writing\\nA prescription is an instruction from a prescriber to a dispenser. Every country has its\\nown standards for the minimum information required for a prescription, and its own laws\\nand regulations to define which drugs require a prescription and who is entitled to write it.\\nMany countries have separate regulations for prescriptions for controlled drugs such as\\nopioid analgesics. The following guidelines will help to ensure that prescriptions are\\ncorrectly interpreted and leave no doubt the intension of the prescriber. The guidelines are\\nrelevant for primary care prescribing; they may, however, be adapted for use in hospitals\\nor other specialist units.\\nPrescription form\\nThe most important requirement is that the prescription be clear and legible and indicate\\nprecisely what should be given. The local language may be preferred.\\nThe following details should be shown on the form:\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 23, 'source_type': 'Authorotative', 'priority': '1'}, page_content='precisely what should be given. The local language may be preferred.\\nThe following details should be shown on the form:\\n\\uf0b7\\nThe prescriber’s name, address and telephone number. This will allow either the\\npatient or the dispenser to contact the prescriber for any clarification or potential\\nproblem with the prescription.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n9\\n\\uf0b7\\nDate of the prescription. In many countries the validity of a prescription has no time\\nlimit, but in some countries pharmacists do not dispense drugs on prescriptions older\\nthan 3 to 6 months.\\n\\uf0b7\\nName, form and strength of the drug. The International Non-proprietary Name of the\\ndrug should always be used. If there is a specific reason to prescribe a special brand,\\nthe trade name can be added. Generic substitution is allowed in some countries. The\\npharmaceutical form (for example ‘tablet’, ‘oral solution’, ‘eye ointment’) should also\\nbe stated.\\n\\uf0b7\\nThe strength of the drug should be stated in standard units using abbreviations that are\\nconsistent with the System International (SI). ‘Microgram’ and ‘nanogram’ should\\nnot, however, be abbreviated. Also, ‘units’ should not be abbreviated. Avoid decimals\\nwhenever possible. If unavoidable, a zero should be written in front of the decimal\\npoint.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='not, however, be abbreviated. Also, ‘units’ should not be abbreviated. Avoid decimals\\nwhenever possible. If unavoidable, a zero should be written in front of the decimal\\npoint.\\n\\uf0b7\\nSpecific areas for filling in details about the patient including name, address and age.\\nDirections\\nDirections specifying the route, dose and frequency should be clear and explicit; use of\\nphrases such as ‘take as directed’ or ‘take as before’ should be avoided.\\nFor preparations which are to be taken on an ‘as required’ basis, the minimum dose\\ninterval should be stated together with, where relevant, the maximum daily dose. It is\\ngood practice to qualify such prescriptions with the purpose of the medication (for\\nexample ‘every 6 hours as required for pain’, ‘at night as required to sleep’).\\nIt is good practice to explain the directions to the patient; these directions will then be\\nreinforced by the label on the medicinal product and possibly by appropriate counseling'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='It is good practice to explain the directions to the patient; these directions will then be\\nreinforced by the label on the medicinal product and possibly by appropriate counseling\\nby the dispenser. It may be worthwhile giving a written note for complicated regimens\\nalthough it must be borne in mind that the patient may lose the separate note.\\nQuantity to be dispensed\\nThe quantity of the medicinal product to be supplied should be stated such that it is not\\nconfused with either the strength of the product or the dosage directions.\\nAlternatively, the length of the treatment course may be stated (for example ‘for 5 days’).\\nWherever possible, the quantity should be adjusted to match the pack sizes available.\\nFor liquid preparations the quantity should be stated in milliliters (abbreviated as ‘ml’) or\\nlitres (preferably not abbreviated since the letter ‘l’ could be confused with the figure ‘1’).\\nNarcotics and controlled substances'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 24, 'source_type': 'Authorotative', 'priority': '1'}, page_content='litres (preferably not abbreviated since the letter ‘l’ could be confused with the figure ‘1’).\\nNarcotics and controlled substances\\nThe prescribing of a medicinal product that is liable to abuse requires special attention\\nand may be subject to specific statutory requirements. Practitioners may need to be\\nauthorized to prescribe controlled substances; in such cases it might be necessary to\\nindicate details of authority on the prescription.\\nIn particular, the strength, directions and the quantity of the controlled substance to be\\ndispensed should be stated clearly, with all quantities written in words as well as in'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 25, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Introduction to Rational Use of Medicines\\n10\\nfigures to prevent alteration. Other details such as patient particulars and date should also\\nbe filled in carefully to avoid alteration.\\nReferences\\n1.\\nThe Guide to Good Prescribing; Geneva: WHO; 1994\\n2.\\nWH0 Model Formulary 2008.\\n3.\\nwww.cdsco.nic.in/pharmacovigilance.htm'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 26, 'source_type': 'Authorotative', 'priority': '1'}, page_content='11\\nChapter 2\\nCOMMON CONDITIONS\\nFEVER\\nA body temperature greater than 37.7°C is defined as fever. Fever may be continuous,\\nintermittent or remittent.\\nInvestigations\\nA meticulous history of chronology of symptoms, any associated focal symptom(s), exposure to\\ninfectious agents and occupational history may be useful. A thorough physical examination\\nrepeated on a regular basis may provide potentially diagnostic clues.\\n\\uf0b7\\nIf there are no clinical clues, the tests include a complete haemogram with ESR, smear for\\nmalaria parasite, blood culture, Widal test and urine analysis including urine culture.\\n\\uf0b7\\nIf the febrile illness is prolonged to more than 2 weeks, an X-ray chest is indicated even in\\nthe absence of respiratory symptoms. Any abnormal fluid collection should be sampled.\\nTreatment\\nRoutine use of antipyretics in low-grade fever is not justified. This may mask important clinical\\nindications. However, in acute febrile illnesses suggestive of viral or bacterial cause, fever'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 26, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Routine use of antipyretics in low-grade fever is not justified. This may mask important clinical\\nindications. However, in acute febrile illnesses suggestive of viral or bacterial cause, fever\\nshould be treated.\\nNon pharmacological treatment\\nHydrotherapy and rest\\nPharmacological treatment\\nNon-specific\\n\\uf0b7\\nTab. paracetamol 500-1000 mg 6-8 hourly. Or Tab. ibuprofen 400-600 mg 8 hourly.\\nSpecific\\n\\uf0b7\\nAntibiotics/antimalarials depending upon the cause suggested by clinical and laboratory\\nevaluation.\\nOutcome\\nIn most cases of fever, patient may either recover spontaneously or a diagnosis is reached after\\nrepeated clinical evaluation and investigations. If no diagnosis is reached in up to 3 weeks,\\npatient is said to be having fever of unknown origin (FUO) and should be managed accordingly.\\nPatient education\\n\\uf0b7\\nSelf medication should be avoided.\\n\\uf0b7\\nAntibiotics should be taken only on advice of a physician.\\n\\uf0b7\\nAvoid covering the patient having high fever with blanket etc.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 26, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patient education\\n\\uf0b7\\nSelf medication should be avoided.\\n\\uf0b7\\nAntibiotics should be taken only on advice of a physician.\\n\\uf0b7\\nAvoid covering the patient having high fever with blanket etc.\\n\\uf0b7\\nPlenty of fluids should be taken. Stay in cool environment. Cold sponging of face and limbs\\nshould be done repeatedly.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 27, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Common Conditions\\n12\\n\\uf0b7\\nCommon causes include\\n-\\nInfections, particularly extrapulmonary tuberculosis, typical and atypical mycobacterial\\ninfections, Pneumocystis carinii pneumonia, toxoplasmosis, lymphoma etc. In neutropenic\\npatients, gram negative bacterial, staphylococcal and fungal infections are important causes.\\n-\\nNeoplastic conditions\\n-\\nNoninfectious inflammatory causes collagen vascular diseases, drug fevers\\n\\uf0b7\\nProlonged unexplained fever, often with no localizing clue on history, physical examination\\nand basic laboratory investigations.\\nReferences\\n1.\\nAlterations in Body Temperature. In: Harrison's Principles of Internal Medicine. Kasper DL, Braunwald E,\\nFauci AS et al (eds), 16th Edition, 2005, McGraw Hill Company Inc., New York, pp 104-25.\\n2.\\nPhysiological Changes in Infected Patients. In: Oxford Textbook of Medicine. Warrell DA, Cox TM, Firth\\nJD, Benz EJ Jr (eds), 4th Edition, 2003. Oxford University Press, 1289-92.\\nFEVER OF UNKNOWN ORIGIN (FUO)\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 27, 'source_type': 'Authorotative', 'priority': '1'}, page_content='JD, Benz EJ Jr (eds), 4th Edition, 2003. Oxford University Press, 1289-92.\\nFEVER OF UNKNOWN ORIGIN (FUO)\\nFUO is defined as the presence of fever of 38.3°C or more recorded on several occasions,\\nevolving for at least 3 weeks with no diagnosis reached even after one week of relevant and\\nintelligent investigations. FUO is usually an uncommon presentation of common diseases.\\nSalient features\\nInvestigations\\n\\uf0b7\\nA detailed clinical history, repeated physical examination to provide potentially\\ndiagnostic clues (PDC).\\n\\uf0b7\\nNo single algorithmic approach to diagnosis can be recommended for all patients of FUO\\nand diagnostic approach needs to be individualized.\\n\\uf0b7\\nA complete haemogram including peripheral blood smear for malaria parasite, serum\\nbiochemistry particularly liver function tests, a tuberculin test and an X-ray of chest\\nshould be done in every patient with prolonged fever.\\n\\uf0b7\\nOther investigations which are often helpful include tests related to collagen vascular'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 27, 'source_type': 'Authorotative', 'priority': '1'}, page_content='should be done in every patient with prolonged fever.\\n\\uf0b7\\nOther investigations which are often helpful include tests related to collagen vascular\\ndiseases, an ultrasonography to localize intra-abdominal foci of infections and a contrast\\nenhanced computed tomography (CECT) of chest and abdomen in detecting mediastinal\\nlymph nodes and parenchymal lung abnormalities not seen on conventional chest X-ray.\\n\\uf0b7\\nFurther, diagnostic approach should take into consideration the PDCs from the evaluation\\nof history, results of repeated physical examination, basic investigations and any\\ninvestigations done prior to this episode. If any abnormal or doubtful lesion is detected\\nFNAC/biopsy should be obtained.\\nTreatment\\nSometimes evaluation may need discontinuation of all drugs being taken by the patient to rule\\nout drug fever as the cause of FUO.\\nSymptomatic treatment for fever (for details see section on fever)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Common Conditions\\n13\\n\\uf0b7\\nMajor criteria are pancarditis, polyarthritis, chorea, erythema marginatum and subcutaneous\\nnodule.\\n\\uf0b7\\nMinor criteria are arthralgia, fever, raised PR interval.\\n\\uf0b7\\nCold sponging may be done if fever produces discomfort. The emphasis in patients with\\nclassic FUO is on continued observation and examination.\\n\\uf0b7\\n(Caution: Avoid 'shotgun' trials. Empirical therapies consisting of therapeutic trials\\ncommonly used in patients with FUO are: antibiotics, anti-tubercular treatment (ATT)\\nand corticosteroids).\\n\\uf0b7\\nThe ability of glucocorticoids and NSAIDs to mask fever while permitting the spread of\\ninfection dictates that their use should be avoided unless infection has been largely ruled\\nout.\\n\\uf0b7\\nIf on the basis of clinical evaluation and inability to reach a definitive diagnosis, a\\ntherapeutic trial is started, the following principles must be kept in mind:\\n-\\nGive only one set of trial at a given time\\n-\\nThe doses of drugs and period of therapeutic trial must be adequate-\\n-\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content='therapeutic trial is started, the following principles must be kept in mind:\\n-\\nGive only one set of trial at a given time\\n-\\nThe doses of drugs and period of therapeutic trial must be adequate-\\n-\\nThe patient must be followed closely for response\\nPatient education\\n\\uf0b7\\nSelf medication should be avoided.\\n\\uf0b7\\nAntibiotics should be taken only on advice of a physician.\\n\\uf0b7\\nPlenty of fluids should be taken. Stay in a cool environment.\\nACUTE RHEUMATIC FEVER\\nRheumatic fever is due to an autoimmune reaction to group streptococci and involves many\\norgans, primarily the heart, the joints and the central nervous system.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nBed rest for two weeks followed by gradual ambulation\\nPharmacological treatment\\n\\uf0b7\\nTab.  penicillin V 500 mg BD  for 10 days or Inj. benzathine penicillin G- 1.2 million\\nunits in single does or Tab. erythromycin 250 mg QID for 10 days – if patient is allergic\\nto penicillin.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 28, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTab.  penicillin V 500 mg BD  for 10 days or Inj. benzathine penicillin G- 1.2 million\\nunits in single does or Tab. erythromycin 250 mg QID for 10 days – if patient is allergic\\nto penicillin.\\n\\uf0b7\\nFor secondary prophylaxis for rheumatic fever, give Inj. benzathine penicillin 1.2 million\\nunits every 3 weeks or Tab. penicillin V 250 mg BD daily or Tab. erythromycin 250 mg\\ntwice daily.\\n\\uf0b7\\nDuration of prophylaxis is given in Table 1.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 29, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n14\\nTable 1. Duration of secondary prophylaxis in acute rheumatic fever\\nCategory of Patient\\nDuration of Prophylaxis\\nRheumatic fever without carditis\\nFor 5 years after the last attack or 21 years of\\nage (whichever is longer).\\nRheumatic fever with carditis but no\\nresidual valvular disease\\nFor 10 years after the last attack, or 21 years of\\nage (whichever is longer).\\nRheumatic fever with persistent valvular\\ndisease, evident clinically or on\\nechocardiography\\nFor 10 years after the last attack, or 40 years of\\nage (whichever is longer). Sometimes lifelong\\nprophylaxis may be required.\\n\\uf0b7\\nArthritis: Tab. aspirin 2 g QID in adults and 80-100 mg/kg/day in children till symptoms\\npersist or Tab. naproxen: 10-20 mg/kg/day can also be used.\\n\\uf0b7\\nCarditis: Tab. prednisolone 1-2 mg/kg/day can be used for short periods or up to a\\nmaximum of 3 weeks.\\n\\uf0b7\\nChorea: It occurs as a long term sequelae (3-6 months). Carbamazepine or sodium'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 29, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nCarditis: Tab. prednisolone 1-2 mg/kg/day can be used for short periods or up to a\\nmaximum of 3 weeks.\\n\\uf0b7\\nChorea: It occurs as a long term sequelae (3-6 months). Carbamazepine or sodium\\nvalproate is preferred to haloperidol (0.05 mg/kg/day) to reduce the abnormal movements\\nbut response may take up to 2 weeks. Treatment should continue up to 1-2 weeks after\\nsymptoms subside.\\nANAEMIA\\nAnaemia is defined as a low haemoglobin level (less than 13.5 g/dl in males and less than\\n13.5 gm/dl in females). The common causes of anaemia in India includes,reduced production\\ndue to deficiency of iron, folic acid, rarely vitamin B12, or an ineffective erythropoiesis\\nsecondary to many causes (anaemia of chronic disease, secondary to infections and\\ninflammation, endocrinal disorders, primary bone marrow disorders like infiltration or\\nhypoplasia),  blood loss (which also leads to iron deficiency) and increased destruction of\\nRBCs (haemolysis due to many causes of which thalassaemia is the commonest).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n15\\nSalient features\\nPharmacological treatment\\nIron deficiency anaemia\\n\\uf0b7\\nTreat the underlying cause: menorrhagia in women, gastrointestinal blood loss in all age\\ngroups including hookworm infestation, dietary deficiency, rarely malabsorption.\\n\\uf0b7\\nTab. ferrous sulfate 200 mg 3 times a day.\\n\\uf0b7\\nReduce the dose as haemoglobin rises to over 10 g/dl. Once haemoglobin is normal,\\ncontinue with 1 tablet daily for at least three months.\\n\\uf0b7\\nOther preparations of iron are not superior, but they can be tried if patient does not find\\nferrous sulfate suitable. These include ferrous fumarate and ferrous gluconate. The rate of\\nrise of haemoglobin should be 1 g/dl per week.\\n\\uf0b7\\nIf this does not occur, consider ongoing blood loss, noncompliance, and associated\\nhaemoglobinopathy like thalassaemia carrier status, malabsorption, or an incorrect\\ndiagnosis.\\n\\uf0b7\\nParenteral iron does not lead to a faster rise in haemoglobin. It is indicated in the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content='haemoglobinopathy like thalassaemia carrier status, malabsorption, or an incorrect\\ndiagnosis.\\n\\uf0b7\\nParenteral iron does not lead to a faster rise in haemoglobin. It is indicated in the\\nfollowing situations: (i) malabsorption of iron, (ii) intolerance of oral iron, (iii) in late\\npregnancy to ensure that foetal stores of iron are replenished rapidly, (iv) if ongoing\\nblood loss exceeds the capacity to absorb oral iron (like in inoperable malignancy) and (v)\\nin noncompliant patient. There is danger of anaphylactoid reactions; hence facilities to\\nmanage these should be readily available.\\nFolic acid deficiency\\n\\uf0b7\\nTreat the cause: Dietary deficiency, increased requirement as in pregnancy and children,\\nhaemolytic anaemia.\\n\\uf0b7\\nTab. folic acid 5 mg daily. This dose is adequate even in malabsorption syndrome.\\nVitamin B12 deficiency\\n\\uf0b7\\nTiredness, weakness and lack of desire to work.\\n\\uf0b7\\nNails and tongue look pale. Severe anaemia produces general pallor and swelling of feet.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 30, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Vitamin B12 deficiency\\n\\uf0b7\\nTiredness, weakness and lack of desire to work.\\n\\uf0b7\\nNails and tongue look pale. Severe anaemia produces general pallor and swelling of feet.\\n\\uf0b7\\nMost aetiologies may be determined on the basis of MCV performed in an accurate cell\\ncounter as follows:\\n\\uf0b7\\nLow MCV - Iron deficiency or haemoglobfnopathy like thalassaemia.\\n\\uf0b7\\nHigh MCV - Folic acid or B12 deficiency. Less commonly alcohol intake, liver disease,\\nhaemolysis and hypothyroidism.\\n\\uf0b7\\nNormal MCV - Anaemia of chronic disease, primary bone marrow disorders, renal\\nfailure, haemolysis.\\n\\uf0b7\\nIn case of associated leucocyte and platelet abnormalities or if anaemia does not respond\\nto therapy in 4 weeks despite correcting the apparent cause, a bone marrow examination\\nby aspiration/biopsy should be performed.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 31, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n16\\n\\uf0b7\\nThe onset of fever is typically gradual, continuous (temperature upto 40º C)\\nconstitutional symptoms such as malaise, anorexia, lethargy, headache.\\n\\uf0b7\\nConstipation or diarrhea (pea-soup stools) which may be associated with abdominal\\npain and tenderness.\\n\\uf0b7\\nHepatomegaly and splenomegaly may be observed.\\n\\uf0b7\\nComplications such as hepatitis, meningitis, pneumonitis and myocarditis can occur\\nafter the first week.\\n\\uf0b7\\nTreat the cause: Dietary deficiency in vegetarians, pernicious anaemia. Although\\nuncommon, it is also under diagnosed due to lack of facilities.\\n\\uf0b7\\nTab. vitamin B complex, as in haematinic tablets. Or Inj. B12 1000 mcg IM, one injection\\non alternate days for total 5 injections, then once a week for 5 weeks, then once in 3 to 6\\nmonths will be adequate for most patients.\\nPatient education\\n\\uf0b7\\nEducate the patient about preventive measures for worm infestation.\\n\\uf0b7\\nInform about importance of taking adequate food with green leafy vegetables to meet the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 31, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patient education\\n\\uf0b7\\nEducate the patient about preventive measures for worm infestation.\\n\\uf0b7\\nInform about importance of taking adequate food with green leafy vegetables to meet the\\nnutritional requirement.\\n\\uf0b7\\nCooking food in iron utensils may increase iron content in the diet.\\n\\uf0b7\\nInstruct the patient to take iron tablets after food; iron tablets sometimes produce stomach\\nupset.\\n\\uf0b7\\nInform the patient that the stools could turn black during iron therapy\\n\\uf0b7\\nReduce the dose of iron if it produces stomach ache, diarrhoea or constipation.\\n\\uf0b7\\nExplain that the response to iron therapy is gradual and it takes weeks or months for\\nblood to become normal. Continue iron tablets for six months.\\n\\uf0b7\\nKeep iron tablets out of the reach of children. They may swallow the tablets as candies\\ncausing adverse reactions including death.\\nTYPHOID FEVER\\nIt is caused by Salmonella typhi and Salmonella paratyphi. Salmonella typhi causes a variety'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 31, 'source_type': 'Authorotative', 'priority': '1'}, page_content='causing adverse reactions including death.\\nTYPHOID FEVER\\nIt is caused by Salmonella typhi and Salmonella paratyphi. Salmonella typhi causes a variety\\nof illnesses including asymptomatic carrier state, gastro-enteritis and enteric fever.\\nSalient features\\nInvestigations\\n\\uf0b7\\nDiagnosis is suggested by\\n-\\nRising of O antibodies (Widal test) and\\n-\\nConfirmed by isolation of organism in blood, bone marrow, urine or stool\\nPharmacological treatment\\n\\uf0b7\\nMost patients with uncomplicated enteric fever can be managed at home with oral\\nantibiotics and antipyretics.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 32, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n17\\n\\uf0b7\\nPatients with persistent vomiting, diarrhea, and/or abdominal distension should be\\nhospitalized and given supportive therapy as well as a parenteral third-generation\\ncephalosporin or fluoroquinolone, depending on the susceptibility profile (Table 2).\\n\\uf0b7\\nTherapy should be administered for at least 10 days or for 5 days after fever resolution.\\nTable 2. Dosage schedule of antibiotics in treatment of typhoid fever\\nIndication\\nAgent\\nDosage (Route)\\nDuration, Days\\nEmpirical\\nTreatment\\nCeftriaxonea\\n1-2 g/d IV\\n7–14\\nFully\\nSusceptible\\nCiprofloxacinb (first line)\\n500 mg BD (PO) or 400\\nmg BD (IV)\\n5–7\\nAmoxicillin (second line)\\n1 g TDS (PO) or 2 g QID\\n(IV)\\n14\\nChloramphenicol\\n25 mg/kg TDS (PO or IV)\\n14–21\\nTrimethoprim-\\nsulfamethoxazole\\n160/800 mg BD (PO)\\n7–14\\nCiprofloxacin\\n500 mg BD (PO) or 400\\nmg BD (IV)\\n5–7\\nMultidrug-\\nResistant\\nCeftriaxone\\n2–3 g/day (IV)\\n7–14\\nAzithromycin\\n1 g/day (PO)c\\n5\\nCeftriaxone\\n2–3 g/d (IV)\\n7–14\\nAzithromycin\\n1 g/d (PO)\\n5\\nNalidixic Acid–\\nResistant'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 32, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mg BD (IV)\\n5–7\\nMultidrug-\\nResistant\\nCeftriaxone\\n2–3 g/day (IV)\\n7–14\\nAzithromycin\\n1 g/day (PO)c\\n5\\nCeftriaxone\\n2–3 g/d (IV)\\n7–14\\nAzithromycin\\n1 g/d (PO)\\n5\\nNalidixic Acid–\\nResistant\\nHigh-dose ciprofloxacin\\n750 mg bid (PO) or 400\\nmg q8h (IV)\\n10–14\\naOr another third-generation cephalosporin [e.g., cefotaxime, 2 g TDS (IV); or cefixime, 400 mg\\nbid (PO)].\\nbOr ofloxacin 400 mg bid (PO) for 2–5 days.\\ncOr 1 g on day 1 followed by 500 mg/day PO for 6 days.\\n\\uf0b7\\nThe 1–5% of patients who develop chronic carriage of Salmonella can be treated for 4–6\\nweeks with an appropriate oral antibiotic.\\n\\uf0b7\\nTreatment with oral amoxicillin, cotrimoxazole, ciprofloxacin, or norfloxacin is 80%\\neffective in eradicating chronic carriage of susceptible organisms.\\n\\uf0b7\\nHowever, in cases of anatomic abnormality (e.g., biliary or kidney stones), eradication\\noften requires both antibiotic therapy and surgical correction.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 33, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n18\\n\\uf0b7\\nIt is an acute and chronic illness characterized by paroxysms of fever, chills, sweats,\\nfatigue, anemia and splenomegaly. P. falciparum malaria (severe and complicated\\nmalaria) is associated in varying degrees with the following clinical signs.\\n\\uf0b7\\nSymptoms of cerebral malaria include mental clouding, coma, convulsions, delirium\\nand occasionally localizing signs, hyperpyrexia (more than 40.5ºC), haemolysis,\\noliguria, anuria, pulmonary edema and macroscopic haemoglobinuria.\\nMALARIA\\nParastitic infection due to protozoa of genus Plasmodium transmitted by the female anopheles\\nmosquito. There are four plasmodia species: Plasmodium falciparum, Plasmodium vivax,\\nPlasmodium malaria, Plasmodium ovale.\\nSalient features\\nInvestigations\\nDiagnosis is made by presence of protozoa in the blood in thick and thin smear slides (thick\\nsmear for easy detection of parasite and thin smear for identification of species).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 33, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Investigations\\nDiagnosis is made by presence of protozoa in the blood in thick and thin smear slides (thick\\nsmear for easy detection of parasite and thin smear for identification of species).\\nNote: That blood films may be negative even in a severe attack because of parasites in the\\ndeep capillaries.\\nPharmacological treatment (Figure 1, 2 and 3)\\nFigure 1. Treatment where microscopy result is available within 24 hours'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 34, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n19\\nFigure 2. Treatment where microscopy result is not available within 24 hours and\\nmonovalent RDT is used\\nFigure 3. Treatment where microscopy result is not available within 24 hours and\\nbivalent RDT is used'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 35, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n20\\nTreatment of P.vivax malaria\\n\\uf0b7\\nTab. chloroquine: 25 mg/kg body weight divided over three days i.e.\\n\\uf0d810 mg/kg on day 1\\n\\uf0d810 mg/kg on day 2\\n\\uf0d85 mg/kg on day 3\\n\\uf0b7\\nTab. primaquine: 0.25 mg/kg body weight daily for 14 days.\\n\\uf0b7\\nPrimaquine is contraindicated in infants, pregnant women and individuals with G6PD\\ndeficiency. 14 day regimen of primaquine should be given under supervision.\\nTreatment of P. falciparum malaria\\n\\uf0b7\\nArtemisinin based Combination Therapy (ACT-SP) – Tab. artesunate 4 mg/kg body weight\\ndaily for 3 days plus sulfadoxine (25 mg/kg body weight) - pyrimethamine (1.25 mg/kg\\nbody weight) on first day.\\n\\uf0b7\\nTab. primaquine: 0.75 mg/kg body weight on day 2\\nTreatment of mixed infections (P.vivax + P.falciparum) cases\\nAll mixed infections should be treated with full course of ACT and primaquine 0.25 mg per\\nkg body weight daily for 14 days (Table 3).\\nTable 3. Dosage schedule for treatment of mixed infection (P.vivax + P.falciparum)\\nAge\\nDay 1\\nDay 2\\nDay 3\\nDays 4-14\\nAS'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 35, 'source_type': 'Authorotative', 'priority': '1'}, page_content='kg body weight daily for 14 days (Table 3).\\nTable 3. Dosage schedule for treatment of mixed infection (P.vivax + P.falciparum)\\nAge\\nDay 1\\nDay 2\\nDay 3\\nDays 4-14\\nAS\\n(50 mg)\\nSP\\n(500 mg +\\n25 mg)\\nPQ\\n(2.5 mg)\\nAS tablet\\n(50 mg)\\nPQ\\n(2.5 mg)\\nAS tablet\\n(50 mg)\\nPQ\\n(2.5 mg)\\nPQ\\n(2.5 mg)\\nLess than 1 yr\\n1/2\\n1/2\\n0\\n1/2\\n0\\n1/2\\n0\\n0\\n1-4 years\\n1\\n1\\n1\\n1\\n1\\n1\\n1\\n1\\n5-8 years\\n2\\n1 .5\\n2\\n2\\n2\\n2\\n2\\n2\\n9-14 years\\n3\\n2\\n4\\n3\\n4\\n3\\n4\\n4\\n15 yrs or more\\n4\\n3\\n6\\n4\\n6\\n4\\n6\\n6\\nAS – artesunate, SP – sulfadoxine-pyrimethamine, PQ - primaquine'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n21\\nTreatment of complicated or severe malaria (Table 4)\\nTable 4. Treatment of severe and complicated malaria\\nInitial parenteral treatment for at least 48hrs.\\nChoose any one of the following\\nFollow-up treatment, when patient\\ncan take oral medications following\\nparenteral  treatment\\nQuinine: 20mg quinine salt/kg body weight\\non admission (IV infusion or divided IM injection)\\nfollowed by maintenance dose of 10 mg/kg 8 hourly;\\ninfusion rate should not exceed 5 mg/kg per hour.\\nLoading dose of 20mg/kg should not be given, if the\\npatient has already received quinine.\\nQuinine 10 mg/kg three times a day\\nplus doxycycline 100 mg once a day\\nor clindamycin in pregnant women\\nand children under 8 years of age, to\\ncomplete 7 days of treatment.\\nArtesunate: 2.4 mg/kg IV or IM given on admission,\\nthen at 12 h and 24 h, then once a day or\\nArtemether: 3.2 mg/kg IM given on admission then\\n1.6 mg/kg per day or\\nArteether: 150 mg daily IM for 3 days in adults only'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"then at 12 h and 24 h, then once a day or\\nArtemether: 3.2 mg/kg IM given on admission then\\n1.6 mg/kg per day or\\nArteether: 150 mg daily IM for 3 days in adults only\\n(not recommended for children).\\nTreat with: ACT-SP for 3 days + PQ\\nsingle dose on second day to\\ncomplete 7 days of treatment.\\nNote: The parenteral treatment in severe malaria cases should be given for minimum of 24 hours once started\\n(irrespective of the patient's ability to tolerate oral medication earlier than 24 hours).\\nChemoprophylaxis of malaria\\nShort term chemoprophylaxis (up to 6 weeks)\\nDoxycycline: 100 mg once daily for adults and 1.5 mg/kg once daily for children\\n(contraindicated in children below 8 years). The drug should be started 2 days before travel\\nand continued for 4 weeks after leaving the malarious area.\\nChemoprophylaxis for longer stay (more than 6 weeks)\\nMefloquine: 250 mg weekly for adults and should be administered two weeks before, during\\nand four weeks after exposure.\\nDENGUE\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 36, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chemoprophylaxis for longer stay (more than 6 weeks)\\nMefloquine: 250 mg weekly for adults and should be administered two weeks before, during\\nand four weeks after exposure.\\nDENGUE\\nDengue is the most important emerging tropical viral disease of human beings in the world\\ntoday.  All four dengue virus (Dengue 1, 2, 3 and 4) infections may be asymptomatic, may\\nlead to dengue fever (DF), dengue hemorrhagic fever (DHF) or when associated with plasma\\nleakage may lead to hypovolemic shock and dengue shock syndrome (DSS).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 37, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n22\\nSalient features\\nDengue hemorrhagic fever (DHF), if one or more of the following are present\\n\\uf0b7\\nPositive tourniquet test\\n\\uf0b7\\nPetechiae, purpura or ecchymosis\\n\\uf0b7\\nBleeding from mucosa\\n\\uf0b7\\nHaematemesis, melena\\n\\uf0b7\\nThrombocytopenia (platelets 100,000 cells/mm3 or less) and evidence of plasma leakage.\\nDengue shock syndrome (DSS)\\n\\uf0b7\\nAll the above criteria of DHF plus signs of circulatory failure.\\nNotes: The tourniquet test is performed by inflating a blood pressure cuff to mid way\\nbetween the systolic and diastolic pressure.\\nNon pharmacological treatment\\n\\uf0b7\\nBed rest is advisable during the acute phase.\\n\\uf0b7\\nUse cold sponging to keep temperature below 39ºC\\nPharmacological treatment\\n\\uf0b7\\nManagement of dengue fever is symptomatic and supportive\\n\\uf0b7\\nAntipyretics may be used to lower the body temperature. Aspirin/NSAIDs like ibuprofen\\netc should be avoided since it may cause gastritis, vomiting, acidosis and platelet\\ndysfunction.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 37, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAntipyretics may be used to lower the body temperature. Aspirin/NSAIDs like ibuprofen\\netc should be avoided since it may cause gastritis, vomiting, acidosis and platelet\\ndysfunction.\\n\\uf0b7\\nParacetamol is preferable in the doses as follows: 1-2 years: 60 –120 mg/doses, 3-6 years:\\n120 mg/dose, 7-12 years: 240 mg/dose, Adult : 500mg/dose\\nNote: In children the dose is calculated as per 10mg/kg body weight per dose which can\\nbe repeated at the interval of 6 hrs.\\n\\uf0b7\\nOral fluid and electrolyte therapy are recommended for patients with excessive sweating\\nor vomiting.\\n\\uf0b7\\nPatients should be monitored in DHF endemic area until they become afebrile for one\\nday without the use of antipyretics and after platelet and haematocrit determinations are\\nstable, platelet count is more than 50,000/mm3.\\nManagement of Dengue Hemorrhagic Fever (Febrile Phase)\\n\\uf0b7\\nThe management of febrile phase is similar to that of DF.\\n\\uf0b7\\nParacetamol is recommended to keep the temperature below 39OC. Copious amount of'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 37, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Management of Dengue Hemorrhagic Fever (Febrile Phase)\\n\\uf0b7\\nThe management of febrile phase is similar to that of DF.\\n\\uf0b7\\nParacetamol is recommended to keep the temperature below 39OC. Copious amount of\\nfluid should be given orally, to the extent the patient tolerates, oral hydration solution\\n(ORS), such as those used for the treatment of diarrhoeal diseases and/or fruit juices are\\npreferable to plain water\\n\\uf0b7\\nDengue fever is an acute febrile illness of 2-7 days with two or more of the following\\nmanifestations. Headache, retro orbital pain, myalgia, arthralgia, rash.\\n\\uf0b7\\nHemorrhagic manifestation (petechiae and positive tourniquet test) and Leucopenia'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 38, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n23\\n\\uf0b7\\nIV fluid may be administered if the patient is vomiting persistently or refusing to feed.\\n\\uf0b7\\nPatients should be closely monitored for the initial signs of shock. The critical period is\\nduring the transition from the febrile to the afebrile stage and usually occurs after the\\nthird day of illness.\\n\\uf0b7\\nSerial haematocrit determinations are essential guide for treatment, since they reflect the\\ndegree of plasma leakage and need for intravenous administration of fluids.\\n\\uf0b7\\nHaematocrit should be determined daily from the third day until the temperature has\\nremained normal for one or two days. If haematocrit determination is not possible,\\nhaemoglobin determination may be carried out as an alternative.\\n\\uf0b7\\nThe details of IV treatment when required for patients are given in Figure 4.\\nFigure 4. Treatment algorithm of dengue'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 39, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n24\\nManagement of DHF Grade I and Grade II:\\n\\uf0b7\\nAny person who has dengue fever with thrombocytopenia and haemoconcentration and\\npresents with abdominal pain, black tarry stools, epistaxis, bleeding from the gums and\\ninfection etc needs to be hospitalized.\\n\\uf0b7\\nAll these patients should be observed for signs of shock. The critical period for\\ndevelopment of shock is transition from febrile to abferile phase of illness, which usually\\noccurs after third day of illness.\\n\\uf0b7\\nA rise of haemoconcentration indicates need for IV fluid therapy. If despite the treatment,\\nthe patient develops fall in BP, decrease in urine output or other features of shock, the\\nmanagement for Grade III/IV DHF/DSS should be instituted.\\n\\uf0b7\\nOral rehydration should be given along with antipyretics like paracetamol sponging, etc.\\nas described above.\\n\\uf0b7\\nThe detailed treatment for patient with DHF Grade I and II is given at Figure 5. Common'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 39, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Oral rehydration should be given along with antipyretics like paracetamol sponging, etc.\\nas described above.\\n\\uf0b7\\nThe detailed treatment for patient with DHF Grade I and II is given at Figure 5. Common\\nsigns of complications are observed during the afebrile phase of DHF. Immediately after\\nhospitalization, the haematocrit, platelet count and vital signs should be examined to\\nassess the patient’s condition and intravenous fluid therapy should be started. The patient\\nrequires regular and sustained monitoring.\\nFigure 5. Volume replacement flow chart for patients with dengue haemorrhagic fever\\ngrade I and II'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n25\\nFluid requirement\\n\\uf0b7\\nThe volume of fluid required to be replaced should be just sufficient to maintain effective\\ncirculation during the period of plasma leakage. To ensure adequate fluid replacement\\nand avoid over-fluid infusion, the rate of intravenous fluid should be adjusted throughout\\nthe 24 to 48 hour period of plasma leakage by periodic haematocrit determinations and\\nassessment of vital signs.\\n\\uf0b7\\nThe required regimen of fluid should be calculated on the basis of body weight and\\ncharted on a 1-3 hourly basis, or more frequently in the case of shock. The flow of fluid\\nand the time of infusion are dependent on the severity of DHF. The schedule given below\\nis a guideline and calculated for moderate dehydration of about 6% deficit (plus\\nmaintenance) (Table 5).\\nTable 5. Fluid requirement as per body weight of the patient\\nWeight on\\nadmission (kg)\\nFluid requirement/kg body\\nweight/day (ml/kg)\\n<7\\n220\\n7-11\\n165\\n12-18\\n130\\n>18\\n90\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content='maintenance) (Table 5).\\nTable 5. Fluid requirement as per body weight of the patient\\nWeight on\\nadmission (kg)\\nFluid requirement/kg body\\nweight/day (ml/kg)\\n<7\\n220\\n7-11\\n165\\n12-18\\n130\\n>18\\n90\\n\\uf0b7\\nIn older children who weigh more than 40 kg, the volume needed for 24 hours should be\\ncalculated as twice that required for maintenance (using the Holiday and Segar formula).\\nThe maintenance fluid should be calculated as follows:\\nTable 6. Maintenance fluid requirement according to Holiday and Segar formula\\nBody weight in kg\\nMaintenance volume for 24 hours\\n<10kg\\n10-20kg\\n>20kg\\n100 ml / kg\\n1000+50 ml / kg\\n1500+20 ml / kg\\nFor a child weighing 40 kgs, the maintenance is: 1500 + (20x20) = 1900 ml. This means that\\nthe child requires 3800 ml IV fluid during 24 hours.\\nIndications of red cell transfusion\\n\\uf0b7\\nLoss of blood (overt blood) -10% or more of total blood volume\\n\\uf0b7\\nPreferably whole blood/ component to be used\\n\\uf0b7\\nRefractory shock despite adequate fluid administration and declining haematocrit -'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 40, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nLoss of blood (overt blood) -10% or more of total blood volume\\n\\uf0b7\\nPreferably whole blood/ component to be used\\n\\uf0b7\\nRefractory shock despite adequate fluid administration and declining haematocrit -\\nreplacement volume should be 10 ml/kg body wt at a time and coagulogram should be\\ndone.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 41, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n26\\n\\uf0b7\\nAcute self limiting illness Incubation period is of 2 to 4 days. Abrupt onset presenting\\nas fever with severe joint pain\\n\\uf0b7\\nAfter 1 – 4 days, fever subsides, there will be a afebrile period 3 days, fever returns with\\nan itching maculopapular rash on trunk and extensor surfaces of limbs.\\n\\uf0b7\\nAfter another 3-6 days fever subsides and there is complete recovery.\\n\\uf0b7\\nCripping arthropathy can occur intermittently for upto 4 months, in some cases even\\nupto 5 years.\\n\\uf0b7\\nIf fluid overload is present, PCV is to be given\\nIndications of platelet transfusion\\n\\uf0b7\\nIn general there is no need to give prophylactic platelets even at less than 20,000\\ncells/mm3.\\n\\uf0b7\\nProphylactic platelet transfusion may be given at level of less than 10,000 cells/mm3 in\\nabsence of bleeding manifestations.\\n\\uf0b7\\nProlonged shock; with coagulopathy and abnormal coagulogram.\\n\\uf0b7\\nIn case of systemic massive bleeding, platelet transfusion may be needed in addition to\\nred cell transfusion.\\nCHIKUNGUNYA'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 41, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nProlonged shock; with coagulopathy and abnormal coagulogram.\\n\\uf0b7\\nIn case of systemic massive bleeding, platelet transfusion may be needed in addition to\\nred cell transfusion.\\nCHIKUNGUNYA\\nChikungunya is caused by an alpha virus closely related to O’ nyong – nyong virus. The main\\nvector is Aedes aegypti mosquito.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nMild exercises and physiotherapy may be suggested in recovering persons.\\n\\uf0b7\\nExposure to warm environment may be suggested\\n\\uf0b7\\nNon weight bearing exercises\\n\\uf0b7\\nSurgery in severely damaged joints\\nPharmacological treatment\\n\\uf0b7\\nAcute stage of illness\\n\\uf0b7\\nTreat symptomatically (Tab. paracetamol 1 gm 3-4 times a day for fever, headache and\\npain.)\\n\\uf0b7\\nAvoid aspirin and steroid because of risk of GI side effects and Reye’s syndrome with\\naspirin.\\n\\uf0b7\\nTab. hydroxychloroquinine 200mg orally once daily or Tab. chloroquinine phosphate\\n300mg per day for a period of 4 weeks in cases where arthralgia is refractory to other\\ndrugs.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 41, 'source_type': 'Authorotative', 'priority': '1'}, page_content='aspirin.\\n\\uf0b7\\nTab. hydroxychloroquinine 200mg orally once daily or Tab. chloroquinine phosphate\\n300mg per day for a period of 4 weeks in cases where arthralgia is refractory to other\\ndrugs.\\n\\uf0b7\\nSide effects of hydroxychloroquinine include retinal damage and elevated liver enzymes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 42, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n27\\nPulmonary tuberculosis (PTB): The most common symptom of PTB is a persistent cough\\nof two weeks or more, with or without expectoration. It may be accompanied by one or\\nmore of the following symptoms,\\n\\uf0b7\\nFever, night sweats, weight loss\\n\\uf0b7\\nChest pain, hemoptysis, shortness of breath, tiredness and loss of appetite\\nSuch patients should be selected and subjected for sputum examination. This enhances the\\nchances of detection of the bacilli in the smear microscopy.\\nExtra pulmonary tuberculosis: A person with extra-pulmonary TB may have symptoms\\nrelated to the organs affected along with constitutional symptoms stated above.\\n\\uf0b7\\nEnlarged cervical lymph nodes with or without discharging sinuses (TB Lymphadenitis)\\n\\uf0b7\\nChest pain with or without dyspnoea in pleural TB\\n\\uf0b7\\nPain and swelling of the joints in bone tuberculosis (fever, backache, deformity in spinal\\nTB).\\n\\uf0b7\\nSigns of raised intra-cranial tension like irritability, headache, vomiting, fever, stiffness'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 42, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPain and swelling of the joints in bone tuberculosis (fever, backache, deformity in spinal\\nTB).\\n\\uf0b7\\nSigns of raised intra-cranial tension like irritability, headache, vomiting, fever, stiffness\\nof the neck and mental confusion in TB meningitis\\n\\uf0b7\\nPainless haematuria or sterile pyuria in renal tuberculosis and, infertility in genito-\\nurinary TB.\\nTUBERCULOSIS\\nSalient features\\nInvestigations\\n\\uf0b7\\nPulmonary TB in adults (Figure 6)\\n-\\nSputum smear microscopy\\n-\\nChest x-ray\\n-\\nSputum culture and drug sensitivity testing(DST) for diagnosis of Drug Resistant TB.\\n-\\nNewer rapid diagnostic tools for detection of multi drug resistant (MDR) TB.\\n-\\nNewer tools under evaluation for diagnosis of MDR/XDR TB'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 43, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n28\\nFigure 6. Algorithm for diagnosis of pulmonary tuberculosis\\n\\uf0b7\\nPaediatric TB patients (Figure 7)\\n-\\nIn all children with presumptive intra-thoracic TB, microbiological confirmation\\nshould be sought through examination of respiratory specimens (like sputum by\\nexpectoration, gastric aspirate, induced sputum, bronchio-alveolar lavage or any other\\nappropriate specimen) with diagnostic test like smear microscopy or rapid molecular\\ntest or culture.\\n-\\nIn the event of negative or unavailable microbiological results, a diagnosis of\\nprobable TB in children should be based on the presence of abnormalities consistent\\nwith TB on radiography, a history of exposure to an infectious case, evidence of TB\\ninfection and clinical findings suggestive of TB.\\n-\\nFor children with presumptive extra-pulmonary TB, appropriate specimens from the\\npresumed sites of involvement should be obtained for microscopy, culture and DST,\\nrapid molecular test and histopathological examination.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 44, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n29\\nFigure 7. Diagnostic algorithm for pediatric pulmonary tuberculosis\\n\\uf0b7\\nExtra-pulmonary TB\\n-\\nDemonstration of AFB bacilli in a smear from extra pulmonary site is often difficult\\nbecause of low bacillary load. The clinical features pertaining to the system affected\\nshould be considered in the diagnosis of extra pulmonary tuberculosis.\\n-\\nHowever, the following are some of the special investigations which are helpful in\\ndiagnosing extra pulmonary tuberculosis. These may be radiological, cytological /\\npathological, biochemical and immunological (Figure 8).\\n(a) Fine Needle Aspirations Cytology and direct smear examination\\n(b) Excision / Biopsy of specimen for histopathological examination\\n(c) Fluid for cytology , biochemical analysis and smear examination\\n(d) X-ray of the involved region\\n(e) Ultrasonography for abdominal tuberculosis\\n(f) Culture for Mycobacterium tuberculosis\\n(g) Computerized tomography (CT) and  magnetic resonance imaging (MRI)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 45, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n30\\nFigure 8. Diagnostic algorithm for TB lymphadenitis\\n\\uf0b7\\nDiagnosis of Pleural TB\\n-\\nTubercular pleural effusion is considered as extra pulmonary tuberculosis. TB\\nPatients presenting with chest pain with or without difficulty in breathing for more\\nthan two weeks should be referred for chest radiograph.\\n-\\nIn pleural effusion, chest X-ray features may include obliteration of costophrenic\\nangle and varying degree of effusion.\\n-\\nBiochemical and cytological analysis of the aspirated pleura fluid will help in\\nconfirming the diagnosis. Pleural fluid is generally an exudate with mainly\\nlymphocytes and few mesothelial cells.\\n-\\nPleural biopsy is confirmatory in a high proportion of patients.\\nPharmacological treatment\\nRevised National Tuberculosis Control Programme (RNTCP) uses\\nshort course\\nchemotherapy given intermittently - thrice weekly under Direct Observation for both\\npulmonary and extra pulmonary tuberculosis patients.\\nTreatment regimens'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 45, 'source_type': 'Authorotative', 'priority': '1'}, page_content='short course\\nchemotherapy given intermittently - thrice weekly under Direct Observation for both\\npulmonary and extra pulmonary tuberculosis patients.\\nTreatment regimens\\nFor the purpose of treatment regimen to be used, TB patients are classified into two groups,\\nnamely, “New” or “Previously Treated”, based on the history of previous treatment.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 46, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n31\\n\\uf0b7\\nRegimen for New cases: This regimen is prescribed to all new pulmonary (smear\\npositive and negative) and extra pulmonary tuberculosis. The regimen is 2H3R3Z3 E3 / 4\\nH3R3.\\n\\uf0b7\\nRegimen for Previously Treated cases: This regimen is prescribed for TB patients who\\nhave had more than one month anti-tuberculosis treatment previously. These patients are\\nat a higher risk of having drug resistance. Hence, 5 drugs are prescribed in the intensive\\nphase and the total duration of treatment is 8 months. Relapses, treatment after Default,\\nFailures and Others are treated with this regimen. The regimen is 2S3H3R3Z3 E3 / 1H3R3Z3\\nE3 / 5 H3R3 E3. The table below indicates the treatment regimen, type of patients and\\nregimens prescribed (Table 6).\\nTable 6. Treatment regimens recommended by RNTCP for treatment of Tuberculosis\\nTreatment\\ngroups\\nType of patient\\nRegimen1\\nIntensive\\nPhase (IP)\\nContinuation\\nPhase (CP)\\nNew*\\nSputum smear-positive\\nSputum smear-negative\\nExtra-pulmonary\\nOthers'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 46, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\ngroups\\nType of patient\\nRegimen1\\nIntensive\\nPhase (IP)\\nContinuation\\nPhase (CP)\\nNew*\\nSputum smear-positive\\nSputum smear-negative\\nExtra-pulmonary\\nOthers\\n2H3R3Z3E3\\n4H3R3\\nPreviously\\nTreated**\\nSmear-positive relapse\\nSmear-positive failure\\nSmear-positive treatment after default\\nOthers1\\n2H3R3Z3E3S3\\n/ 1H3R3Z3E3\\n5H3R3E3\\n* New includes former categories I and III\\n** Previously treated is former category II.\\n1 - In rare and exceptional cases, patients who are sputum smear-negative or who have extra-\\npulmonary disease can have recurrence or non-response. This diagnosis in all such cases\\nshould always be made by an MO and should be supported by culture or histological\\nevidence of current, active TB. In these cases, the patient should be typed as ‘Others’ and\\ngiven treatment regimen for previously treated\\n\\uf0b7\\nThe number before the letters refers to the number of months of treatment. The subscript\\nafter the letters refers to the number of doses per week.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 46, 'source_type': 'Authorotative', 'priority': '1'}, page_content='given treatment regimen for previously treated\\n\\uf0b7\\nThe number before the letters refers to the number of months of treatment. The subscript\\nafter the letters refers to the number of doses per week.\\n\\uf0b7\\nThe dosage strengths are as follows: isoniazid (H) 600 mg, rifampicin (R) 450 mg,\\npyrazinamide (Z) 1500 mg, ethambutol (E) 1200 mg, streptomycin (S) 750 mg.\\n\\uf0b7\\nPatients who weigh 60 kg or more receive additional rifampicin 150 mg.\\n\\uf0b7\\nPatients more than 50 years old receive streptomycin 500 mg. Patients who weigh less\\nthan 30kg, receive drugs as per paediatric weight band boxes according to body weight\\n(Table 7).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 47, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n32\\nTable 7. Drug dosages for adults in the blister packs\\nDrugs\\nDose\\n(thrice a week)\\nNumber of tablets in blister\\npack\\nIsoniazid\\n(H)\\n600mg\\n2 x 300 mg\\nRifampicin     (R)\\n450mg\\n1 x 450 mg\\nPyrazinamide (Z)\\n1500mg\\n2 x 750 mg\\nEthambutol     (E)\\n1200mg\\n2 x 600 mg\\nStreptomycin  (S)\\n0.75g\\n-\\n\\uf0b7\\nTreatment of Pediatric TB (Table 8, 9 and 10, Figure 9)\\nPediatric cases are to be treated under RNTCP with the same thrice weekly short course\\nchemotherapy regimens (“New” or “Previously treated”) given under Directly Observed\\nTreatment Short Course (DOTS) as for adult patients.  They are to be registered in the\\nrespective RNTCP TB Register. Pediatric patient-wise boxes are available with different\\ndosages under two weight bands for children weighing 6 to 10 kg and 11 to 17 kg.\\nWherever possible, before a child is started on the “Previously Treated” regimen, she/he\\nshould be examined by a pediatrician or TB expert.\\nTable 8. Pediatric patient wise boxes (PWB) with dosages'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 47, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Wherever possible, before a child is started on the “Previously Treated” regimen, she/he\\nshould be examined by a pediatrician or TB expert.\\nTable 8. Pediatric patient wise boxes (PWB) with dosages\\nIP – Intensive phase, CP – Continuation phase\\nTable 9. Pediatric patient wise boxes (PWB) for new cases according to weight band\\nWeight band\\nFor New cases\\nProlongation of IP\\nIP\\nCP\\n6-10 Kg\\nPC 13\\nPC 15\\n11-17 Kg\\nPC 14\\nPC 16\\n18-25 Kg\\nPC 13 + PC 14\\nPC 15 + PC16\\n26-30 kg*\\nPC 14 x 2\\nPC 16 x 2\\n* For children weighing >30 kgs, adult PWB are to be used\\nIP – Intensive phase, CP – Continuation phase\\nDRUGS\\nProduct code (PC) -13\\nProduct code (PC) -14\\nPC-15\\nPC-16\\nIP\\n24 blisters\\nCP\\n18 blisters\\nIP\\n24 blisters\\nCP\\n18 blister\\n12 blisters\\n12 blisters\\nIsoniazid\\n75 mg\\n75 mg\\n150 mg\\n150 mg\\nProlongation\\nof IP for PC\\n13\\nProlongation\\nof IP for PC\\n14\\nRifampicin\\n75 mg\\n75 mg\\n150 mg\\n150 mg\\nPyrazinamide\\n250 mg\\n500 mg\\nEthambutol\\n200 mg\\n400 mg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 48, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n33\\nTable 10. Pediatric patient wise boxes for previously treated cases according to weight\\nband\\nWeight\\nFor previously treated cases\\nProlongation\\nof IP\\nIP (Intensive phase)\\nCP (Continuation phase)\\n6-10 Kg\\n(PC 13+ PC15)\\n+\\n(24 vials Inj sm*)\\n(PC 13 + 54 Tab E 200 mg)\\n+\\n(PC 15 without Z)\\nPC 15\\n11-17 Kg\\n(PC 14 + PC16)\\n+\\n(24 vials Inj sm*)\\n(PC 14 + 54 E  400 mg)\\n+\\n(PC 16 without Z)\\nPC 16\\n18-25 Kg\\n(PC 13 + PC 14 + PC 15\\n+ PC 16)\\n+\\n(24 vials Inj sm*)\\n(PC 13 + PC14 + 54 Tab E 600 mg)\\n+\\n(PC 15+ PC 16 without Z)\\nPC 15 + PC\\n16\\n26-30 kg\\n(PC 14 x 2)+ (PC 16 x 2)\\n+\\n(24 vials Inj sm*)\\n(PC 14 x 2+ 54 Tab E 800 mg)\\n+\\n(PC 16 x 2 without Z)\\nPC 16 x 2\\n* Injection streptomycin 15mg/kg body weight\\nFigure 9. Clinical monitoring of children with Tuberculosis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 49, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n34\\nNon DOTS (ND) treatment regimen under RNTCP\\nIn rare and exceptional situations, non-DOTS treatment (with a self-administered non-\\nrifampicin containing regimen) may be needed in a few TB cases. Examples include:\\n-\\nThose with adverse reactions to rifampicin and / or pyrazinamide\\n-\\n“New” patients who refuse DOTS despite all efforts\\nThis is a treatment regimen of 12-month duration comprising 2 months of SHE and 10\\nmonths of HE (2SHE / 10HE). Dosages administered per day in the regimen are:\\nIsoniazid\\n-\\n300 mg\\nEthambutol\\n-\\n800 mg\\nStreptomycin\\n-\\n750 mg (500 mg for those >50 years of age)\\nThose who weigh less than 30 kg receive dosages calculated as per body-weight.\\n\\uf0b7\\nDrug resistant tuberculosis (MDR/XDR-TB)\\nMDR TB suspect: A patient suspected of drug-resistant tuberculosis, based on RNTCP\\ncriteria for submission of specimens for drug-susceptibility testing.\\nMDR TB suspect criteria\\nCriteria A\\n-\\nAll failures of new TB cases\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 49, 'source_type': 'Authorotative', 'priority': '1'}, page_content='criteria for submission of specimens for drug-susceptibility testing.\\nMDR TB suspect criteria\\nCriteria A\\n-\\nAll failures of new TB cases\\n-\\nSmear positive previously treated cases who remain smear positive at 4th month\\nonwards\\n-\\nAll pulmonary TB cases who are contacts of known MDR TB case\\nCriteria B (in addition to Criteria A)\\n-\\nAll smear positive previously treated pulmonary TB cases at diagnosis\\n-\\nAny smear positive follow up result in new or previously treated cases\\nCriteria C (in addition to Criteria B)\\n-\\nAll smear negative previously treated pulmonary TB cases at diagnosis,\\n-\\nHIV TB co-infected cases at diagnosis\\nIn other words, for districts implementing MDR Suspect Criteria B, any smear-positive\\ndiagnostic (except in a new patient) or any smear-positive follow-up result, should prompt a\\nreferral for DST.\\nMDR-TB case: A TB patient whose sputum is culture positive for Mycobacterium\\ntuberculosis and is resistant in-vitro to isoniazid and rifampicin with or without other anti-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 49, 'source_type': 'Authorotative', 'priority': '1'}, page_content='referral for DST.\\nMDR-TB case: A TB patient whose sputum is culture positive for Mycobacterium\\ntuberculosis and is resistant in-vitro to isoniazid and rifampicin with or without other anti-\\ntubercular drugs based on DST results from an RNTCP-certified culture and DST laboratory\\nExtensive Drug Resistant Tuberculosis (XDR TB) case: An MDR TB case whose\\nrecovered\\nM. tuberculosis\\nisolate is resistant to at least\\nisoniazid, rifampicin, a\\nfluoroquinolone (ofloxacin, levofloxacin, or moxifloxacin) and a second-line injectable anti-\\nTB drug (kanamycin, amikacin, or capreomycin) at a RNTCP-certified culture and DST\\nlaboratory. A patient is confirmed to have MDR or XDR TB only when the results are from a\\nRNTCP quality-assured culture and DST Laboratory and by a RNTCP-endorsed testing\\nmethod mentioned as below:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 50, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n35\\nChoice of Diagnostic Technology\\nCurrently, the programme is scaling up the laboratory capacity of various culture and DST\\nlaboratories at state level IRLs and other laboratories. The choice of technology to be used for\\ndiagnosis of MDR TB has been determined as per recommendations of the National\\nLaboratory Committee. Thus, for DST at certified laboratory, wherever available Molecular\\nDST (e.g. Line Probe Assay (LPA)) is preferred diagnostic method because of the rapid and\\nhighly-accurate rifampicin results, followed in preference by Liquid C-DST and then Solid\\nC-DST.\\nMDR Diagnostic Technology Choice\\nFirst\\nMolecular DST (e.g. LPA DST)\\nSecond               Liquid culture isolation and LPA DST\\nThird                 Solid culture isolation and LPA DST\\nFourth                Liquid culture isolation and Liquid DST\\nFifth                   Solid culture isolation and DST\\nSimilarly for follow up cultures, wherever available, liquid culture will be preferred over'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 50, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Fifth                   Solid culture isolation and DST\\nSimilarly for follow up cultures, wherever available, liquid culture will be preferred over\\nsolid culture. However, this will be liquid cultures for at least the crucial months of follow-up\\n(IP-3, 4, 5, 6 and CP-18, 21, 24) and over and beyond this, it will be determined by the\\nworkload of individual laboratories.\\nTable 11. Grouping anti-TB agents (first line and second line drugs)\\nGrouping\\nDrugs\\nGroup 1: First-line oral anti-TB\\nagents\\nIsoniazid \\n(H); \\nRifampicin \\n(R); \\nEthambutol \\n(E);\\nPyrazinamide(Z)\\nGroup \\n2: \\nInjectable \\nanti-TB\\nagents\\nStreptomycin (S); Kanamycin (Km); Amikacin (Am);\\nCapreomycin (Cm); Viomycin (Vm).\\nGroup 3: Fluoroquinolones\\nCiprofloxacin (Cfx); Ofloxacin (Ofx); Levofloxacin\\n(Lvx);\\nMoxifloxacin (Mfx); Gatifloxacin (Gfx)\\nGroup 4: Oral second-line anti-\\nTB agents\\nEthionamide (Eto); Prothionamide (Pto); Cycloserine\\n(Cs);\\nTerizadone (Trd); para-aminosalicylic acid (PAS)\\nGroup 5: Agents with unclear'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 50, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Group 4: Oral second-line anti-\\nTB agents\\nEthionamide (Eto); Prothionamide (Pto); Cycloserine\\n(Cs);\\nTerizadone (Trd); para-aminosalicylic acid (PAS)\\nGroup 5: Agents with unclear\\nefficacy (not recommended by\\nWHO for routine use in MDR-TB\\npatients)\\nClofazimine (Cfz); Linezolid (Lzd); Amoxicillin\\n/\\nClavulanate\\n(Amx/Clv); thioacetazone (Thz); imipenem/cilastatin\\n( Ipm / Cln);\\nhigh-dose isoniazid (high-dose H); Clarithromycin (Clr)\\n-\\nAll drugs should be given in a single daily dosage under directly observed treatment (DOT)\\nby a DOT Provider. All patients will receive drugs under direct observation on 6 days of the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 51, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n36\\nweek. On Sunday, the oral drugs will be administered unsupervised whereas injection\\nkanamycin will be omitted.\\n-\\nIf intolerance occurs to the drugs, ethionamide, cycloserine and PAS may be split into two\\ndosages and the morning dose administered under DOT. The evening dose will be self-\\nadministered. The empty blister packs of the self-administered doses will be checked the next\\nmorning during DOT.\\n-\\nPyridoxine should be administered to all patients on an RNTCP Category IV regimen.\\nDrug dosages for MDR-TB cases are base on the weight bands as shown in below (Table 12).\\n\\uf0b7\\nTreatment of MDR TB (Category IV regimen)\\n-\\nRNTCP will be using a standardised treatment tegimen (Cat IV) for the treatment of\\nMDR-TB cases (and those with rifampicin resistance) under the programme.\\n-\\nCat IV regimen comprises of 6 drugs (Table 11) kanamycin, high dose levofloxacin,\\nethionamide, pyrazinamide, ethambutol and cycloserine during 6-9 months of the intensive'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 51, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\nCat IV regimen comprises of 6 drugs (Table 11) kanamycin, high dose levofloxacin,\\nethionamide, pyrazinamide, ethambutol and cycloserine during 6-9 months of the intensive\\nphase (IP) and 4 drugs- high dose levofloxacin, ethionamide, ethambutol and cycloserine\\nduring the 18 months of the continuation phase (CP).\\n-\\nP-aminosalicylic acid (PAS) is included in the regimen as a substitute drug in case of\\nintolerance i.e. severe ADR leading to discontinuation of drug to any of the drug in the Cat\\nIV regimen.\\n-\\nFor management of patients with Km mono resistance, the committee recommended\\nreplacement of Km with capreomycin, If Km is intolerant, substitute amikacin (AK) if\\npossible, or PAS if injectable agent not feasible.\\n\\uf0b7\\nDrug dosages and administration\\nTable 12. Dosage and weight band recommendations of second line drugs\\nS.No\\nDrugs\\n16-25 Kgs\\n26-45 Kgs\\n46-70 Kgs\\n1\\n2\\n3\\n4\\n5\\n6\\n7\\n8\\nKanamycin\\nLevofloxacin (High Dose)\\nEthionamide\\nEthambutol\\nPyrazinamide\\nCycloserine\\nPAS (80% Bioavailability)1'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 51, 'source_type': 'Authorotative', 'priority': '1'}, page_content='S.No\\nDrugs\\n16-25 Kgs\\n26-45 Kgs\\n46-70 Kgs\\n1\\n2\\n3\\n4\\n5\\n6\\n7\\n8\\nKanamycin\\nLevofloxacin (High Dose)\\nEthionamide\\nEthambutol\\nPyrazinamide\\nCycloserine\\nPAS (80% Bioavailability)1\\nPyridoxine\\n500 mg\\n250 mg\\n375 mg\\n400 mg\\n500 mg\\n250 mg\\n5 gm\\n50 mg\\n500 mg\\n750 mg\\n500 mg\\n800 mg\\n1250 mg\\n500 mg\\n10 gm\\n100mg\\n750 mg\\n1000 mg\\n750 mg\\n1200 mg\\n1500 mg\\n750 mg\\n12 gm\\n100mg\\n1 In case of PAS with 60% bioavailability the dose will be increased to 7 gm (16-25 Kg); 14\\ngm (26-45 Kg) and 16 gm (> 45 Kg)\\n-\\nIf a patient gains 5 kg or more in weight during treatment and crosses the weight-band\\nrange, the DOTS–Plus site committee may consider moving the patient to the higher\\nweight-band drug dosages.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 52, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n37\\n-\\nSimilarly if a patient loses 5 kgs or more in weight during treatment and crosses the\\nweight band the DOTS Plus site committee may consider moving the patient to the lower\\nweight band.\\n-\\nThe new higher/lower dosages are provided whenever the patient is due for the next\\nsupply of drugs in the normal course of treatment and not as soon as change of weight is\\nnoted.\\n-\\nThe dosages of 2nd line drugs for MDR TB cases in paediatric age group weighing < 16\\nkg as per the Table 13.\\nTable 13. Dosage of 2nd line drugs for treatment of pediatric MDR TB cases\\nDrug\\nDaily Dose – mg/kg body weight\\nKanamycin\\n15-30\\nLevofloxacin\\n7.5-10\\nEthionamide\\n15-20\\nCycloserine\\n15-20\\nPAS\\n150\\nEthambutol\\n25\\nPyrazinamide\\n30-40\\n-\\nThe dosages for higher weight patients include use additional dosages of some 2nd line\\ndrugs for MDR TB cases in patients weighing > 70 kg taking the dosage to kanamycin (1\\ngm), ethionamide (1 gm), cycloserine (1 gm), ethambutol (1.6 gm) and pyrazinamide (2'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 52, 'source_type': 'Authorotative', 'priority': '1'}, page_content='drugs for MDR TB cases in patients weighing > 70 kg taking the dosage to kanamycin (1\\ngm), ethionamide (1 gm), cycloserine (1 gm), ethambutol (1.6 gm) and pyrazinamide (2\\ngm). All these are well within the maximum permissible dosage for each drug as per the\\nWHO guidelines.\\n\\uf0b7\\nTreatment of XDR-TB (Category V)\\nAll XDR-TB patients who are considered for category V regimen, will be screened by the\\nDOTS-Plus  committee and if found suitable will be referred to a thoracic surgeon for\\nconsideration of surgery to improve the treatment outcomes. Identification must be done for\\nthe site (tertiary centres) with such surgical facilities.\\nXDR Regimen (Table 14)\\n6-12 months Cm, PAS, Mfx, High dose‐H, Cfz, Lzd, Amx/Clv\\n18 months PAS, Mfx, High dose‐H, Cfz, Lzd, Amx/Clv\\n-\\nThe Category V treatment regimen consists of 7 drugs, with 2 reserve/substitute drugs.\\nThe dosage of the drugs would vary as per the weight of the patient (≤ 45Kg or > 45Kg).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 52, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\nThe Category V treatment regimen consists of 7 drugs, with 2 reserve/substitute drugs.\\nThe dosage of the drugs would vary as per the weight of the patient (≤ 45Kg or > 45Kg).\\nAll drugs are to be given on a daily basis. Injections of capreomycin will be given for 6\\ndays/week (not on Sundays).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n38\\n-\\nAll morning doses are to be supervised by the DOT Provider except on Sundays. After\\ntaking DOT for morning doses on Saturday, next day medicines would be given to the\\npatient to be taken at home on Sunday.\\n-\\nEmpty blisters of medicines taken unsupervised in evening and on Sundays are to be\\ncollected by DOT Provider.\\n-\\nThe change from IP to CP will be done only after achievement of culture conversion i.e.\\n2 consecutive negative cultures taken at least one month apart. In case of delay in culture\\nconversion, the IP can be extended from 6 months up to a maximum of 12 months. In\\ncase of extension, the DOTS – Plus site Committee, which will be responsible for\\ninitiating and monitoring the Category V regimen, can decide on administering\\ncapreomycin injection intermittently (3 times/week) for the months 7 to 12.\\nTable 14. Drugs and Dosages for management of XDR TB\\nDrugs\\nDosage/day\\n< 45 Kgs\\n> 45 Kgs\\nInj. Capreomycin (Cm)\\n750 mg\\n1000 mg\\nPAS\\n10 gm\\n12 gm\\nMoxifloxacin (Mfx)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Table 14. Drugs and Dosages for management of XDR TB\\nDrugs\\nDosage/day\\n< 45 Kgs\\n> 45 Kgs\\nInj. Capreomycin (Cm)\\n750 mg\\n1000 mg\\nPAS\\n10 gm\\n12 gm\\nMoxifloxacin (Mfx)\\n400 mg\\n400 mg\\nHigh dose INH (High dose-H)\\n600 mg\\n900 mg\\nClofazimine (Cfz)\\n200 mg\\n200 mg\\nLinezolid (Lzd)\\n600 mg\\n600 mg\\nAmoxiclav (Amx/Clv)\\n875/125 mg BD\\n875/125 mg BD\\nPyridoxine\\n100 mg\\n100 mg\\nReserve/Substitute drugs\\nClarithromycin (Clr)\\n500 mg BD\\n500 mg BD\\nThiacetazone (Thz)#\\n150 mg\\n150 mg\\n# Depending on availability, not to be given to HIV positive cases\\nThe reserve/substitute drugs would be used in the following conditions:\\n-\\nIn case the patient was on PAS in Category IV, PAS will be replaced with one of\\nthe reserve drugs in the Category V regimen\\n-\\nIf the patient is unable to tolerate one or more of the drugs\\n-\\nIf the patient is found to be resistant to capreomycin\\n\\uf0b7\\nHIV co-infection with TB\\n-\\nTB patients living with HIV should receive the same duration of TB treatment with\\ndaily regimen as HIV negative TB patients.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 53, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nHIV co-infection with TB\\n-\\nTB patients living with HIV should receive the same duration of TB treatment with\\ndaily regimen as HIV negative TB patients.\\n-\\nAntiretroviral therapy (ART) must be offered to all patients with HIV and TB as well\\nas drug-resistant TB requiring second-line anti-TB drugs, irrespective of CD4 cell-\\ncount, as early as possible (within the first 8 weeks) following initiation of anti-TB\\ntreatment. Appropriate arrangements for access to antiretroviral drugs should be made'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n39\\nfor patients. However, initiation of treatment for TB should not be delayed. Patients\\nwith TB and HIV infection should also receive co-trimoxazole as prophylaxis for\\nother infections.\\n-\\nPeople living with HIV should be screened for TB using four symptom complex\\n(current cough or, fever or weight loss or night sweats) at HIV care settings and those\\nwith any of these symptoms should be evaluated for ruling out active TB. Such\\npatients in whom active TB is ruled out, Isoniazid Preventive Therapy (IPT) in the\\ndosage of 10 mg/Kg body weight should be offered to them for 6 months.\\n\\uf0b7\\nAdherence\\n-\\nSupervision and support should be individualized.\\n-\\nEnsuring Adherence in M/XDR TB patients: Patient support systems, including direct\\nobservation of treatment, are required to ensure adherence. It should be ensured that\\nthe patient consumes all the dosages of the drugs.\\n-\\nTrained treatment supporter for treatment adherence: Such measures may include'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the patient consumes all the dosages of the drugs.\\n-\\nTrained treatment supporter for treatment adherence: Such measures may include\\nidentification and training of a treatment supporter (for TB and, if appropriate, for\\nHIV, diabetes mellitus etc.) who is acceptable, accessible and accountable to the\\npatient and to the health system.\\n-\\nInformation Communication Technology\\nto promote treatment literacy and\\nadherence: Optimal use of Information Communication Technology (ICT) should be\\ndone to promote treatment literacy and adherence\\nOther important points to remember\\n\\uf0b7\\nPublic Health Responsibility- Any practitioner treating a TB patient is assuming an\\nimportant public health responsibility to prevent ongoing transmission of the infection\\nand the development of drug resistance. To fulfill this responsibility the practitioner must\\nnot only prescribe an appropriate regimen, but also utilize local public health services /'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and the development of drug resistance. To fulfill this responsibility the practitioner must\\nnot only prescribe an appropriate regimen, but also utilize local public health services /\\ncommunity health services, and other agencies including NGOs when necessary, to assess\\nthe adherence of the patient and to address poor adherence when it occurs.\\n\\uf0b7\\nMaintain Records for all TB patients: A written record of all medications given,\\nmicrobiological response and adverse reactions should be maintained for all patients.\\nEvery patient’s clinical outcome should be recorded in the case register and available for\\npublic health monitoring.\\n\\uf0b7\\nNotification of TB Cases: All health establishments must report all TB cases and their\\ntreatment outcomes to public health authorities (District Nodal Officer for Notification).\\nProper feedback need to be ensured to all health care providers who refer cases to public\\nhealth system on the outcome of the patients which they had referred.\\n\\uf0b7\\nContact Investigation:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 54, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Proper feedback need to be ensured to all health care providers who refer cases to public\\nhealth system on the outcome of the patients which they had referred.\\n\\uf0b7\\nContact Investigation:\\nAll providers of care for patients with TB should ensure all household contacts (including\\nchildren) and other persons who are in close contact with TB patients are screened for TB\\nas per defined diagnostic standards.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n40\\nIn case of pediatric TB patients, reverse contact tracing for search of any active TB case in\\nthe household of the child must be undertaken.\\nThe highest priority contacts of known TB cases for intensive case finding (such as are:\\n-\\nPersons with symptoms suggestive of TB\\n-\\nChildren aged <6 years\\n-\\nKnown or suspected immune-compromised patient, particularly HIV infection.\\n-\\nDiabetes Mellitus\\n-\\nOther higher risks including pregnancy, mental disorders, smokers and alcoholics etc.\\n-\\nPatients with DR-TB - In case of contact with a DR-TB index case, close clinical\\nmonitoring should be provided, as there is no evidence that treatment of latent\\ninfection with available drugs is presently effective\\nFollow up\\nFollow up smear and culture schedule during treatment\\n-\\nFor follow up examination two sputum specimens will be collected and examined by\\nsmear and culture at least 30 days apart from the 3rd to 7th month of treatment (i.e. at'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\nFor follow up examination two sputum specimens will be collected and examined by\\nsmear and culture at least 30 days apart from the 3rd to 7th month of treatment (i.e. at\\nthe end of the months 3, 4, 5, 6 and 7) and at 3-monthly intervals from the 9th month\\nonwards till the completion of treatment (i.e. at the end of the months 9, 12, 15, 18, 21\\nand 24).\\n-\\nThe two specimens for smear and culture at the RNTCP accredited lab (one early\\nmorning and one supervised spot) will be collected and transported from the\\nrespective DTC to the RNTCP accredited laboratory.\\n-\\nIf any of the cultures in the last three quarters becomes positive, it will be followed up\\nby monthly cultures in the following 3 months.\\nTable 15. Common adverse effects of 2nd line drugs and management strategies\\nAdverse effects\\nSuspected agent(s)\\nSuggested management strategies\\nGastrointestinal\\nNausea and\\nvomiting\\nPAS, isoniazid, moxifloxacin\\nlinezolid, clofazamine\\namoxyclav, alarithromycin\\nthioacetazone\\n\\uf02d'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 55, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Adverse effects\\nSuspected agent(s)\\nSuggested management strategies\\nGastrointestinal\\nNausea and\\nvomiting\\nPAS, isoniazid, moxifloxacin\\nlinezolid, clofazamine\\namoxyclav, alarithromycin\\nthioacetazone\\n\\uf02d\\nAssess for dehydration; initiate rehydration\\nif indicated\\n\\uf02d\\nInitiate anti-emetic therapy\\n\\uf02d\\nDiscontinue suspected agent if this can be\\ndone without compromising regimen –\\nrarely necessary\\nGastritis\\nPAS, moxifloxacin\\nisoniazid, linezolid\\namoxiclav, clarithromycin\\nthioacetazone\\n\\uf02d\\nH2-blockers, proton-pump inhibitors, or\\nantacids\\n\\uf02d\\nStop suspected agent(s) for short periods of\\ntime (e.g., one to seven days)\\n\\uf02d\\nLower dose of suspected agent, if this can\\nbe done without compromising regimen\\n\\uf02d\\nDiscontinue suspected agent if this can be\\ndone without compromising regimen\\nHepatitis\\nIsoniazid, PAS, moxifloxacin\\nlinezolid\\n\\uf02d\\nStop all therapy pending resolution of\\nhepatitis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 56, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n41\\n\\uf02d\\nEliminate other potential causes of hepatitis\\n\\uf02d\\nConsider suspending most likely agent\\npermanently. Reintroduce remaining drugs,\\none at a time with the most hepatotoxic\\nagents last, while monitoring liver function\\nCutaneous and hypersensitivity reactions\\nHypersensitivity\\nPAS, linezolid,\\nclarithromycin\\n\\uf02d\\nWithhold all drugs and treat\\nsymptomatically with antihistamines/\\nsteroids till the reaction subsides.\\n\\uf02d\\nIdentify offending drug in severe forms\\n\\uf02d\\nAttempt desensitization of the offending\\ndrug\\n\\uf02d\\nDiscontinue suspected agent and substitute\\nwith the reserve drug\\nCutaneous\\nLinezolid,\\nclofazamine\\n\\uf02d\\nTreat symptomatically with antihistamines\\ntill the reaction subsides.\\n\\uf02d\\nPatient should be counseled on the skin\\ndiscoloration with long term use of\\nclofazamine\\nPsychiatric\\nDepression\\nSocio-economic\\ncircumstances,\\nchronic disease,\\nmoxifloxcin,\\nisoniazid\\n\\uf02d\\nImprove socioeconomic conditions\\n\\uf02d\\nGroup or individual counseling\\n\\uf02d\\nInitiate antidepressant therapy\\n\\uf02d'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 56, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatric\\nDepression\\nSocio-economic\\ncircumstances,\\nchronic disease,\\nmoxifloxcin,\\nisoniazid\\n\\uf02d\\nImprove socioeconomic conditions\\n\\uf02d\\nGroup or individual counseling\\n\\uf02d\\nInitiate antidepressant therapy\\n\\uf02d\\nLower dose of suspected agent if this can be\\ndone without compromising the regimen\\n\\uf02d\\nDiscontinue suspected agent if this can be\\ndone without compromising regimen\\nNeurological\\nPeripheral\\nneuropathy\\nIsoniazid, linezolid\\n\\uf02d\\nIncrease pyridoxine to maximum daily dose\\n(200 mg per day)\\n\\uf02d\\nInitiate therapy with tricyclic\\nantidepressants such as amitriptyline. Non-\\nsteroidal anti-inflammatory drugs or\\nacetaminophen may help alleviate\\nsymptoms\\n\\uf02d\\nLower dose of suspected agent, if this can\\nbe done without compromising regimen\\n\\uf02d\\nDiscontinue suspected agent if this can be\\ndone without compromising regimen\\nConvulsions\\nIsoniazid, moxifloxacin,\\nlinezolid\\n\\uf02d\\nSuspend suspected agent pending resolution\\nof convulsions\\n\\uf02d\\nInitiate anticonvulsant therapy (e.g.\\nphenytoin, valproic acid)\\n\\uf02d'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 56, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Convulsions\\nIsoniazid, moxifloxacin,\\nlinezolid\\n\\uf02d\\nSuspend suspected agent pending resolution\\nof convulsions\\n\\uf02d\\nInitiate anticonvulsant therapy (e.g.\\nphenytoin, valproic acid)\\n\\uf02d\\nIncrease pyridoxine to maximum daily dose\\n(200 mg per day).\\n\\uf02d\\nRestart suspected agent or reinitiate\\nsuspected agent at lower dose, if essential to\\nthe regimen'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 57, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n42\\n\\uf02d\\nDiscontinue suspected agent if this can be\\ndone without compromising regimen\\nHearing loss\\nCapreomycin\\nclarithromycin\\n\\uf02d\\nDocument hearing loss and compare with\\nbaseline audiometry if available\\n\\uf02d\\nChange parenteral treatment to\\ncapreomycin if patient has documented\\nsusceptibility to capreomycin\\n\\uf02d\\nIncrease frequency and/or lower dose of\\nsuspected agent if this can be done without\\ncompromising the regimen(consider\\nadministration three times per week)\\n\\uf02d\\nDiscontinue suspected agent if this can be\\ndone without compromising the regimen\\nOcular\\nLinezolid\\nIn consultation with the ophthalmologist\\nMusculoskeletal\\nArthralgia\\nMoxifloxacin\\n\\uf02d\\nInitiate therapy with non-steroidal anti-\\ninflammatory drugs.\\n\\uf02d\\nLower dose of suspected agent, if this can\\nbe done without compromising regimen.\\n\\uf02d\\nDiscontinue suspected agent if this can be\\ndone without compromising regimen\\nMusculoskeletal\\nMoxifloxacin\\nIn consultation with the orthopedician\\nHaematological\\nHaematalogic\\nCapreomycin, PAS,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 57, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf02d\\nDiscontinue suspected agent if this can be\\ndone without compromising regimen\\nMusculoskeletal\\nMoxifloxacin\\nIn consultation with the orthopedician\\nHaematological\\nHaematalogic\\nCapreomycin, PAS,\\nlinezolid, clarithromycin\\nMonitor for anemia, bleeding tendency and cell\\ncounts\\nRenal\\nRenal toxicity\\nCapreomycin\\nlinezolid\\nclarithromycin\\n\\uf02d\\nDiscontinue suspected agent\\n\\uf02d\\nConsider using capreomycin if an\\naminoglycoside had been the prior\\ninjectable in regimen\\n\\uf02d\\nConsider dosing 2 to 3 times a week if drug\\nis essential to the regimen and patient can\\ntolerate (close monitoring of creatinine)\\n\\uf02d\\nAdjust all TB medications according to the\\ncreatinine clearance\\nMetabolic and Electrolytes\\nMetabolic and\\nelectrolyte\\nCapreomycin, linezolid\\nmoxifloxacin\\nPeriodic monitoring of serum electrolytes and\\nblood sugar\\nEndocrine\\nThyroid\\ndysfunction\\nPAS\\nSupplement with thyroxine\\nCardiovascular\\nQT prolongation\\nMoxifloxacin, clarithromycin\\n\\uf02d\\nMonitor for QT prolongation, monitor\\nplatelet count, bleeding tendencies'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 58, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n43\\n\\uf0b7\\nChemoprophylaxis of contacts of MDR-TB cases\\nAmong contacts of patients with MDR-TB, the use of isoniazid may reasonably be\\nquestioned. Although alternative prophylaxis treatments have been suggested, there is no\\nconsensus regarding the choice of the drug(s) and the duration of treatment. Prompt\\ntreatment of MDR-TB is the most effective way of preventing the spread of infection to\\nothers. The following measures should be taken to prevent spread of MDR-TB infection:\\n-\\nEarly diagnosis and appropriate treatment of MDR-TB cases;\\n-\\nScreening of contacts as per RNTCP guidelines\\n-\\nFurther research into effective and non-toxic chemoprophylaxis in areas of high\\nMDR-TB prevalence.\\nPatient education\\n-\\nProviding counseling and health education to the MDR-TB patient and their family\\nmembers about the disease and about the necessity of taking regular and adequate\\ntreatment is of utmost importance.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 58, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Providing counseling and health education to the MDR-TB patient and their family\\nmembers about the disease and about the necessity of taking regular and adequate\\ntreatment is of utmost importance.\\n-\\nHealth education and counseling is provided to all patients and family members at\\ndifferent levels of health care, right from one at the periphery to those at the DOTS-Plus\\nsite facility. It is started at the initial point of contact and carried on a continuous basis at\\nall visits by the patient to a health facility. The counseling and motivation is required to\\nbe done not only of the patient but also of the family members.\\nEPILEPSY\\nA seizure is a paroxysmal event due to abnormal excessive or synchronous neuronal activity\\nin the brain. Epilepsy describes a condition in which a person has recurrent seizures due to a\\nchronic, underlying process.\\nClassification of Seizures\\n\\uf0b7\\nGeneralized seizures\\nTonic clonic, clonic, tonic, absence (typical/ atypical), atonic and myoclonic'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 58, 'source_type': 'Authorotative', 'priority': '1'}, page_content='chronic, underlying process.\\nClassification of Seizures\\n\\uf0b7\\nGeneralized seizures\\nTonic clonic, clonic, tonic, absence (typical/ atypical), atonic and myoclonic\\nMay be focal, generalized, or unclear epileptic spasms\\n\\uf0b7\\nFocal seizures (can be further described as having motor, sensory, autonomic, cognitive,\\nor other features) with and without dyscognitive features\\nInvestigations\\nIt should be made sure that the patient had a seizure and other differentials should be ruled\\nout.  In the patient with prior seizures or a known history of epilepsy, the evaluation is\\ndirected toward (1) underlying cause and precipitating factors (2) adequacy of current\\ntherapy.\\nPharmacological treatment\\n\\uf0b7\\nTreatment of underlying conditions\\n-\\nMetabolic imbalances such as abnormal serum electrolytes and glucose, medications\\n(theophylline), illicit drug use (e.g., cocaine), structural CNS lesion such as a brain\\ntumor, vascular malformation, or brain abscess.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 59, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n44\\n\\uf0b7\\nAvoidance of precipitating factors like sleep deprivation, alcohol, bright light, etc.\\n\\uf0b7\\nAntiepileptic drug therapy mainstay of treatment for most patients with epilepsy.\\nTable 16. Selection of antiepileptic drugs according to classification of epilepsy\\nGeneralized tonic\\nclonic seizures\\nFocal seizures\\nTypical absence\\nseizures\\nAtypical absence,\\nmyoclonic and atonic\\nseizures\\nFirst line drugs\\nValproic acid\\nLamotrigine\\nValproic acid\\nValproic acid\\nLamotrigine\\nCapbamazepine\\nEthosuximide\\nLamotrigine\\nTopiramate\\nOxcarbazepine\\nTopiramate\\nPhenytoin\\nLevetiracetam\\nAlternatives\\nZonisamide\\nTopiramate\\nLamotrigine\\nClonazepam\\nPhenytoin\\nZonisamide\\nClonazepam\\nFelbamate\\nCapbamazepine\\nValproic acid\\nOxcarbazepine\\nTiagabine\\nPhenobarbitone\\nGabapentin\\nPrimidone\\nLacosamide\\nFelbamate\\nPhenobarbitone\\nPrimidone\\nFelbamate\\nPregnancy\\n\\uf0b7\\nMost women with epilepsy who become pregnant will have an uncomplicated gestation'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 59, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Tiagabine\\nPhenobarbitone\\nGabapentin\\nPrimidone\\nLacosamide\\nFelbamate\\nPhenobarbitone\\nPrimidone\\nFelbamate\\nPregnancy\\n\\uf0b7\\nMost women with epilepsy who become pregnant will have an uncomplicated gestation\\nand deliver a normal baby. Since the potential harm of uncontrolled convulsive seizures\\non the mother and fetus is considered greater than the teratogenic effects of antiepileptic\\ndrugs, it is currently recommended that pregnant women be maintained on effective drug\\ntherapy. Patients should take folic acid (1–4 mg/d), to prevent development of neural tube\\ndefects.\\nContraception\\n\\uf0b7\\nDrugs such as carbamazepine, phenytoin, phenobarbital, and topiramate can significantly\\ndecrease the efficacy of oral contraceptives via enzyme induction and other mechanisms.\\nPatients should be advised to consider alternative forms of contraception.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 60, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n45\\nSTATUS EPILEPTICUS\\nStatus epilepticus refers to continuous seizures or repetitive, discrete seizures with impaired\\nconsciousness in the interictal period. The duration of seizure activity sufficient to meet the\\ndefinition of status epilepticus has traditionally been specified as 15–30 minutes. The\\ntreatment plan for an adult with status epilepticus is as in Figure 10.\\nFigure 10. Treatment algorithm for generalized tonic clonic status epilepticus in adults'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 61, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common Conditions\\n46\\n\\uf0b7\\nBurning micturition, urinary frequency, flank pain, fever\\n\\uf0b7\\nPredisposing factors are diabetes mellitus, large prostate, and circumcision.\\n\\uf0b7\\nCommon organisms are E. coli, Pseudomonas, Klebsiella.\\nURINARY TRACT INFECTION\\nUrinary tract infections include infection of any part of urinary tract from kidneys to urethra.\\nIt can be caused by unhygenic lifestyle, sexually transmitted, per urethral catheterization,\\nrenal calculus disease and vesicoureteric reflux.\\nSalient features\\nInvestigations\\n\\uf0b7\\nTC with DC, X-ray KUB, USG-KUB, Urine (routine and microbiological examination)\\n\\uf0b7\\nUrine culture and sensitivity to be done if bacterial colony count is more than 1000.\\nNon pharmacological treatment\\nPlenty of fluids orally, maintain hygiene\\nPharmacological treatment\\n\\uf0b7Tab. ciprofloxacin 500 mg twice a day for five days.\\n\\uf0b7In resistance cases 3rd generation cephalosporins (cefixime) followed by antibiotics as per\\nculture and sensitivity report.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 61, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7Tab. ciprofloxacin 500 mg twice a day for five days.\\n\\uf0b7In resistance cases 3rd generation cephalosporins (cefixime) followed by antibiotics as per\\nculture and sensitivity report.\\n\\uf0b7If fever then Tab. paracetamol 500 mg thrice a day for three days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 62, 'source_type': 'Authorotative', 'priority': '1'}, page_content='47\\nChapter 3\\nEMERGENCY CONDITIONS\\nCARDIOPULMONARY RESUSCITATION\\nCardiopulmonary resuscitation (CPR) consists of a series of maneuvers by which oxygenated\\nblood supply to brain and vital organs is maintained during cardiopulmonary arrest (CPA) i.e.\\ncessation of respiration and circulation. In children, CPA is not sudden but end result of long\\nperiod of hypoxaemia secondary to inadequate ventilation, oxygenation or circulation. Therefore,\\nprompt management of these is essential to prevent CPA, the outcome of which is poor.\\nDiagnosis of cardiopulmonary and cardiac arrest\\n1. Absence of pulse in major arteries (carotid or femoral in older children and\\nfemoral or brachial in infants as carotid is difficult to palpate due to short neck).\\n2. Absence of heart sounds on auscultation.\\n3. Asystole /ventricular fibrillation on ECG.\\nRespiratory arrest\\nAbsence of respiration on examination (absent chest movements), listening (absent air flow on'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 62, 'source_type': 'Authorotative', 'priority': '1'}, page_content='3. Asystole /ventricular fibrillation on ECG.\\nRespiratory arrest\\nAbsence of respiration on examination (absent chest movements), listening (absent air flow on\\nbringing ears in front of mouth) and feeling (absent air flow on keeping hands in front of mouth\\nor nose).\\nLevels of CPR\\nBasic life support (BLS): The elements of CPR are provided without additional equipment.\\nSkill and speed are most essential.\\nAdvanced cardiac life support (ACLS): Use of equipment and drugs for assisting ventilation\\nor circulation.\\nPrimary survey to assess the patient\\'s condition:\\n\\uf0b7\\nTap the patient on the shoulder and ask, \"Are you all right?\"\\n\\uf0b7\\nIf the patient does not respond, call for help.\\n\\uf0b7\\nGive 2 minutes (5 cycles) of CPR before leaving patient to call for help.\\n\\uf0b7\\nCheck for pulse or any other signs of life; begin CPR, 30 compressions to 2 respirations\\n(push hard and fast--100/minute and release chest completely).\\n\\uf0b7\\nOpen airway and check for breathing. Give 2 breaths that make the chest rise.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 62, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(push hard and fast--100/minute and release chest completely).\\n\\uf0b7\\nOpen airway and check for breathing. Give 2 breaths that make the chest rise.\\n\\uf0b7\\nStart an IV line.\\n\\uf0b7\\nBegin oxygen.\\n\\uf0b7\\nAttach a monitor\\n\\uf0b7\\nIntravenous / Intra osseous (IO) access is a priority over advanced airway management. If an\\nadvanced airway is placed, change to continuous chest compressions without pauses for\\nbreaths. Give 8 to 10 breaths per minute and check rhythm every 2 minutes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 63, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n48\\nCHART\\nSIMPLIFIED ADULT BLS\\nSource 2010 American Heart Association  Guidelines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 64, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n49\\nADULT BLS HEALTHCARE PROVIDERS\\nSource 2010 American Heart Association   Guidelines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 65, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n50\\nAHA ACLS ADULT CARDIAC ARREST ALGORITHM\\nSource 2010 American Heart Association   Guidelines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 66, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n51\\nAHA ACLS ADULT CARDIAC ARREST ALGORITHM\\nSource 2010 American Heart Association   Guidelines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 67, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n52\\nANAPHYLAXIS\\nIt is a generalized hypersensitivity reaction characterized by hypotension, peripheral\\ncirculatory collapse and respiratory difficulty in the form of stridor and dyspnoea.\\nAnaphylaxis can be due to food, inhaled/ingested allergens or drugs. Symptoms occur\\ninstantaneously or within a few minutes following exposure to the offending agent.\\nAnaphylaxis to oral drugs may take 1-2 hours, but in many patients it can be instantaneous. A\\nsevere anaphylactoid reaction is a life-threatening emergency. Effective treatment depends on\\nprompt diagnosis and rapid supplementation of appropriate therapy.\\nClinical criteria for diagnosis\\nAnaphylaxis is highly likely when any one of the following three criteria is fulfilled:\\n1. Acute onset of an illness (minutes to several hours) with involvement of the skin, mucosal\\ntissue, or both (e.g., generalized urticaria, itching or flushing, swollen lips/tongue/uvula)\\nwith one of the following,\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 67, 'source_type': 'Authorotative', 'priority': '1'}, page_content='tissue, or both (e.g., generalized urticaria, itching or flushing, swollen lips/tongue/uvula)\\nwith one of the following,\\n\\uf0b7\\nRespiratory compromise (e.g., dyspnoea, wheeze-bronchospasm, stridor, reduced\\npeak expiratory flow (PEF), hypoxemia)\\n\\uf0b7\\nReduced blood pressure or associated symptoms of end-organ dysfunction (e.g.\\nhypotonia, collapse, syncope, incontinence)\\n\\uf0b7\\nInvolvement of the skin-mucosal tissue\\n\\uf0b7\\nPersistent gastrointestinal symptoms (e.g., cramping abdominal pain, vomiting) or\\n2. Reduced blood pressure after exposure to known allergen,\\n\\uf0b7\\nInfants and children- low systolic blood pressure (age-specific) or greater than 30%\\ndecrease in systolic blood pressure\\n\\uf0b7\\nAdults- systolic blood pressure of less than 90 mm Hg or greater than 30% decrease\\nfrom baseline'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 68, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n53\\nSkin, subcutaneous tissue, and mucosa\\n\\uf0b7\\nFlushing, itching, urticaria (hives), angioedema, morbilliform rash, piloerection\\n\\uf0b7\\nPeriorbital itching, erythema and edema, conjunctival erythema, tearing\\n\\uf0b7\\nItching of lips, tongue, palate, and external auditory canals; and swelling of lips, tongue,\\nand uvula\\n\\uf0b7\\nItching of genitalia, palms, and soles\\nRespiratory\\n\\uf0b7\\nNasal itching, congestion, rhinorrhea, sneezing\\n\\uf0b7\\nThroat itching and tightness, dysphonia, hoarseness, stridor, dry staccato cough\\n\\uf0b7\\nLower airways: increased respiratory rate, shortness of breath, chest tightness, deep cough,\\nwheezing/bronchospasm, decreased peak expiratory flow\\n\\uf0b7\\nCyanosis, respiratory arrest\\nGastrointestinal\\n\\uf0b7\\nAbdominal pain, nausea, vomiting (stringy mucus), diarrhea, dysphagia\\nCardiovascular system\\n\\uf0b7\\nChest pain\\n\\uf0b7\\nTachycardia, bradycardia (less common), other arrhythmias, palpitations\\n\\uf0b7\\nHypotension, feeling faint, urinary or fecal incontinence, shock\\n\\uf0b7\\nCardiac arrest\\nCentral nervous system\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 68, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nChest pain\\n\\uf0b7\\nTachycardia, bradycardia (less common), other arrhythmias, palpitations\\n\\uf0b7\\nHypotension, feeling faint, urinary or fecal incontinence, shock\\n\\uf0b7\\nCardiac arrest\\nCentral nervous system\\n\\uf0b7\\nAura of impending doom, uneasiness (in infants and children, sudden behavioral change,\\ne.g. irritability, cessation of play, clinging to parent); throbbing\\n\\uf0b7\\nHeadache (pre-epinephrine), altered mental status, dizziness, confusion, tunnel vision\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nRemove exposure to trigger if possible (discontinue intravenous diagnostic or therapeutic\\nagent that seems to triggering symptoms). Place the patient supine and elevate the\\nextremities.\\n\\uf0b7\\nObserve vital signs frequently and if possible, monitor electrocardiogram and pulse\\noximetry.\\n\\uf0b7\\nFor severe anaphylaxis with shock, initial management should be directed at the ABC of\\nresuscitation, namely maintenance of adequate airway - suction, breathing, and\\ncirculation. If working alone, call for assistance.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 68, 'source_type': 'Authorotative', 'priority': '1'}, page_content='resuscitation, namely maintenance of adequate airway - suction, breathing, and\\ncirculation. If working alone, call for assistance.\\nPharmacological treatment\\n\\uf0b7\\nInj. adrenaline 1:1000 (1mg/ml), 0.01 ml/kg (maximum 0.3 ml in children and 0.5 ml in\\nadults) IM (mid anterolateral aspect of thigh). If necessary, dose can be repeated every 15\\nminutes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 69, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n54\\n\\uf0b7\\nIf the anaphylaxis is due to an allergen extract or to a hymenoptera sting into an\\nextremity, half the dose of adrenaline can be infiltrated locally, subcutaneously after\\ndilution with 2 ml saline.\\n\\uf0b7\\nHigh flow oxygen (4-6 lit/min by face mask or oropharyngeal airway).\\n\\uf0b7\\nEstablish two wide bore intravenous lines. Commence rapid fluid resuscitation with Inj.\\nNS (0.9% normal saline) at rate of 5-10 ml/kg in 5 to 10 minutes. One to two litres of\\nfluid bolus can be given.\\n\\uf0b7\\nIntubate and commence intermittent positive pressure ventilation if severe laryngeal\\nobstruction, bronchospasm, circulatory shock or coma.\\n\\uf0b7\\nIf no response to the initial intramuscular dose of adrenaline, administer adrenaline 5\\nmcg/kg slowly in to the intravenous line. Repeat at 5 minutes intervals depending on\\nresponse. If the patient remains in shock, start an adrenaline infusion (preferably via a\\ncentral venous line), commencing at 0.1 mcg/kg/min in children and 0.2 mcg/kg/min in'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 69, 'source_type': 'Authorotative', 'priority': '1'}, page_content='response. If the patient remains in shock, start an adrenaline infusion (preferably via a\\ncentral venous line), commencing at 0.1 mcg/kg/min in children and 0.2 mcg/kg/min in\\nadults with titration required to restore blood pressure. Large doses of adrenaline may\\nbe needed.\\n\\uf0b7\\nCommence cardiopulmonary resuscitation, if necessary.\\n\\uf0b7\\nIf the only manifestation of anaphylaxis is urticaria or angioedema, initial IM dose of\\nadrenaline should be given in addition to antagonists. If no other manifestation, patient\\ncan be kept under observation for at least 12 hours and then discharged.\\nAdditional measures\\n\\uf0b7\\nIV infusion of chlorpheniramine 10 mg (adult), 2.5-5 mg (child) or diphenhydramine 25-\\n50 mg (adult) (1 mg/kg, maximum 50 mg [child]).\\n\\uf0b7\\nInj. salbutamol solution, 2.5 to 5 mg/3 ml given by nebulizer and face mask.\\n\\uf0b7\\nIV hydrocortisone infusion 200 mg (adult), maximum 100 mg (child); or\\nmethylprednisolone 50-100 mg (adult); 1 mg/kg, maximum 50 mg (child).\\nSupportive treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 69, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIV hydrocortisone infusion 200 mg (adult), maximum 100 mg (child); or\\nmethylprednisolone 50-100 mg (adult); 1 mg/kg, maximum 50 mg (child).\\nSupportive treatment\\nAll patients with severe anaphylactic reaction must be hospitalized. Patients who remain\\nclinically unstable after initial resuscitation should be admitted to intensive care unit (ICU).\\nPatients responding to the initial treatment should be observed for possible late reaction.\\nPatient education\\nTo check and look for the cause (food, drugs etc.) and to avoid it in future\\nACUTE AIRWAY OBSTRUCTION\\nThe cause of acute airway obstruction can be underlying malignancy, abscess, laryngeal cyst\\nor laryngocele. It is necessary to assess the severity of the condition before initiating the\\ntreatment.\\nEmergency treatment\\n\\uf0b7\\nHead extension with lower jaw thrust forward\\n\\uf0b7\\nSuctioning for clearing secretions'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 70, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n55\\n\\uf0b7\\nVentilatory mask with 100% oxygen\\n\\uf0b7\\nEndotracheal intubation or tracheostomy\\nIn stable patient\\n\\uf0b7\\nPlain X-ray neck\\n\\uf0b7\\nFibre optic endoscopy / micro-laryngoscopy / bronchoscopy to find out the cause\\nTreatment guidelines\\nAssess Severity of airway\\nPortable radiographic ultrasonography\\nECG monitoring and supplemental oxygen\\nPulse oximetry, blood pressure\\nCricothyrotomy\\nTracheostomy\\nEmergency intubation\\nSTRIDOR\\nStridor is noisy, harsh and difficult breathing due to obstruction of the airway. It is classified\\ninspiratory, expiratory and biphasic type. Inspiratory stridor occurs due to an obstruction at or\\nabove the level of vocal cords. Expiratory stridor is due to obstruction at bronchiolar level\\nsuch as bronchial asthma while biphasic stridor occurs in tracheal and subglottic stenosis. In\\nchildren the stridor of laryngo-tracheo-bronchitis has a crowing quality and is called ‘Croup’.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nHumidified oxygen\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 70, 'source_type': 'Authorotative', 'priority': '1'}, page_content='children the stridor of laryngo-tracheo-bronchitis has a crowing quality and is called ‘Croup’.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nHumidified oxygen\\n\\uf0b7\\nInj. hydrocortisone 100 mg IV stat and can be repeated as required.\\n\\uf0b7\\nInj. ampicillin 500mg QID IV/for 5-7 days\\n\\uf0b7\\nInj. adrenaline 0.2-0.5mg subcutaneously if necessary.\\n•\\nRestlessness, anxiety and distress, labored / noisy breathing, predominantly on\\ninspiration\\n•\\nDifficulty in swallowing and speaking\\n•\\nIn children: cyanosis, chest retraction, tachypnea, altered level of consciousness,\\nfeeding difficulties'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 71, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n56\\nSHOCK\\nShock is defined as a circulatory insufficiency that creates an imbalance between tissue\\noxygen supply and demand.\\nClassification and causes of shock\\n1. Haemorrhagic shock\\n\\uf0b7\\nTraumatic – blunt or penetrating injury, fractures of long bones and pelvis\\n\\uf0b7\\nNon-traumatic - GI bleeds (e.g. peptic ulcer, gastric mucosal erosions, oesophageal\\nvarices, typhoid bleeds,\\ndisseminated\\nintravascular coagulation (DIC),\\naortic\\ndissection, rupture of aneurysm of a large vessel\\n2. Hypovolaemic shock\\n\\uf0b7\\nFluid loss from vomiting and/or diarrhoea e.g. in cholera, other GI infections\\n\\uf0b7\\nFluid loss in diabetes mellitus, adrenal insufficiency, excessive sweating, exfoliative\\ndermatitis, diabetes insipidus, reaccumulation of ascites after tapping\\n\\uf0b7\\nSequestration of fluid e.g. in intestinal obstruction, pancreatitis, burns, crush injuries\\n3. Cardiogenic shock\\n\\uf0b7\\nAcute myocardial infarction\\n\\uf0b7\\nCardiomyopathy, cardiac arrhythmias\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 71, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nSequestration of fluid e.g. in intestinal obstruction, pancreatitis, burns, crush injuries\\n3. Cardiogenic shock\\n\\uf0b7\\nAcute myocardial infarction\\n\\uf0b7\\nCardiomyopathy, cardiac arrhythmias\\n\\uf0b7\\nMechanical causes e.g. valvular disease, outflow tract obstruction, ruptured\\nventricular septum\\n4. Distributive or vasogenic (relative hypovolaemia)\\n\\uf0b7\\nSeptic shock; toxic shock syndrome\\n\\uf0b7\\nAnaphylactic\\n\\uf0b7\\nNeurogenic\\nShock is a progressive disorder, if untreated can lead to severe haemodynamic and metabolic\\ndeterioration causing multi-organ failure. Stages of shock can be arbitrarily classified as:\\n\\uf0b7\\nEarly compensated shock - Vital organ function is maintained by intrinsic compensatory\\nmechanisms. Blood pressure is usually normal, there is increasing tachycardia and\\nhypotension. The skin is cold and clammy, increased capillary refill time (>3 sec). If there\\nis delay in treatment it may-lead to decompensated shock.\\n\\uf0b7\\nDecompensated shock - There is fall in blood pressure and cardiac output. Features of'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 71, 'source_type': 'Authorotative', 'priority': '1'}, page_content='is delay in treatment it may-lead to decompensated shock.\\n\\uf0b7\\nDecompensated shock - There is fall in blood pressure and cardiac output. Features of\\nperipheral poor perfusion are compounded with manifestations of vital organ impairment.\\nPatient may have alteration of mentation (impaired cerebral perfusion), oliguria (renal\\nhypoperfusion) and myocardial ischaemia (coronary flow impairment). Patient has\\nacrocyanosis, cold and damp extremities and a pale look. If untreated, progress to\\nirreversible state of shock.\\n\\uf0b7\\nIrreversible shock is a term applied to the clinical situation in which even\\nhaemodynamic correction does not halt the progressive organ failure.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 72, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n57\\n\\uf0b7\\nTachycardia, blood pressure may be normal or elevated due to compensatory\\nmechanisms, later falls as cardiovascular compensation fails. Neck veins may be\\ndistended or flattened, depending on the etiology of shock. Decreased coronary\\nperfusion pressures can lead to ischemia, decreased ventricular compliance, and\\nincreased left ventricular diastolic pressure and pulmonary edema.\\n\\uf0b7\\nTachypnea, increased minute ventilation, and increased dead space are common.\\nBronchospasm, hypocapnia with progression to respiratory failure, and adult\\nrespiratory distress syndrome can be seen.\\n\\uf0b7\\nSkin pale, dusky, clammy skin with cyanosis, sweating, altered temperature, and\\ndecreased capillary refill, oliguria.\\nSalient features\\nTreatment\\n\\uf0b7\\nStart oxygen 4-6 L/min\\n\\uf0b7\\nAirway control, endotracheal intubation\\n\\uf0b7\\nAdequate venous access. Large-bore peripheral intravenous catheters for adequate fluid\\nresuscitation. Central venous access may be necessary for monitoring and employing'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 72, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAdequate venous access. Large-bore peripheral intravenous catheters for adequate fluid\\nresuscitation. Central venous access may be necessary for monitoring and employing\\npulmonary artery catheters, venous pacemakers, and long-term vasopressor therapy.\\n\\uf0b7\\nVolume replacement. Isotonic, intravenous crystalloid fluids (0.9% NaCl, Ringer’s\\nlactate) are preferred for the initial resuscitation phase. Initial bolus volume is 20 to 40\\nml/kg over 10 to 20 min (rapid infusion). Colloids (dextran, hetastarch, etc.) can be used\\ntill blood is available.\\n\\uf0b7\\nBlood is the ideal resuscitative fluid for hemorrhagic shock or in the presence of\\nsignificant anemia. Fully cross-matched blood is preferred, but if more rapid intervention\\nis required, type specific or type O negative blood may be employed. The decision to use\\nplatelets or fresh frozen plasma (FFP) should be based on evidence of impaired\\nhemostasis and on frequent monitoring of coagulation parameters. Platelets are generally'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 72, 'source_type': 'Authorotative', 'priority': '1'}, page_content='platelets or fresh frozen plasma (FFP) should be based on evidence of impaired\\nhemostasis and on frequent monitoring of coagulation parameters. Platelets are generally\\ngiven if there is ongoing hemorrhage and the platelet count is 50,000 or less; FFP is\\nindicated if the prothrombin time is prolonged more than 1.5 times.\\n\\uf0b7\\nVasopressors should be used if there is persistent hypotension after adequate volume\\nresuscitation. Inj. dobutamine 2.0 to 20.0 µg/kg/min for systolic BP over 100 mmHg,\\ndopamine 2.5 to 20.0 µg/kg/min for systolic BP 70 to 100 mmHg, and Inj. norepinephrine\\n0.5 to 30.0 µg/min for systolic BP under 70 mmHg.\\n\\uf0b7\\nAcidosis should be treated with adequate ventilation and fluid resuscitation. Use of\\nsodium bicarbonate (1 meq/kg) is controversial. If it is used, it is given only in the setting\\nof severe acidosis refractory to ventilation and fluid resuscitation.\\n\\uf0b7\\nEarly surgical or medical consultation for admission or transfer as indicated.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 73, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n58\\nMonitoring\\nSpecial care in ICU should be taken by careful and continuous monitoring of BP, pulse rate\\nand respiratory rate, urine output and mental status frequently. Sedated patients should be\\nallowed to awaken (\"drug holiday\") daily to assess their neurologic status and to shorten\\nduration of ventilator support.\\nManagement guidelines for common causes of shock\\nHemorrhagic Shock\\n\\uf0b7\\nEnsure adequate ventilation/oxygenation\\n\\uf0b7\\nProvide immediate control of hemorrhage (e.g., traction for long bone fractures, direct\\npressure)\\n\\uf0b7\\nInitiate judicious infusion of isotonic crystalloid solution (10–20 ml/kg) or colloid\\nsolution\\n\\uf0b7\\nWith evidence of poor organ perfusion and 30-minute anticipated delay to hemorrhage\\ncontrol, begin packed red blood cell (PRBC) infusion (5–10 ml/kg)\\n\\uf0b7\\nTreat coincident dysrhythmias (e.g., atrial fibrillation with synchronized cardioversion)\\nCardiogenic Shock\\n\\uf0b7\\nAmeliorate increased work of breathing; provide oxygen and positive end-expiratory'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 73, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTreat coincident dysrhythmias (e.g., atrial fibrillation with synchronized cardioversion)\\nCardiogenic Shock\\n\\uf0b7\\nAmeliorate increased work of breathing; provide oxygen and positive end-expiratory\\npressure (PEEP) for pulmonary edema\\n\\uf0b7\\nBegin vasopressor or inotropic support; Inj. norepinephine (0.5 µg/min) and Inj.\\ndobutamine (5 µg/kg/min)\\n\\uf0b7\\nSeek to reverse the insult (e.g., initiate thrombolysis, arrange percutaneous transluminal\\nangioplasty)\\n\\uf0b7\\nConsider intra-aortic balloon pump counterpulsation for refractory shock\\nSeptic Shock\\n\\uf0b7\\nEnsure adequate oxygenation\\n\\uf0b7\\nAdminister 20 ml/kg of crystalloid (0.9% normal saline or RL) or 5 ml/kg of colloid\\n(hemaccel or hetastarch), and titrate infusion to adequate central venous pressure and\\nurine output\\n\\uf0b7\\nBegin antimicrobial therapy; attempt surgical drainage or débridement\\n\\uf0b7\\nBegin packed RBC infusion for hemoglobin < 8 g/dL\\n\\uf0b7\\nIf volume restoration fails to improve organ perfusion, begin vasopressor support; initial'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 73, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nBegin packed RBC infusion for hemoglobin < 8 g/dL\\n\\uf0b7\\nIf volume restoration fails to improve organ perfusion, begin vasopressor support; initial\\nchoice includes dopamine infusion at 5–15 µg/kg/min\\nFLUID AND ELECTROLYTE IMBALANCE AND REPLACEMENT (IN ADULTS)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 74, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Emergency Conditions\\n59\\nDisturbances in fluid and electrolyte balance occur in a wide spectrum of diseases such as\\nfollowing burns, trauma and major surgery. The conventional and easy method of evaluating\\ndisturbances in fluid and electrolyte balance is the frequent measurement of the concentration\\nof serum electrolytes. It is crucial to remember that intracellular and extracellular electrolytes\\nare normally constant, and that major shifts in and out of 'compartments' can occur in disease\\nwith minimal changes in serum electrolyte. Compositional changes also involve disturbances\\nin acid-base balance.\\nI.\\nVolume deficit\\n\\uf0b7Obvious causes\\nVomiting, diarrhoea, intestinal fistulae, nasogastric suction, fluid loss following burns,\\nsequestration of fluid in soft tissue injuries and infections, diuretics, renal disease/adrenal\\ninsufficiency\\n\\uf0b7Less obvious causes\\nInadequate fluid intake, fluid loss through excessive sweating as in high fever, hot humid\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 74, 'source_type': 'Authorotative', 'priority': '1'}, page_content='insufficiency\\n\\uf0b7Less obvious causes\\nInadequate fluid intake, fluid loss through excessive sweating as in high fever, hot humid\\ntemperature, haemodialysis, haemofiltration from surgical incisions and tetanus\\nTreatment\\nThe first principle is to restore circulating volume through infusion of intravenous fluids.\\nOnce this is satisfactorily achieved, disturbances in electrolytes and acid-base balance if\\npresent need to be rectified. Various fluids used for volume replacement are given below:\\nReplacement fluids\\n\\uf0b7\\nReplacement fluids are used to replace abnormal loss of blood, plasma or other\\nextracellular fluids as first line treatment for hypovolemia in:\\n-\\nPatients with established hypovolemia e.g. haemorrhagic shock.\\n-\\nMaintenance of normovolaemia in patients with ongoing fluid losses e.g. surgical\\nblood loss.\\n\\uf0b7\\nIntravenous replacement fluids are the first line of treatment for hypovolemia.\\n\\uf0b7\\nCrystalloid maintenance fluids, which contain dextrose, are not suitable for use as'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 74, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"blood loss.\\n\\uf0b7\\nIntravenous replacement fluids are the first line of treatment for hypovolemia.\\n\\uf0b7\\nCrystalloid maintenance fluids, which contain dextrose, are not suitable for use as\\nreplacement fluids. However, crystalloid solutions with a similar concentration of\\nsodium to plasma (normal saline or balanced salt) solutions (Ringer's lactate or\\nHartmann's solutions) are effective as replacement fluids. These should be available in\\nall hospitals where intravenous replacement fluids are used. Crystalloids should be\\ninfused in a volume at least three times the volume lost in order to correct hypovolemia.\\n\\uf0b7\\nAll colloid solutions (albumins, dextran, gelatins and hydroxyethyl starch solutions) are\\nreplacement fluids. However, they have not been shown to be superior to crystalloids in\\nresuscitation. Colloid solutions should be infused in a volume equal to the blood\\nvolume deficit.\\n\\uf0b7\\nPlasma should never be used as a replacement fluid.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 74, 'source_type': 'Authorotative', 'priority': '1'}, page_content='resuscitation. Colloid solutions should be infused in a volume equal to the blood\\nvolume deficit.\\n\\uf0b7\\nPlasma should never be used as a replacement fluid.\\n\\uf0b7\\nPlain water should never be infused intravenously as it can cause haemolysis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 75, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n60\\n\\uf0b7\\nIn addition to the intravenous route, the intraosseous, oral, rectal or subcutaneous routes\\ncan be used for the administration of fluids, blood and certain drugs. However, with the\\nexception of intraosseous route, other routes are generally unsuitable in severely\\nhypovolemic patients.\\n\\uf0b7\\nRectal fluids are administered through a plastic or rubber enema tube which is inserted\\ninto the rectum and connected to a bag or bottle of fluid. A safe and effective solution\\nfor a rectal rehydration is 1 liter of clean drinking water with teaspoon of table salt.\\n\\uf0b7\\nSubcutaneous fluids can be used when other route of administration of fluids are\\nunavailable. A cannula or needle is inserted into the subcutaneous tissue (the abdominal\\nwall is a preferred site) and sterile fluids are administered in a conventional manner. Do\\nnot give dextrose-containing solutions subcutaneously as they can cause sloughing of\\ntissues.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 75, 'source_type': 'Authorotative', 'priority': '1'}, page_content='wall is a preferred site) and sterile fluids are administered in a conventional manner. Do\\nnot give dextrose-containing solutions subcutaneously as they can cause sloughing of\\ntissues.\\n\\uf0b7\\nOral and nasogastric fluids: Oral rehydration can often be used in mildly hypovolemic\\npatients if the oral route is not contraindicated. Do not use if:\\n-\\nThe patient is unconscious.\\n-\\nThe patient has gastrointestinal lesions or reduced gut motility e.g. obstruction.\\n-\\nGeneral anaesthesia and surgery is planned imminently.\\nWHO/UNICEF formula for oral rehydration fluid:\\nDissolve in one litre of drinkable water\\nSodium chloride\\n2.6 g/L\\nTrisodium citrate, dihydrate\\n2.9 g/L\\nPotassium chloride\\n1.5 g/L\\nGlucose anhydrous\\n13.5 g/L\\nResulting concentrations\\nNa 75 mmol/L, CI 65 mmol/L, K 20 mmol/L, Glucose anhydrous 75 mmol/ L, Citrate 10\\nmmol/L, total osmolarity 245 mmol/L.\\nMaintenance fluids\\nMaintenance fluids are used to replace the normal physiological loss that occurs through skin,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 75, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mmol/L, total osmolarity 245 mmol/L.\\nMaintenance fluids\\nMaintenance fluids are used to replace the normal physiological loss that occurs through skin,\\nlung, faeces and urine. Since a considerable proportion of the loss is water, maintenance\\nfluids are mainly composed of water in the form of a dextrose solution. Some electrolytes\\nmay also be included in these solutions.\\nBefore giving any intravenous infusion:\\n\\uf0b7\\nCheck that the seal of the infusion fluid bottle or bag is not broken.\\n\\uf0b7\\nCheck the expiry date.\\n\\uf0b7\\nCheck that the solution is clear and free from visible particles.\\nII.\\nVolume excess\\nVolume excess is often iatrogenic when the fluid intake has consistently exceeded the\\noutput. Excessive intravenous infusions of saline and blood transfusions are important'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 76, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n61\\ncauses of hypervolemia. Renal insufficiency, congestive heart failure, liver disease and\\nother causes of sodium retention, or excessive sodium administration can all produce\\nincrease in extracellular fluid content and hypervolemia.\\nSalient features\\nTreatment\\nIn moderate volume excess, salt restriction, restriction of fluid intake and the use of\\nfrusemide as a diuretic will solve the problem. Fulminant pulmonary oedema secondary to\\nover hydration from over transfusion of blood or fluids is more appropriately dealt with by\\nphlebotomy in stages so that pulmonary capillary wedge pressure is reduced below 15 mm\\nHg. Rarely ultrafiltration (dialysis) may be required.\\nReferences\\n1.\\nAnaesthesia at the District Hospital. In: World Health Organization in collaboration with the World\\nFederation of Societies of Anesthesiologists, Geneva, 2nd Edition, 2000, WHO.\\n2.\\nDrugs Used in Anaesthesia. In: WHO Model Prescribing Information, 1989, World Health Organization.\\n3.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 76, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Federation of Societies of Anesthesiologists, Geneva, 2nd Edition, 2000, WHO.\\n2.\\nDrugs Used in Anaesthesia. In: WHO Model Prescribing Information, 1989, World Health Organization.\\n3.\\nAnaesthesia at the District Hospital. In: World Health Organization in collaboration with the World\\nFederation of Societies of Anesthesiologists, Geneva, 1988, World Health Organization.\\nSEPTICEMIA\\nSepticemia is a clinical syndrome caused by invasion of bloodstream by microorganisms.\\nGram-negative and gram-positive bacteria account for most common sepsis cases.\\nDefinitions\\n\\uf0b7\\nBacteremia (fungemia): presence of viable bacteria (fungi) in the blood, as evidenced by\\npositive blood cultures.\\n\\uf0b7\\nSystemic Inflammatory Response Syndrome (SIRS): at least two of the following\\nconditions: (1) oral temperature of >38° C or <35° C, (2) respiratory rate of >20\\nbreaths/min or partial pressure of arterial carbon dioxide (PaCO2) of <32 mm Hg, (3)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 76, 'source_type': 'Authorotative', 'priority': '1'}, page_content='conditions: (1) oral temperature of >38° C or <35° C, (2) respiratory rate of >20\\nbreaths/min or partial pressure of arterial carbon dioxide (PaCO2) of <32 mm Hg, (3)\\nheart rate of >90 beats/min, (4) leukocyte count of >12,000/dl or <4000/dl or >10%\\nbands.\\n\\uf0b7\\nSevere sepsis: sepsis with one or more signs of organ dysfunction, hypoperfusion, or\\nhypotension, such as metabolic acidosis, alteration in mental status, oliguria, or adult\\nrespiratory distress syndrome.\\n\\uf0b7\\nOedema, ascites, pleural effusion,\\nneck veins full, pulmonary congestion,\\nhyperdynamic circulation with tachycardia, a warm skin, and a bounding pulse.\\n\\uf0b7\\nIncrease in the systolic pressure and pulse pressure.\\n\\uf0b7\\nCentral venous Pressure (CVP) > 12 mmHg, Pulmonary Capillary Wedge Pressure\\n(PCWP) >20 mmHg in the presence of pulmonary oedema.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 77, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n62\\n\\uf0b7\\nSeptic shock: sepsis with hypotension that is unresponsive to fluid resuscitation plus\\norgan dysfunction or perfusion abnormalities as listed for severe sepsis.\\n\\uf0b7\\nMultiple Organ Dysfunction Syndrome (MODS): dysfunction of more than one organ,\\nrequiring intervention homeostasis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 78, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n63\\n\\uf0b7\\nFever or hypothermia may be seen in sepsis. Hypothermia is more often seen in patients\\nat the extremes of age and in immunocompromised patients.\\n\\uf0b7\\nOther signs include tachycardia, wide pulse pressure, tachypnea, and hypotension.\\n\\uf0b7\\nMental status changes ranging from mild disorientation to coma are commonly seen.\\n\\uf0b7\\nOphthalmic manifestations include retinal hemorrhages, cotton-wool spots, and\\nconjunctival petechiae.\\n\\uf0b7\\nCardiovascular manifestations initially include vasodilation, resulting in warm\\nextremities.\\n\\uf0b7\\nCardiac output is maintained early in sepsis through a compensatory tachycardia. As\\nsepsis progresses, hypotension may occur. Patients in septic shock may demonstrate a\\ndiminished response to volume replacement.\\n\\uf0b7\\nRenal manifestations include azotemia, oliguria, and active urinary sediment due to\\nacute tubular necrosis.\\n\\uf0b7\\nHepatic dysfunction present as cholestatic jaundice, increases in transaminases, alkaline'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 78, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Renal manifestations include azotemia, oliguria, and active urinary sediment due to\\nacute tubular necrosis.\\n\\uf0b7\\nHepatic dysfunction present as cholestatic jaundice, increases in transaminases, alkaline\\nphosphatase, and S.bilirubin. Painless mucosal erosions may occur in the stomach and\\nduodenum and cause upper GI bleeds.\\n\\uf0b7\\nSkin findings include cellulitis, erysipelas, and fasciitis. Hypotension and disseminated\\nintravascular coagulation (DIC) can also produce skin changes, including acrocyanosis\\nand necrosis of peripheral tissues.\\n\\uf0b7\\nHematologic changes include neutropenia, neutrophilia, thrombocytopenia, and DIC.\\nThrombocytopenia occurs in over 30 percent of patients with sepsis. DIC is more often\\nassociated with gram-negative sepsis. Decompensated DIC presents with clinical\\nbleeding and thrombosis. Laboratory studies can show thrombocytopenia, prolonged\\nprothrombin time (PT) and partial prothromboplastin time (PTT), decreased fibrinogen'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 78, 'source_type': 'Authorotative', 'priority': '1'}, page_content='bleeding and thrombosis. Laboratory studies can show thrombocytopenia, prolonged\\nprothrombin time (PT) and partial prothromboplastin time (PTT), decreased fibrinogen\\nlevel and antithrombin levels, and increased fibrin monomer, fibrin split values, and D-\\ndimer values.\\n\\uf0b7\\nHyperglycemia may be the result of increased catecholamines, cortisol, and glucagon.\\nIncreased insulin resistance, decreased insulin production, and impaired utilization of\\ninsulin may further contribute to hyperglycemia.\\n\\uf0b7\\nArterial blood gas (ABG) studies in early sepsis may reveal hypoxemia and respiratory\\nalkalosis. As perfusion worsens and glycolysis increases, a metabolic acidosis results.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nAggressive airway management with high-flow oxygen and endotracheal intubation\\n\\uf0b7\\nRapid infusion of crystalloid IV fluid (Ringer’s lactate or normal saline) at 500 ml (20\\nml/kg in children) every 5 to 10 min; 4 to 6 L (60 ml/kg in children)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n64\\n\\uf0b7\\nRemove source of infection-remove indwelling IV catheters and send the tips for\\nquantitative culture. Replace urinary drainage catheters if obstructed. Consult the\\nappropriate specialist for drainage of intra-abdominal, sinus, or soft tissue abscesses.\\n\\uf0b7\\nMonitor blood pressure, pulse, capillary refill, central venous pressure, pulmonary\\ncapillary wedge pressure, and urine output (>30 ml/h in adults, 1 ml/kg/h in children) to\\nevaluate therapy. If blood loss is suspected, blood replacement may be necessary\\nPharmacological treatment\\n\\uf0b7\\nInj. dopamine 5 to 20 µg/kg/min, titrated to response, if hypotension is refractory to IV\\nfluid.\\n\\uf0b7\\nIf blood pressure remains <70 mmHg despite preceding measures, Inj. norepinephrine 8-\\n12 µg/min loading dose and a 2-4 µg/min infusion to maintain mean arterial blood\\npressure of at least 60 mmHg should be started.\\n\\uf0b7\\nEmpiric antibiotic therapy. Dosages should be the maximum allowed and given'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content='pressure of at least 60 mmHg should be started.\\n\\uf0b7\\nEmpiric antibiotic therapy. Dosages should be the maximum allowed and given\\nintravenously. When source is unknown, therapy should be effective against both gram-\\npositive and gram-negative organisms.\\n\\uf0b7\\nIn adults, a third-generation cephalosporin (ceftriaxone 1 g IV, cefotaxime 2 g IV, or\\nceftazidime 2 g IV) or an antipseudomonal beta lactamase–susceptible penicillin can also\\nbe used. Addition of an aminoglycoside (gentamicin 2 mg/ kg IV, tobramycin 2 mg/kg\\nIV) to this regimen is recommended.\\n\\uf0b7\\nIn immunocompromised adults, ceftazidime 2 g IV, imipenem 750 mg IV, or meropenem\\n1 g IV alone is acceptable. If gram-positive infection is suspected (indwelling catheter or\\nIV drug use), oxacillin 2 g IV or vancomycin 15 mg/ kg IV should be added. If an\\nanaerobic source is suspected (intraabdominal, genital tract, odontogenic, and necrotizing\\nsoft tissue infection), metronidazole 7.5 mg/kg IV or clindamycin 900 mg IV should'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content='anaerobic source is suspected (intraabdominal, genital tract, odontogenic, and necrotizing\\nsoft tissue infection), metronidazole 7.5 mg/kg IV or clindamycin 900 mg IV should\\nadditionally be administered. If Legionella is a potential source, erythromycin 500 mg IV\\nshould be added.\\n\\uf0b7\\nAcidosis to be treated with oxygen, ventilation, and IV fluid replacement. If acidosis is\\nsevere, administration of sodium bicarbonate 1 meq/kg IV is acceptable as directed by\\nABGs.\\n\\uf0b7\\nDIC should be treated with fresh-frozen plasma 15 to 20 ml/kg initially to keep PT at 1.5\\nto 2 times normal and treated with platelet infusion to maintain serum concentration of 50\\nto 100,000.\\n\\uf0b7\\nInj. hydrocortisone (100 mg IV)  for adrenal insufficiency\\nORGANOPHOSPHOROUS POISONING\\nOrganophosphorous (OP) insecticides are highly lipid soluble and are rapidly absorbed via\\ndermal, gastrointestinal and respiratory routes. Common agents for OP poisoning are\\nmalathion, parathion, chlorpyrifos, dichlorvos, methylparathion\\nwhich'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 79, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dermal, gastrointestinal and respiratory routes. Common agents for OP poisoning are\\nmalathion, parathion, chlorpyrifos, dichlorvos, methylparathion\\nwhich\\nare used as\\ninsecticides.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 80, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n65\\n\\uf0b7\\nClinical features include dyspnoea, tightness around chest, nausea, vomiting, diarrhea,\\nabdominal pain, excessive sweating and salivation, miosis, blurred vision, lacrimation,\\nheadache, giddiness, drowsiness, bradycardia, arrhythmias, QT prolongation,\\nhypotension, fasciculation, muscle weakness, seizures and coma.\\n\\uf0b7\\nDiagnosis can be confirmed by red blood cell (RBC) cholinesterase and plasma\\ncholinesterase level which is reduced to 20% of the normal values.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nMaintain patent airway: oral airway/intubation/mechanical ventilation if required\\n\\uf0b7\\nMonitor vitals- temperature, pulse, blood pressure, respiratory rate\\n\\uf0b7\\nStart intravenous line placement: maintenance IV fluids\\n\\uf0b7\\nDecontamination: remove of all clothes\\n\\uf0b7\\nGastric lavage with activated charcoal and sample collection\\n\\uf0b7\\nWash  skin with soap and water\\nPharmacological treatment\\n\\uf0b7\\nInj. atropine 2 mg IV bolus, repeat every 5-10 minutes until atropinization (pulse'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 80, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nWash  skin with soap and water\\nPharmacological treatment\\n\\uf0b7\\nInj. atropine 2 mg IV bolus, repeat every 5-10 minutes until atropinization (pulse\\n>80/min, pupillary dilation and drying of secretions) followed by atropine IV infusion at\\n0.02-0.08 mg/kg/min to maintain atropinasation (glycopyrronium can be used in place\\natropine to avoid CNS toxicity).\\n\\uf0b7\\nInj. pralidoxime IV 30mg/kg immediately followed by 8 mg/kg/hr continued for at least\\n24 hours. If an infusion cannot be used, 30 mg/kg every 4 hourly.\\n\\uf0b7\\nInj. obidoxime 4 mg/kg bolus initially followed by 0.5 mg/kg/hr infusion Alternatively, 4\\nmg/kg bolus followed by 2 mg/kg every 4 hourly.\\n\\uf0b7\\nIV crystalloids: normal saline/ringer’s lactate.\\n\\uf0b7\\nBenzodiazepines: midazolam/lorazepam/diazepam for treatment and prophylaxis of\\nseizures\\nKEROSENE AND PETROL POISONING\\nSalient features\\n\\uf0b7\\nMost common accidental poisoning in children.\\n\\uf0b7\\nInhalational of vapours or pulmonary aspiration can cause toxicity. The lethal dose is 30-100\\nml.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 80, 'source_type': 'Authorotative', 'priority': '1'}, page_content='KEROSENE AND PETROL POISONING\\nSalient features\\n\\uf0b7\\nMost common accidental poisoning in children.\\n\\uf0b7\\nInhalational of vapours or pulmonary aspiration can cause toxicity. The lethal dose is 30-100\\nml.\\n\\uf0b7\\nMild- breathing difficulty, throat pain, nausea / vomiting, vision loss, low blood pressure,\\nconvulsions, headache, weakness, burns / irritation.\\n\\uf0b7\\nSevere: pulmonary edema, hemoptysis, mental confusion, hallucination, stupor, cyanosis,\\nconvulsions, coma, death (due to ventricular fibrillation / respiratory failure).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 81, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n66\\n\\uf0b7\\nGastric irritation within half an hour of taking the poison.\\n\\uf0b7\\nBitter taste, dry mouth and throat, burning pain in the stomach and difficulty in swallowing\\nand talking.\\n\\uf0b7\\nGiddiness, ataxia, incoordination of muscles, flushed appearance of the face, dry hot skin,\\nrise in temperature, diplopia, dilated pupils with loss of accommodation, reddening of the\\nconjunctiva and drowsiness. Sometimes, an erythematous rash appears all over the body.\\n\\uf0b7\\nFull, bounding pulse which later becomes weak and irregular.\\n\\uf0b7\\nMuttering delirium, tries to run away from the bed, picks at bed clothes, tries to pull\\nimaginary threads from the tips of his fingers and develops dreadful hallucinations of sight\\nand hearing. The condition may pass on to stupor, convulsions, coma and sometimes death\\nfrom respiratory failure.\\n\\uf0b7\\nDeath may occur within 4-24 hours.\\nInvestigations\\nChest x ray: perihilar densities, basal pneumonitis, atelectasis, consolidation\\nTreatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 81, 'source_type': 'Authorotative', 'priority': '1'}, page_content='from respiratory failure.\\n\\uf0b7\\nDeath may occur within 4-24 hours.\\nInvestigations\\nChest x ray: perihilar densities, basal pneumonitis, atelectasis, consolidation\\nTreatment\\n\\uf0b7\\nRemove all contaminated clothes of the patient\\n\\uf0b7\\nFlush the skin and oral cavity for at least 15 minutes\\n\\uf0b7\\nIf the chemical is swallowed, immediately give the person water or milk\\n\\uf0b7\\nIf the person breathed in the poison, immediately move him or her to fresh air with patent\\nairway with head low position\\n\\uf0b7\\nDo not induce emesis\\n\\uf0b7\\nPut the patient on monitor for vital signs – temperature, pulse, blood pressure, respiratory\\nrate\\n\\uf0b7\\nProvide oxygen through nasal cannula or face mask\\n\\uf0b7\\nTake IV line – start intravenous crystalloids as a supportive therapy\\n\\uf0b7\\nPatients should be monitored for respiratory complications.\\nDATURA POISONING\\nDatura stramonium (thorn apple) grows in India at high altitudes. The seeds and fruits are the\\nmost poisonous parts of the plant with hyoscine, hyoscyamine and traces of atropine, as the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 81, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Datura stramonium (thorn apple) grows in India at high altitudes. The seeds and fruits are the\\nmost poisonous parts of the plant with hyoscine, hyoscyamine and traces of atropine, as the\\nactive principles.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nStomach wash with 1:10,000 potassium permanganate solution or 5% tannic acid\\nsolution.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 82, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n67\\n\\uf0b7\\nDecontamination of the patient must be individualized, based on time since exposure,\\ntype of anticholinergic agent involved, route of exposure, probable amount ingested, and\\nseverity of the clinical condition.\\n\\uf0b7\\nEarly gastric emptying (within 1 hour) may be considered for large ingestions, when an\\nasymptomatic patient presents immediately after ingestion.\\n\\uf0b7\\nMeasure core body temperature with a flexible rectal probe. Aggressive temperature\\nreduction with ice water or evaporative cooling with mist and fans should be the first\\npriority in the severely hyperthermic patient. Antipyretic agents and simple cooling\\nblankets are ineffective.\\nPharmacological treatment\\n\\uf0b7\\nBenzodiazepines like midazolam or lorazepam can be used to control agitation and\\nsedation.\\nInj. midazolam 0.01-0.1 mg/kg IV or Inj. lorazepam 0.05-0.1 mg/kg IV\\n\\uf0b7\\nIn severe poisoning, Inj. physostigmine 1.2 mg IM or IV, to be repeated after half an'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 82, 'source_type': 'Authorotative', 'priority': '1'}, page_content='sedation.\\nInj. midazolam 0.01-0.1 mg/kg IV or Inj. lorazepam 0.05-0.1 mg/kg IV\\n\\uf0b7\\nIn severe poisoning, Inj. physostigmine 1.2 mg IM or IV, to be repeated after half an\\nhour, if necessary. Watch for side effects (bradycardia, heart block, excessive secretions).\\n\\uf0b7\\nInj. diazepam 10 mg IV diluted slowly may be given for convulsions.\\nABDOMINAL INJURY\\nAbdominal injuries are quite common in this new era and it is must for a surgeon to quickly\\nassess and promptly manage such injuries which can be fatal. They can be broadly classified\\nas penetrating abdominal injury and blunt abdominal injury.\\nI.\\nPenetrating abdominal injury\\n\\uf0b7\\nPenetrating abdominal injuries caused by sharp weapon injury, missile injury/gunshot\\ninjury etc\\n\\uf0b7\\nHistory of time and place of injury, nature of injury, direction of injuring weapon\\n\\uf0b7\\nPhysical examination assess vitals, assess wound thoroughly, look for peritoneal breach\\nInvestigations\\n\\uf0b7\\nGenerally no investigations are required before proceeding for laparotomy.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 82, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPhysical examination assess vitals, assess wound thoroughly, look for peritoneal breach\\nInvestigations\\n\\uf0b7\\nGenerally no investigations are required before proceeding for laparotomy.\\n\\uf0b7\\nX-ray abdomen standing can be done in cases where peritoneal breach is in doubt\\nTreatment\\n\\uf0b7\\nResuscitate the patient, secure airway, maintain breathing, maintain circulation, arrange\\nfor compatible blood.\\n\\uf0b7\\nEmergency exploratory laparotomy and further management according to organ injured.\\nII. Blunt abdominal injury\\nBlunt abdominal injuries can be due to assault by blunt objects, road traffic accidents and\\nfalls.\\nInvestigations\\n\\uf0b7\\nHaemoglobin levels,  hematocrit, X-ray abdomen standing'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 83, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n68\\n\\uf0b7\\nThe common agents causing chemical injuries are alkalis (lime, cement, plasters),\\nacids, solvents, detergents and irritants. Alkalis tend to penetrate more deeply than\\nacids, as the latter coagulate surface proteins, forming a protective barrier.\\n\\uf0b7\\nSymptoms include redness, pain, photophobia, blepharospasm and watering of eyes.\\n\\uf0b7\\nCorneal epithelial defects ranging from scattered superficial punctate keratopathy\\n(SPK), to focal epithelial loss, to sloughing of the entire epithelium may occur.\\n\\uf0b7\\nFocal areas of  conjunctival  chemosis, hyperemia, hemorrhages, or a combination of\\nthese\\n\\uf0b7\\nMild eyelid edema, mild anterior chamber (AC) reaction and first- and second-degree\\nburns of the periocular skin.\\n\\uf0b7\\nUSG- abdomen, CECT- abdomen and pelvis.\\nTreatment\\n\\uf0b7\\nResuscitate the patient, secure airway, maintain breathing, maintain circulation, arrange\\nfor compatible blood.\\n\\uf0b7\\nTemperature, pulse, respiratory rate, blood pressure (TPRBP) charting, abdominal girth\\n(AG) charting.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 83, 'source_type': 'Authorotative', 'priority': '1'}, page_content='for compatible blood.\\n\\uf0b7\\nTemperature, pulse, respiratory rate, blood pressure (TPRBP) charting, abdominal girth\\n(AG) charting.\\n\\uf0b7\\nManagement of blunt abdominal trauma depends upon vitals of the patients and organs\\ninvolved as per seen in USG- Abdomen and Contrast Enhanced Computed Tomography\\n(CECT) abdomen.\\n\\uf0b7\\nAll patients whose vitals are unstable are to be explored. Emergency exploratory\\nlaparotomy and followed by management according to organ involved.\\n\\uf0b7\\nAll patients whose vitals are stable are reviewed by CECT-abdomen and pelvis and\\nmanaged according to organs involved and grade of injury.\\nFOREIGN BODY IN EAR\\nOccasionally a fly or an insect gets trapped in the external canal and cause distress and\\ndiscomfort. The foreign body could be animate-insects or inanimate, organic -seeds or\\ninorganic -stones, beads, cotton buds, match sticks etc.\\nTreatment\\n\\uf0b7\\nInsects - immobilized using oil and remove with forceps\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 83, 'source_type': 'Authorotative', 'priority': '1'}, page_content='inorganic -stones, beads, cotton buds, match sticks etc.\\nTreatment\\n\\uf0b7\\nInsects - immobilized using oil and remove with forceps\\n\\uf0b7\\nVegetable foreign bodies – remove with foreign body hook (syringing is not advisable).\\n\\uf0b7\\nNon-organic foreign bodies- remove with syringing and foreign body hook.\\n\\uf0b7\\nImpacted foreign bodies- remove under general anesthesia using the microscope\\nCHEMICAL INJURIES OF EYE\\nSalient features\\nInvestigations'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 84, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n69\\n\\uf0b7History: Time of injury? Specific type of chemical? Time between exposure and irrigation\\nof eyes? Duration and type of irrigation? Was the patient wearing eye protection?\\n\\uf0b7Slit-lamp examination with fluorescein staining.\\n\\uf0b7If you suspect an epithelial defect but do not see one with fluorescein staining, repeat the\\nfluorescein application to the eye. Sometimes the defect is slow to take up the dye. If the\\nentire epithelium sloughs off, only Bowman membrane remains, which may take up\\nfluorescein poorly.\\n\\uf0b7Eyelid eversion to search for foreign bodies.\\n\\uf0b7Evaluate for conjunctival ulcerations/defects.\\n\\uf0b7Check the intraocular pressure (IOP). In the presence of a distorted cornea, IOP may be\\nmost accurately measured with a tonometer.\\nGrading of severity\\n\\uf0b7\\nGrade 1 is characterized by clear cornea (epithelial damage only) and no limbal ischemia\\n(excellent prognosis).\\n\\uf0b7\\nGrade 2 shows hazy cornea but with visible iris details and less than one-third of the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 84, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(excellent prognosis).\\n\\uf0b7\\nGrade 2 shows hazy cornea but with visible iris details and less than one-third of the\\nlimbus being ischemic (good prognosis).\\n\\uf0b7\\nGrade 3 manifests total loss of corneal epithelium, stromal haze obscuring iris details and\\nbetween one-third and half limbal ischemia (guarded prognosis).\\n\\uf0b7Grade 4 shows opaque cornea and more than half limbal ischemia (very poor prognosis).\\nNon pharmacological treatment\\nA. Copious irrigation\\n\\uf0b7\\nPlace an eyelid speculum and instill topical anesthetic.\\n\\uf0b7\\nCopious irrigation using saline or ringer lactate solution for at least 30 minutes. Tap water\\ncan be used in the absence of these solutions and may be more efficacious in inhibiting\\nelevated intracameral pH than normal saline for alkali burns.\\n\\uf0b7\\nCheck pH and if not neutral, repeat irrigation.\\n\\uf0b7\\nNEVER use acidic solutions to neutralize alkalis or vice versa.\\nB. Double-eversion of the upper eyelid:\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 84, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nCheck pH and if not neutral, repeat irrigation.\\n\\uf0b7\\nNEVER use acidic solutions to neutralize alkalis or vice versa.\\nB. Double-eversion of the upper eyelid:\\n\\uf0b7\\nIt should be performed so that any retained particulate matter trapped in the fornices is\\nidentified and removed with cotton tip applicator.\\n\\uf0b7\\nCalcium hydroxide particles may be more easily removed with a cotton-tipped applicator\\nsoaked in disodium ethylenediaminetetraacetic acid (EDTA).\\nC. Debridement: Necrosed area of conjunctiva and cornea should be debrided to promote\\nhealing.\\nD. Hospitalization: It is required for severe injuries to ensure regular eye drop instillation.\\nPharmacological treatment\\nThe main aims of treatment of chemical burns are to reduce inflammation, promote epithelial\\nregeneration and prevent corneal ulceration.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 85, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n70\\n\\uf0b7\\nSymptoms include foreign body sensation, watering and redness with history of\\ntrauma\\n\\uf0b7\\nConjunctival or corneal foreign body with or without rust ring, conjunctival injection,\\neyelid edema, mild anterior chamber reaction, and superficial punctuate keraptopathy.\\n\\uf0b7\\nSteroids\\n-\\nIt reduces inflammation. However, they also impair stromal healing by reducing\\ncollagen synthesis and inhibiting fibroblast migration.\\n-\\nSo topical steroids may be used initially (usually 4–8 times daily, strength depending\\non injury severity) but must be tapered off after 7–10 days when sterile corneal\\nulceration is most likely to occur.\\n-\\nSteroids may be replaced by topical NSAIDs, which do not affect keratocyte function.\\n\\uf0b7\\nCycloplegia may improve comfort.\\n\\uf0b7\\nTopical antibiotic drops are used for prophylaxis of bacterial infection\\n\\uf0b7\\nAscorbic acid\\nImproves wound healing and promotes the synthesis of mature collagen by corneal'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 85, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTopical antibiotic drops are used for prophylaxis of bacterial infection\\n\\uf0b7\\nAscorbic acid\\nImproves wound healing and promotes the synthesis of mature collagen by corneal\\nfibroblasts. Topical sodium ascorbate 10% is given 2-hourly in addition to a systemic\\ndose of 1–2 g vitamin C (L-ascorbic acid) QID (not in patients with renal disease).\\n\\uf0b7\\nTetracyclines should be considered if there is significant corneal melting and can be\\nadministered both topically (tetracycline ointment QID) and systemically (doxycycline\\n100 mg BD tapering to once daily).\\n\\uf0b7\\nSymblepharon should be prevented by lysis of developing adhesions with a sterile glass\\nrod or damp cotton bud.\\nSurgical treatment\\n\\uf0b7\\nEarly surgery may be necessary to promote revascularization of the limbus, restore the\\nlimbal cell population and re-establish the fornices.\\n\\uf0b7\\nKeratoplasty should be delayed for at least 6 months and preferably longer to allow\\nmaximal resolution of inflammation.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 85, 'source_type': 'Authorotative', 'priority': '1'}, page_content='limbal cell population and re-establish the fornices.\\n\\uf0b7\\nKeratoplasty should be delayed for at least 6 months and preferably longer to allow\\nmaximal resolution of inflammation.\\n\\uf0b7\\nKeratoprosthesis may be required in very severely damaged eyes because the results of\\nconventional grafting are poor.\\nCORNEAL AND CONJUNCTIVAL FOREIGN BODIES IN EYE\\nSalient features\\nInvestigations\\n\\uf0b7\\nDetermine the mechanism of injury [e.g., metal striking metal, power tools or weed-\\nwhackers may suggest an intraocular foreign body (IOFB)]. Attempt to determine the\\nsize, weight, velocity, force, and shape of the object. Document visual acuity before any\\nprocedure is performed.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 86, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n71\\n\\uf0b7\\nExamine closely for iris tears and transillumination defects, lens opacities, AC\\nshallowing, and asymmetrically low IOP.\\n\\uf0b7\\nIf there is no evidence of perforation, evert the eyelids and inspect the fornices for\\nadditional foreign bodies.\\n\\uf0b7\\nDilate the eye and examine the posterior segment for a possible intraocular foreign body\\n\\uf0b7\\nAvoid magnetic resonance imaging (MRI) if there is a history of possible metallic foreign\\nbody.\\nTreatment\\nCorneal foreign body\\n\\uf0b7\\nApply topical anesthetic (e.g., proparacaine 0.5% eye drops).\\n\\uf0b7\\nRemove the corneal foreign body with a cotton tip applicator, 26 no needle or fine forceps\\nat a slit lamp.\\n\\uf0b7\\nMultiple superficial foreign bodies may be more easily removed by irrigation.\\n\\uf0b7\\nRemove the rust ring as completely as possible on the first attempt. This may require an\\nophthalmic drill. It is sometimes safer to leave a deep, central rust ring to allow time for'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 86, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nRemove the rust ring as completely as possible on the first attempt. This may require an\\nophthalmic drill. It is sometimes safer to leave a deep, central rust ring to allow time for\\nthe rust to migrate to the corneal surface, at which point it can be removed more easily.\\n\\uf0b7\\nMeasure the size of the resultant corneal epithelial defect.\\n\\uf0b7\\nTreat epithelial defect with antibiotics and carboxy methyl cellulose (CMC) eyedrops, if\\nnecessary pad it.\\n\\uf0b7\\nAlert the patient to return as soon as possible if there is any worsening of symptoms.\\nConjunctival foreign body\\n\\uf0b7\\nRemove foreign body under topical anesthesia.\\n-\\nMultiple or loose foreign bodies can often be removed with saline irrigation.\\n-\\nA foreign body can be removed with a cotton-tipped applicator soaked in topical\\nanesthetic or with fine forceps.\\n-\\nFor deeply embedded foreign bodies, consider pretreatment with a cotton-tipped\\napplicator soaked in phenylephrine 2.5% to reduce conjunctival bleeding.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 86, 'source_type': 'Authorotative', 'priority': '1'}, page_content='anesthetic or with fine forceps.\\n-\\nFor deeply embedded foreign bodies, consider pretreatment with a cotton-tipped\\napplicator soaked in phenylephrine 2.5% to reduce conjunctival bleeding.\\n-\\nSmall, relatively inaccessible, buried subconjunctival foreign bodies may sometimes\\nbe left in the eye without harm unless they are infectious or proinflammatory.\\nOccasionally, they will surface with time, at which point they may be removed more\\neasily.\\n\\uf0b7\\nSweep the conjunctival fornices with a glass rod or cotton-tipped applicator soaked with a\\ntopical anesthetic to catch any remaining pieces.\\n\\uf0b7\\nA topical antibiotic (e.g., bacitracin ointment BD; trimethoprim/polymyxin B or\\nmoxifloxacin/ciprofloxacin/ofloxacin drops QID) may be used.\\n\\uf0b7\\nArtificial tears may be given for irritation.\\nFollow-up'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 87, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n72\\n\\uf0b7\\nCorneal foreign body: Follow up as with corneal abrasion. If residual rust ring remains,\\nreevaluate in 24 hours.\\n\\uf0b7\\nConjunctival foreign body: Follow up as needed, or in 1 week if residual foreign bodies\\nwere left in the conjunctiva.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 88, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n73\\n\\uf0b7\\nThe patient presents with blurred vision, history of blunt trauma and pain in eye.\\n\\uf0b7\\nBlood or clot or both can be observed in the anterior chamber, usually visible without a\\nslit lamp.\\n\\uf0b7\\nA total (100%) hyphema may be black or red. When black, it is called an “8-ball” or\\n“black ball” hyphema.\\n\\uf0b7\\nWhen red, the circulating blood cells may settle with time to become less than a 100%\\nhyphema.\\nTRAUMATIC HYPHEMA\\nSalient features\\nInvestigations\\n\\uf0b7\\nHistory of traumatic event including force, velocity, type, and direction of injury should\\nbe taken.\\n\\uf0b7\\nUse of medications with anticoagulant properties [aspirin, NSAIDs, warfarin  or\\nclopidogrel], personal or family history of sickle cell disease/trait, symptoms of\\ncoagulopathy (e.g., bloody nose-blowing, bleeding gums with tooth brushing, easy\\nbruising)\\n\\uf0b7\\nOcular examination, first ruling out a ruptured globe. Document the extent (e.g., measure\\nthe hyphema height) and location of any clot and blood.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 88, 'source_type': 'Authorotative', 'priority': '1'}, page_content='bruising)\\n\\uf0b7\\nOcular examination, first ruling out a ruptured globe. Document the extent (e.g., measure\\nthe hyphema height) and location of any clot and blood.\\n\\uf0b7\\nMeasure the IOP. Perform a dilated retinal evaluation without scleral depression.\\n\\uf0b7\\nConsider a CT scan of the orbits and brain (axial and coronal views, with 1- to 3-mm\\nsections through the orbits) when indicated (e.g., suspected orbital fracture or IOFB, loss\\nof consciousness).\\nTreatment\\n\\uf0b7\\nConfine either to bed rest with bathroom privileges or to limited activity. Elevate head of\\nbed to allow blood to settle.\\n\\uf0b7\\nPlace a shield (metal or clear plastic) over the involved eye at all times. Do not patch\\nbecause this prevents recognition of sudden visual loss in the event of a rebleed.\\n\\uf0b7\\nAtropine 1% solution BD to TDS or scopolamine 0.25% BD to TDS.\\n\\uf0b7\\nNo aspirin-containing products or NSAIDs.\\n\\uf0b7\\nMild analgesics only (e.g., acetaminophen). Avoid sedatives.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 88, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAtropine 1% solution BD to TDS or scopolamine 0.25% BD to TDS.\\n\\uf0b7\\nNo aspirin-containing products or NSAIDs.\\n\\uf0b7\\nMild analgesics only (e.g., acetaminophen). Avoid sedatives.\\n\\uf0b7\\nUse topical steroids (e.g., prednisolone acetate 1% four to eight times per day) if any\\nsuggestion of iritis (e.g., photophobia, deep ache, ciliary flush), evidence of lens capsule\\nrupture, any protein (e.g., fibrin), or definitive white blood cells in anterior\\nchamber. Reduce the frequency of steroids as soon as signs and symptoms resolve to\\nreduce the likelihood of steroid-induced glaucoma.\\n\\uf0b7\\nFor increased IOP:\\n-\\nStart with a beta-blocker (e.g., timolol 0.5% or levobunolol 0.5% BD).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n74\\n-\\nIf IOP still high, add topical alpha-agonist (e.g., apraclonidine 0.5%, or brimonidine\\n0.2% TDS) or topical carbonic anhydrase inhibitor (e.g., dorzolamide 2%, or\\nbrinzolamide 1% TDS). Avoid prostaglandin analogs and miotics (may increase\\ninflammation). In children under 5, topical alpha-agonists are contraindicated.\\n-\\nIf topical therapy fails, add acetazolamide (500 mg orally, BD for adults, 20\\nmg/kg/day divided three times per day for children) or mannitol [1 to 2 g/kg\\nintravenously IV over 45 minutes once a day]. If mannitol is necessary to control the\\nIOP, surgical evacuation may be imminent.\\n\\uf0b7\\nIf hospitalized, use antiemetics for severe nausea or vomiting [e.g., prochlorperazine 10\\nmg IM TDS or 25 mg BD].\\n\\uf0b7\\nIndications for surgical evacuation of hyphema:\\n-\\nCorneal stromal blood staining.\\n-\\nSignificant visual deterioration.\\n-\\nHyphema that does not decrease to <50% by 8 days [to prevent peripheral anterior\\nsynechiae (PAS)].\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\nCorneal stromal blood staining.\\n-\\nSignificant visual deterioration.\\n-\\nHyphema that does not decrease to <50% by 8 days [to prevent peripheral anterior\\nsynechiae (PAS)].\\n-\\nIOP >60 mm Hg for >48 hours, despite maximal medical therapy (to prevent optic\\natrophy).\\n-\\nIOP >25 mm Hg with total hyphema for >5 days (to prevent corneal stromal blood\\nstaining).\\nFollow up\\n\\uf0b7\\nThe patient should be seen daily for 3 days after initial trauma to check visual acuity,\\nIOP, and for a slit-lamp examination.\\n\\uf0b7\\nLook for new bleeding, increased IOP, corneal blood staining, and other intraocular\\ninjuries as the blood clears (e.g., iridodialysis; subluxated, disclocated, or cataractous\\nlens). Hemolysis, which may appear as bright red fluid, should be distinguished from a\\nrebleed, which forms a new, bright red clot. If the IOP is increased, treat as described\\nearlier.\\n\\uf0b7\\nThe patient should be instructed to return immediately if a sudden increase in pain or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content='rebleed, which forms a new, bright red clot. If the IOP is increased, treat as described\\nearlier.\\n\\uf0b7\\nThe patient should be instructed to return immediately if a sudden increase in pain or\\ndecrease in vision is noted (which may be symptoms of a rebleed or secondary\\nglaucoma). If a significant rebleed or an intractable IOP increase occurs, the patient\\nshould be hospitalized.\\n\\uf0b7\\nAfter the initial close follow-up period, the patient may be maintained on a long-acting\\ncycloplegic (e.g., atropine 1% solution OD to BD, scopolamine 0.25% OD to BD),\\ndepending on the severity of the condition. Topical steroids may be tapered as the blood,\\nfibrin, and white blood cells resolve.\\n\\uf0b7\\nGlasses or eye shield during the day and eye shield at night. As with any patient,\\nprotective eyewear (polycarbonate or Trivex lenses) should be worn any time a\\nsignificant potential for an eye injury exists.\\n\\uf0b7\\nThe patient must refrain from strenuous physical activities (including bearing down or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 89, 'source_type': 'Authorotative', 'priority': '1'}, page_content='significant potential for an eye injury exists.\\n\\uf0b7\\nThe patient must refrain from strenuous physical activities (including bearing down or\\nvalsalva maneuvers) for 1 week after the initial injury or rebleed. Normal activities may'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 90, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n75\\nbe resumed 1 week from the date of injury or rebleed. This period should be extended if\\nblood remains in the anterior chamber.\\n\\uf0b7\\nIf patient was hospitalized, see 2 to 3 days after discharge. If not hospitalized, see several\\ndays to 1 week after initial daily follow-up period, depending on severity of condition\\n(amount of blood, potential for IOP increase, other ocular or orbital pathologic\\nprocesses).\\nDOG BITE (RABIES)\\nRabies can be transmitted by dog bite or following non-bite exposure to mucous membrane\\nor an open wound (one that has bled within 24 hours) with saliva. Bites from dogs in\\ndeveloping countries should always be considered high risk, and prophylaxis should be given\\nwithout waiting for test results.\\nSalient features\\nGuidelines for Determining Need for Rabies Prophylaxis (Adapted from Human rabies\\nprevention—United States, 1999. Recommendations of the Advisory Committee on\\nImmunization Practices)\\nAnimal type & evaluation'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 90, 'source_type': 'Authorotative', 'priority': '1'}, page_content='prevention—United States, 1999. Recommendations of the Advisory Committee on\\nImmunization Practices)\\nAnimal type & evaluation\\nPost-exposure prophylaxis recommendations\\n\\uf0b7\\nDogs, cats, and ferrets\\nDo not start vaccination unless animal develops\\n(healthy and available for 10-days)\\nclinical signs of rabies during observation\\nperiod*\\n\\uf0b7\\nRabid or suspected rabid\\nImmediately vaccinate.\\n\\uf0b7\\nUnknown (escaped)\\nConsult public health officials.\\n* 10-days observation period, begin postexposure prophylaxis at the first sign of rabies. If the\\nanimal exhibits clinical signs of rabies, it should be euthanized immediately and tested.\\nTreatment of dog bite and Post-exposure prophylaxis of rabies\\nThree steps: wound care, passive immunization, and active immunization.\\nImmediate measures\\n\\uf0b7\\nEarly treatment is essential (less than 3 hours after the bite/injury occurred).\\n\\uf0b7\\nProdromal symptoms - such as headache, malaise, sore throat and fever last about 3-4\\ndays. Pain and tingling at the bitten site.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 90, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nProdromal symptoms - such as headache, malaise, sore throat and fever last about 3-4\\ndays. Pain and tingling at the bitten site.\\n\\uf0b7\\nStage of excitation - patient is intolerant to noise, bright light or a cold draught.\\nAerophobia may be present. Hydrophobia is a characteristic symptom of rabies.\\nExamination shows increased reflexes, dilatation of pupils, increased sweating,\\nlacrimation and salivation. Mental changes include fear of death, anger, irritability and\\ndepression.\\n\\uf0b7\\nConvulsions may occur resulting in death, paralysis and coma. The total duration of\\nillness lasts for 2-3 days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 91, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n76\\n\\uf0b7\\nScrub the wound and its edges with soap and water.\\n\\uf0b7\\nIf the wound is a puncture, swab deeply in the wound and around its edges.\\n\\uf0b7\\nFollow with application of a virucidal agent: 1% or 2% benzalkonium chloride or\\npovidone-iodine and rinse.\\n\\uf0b7\\nTetanus prophylaxis should be given as indicated by patient’s current immunization\\nstatus.\\n\\uf0b7\\nDo not suture bite wounds immediately. If suturing is required, hold it for 24-48 hours,\\napplying minimum number of stitches under the cover of antirabies immunoglobulin\\nlocally.\\nNon immunized persons\\n\\uf0b7\\nHuman rabies immuno globulin (HRIG)- full dose should be infiltrated around wound(s),\\nand the  remaining volume should be administered IM at an anatomic site distant from\\nvaccine administration. Do not administer vaccine in the same syringe as HRIG may\\npartially suppress active production of antibody.\\n\\uf0b7\\nVaccine Human diploid cell vaccine (HDCV) injected IM (deltoid area), one each on'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 91, 'source_type': 'Authorotative', 'priority': '1'}, page_content='partially suppress active production of antibody.\\n\\uf0b7\\nVaccine Human diploid cell vaccine (HDCV) injected IM (deltoid area), one each on\\ndays 0, 3, 7, 14, and 28. The vaccine should be administered in the deltoid rather than the\\ngluteal region, to avoid accidental injection into fat, which will prevent antibody\\nformation.\\n\\uf0b7\\nRabies vaccine adsorbed (RVA) and purified chick embryo culture (PCEC) vaccine-\\nadministered for prophylaxis by the intramuscular route and should have antibody titers\\nchecked at 2 to 4 weeks.  It is associated with fewer hypersensitivity reactions in patients\\nreceiving boosters and prophylaxis during pregnancy does not increase in fetal wastage,\\ncongenital defects, should not be withheld when indicated.\\n\\uf0b7\\nCorticosteroids, antimalarials, and other immunosuppressives can interfere with the\\ndevelopment of active immunity and should be withheld during the course of treatment if\\npossible.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 91, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nCorticosteroids, antimalarials, and other immunosuppressives can interfere with the\\ndevelopment of active immunity and should be withheld during the course of treatment if\\npossible.\\n\\uf0b7\\nPatients with a history of hypersensitivity should nevertheless be cautiously given\\nimmunoprophylaxis in a controlled setting, with antihistamines and epinephrine available\\nPreviously immunized persons\\n\\uf0b7\\nHRIG should not be administered.\\n\\uf0b7\\nVaccine HDCV or PCECV 1.0 ml, IM (deltoid area), on days 0 and 3.\\nReferences\\n1.\\nHuman rabies prevention—United States, 1999. Recommendations of the Advisory Committee on\\nImmunization Practices (ACIP).\\n2.\\nMMWR Morb Mortal Wkly Rep 48:1, 1999.\\n3.\\nhttp://www.cdc.gov/rabies/exposure/types.html; 2008.\\n4.\\nCenters for Disease Control and Prevention: Rabies post-exposure.\\n5.\\nhttp://www.cdc.gov/rabies/exposure/postexposure.html; 2008.\\n6.\\nRosen’s Textbook of Emergency Medicine, 7th edition'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 92, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Emergency Conditions\\n77\\nSNAKE BITE\\nIndia is estimated to have the highest snakebite mortality in the world, with WHO estimates\\nplacing the number of bites at 83,000 per annum with 11000 deaths. Most of the fatalities are\\ndue to the victim not reaching the hospital in time where definite treatment can be\\nadministered.\\nSnakes in India\\nThere are about 236 species of snakes in India, most of which are non-poisonous, however,\\nthere are 13 known species that are poisonous and four of these, namely Indian cobra,\\nRussell's viper, saw- scaled viper and Indian krait are highly venomous and are believed to be\\nresponsible for most of the poisonous bites in India\\nSalient features\\nInvestigations\\n\\uf0b7\\nIdentification of snake, local swelling within few minutes after bite is an important sig of\\nviper envenomization.\\n\\uf0b7\\nBlood stained sputum and non clotting of blood are diagnostic criteria for Russel viper\\nand Saw scaled viper poisoning.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 92, 'source_type': 'Authorotative', 'priority': '1'}, page_content='viper envenomization.\\n\\uf0b7\\nBlood stained sputum and non clotting of blood are diagnostic criteria for Russel viper\\nand Saw scaled viper poisoning.\\n\\uf0b7\\nPtosis and glossopharyngeal palsy are diagnostic criteria for Cobra and Indian Krait\\npoisoning.\\n\\uf0b7\\nInvestigations include\\n-\\n20 minute whole blood clotting test\\n-\\nHb/ platelet count/ peripheral smear/ PT/ APTT/ FDP/ D-Dimer\\n-\\nUrine examination for proteinuria/RBC/ hemoglobinuria/ myoglobinuria\\n-\\nSerum creatinine/ urea/ potassium\\n-\\nOxygen saturation/ PR/BP/ RR/ postural blood pressure\\n-\\nECG/ X-Ray/ CT/ ultrasound (the use of X-Ray and ultrasound are of unproven\\nbenefit,       apart from identification of bleeding in viperine bites).\\n-\\nELISA to confirm snake species\\nTreatment\\nFirst aid measures (RIGHT approach)\\nR: reassure patient and control anxiety\\nI: immobilize bitten part by splinting the limb\\n\\uf0b7\\nViper envenomization (haemovasculotoxic): swelling and local pain, tender'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 92, 'source_type': 'Authorotative', 'priority': '1'}, page_content='First aid measures (RIGHT approach)\\nR: reassure patient and control anxiety\\nI: immobilize bitten part by splinting the limb\\n\\uf0b7\\nViper envenomization (haemovasculotoxic): swelling and local pain, tender\\nenlargement of local lymph nodes, bleeding from any orifice,epistaxis, vomiting,\\nhypotension, petechiae, purpura, ecchymoses\\n\\uf0b7\\nElapid envenomization (neurotoxic): swelling and local pain, local necrosis and\\nblistering, descending paralysis, ptosis, diplopia, ophthalmoplegia,\\nparalysis \\nof\\njaw and tongue, numbness around the lip and mouth, inadequate ventilation,\\nparadoxical respiration.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 93, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n78\\nG-H: get to hospital- transfer the victim to the nearest treatment facility\\nT: tell the doctor about any symptoms\\nDo Not: Apply tourniquet, wash the bite site with soap and any other solution, make cuts or\\nincision on or near bitten area, apply extreme cold or herbal and folk remedies, suck venom,\\ngive  the victim drink, alcohol or drugs\\n\\uf0b7\\nEnsure airway, breathing and shock management\\n\\uf0b7\\nPain can be relieved with non sedating analgesic- oral paracetamol\\n\\uf0b7\\nAnti-snake venom (ASV) is the mainstay of treatment. In India polyvalent ASV is\\navailable which is effective against all the four common species. ASV should be\\nadministered only when there are definite signs of envenomation i.e. coagulopathy or\\nneurotoxicity\\n\\uf0b7\\nMild and severe envenomation requires 8 to 10 vials. Each vial is 10 ml of reconstituted\\nASV. Children should receive the same ASV dosage as adults. ASV should be\\nadministered over 1 hour at constant speed and patient should be closely monitored for 2'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 93, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ASV. Children should receive the same ASV dosage as adults. ASV should be\\nadministered over 1 hour at constant speed and patient should be closely monitored for 2\\nhours.\\n\\uf0b7\\nASV reactions: Anaphylaxis may be life-threatening. if anaphylaxis is evident, ASV\\nshould be discontinued. Inj. hydrocortisone 100 mg + antihistamine or Inj. adrenaline\\nsubcutaneously can be administered for ASV reaction\\n\\uf0b7\\nRepeat dose of 5-10 vials of ASV i.e. half to one full dose, should continue 6 hourly till\\ncoagulation is restored unless a species is identified against which polyvalent ASV is\\nineffective. Only for snakes which inject massive amounts of venom, such as the King\\nCobra or Australian elapids, massive doses of 50+ vials are required.\\nFollow up\\nA snakebite victim discharged within 24 hrs should be advised to return if there is any\\nworsening of symptoms or signs such as bleeding, pain or swelling at the site of bite,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 93, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Follow up\\nA snakebite victim discharged within 24 hrs should be advised to return if there is any\\nworsening of symptoms or signs such as bleeding, pain or swelling at the site of bite,\\ndifficulty in breathing, altered sensorium etc. Explain about the signs and symptoms of serum\\nsickness which may manifest after 5-10 days.\\nINSECT AND ARACHNID BITES\\nInsect arachnid (spider, scorpion) bites and stings are common and usually cause minor\\nirritation. However, some stings can be painful and trigger a serious allergic reaction.\\nSalient features\\n\\uf0b7\\nSkin around the bite becomes red, swollen and itchy. The venom from a sting often\\ncauses a swollen, itchy, red mark (a weal) to form on the skin. This can be painful and\\nitchy for a few days, but is harmless in most cases. They can usually be treated at\\nhome.\\n\\uf0b7\\nThe severity of bites and stings varies depending on the type of insect and sensitivity\\nof the person. In rare cases, some people can have a serious allergic reaction'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 93, 'source_type': 'Authorotative', 'priority': '1'}, page_content='home.\\n\\uf0b7\\nThe severity of bites and stings varies depending on the type of insect and sensitivity\\nof the person. In rare cases, some people can have a serious allergic reaction\\n(anaphylaxis) to a bite or sting that requires immediate medical treatment.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 94, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Emergency Conditions\\n79\\nNon pharmacological treatment\\n\\uf0b7\\nRemove a sting- by scraping it out with fingernails. Be careful during removing the sting,\\nprevent further spread the venom into the skin and do not puncture venomous sac.\\n\\uf0b7\\nMinor bites and stings can be treated by washing the affected area with soap and water,\\nplacing a cold compress (a cloth cooled with cold water) over the affected area to reduce\\nswelling\\n\\uf0b7\\nDo not scratch the area because it can become infected.\\n\\uf0b7\\nWrap an ice pack  in a towel and place it on the swelling\\nPharmacological treatment\\nIf the bite or sting is painful or swollen\\n\\uf0b7\\nTab. paracetamol or ibuprofen(children under 16 years old should not be given aspirin)\\n\\uf0b7\\nApply \\na \\nspray \\nor \\ncream \\nthat \\ncontains local \\nanesthetic, antihistamine or mild\\nhydrocortisone (1%) on the affected area to prevent itching and swelling\\n\\uf0b7\\nTab. cetrizine 10 mg once a day and topical administration of calamine lotion to relieve\\npruritus\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 94, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hydrocortisone (1%) on the affected area to prevent itching and swelling\\n\\uf0b7\\nTab. cetrizine 10 mg once a day and topical administration of calamine lotion to relieve\\npruritus\\n\\uf0b7\\nSystemic corticosteroids may be appropriate if there are severe side-effects.\\n\\uf0b7\\nAny person who collapses, or complains of wheezing, feeling of anxiety or faintness,\\ngeneralized itching, or tightness in the chest within 1 hour of being stung by an insect\\nshould be treated as having anaphylactic shock. Inj. adrenaline 1 mg (as hydrogen\\ntartrate) 0.5-1.0 ml IM injection (1:1000 solution), repeat every 15-20 min if required. All\\npatients should be observed at least for 24 hours for recurrent anaphylaxis (see section on\\nanaphylactic shock).\\nSCORPIONS BITE\\n\\uf0b7\\nSimple analgesics, such as paracetamol and aspirin, can be given to relieve pain.\\nHowever, because of the potential for severe reactions, every effort should be made to get\\nthe patient to a hospital as soon as possible.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 94, 'source_type': 'Authorotative', 'priority': '1'}, page_content='However, because of the potential for severe reactions, every effort should be made to get\\nthe patient to a hospital as soon as possible.\\n\\uf0b7\\nVasodilators, administered in a hospital setting within 24 hours of the attack, may\\nattenuate the cardiovascular response and possibly reduce mortality.\\n\\uf0b7\\nIn endemic area, species-specific antiscorpions sera may be available locally and this can\\nbe of value if administered within few hours.\\nReference\\n1.\\nDrugs used in Skin Diseases. In: WHO Model Prescribing Information, 1997, WHO, Geneva.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 95, 'source_type': 'Authorotative', 'priority': '1'}, page_content='80\\n\\uf0b7\\nSymptoms include fever, night sweats, weight loss, anorexia, cough, dyspnoea,\\narthralgia, chest pain.\\n\\uf0b7\\nSigns are murmur, splenomegaly, clubbing, embolic feature and signs of immune\\ncomplex deposition, like Janeway lesions, Roth spots, splinter hemorrhages\\nChapter 4\\nCARDIOVASCULAR DISEASES\\nINFECTIVE ENDOCARDITIS\\nIt is a microbial infection of endothelial surface of heart. Acute bacterial endocarditis is\\ncaused by S. aureus, group A hemolytic streptococci, pnuemococci or gonococci. Sub acute\\nbacterial endocarditis is caused by virulent S. Viridans or other streptococci.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nEmpirical therapy: Pending the availability of diagnostic data, blood culture–negative sub\\nacute native valve endocarditis is treated either with Inj. ampicillin-sulbactam  12 g every\\n24 h or with Inj. ceftriaxone 1 gm OD plus Inj. gentamicin 3 mg/kg QID IV; Tab.\\ndoxycycline 100 mg twice daily is added for Bartonella coverage.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 95, 'source_type': 'Authorotative', 'priority': '1'}, page_content='24 h or with Inj. ceftriaxone 1 gm OD plus Inj. gentamicin 3 mg/kg QID IV; Tab.\\ndoxycycline 100 mg twice daily is added for Bartonella coverage.\\n\\uf0b7\\nAfter blood culture report organism specific antibiotic therapy are as under Streptococci :\\n-\\nPenicillin sensitive: Inj. penicillin G  2–3 MU IV q4h or Inj. ceftriaxone  2 g IV QID\\nfor 2 weeks plus Inj. gentamicin 3 mg/kg QID IV or IM, as a single dose or divided\\ninto equal doses TDS for 2 weeks.\\n-\\nPenicillin resistant: Inj. ceftriaxone 2 g IV QID for 4 weeks plus Inj. gentamicin 3\\nmg/kg QID  IV or IM, as a single dose or divided into equal doses TDS  for 2 weeks\\n\\uf0b7\\nEnterococci:  Inj. penicillin G 4–5 MU IV every 4 hours plus Inj. gentamicin 1 mg/kg IV\\nTDS, both for 4–6 weeks.\\n\\uf0b7\\nStaphylococci: Inj. nafcillin or oxacillin 2 g IV q4h for 4–6 weeks or Inj. cefazolin 2 g IV\\nTDS for 4–6 weeks. If methicillin resistant: Inj. vancomycin 15 mg/kg IV 12 hours for 4\\nto 6 weeks.\\n\\uf0b7\\nHACEK group: Inj. ceftriaxone 2 g OD  IV for 4 weeks\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 95, 'source_type': 'Authorotative', 'priority': '1'}, page_content='TDS for 4–6 weeks. If methicillin resistant: Inj. vancomycin 15 mg/kg IV 12 hours for 4\\nto 6 weeks.\\n\\uf0b7\\nHACEK group: Inj. ceftriaxone 2 g OD  IV for 4 weeks\\n\\uf0b7\\nProphylaxis for infective endocarditis in patients with vulnerable heart valve. Dental\\nprocedures wherein there is manipulation of gingival tissue or peri-apical regions of the\\nteeth or perforation of the oral mucosa (including surgery on the respiratory track).\\nAntibiotic regimens for prophylaxis\\n\\uf0b7\\nTab. amoxicillin 2 g 1 hour before procedure\\n\\uf0b7\\nInability to take oral medication: Inj. ampicillin 2gm IV/IM 1 hour before procedure\\n\\uf0b7\\nPenicillin allergy:  Tab. clarithromycin or azithromycin 500 mg 1 hour before procedure\\nor Tab. cephalexin 2 gm, 1 hour before procedure or Tab. clindamycin 600 mg 1 hour\\nbefore procedure'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n81\\n\\uf0b7\\nMay be caused by viruses, bacteria, mycobacteria, connective tissue disorders, uremia,\\nmalignancy, radiation or trauma.\\n\\uf0b7\\nPleuritic chest pain which relieves on bending forward breathlessness, tachycardia\\n\\uf0b7\\nFever, pleural rub, elevated ESR, irregular pulse, symmetric enlargement of cardiac\\nsilhouette\\n\\uf0b7\\nFever, chest pain, basal rales, pedal edema, cardiomegaly, syncope, ventricular\\nectopy,\\n\\uf0b7\\nLVH, raised Jugular Venous Pressure (JVP), diffuse dyskinetic apex beat, S3,\\nhepatomegaly, peripheral edema, murmurs of mitral and tricuspid regurgitation\\n\\uf0b7\\nPenicillin allergy, inability to tolerate oral medication: Inj. cefazolin or ceftriaxone 1 gm\\nIV/IM,30 min before procedure or clindamycin 600 mg IV/IM, 1 hour before procedure.\\nACUTE PERICARDITIS\\nInflammation of pericardium is called as pericarditis.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nTab. aspirin 650 mg orally every 3-4 hours or other NSAIDs like Tab. indomethacin 100-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Inflammation of pericardium is called as pericarditis.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nTab. aspirin 650 mg orally every 3-4 hours or other NSAIDs like Tab. indomethacin 100-\\n150 mg orally daily in divided doses are usually effective.\\n\\uf0b7\\nTuberculosis pericarditis: Anti tuberculosis  treatment\\n\\uf0b7\\nUremic pericarditis: dialysis\\n\\uf0b7\\nUsually with antibiotics patients have to be carefully observed as they may develop\\npericardial effusion. If cardiac tamponade develops, pericardiocentesis must be carried\\nout at once.\\nCARDIOMYOPATHY\\nThe cardiomyopathies are a group of diseases that affect the heart mused itself and are not the\\nresult of hypertension, congenital or acquired valvular, coronary or pericardial abnormalities.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nSalt restriction, alcohol discontinuation\\nPharmacological treatment\\nStandard therapy for heart failure with following drugs:\\n\\uf0b7\\nDiuretics- hydrochlorothiazide 6.25–50 mg  or chlorthalidone 25–50 mg, loop diuretics-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 96, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Pharmacological treatment\\nStandard therapy for heart failure with following drugs:\\n\\uf0b7\\nDiuretics- hydrochlorothiazide 6.25–50 mg  or chlorthalidone 25–50 mg, loop diuretics-\\nfurosemide 40–80 mg, aldosterone antagonists- spironolactone 25–100 mg\\n\\uf0b7\\nBeta blockers: atenolol 25–100 mg, metoprolol 25–100 mg,  propranolol 40–160 mg\\n\\uf0b7\\nACE inhibitors: captopril 25–200 mg, lisinopril 10–40 mg, ramipril 2.5–20 mg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 97, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n82\\n\\uf0b7\\nNonspecific symptoms are fatigue, headache, epistaxis.\\n\\uf0b7\\nUncontrolled hypertension can lead to target organ damage (TOD) such as coronary\\nartery disease (CAD), left ventricular hypertrophy (LVH), cerebrovascular accidents\\n(CVA), transient ischemic attacks (TIA), retinopathy, peripheral vascular diseases\\nincluding dissecting aneurysm, renal disease.\\n\\uf0b7\\nAssociated risk factors are - age >55 years in males and >65 years in females, smoking,\\ndiabetes mellitus, microalburninuria or GFR <60 ml/hr, hyperlipidemia, family history,\\nobesity, sedentary life-style and ethnic group.\\n\\uf0b7\\nAngiotensin II antagonists: losartan 25–100 mg, valsartan 80–320 mg, candesartan 2–32\\nmg\\n\\uf0b7\\nCalcium antagonists: nifedipine (long-acting) 30–60 mg, verapamil (long-acting) 120–\\n360 mg, diltiazem (long-acting) 180-420 mg\\nHypertrophic cardiomyopathy\\n\\uf0b7\\nβ blockers is the first line of drug.\\n\\uf0b7\\nCalcium channel blockers, especially verapamil, have also been effective in symptomatic'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 97, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Hypertrophic cardiomyopathy\\n\\uf0b7\\nβ blockers is the first line of drug.\\n\\uf0b7\\nCalcium channel blockers, especially verapamil, have also been effective in symptomatic\\npatients. Diuretics for heart failure\\n\\uf0b7\\nDual chamber pacing for refractory cases\\n\\uf0b7\\nNonsurgical septal ablation with alcohol injection in septal branches.\\nDrugs to be avoided\\n\\uf0b7\\nCalcium channel blockers and NSAIDs – in dilated cardiomyopathy\\n\\uf0b7\\nDigitalis, Nitrates, Vasodilators, B-agonists- avoided in Hypertrophic obstructive\\ncardiomyopathy (HOCM)\\nHYPERTENSION\\nUsually asymptomatic and discovered on routine measurement of blood pressure. Secondary\\nhypertension (HT) presents as a part of a symptom complex as in acromegaly, Cushing's\\ndisease, renovascular or renal parenchymal disease, connective tissue disorders (SLE,\\nscleroderma, etc.), or coarctation of aorta.\\nSalient features\\nInvestigations\\nRoutine laboratory tests recommended before initiating therapy include,\\n\\uf0b7\\nElectrocardiogram\\n\\uf0b7\\nUrinalysis;\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 97, 'source_type': 'Authorotative', 'priority': '1'}, page_content='scleroderma, etc.), or coarctation of aorta.\\nSalient features\\nInvestigations\\nRoutine laboratory tests recommended before initiating therapy include,\\n\\uf0b7\\nElectrocardiogram\\n\\uf0b7\\nUrinalysis;\\n\\uf0b7\\nBlood glucose and hematocrit; serum potassium, creatinine (or the corresponding\\nestimated GFR, and calcium;\\n\\uf0b7\\nLipid profile (after a 9-12 hour fast) that includes high-density lipoprotein, cholesterol,\\nlow-density lipoprotein cholesterol, and triglycerides.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 98, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n83\\n\\uf0b7\\nOptional tests include measurement of urinary albumin excretion or albumin/creatinine\\nratio. More extensive testing for identifiable causes is not indicated generally unless BP\\ncontrol is not achieved.\\nPrecautions to be taken while measuring BP\\n\\uf0b7\\nThe auscultatory method of BP measurement with a properly calibrated and validated\\ninstrument should be used. BP should be measured using an appropriate size cuff in both\\nupper limbs and at least one lower limb in both supine and erect posture.\\n\\uf0b7\\nPatient should have been resting for at least 5 minutes and should not have consumed\\ncoffee, smoked during the last 30 minutes before measuring the blood pressure. At least 2\\nmeasurements should be made. Systolic BP is the point at which the first of 2 or more\\nsounds are heard (phase 1) and diastolic BP is the point before the disappearance of\\nsounds (phase 5).\\nNon pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 98, 'source_type': 'Authorotative', 'priority': '1'}, page_content='sounds are heard (phase 1) and diastolic BP is the point before the disappearance of\\nsounds (phase 5).\\nNon pharmacological treatment\\n\\uf0b7\\nReduce dietary sodium intake to no more than 100 mmol per day (2.4 g sodium or 6 g\\nsodium chloride).\\n\\uf0b7\\nAdopt DASH eating plan- diet rich in fruits, vegetables, with low fat dairy products\\nwith a reduced content of saturated and total fat.\\n\\uf0b7\\nLife-style modification - exercise consisting of vigorous aerobic exercise like brisk\\nwalking, swimming or jogging at least 20 to 30 minutes on most days of the week with\\nthe heart rate reaching 65-70% of maximal heart rate.\\n\\uf0b7\\nWeight control using a combination of dietary and exercise measures to maintain normal\\nbody weight (body mass index 18.5-24.9 kg nr).\\n\\uf0b7\\nModeration of alcohol consumption - limit alcohol to no more than 2 drinks (1 oz or 30\\nml ethanol; e.g., 24 oz beer, 10 oz wine, or 3 oz 80-proof whiskey) per day in most men\\nand to no more than 1 drink per day in women and lighter weight persons.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 98, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ml ethanol; e.g., 24 oz beer, 10 oz wine, or 3 oz 80-proof whiskey) per day in most men\\nand to no more than 1 drink per day in women and lighter weight persons.\\n\\uf0b7\\nCessation of smoking.\\n\\uf0b7\\nYoga\\nPharmacological treatment\\n\\uf0b7\\nPre – hypertension: behavioral modification follow up\\nStage 1: thiazide diuretics OR calcium channel blockers   or beta blockers or ACEI\\nStage 2: Combination therapy (dosages to be adjusted according to blood pressure\\nresponse)\\n\\uf0b7\\nDiuretics preferred in obese, elderly, CCF\\n\\uf0b7\\nBeta blockers in young, coronary artery disease (CAD), vascular headache, atrial\\nfibrillation\\n\\uf0b7\\nCalcium channel blockers in  elderly, CAD, ACEI in  diabetic, LVF, young\\n\\uf0b7\\nAlpha blockers: prostatitism, dyslipidemia\\n\\uf0b7\\nAlpha methyl dopa- pregnancy'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 99, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n84\\nDose of commonly uses antihypertensive drugs\\n\\uf0b7\\nTab. hydrochlorothiazide 12.5 -25 mg OD or BD\\n\\uf0b7\\nTab. frusemide 20-40 mg twice day\\n\\uf0b7\\nTab. frusemide 20 + spironolactone  50 mg 1-2 times day\\n\\uf0b7\\nTab. indapamide 2-5 mg daily\\n\\uf0b7\\nTab. atenolol 25-100 mg daily or Tab. metoprolol 25-150 mg BD\\n\\uf0b7\\nTab. amlodipine 2.5- 20 mg OD or Cap. nifedipine 20-80 mg as sustained release daily\\n\\uf0b7\\nTab. enalapril 2.5 mg OD or Tab.  lisinopril 2.5 mg OD or Tab. ramipril1.25-10 mg OD\\n\\uf0b7\\nTab. losartan 25-50 mg OD or BD\\n\\uf0b7\\nTab. prazosin 1-20 g OD at bed time\\n\\uf0b7\\nTab. clonidine 0.05-0.6 mg  BD or Tab. methyldopa 250-1000 mg OD\\nAccelerated hypertension\\nPatients presenting with BP 200/140 mm Hg or more without papilledema\\n\\uf0b7\\nInj. enalapril 1.25-5 mg IV 6 hourly Or Inj. nitroprusside 0.25-1.0 mcg/Kg/min IV\\ninfusion (dose to be titrated with BP, maximum dose for 10 meg only) Or\\n\\uf0b7\\nInj. nitroglycerine 5-100mcg/min infusion Or\\n\\uf0b7\\nInj. hydralazine 10-20 mg IV or IM, if no response at 20 mg change the drug Or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 99, 'source_type': 'Authorotative', 'priority': '1'}, page_content='infusion (dose to be titrated with BP, maximum dose for 10 meg only) Or\\n\\uf0b7\\nInj. nitroglycerine 5-100mcg/min infusion Or\\n\\uf0b7\\nInj. hydralazine 10-20 mg IV or IM, if no response at 20 mg change the drug Or\\n\\uf0b7\\nInj. labetalol 20-80 mg IV every 5-10 min up to a total of 300 mg, infusion 0.5-2 mg/min,\\noral 100-600 mg 2 times a day. Or\\n\\uf0b7\\nInj. phentolamine 5-15 mg IV (especially useful in pheochromocytoma)\\nMalignant hypertension\\n\\uf0b7\\nPatients presenting with BP 200/140 mm Hg and evidence of vascular damage like\\npapilledema, deranged renal function, should be referred to a tertiary care centre.\\nResistant hypertension\\n\\uf0b7\\nResistant hypertension is the failure to reach goal BP in patients who are adhering to full\\ndoses of an appropriate 3-drug regimen that includes a diuretic. Refer these patients to\\nhypertension specialist.\\nFollow up\\n\\uf0b7\\nRegular BP monitoring to ensure optimal or normal BP in young or middle aged or\\ndiabetic subjects (130/80 mm Hg) and at least high normal BP in elderly patients (140/90'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 99, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Follow up\\n\\uf0b7\\nRegular BP monitoring to ensure optimal or normal BP in young or middle aged or\\ndiabetic subjects (130/80 mm Hg) and at least high normal BP in elderly patients (140/90\\nmm Hg).\\n\\uf0b7\\nMonitor all risk factors for coronary artery disease.\\n\\uf0b7\\nEnsure compliance with life-style modification.\\n\\uf0b7\\nAssess for complications and target organ damage.\\n\\uf0b7\\nIn accelerated or malignant HT, avoid sudden fall in diastolic BP to below 100 mm Hg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 100, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n85\\n\\uf0b7\\nPrecordial chest pain due to stress or exertions, palpitation, breathlessness symptoms\\nare typically associated with exertion and emotional upset and are relieved quickly by\\nrest and/or sublingual nitrates ECG shows  ST depression, T wave inversion, LVH.\\nHypertension in children and adolescents\\n\\uf0b7\\nIn children and adolescents, hypertension is defined as BP that is, on repeated\\nmeasurement, at the 95th percentile or greater adjusted for age, height, and gender. The\\nfifth Korotkoff sound is used to define diastolic BP.\\n\\uf0b7\\nBe alert for possibility of identifiable causes of hypertension in younger children (i.e.,\\nkidney disease, coarctation of aorta).\\n\\uf0b7\\nLife style interventions are strongly recommended, with pharmacological therapy\\ninstituted for a higher levels of BP or if there is insufficient response to lifestyle\\nmodification.\\n\\uf0b7\\nChoices of antihypertensive drugs are similar in children and adults, but effective doses'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 100, 'source_type': 'Authorotative', 'priority': '1'}, page_content='instituted for a higher levels of BP or if there is insufficient response to lifestyle\\nmodification.\\n\\uf0b7\\nChoices of antihypertensive drugs are similar in children and adults, but effective doses\\nfor children are often smaller and should be adjusted carefully.\\nPatient education\\n\\uf0b7\\nExplain consequences of uncontrolled HT and the need for the long-term control with\\nmedication.\\n\\uf0b7\\nAdvice regarding control of other risk factors likes diabetes, hyperlipidemia, etc.\\n\\uf0b7\\nDiuretics should be taken in the morning and if two doses a day are required second dose\\nshould be given before 4 PM.\\n\\uf0b7\\nManage target organ damage - referral to a higher centre for CAD (PTCA/ CABG),\\nnephropathy (prepare for dialysis or transplant), carotid doppler to determine presence of\\natheroma and possibility of end arterectomy\\nANGINA PECTORIS\\nIt is clinically syndrome due to myocardial ischemia, caused by critical obstruction in\\ncoronary arteries due to atherosclerosis, calcific arotic stenosis, or due to spasm or emboli.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 100, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ANGINA PECTORIS\\nIt is clinically syndrome due to myocardial ischemia, caused by critical obstruction in\\ncoronary arteries due to atherosclerosis, calcific arotic stenosis, or due to spasm or emboli.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoid heavy exertion, take rest during acute stage, stop smoking, weight reduction.\\nPharmacological treatment\\n\\uf0b7\\nTab. isosorbide dinitrate 5 mg sublingual during the attack, dose repeated as required or\\nTab nitroglycerine 0.3-0.6 mg sublingual\\n\\uf0b7\\nIf attack occurs twice in week, chronic prophylaxis is recommended with Tab. metoprolol\\n50 mg BD or Tab.  atenolol 50 mg OD\\n\\uf0b7\\nIf beta blockers are contraindicated or angina persists- Tab. diltiazem- 60-120 mg/day\\n\\uf0b7\\nTab. aspirin 100-150 mg/ day or Tab. clopidogrel 75 mg/day'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 101, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n86\\n\\uf0b7\\nChest pain, breathlessness, perspiration, syncope, tachy or bardycardia, hypo or\\nhypertension, sudden cardiac arrest, ECG changes showing ischemia or infarction, raised\\ncardiac markers\\nMYOCARIDAL INFRACTION\\nMyocardial Infarction (MI) is due to the formation of occlusive thrombus at the site of\\nrupture of an atheromatous plaque in a coronary artery.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nHospitalization and compete immobilization\\n\\uf0b7\\nOxygen – 4-6 liters / min\\n\\uf0b7\\nOral  uncoated chewable Tab. aspirin – 325 mg\\n\\uf0b7\\nTab.  isosorbide dinitrate – 5 mg up to 3 times sublingually\\n\\uf0b7\\nTab. atorvastatin – 80 mg\\n\\uf0b7\\nTab. clopidogrel – 300 mg\\n\\uf0b7\\nInj. morphine sulphate 10 mg or Inj. diamorphine 5 mg IV\\n\\uf0b7\\nConsider thrombolysis with intravenous streptokinase or alteplase. Thrombolysis to be\\ndone within 30 mins of time of admission.\\n\\uf0b7\\nInj. streptokinase 1.5 million units in 100 ml of saline as an intravenous infusion over 1'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 101, 'source_type': 'Authorotative', 'priority': '1'}, page_content='done within 30 mins of time of admission.\\n\\uf0b7\\nInj. streptokinase 1.5 million units in 100 ml of saline as an intravenous infusion over 1\\nhour. The drug may cause hypotension, which can be managed with fluids and restricting\\nthe infusion at a slower rate. Or\\n\\uf0b7\\nInj. alteplase - rTPA (Recombinant tissue plasminogen activator):  The regimen is given\\nover 90 minutes (bolus dose of 15 mg followed by 0.75 mg/kg of body weight and then\\n0.5 mg/kg body weight over 60 minutes)\\n\\uf0b7\\nInj. metoprolol 5 mg IV every 2-5 minutes for 3 doses and changed to Tab. metoprolol 50\\nmg  every 6 hours for 48 hours, followed by 100 mg every 12 hours.\\n\\uf0b7\\nInj. Nitroglycerine IV  0.6 – 1.2 mg/hour\\n\\uf0b7\\nInj. heparin 200 units/Kg  SC twice daily for 5 days is given in addition to oral aspirin\\nmay prevent reinfarction after successful thrombolysis and reduce the risk of\\nthromboembolic complications.\\n\\uf0b7\\nMonitor ECG, blood pressure and cardiac enzymes\\nContraindications to thrombolytic therapy\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 101, 'source_type': 'Authorotative', 'priority': '1'}, page_content='thromboembolic complications.\\n\\uf0b7\\nMonitor ECG, blood pressure and cardiac enzymes\\nContraindications to thrombolytic therapy\\n\\uf0b7\\nAbsolute contraindications are active internal bleeding, previous sub-arachnoid or intra-\\ncerebral hemorrhage, non hemorrhagic stroke within the last 1 year, uncontrolled\\nhypertension (systolic > 180mm Hg, diastolic > 110mmHg)\\n\\uf0b7\\nRelative contra-indications are current use of anti-coagulants, recent (< 2 weeks) invasive\\nsurgical procedure, recent prolonged (> 10 min) cardiopulmonary resuscitation, known\\nbleeding diathesis, pregnancy, hemorrhage prone ophthalmic conditions, active peptic ulcer'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 102, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n87\\n\\uf0b7\\nCough expectoration, breathlessness, pedal edema, hypo or hyper tension, easy fatigability.\\n\\uf0b7\\nRaised jugular venous pressure, positive abdominojugular reflex, basal rales, pulmonary\\nedema, orthopnea, paroxysmal nocturnal dyspnea (PND). S3, hepatomegaly, ascites, sinus\\ntachycardia. Chest X ray shows cardiomegaly, pulmonary congestion.\\ndisease, recent history of severe hypertension. Notes: Streptokinase should not be used, if\\ngiven in the preceding 5 days to 2 years because of the risk of allergic reactions.\\nCONGESTIVE HEART FAILURE (CHF)\\nCHF is critical syndrome of inadequate cardiac output resulting in fluid retention in the\\nlungs, abdominal organs and peripheral tissue.\\nSalient features\\nPatients of heart failure are divided in 4 categories for management (Figure 1).\\nFor category A – No further treatment needed\\nFor category B – Diuretics and vasodilators\\nFor category C – Ionotropic agents\\nFor category L– Fluid challenge can be given'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 102, 'source_type': 'Authorotative', 'priority': '1'}, page_content='For category A – No further treatment needed\\nFor category B – Diuretics and vasodilators\\nFor category C – Ionotropic agents\\nFor category L– Fluid challenge can be given\\nFigure 1. Categories of heart failure for ease of management\\nNon pharmacological treatment\\n\\uf0b7\\nRestrict physical activity, bed rest in propped up position with a back rest. Dietary salt\\n(sodium) restriction (2 – 3 g/day).\\n\\uf0b7\\nAvoid and discontinue NSAIDs, high dose Beta blockers and calcium channel blocker.\\nFluid restriction depending on output and other conditions.\\nPharmacological treatment\\n\\uf0b7\\nTreatment consists of judicious mix of vasodilators, diuretics and inotropic support\\n\\uf0b7\\nInj. furosemide 40 – 80 mg IV stat every 2 to 3 hours with maximum up to 200 mg/day.\\nMaintenance dose is 40 mg IV 12 hourly.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 103, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n88\\n\\uf0b7\\nPalpitation, breathlessness, syncope, chest pain, “gabharaman”, visual disturbances.\\ntachy or bradycardia, hypo or hypertension. ECG changes according to type of\\narrhythmia\\n\\uf0b7\\nTab. spironolactone 25 – 200 mg/day or Tab. chlorthiazide 250 – 500 mg/day or Tab.\\nindapamide 2.5 – 5 mg/day or Tab. benzthiazide 25 mg plus Tab. triamterene 50 mg/day.\\n\\uf0b7\\nTab. enalapril 2.5 -20 mg/day or Tab. lisinopril 2.5 – 10 mg/day\\n\\uf0b7\\nTab. isosorbide mononitrate 60 mg/day as slow release preparation at night\\n\\uf0b7\\nDigoxin is indicated in fast ventricular rate (e.g. atrial fibrillation) and LVEF < 30 %.\\nTab. digoxin 0.5 mg first day followed  by 0.25 mg/day 5 days/week\\n\\uf0b7\\nTab. carvedilol 3.15 – 25 mg per day in one or two divided doses is useful in all\\nsymptomatic or asymptomatic heart failure and in case of reduced ejection fraction (40%)\\n\\uf0b7\\nInj. heparin 5000 IU 12 hourly SC if patients is bedridden\\nMonitoring of CHF patient\\n\\uf0b7\\nStrict intake – output charting\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 103, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nInj. heparin 5000 IU 12 hourly SC if patients is bedridden\\nMonitoring of CHF patient\\n\\uf0b7\\nStrict intake – output charting\\n\\uf0b7\\nDaily weight and abdominal girth measurement\\n\\uf0b7\\nSerum electrolytes and uric acid\\nARRHYTHMIAS\\nArrhythmias are divided into supraventricular tachycardia, ventricular tachycardia,\\nbradyarrhythmias\\nSalient features\\nSUPRAVENTRICULAR TACHYCARDIA\\nPharmacological treatment\\n\\uf0b7\\nDepends on the hemodynamic status of the patient.\\n\\uf0b7\\nIf he is haemodynamically stable:\\n-\\nTreatment of acute episode includes vagal maneuvers (carotid sinus massage, valsalva\\nmaneuver)\\n-\\nIf the measure fails, AV nodal blocking drugs are tried. Inj. adenosine 6 mg IV bolus\\nfollowed by 10 ml saline flush is given. 12 mg IV bolus can be repeated if no\\nresponse after 2 minutes. Contraindications include sick sinus syndrome or second or\\nthird degree AV block.\\n-\\nInj. metoprolol 5 mg IV can be repeated after 5 minutes or\\n-\\nInj. verapamil 5-10 mg IV bolus over 2-3 min. can be repeated after 15 mins or Inj.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 103, 'source_type': 'Authorotative', 'priority': '1'}, page_content='third degree AV block.\\n-\\nInj. metoprolol 5 mg IV can be repeated after 5 minutes or\\n-\\nInj. verapamil 5-10 mg IV bolus over 2-3 min. can be repeated after 15 mins or Inj.\\ndiltiazem 0.25 mg/kg IV bolus over 2 min. followed by IV infusion at a rate of\\n10mg/hour.\\n-\\nIf haemodynamically unstable, prompt synchronized direct current (DC).\\nCardioversion (using 10 to 100 joules) has to be done.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 104, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n89\\nMaintenance therapy\\nOnce sinus rhythm is established, chronic maintenance therapy includes,\\n\\uf0b7\\nTab.  diltiazem 30 mg TDS or Tab. verapamil - 40 mg TDS OR\\n\\uf0b7\\nTab. metoprolol 25-100 mg BD or Tab.  atenolol 25-100 BD OR\\n\\uf0b7\\nTab. digoxin 0.125-0.5 mg OD\\nCurative therapy\\nFor supraventricular tachycardia involving accessary pathway is radio-frequency ablation.\\nVENTRICULAR TACHYCARDIA\\nRuns of three or more consecutive idioventricular beats exceeding a rate of 100 beats per\\nminute.\\nTypes:\\n\\uf0b7\\nSustained – If ventricular tachycardia (VT) persists for > 30 seconds.\\n\\uf0b7\\nNon-sustained – 3 beats to 30 seconds.\\n\\uf0b7\\nMonomorphic - Configurations uniform\\n\\uf0b7\\nPolymorphic – Configuration varies from beat to beat\\nPharmacological treatment\\n1. Patients with nonsustained arrhythmias, without organic cardiac disease are\\nasymptomatic- need not be treated.\\n2. Patients with sustained VT in the absence of cardiac disease are symptomatic and require\\ntherapy with  Tab. amiodarone 200-400 mg /day TDS'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 104, 'source_type': 'Authorotative', 'priority': '1'}, page_content='asymptomatic- need not be treated.\\n2. Patients with sustained VT in the absence of cardiac disease are symptomatic and require\\ntherapy with  Tab. amiodarone 200-400 mg /day TDS\\n3.\\nIn patients with VT with organic cardiac disease, if haemodynamic instability,\\nunsynchronized the arrhythmia.\\n4. If haemodynamically stable, the following drugs can be administered:\\n5. Inj. lidocaine – 1 mg/kg IV bolus, 0.5-1 mg/kg boluses may be repeated at 5 min intervals\\nfollowed by 2-4 mg/min maintenance Infusion.\\n\\uf0b7\\nInj. amiodarone may be tried.\\n\\uf0b7\\nIf   these drugs fail, over drive padding has to be done.\\n\\uf0b7\\nTo prevent recurrences, sustained VT-ICD implantation is effective.\\nATRIAL FIBRILLATION\\nCommon arrhythmia, a variant of supraventricular tachycardia.\\nSalient features\\nPharmacological treatment\\nAcute atrial fibrillation\\n\\uf0b7\\nPalpitation, breathlessness, gabharaman, giddiness.\\nTachycardia, irregularly\\nirregular pulse, hypotension is commoner than hypertension'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 105, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Cardiovascular Diseases\\n90\\n\\uf0b7\\nTreat the precipitating factors like thyrotoxicosis\\n\\uf0b7\\nIf the patient is haemodynamically unstable, electrical cardio version using 200 joules is\\nthe treatment of choice.\\n\\uf0b7\\nIf  haemodynamically stable, ventricular rate control is adequate by Tab. metaprolol 25-\\n100 mg BD\\n\\uf0b7\\nTab. warfarin 5 mg OD and dose adjust as per INR\\nSurgical treatment\\n\\uf0b7\\nAblation around pulmonary veins.\\nBRADYARRHYTHMIAS\\nSinus bradycardia – regular heart rate < 60/min.\\nTypes: sino atrial block and atrioventricular block\\nPharmacological treatment\\n\\uf0b7\\nInj.atropine 0.6 mg IV repeated 4- 6 hourly or Inj. isoproterenol 2-10 mcg/min infusion\\nSurgical treatment\\n\\uf0b7\\nTemporary pacemaker\\n\\uf0b7\\nIf needed permanent pacemaker insertion.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 106, 'source_type': 'Authorotative', 'priority': '1'}, page_content='91\\n\\uf0b7\\nRepeated attacks of headache lasting 4–72 h in patients with a normal physical\\nexamination, no other reasonable cause for the headache, and at least 2 of the\\nfollowing features\\n\\uf0b7\\nUnilateral pain, throbbing pain aggravated by movement, moderate or severe intensity\\nalong with one of the following features:\\n\\uf0b7\\nNausea/vomiting and or photophobia and phonophobia\\nChapter 5\\nCENTRAL NERVOUS SYSTEM DISEASES\\nMIGRAINE\\nMost often begins at puberty and most affects those aged between 35 and 45 years.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nAvoidance of factors that triggers a migraine attack and suitable life-style modification.\\nPharmacological treatment\\n\\uf0b7\\nThe combination of acetaminophen, aspirin, and caffeine has been use for the treatment of\\nmild to moderate migraine.\\n\\uf0b7\\nIf NSAIDs/analgesics fail, Tab. sumatriptan 50 mg or 100 mg PO or Tab. zolmitriptan 2.5\\nmg PO can be used.\\n\\uf0b7\\nIf  early nausea or difficulties taking tablets, zolmitriptan 5 mg nasal spray or  sumatriptan 20'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 106, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mg PO can be used.\\n\\uf0b7\\nIf  early nausea or difficulties taking tablets, zolmitriptan 5 mg nasal spray or  sumatriptan 20\\nmg nasal spray is used.\\n\\uf0b7\\nParenteral administration of drugs such as dihydroergotamine and sumatriptan is used for the\\nrapid relief of a migraine attack.\\n\\uf0b7\\nPatients with an increasing frequency of migraine attacks, or with attacks that are either\\nunresponsive or poorly responsive to abortive treatments, are good candidates for preventive\\nagents. In general, a preventive medication should be considered in the subset of patients\\nwith five or more attacks a month. The drugs that have been used for the prophylactic\\ntreatment of migraine include\\n-\\nTab. propranolol  40–120 mg BD or Tab. sodium valproate: 400–600 mg BD\\n-\\nTab. topiramate :25–200 mg/d OD\\nPatient education\\n\\uf0b7\\nIdentify the triggers for the migraine attack (lack of sleep, chocolates, wine etc) and avoid\\nthem.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 107, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n92\\n\\uf0b7\\nEpisodic TTH attacks usually last a few hours, but can persist for several days.\\n\\uf0b7\\nThis headache is described as pressure or tightness, like a band around the head,\\nsometimes spreading into or from the neck.\\n\\uf0b7\\nCH is relatively uncommon, more common in males. Most people developing CH are\\nin their 20s or older.\\n\\uf0b7\\nIt is characterized by frequent recurring, brief but extremely severe headache\\nassociated with pain around the eye with tearing and redness, the nose runs or is\\nblocked on the affected side and the eyelid may drop.\\nTENSION-TYPE HEADACHE (TTH)\\nTTH often begins during the teenage years.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nThe pain of TTH can generally be managed with simple analgesics such as\\nacetaminophen, aspirin, or NSAIDs.\\n\\uf0b7\\nBehavioral approaches including relaxation can also be effective.\\n\\uf0b7\\nFor chronic TTH, Tab. amitriptyline 10–75 mg at night time is the only proven treatment\\nCLUSTER HEADACHE (CH)\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 107, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nBehavioral approaches including relaxation can also be effective.\\n\\uf0b7\\nFor chronic TTH, Tab. amitriptyline 10–75 mg at night time is the only proven treatment\\nCLUSTER HEADACHE (CH)\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nCluster headache attacks peak rapidly, and thus a treatment with quick onset is\\nrequired.  Many patients with acute cluster headache respond very well to oxygen\\ninhalation. This should be given as 100% oxygen at 10–12 L/min for 15–20 min.\\n\\uf0b7\\nInj. sumatriptan 6 mg SC is rapid in onset and will usually shorten an attack to 10–15\\nmin.\\nSumatriptan (20 mg) and zolmitriptan (5 mg) nasal sprays are both effective in\\nacute cluster headache.\\nPreventive treatments of cluster headache\\nShort-Term prevention\\nLong-term prevention\\nEpisodic Cluster Headache\\nEpisodic Cluster Headache  and  Prolonged\\nChronic Cluster Headache\\nPrednisone 1 mg/kg up to 60 mg daily,\\ntapering over 21 days\\nMethysergide 3–12 mg/d\\nVerapamil 160–960 mg/d\\nMethysergide 3-12mg.d\\nVerapamil 160–960 mg/d'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 107, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chronic Cluster Headache\\nPrednisone 1 mg/kg up to 60 mg daily,\\ntapering over 21 days\\nMethysergide 3–12 mg/d\\nVerapamil 160–960 mg/d\\nMethysergide 3-12mg.d\\nVerapamil 160–960 mg/d\\nGreater occipital nerve injection'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 108, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n93\\n\\uf0b7\\nSymptoms include weakness, numbness, paresthesia, dysphasia, dysarthria, dysphagia,\\ndyspraxia, hemianopia, falls, change in personality, ataxia, reduced sensations and\\nimpaired sensorium.\\nSTROKE\\nStroke is the abrupt onset of neurologic deficit that is attributable to a focal vascular cause.\\nTIA (Transient Ischemic Attacks) requires that all neurologic signs and symptoms resolve\\nwithin 24 hours regardless of whether there is imaging evidence of new permanent brain\\ninjury. However, a newly proposed definition classifies those with new brain infarction as\\nischemic strokes regardless of whether symptoms persist.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nRapid evaluation is necessary for the use of time sensitive treatments such as\\nthrombolysis. Close attention is paid to the ABC’s i.e. Airway, Breathing and Circulation\\nof the patient and treat hypoglycemia or hyperglycemia if identified. Once the diagnosis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 108, 'source_type': 'Authorotative', 'priority': '1'}, page_content='thrombolysis. Close attention is paid to the ABC’s i.e. Airway, Breathing and Circulation\\nof the patient and treat hypoglycemia or hyperglycemia if identified. Once the diagnosis\\nof stroke is made, a brain imaging study is necessary to determine if the cause of stroke is\\nischemia or hemorrhage. CT is useful in identifying early hemorrhage while MRI is\\nuseful in identifying early infarct.\\n\\uf0b7\\nBlood pressure should be lowered if there is malignant hypertension or concomitant\\nmyocardial ischemia or if blood pressure is >185/110 mm Hg and thrombolytic therapy is\\nanticipated (See section of hypertension)\\n\\uf0b7\\nFever is treated with antipyretics and surface cooling.\\n\\uf0b7\\nEuglycemia is to be maintained.\\n\\uf0b7\\nBetween 5 and 10% of patients develop enough cerebral edema to cause herniation. Other\\nanti-edema measures such as head elevation, Tab. furosemide 40 mg OD and\\nhyperventilation are useful.\\n\\uf0b7\\nCommon complications of bedridden patients—infections (pneumonia, urinary, and skin)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 108, 'source_type': 'Authorotative', 'priority': '1'}, page_content='anti-edema measures such as head elevation, Tab. furosemide 40 mg OD and\\nhyperventilation are useful.\\n\\uf0b7\\nCommon complications of bedridden patients—infections (pneumonia, urinary, and skin)\\nand deep venous thrombosis (DVT) with pulmonary embolism are to be prevented.\\n\\uf0b7\\nIntravenous thrombolysis (Table 1):\\n\\uf0b7\\nTab. aspirin 75 mg OD\\n\\uf0b7\\nInj. heparin 5000 IU SC\\n\\uf0b7\\nProper rehabilitation of the stroke patient includes early physical, occupational, and\\nspeech therapy.\\nSecondary prevention of stroke and TIA\\n\\uf0b7\\nControl of risk factors such as hypertension, diabetes, dyslipidemia, smoking cessation.\\n\\uf0b7\\nTab. aspirin 75-325 mg/day is recommended for stroke prevention.\\n\\uf0b7\\nTab. warfarin is useful for stroke prevention with a target INR of 2-3 in patients with\\nchronic nonvalvular AF as well as untreated rheumatic heart disease with AF.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 109, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n94\\nTreatment of haemorrhagic stroke\\n\\uf0b7\\nInj. mannitol 20% 1g/kg stat followed by 0.5 g/kg IV infusion, Inj. furosemide 40 mg IV\\nstat, elevation of head end and hyperventilation are useful.\\n\\uf0b7\\nAntihypertensive agents are instituted if BP is more than 180mmHg systolic or\\n>130mmHg diastolic. Goal is to keep a mean arterial pressure of less than 130mmHg.\\n\\uf0b7\\nWith thrombocytopenia (platelet count less than 50,000/µl), transfusion of fresh platelets\\nis indicated.\\n\\uf0b7\\nPatients with cerebellar hemorrhages or with depressed mental status and radiographic\\nevidence of hydrocephalus should undergo urgent neurosurgical evaluation.\\n\\uf0b7\\nThrombolytic agents are the mainstay (Table 1).\\nTable 1. Indications, contraindications and dosage schedule of thrombolytic agents in\\nstroke\\nIndications\\nContraindications\\n\\uf0b7\\nClinical diagnosis of stroke\\n\\uf0b7\\nOnset \\nof \\nsymptom \\nto \\ndrug\\nadministration <3 hours\\n\\uf0b7\\nCT scan showing no haemorrhage\\nor edema of >1/3rd of middle'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 109, 'source_type': 'Authorotative', 'priority': '1'}, page_content='stroke\\nIndications\\nContraindications\\n\\uf0b7\\nClinical diagnosis of stroke\\n\\uf0b7\\nOnset \\nof \\nsymptom \\nto \\ndrug\\nadministration <3 hours\\n\\uf0b7\\nCT scan showing no haemorrhage\\nor edema of >1/3rd of middle\\ncerebral artery (MCA) territory\\n\\uf0b7\\nAge >18 years\\n\\uf0b7\\nConsent of patient\\n\\uf0b7\\nSustained BP >185/110 mm Hg despite\\ntreatment\\n\\uf0b7\\nPlatelets <100,000; HCT <25%; glucose\\n<50 or >400 mg/dl\\n\\uf0b7\\nUse of heparin within 48 h and prolonged\\nPTT, or elevated INR\\n\\uf0b7\\nRapidly improving symptoms\\n\\uf0b7\\nPrior stroke or head injury within 3\\nmonths; prior intracranial hemorrhage\\n\\uf0b7\\nMajor surgery in preceding 14 days\\n\\uf0b7\\nMinor stroke symptoms\\n\\uf0b7\\nGI bleeding in preceding 21 days\\n\\uf0b7\\nRecent myocardial infarction\\n\\uf0b7\\nComa or stupor\\nAdministration\\n\\uf0b7\\nAdminister rtPA (recombinant tissue plasminogen activator like alteplase or\\ntenecteplase) 0.9 mg/kg IV (maximum 90 mg) IV as 10% of total dose by bolus,\\nfollowed by remainder of total dose over 1 h\\n\\uf0b7\\nFrequent cuff blood pressure monitoring\\n\\uf0b7\\nNo other antithrombotic treatment for 24 h\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 109, 'source_type': 'Authorotative', 'priority': '1'}, page_content='followed by remainder of total dose over 1 h\\n\\uf0b7\\nFrequent cuff blood pressure monitoring\\n\\uf0b7\\nNo other antithrombotic treatment for 24 h\\n\\uf0b7\\nFor decline in neurologic status or uncontrolled blood pressure, stop infusion, give\\ncryoprecipitate, and reimage brain emergently\\n\\uf0b7\\nAvoid urethral catheterization for 2 h'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 110, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n95\\n\\uf0b7\\nPresence of Bell’s phenomenon, affection of upper as well as lower part of face, involvement\\nof taste and lacrimation,\\n\\uf0b7\\nAbsence of emotional facial movements and absence of other neurological findings favour a\\ndiagnosis of peripheral or LMN facial palsy, the commonest cause being Bell’s palsy.\\n\\uf0b7\\nCardinal features include bradykinesia, rest tremor, rigidity, gait disturbance and\\npostural instability. Other motor features include micrographia, masked facies, reduced\\neye blink, soft voice (hypophonia) and dysphagia.\\n\\uf0b7\\nNon motor features include anosmia, sensory disturbances (e.g., pain), mood disorders\\n(e.g., depression), sleep disturbances, autonomic disturbances, orthostatic hypotension,\\ngastrointestinal disturbances, genitourinal disturbances, sexual dysfunction\\nand\\ncognitive impairment/dementia.\\nFACIAL PALSY\\nIt can be caused by upper motor neuron (UMN) or lower motor neuron (LMN) lesion.\\nSalient features\\nInvestigations\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 110, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"and\\ncognitive impairment/dementia.\\nFACIAL PALSY\\nIt can be caused by upper motor neuron (UMN) or lower motor neuron (LMN) lesion.\\nSalient features\\nInvestigations\\n\\uf0b7\\nIn a typical case, no investigations are required.\\n\\uf0b7\\nIn uncertain cases, it is necessary to get an ESR, blood sugar, workup for sarcoidosis or\\nMRI scanning maybe indicated. MRI often shows swelling and enhancement of the facial\\nnerve in idiopathic Bell's palsy.\\n\\uf0b7\\nElectromyography may aid in diagnosis as well as prognosis\\nNon- pharmacological treatment\\n\\uf0b7\\nUse of paper tape to depress the upper eyelid during sleep and prevent corneal drying.\\n\\uf0b7\\nMassage of the weakened muscles.\\n\\uf0b7\\nSplinting of lower part of face to prevent drooping.\\n\\uf0b7\\nFacial retraining (mime therapy)\\nPharmacological treatment\\n\\uf0b7\\nTab. prednisone 60-80 mg daily during the first 5 days and then tapered over the next 5\\ndays modestly shortens the recovery period and improves the functional outcome.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 110, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Pharmacological treatment\\n\\uf0b7\\nTab. prednisone 60-80 mg daily during the first 5 days and then tapered over the next 5\\ndays modestly shortens the recovery period and improves the functional outcome.\\n\\uf0b7\\nTab. acyclovir 400 mg five times daily for 10 days in combination with prednisone.\\nPARKINSON'S DISEASE\\nParkinson's disease (PD) is the second commonest neurodegenerative disease.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nLevodopa\\n-\\nTab. carbidopa/levodopa (1:4) 10/100mg - 25/200mg 4-6 times a day\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 111, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Central Nervous System Diseases\\n96\\n\\uf0b7\\nMost common causes of dementia are Alzheimer's disease, vascular dementia (multi\\nin fact/ diffuse white matter disease (Binswanger's), alcoholism, parkinson’s disease,\\ndrug or medical intoxication\\n\\uf0b7\\nBrief screening tools such as the mini-mental status examination (MMSE) help to\\nconfirm the presence of cognitive impairment.\\n-\\nAdverse effects: Acute side effects include nausea, vomiting, and orthostatic\\nhypotension.\\n-\\nMotor complications like wearing-off effect, dyskinesia, on-off phenomenon develop\\nwith long-term therapy.\\n\\uf0b7\\nDopamine Agonists- Tab. pramipexole 0.25–1.0 mg TDS, Tab. ropinirole 6–24 mg/d\\n\\uf0b7\\nAdverse effect: Acute side effects include nausea, vomiting, and orthostatic hypotension,\\nhallucination.\\n\\uf0b7\\nMAO-B Inhibitors- Tab. selegiline 5 mg BD\\n\\uf0b7\\nCOMT Inhibitors- Tab. entacapone 200 mg with each levodopa dose or Tab. tolcapone\\n100–200 mg TDS\\n\\uf0b7\\nAdverse effects: Primarily dopaminergic (nausea, vomiting, increased dyskinesia). Cases\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 111, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nCOMT Inhibitors- Tab. entacapone 200 mg with each levodopa dose or Tab. tolcapone\\n100–200 mg TDS\\n\\uf0b7\\nAdverse effects: Primarily dopaminergic (nausea, vomiting, increased dyskinesia). Cases\\nof fatal hepatic toxicity have been reported with tolcapone.\\n\\uf0b7\\nCentral-acting anticholinergic agents- Tab. trihexyphenidyl 2 mg TDS\\n\\uf0b7\\nNMDA-receptor antagonist - Tab. amantadine 100-300 mg/day.\\nDEMENTIA\\nIt is defined as an acquired deterioration in cognitive abilities that impairs the successful\\nperformance of activities of daily living. Memory is the most common cognitive ability lost\\nwith dementia.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nThe major goals of dementia management are to treat correctable causes and to provide\\ncomfort and support to the patient and caregivers.\\n\\uf0b7\\nTreatment of underlying causes might include thyroid replacement for hypothyroidism;\\nvitamin therapy for thiamine or B12 deficiency or for elevated serum homocysteine;'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 111, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTreatment of underlying causes might include thyroid replacement for hypothyroidism;\\nvitamin therapy for thiamine or B12 deficiency or for elevated serum homocysteine;\\nantimicrobials for opportunistic infections or antiretroviral for HIV; ventricular shunting\\nfor NPH; or appropriate surgical, radiation, and/or chemotherapeutic treatment for CNS\\nneoplasm. Drugs used for dementia are listed below:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 112, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n97\\nTable 2. Drugs used in the treatment of dementia\\nDrug\\nDose\\nSide effect\\nTab. donepezil\\n10 mg daily\\nnausea, diarrhea, abdominal cramps, altered\\nsleep with unpleasant or vivid dreams,\\nbradycardia, muscle cramps\\nTab. rivastigmine\\n6 mg twice daily\\nTab. galantamine\\n24 mg daily\\nTab. memantine\\n10 mg twice daily\\ndizziness, confusion, headache, syncope or\\nhypotension\\nGUILLAIN-BARRÉ SYNDROME (GBS)\\nGBS manifests as a rapidly evolving areflexic motor paralysis with or without sensory\\ndisturbance.\\nDiagnostic criteria for GBS\\nI. Required for Diagnosis\\n1. Progressive weakness of variable degree from mild paresis to complete paralysis\\n2. Generalized hypo- or areflexia\\nII. Supportive of Diagnosis\\n1. Clinical features\\n\\uf0b7\\nSymptom progression: Motor weakness rapidly progresses initially but ceases by 4\\nweeks.\\n\\uf0b7\\nDemonstration of relative limb symmetry regarding paresis.\\n\\uf0b7\\nFrequent cranial nerve involvement: Facial (cranial nerve VII) 50% and typically bilateral'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 112, 'source_type': 'Authorotative', 'priority': '1'}, page_content='weeks.\\n\\uf0b7\\nDemonstration of relative limb symmetry regarding paresis.\\n\\uf0b7\\nFrequent cranial nerve involvement: Facial (cranial nerve VII) 50% and typically bilateral\\nbut asymmetric; occasional involvement of cranial nerves XII, X, and occasionally III,\\nIV, and VI as well as XI.\\n\\uf0b7\\nAutonomic dysfunction can include tachycardia, other arrhythmias, postural hypotension,\\nhypertension, other vasomotor symptoms.\\n\\uf0b7\\nA preceding gastrointestinal illness (e.g., diarrhea) or upper respiratory tract infection is\\ncommon.\\n2. Cerebrospinal fluid features supporting diagnosis\\n\\uf0b7\\nElevated or serial elevation of CSF protein.\\n\\uf0b7\\nCSF cell counts are <10 mononuclear cell/mm3.\\n3. Electrodiagnostic medicine findings supportive of diagnosis\\n\\uf0b7\\nNCV slowing/conduction block at some time during disease process.\\n\\uf0b7\\nDistal motor latency increase may reach 3 times normal values.\\n\\uf0b7\\nF-waves indicate proximal NCV slowing.\\nIII. Findings reducing possibility of diagnosis\\n1. Asymmetric weakness'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 112, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nDistal motor latency increase may reach 3 times normal values.\\n\\uf0b7\\nF-waves indicate proximal NCV slowing.\\nIII. Findings reducing possibility of diagnosis\\n1. Asymmetric weakness\\n2. Failure of bowel/bladder symptoms to resolve'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 113, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n98\\n\\uf0b7\\nFever with headache, neck stiffness, photophobia, nausea , vomiting and altered mental\\nstatus. It is associated with a CNS inflammatory reaction that may result in decreased\\nconsciousness, seizures, raised intracranial pressure (ICP), and stroke.\\n\\uf0b7\\nCommon organisms are Streptococcus pneumonia, Haemophilus influenza, Neisseria\\nmeningitides, Listeria monocytogenes, Group B streptococcus, less frequent organism\\nare Staph. Aureus and coagulase negative Staphylococcus group A & group B\\nStreptococcus, enteric gram negative bacilli.\\n3. Severe bowel/bladder dysfunction at initiation of disease\\n4. Greater than 50 mononuclear cells/mm3 in CSF\\n5. Well-demarcated sensory level\\nIV. Exclusion criteria\\n1. Diagnosis of other causes of acute neuromuscular weakness (e.g., myasthenia gravis,\\nbotulism, poliomyelitis, toxic neuropathy).\\n2. Abnormal CSF cytology suggesting carcinomatous invasion of the nerve roots\\nNon pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 113, 'source_type': 'Authorotative', 'priority': '1'}, page_content='botulism, poliomyelitis, toxic neuropathy).\\n2. Abnormal CSF cytology suggesting carcinomatous invasion of the nerve roots\\nNon pharmacological treatment\\n\\uf0b7\\nMonitor Airway, Breathing and Circulation. Also includes mechanical ventilator support,\\nmanagement of autonomic dysfunction and physical therapy.\\nPharmacological treatment\\n\\uf0b7\\nThe available treatment modalities are plasma exchange and intravenous immunoglobulin\\n(IVIG). Both are equally effective. Corticosteroids are not recommended for treatment of\\nGBS.\\n\\uf0b7\\nPlasma exchange:\\n-\\nThe advised regimen of plasma exchange removes a total of 200 to 250 ml/kg of\\nplasma in four to six treatments on alternate days, or over a shorter period if there is\\nno coagulopathy. The replacement fluid is saline combined with 5% albumin.\\n\\uf0b7\\nIVIG:\\n-\\n0.4 g/kg per day for 5 consecutive days\\n-\\nIt is both easier to administer and probably safer because there is no need for large\\nintravenous access.\\n-\\nDisadvantage is the higher cost of therapy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 113, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\n0.4 g/kg per day for 5 consecutive days\\n-\\nIt is both easier to administer and probably safer because there is no need for large\\nintravenous access.\\n-\\nDisadvantage is the higher cost of therapy.\\nACUTE BACTERIAL MENINGITIS\\nIt is an acute purulent infection of the meninges within the sub-arachnoid space.\\nSalient features\\nInvestigations\\nCSF analysis (Table 3)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 114, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n99\\nTable 3. Cerebrospinal fluid characteristics of different etiologies of meningitis\\nCharacteristics\\nNormal\\nBacterial\\nViral\\nFungal/TB\\nPressure(cmH2O)\\n5-20\\n>30\\nNormal or mildly\\nincreased\\n-\\nAppearance\\nNormal\\nTurbid\\nClear\\nFibrin web\\nProtein(g/L)\\n0.18-0.45\\n>1\\n<1\\n0.1-0.5\\nGlucose(mmol/L)\\n2.5-3.5\\n<2.2\\nNormal\\n1.6-2.5\\nGram Stain\\nNormal\\n60-90% positive\\nNormal\\n-\\nGlucose-\\nCSF: Serum ratio\\n0.6\\n<0.4\\n>0.6\\n<0.4\\nWCC\\n<3\\n>500\\n<1000\\n100-500\\nOthers\\n-\\n90% PMN\\nMonocytes\\n10% have>90%PMN\\n30%have>50%PMN\\nMonocytes\\nPharmacological treatment\\nFollowing table shows choice of antibiotic as per patient characteristics and their dose and\\nfrequency in empirical therapy of bacterial meningitis and focal CNS infections\\nTable 4. Choice of antibiotics for the treatment of bacterial meningitis as per patient\\ncharacteristics\\nIndication\\nAntibiotic\\nPreterm infants to infants <1 month\\nAmpicillin + cefotaxime\\nInfants 1–3 month\\nAmpicillin + cefotaxime or ceftriaxone'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 114, 'source_type': 'Authorotative', 'priority': '1'}, page_content='characteristics\\nIndication\\nAntibiotic\\nPreterm infants to infants <1 month\\nAmpicillin + cefotaxime\\nInfants 1–3 month\\nAmpicillin + cefotaxime or ceftriaxone\\nImmunocompetent children >3 months and adults <55 Cefotaxime, ceftriaxone or cefepime +\\nvancomycin\\nAdults >55 and adults of any age with alcoholism or\\nother debilitating illnesses\\nAmpicillin + cefotaxime, ceftriaxone or\\ncefepime + vancomycin\\nHospital-acquired meningitis, posttraumatic or post\\nneurosurgery meningitis, neutropenic patients, or\\npatients with impaired cell-mediated immunity\\nAmpicillin + ceftazidime or meropenem\\n+ vancomycin\\nAntimicrobial Agent\\nTotal Daily Dose and Dosing Interval\\nAmpicillin\\n12 g/d, every 4 hourly\\nCefipime\\n6 g/d, every 8 hourly\\nCefotaxime\\n12 g/d, every 12 hourly\\nCeftriaxone\\n4 g/d, every 12 hourly\\nCeftazidime\\n6 g/d, every 8 hourly\\nGentamicin\\n7.5 (mg/kg)/d, every 8 hourly'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 115, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Central Nervous System Diseases\\n100\\n\\uf0b7\\nAcute or subacute onset of fever, headache, altered consciousness, focal neurological\\nsymptoms\\n\\uf0b7\\nCommon cause are Herpes simplex I virus and Varicella zoster virus.\\nMeropenem\\n3 g/d, every 8 hourly\\nMetronidazole\\n1500–2000 mg/d, every 6 hourly\\nPenicillin G\\n20–24 million U/d, every 4 hourly\\nVancomycin\\n2 g/d, every 12 hourly\\n\\uf0b7\\nOnce culture report comes therapy should be changed accordingly\\n\\uf0b7\\nInj. dexamethasone 0.15 mg/kg every 6 hourly IV for 2 days. It should be started shortly\\nbefore the antibiotic.\\n\\uf0b7\\nEmergency treatment of increased ICP includes elevation of the patient's head to 30–45°,\\nintubation and hyperventilation (PaCO2 25–30 mm Hg), and Inj. mannitol 20% 1 g/kg stat\\nfollowed by 0.5g/kg every 4-6 hourly.\\n\\uf0b7\\nA 7-day course of intravenous antibiotic therapy is adequate for uncomplicated\\nmeningococcal meningitis.\\n\\uf0b7\\nThe index case and all close contacts should receive chemoprophylaxis with a 2-day\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 115, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nA 7-day course of intravenous antibiotic therapy is adequate for uncomplicated\\nmeningococcal meningitis.\\n\\uf0b7\\nThe index case and all close contacts should receive chemoprophylaxis with a 2-day\\nregimen of rifampin (600 mg every 12 h for 2 days in adults and 10 mg/kg every 12 h for\\n2 days in children more than 1 year of age).\\n\\uf0b7\\nA 2-week course of intravenous antimicrobial therapy is recommended for pneumococcal\\nmeningitis. Meningitis due to L. monocytogenes is treated with ampicillin for at least 3\\nweeks. Gentamicin is added in critically ill patients (2 mg/kg loading dose, then 7.5\\nmg/kg per day given every 8 h and adjusted for serum levels and renal function). A 3-\\nweek course of intravenous antibiotic therapy is recommended for meningitis due to\\ngram-negative bacilli.\\n\\uf0b7\\nTuberculous meningitis is treated as per RNTCP protocol.\\nVIRAL ENCEPHALITIS\\nIn encephalitis the brain parenchyma is also involved. Many patients with encephalitis also'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 115, 'source_type': 'Authorotative', 'priority': '1'}, page_content='gram-negative bacilli.\\n\\uf0b7\\nTuberculous meningitis is treated as per RNTCP protocol.\\nVIRAL ENCEPHALITIS\\nIn encephalitis the brain parenchyma is also involved. Many patients with encephalitis also\\nhave evidence of associated meningitis (meningoencephalitis).\\nSalient features\\nInvestigations\\nCSF analysis as in acute bacterial meningitis (Table 3)\\nPharmacological treatment\\n\\uf0b7\\nSpecific antiviral therapy should be initiated when appropriate.\\n\\uf0b7\\nFollowing table shows drugs, dose duration and their common side effects (Table 5).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 116, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n101\\nTable 5. Dosages and side effects of antivirals in the treatment of viral encephalitis\\nDrug\\nDose\\nDuration\\nEtiology\\nSide effect\\nAcyclovir\\n10 mg/kg\\nevery 8 hrly\\n14 to 21\\ndays\\nHSV,VZV,EBV\\nnausea, vomiting, diarrhea  and\\nNeurotoxicity (lethargy or\\nobtundation, disorientation,\\nconfusion, agitation, hallucinations,\\ntremors, seizures)\\nGanciclovir\\n5mg/kg every\\n12 hrly,\\nfollowed by 5\\nmg/kg\\nIndefinite\\nCMV\\nGranulocytopenia \\nand\\nthrombocytopenia, \\nGastrointestinal\\nside \\neffects, \\nincluding \\nnausea,\\nvomiting, diarrhea, and abdominal\\npain\\nRibavirin\\n15 mg/kg in\\ndivided doses\\nevery 8 hrly\\nCalifornia\\nencephalitis\\n(LaCrosse)\\nvirus, severe\\nadenovirus or\\nrotavirus\\nencephalitis.\\nHemolysis, nausea, vomiting,\\ndiarrhea, and abdominal pain\\n\\uf0b7\\nBasic management and supportive therapy should include careful monitoring of ICP, fluid\\nrestriction, avoidance of hypotonic intravenous solutions, and suppression of fever.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 116, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nBasic management and supportive therapy should include careful monitoring of ICP, fluid\\nrestriction, avoidance of hypotonic intravenous solutions, and suppression of fever.\\n\\uf0b7\\nSeizures should be treated with standard anticonvulsant regimens, and prophylactic\\ntherapy should be considered in view of the high frequency of seizures in severe cases of\\nencephalitis.\\nNEUROCYSTICERCOSIS\\nNeurocysticercosis is the most common parasitic disease of the CNS worldwide. Humans\\nacquire cysticercosis by the ingestion of food contaminated with the eggs of the parasite T.\\nsolium.\\nDiagnostic criteria for cysticerosis\\nAbsolute criteria\\n\\uf0b7\\nDemonstration of cysticercus by histologic or microscopic exam of biopsy material\\n\\uf0b7\\nVisualization of the parasite in the eye by fundoscopy\\n\\uf0b7\\nNeuro-radiologic demonstration of cystic lesion containing a characteristic scolex.\\nMajor criteria\\n\\uf0b7\\nNeuro-radiologic lesions suggestive of neuro-cysticercosis.\\n\\uf0b7\\nDemonstration of antibodies to cystic in serum.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 116, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Major criteria\\n\\uf0b7\\nNeuro-radiologic lesions suggestive of neuro-cysticercosis.\\n\\uf0b7\\nDemonstration of antibodies to cystic in serum.\\n\\uf0b7\\nResolution of intracranial cystic lesions spontaneously or after therapy with albendazole\\nor praziquantel alone.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 117, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n102\\nMinor criteria\\n\\uf0b7\\nLesions compatible with neuro-cysticercosis detect by neuro-imagining studies.\\n\\uf0b7\\nClinical manifestations suggestive of neuro-cysticercosis.\\n\\uf0b7\\nDemonstration of antibodies to cysticerd or cycticercal antigen in CSF by ELISA.\\n\\uf0b7\\nEvidence of cysticercosis outside the central nervous system.\\nEpidemiologic criteria\\n\\uf0b7\\nResidence in a cysticercosis endemic area\\n\\uf0b7\\nFrequent travel to a cysticercosis endemic area\\n\\uf0b7\\nHousehold contact with an individual infected with Taenia sodium\\nDiagnosis is confirmed by either one absolute criteria or a combination to two major criteria\\none minor criterion and one epidemiologic criterion.\\nInvestigations\\n\\uf0b7\\nEnzyme-linked immunoelectrotransfer blot (EITB) of serum for cysticercal antibodies.\\nELISA of serum and CSF\\n\\uf0b7\\nCT scan shows the cyst and granuloma stages of neuro-cysticercosis. Located in the\\ncortex or the gray white junction and present as punctuate hyperdense lesion with ring'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 117, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ELISA of serum and CSF\\n\\uf0b7\\nCT scan shows the cyst and granuloma stages of neuro-cysticercosis. Located in the\\ncortex or the gray white junction and present as punctuate hyperdense lesion with ring\\nenhancement with edema around the cyst, associated with the death of the organism.\\n\\uf0b7\\nMRI use of contrast shows cysticerus death, visible as enhancement of the cyst wall,\\nwhich indicates that the cyst has changed into a granuloma. In addition MRI shows\\nvasogenic edema around the cyst.\\n\\uf0b7\\nSoft tissue radiography can be performed to look for extraneural cysts.\\n\\uf0b7\\nElectro encephalography (EEG): in children with intractable seizures.\\n\\uf0b7\\nStool examination: Presence of ova may be the sole diagnostic confirmation in children.\\nPharmacological treatment\\n\\uf0b7\\nTreatment with anthelminthic drugs can result in complete resolution or significant\\nregression 80-90% of patients.\\n\\uf0b7\\nTab. praziquantel 5-10 mg/kg single dose can be administered to individuals found to\\nhave T solium tapeworms in their stool.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 117, 'source_type': 'Authorotative', 'priority': '1'}, page_content='regression 80-90% of patients.\\n\\uf0b7\\nTab. praziquantel 5-10 mg/kg single dose can be administered to individuals found to\\nhave T solium tapeworms in their stool.\\n\\uf0b7\\nTab. albendazole 400 mg PO BD for 14 days with meals.\\n\\uf0b7\\nTab. phenytoin 300 mg PO, pediatric dose: 4-8 mg / kg / day PO divided BD / TDS to\\nprevent seizures.\\n\\uf0b7\\nTo avoid inflammatory response in the CNS, the patient must be started on\\nanticonvulsants and high dose glucocorticoids.\\nSurgical treatment\\n\\uf0b7\\nReserve neurosurgical intervention for cases of cysts that have failed to resolve with anti-\\nhelminthic treatment and are causing severe neurologic sequelae.\\nPatient education\\n\\uf0b7\\nProlonged freezing or thorough cooking of pork to kill the parasite.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 118, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n103\\n\\uf0b7\\nParaplegia is weakness of both lower limbs and quadriplegia is weakness of all four\\nlimbs. Paraplegia or quadriplegia maybe caused by lesions of cerebrum, spinal cord,\\nmotor roots, peripheral nerves, myoneural junction or muscles. The lesions of the\\nspinal cord may be compressive or non-compressive.\\n\\uf0b7\\nPersonal hygiene or through washing and avoiding unpeeled fruits and vegetables in\\nendemic areas.\\nPARAPLEGIA AND QUADRIPLEGIA\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nThe treatment depends on the underlying etiology. E.g. compressive myelopathies usually\\nrequire urgent surgical intervention.\\n\\uf0b7\\nIndications for corticosteroids in paraplegia: neoplastic spinal cord compression,\\ntraumatic spinal cord injuries, acute transverse myelitis, multiple sclerosis, neuromyelitis\\noptica, sarcoid myelitis, ADEM. The dose is Inj. methylprednisolone 1 g IV for 3-5 days.\\nContinuation of steroids depends on the underlying cause.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 118, 'source_type': 'Authorotative', 'priority': '1'}, page_content='optica, sarcoid myelitis, ADEM. The dose is Inj. methylprednisolone 1 g IV for 3-5 days.\\nContinuation of steroids depends on the underlying cause.\\n\\uf0b7\\nFever: The loss of normal thermoregulation and inability to maintain normal body\\ntemperature can produce recurrent fever (quadriplegic fever), although most episodes of\\nfever are due to infection of the urinary tract, lung, skin, or bone.\\n\\uf0b7\\nBladder dysfunction: It generally results from loss of supraspinal innervation of the\\ndetrusor muscle of the bladder wall and the sphincter musculature.\\n-\\nDetrusor spasticity is treated with anticholinergic drugs like Tab. oxybutynin 2.5–5\\nmg QID or tricyclic antidepressants that have anticholinergic properties, Tab.\\nimipramine, 25–200 mg/d.\\n-\\nFailure of the sphincter muscle to relax during bladder emptying (urinary\\ndyssynergia) may be managed with the adrenergic blocking agent Tab. terazosin\\nhydrochloride 1–2 mg TDS or QID, with intermittent catheterization, or, if that is not'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 118, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dyssynergia) may be managed with the adrenergic blocking agent Tab. terazosin\\nhydrochloride 1–2 mg TDS or QID, with intermittent catheterization, or, if that is not\\nfeasible, by use of a condom catheter in men or a permanent indwelling catheter.\\n-\\nBladder areflexia due to acute spinal shock or conus lesions is best treated by\\ncatheterization.\\n-\\nSurgical options include the creation of an artificial bladder.\\n\\uf0b7\\nBowel regimens and disimpaction are necessary in most patients to ensure at least\\nbiweekly evacuation and avoid colonic distention or obstruction.\\n\\uf0b7\\nDuring the first 2 weeks, use of calf-compression devices and anticoagulation with Inj.\\nheparin 5000 U SC every 12 h or Tab. warfarin (INR, 2–3) are recommended. In cases of\\npersistent paralysis, anticoagulation should probably be continued for 3 months.\\n\\uf0b7\\nProphylaxis against decubitus ulcers: frequent changes in position in a chair or bed, the\\nuse of special mattresses such as water or air beds, and cushioning of areas where'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 119, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n104\\npressure sores often develop, such as the sacral prominence and heels. Early treatment of\\nulcers with careful cleansing, surgical or enzyme debridement of necrotic tissue, and\\nappropriate dressing and drainage.\\n\\uf0b7\\nSpasticity: stretching exercises are recommended to maintain mobility of joints. Tab.\\nbaclofen 15–240 mg/d in divided doses is effective. Tab. diazepam 2-4 mg at bed time\\nacts by a similar mechanism and is useful for leg spasms that interrupt sleep. Tab.\\nTizanidine 2–8 mg TDS is another option.\\nVERTIGO\\nVertigo is defined as the hallucination of movement, either of self (subjective) or the\\nenvironment (objective). When patient presents with this type of dizziness, the next step is to\\ndetermine whether the symptom is central (brain) or peripheral (inner ear, 8th cranial nerve) in\\norigin (Table 6).\\nInvestigations\\nPatients are to be subjected to thorough history, clinical examination and various tests such as'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 119, 'source_type': 'Authorotative', 'priority': '1'}, page_content='origin (Table 6).\\nInvestigations\\nPatients are to be subjected to thorough history, clinical examination and various tests such as\\nhead thrust test, head shaking test, Dix Hallpick’s test, calorie test, CT and MRI brain, X-ray\\nneck, blood sugar and carotid vertebral doppler.\\nTable 6. Features of Peripheral and Central Vertigo\\nClinical features\\nPeripheral\\n(Labyrinth or Vestibular Nerve)\\nCentral (Brainstem\\nOr   Cerebellum)\\nDirection of associated\\nnystagmus\\nUnidirectional;\\nfast phase opposite lesion\\nBidirectional (direction-\\nchanging) or Unidirectional\\nPurely horizontal\\nnystagmus without\\ntorsional component\\nUncommon\\nMay be present\\nPurely vertical or purely\\ntorsional nystagmus\\nNever present\\nMay be present\\nVisual fixation\\nInhibits nystagmus\\nNo inhibition\\nTinnitus and/or Deafness\\nOften present\\nUsually absent\\nAssociated central\\nnervous system\\nabnormalities\\nNone\\nExtremely common  (e.g.,\\ndiplopia, hiccups, cranial\\nneuropathies, dysarthria)\\nCommon causes\\nBenign \\nparoxysmal \\npositional'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 119, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Usually absent\\nAssociated central\\nnervous system\\nabnormalities\\nNone\\nExtremely common  (e.g.,\\ndiplopia, hiccups, cranial\\nneuropathies, dysarthria)\\nCommon causes\\nBenign \\nparoxysmal \\npositional\\nvertigo, labyrinthitis, vestibular\\nneuritis, \\nMénière's \\ndisease,\\nlabyrinthine \\nischemia, \\ntrauma,\\ntoxin\\nVascular, \\ndemyelinating,\\nneoplasm\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 120, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Central Nervous System Diseases\\n105\\nPharmacological treatment\\nThese medications should be reserved for short-term control of active vertigo. They are less\\nhelpful for chronic dizziness and may hinder central compensation.\\n\\uf0b7\\nAntihistamines like Tab. meclizine (25–50 mg 3 times daily), Tab. dimenhydrinate (50\\nmg 1–2 times daily) and Tab. promethazine (25 mg 2–3 times daily, also can be given\\nrectally and IM)\\n\\uf0b7\\nBenzodiazepines like Tab. diazepam (2.5 mg 1–3 times daily) and Tab. clonazepam (0.25\\nmg 1 – 3 times daily.\\n\\uf0b7\\nAnticholinergic agents like scopolamine transdermal patch (for motion sickness only)\\n\\uf0b7\\nPhysical therapy like repositioning manoeuvres (for BPPV)\\n\\uf0b7\\nDiuretics and/or low-sodium (1 g/d) diet (for Ménière's disease)\\n\\uf0b7\\nAntimigrainous drugs (for vestibular migraine)\\n\\uf0b7\\nSelective serotonin reuptake inhibitors (for psychosomatic vertigo)\\nBenign Paroxysmal Positional Vertigo (BPPV)\\n\\uf0b7\\nA common cause of recurrent vertigo\\n\\uf0b7\\nEpisodes are brief (less than 1 min and typically 15–20 s)\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 120, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Benign Paroxysmal Positional Vertigo (BPPV)\\n\\uf0b7\\nA common cause of recurrent vertigo\\n\\uf0b7\\nEpisodes are brief (less than 1 min and typically 15–20 s)\\n\\uf0b7\\nAlways provoked by changes in head position relative to gravity, such as lying down,\\nrolling over in bed, rising from a supine position, and extending the head to look upward.\\n\\uf0b7\\nWith posterior canal BPPV, the nystagmus beats upward and torsionally\\n\\uf0b7\\nHorizontal canal BPPV resulting in a horizontal nystagmus\\n\\uf0b7\\nSuperior (also called anterior) canal involvement is rare.\\n\\uf0b7\\nBPPV is treated with repositioning maneuvers that utilize gravity to remove the otoconia\\nfrom the semicircular canal.\\n\\uf0b7\\nFor posterior canal BPPV, the Epley maneuver is the most commonly used procedure.\\nVestibular Migraine\\n\\uf0b7\\nUsually part of migraine aura but can occur independently. The duration of vertigo may\\nbe from minutes to hours. Vestibular migraine typically is treated with medications that\\nare used for prophylaxis of migraine headaches.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 120, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"be from minutes to hours. Vestibular migraine typically is treated with medications that\\nare used for prophylaxis of migraine headaches.\\n\\uf0b7\\nAntiemetics may be helpful to relieve symptoms at the time of an attack.(See vomiting\\nsection)\\nMénière's Disease\\n\\uf0b7\\nAttack consists of vertigo, hearing loss, & pain, pressure or fullness in affected ear.\\n\\uf0b7\\nDiuretics and sodium restriction are the initial treatments.\\n\\uf0b7\\nIf attacks persist, injections of gentamicin into the middle ear or full ablative procedures\\nare required.\\n\\uf0b7\\nTab. betahistine 24-48 mg/day relieves pressure from excess fluid. Initial dose 16 mg\\nTDS initially with maintenance.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 121, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Central Nervous System Diseases\\n106\\nPsychosomatic Dizziness/vertigo\\n\\uf0b7\\nImportant role in chronic dizziness\\n\\uf0b7\\nDizziness may be a somatic manifestation of a psychiatric condition such as major\\ndepression, anxiety, or panic disorder.\\n\\uf0b7\\nThus, treatment with antianxiety medications and cognitive/behavioral therapy may be\\nhelpful.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 122, 'source_type': 'Authorotative', 'priority': '1'}, page_content='107\\n\\uf0b7\\nPeriorbital and generalized pitting edema, transudative  pleural effusion, ascites, xanthomata\\n\\uf0b7\\nDiseases confined to kidney: Minimal change disease, membranous nephropathy, focal\\nsegmental glomerulosclerosis, membranoproliferative GN, mesangioproliferative GN\\n\\uf0b7\\nSystemic diseases diabetes mellitus, SLE, amyloidosis, Henoch Schonlein purpura,\\npreeclampsia\\n\\uf0b7\\nHereditary diseases like congenital nephritic syndrome and Alports syndrome\\nChapter 6\\nGENITOURINARY DISEASES\\nNEPHROTIC SYNDROME\\nNephrotic syndrome is defined as proteinuria more than 3.5 gm/day in adults and more than\\n40mg/m2/hr in children. Associated features are hypoalbuminemia, hyperlipidemia and\\nedema.\\nSalient features\\nInvestigation\\n\\uf0b7\\nUrine analysis : Dipstick test for proteinuria\\n\\uf0b7\\nUrine microscopic examination for deposits\\n\\uf0b7\\n24 hrs. urinary protein: more than 3.5 gm/day establishes the diagnosis.\\n\\uf0b7\\nRenal function tests: Blood urea, Serum creatinine – Usually normal in isolated nephrotic\\nsyndrome.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 122, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\n24 hrs. urinary protein: more than 3.5 gm/day establishes the diagnosis.\\n\\uf0b7\\nRenal function tests: Blood urea, Serum creatinine – Usually normal in isolated nephrotic\\nsyndrome.\\nIndications for renal biopsy in nephrotic syndrome\\n\\uf0b7\\nAge > 10 yrs., Micro – hematuria in urine analysis., No response to steroid therapy in\\nadequate doses for a period of 4 weeks., Associated renal failure, Low C3 levels, ANA\\npositive, Evidence of systemic diseases.\\nNon pharmacological treatment\\n\\uf0b7\\nDiet: Protein 0.8g/kg/day and  1 g protein per gm lost in urine, 35 kcals/kg/day\\ncarbohydrates\\nPharmacological treatment\\n\\uf0b7\\nIn children less than 10 yrs., without hematuria, without renal failure, start empirical\\nsteroids viz. Tab. prednisolone 2mg/kg/day for 4 weeks, taper over next 4 weeks.\\n\\uf0b7\\nTab. atorvastatin 10-20mg/day for hyperlipidemia\\n\\uf0b7\\nTab  furosemide  40-80 mg BD\\n\\uf0b7\\nTab. enalapril  1.25-5 mg/day\\n\\uf0b7\\nTreatment of infections\\nCHRONIC KIDNEY DISEASE'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 122, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTab. atorvastatin 10-20mg/day for hyperlipidemia\\n\\uf0b7\\nTab  furosemide  40-80 mg BD\\n\\uf0b7\\nTab. enalapril  1.25-5 mg/day\\n\\uf0b7\\nTreatment of infections\\nCHRONIC KIDNEY DISEASE\\nAn irreversible, sustainable and usually gradual loss of renal function leading to clinical and\\nlaboratory symptom of uraemia. The important underlying diseases are diabetes mellitus,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 123, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Genitourinary Diseases\\n108\\nhypertension, chronic glumerulonephritis, chronic pylonephritis, analgesic nephropathy and\\npolycystic disease.\\nSalient features\\n.\\nInvestigations\\n\\uf0b7\\nHigh risk - obesity, smoking, diabetes, hypertension and family history of renal disease.\\n\\uf0b7\\nMeasure BP, Urine for proteinuria, hematuria and other sediments.\\n\\uf0b7\\nEstimate serum creatinine, screen them at least yearly.\\nDiagnosis\\n\\uf0b7\\nEither one of the following establishes the diagnosis; Kidney damage for more than 3\\nmonths as defined by any structural or functional abnormalities of the kidney with or\\nwithout decreased glomerular filtration rate (GFR). Decrease in GFR to < 6.0ml/min for\\nmore than 3 months. The formula for calculation of GFR = (140 – age) x (Wt. in kg) x\\n(0.85 if female) / (72 x Cr in mg/dl)\\nStaging: Chronic kidney disease has been divided into five stages (Table 1).\\nTable 1. Stages of chronic kidney disease\\nStage\\nDescription\\nGFR\\n(ml/1.73m2/min)\\nStage-I\\nKidney damage with normal or GFR\\n> 90\\nStage-II'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 123, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Table 1. Stages of chronic kidney disease\\nStage\\nDescription\\nGFR\\n(ml/1.73m2/min)\\nStage-I\\nKidney damage with normal or GFR\\n> 90\\nStage-II\\nKidney damage with mild GFR\\n60 – 89\\nStage-III\\nModerate in GFR\\n30 – 59\\nStage-IV\\nSevere in GFR\\n15 – 29\\nStage-V\\nEnd stage renal disease\\n< 15\\nNon pharmacological treatment\\n\\uf0b7\\nDecrease protein intake to 0.6/kg/day\\n\\uf0b7\\nModerates sodium restriction to 60mmol/day\\n\\uf0b7\\nPhosphate restriction to 1000mg/day\\n\\uf0b7\\nObesity: Aim for ideal body mass index of <25\\n\\uf0b7\\nCessation of smoking\\nPharmacological treatment\\nStep – 1 Look for clues with respect to etiology:\\n\\uf0b7\\nHistory of hypertension or diabetes mellitus.\\n\\uf0b7\\nSymptoms related to lower urinary tract, recent infections.\\n\\uf0b7\\nFeatures of connective tissue disease.\\n\\uf0b7\\nThe symptom of uremia developed gradually and late. Fatigue, dyspnoea, anorexia,\\nvomiting, ankle edema, pruritus, and neuromuscular disturbances.\\n\\uf0b7\\nExamination shows presence of pallor, nail dystrophy, purpura, hypertension,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 123, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vomiting, ankle edema, pruritus, and neuromuscular disturbances.\\n\\uf0b7\\nExamination shows presence of pallor, nail dystrophy, purpura, hypertension,\\ncardiomegaly, CHF, features of pulmonary edema, pleural effusion and pericarditis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 124, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Genitourinary Diseases\\n109\\n\\uf0b7\\nPast medical record suggestive of proteinuria.\\n\\uf0b7\\nPregnancy related problems.\\n\\uf0b7\\nPast renal evaluation\\n\\uf0b7\\nFamily history of hereditary kidney disease like ADPKD / Alports syndrome.\\nStep – 2 Reversible factors in CKD\\n\\uf0b7\\nObstructive nephropathy, urinary tract infections, extra renal infections\\n\\uf0b7\\nNephrotoxic drugs, hypovolemia\\n\\uf0b7\\nCongestive cardiac failure, pericardial temponade\\n\\uf0b7\\nHypokalemia / Hyperuricemia\\nStep - 3\\n\\uf0b7\\nIn patients with proteinuria > 1g/day, BP target is <125/75mmHg\\n\\uf0b7\\nIf proteinuria <1g/day, BP target is <135/85 mmHg\\n\\uf0b7\\nTab. frusemide 40-160 mg/ day or Tab. amlodipine 5-20 mg/day\\n\\uf0b7\\nIn diabetic nephropathy- Tab. enalapril 1.25-5 mg/day\\n\\uf0b7\\nIf hyperlipidemia – Tab. atorvastatin 10-20 mg/day\\n\\uf0b7\\nIf anemic. Inj. EPO 80-120unit/kg/week  SC\\nStep – 4 Prevent and treat complications\\nMalnutrition\\n\\uf0b7\\nDietary protein intake of 0.6g/kg body weight/day\\n\\uf0b7\\nDietary calorie intake of 30-35 kcal/kg/day\\nCardiovascular disease\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 124, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Step – 4 Prevent and treat complications\\nMalnutrition\\n\\uf0b7\\nDietary protein intake of 0.6g/kg body weight/day\\n\\uf0b7\\nDietary calorie intake of 30-35 kcal/kg/day\\nCardiovascular disease\\n\\uf0b7\\nCommonest cause of mortality in CKD patients.Risk for IHD increases by 30% for every\\nincrease in serum creatinine by 0.23mg/dl.\\n\\uf0b7\\nAt least yearly screening for cardiovascular disease should be done.\\nRenal osteodystrophy\\n\\uf0b7\\nTarget calcium – 8.8 to 9.7mg/dl, Phosphorous – 3.5 to 5.5 mg/dl, Calcium –\\nPhosphorous product < 55 mg2/dl.\\n\\uf0b7\\nThis is achieved by phosphate restricted diet. Tab. calcium carbonate 1 g/day and Tab.\\nvitamin D3- 0.25- 2 mcg/day\\nStep – 5 Prepare for renal replacement therapy\\n\\uf0b7\\nEarly referral to Nephrologists\\n\\uf02d\\nVaccination- Hepatitis B vaccine 40 micro grams 3 doses 0, 1st and 2nd month\\nfollowed by booster dose at 6th months.\\n\\uf0b7\\nEarly creation of arterio-venous fistula when the GFR is <25 ml/min or serum creatinine\\n> 4.0meg/l.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 125, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Genitourinary Diseases\\n110\\nACUTE RENAL FAILURE (ARF)\\nAcute renal failure is defined as a rapid decline in renal function reflected by GFR over hours\\nto days as evidenced by raising creatinine values.\\nSalient features\\nEtiology\\n\\uf0b7\\nPre-renal – 70%\\n\\uf02d\\nHypovolemia – diarrhea, persistant, vomiting, burns, haemorrhage.\\n\\uf02d\\nLow cardiac output – CCF\\n\\uf02d\\nSystemic vasodilatation – Sepsis, Hepato renal syndrome.\\n\\uf02d\\nDrugs – NSAIDs\\n\\uf0b7\\nRenal - – 25%\\n\\uf02d\\nCan occur due to disease process in glomeruli / tubules / interstitial / vasculature.\\n\\uf02d\\nAcute tubular necrosis can occur due to Ischemic kidney injury – can occur with any\\ncause of pre renal failure if prolonged.\\n\\uf02d\\nNephrotoxic drugs (commonly used) NSAIDs, aminoglycosides, amphotericin-B.\\n\\uf0b7\\nPost renal – 5%\\n\\uf02d\\nProstatic hyperplasia with obstruction, Renal stone disease, Carcinoma of cervix\\nInvestigations\\n\\uf0b7\\nBlood : Urea, Creatinine, Serum Electrolytes, Serum Calcium, Serum PO4, Serum\\nAlbumin\\n\\uf0b7\\nUrine Analysis\\n\\uf02d\\nPre-renal: occasional hyaline and granular casts.\\n\\uf02d'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 125, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Investigations\\n\\uf0b7\\nBlood : Urea, Creatinine, Serum Electrolytes, Serum Calcium, Serum PO4, Serum\\nAlbumin\\n\\uf0b7\\nUrine Analysis\\n\\uf02d\\nPre-renal: occasional hyaline and granular casts.\\n\\uf02d\\nPost-renal: Few hyaline casts.\\n\\uf02d\\nProteinuria usually small amounts, WBC’s, epithelial cells, muddy brown appearance.\\n\\uf02d\\nCalculate FeNa (Fractional Excretion of Sodium)\\n\\uf02d\\nUrine Na x Serum Creatinine x Serum Na x Urine Creatinine x 100\\n< 1 – Pre-renal; > 2 – Renal\\nPharmacological treatment\\n\\uf0b7\\nPre – Renal- Hydration by Inj . normal saline 0.9% , eliminate toxins and  treat\\nunderlying cause\\n\\uf0b7\\nRenal:  Eliminate toxins,  Nephrology consultation\\n\\uf0b7\\nPost renal : Relieve obstruction, Urology consultation\\n\\uf0b7\\nAnorexia, fatigue, mental status changes, nausea/vomiting, pruritus, shortness of breaths\\n\\uf0b7\\nSigns are pericardial rub, pedal edema, pulmonary rales, raised JVP, seizures. Look for clues\\nfor etiology of renal failure.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 126, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Genitourinary Diseases\\n111\\n\\uf0b7\\nAs serum potassium increases ECG becomes progressively abnormal viz.\\n\\uf02d\\nTenting of T waves.\\n\\uf02d\\nProlonged PR and QRS interval\\n\\uf02d\\nFlattened P waves, sine wave and asystole.\\n\\uf0b7\\nMuscle paralysis can also be a feature of hyperkalemia.\\n\\uf0b7\\nIndications for Dialysis are hyperkalemia, metabolic Acidosis volume Overload,\\nencephalopathy, and pericarditis.\\nHYPOKALEMIA\\nDefined as serum potassium <3.5 meq/l.\\nSalient feature\\nNon- pharmacological treatment\\n\\uf0b7\\nDietary- Potassium rich food in form of fruit juices, banana, coconut water, dry fruits.\\nPharmacological treatment\\n\\uf0b7\\nUrgent treatment is required in rare situations like periodic paralysis, ventricular ectopics\\nor in the setting of myocardial infarction.\\n\\uf0b7\\nIV KCL only required when patient not able to take orally and Potassium <2.5 mEq/l\\n\\uf0b7\\nOral potassium chloride 15ml TDS is usually sufficient if there are no cardiovascular or\\nneurological emergencies.\\nHYPERKALEMIA\\nHyperkalemia is defined by serum potassium > 5.5meq/l.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 126, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nOral potassium chloride 15ml TDS is usually sufficient if there are no cardiovascular or\\nneurological emergencies.\\nHYPERKALEMIA\\nHyperkalemia is defined by serum potassium > 5.5meq/l.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nInj. calcium gluconate 10ml of 10% solution over 10 min. Effect lasts for 30-60 mins.\\nRepeat hourly.\\n\\uf0b7\\nInfuse 25% dextrose 100ml + 10 units of regular insulin. The effect lasts for 4-6 hours.\\n\\uf0b7\\nSalbutamol nebulization 10mg (2-8 times the normal dose).\\n\\uf0b7\\nInj. sodium bicarbonate 7.5%   50-100 ml is given bolus i.v. slowly over 10-20 mins\\nfollowed by drip.\\n\\uf0b7\\nCation exchange resins- sodium polystyrene sulphonate (Keyxalate), usual dose is 25-30\\ngm mixed with 100 ml 20% sorbitol 3-4 times daily.\\n\\uf0b7\\nNote: All three steps are to be combined. All these can buy time before patient reaches\\nthe tertiary care center for dialysis.\\n\\uf0b7\\nIt can present with muscular symptoms like flaccid paralysis, cardiovascular'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 126, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the tertiary care center for dialysis.\\n\\uf0b7\\nIt can present with muscular symptoms like flaccid paralysis, cardiovascular\\nproblems like ventricular arrhythmias and renal involvement like polyuria.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 127, 'source_type': 'Authorotative', 'priority': '1'}, page_content='112\\n\\uf0b7\\nTiredness, weakness, dry skin, feeling cold, hair loss, difficulty concentrating and poor\\nmemory, constipation, weight gain with poor appetite, dyspnea, hoarse voice,\\nmenorrhagia (later oligomenorrhea or amenorrhea), paresthesia, impaired hearing\\n\\uf0b7\\nExamination shows dry coarse skin; cool peripheral extremities, puffy face, hands, and\\nfeet (myxedema), diffuse alopecia, bradycardia, peripheral edema, delayed tendon\\nreflex relaxation, carpal tunnel syndrome, serous cavity effusions\\nChapter 7\\nENDOCRINE DISEASES\\nHYPOTHYROIDISM\\nHypothyroidism may be primary; common causes are autoimmune, iatrogenic due to I131,\\nantithyroid drugs, lithium treatment, thyroidectomy. It may be secondary to pituitary or\\nhypothalamic disorders.\\nSalient features\\nInvestigation: diagnosis is confirmed by\\n\\uf0b7\\nLow serum free T3 and T4\\n\\uf0b7\\nElevated S. TSH in thyroid types and low in suprathyroid types.\\n\\uf0b7\\nThyroid peroxidase (TPO) Anti TPO antibody in autoimmune hypothyroidism.\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 127, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nLow serum free T3 and T4\\n\\uf0b7\\nElevated S. TSH in thyroid types and low in suprathyroid types.\\n\\uf0b7\\nThyroid peroxidase (TPO) Anti TPO antibody in autoimmune hypothyroidism.\\nPharmacological treatment\\n\\uf0b7\\nTab. levothyroxine 50-100 mcg/day. Dose to be adjusted based on TSH level. Measure\\nTSH level after about 2 months of instituting therapy\\n\\uf0b7\\nAdjust by 12.5 mcg/day with similar increment every 2-3 months until TSH level is\\nnormalized.\\n\\uf0b7\\nWhen full replacement is achieved, follow up measurement at annual intervals and later\\nby a 2-3 yearly interval.\\n\\uf0b7\\nSpecial treatment considerations- A hypothyroid woman should be euthyroid prior to\\nconception and during early pregnancy. Maintain FT4 0.8 to 1.2.\\n\\uf0b7\\nElderly required less thyroxine (20%) especially those with CAD, starting dose 12.5\\nmcg/day with similar increment every 2-3 months until TSH level is normalized.\\nPatient education\\n\\uf0b7\\nL-thyroxine should be taken as a single daily dose, ideally on awakening, at least 30\\nminutes before breakfast.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 127, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patient education\\n\\uf0b7\\nL-thyroxine should be taken as a single daily dose, ideally on awakening, at least 30\\nminutes before breakfast.\\n\\uf0b7\\nFiber and bran products may impair absorption\\n\\uf0b7\\nMetabolism of L-thyroxine is increased by phenytoin, rifampicin and carbamazepine.\\n\\uf0b7\\nExplain to the patient that the treatment is lifelong.\\n\\uf0b7\\nOver treatment may lead to decreased bone mineral density and adverse cardiac\\ncomplications.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 128, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n113\\n\\uf0b7\\nHyperactivity, irritability, dysphoria, heat intolerance and sweating, palpitations, fatigue and\\nweakness, weight loss with increased appetite, diarrhea, polyuria, oligomenorrhea, loss of\\nlibido.\\n\\uf0b7\\nExaminations shows tachycardia; atrial fibrillation in the elderly\\n\\uf0b7\\nTremor, goiter warm, moist skin. Muscle weakness, proximal myopathy, lid retraction or lag\\nMyxedema coma\\nNon- pharmacological treatment\\n\\uf0b7\\nWarm blanket, mechanical ventilation for respiratory failure.\\n\\uf0b7\\nCorrection of metabolic disturbances and treat precipitating factors.\\nPharmacological treatment\\n\\uf0b7\\nInj. L-thyroxine 500 mcg IV bolus, then 50-100 mcg IV daily.\\n\\uf0b7\\nIf intravenous preparation is not available, the same dose is administered through Ryle’s\\ntube.\\n\\uf0b7\\nOnce acute phase is over, maintain L-thyroxine as above.\\n\\uf0b7\\nInj. hydrocortisone 100 mg IV stat, 25-50 mg 8 hourly.\\n\\uf0b7\\nCaution: Avoid sedative and anesthetic agents.\\nHYPERTHYROIDISM'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 128, 'source_type': 'Authorotative', 'priority': '1'}, page_content='tube.\\n\\uf0b7\\nOnce acute phase is over, maintain L-thyroxine as above.\\n\\uf0b7\\nInj. hydrocortisone 100 mg IV stat, 25-50 mg 8 hourly.\\n\\uf0b7\\nCaution: Avoid sedative and anesthetic agents.\\nHYPERTHYROIDISM\\nClassically occurs in Grave’s disease, which is characterized by diffuse goitre,\\nopthalmopathy and dermopathy in varying combinations. Other causes are toxic muti-\\nnodular goitre and toxic adenomas.\\nSalient features\\nInvestigations\\n\\uf0b7\\nLow or undetectable S.TSH and increased S. Free T3 and Free T4.\\nPharmacological treatment\\nAdjunctive treatment\\n\\uf0b7\\nFor adrenergic symptoms, Tab. propranolol 40-120 mg a day.\\n\\uf0b7\\nTab. propylthiouracil 100-150 mg every 6-8 hours (Drug of choice for hyperthyroidism in\\npregnancy) or Tab. carbimazole 10-20 mg   every 8-12 hours.\\n\\uf0b7\\nAfter euthyroid state is achieved in 6-8 weeks once daily dosage.\\n\\uf0b7\\nReview with serum TSH and FT3 after 3-4 weeks treatment has been initiated.\\n\\uf0b7\\nOnce controlled reduce to the smallest effective dose or continue initial dose combined\\nwith L-thyroxin.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 128, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nReview with serum TSH and FT3 after 3-4 weeks treatment has been initiated.\\n\\uf0b7\\nOnce controlled reduce to the smallest effective dose or continue initial dose combined\\nwith L-thyroxin.\\n\\uf0b7\\nDrugs are given for an average of 2 years.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 129, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n114\\nDefinitive treatment is Surgery/ Ablation of thyroid tissue\\n\\uf0b7\\nSubtotal thyroidectomy in younger patients in whom antithyroid therapy has been\\nunsuccessful and in very large goiters.\\n\\uf0b7\\nRadioactive iodine (I131) method of choice in elderly, younger patients who have\\ncompleted family with recurrent thyrotoxicosis following surgery or when surgery is\\nrefused or contraindicated.\\n\\uf0b7\\nCaution :  Pregnancy\\nOphthalmopathy\\n\\uf0b7\\nRefer to ophthalmologist.\\n\\uf0b7\\nMild cases: diuretic to decrease edema, tinted sunglasses and 1% methyl cellulose eye\\ndrops.\\n\\uf0b7\\nRefer patients with severe and progressive exopthalmos to an ophthalmologist.\\nThyrotoxic crisis or thyroid storm\\n\\uf0b7\\nTab. propylthiouracil 600 mg loading doses, then 200-300 mg every 6 hourly orally or\\nthrough Ryle’s tube.\\n\\uf0b7\\nTab. carbimazole 15-25 mg 6 hourly.\\n\\uf0b7\\n1 hour after the 1st dose of antithyroid drug, saturated solution of potassium iodide (SSKI)\\n5drops every 6 hourly  or\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 129, 'source_type': 'Authorotative', 'priority': '1'}, page_content='through Ryle’s tube.\\n\\uf0b7\\nTab. carbimazole 15-25 mg 6 hourly.\\n\\uf0b7\\n1 hour after the 1st dose of antithyroid drug, saturated solution of potassium iodide (SSKI)\\n5drops every 6 hourly  or\\n\\uf0b7\\nLugol’s iodine 10 drops 3 times a day or Sodium iodide 1 g IV slowly\\n\\uf0b7\\nTab. propranolol 40-60 mg 4 hourly or 0.5 -2.0 mg every 4 hours,\\n\\uf0b7\\nInj. dexamethasone 2 mg IV 6 hourly.\\n\\uf0b7\\nSupportive treatment: Cooling, antipyretics, antibiotics, IV fluids.\\n\\uf0b7\\nOnce euthyroid states are achieved, manage as already outlined.\\nHYPOCALCEMIA\\nCaused by hypoparathyrodism, pseudohypoparathyrodism, vitamin D deficiency states,\\nchronic renal failure, malabsorption syndrome, and hypomagnesemia.\\nSalient features\\n.\\nInvestigation\\n\\uf0b7\\nTotal S. calcium <8.5 mg/dl\\n\\uf0b7\\nECG : Prolongation of QTc\\n\\uf0b7\\nIn hypoalbuminemia, add 1 mg/dl of calcium to the estimated level for every 1 gm fall\\nof albumin below 4 gm/dl ( Correct S. Calcium)\\n\\uf0b7\\nTreatment depends on the cause, the severity, the presence of symptoms, and how'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 129, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of albumin below 4 gm/dl ( Correct S. Calcium)\\n\\uf0b7\\nTreatment depends on the cause, the severity, the presence of symptoms, and how\\nrapidly the hypocalcemia developed.\\n\\uf0b7\\nCircumoral paresthesias, muscle cramps, confusion, tetany, convulsion. Positive\\nchovstek,s sign and trousseau’s sign'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 130, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n115\\n\\uf0b7\\nFatigue, depression , confusion, anorexia, nausea, vomiting and constipation\\nand\\npolyurea\\n\\uf0b7\\nSevere hypocalcemia may result in seizures, tetany, refractory hypotension or\\narrhythmias that require a more aggressive approach\\nPharmacological treatment\\n\\uf0b7\\nSevere symptomatic hypocalcaemia: 20 ml of 10% Inj. ca.gluconate solution over 10-\\n15 mins followed by 60-80ml of 10% solution in 1lt of 5% distilled water (0.5-0.25\\nmg/kg/hr elemental calcium)\\n\\uf0b7\\nCaution: Should not be mixed with bicarbonate as it may result in precipitation of\\ncalcium carbonate.\\n\\uf0b7\\nIf associated with hypomagnesemia : Inj. magnesium sulphate 1-2 gm IV day 1\\nfollowed by oral magnesium oxide 600-1200 mg 3 times a day to replenish stores.\\nAsymptomatic hypocalcemia / maintenance treatment\\n\\uf0b7\\nTreat underlying condition if possible. Long term treatment is required in conditions\\nsuch as hypoparathyroidism, pseudohypoparathyroidism and chronic vitamin D\\ndeficiency states.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 130, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTreat underlying condition if possible. Long term treatment is required in conditions\\nsuch as hypoparathyroidism, pseudohypoparathyroidism and chronic vitamin D\\ndeficiency states.\\n\\uf0b7\\nTab. calcium carbonate (40% elemental ca) 1-2 gm elemental calcium orally 3 times a\\nday initially and subsequently maintenance dose of 0.4-1.5 g 3 times a day.\\n\\uf0b7\\nIn CRF,\\ncalcium alone gives inadequate results. Correct concomitant hyper-\\nphosphatemia before instituting following therapy: Vit D 50000 IU/day for 1-2 weeks,\\nthen weekly or bimonthly.\\n\\uf0b7\\nCalcitriol 0.25 mcg orally daily- more expensive and less toxic.\\n\\uf0b7\\nAdvise low Phosphate diet and Phosphate binding agents.\\nHYPERCALCEMIA\\nThe common causes are hyperparathyroidism and malignancy. Others include excessive\\nvitamin D action, high bone turnover rate or renal failure. Hypercalcemia is defined as 10.5\\nmEq/L.\\nSalient features\\nInvestigation\\n\\uf0b7\\nSymptoms appear when S. Ca >11.5-12.0mg/dl. Severe hypercalcemia >15-18 mg/dl can\\nresult in death.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 130, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mEq/L.\\nSalient features\\nInvestigation\\n\\uf0b7\\nSymptoms appear when S. Ca >11.5-12.0mg/dl. Severe hypercalcemia >15-18 mg/dl can\\nresult in death.\\n\\uf0b7\\nECG : Short QTc and occasionally arrhythmias\\nPharmacological treatment\\nA. Mild\\n\\uf0b7\\nRehydration – isotonic saline 2-4 lt/day increase calcium excretion.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 131, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n116\\n\\uf0b7\\nAfter correcting dehydration administer Inj. frusemide 20-40 mg BD.\\n\\uf0b7\\nMonitor electrolytes especially potassium and magnesium and replace accordingly.\\nB. Moderate to severe\\n\\uf0b7\\nAggressive preceding approach- isotonic saline 6 lt plus Inj. frusemide up to 100 mg\\nevery 1 to 2 hours.\\n\\uf0b7\\nInj. calcitonin 2-8 U/kg IV/SC/IM every 6-12 hr: rapid but mild action.\\n\\uf0b7\\nInj. pamindronate 30-90 mg IV infusion in 0.9% saline over 4-24 hrs: response last for\\nwks OR Tab. alendronate sodium 10 mg orally in the morning with full glass of water at\\nleast 30 mins before any food or drink: remain in upright position for at least 30 mins. OR\\nInj. zolendronate 1-4 mg IV in few mins.\\n\\uf0b7\\nTab. prednisolone 40-100 mg/day in 4 divided doses. Useful in osteolytic malignancies,\\nVit. D intoxication and sarcoidosis.\\n\\uf0b7\\nTab. phosphorus (sodium and potassium phosphate) 1-1.5 g/day in 4 divided doses for\\nseveral days when hypophosphatemia is present.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 131, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Vit. D intoxication and sarcoidosis.\\n\\uf0b7\\nTab. phosphorus (sodium and potassium phosphate) 1-1.5 g/day in 4 divided doses for\\nseveral days when hypophosphatemia is present.\\n\\uf0b7\\nPeritoneal/Hemo dialysis with calcium free dialyses is useful especially in cases\\ncomplicated by renal failure.\\nDIABETES MELLITUS\\nDiabetes mellitus (DM) refers to a group of common metabolic disorders that share the\\nphenotype of hyperglycemia. Several distinct types of DM are caused by a complex\\ninteraction of genetics and environmental factors. The factors contributing to hyperglycemia\\ninclude reduced insulin secretion, decreased glucose utilization, and increased glucose\\nproduction.\\nSalient features\\nClassification\\n\\uf0b7\\nPolydypsia, polyuria, polyphagia and unexplained weight loss.\\n\\uf0b7\\nRandom blood sugar >200 mg/dl, Fasting plasma glucose >126 mg/dl\\n\\uf0b7\\nTwo hour plasma glucose >200 mg/dl after 75 g glucose load\\n\\uf0b7\\nImpaired fasting glucose (IFG) 100-125 mg/dl  and impaired glucose tolerance – 2 h'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 131, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTwo hour plasma glucose >200 mg/dl after 75 g glucose load\\n\\uf0b7\\nImpaired fasting glucose (IFG) 100-125 mg/dl  and impaired glucose tolerance – 2 h\\nplasma glucose  140-199 mg/dl are considered as pre diabetics.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 132, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n117\\nNon- pharmacological treatment\\nCaloric requirement for normal weight individual: according to the nature of work\\nSedentary\\nModerate\\nHeavy\\nMale\\n1800-2000\\n1800-2000\\n2200-3000\\nFemale\\n1200-1500\\n1400-1600\\n1600-2400\\n\\uf0b7\\nCaloric distribution : Carbohydrate : 45-65%, Protein – 10-35% , 20-35% from fat,\\nsaturated fat <7%, Polyunsaturated fat 10% of Kcal/day\\n\\uf0b7\\nExercise: Regular physical exercise for half and one hour (for sedentary workers) is\\nrecommended to have better control of diabetes. At least 150 min/ week of moderate\\nintensity aerobic physical activity.\\nPharmacological treatment\\nType 1 DM- Insulin therapy (Table 1)\\n\\uf0b7\\nDose of human insulin – 0.5 units/kg/day to 1.0 units/kg/day\\n\\uf0b7\\nCombination of regular + lente/semilente insulin should be used\\n\\uf0b7\\nOne third of the total insulin requirement is given as regular and two third as lente/semi\\nlente\\n\\uf0b7\\nOne third of the total dose is used before dinner and two third before breakfast\\n\\uf0b7\\nInsulin is given SC 30-45 min before meals\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 132, 'source_type': 'Authorotative', 'priority': '1'}, page_content='lente\\n\\uf0b7\\nOne third of the total dose is used before dinner and two third before breakfast\\n\\uf0b7\\nInsulin is given SC 30-45 min before meals\\n\\uf0b7\\nMedial aspect of thigh and abdominal wall are generally used for injection.  Rotate\\ninjection site frequently\\n\\uf0b7\\nDose, type and timing of insulin is adjusted according preprandial blood sugar levels\\n\\uf0b7\\nPatient must be trained for administration of SC injections\\n\\uf0b7\\nEnsure meals after injection and explain features of hypoglycaemia to the patient'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 133, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n118\\nTable 1. A list of various insulin preparations\\nTime of Action\\nInsulin Preparation\\nOnset, h\\nPeak, h\\nEffective\\nDuration, h\\nShort-acting\\nAspart\\n<0.25\\n0.5–1.5\\n3–4\\nGlulisine\\n<0.25\\n0.5–1.5\\n3–4\\nLispro\\n<0.25\\n0.5–1.5\\n3–4\\nRegular\\n0.5–1\\n2–3\\n4–6\\nLong-acting\\nDetemir\\n1–4\\n—\\nUp to 24\\nGlargine\\n1–4\\n—\\nUp to 24\\nNPH\\n1–4\\n6–10\\n10–16\\nInsulin combinations\\n75/25–75% protamine lispro, 25% lispro\\n<0.25\\n1.5 h\\nUp to 10–16\\n70/30–70% protamine aspart, 30% aspart\\n<0.25\\n1.5 h\\nUp to 10–16\\n50/50–50% protamine lispro, 50% lispro\\n<0.25\\n1.5 h\\nUp to 10–16\\n70/30–70% NPH, 30% regular\\n0.5–1\\nDual\\n10–16\\nType 2 DM (Figure 1)\\n\\uf0b7\\nIf non pharmacological measures not sufficient, oral agents may be used alone and in\\ncombination.\\n\\uf0b7\\nLevel of hyperglycemia influence the initial choice of oral hypoglycaemic agents (Table\\n2).\\n\\uf0b7\\nTherapy can be started with either sulfonylureas or Metformin. Metformin has the\\nadvantage of promoting mild weight loss in obese patients.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 133, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2).\\n\\uf0b7\\nTherapy can be started with either sulfonylureas or Metformin. Metformin has the\\nadvantage of promoting mild weight loss in obese patients.\\n\\uf0b7\\nTreatment may be started with any of the following drugs: Tab. glimipride l-8mg/day Or\\nTab. glipizide 2.5 - 40 mg/day. Or Tab. glipizide extended release 5-10 mg/day Or Tab.\\nglyburide (glibenclamide) 1.25-20 mg/day. Or Tab. metformin 500 mg once or twice a\\nday in obese patients and increase the dose to 1000 mg 2 times a day; The dose can be\\nincreased every 2-3 weeks. All drugs should be taken 30-45 min before meals.\\n\\uf0b7\\nCombination therapy, following combination can be given if inadequate glycaemic\\ncontrol with single oral hypoglycaemic agent: Sulphonylurea + metformin\\n\\uf0b7\\nInsulin may be required in patients with primary or secondary failure to oral agents; often\\nas single dose of intermediate acting insulin 0.3-0.4 units/kg/day either before breakfast'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 134, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n119\\nor at bedtime in combination with Tab. metformin. Insulin is also required in situations\\nlike pregnancy, surgery, infection, etc.\\nFigure 1. Algorithm for management of Type 2 DM\\nTable 2. Oral hypoglycaemic drugs with their dose and their common ADRs\\nDrugs\\nDose\\nHbA1c\\nreduction\\n(%)\\nAdvantages\\nDisadvantages\\nContraindications\\nBiguanides\\nMetformin\\nInitially\\n500mg OD to\\nmax \\n2000\\nmg/d\\n1-2\\nWeight\\nneutral,\\nDo not cause\\nhypoglycemia\\n, inexpensive\\nDiarrhoea,\\nnausea, lactic\\nacidosis\\nSerum \\ncreatinine\\n>1.5 mg/dl (men)\\n>1.4 \\nmg/dl\\n(women), \\nCHF,\\nradiographic\\ncontrast \\nstudies,\\nseriously ill patients,\\nacidosis\\nInsulin secretagogues: Sulfonylureas\\nGlimepiride\\nGlipizide\\nGlyburide\\n1-8mg/d\\n5-40mg/d\\n1.25-20mg/d\\n1-2\\nInexpensive\\nHypoglycemia,\\nweight gain\\nRenal/liver disease\\nInsulin secretagogues: Non-sulfonylureas\\nRepaglinide\\n0.5-16mg/d\\n1-2\\nShort onset of\\naction, lower\\npostprandial\\nglucose\\nHypoglycemia\\nRenal/liver disease\\nThiazolidinediones\\nPioglitazone\\n15-45 mg/d\\n0.5-1.4'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 134, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Repaglinide\\n0.5-16mg/d\\n1-2\\nShort onset of\\naction, lower\\npostprandial\\nglucose\\nHypoglycemia\\nRenal/liver disease\\nThiazolidinediones\\nPioglitazone\\n15-45 mg/d\\n0.5-1.4\\nLower insulin\\nrequirements\\nPeripheral\\nedema, \\nCHF,\\nCHF, liver disease'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 135, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n120\\nweight \\ngain,\\nfractures,\\nmacular edema\\nα -Glucosidase inhibitors\\nAcarbose\\nVoglibose\\n50-100mg\\n0.2-0.3mg\\n(per meal)\\n0.5-0.8\\nReduce\\npostprandial\\nglycemia\\nGI flatulence,\\nliver function\\ntests\\nRenal/liver disease\\nDipeptidyl peptidase IV inhibitors\\nSaxagliptin\\nSitagliptin\\nVildagliptin\\n2.5-5mg/d\\n100mg/d\\n50-100mg/d\\n0.5-0.8\\nDo not cause\\nhypoglycemia\\nReduce dose with\\nrenal disease\\nPatient education\\n\\uf0b7\\nEducation topics important for optimal diabetes care include self-monitoring of blood\\nglucose; urine ketone monitoring (type 1 DM); insulin administration; guidelines for\\ndiabetes management during illnesses; prevention and management of hypoglycaemia,\\nfoot and skin care; diabetes management before, during, and after exercise; and risk\\nfactor–modifying activities.\\n\\uf0b7\\nMedical nutrition therapy (MNT) is a term used to describe the optimal coordination of\\ncaloric intake with other aspects of diabetes therapy (insulin, exercise, weight loss).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 135, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nMedical nutrition therapy (MNT) is a term used to describe the optimal coordination of\\ncaloric intake with other aspects of diabetes therapy (insulin, exercise, weight loss).\\nPrimary prevention measures of MNT are directed at preventing or delaying the onset of\\ntype 2 DM in high-risk individuals (obese or with prediabetes) by promoting weight\\nreduction.\\n\\uf0b7\\nExplain about the warning symptoms and signs of hypoglycaemia and need to take\\nsweets/candies/drinks in such a situation.\\n\\uf0b7\\nRegular follow up to monitor BP (quarterly), HbA1C testing (2-4 times/year), eye\\nexamination (annual), foot examination (1-2 times/year by physician; daily by patient);\\nscreening for diabetic nephropathy (annual); lipid profile (annual).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 136, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n121\\nFigure 2. Diabetes algorithm for achieving glycemic control\\nAbbreviations: MET: Metformin , DPP4: dipeptidyl peptidase-4 inhibitors , TZD:\\nthiazolidinediones , GLP-1 : glucagon-like peptide-1 , FPG : fasting plasma glucose ,PPG:\\npost prandial glucose, AGI:alfa glucosidase inhibitors, SU : sulfonylureas\\nDIABETIC KETOACIDOSIS\\nDiabetic ketoacidosis is an acute complication of diabetes. It consists of hyperglycemia,\\nketosis (positive serum ketones) and metabolic acidosis (with increased anion gap).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 137, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n122\\n\\uf0b7\\nNausea, vomiting, abdominal pain, dehydration and altered sensorium.\\n\\uf0b7\\nDKA results from relative or absolute insulin deficiency combined with counter\\nregulatory hormone excess (glucagon, catecholamines, cortisol, and growth hormone).\\n\\uf0b7\\nPrecipitating factors for DKA include noncompliance, infection, trauma, infarction,\\npregnancy and drug abuse.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nDemonstration of ketones in urine (or elevated levels in blood), hyperglycaemia, low\\narterial pH, low bicarbonate (>15 mmol/1) and high anion gap (>15 mmol/1).\\nPharmacological treatment\\n\\uf0b7\\nAdmit to hospital; intensive-care setting may be necessary for frequent monitoring or if\\npH <7.00 or unconscious. If the patient is vomiting or has altered mental status, a\\nnasogastric tube should be inserted to prevent aspiration of gastric contents.\\n\\uf0b7\\nAssess: Serum electrolytes (K+, Na+, Mg2+, Cl–, bicarbonate, phosphate), acid-base'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 137, 'source_type': 'Authorotative', 'priority': '1'}, page_content='nasogastric tube should be inserted to prevent aspiration of gastric contents.\\n\\uf0b7\\nAssess: Serum electrolytes (K+, Na+, Mg2+, Cl–, bicarbonate, phosphate), acid-base\\nstatus- pH, HCO3–, PCO2, β-hydroxybutyrate (or S.acetone), renal function (creatinine,\\nurine output)\\n\\uf0b7\\nReplace fluids: 2–3 L of 0.9% saline over first 1–3 hr (15–20 ml/kg per hour);\\nsubsequently, 0.45% saline at 250–500 ml/h; change to 5% glucose and 0.45% saline at\\n150–250 ml/h when plasma glucose reaches 200 mg/dl. Fluid replacement needs to be\\nclosely monitored in elderly and those with cardiac or renal compromise.\\n\\uf0b7\\nAdminister short-acting insulin: IV (0.1units/kg), then 0.1 units/kg per hour by\\ncontinuous IV infusion; increase two- to threefold if no response by 2–4 h. If the initial\\nserum potassium is <3.3 mEq/L, do not administer insulin until the potassium is\\ncorrected. If the initial serum potassium is >5.2 mEq/L, do not supplement K+ until the\\npotassium is corrected.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 137, 'source_type': 'Authorotative', 'priority': '1'}, page_content='serum potassium is <3.3 mEq/L, do not administer insulin until the potassium is\\ncorrected. If the initial serum potassium is >5.2 mEq/L, do not supplement K+ until the\\npotassium is corrected.\\n\\uf0b7\\nAssess patient: Initiate appropriate workup for precipitating event (cultures, CXR, ECG).\\n\\uf0b7\\nReplace K+: 10 meq/h when plasma K+< 5.0–5.2 mEq/L (or 20–30 mEq/L of infusion\\nfluid), ECG normal, urine flow and normal creatinine documented; administer 40–80\\nmEq/h when plasma K+< 3.5 mEq/L or if bicarbonate is given. The goal is to maintain the\\nserum potassium at >3.5 mEq/L.\\n\\uf0b7\\nBicarbonate replacement: Despite a bicarbonate deficit, bicarbonate replacement is not\\nusually necessary. However, in the presence of severe acidosis (arterial pH <6.9), it is\\nadvised to administer bicarbonate [50 mEq/L of sodium bicarbonate in 200 ml of sterile\\nwater with 10 mEq/L KCl per hour for 2 h until the pH is >7.0].\\n\\uf0b7\\nPhosphate and Magnesium: If the serum phosphate < 1 mg/dl, then phosphate supplement'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 137, 'source_type': 'Authorotative', 'priority': '1'}, page_content='water with 10 mEq/L KCl per hour for 2 h until the pH is >7.0].\\n\\uf0b7\\nPhosphate and Magnesium: If the serum phosphate < 1 mg/dl, then phosphate supplement\\nshould be considered and the serum calcium monitored. Hypomagnesemia may develop\\nduring DKA therapy and may also require supplementation.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 138, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n123\\n\\uf0b7\\nMonitoring: Measure capillary glucose every 1–2 h; measure electrolytes (especially K+,\\nbicarbonate, phosphate) and anion gap every 4 h for first 24 h. Monitor blood pressure,\\npulse, respirations, mental status, fluid intake and output every 1–4 hrs.\\n\\uf0b7\\nHyperglycemia usually improves at a rate of 75–100 mg/dl per hour. As ketoacidosis\\nimproves, β-hydroxybutyrate is converted to acetoacetate. Ketone body levels may appear\\nto increase if measured by laboratory assays that use the nitroprusside reaction, which\\nonly detects acetoacetate and acetone.\\n\\uf0b7\\nContinue above until patient is stable, glucose goal is 150–250 mg/dl, and acidosis is\\nresolved. Insulin infusion may be decreased to 0.05–0.1 units/kg per hour.\\n\\uf0b7\\nAdminister long-acting insulin as soon as patient is eating. Allow for overlap in insulin\\ninfusion and SC insulin injection.\\nHyperglycemic Hyperosmolar Nonketotic Coma\\n\\uf0b7\\nIt is an acute metabolic derangement whose notable features are marked hyperglycemia,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 138, 'source_type': 'Authorotative', 'priority': '1'}, page_content='infusion and SC insulin injection.\\nHyperglycemic Hyperosmolar Nonketotic Coma\\n\\uf0b7\\nIt is an acute metabolic derangement whose notable features are marked hyperglycemia,\\nhyperosmolality (>350 mOsmol/L), and prerenal azotemia.\\n\\uf0b7\\nIn HONC, fluid losses and dehydration are usually more pronounced than in DKA due to\\nthe longer duration of the illness.\\n\\uf0b7\\nThe patients are usually older, more likely to have mental status changes, even with\\nproper treatment, HHS has a substantially higher mortality rate than DKA.\\nChronic Complications of DM\\nMicrovascular\\nComplications\\nTreatment\\nDiabetic Retinopathy\\n\\uf0b7\\nProliferative retinopathy is usually treated with panretinal\\nlaser photocoagulation, whereas macular edema is treated\\nwith focal laser photocoagulation.\\n\\uf0b7\\nRegular fundus examination is required to monitor the\\nretinopathy.\\nDiabetic Nephropathy\\n\\uf0b7\\nAdministration of ACE inhibitors or ARBs\\n\\uf0b7\\nInsulin and other OHA requirement may decrease\\n\\uf0b7\\ngive drugs according to renal clearance\\nDiabetic Neuropathy\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 138, 'source_type': 'Authorotative', 'priority': '1'}, page_content='retinopathy.\\nDiabetic Nephropathy\\n\\uf0b7\\nAdministration of ACE inhibitors or ARBs\\n\\uf0b7\\nInsulin and other OHA requirement may decrease\\n\\uf0b7\\ngive drugs according to renal clearance\\nDiabetic Neuropathy\\n\\uf0b7\\nOnce fully developed is difficult to treat.\\n\\uf0b7\\nThe following drugs can be tried amitriptylin, pregabalin,\\ngabapentin, carbamazepine, SSRI\\n\\uf0b7\\nCan \\nlead \\nto \\nautonomic \\ndysfunction \\nand \\northostatic\\nhypotension.\\n\\uf0b7\\nFoot and joints most be examined for presence of injury.\\nDiabetic Gastropathy\\n\\uf0b7\\nSmaller, more frequent meals that are easier to digest.\\n\\uf0b7\\nDopamine antagonist’s metoclopramide, 5–10 mg, and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 139, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Endocrine Diseases\\n124\\ndomperidone, 10–20 mg, before each meal. Erythromycin\\nmay promote gastric emptying.\\n\\uf0b7\\nDiabetic diarrhoea treated with loperamide and may respond\\nto octreotide (50–75 g three times daily, SC).\\nDiabetic Cystopathy\\n\\uf0b7\\nTimed voiding or self-catheterization, possibly with the\\naddition of bethanechol.\\n\\uf0b7\\nDrugs that inhibit type 5 phosphodiesterase are effective for\\nerectile dysfunction\\nMacrovascular Complication- Atherosclerotic cardiovascular disease are the common\\ncause of death in diabetic population\\nAtherosclerotic CVD are the common cause of death in diabetic population.\\nRisk factor reduction is important. The important lipid target are as follows\\n\\uf0b7\\nLDL < 2.6 mmol/l (100 mg/dl);\\n\\uf0b7\\nHDL >1 mmol/l (40 mg/dl) in men and >1.3 mmol/l (50 mg/dl) in women; and\\n\\uf0b7\\nTriglycerides<1.7 mmol/l (150 mg/dl).\\nIf the patient is known to have CHD, an LDL goal of <1.8 mmol/L (70 mg/dl).\\nGestational Diabetes\\nPlease refer Obstetrics and Gynecology chapter – Pregnancy with diabetes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 140, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"125\\n\\uf0b7\\nRecurrent, painful, rounded ulcer with yellowish gray fibrinoid centre.\\n\\uf0b7\\nUlcer typically has recurrent appearance even after successful treatment\\nChapter 8\\nGASTROINTESTINAL DISEASES\\nAPHTHOUS ULCERS\\nSalient features\\nRule out secondary causes like malabsorption syndrome, inflammatory bowel disease,\\nBehcet's disease and recurrent trauma from tooth/denture and treat accordingly\\nNon- pharmacological treatment\\nOral hygiene - repeated mouth wash with plain water specially after eating any thing\\nPharmacological treatment\\n\\uf0b7\\nSymptomatic treatment with application of any gel containing local anaesthetic before\\ntaking meals.\\n\\uf0b7\\nOnly in severe cases with large multiple ulcers.\\n\\uf0b7\\nPellets hydrocortisone 5 mg to be kept on the ulcer and sucked every 4 hours for 3-5 days.\\nOr Tab. prednisolone 0.5 mg/kg/day in a single dose for 3-5 days.\\nPatient education\\n\\uf0b7\\nMaintain good oral hygiene.\\n\\uf0b7\\nAvoid precipitating factors, if any.\\n\\uf0b7\\nEnsure toothbrush has aligned bristles.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 140, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Or Tab. prednisolone 0.5 mg/kg/day in a single dose for 3-5 days.\\nPatient education\\n\\uf0b7\\nMaintain good oral hygiene.\\n\\uf0b7\\nAvoid precipitating factors, if any.\\n\\uf0b7\\nEnsure toothbrush has aligned bristles.\\n\\uf0b7\\nAvoid chewing betel leaf and other condiments,excessive carbonated drinks and spicy or\\nsharp/crispy foods.\\n\\uf0b7\\nTake plenty of green leafy vegetables.\\nDYSPEPSIA\\nIt is a non-specific group of symptoms related to the upper gastrointestinal tract.  It is also\\nreferred to as non-ulcer dyspepsia / functional dyspepsia.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nCap. omeprazole 20 mg once a day 45 minutes before breakfast for 4 to 6 weeks or\\n\\uf0b7\\nTab. ranitidine 150 mg twice a day 45 min. before breakfast and dinner for 4 to 6 weeks.\\n\\uf0b7\\nAntacids 2 to 3 teaspoon or 2 tabs (chewable) when symptomatic despite above\\nmedication.\\n\\uf0b7\\nFor those with dysmotility symptoms,\\n\\uf0b7\\nEpigastric burning pain, early satiety, post prandial fullness, hiccups, halitosis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 141, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n126\\n-\\nTab. domperidone 10 mg three times a day 30 minutes Before breakfast, lunch and dinner\\n\\uf0b7\\nDuration: Short courses of therapy (4 to 6 weeks) of the drug may be repeated or long-\\nterm treatment may be continued for up to a year.  Intermittent therapy or biweekly PPI is\\nalso recommended in those requiring long-term treatment\\n\\uf0b7\\nAnti-H.pylori treatment is recommended for those on long term NSAIDs or those with\\nDuodenal / gastric ulcers (complicated e.g. bleeding). Combination of Cap.omeprazole 20\\nmg twice a day with Cap. amoxicillin 500 mg thrice a day with Tab. metronidazole 400\\nmg thrice day Followed by Cap. omeprazole 20 mg once a day for three weeks. It is\\ndesirable that the anti-H pylori regimen is taken for at least 14 days.\\nPatient education\\n\\uf0b7\\nAvoid excess tea, coffee, fried food items and abstain from alcohol and smoking.\\n\\uf0b7\\nAvoid unnecessary NSAIDs: prefer paracetamol especially those with ulcer like'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 141, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patient education\\n\\uf0b7\\nAvoid excess tea, coffee, fried food items and abstain from alcohol and smoking.\\n\\uf0b7\\nAvoid unnecessary NSAIDs: prefer paracetamol especially those with ulcer like\\nsymptoms or those with documented duodenal/gastric ulcer.\\n\\uf0b7\\nFollow meals at regular intervals:4 hourly (including snacks)\\n\\uf0b7\\nDaily exercise to maintain optimum weight.\\nPEPTIC ULCER DISEASE\\nThere is ulceration of the gastric or duodenal mucosa due to acid and pepsin.\\nSalient features\\nPharmacological treatment\\nRecommended for patients on long term NSAIDs, bleeding peptic ulcer. Preferred two-week\\ntriple therapy (Table 1), followed by Proton Pump Inhibitor (PPI) for 3 weeks.\\nTable 1. Preferred regimen for eradication of H.pylori\\nDrug\\nDose(mg)\\nFrequency\\nDuration\\nBismuth subsalicylate\\nTetracycline\\nMetronidazole\\n2 tab\\n250 mg\\n500 mg\\nQID\\nQID\\nQID\\nTwo\\nWeek\\nBismuth citrate\\nAmoxicillin\\nMetronidazole\\n400 mg\\n500 mg\\n500 mg\\nBD\\nBD\\nBD\\nTwo\\nWeek\\nOmeprazole\\nAmoxicillin\\nClarithromycin\\n20 mg\\n1 gm\\n500 mg\\nBD\\nBD\\nBD\\nTwo\\nWeek\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 141, 'source_type': 'Authorotative', 'priority': '1'}, page_content='2 tab\\n250 mg\\n500 mg\\nQID\\nQID\\nQID\\nTwo\\nWeek\\nBismuth citrate\\nAmoxicillin\\nMetronidazole\\n400 mg\\n500 mg\\n500 mg\\nBD\\nBD\\nBD\\nTwo\\nWeek\\nOmeprazole\\nAmoxicillin\\nClarithromycin\\n20 mg\\n1 gm\\n500 mg\\nBD\\nBD\\nBD\\nTwo\\nWeek\\n\\uf0b7\\nHeart burn, relation with foods. In advance cases upper abdominal pain, weight loss,\\nanorexia, cachexia may develop.\\n\\uf0b7\\nHistory of NSAIDs or steroid ingestion.\\n\\uf0b7\\nIn case of perforation: severe abdominal pain, guarding, rigidity, shock.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 142, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n127\\n\\uf0b7\\nAbdominal pain, alternate diarrhea and constipation.\\n\\uf0b7\\nAbdominal distension, relief of abdominal symptoms with bowel motions, increased\\nfrequency of stool, sense of incomplete evacuation.\\n\\uf0b7\\nPencil thin stool, heart burn, bloating, back pain, weakness, faintness, palpitation\\nNon-Helicobacter pylori peptic ulcer\\n\\uf0b7\\nAny PPI for 4 to 6 weeks, 45 minutes before breakfast.\\n\\uf0b7\\nTab. ranitidine 150 mg BD OR Tab. famotidine 40 mg OD equally efficacious but takes\\nlonger time for symptom relief.\\nPatient education\\n\\uf0b7\\nStop smoking.\\n\\uf0b7\\nCurtail alcohol intake.\\n\\uf0b7\\nAvoid NSAIDs, prefer paracetamol.\\n\\uf0b7\\nAvoid foods which aggravate symptoms; no ride for bland diet or excess milk.\\n\\uf0b7\\nMeals at regular intervals.\\nVOMITING\\nVomiting is the forceful expulsion of the gastric contents due to contraction of abdominal\\nmusculature and simultaneous relaxation of gastric funds and lower esophageal sphincter.\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 142, 'source_type': 'Authorotative', 'priority': '1'}, page_content='musculature and simultaneous relaxation of gastric funds and lower esophageal sphincter.\\nPharmacological treatment\\n\\uf0b7\\nHospitalize the patient to give intravenous fluids in case of dehydration.  Start oral fluids\\nas soon as the patient can tolerate.  Appropriate analgesics if patient has severe pain.\\n\\uf0b7\\nAcute vomiting : Rule out gastric outlet obstruction then Inj. odansetron 8 mg IV repeat 8\\nhourly if needed or  Inj. metoclopramide 10 mg IM, repeat after 6 hours if needed or Tab.\\ndomperidone 10 mg three times a day or Tab. metoclopramide 10 mg three times a day\\n\\uf0b7\\nIn pregnancy avoid all drugs, if possible. Tab.  promethazine 25 mg oral/injection is safe\\nin the first trimester\\n\\uf0b7\\nIf there is history of motion sickness then give Tab. cyclizine 50 mg 3 times daily.\\nPatient education\\n\\uf0b7\\nAvoid stale food, cut vegetables, fruits kept in open, drink potable water only.\\n\\uf0b7\\nAvoid NSAIDS, especially if ulcer symptoms are present.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 142, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patient education\\n\\uf0b7\\nAvoid stale food, cut vegetables, fruits kept in open, drink potable water only.\\n\\uf0b7\\nAvoid NSAIDS, especially if ulcer symptoms are present.\\n\\uf0b7\\nPrevent dehydration: Encourage patients to take sips of liquids at short intervals to\\nprevent dehydration.\\n\\uf0b7\\nEndoscopy is necessary, if symptom persists.\\n\\uf0b7\\nPrevent motion sickness by avoiding heavy meal before travel.\\nIRRITABLE BOWEL SYNDROME (IBS)\\nA constellation of gastrointestinal symptoms associated with lower bowel symptoms that\\noccur in absence of an organic disease.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 143, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n128\\n\\uf0b7\\nWatery profuse loose motions which are unaffected by fasting, nausea and vomiting,\\nabdominal cramps, dehydration, hypotension\\nPharmacological treatment\\n\\uf0b7\\nIf pain is predominant: Tab. mebeverine hydrochloride 270 mg three times a day given\\nfor long term or Tab. drotaverine 40 to 80 mg3 times a day\\n\\uf0b7\\nIn those with depressive symptom: Tab. amitriptyline 10 mg HS for 4 to 6 weeks\\n\\uf0b7\\nIn those with diarrheal symptoms Tab. loperamide 2 to 4 mg daily for several days /\\nweeks depending on the critical response.\\n\\uf0b7\\nIn those with constipation symptoms: Isotonic polyethylene glycol (PEG electrolyte)\\nsolution 125-250 ml. Or Lactulose solution 15 to 20 ml at night\\nPatient education\\n\\uf0b7\\nDiet should contain high fiber and supplemented with bulk forming agents such as\\nisaphghul husk.\\n\\uf0b7\\nAvoid caffeine and alcohol.\\n\\uf0b7\\nAvoid milk and other dietary constituents, which worsen the symptoms.\\n\\uf0b7\\nPsychotherapy may be helpful in selected cases\\nACUTE GASTRO ENTERITIS'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 143, 'source_type': 'Authorotative', 'priority': '1'}, page_content='isaphghul husk.\\n\\uf0b7\\nAvoid caffeine and alcohol.\\n\\uf0b7\\nAvoid milk and other dietary constituents, which worsen the symptoms.\\n\\uf0b7\\nPsychotherapy may be helpful in selected cases\\nACUTE GASTRO ENTERITIS\\nIt is a self-limiting illness characterized by diarrhoea, abdominal cramps, nausea and\\nvomiting, usually caused by viruses or bacteria (E. coli, V. cholerae, Staph, aureus, Bacillus\\ncereus, etc). Most of these are noninvasive or toxic diarrhoea. Less commonly patients\\npresent mainly with diarrhoea with passage of mucous and/or blood in stools. This may be\\nassociated with significant systemic symptoms like fever, malaise, etc.\\nSalient features\\nPharmacological treatment (Figure 1)\\n\\uf0b7\\nIn acute gastro enteritis the aim is to correct dehydration and electrolyte imbalance.\\nThere is usually no need to investigate for the etiology immediately.\\n\\uf0b7\\nFurther investigations are necessary if there is bloody diarrhea, clinical evidence of\\ntoxicity or prolonged diarrhea.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 143, 'source_type': 'Authorotative', 'priority': '1'}, page_content='There is usually no need to investigate for the etiology immediately.\\n\\uf0b7\\nFurther investigations are necessary if there is bloody diarrhea, clinical evidence of\\ntoxicity or prolonged diarrhea.\\n\\uf0b7\\nOral rehydration salt (ORS) : given in mild to moderate dehydration , 75 ml/kg in 4 hours\\nin case of moderate dehydration\\n\\uf0b7\\nIV fluid given in patients with severe dehydration (100 ml/kg). 30 ml/kg to be given in 30\\nminutes followed by 70 ml/kg in 2½ hours\\n\\uf0b7\\nTab ciprofloxacin 500 mg two times a day for 3 to 5 days. Indicated only in very ill\\npatients with systemic symptoms associated with bloody diarrhea\\n\\uf0b7\\nIn amoebic dysentery Tab. metronidazole 400mg three times a day for 5 to 7 days. Oral\\nTab. tinidazole 600 mg twice a day for 3 to 5 days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 144, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n129\\n\\uf0b7\\nIn acute giardiasis Tab. tinidazole 1000 mg single dose or Tab. metronidazole 400 mg\\nthree times a day for 3 days.  Hospitalization is needed when there are clinical signs of\\ndehydration especially in young children or in the elderly, suspected cholera, immune\\nsuppressed patients and those with severe systemic symptoms.\\nPatient education\\n\\uf0b7\\nIn the absence of vomiting patient should be asked to take sips of fluid.\\n\\uf0b7\\nFluids used at home can be juices, soups and ORS.\\n\\uf0b7\\nMilk and related products are avoided for at least 2 weeks, because of secondary lactase\\ndeficiency.\\nFigure 1. Algorithm for the treatment of acute diarrhea\\nAcute Diarrhea (< 7 days)\\nAre the following present?\\n1. Severe illness: T >38.5 0C, abdominal pain,\\nbloody diarrhea, >6 stool / 24 hrs,\\ndehydration\\n2. Immunocompromised patients: AIDS, post\\ntransplantation\\n3. Elderly patients\\nNo\\nYes\\nSymptomatic therapy\\nAntidiarrheal agents:\\nLoperamide,\\nBismuth Subsalicylate\\nSend stool for following:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 144, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dehydration\\n2. Immunocompromised patients: AIDS, post\\ntransplantation\\n3. Elderly patients\\nNo\\nYes\\nSymptomatic therapy\\nAntidiarrheal agents:\\nLoperamide,\\nBismuth Subsalicylate\\nSend stool for following:\\n1. Fecal leukocytes\\n2. Routine stool culture\\n3. C.\\ndifficile\\nassay, \\nif \\nrecent\\nhospitalization of antibiotics\\n4. Ova and parasite testing, if :\\na.\\nDiarrhea > 10 days\\nb. Travels to endemic region\\nc.\\nCommunity water borne\\noutbreak\\nd. HIV infection of men who\\nhave sex with men\\n&\\nConsider empire antibiotic therapy while\\nawaiting culture, if:\\n1. Fecal leukocyte positive\\n2. Bloody diarrhea, fever, abdominal\\npain\\nIllness\\nresolves\\nIllness persists\\nfor 7-10 days\\nor worsens'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 145, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n130\\n\\uf0b7\\nPatient may present in acute stage with bloody diarrhoea, may be associated with\\nsystemic symptoms of low to moderate fever, backache, arthralgias.\\n\\uf0b7\\nThe diagnosis is confirmed by sigmoidoscopic examination and mucosal biopsies.\\n\\uf0b7\\nThe disease almost always involves rectum and rest of the colon may be involved to\\nvariable length.\\n\\uf0b7\\nAcute disease is graded as mild (2-4 stool/day), moderate (4-6 stools/day) or severe (> 6\\nstools/day). During remission patient may be asymptomatic or may have extra-intestinal\\nsymptoms.\\nULCERATIVE COLITIS (UC)\\nSalient features\\nNon- pharmacological treatment\\nThere is no specific dietary restriction but patient may avoid any food if the patient is\\nuncomfortable.\\nPharmacological treatment\\nMild to moderate acute ulcerative colitis (distal/left colonic involvement)\\n\\uf0b7\\nTab. sulphasalazine 1 g 3-4 times a day. Or Tab. mesalazine 800 mg 3-4 times a day. Or\\nTab. olsalazine 1-3 g/day in divided doses.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 145, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nTab. sulphasalazine 1 g 3-4 times a day. Or Tab. mesalazine 800 mg 3-4 times a day. Or\\nTab. olsalazine 1-3 g/day in divided doses.\\n\\uf0b7\\nPrednisolone phosphate enema, 20 mg in 100 ml saline 1-2 time a day or Hydrocortisone\\nenema 100-125 mg in 100 ml saline 1-2 times a day (to be prepared fresh).\\n\\uf0b7\\nOr if disease limited to rectum, Hydrocortisone foam 125 mg 1-2 times a day.\\nModerate to severe or extensive acute disease\\n\\uf0b7\\nStart as above.\\n\\uf0b7\\nTab. prednisolone 20-60 mg/day in single or divided doses.\\nFollow-up\\nIf the symptoms do not improve or worsen, patient will need hospitalization.\\nAcute severe disease with systemic symptoms (requires hospitalization under the care of\\nspecialist)\\n\\uf0b7\\nInj. hydrocortisone 100 mg IV 4 times a day or Inj. dexamethasone 4 mg IV 3-4 times a\\nday.\\n\\uf0b7\\nPatient should be kept 'nil by mouth' and should be given adequate intravenous fluids and\\nelectrolytes.\\n\\uf0b7\\nBlood transfusion to be given as per requirement.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 145, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"day.\\n\\uf0b7\\nPatient should be kept 'nil by mouth' and should be given adequate intravenous fluids and\\nelectrolytes.\\n\\uf0b7\\nBlood transfusion to be given as per requirement.\\n\\uf0b7\\nPatient switched over to oral steroids and aminosalicylates to be started as in I after 5\\ndays when patient is allowed to take orally.\\n\\uf0b7\\nIf patient fails to respond to steroids, refer the patient to gastroenterologist for\\nimmunosuppressive therapy or surgery. Once the remission is induced, steroids are\\ntapered slowly over 4-6 weeks period. For acute attack, there is no use of giving steroids\\nfor more than 12 weeks.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 146, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n131\\n\\uf0b7\\nHeartburn, regurgitation, and dysphasia. However, a diagnosis of GERD based on the\\npresence of typical symptoms is correct in only 70% of patients.\\n\\uf0b7\\nIn addition to these typical symptoms, abnormal reflux can cause atypical\\n(extraesophageal) symptoms, such as coughing, chest pain, and wheezing.\\n\\uf0b7\\nFor patients with symptoms and history consistent with uncomplicated GERD, the\\ndiagnosis of GERD may be assumed and empirical therapy begun. Patients who show\\nsigns of GERD complications or other illness or who do not respond to therapy should be\\nconsidered for further diagnostic testing.\\nFollow-up\\n\\uf0b7\\nClose clinical/biochemical/radiological monitoring is required for any complications like\\ntoxic megacolon/perforation.\\nMaintenance of remission\\n\\uf0b7\\nAny of the drugs used in I should be given lifelong.\\nPatient education\\n\\uf0b7\\nPatient should be followed up at 6 monthly intervals and maintenance treatment should be\\ncontinued.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 146, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAny of the drugs used in I should be given lifelong.\\nPatient education\\n\\uf0b7\\nPatient should be followed up at 6 monthly intervals and maintenance treatment should be\\ncontinued.\\n\\uf0b7\\nIn any patient who has disease for more than 10 years, a regular sigmoidoscopy and rectal\\nbiopsy should be done at 6 monthly intervals to look for any dysplasia and total\\ncolonoscopic examination should be done at 2-3 year interval.\\n\\uf0b7\\nPatient should be explained about chronic nature of the disease and continuation of\\nmaintenance treatment for life long with regular follow-up and risk of colonic cancer after\\n10 years of onset of disease\\nGASTROESOPHAGEAL REFLUX DISEASE\\nGastro esophageal reflux is a normal physiologic phenomenon experienced intermittently by\\nmost people, particularly after a meal. Gastro esophageal reflux disease (GERD) occurs when\\nthe amount of gastric juice that refluxes into the esophagus exceeds the normal limit, causing'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 146, 'source_type': 'Authorotative', 'priority': '1'}, page_content='most people, particularly after a meal. Gastro esophageal reflux disease (GERD) occurs when\\nthe amount of gastric juice that refluxes into the esophagus exceeds the normal limit, causing\\nsymptoms with or without associated esophageal mucosal injury (i.e., esophagitis).\\nSalient features\\nInvestigations\\n\\uf0b7\\nUpper GI endoscopy - Endoscopy can help confirm the diagnosis of reflux by\\ndemonstrating complications of reflux (esophagitis, strictures, Barrett oesophagus) and\\ncan help in evaluating the anatomy (e.g., hiatal hernia, masses, strictures)\\n\\uf0b7\\nManometry helps surgical planning by determining the lower esophageal sphincter (LES)\\npressure and identifying any oesophageal motility disorders.\\n\\uf0b7\\nOptional studies include: 24-hour pH probe test  and  nuclear medicine gastric emptying\\nstudy\\nTreatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 147, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n132\\n\\uf0b7\\nTreatment of GERD involves a stepwise approach. The goals are to control symptoms, to\\nheal esophagitis, and to prevent recurrent esophagitis or other complications.\\n\\uf0b7\\nThe treatment is based on lifestyle modification and control of gastric acid secretion\\nthrough medical therapy with antacids or PPIs or surgical treatment with corrective anti\\nreflux surgery.\\nPharmacological treatment\\n\\uf0b7\\nOmeprazole 40 mg twice day half an hour before meals. Along with domperidone 30 mg\\nsustained release\\n\\uf0b7\\nThis therapy causes resolution of GERD symptoms at 4 weeks and healing of esophagitis\\nat 8 weeks so the treatment should be continued up to 8 weeks.\\nSurgical Treatment\\nIndications for surgical treatment include the following:\\n\\uf0b7\\nPatients with symptoms that are not completely controlled by PPI therapy can be\\nconsidered for surgery.\\n\\uf0b7\\nThe presence of Barrett esophagus\\n\\uf0b7\\nThe presence of extraesophageal manifestations of GERD may indicate the need for'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 147, 'source_type': 'Authorotative', 'priority': '1'}, page_content='considered for surgery.\\n\\uf0b7\\nThe presence of Barrett esophagus\\n\\uf0b7\\nThe presence of extraesophageal manifestations of GERD may indicate the need for\\nsurgery; these include the following: (1) respiratory manifestations (e.g., cough,\\nwheezing, aspiration); (2) ear, nose, and throat manifestations (e.g., hoarseness, sore\\nthroat, otitis media); and (3) dental manifestations (e.g., enamel erosion)\\n\\uf0b7\\nYoung patients\\n\\uf0b7\\nPoor patient compliance with regard to medications\\n\\uf0b7\\nPostmenopausal women with osteoporosis\\n\\uf0b7\\nPatients with cardiac conduction defects\\n\\uf0b7\\nCost of medical therapy\\n\\uf0b7\\nTypes of surgery: Open / Laparoscopic Nissen fundoplication\\nPatient education\\n\\uf0b7\\nLifestyle modifications include the following losing weight (if overweight), avoiding\\nalcohol, chocolate, citrus juice, and tomato-based products. Recent guidelines also\\nsuggest avoiding peppermint, coffee, and possibly the onion family as well.\\n\\uf0b7\\nAvoiding large meals and waiting 3 hours after a meal before lying down, elevating the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 147, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"suggest avoiding peppermint, coffee, and possibly the onion family as well.\\n\\uf0b7\\nAvoiding large meals and waiting 3 hours after a meal before lying down, elevating the\\nhead of the bed 8 inches. Lifestyle modification is as effective as antacid therapy.\\nUPPER GASTROINTESTINAL BLEEDING\\nUpper gastrointestinal haemorrhage remains a major medical problem. Causes includes\\nesophageal, gastric, duodenal ulcer , erosions of esophageal,  gastric, duodenal, Mallory\\nWeiss tear, oesophageal varices, tumour, vascular lesion, e.g. dieulafoy's disease and others\\nInvestigations\\n\\uf0b7\\nHb, Abo-Rh, PT,APTT, Upper G.I.Scopy, Ultrasonography\\nTreatment: Primary and general management includes\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 148, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Gastrointestinal Diseases\\n133\\n\\uf0b7\\nEpigastric pain, history of alcoholism, gall stone disease, Cholesterol and metabolic\\nabnormalities, history of similar complains in family.\\n\\uf0b7\\nPer abdomen examination- look for tenderness, guarding, rigidity. Look for fever,\\ntachycardia, tachypnoea, shock.\\nPharmacological treatment\\n\\uf0b7\\nGet wide bore access with IV cannula (16G preferable) for rapid fluid resuscitation,\\nRyle's tube insertion, catheterization,\\n\\uf0b7\\nInj. pantoprazole 40 mg IV 12 hourly, Inj. tranexamic acid  500 mg TDS\\n\\uf0b7\\nInj. octreotide 100 mcg IV 6 hourly, banding-in oesophageal varices, gastric balloon of\\nSengstaken blackmore tube- in oesophageal varices,\\n\\uf0b7\\nInjection sclerotherapy- in oesophageal varices, argon diathermy- in peptic ulcers, laser-in\\npeptic ulcers\\nSurgical treatment\\n\\uf0b7\\nExploratory laprotomy and search for the cause and treat the cause or TIPPS (Tran\\njugular intrahepatic portosystemic shunts) - in uncontrolled portal hypertension cases.\\nACUTE PANCREATITIS\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 148, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nExploratory laprotomy and search for the cause and treat the cause or TIPPS (Tran\\njugular intrahepatic portosystemic shunts) - in uncontrolled portal hypertension cases.\\nACUTE PANCREATITIS\\nAcute pancreatitis is the most common pathology of pancreas. It ranges from self limiting\\nmild pancreatitis to life threatening necrotizing pancreatitis which accounts for 10-20% of\\ntotal cases. Causes of acute pancreatitis: alcoholism gall stone disease, hypercholesterolemia\\nhypercalcemia, hypermagnesemia pancreatic divism, viral infections, familial pancreatitis,\\nothers, idiopathic\\nSalient features\\nInvestigations\\nTC with DC which shows increased with neutrophillia, S.amylase, increased more than 3 fold\\nnormal value, S. lipase (more specific), increased more than 3 fold of normal value, S.\\ncalcium below normal values, USG- Abdomen, shows edema of pancreas, necrosis, CECT-\\nAbdomen (in unresolving and severe cases), delineates pancreatic anatomy more clearly,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 148, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"calcium below normal values, USG- Abdomen, shows edema of pancreas, necrosis, CECT-\\nAbdomen (in unresolving and severe cases), delineates pancreatic anatomy more clearly,\\nChest X Ray, to rule out systemic complications like Acute Respiratory Distress Syndrome\\n(ARDS)\\nPrognostic indicators: Ranson's score, Glasgow score, APACHE II score\\nNon pharmacological treatment\\nNil by mouth, nasogastric tube insertion, avoid alcohol\\nPharmacological treatment\\n\\uf0b7\\nFluid resuscitation, Correction of electrolyte imbalance\\n\\uf0b7\\nInj. diclofenac sodium 75 mg IM 8 hourly and gradually proceeding towards opioid\\nanalogue like  Inj. tramadol  50 mg once day\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 149, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n134\\n\\uf0b7\\nDull epigastric pain, Weight loss, Malnutrition, Pancreatic diabetes\\n\\uf0b7\\nHistory of alcoholism, History of previous attacks of acute pancreatitis.\\n\\uf0b7\\nUsually non specific, Signs of cachexia and malnutrition\\n\\uf0b7\\nInj. pantoprazole 40 mg IV 12 hourly  and  Inj. octreotide 100 microgram IV/SC 6 hourly\\nto 12 hourly till resolution of symptoms\\nSurgical treatment\\n\\uf0b7\\nUsually no surgical intervention is required for acute non necrotising pancreatitis.\\n\\uf0b7\\nCholecystectomy for gall stone pancreatitis after acute pancreatitis is resolved\\nAcute necrotising pancreatitis\\nNon pharmacological treatment\\n\\uf0b7\\nICU monitoring, oxygen by mask, nil by mouth, nasogastric tube insertion per urethral\\ncatheterization\\nPharmacological treatment\\n\\uf0b7\\nFluid resuscitation, correction of electrolyte imbalance\\n\\uf0b7\\nInj. meropenem 1 gm IV 8 hourly\\n\\uf0b7\\nInj. diclofenac sodium  75 mg IM 8 hourly\\n\\uf0b7\\nInj. pantoprazole 40 mg IV 12 hourly\\n\\uf0b7\\nInj. octreotide 100 microgram IV/SC every 6 hourly to 8 hourly'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 149, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nInj. meropenem 1 gm IV 8 hourly\\n\\uf0b7\\nInj. diclofenac sodium  75 mg IM 8 hourly\\n\\uf0b7\\nInj. pantoprazole 40 mg IV 12 hourly\\n\\uf0b7\\nInj. octreotide 100 microgram IV/SC every 6 hourly to 8 hourly\\nSurgical treatment\\n\\uf0b7\\nPancreatic necrosectomy,  distal pancreatectomy ( for disease in body and tail)\\n\\uf0b7\\nCholecystectomy for gall stone pancreatitis after acute pancreatitis is resolved.\\nCHRONIC PANCREATITIS\\nChronic pancreatitis is a disease of pancreas characterized by pancreatic atrophy, fibrosis,\\ncalcification and at times ductal dilatation. It is most commonly caused by repeated alcoholic\\npancreatitis.\\nSalient features\\nInvestigations\\nS. amylase and S. Lipase has usually no role. X-ray abdomen, may show calcification in\\npancreatic region. USG- Abdomen shows atrophic pancreas with or without foci of\\ncalcification and ductal dilatation. Magnetic Resonance Cholangiopancreatography (MRCP)\\ngives excellent anatomy of ductal system. Endoscopic Retrograde Cholangiopancreatography'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 149, 'source_type': 'Authorotative', 'priority': '1'}, page_content='calcification and ductal dilatation. Magnetic Resonance Cholangiopancreatography (MRCP)\\ngives excellent anatomy of ductal system. Endoscopic Retrograde Cholangiopancreatography\\n(ERCP), reserved for chronic pancreatitis due to peri ampullary obstruction\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoidance of alcohol, low fat, Low protein diet\\nPharmacological treatment\\n\\uf0b7\\nEnteric coated pancreatic enzymes, for replacement of pancreatic function,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 150, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Gastrointestinal Diseases\\n135\\n\\uf0b7\\nConstipation is defined as decrease in frequency and liquidity of stool compared to the\\nnormal pattern in a particular individual.\\n\\uf0b7\\nImportant complaints suggesting constipation include straining at defaecation >25% of\\ntime, lumpy/hard stools, sensation of incomplete evacuation, or less than 3 bowel\\nactions per week.\\n\\uf0b7\\nInj. diclofenac sodium 75 mg IM 8 hourly  and gradually proceeding towards opioid\\nanalogue like Inj. tramadol  50 mg\\n\\uf0b7\\nInj. pantoprazole 40 mg IV 12 hourly\\nSurgical treatment\\n\\uf0b7\\nIndicated in severe pain non responding to pharmacological therapy\\n\\uf0b7\\nPeustaw procedure ( LPJ, Longitudinal Pancreatico-jejunostomy), Frey's procedure ( LPJ\\nwith coring out of head ), Duval procedure ( Distal Pancreatico-jejunostomy ), Distal\\npancreatectomy, for lesion confined to body and tail,\\n\\uf0b7\\nDuodenum preserving pancreatic head resection, DPPHR, Beger's procedure, for lesion\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 150, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"pancreatectomy, for lesion confined to body and tail,\\n\\uf0b7\\nDuodenum preserving pancreatic head resection, DPPHR, Beger's procedure, for lesion\\nconfined to head region. Endoscopic stenting, for obstruction in pancreatic duct, coeliac\\nblock, for patients unfit for surgery.\\nCONSTIPATION\\nCommonest cause is habitual, the important contributory factors being insufficient dietary\\nfiber, physical inactivity, suppression of defaecatory urges occurring at inconvenient\\nmoments, prolonged travel etc. Constipation may also occur following an attack of diarrhoea\\non the day after taking a purgative; this needs no treatment. The important secondary causes\\nmay include neurological, hormonal, colonic, malignancy, depression. Secondary causes\\nshould be looked for in case of recent onset or constipation of severe symptoms.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nReassurance - since many patients with normal stools and in pregnancy, imagine that they\\nare constipated.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 150, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Salient features\\nNon- pharmacological treatment\\n\\uf0b7\\nReassurance - since many patients with normal stools and in pregnancy, imagine that they\\nare constipated.\\n\\uf0b7\\nHigh fiber diet and increased intake of fluid with decrease in consumption of caffeinated\\ndrinks.\\n\\uf0b7\\nRetraining of bowels (avoiding suppression of urge to defecate, making a regular habit).\\n\\uf0b7\\nBulk forming agents like 'isapghula husk' or 'psyllium seeds' also help to relieve mild\\nconstipation.\\n\\uf0b7\\nRegular physical exercise such as walk for 1/2 to 1 hour daily and abdominal exercises.\\nPharmacological treatment\\n(Usually required for moderate to severe constipation).\\n\\uf0b7\\nLactulose Soln 15-20 ml orally at night. Or Susp. magnesium sulphate 15-20 ml at night.\\nOr Tab. sodium picosulphate 10 mg at night. Or\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 151, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n136\\n\\uf0b7\\nAbdominal pain in right upper quadrant, fever, history of diarrhea in past 7-10 days.\\n\\uf0b7\\nPhysical examination revels tenderness in right hypochondriac region, Palpable liver\\nand signs of jaundice.\\n\\uf0b7\\nIsotonic polyethylene glycol (PEG) electrolyte solution 125-250 ml.\\n\\uf0b7\\nAny of these may be given 2-4 times a week. Some patients may require treatment for\\nseveral weeks or months if there is no improvement.\\n\\uf0b7\\nTab. mosapride 5 mg 2 or 3 times a day. In some patients may be required for several\\nweeks.\\n\\uf0b7\\nPhosphate enemas to be used on as and when required basis in patients having acute\\nproblem with severe constipation or sub-acute intestinal obstruction.\\nFollow-up\\n\\uf0b7\\nIf patient continues to have severe constipation or symptoms worsen, refer the patient to a\\nspecialist for investigations to rule out secondary causes.\\n\\uf0b7\\nRecent unexplained constipation (not acute) in an elderly person whose bowel habits were\\nalways regular should be investigated.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 151, 'source_type': 'Authorotative', 'priority': '1'}, page_content='specialist for investigations to rule out secondary causes.\\n\\uf0b7\\nRecent unexplained constipation (not acute) in an elderly person whose bowel habits were\\nalways regular should be investigated.\\n\\uf0b7\\nAcute constipation especially when the patient is vomiting and has not passed even wind\\nand appears ill, suspect GIT obstruction and refers immediately to a higher centre.\\nPatient education\\n\\uf0b7\\nDo not use purgative frequently to treat constipation as it may form a habit.\\n\\uf0b7\\nDo not use purgatives to treat constipation with fever and following heart attack. A\\nsuppository or simple enema is preferred.\\n\\uf0b7\\nIn pregnancy ispaghula is preferred.\\nAMOEBIC LIVER ABSCESS\\nAmoebic liver abscess is most common type of liver abscess in tropical countries. It is caused\\nby infection by Entamoeba histolyticum through feco-oral route which reaches liver via portal\\ncirculation, causing necrosis of liver tissue resulting in what is known as anchovy sauce pus.\\nSalient features\\nInvestigations\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 151, 'source_type': 'Authorotative', 'priority': '1'}, page_content='circulation, causing necrosis of liver tissue resulting in what is known as anchovy sauce pus.\\nSalient features\\nInvestigations\\n\\uf0b7\\nTC with D increased, PT, APTT: elevated, Liver Function Tests (S. Billirubin, SGPT, and\\nAlbumin).\\n\\uf0b7\\nChest X Ray (elevated right diaphragm, rules out perforation). USG Abdomen,  CECT\\nAbdomen ( if rupture of abscess is suspected extra peritoneal )\\n\\uf0b7\\nDiagnostic aspiration of abscess  followed by routine microscopic and culture- sensitivity\\nof pus\\nNon- pharmacological treatment\\n\\uf0b7\\nHigh glucose diet, Low protein diet'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 152, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Gastrointestinal Diseases\\n137\\n\\uf0b7\\nAbdominal pain in right upper quadrant (RHC), fever, tenderness in RHC.\\n\\uf0b7\\nPalpable liver and jaundice\\nPharmacological treatment\\n\\uf0b7\\nTab. metronidazole 800 mg TDS for 2 weeks followed by Tab. diloxanide furoate 500 mg\\nBD for 10 days.\\n\\uf0b7\\nInj. diclofenac sodium 75 mg IM 8 hourly.\\n\\uf0b7\\nInj. pantoprazole 40 mg IV 12 hourly.\\n\\uf0b7\\nVit. K injections if PT/APTT is altered.\\nSurgical treatment\\n\\uf0b7\\nAmoebic liver abscess usually does not require drainage. Percutaneus aspiration can be\\ndone in abscess having large size (>100 cc).\\n\\uf0b7\\nExploratory laparotomy with drainage of abscess is required in suspected ruptured liver\\nabscess\\nPYOGENIC LIVER ABCESS\\nIt is the most common type of liver abscess in western world. It can be caused by ascending\\ninfection from biliary tract, infection via portal blood supply, hematogenous via hepatic\\nartery,  direct spread ( gall bladder, duodenum, colon ) or cryptogenic.\\nSalient features\\nInvestigations\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 152, 'source_type': 'Authorotative', 'priority': '1'}, page_content='infection from biliary tract, infection via portal blood supply, hematogenous via hepatic\\nartery,  direct spread ( gall bladder, duodenum, colon ) or cryptogenic.\\nSalient features\\nInvestigations\\n\\uf0b7\\nTC with DC, elevated with neutrophillia, PT, APTT is elevated\\n\\uf0b7\\nLiver Function Tests (S. bilirubin, SGPT, albumin), Chest X Ray ( elevated right\\ndiaphragm, rules out perforation ),USG Abdomen, CECT Abdomen ( if rupture of\\nabscess is suspected extra peritoneally).\\n\\uf0b7\\nDiagnostic aspiration of abscess followed by routine microscopic and culture- sensitivity\\nof pus\\nNon- pharmacological treatment\\n\\uf0b7\\nHigh glucose diet,  low protein diet\\nPharmacological treatment\\n\\uf0b7\\nInj. ceftrioxone 1-2 g IV BD\\n\\uf0b7\\nInj. diclofenac sodium 75 mg IM 8 hourly\\n\\uf0b7\\nInj. pantoprazole 40 mg IV 12 hourly\\n\\uf0b7\\nVit. k injections if PT/APTT are altered\\nSurgical treatment\\n\\uf0b7\\nPercutaneous aspiration can be done in abscess cavity and usually requires 2-3 settings of'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 152, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nInj. pantoprazole 40 mg IV 12 hourly\\n\\uf0b7\\nVit. k injections if PT/APTT are altered\\nSurgical treatment\\n\\uf0b7\\nPercutaneous aspiration can be done in abscess cavity and usually requires 2-3 settings of\\naspirations done alternate day. Percutaneus pigtail catheter can be used to avoid repeated\\naspirations. Laparoscopic drainage of liver abscess if site of abscess permits.\\n\\uf0b7\\nExploratory laparotomy with drainage of abscess is required in suspected ruptured liver\\nabscess.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 153, 'source_type': 'Authorotative', 'priority': '1'}, page_content='138\\n\\uf0b7\\nGeneralized tetanus starts with trismus or lockjaw followed by rigidity, violent, painful,\\ngeneralized muscle spasms and seizures provoked by slightest stimulation. Generalized\\nmuscle spasm may compromise respiration, fever and tachycardia may be present.\\n\\uf0b7\\nPrognosis and management depends on grade.\\nChapter 9\\nINFECTIONS\\nTETANUS\\nIt is an acute neurological disorder resulting from contamination of a wound by an obligate\\nanaerobic organism Clostridium tetani.\\nSalient features\\nInvestigations\\n\\uf0b7\\nClinical - culture of C. tetani from a wound provides supportive evidence. The few\\nconditions that mimic generalized tetanus include strychnine poisoning and dystonic\\nreactions to antidopaminergic drugs. Abdominal muscle rigidity is characteristically\\ncontinuous in tetanus but is episodic in the latter two conditions. Cephalic tetanus can be\\nconfused with other causes of trismus, such as oropharyngeal infection.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 153, 'source_type': 'Authorotative', 'priority': '1'}, page_content='continuous in tetanus but is episodic in the latter two conditions. Cephalic tetanus can be\\nconfused with other causes of trismus, such as oropharyngeal infection.\\n\\uf0b7\\nHypocalcemia and meningoencephalitis are included in the differential diagnosis of\\nneonatal tetanus.\\nGrading\\n\\uf0b7\\nMild or grade 1 – muscle rigidity with few or no spasms.\\n\\uf0b7\\nModerate or grade 2- trismus, dysphagia, rigidity and short lasting spasms.\\n\\uf0b7\\nSevere or grade 3- frequent explosive spasms, autonomic dysfunction particularly\\nsympathetic over activity may be present.\\n\\uf0b7\\nVery severe or grade 4- features of grade 3 plus violent autonomic disturbances involving\\nthe CVS – severe hyper or hypotension.\\nNon- pharmacological treatment\\n\\uf0b7\\nAdmit in a quiet room or ICU with minimum stimulation.\\n\\uf0b7\\nProtection of airways (intubation/tracheostomy) with or without mechanical ventilation.\\nMonitor cardiovascular parameters.\\n\\uf0b7\\nCleaning/exploration/debridement of wound\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 153, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nProtection of airways (intubation/tracheostomy) with or without mechanical ventilation.\\nMonitor cardiovascular parameters.\\n\\uf0b7\\nCleaning/exploration/debridement of wound\\n\\uf0b7\\nMaintain hydration and enteral/parentral nutrition with high calorie and high protein diet.\\nPharmacological treatment\\nGrade 1\\n\\uf0b7\\nTab. diazepam 5-20 mg 3 times a day; slow IV infusion in moderate to severe tetanus; not\\nexceed a dose of 80-100mg in 24 hours.\\n\\uf0b7\\nIf spasms not controlled, Inj. phenobarbitone 200mg IM every 8-12 hours or Inj.\\nchlorpromazine 50 mg IM in adults 4 times a day.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 154, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n139\\n\\uf0b7\\nRodents are the important reservoirs. Leptospires may enter the host through abrasions in the\\nskin or intact mucosa, the conjunctive and the lining of oro-and naso-pharynx in contact with\\nwater contaminated with leptospira.\\n\\uf0b7\\n90% of symptomatic persons have the mild and usual anicteric form of leptospirosis, with or\\nwithout meningitis. Severe leptospirosis with profound jaundice – Weil’s syndrome-occurs\\nin 5 to 10% of patients. The common finding in anicteric leptospirosis is fever with\\nconjunctival suffusion. Mild jaundice may be present.\\n\\uf0b7\\nThe ideal sedative and muscle relaxant schedule for each patient should be individualized.\\nAn objective guide to decrease in rigidity is relaxation of abdominal muscles.\\nGrade 2\\n\\uf0b7\\nTracheostomy\\nGrade 3 and 4\\n\\uf0b7\\nVentilatory support\\n\\uf0b7\\nInj. pancuronium 2-4mg or gallamine 20-40mg IV.\\n\\uf0b7\\nIf hypotension, give vasopressor support and if hypertension, give antihypertensive.\\n\\uf0b7\\nFor bradyarrythmias, Inj. atropine 0.6-1.2 mg IV.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 154, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nInj. pancuronium 2-4mg or gallamine 20-40mg IV.\\n\\uf0b7\\nIf hypotension, give vasopressor support and if hypertension, give antihypertensive.\\n\\uf0b7\\nFor bradyarrythmias, Inj. atropine 0.6-1.2 mg IV.\\nIn addition, give following to all patients;\\n\\uf0b7\\nInj. crystalline 2 mega units 6 hourly IV for 10 days or Inj. metronidazole 500mg 8 hourly\\nor 1gm 12 hourly. Requirement may be according to the infected wound.\\n\\uf0b7\\nInj. human tetanus immunoglobulin (TIG) 3000-5000 units IV or IM or Inj. equine\\nantiserum 10000 units by slow IV injection after sensitivity test when human TIG is not\\navailable.\\n\\uf0b7\\nAntiserum should be given before local manipulation of the wound.\\nLEPTOSPIROSIS\\nLeptospirosis is an infectious disease caused by the spirochete Leptospira.\\nSalient features\\nInvestigations\\n\\uf0b7\\nCulture- Blood, CSF and urine is the definite way of confirming the diagnosis of\\nleptospirosis\\n\\uf0b7\\nMicro agglutination (MAT)\\n-\\nSero conversion / four fold rise in the titer a\\n\\uf0b7\\nELISA / MSAT\\n-\\nPositive\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 154, 'source_type': 'Authorotative', 'priority': '1'}, page_content='leptospirosis\\n\\uf0b7\\nMicro agglutination (MAT)\\n-\\nSero conversion / four fold rise in the titer a\\n\\uf0b7\\nELISA / MSAT\\n-\\nPositive\\nPharmacological treatment\\n\\uf0b7\\nAll clinically suspected leptospirosis patients in endemic area during rainy season should\\nbe given presumptive treatment of leptospirosis and malaria. Tab. doxycycline 100 mg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 155, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n140\\n\\uf0b7\\nAsymptomatic or have mild diarrhoea; some may have sudden onset of explosive and life-\\nthreatening diarrhoea (cholera gravis). In a non-immune individual, after 24 to 48h\\nincubation period, characteristic sudden onset of painless watery voluminous diarrhoea.\\nPatients often vomit. In severe cases, volume loss can exceed 250 ml/kg in the first 24 h. If\\nfluids and electrolytes are not replaced, hypovolemic shock and death may ensue.\\n\\uf0b7\\nFever is usually absent. Muscle cramps due to electrolyte disturbances are common. The\\nstool has a characteristic appearance: a nonbilious, gray, slightly cloudy fluid with flecks of\\nmucus, no blood, and a somewhat fishy, inoffensive odour, known as \"rice-water\" stool.\\n\\uf0b7\\nClinical symptoms parallel volume contraction: At losses of <5% of normal body weight,\\nthirst develops; at 5–10%, postural hypotension, weakness, tachycardia, and decreased skin\\nturgor are documented; and at >10%, oliguria, weak or absent pulses, sunken eyes (and, in'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 155, 'source_type': 'Authorotative', 'priority': '1'}, page_content='thirst develops; at 5–10%, postural hypotension, weakness, tachycardia, and decreased skin\\nturgor are documented; and at >10%, oliguria, weak or absent pulses, sunken eyes (and, in\\ninfants, sunken fontanelles), wrinkled (\"washerwoman\") skin, somnolence, and coma.\\n\\uf0b7\\nComplications due to volume and electrolyte depletion- renal failure.\\ntwice daily for 7 days and  Tab. chloroquine 600mg (base) stat followed by 600 mg after\\n24 hours and  300 mg after another 24 hours in malaria endemic areas in adults.\\nNote: In children less than 6 years 30-50 mg/kg/day of Cap. amoxicillin / Cap. ampicillin\\nshould be given in divided doses 6 hourly for 7 days in place of doxycycline.\\nDefinitive treatment\\n\\uf0b7\\nInj. crystalline penicillin 20 lacs IU IV 6 hourly after negative test dose (ANTD) for 7\\ndays. For children the dose of crystalline penicillin should be 2-4 lacs IU/kg/day for 7\\ndays.\\n\\uf0b7\\nFor penicillin sensitive patients, Inj.ceftrioxone 1 gm IV. once daily for 7 days or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 155, 'source_type': 'Authorotative', 'priority': '1'}, page_content='days. For children the dose of crystalline penicillin should be 2-4 lacs IU/kg/day for 7\\ndays.\\n\\uf0b7\\nFor penicillin sensitive patients, Inj.ceftrioxone 1 gm IV. once daily for 7 days or\\nInj.cefotaxime 1 gm. IV. 6 hours daily for 7 days\\nSymptomatic and supportive treatment\\n\\uf0b7\\nCare of fluid and electrolyte balance. Hypovolemia and hypotension need prompt\\ntreatment with IV fluids.\\nPatients with oligouria, if prerenal azotemia is suspected,\\nprompt diuresis should be attempted with fluid therapy.\\n\\uf0b7\\nHeadache and myalgia to be treated with analgesic. Fever with antipyretic.\\n\\uf0b7\\nRestlessness and anxiety with sedatives and anemia with blood transfusion.\\n\\uf0b7\\nPeritoneal dialysis has been found to be safe, simple and effective procedure for\\nmanagement of renal failure due to leptospirosis. If there is contraindication to peritoneal\\ndialysis, hemodialysis can be done.\\nCHOLERA\\nIt is an acute diarrheal disease that occurs in few hours, result in profound, rapidly'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 155, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dialysis, hemodialysis can be done.\\nCHOLERA\\nIt is an acute diarrheal disease that occurs in few hours, result in profound, rapidly\\nprogressive dehydration and death. Caused by V. cholerae serogroup O1 or O139—i.e., the\\nserogroups with epidemic potential.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n141\\nInvestigation\\n\\uf0b7\\nIdentification of V. cholerae in stool examination directly by dark-field microscopy on a\\nwet mount of fresh stool, and its serotype by immobilization with specific antiserum.\\nLaboratory isolation of the organism requires the use of a selective medium such as\\ntaurocholate-tellurite-gelatin (TTG) agar or thiosulfate–citrate–bile salts–sucrose (TCBS)\\nagar. Standard microbiologic biochemical testing for Enterobacteriaceae will suffice for\\nidentification of V. cholerae. All vibrios are oxidase-positive.\\n\\uf0b7\\nA point-of-care antigen-detection cholera dipstick assay is now commercially available\\nfor use in the field or where laboratory facilities are lacking.\\nNon- pharmacological treatment\\n\\uf0b7\\nORS may be made by adding safe water to prepackaged sachets containing salts and\\nsugar or by adding 0.5 teaspoon of table salt (NaCl; 3.5 g) and 4 tablespoons of table\\nsugar (glucose; 40 g) to 1 L of safe water.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content='sugar or by adding 0.5 teaspoon of table salt (NaCl; 3.5 g) and 4 tablespoons of table\\nsugar (glucose; 40 g) to 1 L of safe water.\\n\\uf0b7\\nPotassium intake in bananas or green coconut water should be encouraged.\\nPharmacological treatment\\n\\uf0b7\\nEuvolemia should first be rapidly restored, and adequate hydration should then be\\nmaintained to replace ongoing fluid losses (Table 1& 2).\\n\\uf0b7\\nWHO recommends \"low-osmolarity\" ORS for treatment of dehydrating diarrhea. If\\navailable, rice-based ORS is considered superior to standard ORS in the treatment of\\ncholera. ORS can be administered via a nasogastric tube to individuals who cannot ingest\\nfluid.\\n\\uf0b7\\nOptimal management for severe dehydration includes the administration of IV fluid and\\nelectrolytes. Ringer\\'s lactate is the best choice among commercial products. It must be\\nused with additional potassium supplements, preferably given by mouth. The total fluid\\ndeficit in severely dehydrated patients (>10% of body weight) can be replaced safely'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"used with additional potassium supplements, preferably given by mouth. The total fluid\\ndeficit in severely dehydrated patients (>10% of body weight) can be replaced safely\\nwithin the first 3–6 h of therapy, half within the first hour. Transient muscle cramps and\\ntetany are common. Thereafter, oral therapy can usually be initiated, with the goal of\\nmaintaining fluid intake equal to fluid output.\\n\\uf0b7\\nPatients with continued large-volume diarrhea may require prolonged IV treatment to\\nmatch gastrointestinal fluid losses. Severe hypokalemia can develop but will respond to\\npotassium given either IV or orally. In the absence of adequate staff to monitor the\\npatient's progress, the oral route of rehydration and potassium replacement is safer than\\nthe IV route.\\nTable 1. Assessing the Degree of Dehydration in Patients with Cholera\\nDegree of Dehydration\\nClinical Findings\\nNone or mild, but diarrhea\\nThirst in some cases; <5% loss of total body weight\\nModerate\\nThirst, \\npostural \\nhypotension,\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 156, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Degree of Dehydration\\nClinical Findings\\nNone or mild, but diarrhea\\nThirst in some cases; <5% loss of total body weight\\nModerate\\nThirst, \\npostural \\nhypotension, \\nweakness, \\ntachycardia,\\ndecreased skin turgor, dry mouth/tongue, no tears; 5–10%\\nloss of total  body weight'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 157, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n142\\nSevere\\nUnconsciousness, lethargy, or \"floppiness\"; weak or absent\\npulse; inability to drink; sunken eyes (and, in infants,\\nsunken fontanelles); >10% loss of total body weight\\nTable 2. Treatment of Cholera, Based on Degree of Dehydration\\nDegree of Dehydration,\\nPatient\\'s Age (Weight)\\nTreatment\\nNone or Mild, but Diarrhea\\n<2 years\\n1/4–1/2 cup (50–100 ml) of ORS, to a maximum of 0.5\\nL/d\\n2 – 9 years\\n1/2–1 cup (100–200 ml) of ORS, to a maximum of 1 L/d\\nMore than 10 years\\nAs much ORS as desired, to a maximum of 2 L/d\\nModerate\\n<4 months (<5 kg)\\n200–400 ml of ORS\\n4–11 months (5–<8 kg)\\n400–600 ml of ORS\\n12–23 months (8–<11 kg)\\n600–800 ml  of ORS\\n2–4 years (11–<16 kg)\\n800–1200 ml  of ORS\\n5–14 years (16–<30 kg)\\n1200–2200 ml of ORS\\n15 years (≥30 kg)\\n2200–4000 ml of ORS\\nSevere\\nAll ages and weights\\nIV fluid replacement with Ringer\\'s lactate (or, if not\\navailable, normal saline): 100 ml /kg in first 3-h period\\n(or first 6-h period for children <12 months old); start'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 157, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Severe\\nAll ages and weights\\nIV fluid replacement with Ringer's lactate (or, if not\\navailable, normal saline): 100 ml /kg in first 3-h period\\n(or first 6-h period for children <12 months old); start\\nrapidly, then slow down; total of 200 ml/kg in first 24 h;\\ncontinue until patient is awake, can ingest ORS, and no\\nlonger has a weak pulse\\n\\uf0b7\\nTab. doxycycline (a single dose of 300 mg) or tetracycline (12.5 mg/kg four times a day\\nfor 3 days) may be effective in adults but is not recommended for children <8 years of\\nage because of possible deposition in bone and developing teeth. Pregnant women and\\nchildren are usually treated with erythromycin or azithromycin (10 mg/kg in children).\\nINFLUENZA INFECTION\\nIt is a respiratory disease of pigs affecting human beings, caused by types A influenza viruses\\nwith regular outbreaks in pigs.  Source of the virus in swine are avian, human and swine.  All\\nthree viruses re-assort and form a new virus which is a mixture of all three.  At present there\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 157, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with regular outbreaks in pigs.  Source of the virus in swine are avian, human and swine.  All\\nthree viruses re-assort and form a new virus which is a mixture of all three.  At present there\\nare four types H1N1, H1N2, H3N2 and H3N1.  The present pandemic is by influenza AH1N1\\ntype.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 158, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n143\\n\\uf0b7\\nSymptoms include fever, headache, cough, sore throat, rhinorrhea, myalgia, fatigue,\\nvomiting, or diarrhea. Patients appear flushed and the skin is hot and dry.  Pharynx is normal\\ndespite a severe sore throat.\\n\\uf0b7\\nThere may be mild cervical lymphadenopathy.  Illness generally resolves over 2-5 days and\\nrecovery occurs in 1 week.  Cough may persist 1-3 weeks longer and post influenza asthenia\\nmay persist for several weeks.\\n\\uf0b7\\nFrank dyspnoea, hyperpnoea, cyanosis, diffuse rales and signs of consolidation are indicative\\nof pulmonary complications. Symptoms of severe disease may include apnea, tachypnoea,\\ndyspnoea, cyanosis, dehydration, altered mental status and extreme irritability.\\nCase Definitions\\n\\uf0b7\\nA confirmed case of H1N1 infection is defined as a person with an acute febrile respiratory\\nillness with laboratory confirmed H1N1 infection at CDC by one or more of the following\\ntests: realtime RT-PCR, viral culture or four fold increase in H1N1 virus specific neutralizing'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 158, 'source_type': 'Authorotative', 'priority': '1'}, page_content='illness with laboratory confirmed H1N1 infection at CDC by one or more of the following\\ntests: realtime RT-PCR, viral culture or four fold increase in H1N1 virus specific neutralizing\\nantibodies.\\n\\uf0b7\\nA probable case of H1N1 is a defined as a person with acute respiratory illness who is\\npositive for influenza A but negative to H2 and HB by RT-PCR.\\n\\uf0b7\\nA suspected case of H1N1 is defined a person with an acute febrile respiratory illness who\\nhas had dose contact with a person who is a swine-origin influenza confirmed case or\\ntravelled to a community one or more confirmed swine origin influenza cases or resides in a\\ncommunity where there are one or more confirmed swine origin influenza A (H1N1) cases.\\nSalient features\\nInvestigations\\nUpper respiratory specimens, nasopharyngeal swab or wash, nasal, aspirate or tracheal\\naspirate should be tested by the state public health laboratory. Real time RT-PCR, viral\\ncultures are to be performed to confirm the H1N1 infection.\\nPharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 158, 'source_type': 'Authorotative', 'priority': '1'}, page_content='aspirate should be tested by the state public health laboratory. Real time RT-PCR, viral\\ncultures are to be performed to confirm the H1N1 infection.\\nPharmacological treatment\\nThe guiding principles are:\\n\\uf0b7\\nEarly implementation of infection control precautions to minimize nosocomical /\\nhousehold spread of disease\\n\\uf0b7\\nPrompt treatment to prevent severe illness & death.\\n\\uf0b7\\nEarly identification and follow up of persons at risk.\\n\\uf0b7\\nTab. oseltamivir is the recommended drug both for prophylaxis and treatment. Dose for\\ntreatment is as follows:  By weight  <15kg 30 mg BD for 5 days , 15-23kg 45 mg BD for\\n5 days , 24 ≤40kg 60 mg BD for 5 days ,  >40kg 75 mg BD for 5 days\\n\\uf0b7\\nFor infants < 3 months 12 mg BD for 5 days, 3-5 months 20 mg BD for 5 days  6-11\\nmonths 25 mg BD for 5 days. If needed dose & duration can be modified as per clinical\\ncondition.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n144\\nCaution: Oseltamivir is generally well tolerated, gastrointestinal side effects (transient\\nnausea, vomiting) may increase with increasing dose.\\nSupportive therapy\\n\\uf0b7\\nIV fluids, parentral nutrition.\\n\\uf0b7\\nOxygen therapy/ ventilatory support.\\n\\uf0b7\\nAntibiotics for secondary infection.\\n\\uf0b7\\nVasopressors for shock.\\n\\uf0b7\\nParacetamol or ibuprofen is prescribed for fever, myalgia and headache. Patient is advised\\nto drink plenty of fluids. Smokers should avoid smoking. For sore throat, short course of\\ntopical decongestants, saline nasal drops, throat lozenges and steam inhalation may be\\nbeneficial.\\n\\uf0b7\\nSalicylate / aspirin is strictly contra-indicated in any influenza patient due to its potential\\nto cause Reye’s syndrome.\\n\\uf0b7\\nThe suspected cases would be constantly monitored for clinical / radiological evidence of\\nlower respiratory tract infection and for hypoxia (respiratory rate, oxygen saturation, level\\nof consciousness).\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content='lower respiratory tract infection and for hypoxia (respiratory rate, oxygen saturation, level\\nof consciousness).\\n\\uf0b7\\nPatients with signs of tachypnea, dyspnea, respiratory distress and oxygen saturation less\\nthan 90 per cent should be supplemented with oxygen therapy. Types of oxygen devices\\ndepend on the severity of hypoxic conditions which can be started from oxygen cannula,\\nsimple mask, partial re-breathing mask (mask with reservoir bag) and non re-breathing\\nmask. In children, oxygen hood or head boxes can be used.\\n\\uf0b7\\nPatients with severe pneumonia and acute respiratory failure (SpO2 < 90% and PaO2 <60\\nmmHg with oxygen therapy) must be supported with mechanical ventilation. Invasive\\nmechanical ventilation is preferred choice. Non invasive ventilation is an option when\\nmechanical ventilation is not available. To reduce spread of infectious aerosols, use of\\nHEPA filters on expiratory ports of the ventilator circuit / high flow oxygen masks is\\nrecommended.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mechanical ventilation is not available. To reduce spread of infectious aerosols, use of\\nHEPA filters on expiratory ports of the ventilator circuit / high flow oxygen masks is\\nrecommended.\\n\\uf0b7\\nMaintain hydration, electrolyte balance and nutrition.\\n\\uf0b7\\nIf the laboratory reports are negative, the patient would be discharged after giving full\\ncourse of oseltamivir. Even if the test results are negative, all cases with strong\\nepidemiological criteria need to be followed up.\\n\\uf0b7\\nImmunomodulating drugs have not been found to be beneficial in treatment of ARDS or\\nsepsis associated multi organ failure. High dose corticosteroids in particular have no\\nevidence of benefit and there is potential for harm. Low dose corticosteroids (Tab.\\nhydrocortisone 200-400 mg/ day) may be useful in persisting septic shock (SBP < 90).\\n\\uf0b7\\nSuspected cases not having pneumonia do not require antibiotic therapy. Antibacterial\\nagents should be administered, if required, as per locally accepted clinical practice'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 159, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nSuspected cases not having pneumonia do not require antibiotic therapy. Antibacterial\\nagents should be administered, if required, as per locally accepted clinical practice\\nguidelines. Patient on mechanical ventilation should be administered antibiotics\\nprophylactically to prevent hospital associated infections.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 160, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n145\\nMajor signs and symptoms:\\n\\uf0b7\\nWeight loss (> 10 kg or > 20% of original weight)\\n\\uf0b7\\nDiarrhoea (> 1 month)\\n\\uf0b7\\nFever for more than 1 month\\nMinor signs:\\n\\uf0b7\\nHerpes zoster (shingles), Pruritic popular rash.\\n\\uf0b7\\nKaposi’s sarcoma\\n\\uf0b7\\nPersistent generalized lymphadenopathy (PGL)\\n\\uf0b7\\nOral candidiasis, Oral hairy leukoplakia\\n\\uf0b7\\nPersistent painful genital ulceration\\n\\uf0b7\\nThe persistence of either Kaposi’s sarcoma or cryptococcal meningitis is sufficient for the\\ncase definition of AIDS.\\nHIV disease is characterized by three phase.\\n\\uf0b7\\nAcute primary illness, Asymptomatic chronic illness, Symptomatic chronic illness\\nHIV AND AIDS\\nHuman immunodeficiency virus (HIV) infection leads to progressive immunodeficiency and\\nincreased susceptibility to infections, including tuberculosis.  The rate of disease progression\\nis highly variable between individuals, ranging from 6 months to than 20 yrs. The median\\ntime to develop Acquired Immunodeficiency Syndrome (AIDS) after transmission is 10 yrs'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 160, 'source_type': 'Authorotative', 'priority': '1'}, page_content='is highly variable between individuals, ranging from 6 months to than 20 yrs. The median\\ntime to develop Acquired Immunodeficiency Syndrome (AIDS) after transmission is 10 yrs\\nin the absence of Antiretroviral therapy (ART). The case definition of AIDS is fulfilled at\\nleast 2 major signs and at least 1 minor sign are present where HIV testing facilities are not\\navailable.  In children if 2 major and 2 minor signs are present (if no other causes for\\nimmunosuppression)\\nSalient features\\nInvestigations\\n\\uf0b7\\nHIV serology\\n\\uf0b7\\nCD4 + T lymphocytes counts (if available)\\n\\uf0b7\\nComplete blood count and chemistry of profile and pregnancy test\\nSupplementary test indicated by history and physical examination\\n\\uf0b7\\nChest x-ray\\n\\uf0b7\\nUrine for routine and microscopic examination\\n\\uf0b7\\nHepatitis C Virus IHCV) and Hepatitis B Virus (HBV) serology (depending on test\\navailability and resources)\\nImportant note: It is most important to confirm the diagnosis of HIV infection by tests'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 160, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nHepatitis C Virus IHCV) and Hepatitis B Virus (HBV) serology (depending on test\\navailability and resources)\\nImportant note: It is most important to confirm the diagnosis of HIV infection by tests\\nperformed by a trained technician, preferably in a diagnostic laboratory.   The test results\\nshould include the type of test performed to establish the diagnosis based on WHO\\nguidelines.  In case there is any doubt, the test should be repeated in a standard/referral\\nlaboratory.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n146\\nWHO Clinical staging of HIV Disease for Adults\\nPrimary HIV Infection\\n\\uf0b7\\nAsymptomatic\\n\\uf0b7\\nAcute retroviral syndrome\\nClinical stage I\\n\\uf0b7\\nAsymptomatic\\n\\uf0b7\\nPersistent generalized lymphadenopathy (PGL)\\nClinical Stage 2\\n\\uf0b7\\nModerate unexplained weight loss (< 10% of presumed or measured body weight)\\n\\uf0b7\\nRecurrent respiratory tract infections.\\n\\uf0b7\\nSinusitis, Bronchitis, otitis media, pharyngitis\\n\\uf0b7\\nHerpes zoster, angular cheilitis, recurrent oral ulcerations.\\n\\uf0b7\\nPapularpruritic eruptions, seborrhoeic dermatitis\\n\\uf0b7\\nFungal nail infections of fingers.\\nClinical stage 3- Conditions where a presumptive diagnosis can be made on the basis of\\nclinical signs or simple investigations.\\n\\uf0b7\\nSevere weight loss (> 10% of presumed or measured body weight)\\n\\uf0b7\\nUnexplained chronic diarrhea for longer than one month.\\n\\uf0b7\\nUnexplained persistent fever (intermittent or constant for longer than one month)\\n\\uf0b7\\nOral candidiasis, Oral hairy leukoplakia\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nUnexplained chronic diarrhea for longer than one month.\\n\\uf0b7\\nUnexplained persistent fever (intermittent or constant for longer than one month)\\n\\uf0b7\\nOral candidiasis, Oral hairy leukoplakia\\n\\uf0b7\\nPulmonary tuberculosis (TB), Severe bacterial infections (e.g. pneumonia, emphysema,\\npomposities, bone or joint infection, meningitis, bacteraemia)\\n\\uf0b7\\nAcute necrotizing ulcerative stomatitis, gingivitis or periodontitis\\nClinical stage 4- Conditions where the diagnosis can be made on the basis of clinical signs or\\nsimple investigations.\\n\\uf0b7\\nHIV wasting syndrome\\n\\uf0b7\\nPneumocystic  pneumonia, recurrent severe or radiological bacterial pneumonia.\\n\\uf0b7\\nChronic herpes simplex infection (orolabial, genital or anorectal of more than one\\nmonth’s duration)\\n\\uf0b7\\nEsophageal candidiasis\\n\\uf0b7\\nExtra-pulmonary tuberculosis including tuberculous lymphadenopathy.\\n\\uf0b7\\nKaposi sarcoma\\n\\uf0b7\\nCentral nervous system (CNS) toxoplasmosis\\n\\uf0b7\\nHIV encephalopathy.\\nConditions where confirmatory diagnostic testing is necessary:\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 161, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nKaposi sarcoma\\n\\uf0b7\\nCentral nervous system (CNS) toxoplasmosis\\n\\uf0b7\\nHIV encephalopathy.\\nConditions where confirmatory diagnostic testing is necessary:\\n\\uf0b7\\nExtra – pulmonary crytococcosis including meningitis.\\n\\uf0b7\\nDisseminated nontuberculous mycobacterial infection.\\n\\uf0b7\\nProgressive multifocal leukoencephalopathy (PML)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 162, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n147\\n\\uf0b7\\nCandida of trachea, bronchi or lungs\\n\\uf0b7\\nCrytosporiodiosis, isosporiasis\\n\\uf0b7\\nVisceral herpes simplex infection.\\n\\uf0b7\\nCytomegalovirus (CMV) infection (retinitis or of an organ other than liver, spleen or\\nlymph nodes)\\n\\uf0b7\\nAny disseminated mycosis (e.g. histoplasmosis, coccidiomycosis, penicilliosis)\\n\\uf0b7\\nRecurrent non-typhoidal salmonella septicaemia\\n\\uf0b7\\nCerebral or B-cell Non-Hodgkin lymphoma\\n\\uf0b7\\nInvasive cervical carcinoma\\n\\uf0b7\\nVisceral leishmaniasis\\nTable 3. Initiation of ART in Adults and Adolescents National Guidelines, 2011\\nBased on WHO Clinical Staging and CD4 Count\\nWHO Clinical Staging\\nCD4 (cells/cu.mm)\\nI and II\\nTreat if CD4 Count <350\\nIII and IV\\nTreat irrespective of CD4 Count\\nInitiation of ART in PLHIV with Pregnancy (Table 4): Same as above. Avoid efavirenz\\nduring first trimester. Strict Monitoring for Adverse effects of Nevirapine is needed if CD4\\ncount is >250.\\nTable 4. Initiation of ART in Person living with HIV (PLHIV) with TB Co-infection\\nType of Tuberculosis\\nEligible'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 162, 'source_type': 'Authorotative', 'priority': '1'}, page_content='count is >250.\\nTable 4. Initiation of ART in Person living with HIV (PLHIV) with TB Co-infection\\nType of Tuberculosis\\nEligible\\nClinical Staging and CD4\\nCounts\\nTiming of ART\\nin relation to start of\\nTB treatment\\nPulmonary TB\\n(Stage III)\\nStart ART irrespective of any\\nclinical stage\\nand\\nirrespective of CD4 counts\\nStart ATT first;\\nStart ART as soon as\\nTB treatment is tolerated\\nafter 2 wks & before 2mth.\\nExtra pulmonary TB\\n(Stage IV)\\nTable 5. Initiation of ART in PLHIV with Hepatitis B or Hepatitis C Co-infection\\nCo-infection\\nWHO Clinical Staging\\nCD4 (cells/cu.mm)\\nHIV-HBV or HIV-HCV\\nco-infection without\\nevidence of chronic active\\nHepatitis\\nI and II\\nStart ART at CD4 Count <350\\nIII & IV\\nStart ART irrespective\\nof CD4 Count\\nHIV-HBV or HIV-HCV\\nco-infection with\\ndocumented evidence of\\nchronic active Hepatitis\\nAll Clinical stages\\nStart ART Irrespective\\nof any CD4 count'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 163, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n148\\n\\uf0b7\\nSub-acute onset of symptoms over a period of weeks.\\n\\uf0b7\\nTypically fever, dry cough and progressive difficulty in breathing, also weight loss, night\\nsweats and fatigue.\\nTable 6. First line ART Regimens National AIDS Control Organization (NACO)\\nGuidelines 2009\\nRegimen\\nNational ART Regimen\\nPreference\\nRegimen I\\nZidovudine + Lamivudine +\\nNevirapine\\nPreferred regimen\\nfor patients with Hb >9 gm/dl\\nRegimen I (a)\\nTenofovir + Lamivudine +\\nNevirapine\\nFor patients with Hb <9 gm/dl\\nRegimen II\\nZidovudine + Lamivudine +\\nEfavirenz\\nPreferred for patients  on anti-\\ntuberculosis treatment, if Hb >9\\ngm/dl\\nRegimen II (a)\\nTenofovir + Lamivudine +\\nEfavirenz\\nFor patients on anti-tuberculosis\\ntreatment and Hb <9 gm/dl\\nTable 7. Second line ART Regimen for Adults and Adolescents in India\\nSecond\\nLine ARVs\\nDosage\\nDosing schedule\\nTDF + 3TC\\nFixed dose combination\\nof TDF 300 mg + 3TC 300 mg\\n0 –0 –1\\n(One tablet in the night)\\nATV/r\\nCap. atazanavir 300 mg\\n0 –0 –1\\n(One tablet in the night)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 163, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Second\\nLine ARVs\\nDosage\\nDosing schedule\\nTDF + 3TC\\nFixed dose combination\\nof TDF 300 mg + 3TC 300 mg\\n0 –0 –1\\n(One tablet in the night)\\nATV/r\\nCap. atazanavir 300 mg\\n0 –0 –1\\n(One tablet in the night)\\nTab. ritonavir 100 mg\\n0 –0 –1\\n(One tablet in the night)\\nOPPORTUNISTIC INFECTIONS\\nThe common conditions and diseases related to AIDS include tuberculosis, pneumocystis\\ncarinii \\npneumonia, \\noesophageal \\ncandidiasis, \\ncryptococcosis, \\ntoxoplasmosis,\\ncryptosporidiosis, cytomegalovirus (CMV), and mycobacterium avium complex (MAC).\\nDiagnosis and management of common opportunistic infections is given herewith.\\nI.\\nPNEUMOCYSTIS CARINII PNEUMONIA (PCP)\\nPneumocystis Carinii is a fungus that infects the lungs\\nSalient features\\nInvestigations\\n\\uf0b7\\nX-ray\\n\\uf0b7\\nInduced sputum examination or bronchoscopy, CD-4 count <200'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 164, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n149\\n\\uf0b7\\nDifficulty in swallowing or retrosternal discomfort. Weight loss is common\\n\\uf0b7\\nCD4 count < 100\\n\\uf0b7\\nUsually made directly in presence of oral candidiasis and dysphagia. Endoscopy is indicated\\nwho fail to respond to a clinical trial of appropriate treatment.\\n\\uf0b7\\nThe diagnosis of esophageal candidiasis should be reconsidered if oral candidiasis is not\\npresent.\\n\\uf0b7\\nAssociated fever and oral ulceration are not common.\\nPharmacological treatment\\n\\uf0b7\\nSevere \\ndisease\\n–\\nhospitalization, \\nintravenous \\ntrimethoprim/sulphamethoxazole\\n(TMP/SMX) (15mg/kg/day for 21 days), supplemental oxygen for patients with severe\\nhypoxemia (PaO2 < 70 mmHg breathing room air at rest). Corticosteroids, prednisolone,\\n40 mg twice daily for 5 days followed by 40 mg once daily for 5 days, followed by 20 mg\\nonce daily for 11 days.\\n\\uf0b7\\nFor moderate disease, an oral agent may be used on outpatient basis, although\\nhospitalization should be considered. While mild cases, oral TMP/SMX can be given as\\nabove.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 164, 'source_type': 'Authorotative', 'priority': '1'}, page_content='once daily for 11 days.\\n\\uf0b7\\nFor moderate disease, an oral agent may be used on outpatient basis, although\\nhospitalization should be considered. While mild cases, oral TMP/SMX can be given as\\nabove.\\nPreventive therapy\\n\\uf0b7\\nTab. dapsone 100 mg once a day for 21 days – preferred second- line option.\\n\\uf0b7\\nTab. clindamycin 450 mg 4 times a day + primaquine 15 mg once daily for 21 days.\\n\\uf0b7\\nTab. atovaquone 750 mg once a day for 21 days.\\n\\uf0b7\\nInj. pentamidine (intravenous) 3-4 mg/kg/day for 21 days.\\nII. OESOPHAGEAL CANDIDIASIS\\nCandidiasis is a fungal infection that frequently occurs in the mouth and vagina.  It is\\nconsidered to be an opportunistic infection when it occurs in the oesophagus.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nPreventive therapy: not recommended because current drugs effectively treat\\n(prophylaxis) disease\\n\\uf0b7\\nAntifungal resistance may develop and drug-drug interactions may occur\\n\\uf0b7\\nTab. fluconazole 100-400 mg once a day for 2 weeks is the treatment of choice.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 164, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(prophylaxis) disease\\n\\uf0b7\\nAntifungal resistance may develop and drug-drug interactions may occur\\n\\uf0b7\\nTab. fluconazole 100-400 mg once a day for 2 weeks is the treatment of choice.\\nAlternative treatment is Inj. amphotericin B 0.3 -0.5 mg/kg/day.\\n\\uf0b7\\nMaintenance therapy by Tab. fluconazole 50 – 100 mg once a day\\n\\uf0b7\\nStopping maintenance therapy when there is evidence that patient who achieves CD4\\ncounts > 100 on ART may cease treatment.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 165, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n150\\n\\uf0b7\\nHeadache, nausea, fever, malaise, altered mental status, irritability and seizures, cough, chest\\npain, breathlessness\\n\\uf0b7\\nPresentation: Sub-acute with progressive symptoms over weeks to months or acute with\\nsymptoms over days.\\n\\uf0b7\\nCD4 count: < 100\\n\\uf0b7\\nAltered mental state (confusion, unusual behavior), headaches, fever, seizures, paralysis,\\ncoma.\\n\\uf0b7\\nPresentation: acute to sub acute over days to weeks, CD4 count <100\\nIII.CRYPTOCOCCOSIS\\nCryptococcosis is a fungus that is inhaled and can cause meningitis.\\nSalient features\\nInvestigations\\n\\uf0b7\\nLumbar puncture to test for the presence of Cryptococcus or cryptococcal antigen in\\ncerebral spinal fluid.  ICP is often raised.\\n\\uf0b7\\nCSF protein and glucose are generally normal and there may be few white blood cells.\\nPharmacological treatment\\n\\uf0b7\\nInj. amphotericin B 0.5 – 0.8 mg/kg/day + flucytosine 100 mg/day 4 times a day for 2\\nweeks then 8 to 10 weeks. Alternative treatment is liposomal amphotericin.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 165, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Pharmacological treatment\\n\\uf0b7\\nInj. amphotericin B 0.5 – 0.8 mg/kg/day + flucytosine 100 mg/day 4 times a day for 2\\nweeks then 8 to 10 weeks. Alternative treatment is liposomal amphotericin.\\n\\uf0b7\\nMaintenance therapy by  flucanozole 200 mg once a day. Cohort studies suggest that\\nmaintenance therapy can be ceased in patients with sustained CD4 response to ART (CD4\\n> 200) for > 3 months\\nIV.TOXOPLASMOSIS\\nToxoplasmosis is a parasite that has a predilection for the brain.\\nSalient features\\nInvestigations\\n\\uf0b7\\nTypical appearance on CT or MRI scans.\\n\\uf0b7\\nDiagnosis is usually presumptive on the basis of appearance on scan.  May show ring\\nshaped contrast enhancing lesions.\\nPharmacological treatment\\n\\uf0b7\\nTab. pyrimethamine 100 – 200 mg loading dose and then 50 – 75 mg once a day given in\\ncombination with sulphadiazine 4 – 6 g/day, 4 times a day or  Tab.  clindamycin 2 – 4\\ng/day, 4 times a day for 6 – 8 weeks duration depending upon response. If sulphadiazine'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 165, 'source_type': 'Authorotative', 'priority': '1'}, page_content='combination with sulphadiazine 4 – 6 g/day, 4 times a day or  Tab.  clindamycin 2 – 4\\ng/day, 4 times a day for 6 – 8 weeks duration depending upon response. If sulphadiazine\\nis used, Tab. folinic acid 25 mg once a day should be given in the presence of cerebral\\nedema.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 166, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n151\\n\\uf0b7\\nLower abdominal pain. Mild diarrhea develops gradually and may lead to full blown\\ndysentery. 0-12 stools per day with blood and mucus and little fecal matter.\\n\\uf0b7\\nCaecal involvement may mimic acute appendicitis. Chronic form i.e. amoebic colitis,\\ncan be confused with inflammatory bowel disease.\\n\\uf0b7\\nUntreated or incompletely treated intestinal infection may result in amoebic liver\\nabscess and involvement of other extra intestinal site.\\n\\uf0b7\\nAcute giardiasis-although diarrhea is common, upper intestinal manifestations such as\\nabdominal pain, bloating, belching, flatus, nausea and vomiting may predominate.\\n\\uf0b7\\nChronic giardiasis – history of one or more episodes of acute diarrhea, increased flatus, loose\\nstools, abdominal distension, borborygmi, eructation of foul tasting gas and passage of foul\\nsmelling flatus, and weight loss.\\n\\uf0b7\\nSymptoms could be intermittent, recurring and gradually debilitating: severe disease may'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 166, 'source_type': 'Authorotative', 'priority': '1'}, page_content='smelling flatus, and weight loss.\\n\\uf0b7\\nSymptoms could be intermittent, recurring and gradually debilitating: severe disease may\\nresult in malabsorption, weight loss, growth retardation and dehydration.\\n\\uf0b7\\nAlternative treatment: pyrimethamine in combination with one of the following: Tab.\\nazithromycin 1 – 15 mg/day or  Tab. atovaquone 3 g/day or Tab. dapsone 100 mg/day or\\nTab. clarithromycin 2 g/day\\n\\uf0b7\\nMaintenance therapy is therapy by Tab. pryimethamine (25 – 75 mg once a day) +\\nsulphadiazine (50 – 100 mg 4 times a day for several days with leucovorin)\\nAMOEBIASIS (INTESTINAL)\\nIt is an infection caused by intestinal protozoa Entamoeba histolytica, which usually spreads\\nby infective cysts in stool that contaminate food and drinking water.\\nSalient features\\nInvestigations\\n\\uf0b7\\nDemonstration of cysts and/or trophozoites of Entamoeba histolytica in the stool.\\nPharmacological treatment\\n\\uf0b7\\nAsymptomatic cyst passers- Tab. diloxanide furoate 500 mg TDS for 10 days\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 166, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nDemonstration of cysts and/or trophozoites of Entamoeba histolytica in the stool.\\nPharmacological treatment\\n\\uf0b7\\nAsymptomatic cyst passers- Tab. diloxanide furoate 500 mg TDS for 10 days\\n\\uf0b7\\nAcute amoebic dysentery and chronic infection\\n-\\nTab. metronidazole 400 – 800 mg 8 hourly PO for 10 days. In children 15 mg/kg divided\\nin three doses for 7 days or Tab. tinidazole (300 mg, 500 mg and 1 g) 2 g orally as single\\ndose. In children 50 mg/kg/day in three divided doses for 10 days\\n-\\nFollowed by Tab. diloxanide furoate 500 mg 8 hourly for 10 days\\nGIARDIASIS\\nIt is an intestinal disease caused by parasite Giardia lamblia that spreads by direct faeco-oral\\ntransmission.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 167, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n152\\n\\uf0b7\\nAsymptomatic or present with symptoms of anemia (Hypochromic microcytic).\\n\\uf0b7\\nPruritic maculopapular dermatitis (ground itch) at site of skin penetration by infective larvae,\\nserpigenous tracts of subcutaneous migration in previously sensitized host.\\n\\uf0b7\\nMild transient pneumonitis because of larvae migration through lungs.\\n\\uf0b7\\nIntestinal manifestations\\n–\\nepigastric pain often with post-prandial accentuation,\\ninflammatory diarrhea.\\n\\uf0b7\\nMajor consequences – progressive iron deficiency anemia and hypoproteinemia\\nInvestigations\\n\\uf0b7\\nDemonstration of cysts and or trophozoites in the stools.\\nPharmacological treatment\\n\\uf0b7\\nTab. tinidazole 2 g as single dose in adults.  In children 50 mg/kg as a single dose Or\\n\\uf0b7\\nTab. metronidazole 400 mg every TDS for 7 days in adults. In children 15 mg/kg divided\\nin three doses for 7 days.\\nPatient education\\n\\uf0b7\\nInfections spread by ingestion of food or water contaminated with cysts. Properly cooked'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 167, 'source_type': 'Authorotative', 'priority': '1'}, page_content='in three doses for 7 days.\\nPatient education\\n\\uf0b7\\nInfections spread by ingestion of food or water contaminated with cysts. Properly cooked\\nfood, use of clean drinking water, proper sanitation and good personal hygiene- hand\\nwashing with soap after defecation and before meals may prevent infection.\\n\\uf0b7\\nInfection can be minimized by avoiding unpeeled fruits and vegetables.\\n\\uf0b7\\nSide effects are usually mild and transient and include nausea, vomiting, abdominal\\ndiscomfort, metallic taste and a disulfiram like reaction, therefore, avoid use of alcohol\\nduring treatment.\\nHOOKWORM INFESTATION\\nThe majority of worm infestations are asymptomatic Infections caused by A.duodenale and\\nN.americanus.\\nThe infective larvae penetrate through skin usually the food and travel\\nthrough subcutaneous issue to the intestines.  The adult forms live in the jejunum and feed on\\nblood, thus leading to chronic blood loss and anemia.\\nSalient features\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 167, 'source_type': 'Authorotative', 'priority': '1'}, page_content='through subcutaneous issue to the intestines.  The adult forms live in the jejunum and feed on\\nblood, thus leading to chronic blood loss and anemia.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nTab. mebendazole 100mg BD for 3 days in children above 2 years of age.\\n(Caution: contraindicated in children less than 2 years) or\\n\\uf0b7\\nTab. pyrantel pamoate (250mg); once daily for 3 days.\\n(Caution; not used in children below 1 year of age)\\n\\uf0b7\\nIn children more than 1 year, susp. pyrental palmoate 10mg/kg as a single dose or Tab\\nalbendazole 400mg to be given as a single dose. In children between 1-2 years of age\\nsyrup albendazole 200mg as a single dose. In children more than 2 years of age syrup\\nalbendazole 400 mg as a single dose.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 168, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n153\\n\\uf0b7\\nMost individuals are asymptomatic. Features of pulmonary involvement because of larval\\nmigration include irritating nonproductive cough, bronchospasm or pneumonitis and burring\\nsubsternal discomfort aggravated by coughing or deep inspiration, dyspnoea, fever,\\neosinophilic pneumonities.\\n\\uf0b7\\nSmall bowel obstruction may get complicated by perforation intussusceptions or volvulus.\\n\\uf0b7\\nAberrant migration of a large worm may cause biliary colic, cholangitis, cholecystitis\\npancreatic and oral expulsion of the worm.\\n\\uf0b7\\nMost infestations are asymptomatic. Cardinal symptoms are perianal pruritis, worse at night\\ndue to migration of female worms. Excessive itching can lead to perianal excoriation and\\nbacterial superinfection. Heavy infection causes abdominal pain and weight loss.\\n\\uf0b7\\nRarely, in female’s vulvovaginitis and pelvic or peritoneal granulomas occur. Eosinophilia.\\nPatient education\\n\\uf0b7\\nHookworm infestation occurs through skin penetration by the infective larvae.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 168, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nRarely, in female’s vulvovaginitis and pelvic or peritoneal granulomas occur. Eosinophilia.\\nPatient education\\n\\uf0b7\\nHookworm infestation occurs through skin penetration by the infective larvae.\\n\\uf0b7\\nThe disease can be prevented by use of boots and gloves while working in the fields.\\nASCARIASIS (ROUNDWORM INFESTATION)\\nAscariasis is caused by Ascaris lumbricoides, the largest nematode parasite of humans\\nreaching up to 40 cm in length.  The worm is located in the large intestine.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nTab mebendazole 100 mg 12 hourly for 3 days in children above 2 years of age. (Caution:\\ncontraindicated in children < 2 years)\\n\\uf0b7\\nTab. pyrantel pamoate 11 mg/kg as a single dose or Tab.  albendazole 400 mg as a single\\ndose. In heavy infestation, however, a 2-3 day course is indicated. (Caution:\\ncontraindicated in pregnancy)\\n\\uf0b7\\nIn children between 1 – 2 years of age Syr. albendazole 200 mg as a single dose. In'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 168, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dose. In heavy infestation, however, a 2-3 day course is indicated. (Caution:\\ncontraindicated in pregnancy)\\n\\uf0b7\\nIn children between 1 – 2 years of age Syr. albendazole 200 mg as a single dose. In\\nchildren more than 2 years, Syr. albendazole 400 mg as a single dose.\\nPatient education\\nProper sanitation and good personal hygiene- hand washing with soap after defecation and\\nbefore meals may prevent infection. Avoid unpeeled fruits and vegetables and use of clean\\ndrinking water.\\nENTEROBIASIS\\nInfection is caused by Enterobius vermicularis (Pin worm). Adult pinworm is around 1 cm\\nlong and dwells in the bowel lumen in the small and large intestine around caecum area.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 169, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n154\\n\\uf0b7\\nIn acute presentation episodic attacks of fever with lymphadenitis and lymphangitis.\\nOccasionally adult worms may be felt subcutaneously.\\n\\uf0b7\\nChronic presentation as a case of lymphatic obstruction due to worm or fibrosis causing\\nmassive lower limb oedema, non pitting type, with skin thickening, hydrocele,\\nchyluria, chylous ascitis,  chylothorax.\\nInvestigations\\nDemonstration of the ova of Enterobius vermicularis in perianal swabs or a cellophane tape\\nshould be pressed against perianal skin. In the morning, when the child gets up, eggs stick to\\nthe tape and can be examined under the microscope.\\nPharmacological treatment\\n\\uf0b7\\nTab. mebendazole 100 mg as a single dose in adults and children more than 2 years of\\nage. (Contraindicated in pregnancy and in children below one year of age). Or Tab.\\npyrantel pamoate 11 mg/kg body weight as a single dose. Or Tab. albendazole 400 mg as\\na single dose.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 169, 'source_type': 'Authorotative', 'priority': '1'}, page_content='age. (Contraindicated in pregnancy and in children below one year of age). Or Tab.\\npyrantel pamoate 11 mg/kg body weight as a single dose. Or Tab. albendazole 400 mg as\\na single dose.\\n\\uf0b7\\nChildren (1-2 years) Syr. albendazole 200 mg as a single dose; More than 2 years 400 mg\\nas a single dose.\\n\\uf0b7\\nRepeat treatment after two weeks.\\nAssessment of response of worm infestation to therapy\\n\\uf0b7\\nRepeat stool, perianal swab examination for ova of Enterobius vermicularis.\\n\\uf0b7\\nAbsolute eosinophil count, haemoglobin and peripheral blood smear examination at\\nmonthly intervals for 3-6 months.\\n\\uf0b7\\nSerum albumin level in hookworm infection.\\nPatient education\\n\\uf0b7\\nTreatment of all family members is required to eliminate asymptomatic reservoirs of\\npotential re infection.\\n\\uf0b7\\nProper sanitation and good personal hygiene, hand washing with soap after defecation\\nand before meals may prevent infection.\\n\\uf0b7\\nInfection can be minimized by avoidance of unpeeled fruits and vegetables and use of'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 169, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and before meals may prevent infection.\\n\\uf0b7\\nInfection can be minimized by avoidance of unpeeled fruits and vegetables and use of\\nclean drinking water. Regular washing and disinfection of linen.\\nFILARIASIS\\nFilariasis is caused by wuchereria bancrofti in 90% of cases. Lymphatics are mainly affected,\\nresulting in gross limb swellings.\\nSalient features\\nInvestigations: Total and differential count shows\\neosinophilia. Immature worms\\n(microfilaria) seen in nocturnal peripheral blood smears.\\nNon- pharmacological treatment\\n\\uf0b7\\nManual lymphoedema drainage'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 170, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Infections\\n155\\n\\uf0b7\\nMultilayer lymphoedema bandage\\n\\uf0b7\\nCompression garments, exercise\\n\\uf0b7\\nSkin care to prevent athlete foot with 3% benzoic acid, for dry skin paraffin ointment, for\\nhyperkeratosis 5% salicylic acid,\\nPharmacological treatment\\nTab. diethylcarbamazine 6mg/kg for 21 days .for acute cases and antipyretics for fever\\nSurgical treatment\\n\\uf0b7\\nBypass procedures\\n\\uf0b7\\nOmental pedicle\\n\\uf0b7\\nNodovenous shunt\\n\\uf0b7\\nLimb reduction procedures'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 171, 'source_type': 'Authorotative', 'priority': '1'}, page_content='156\\n\\uf0b7\\nBlocked ear and pain\\n\\uf0b7\\nTinnitus, reflex cough on manipulation, vertigo\\nChapter 10\\nENT DISEASES\\nEAR-WAX\\nExternal ear wax is the accumulated secretion from ceremonious gland situated in outer part\\nof meatus may form a solid, often hard mass giving rise to deafness and discomfort in the ear.\\nSalient features\\nInvestigations\\n\\uf0b7\\nOtoscopy\\n\\uf0b7\\nBrownish-black mass in external auditory canal.\\nPharmacological treatment\\n\\uf0b7\\nFor severe pain Tab. ibuprofen 400 mg SOS, in children 20 g/kg/day divided into 3 doses.\\n\\uf0b7\\nWax\\nsoftener (turpentine oil\\n-\\n15%, benzocaine\\n-\\n2.7%), chlorbutol\\n-\\n5%,\\nparadichlorobenzene - 2%) 3-4 days before cleaning the ear when the wax is hard.\\n\\uf0b7\\nFollowed by surgical removal (to be carried out by an Otolaryngologist).\\n\\uf0b7\\nSyringing with sterile saline solution at body temperature pushed along the posterior wall\\nof the meatus to take out the wax. The meatus should be mopped dry after syringing.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 171, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nSyringing with sterile saline solution at body temperature pushed along the posterior wall\\nof the meatus to take out the wax. The meatus should be mopped dry after syringing.\\n(Caution: if there is previous history of ear discharge or perforated drum or instrumental\\nmanipulation with ring probe, hook or forceps and suction cleaning).\\nPatient education\\n\\uf0b7\\nWax is a normal secretion and provides protection to the ear drum and should be removed\\nonly if it disturbs hearing.\\n\\uf0b7\\nAvoid cleaning the ear with buds as it can push the wax to the deeper canal.\\nReferences\\n1.\\nDiseases of the External Ear. In: Logan Turner's Diseases of the Nose, Throat and Ear, 10th Edition, pp\\n265-67.\\nKERATOSIS OBTURANS\\nCollection of desquamated epithelium mixed with wax in external auditory canal causing\\nballooning of the canal is known as Keratosis obturans.\\nSalient features\\n\\uf0b7\\nDifficulty in hearing and severe pain\\n\\uf0b7\\nSerosanginuous discharge\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 172, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n157\\n\\uf0b7\\nBlocked ear, movement of pinna painful\\n\\uf0b7\\nSevere pain and occasionally discharge\\n\\uf0b7\\nRegional lymphadenitis\\nInvestigations\\nOtoscopy - cerumen admixed with desquamated debris, external canal granulations and bone\\nerosion\\nTreatment\\n\\uf0b7\\nInitially soften the mass with sodium bicarbonate ear drops daily for several days\\nfollowed by syringing.\\n\\uf0b7\\nRemoval under general anaesthesia using microscope.\\nFURUNCLE\\nFuruncle is the infection of the root of a hair follicle caused by staphylococcus aureus in\\ncartilaginous external auditory canal.\\nSalient features\\nInvestigations\\n\\uf0b7\\nHistory of recent cold and influenza, sign of middle ear infection\\n\\uf0b7\\nOtoscopy examination may reveal boils\\n\\uf0b7\\nMaximum tenderness over tragus and post-auricular lymphadenitis\\n\\uf0b7\\nObliteration of post aural sulcus with forward displacement of aurical\\n\\uf0b7\\nMastoid radiograph show well developed clear cell on affected side\\nNon- pharmacological treatment\\n\\uf0b7\\nLocal heat\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 172, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nMastoid radiograph show well developed clear cell on affected side\\nNon- pharmacological treatment\\n\\uf0b7\\nLocal heat\\nPharmacological treatment\\n\\uf0b7\\n10% ichthamol in glycerine wick pack or  antibiotic steroid cream wick pack (polymyxin\\nB sulphate 500 IU, neomycin sulphate 3400 IU, zinc bacitracin 400 IU, hydrocortisone 10\\nmg, per g) wick packing to be done on alternate day till swelling subsides followed by/or\\n\\uf0b7\\nLocal ear drops (polymyxin B sulphate 1000 U, neomycin sulphate 3400 U,\\nhydrocortisone 10 mg/ml).\\n\\uf0b7\\nSystemic antibacterial like Cap. amoxicillin 500mg TDS 5-7 days or azithromycin 500mg\\nOD for 3-5 days  antibiotics\\n\\uf0b7\\nTab. ibuprofen 400 mg as and when required or Tab. nimesulide 100 mg twice a day.\\n\\uf0b7\\nIncision and drainage may be necessary in some cases.\\nPatient education\\n\\uf0b7\\nPatients with recurrent boils, diabetes mellitus should be ruled out\\n\\uf0b7\\nAvoid ear picking.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 173, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n158\\n\\uf0b7\\nIrritation and itching of ear discharge (thick white debris like.)\\n\\uf0b7\\nIf the discharge is white like blotting paper – candida, black mass with mycelia –\\naspergillus Niger and pale blue and green – aspergillus fumigatus.\\nOTOMYCOSIS\\nOtomycosis is the fungal infection of the ear canal. Secondary growth occurs in patients\\nusing topical antibiotics for otitis externa or middle ear suppuration.\\nSalient features\\nInvestigations\\n\\uf0b7\\nDirect otoscopic examination\\n\\uf0b7\\nMicroscopic examination in 10% KOH\\n\\uf0b7\\nCulture in sabourd’s Dextrose agar\\nNon- pharmacological treatment\\n\\uf0b7\\nRegular ear toilet- by suction/dry mopping/instrumentation.\\nPharmacological treatment\\n\\uf0b7\\nTopical clotrimazole as 1% powder or liquid 3 - 4 times a day to be continued for at least\\na week after clinical resolution of the infection.\\n\\uf0b7\\nTab. ibuprofen 400 mg as and when required. In children 20 mg/kg/day in 3 divided\\ndoses.\\nPatient education\\n\\uf0b7\\nEar is to be kept dry; entry of water into the ear should be prevented.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 173, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nTab. ibuprofen 400 mg as and when required. In children 20 mg/kg/day in 3 divided\\ndoses.\\nPatient education\\n\\uf0b7\\nEar is to be kept dry; entry of water into the ear should be prevented.\\nReferences\\n1. Diseases of the External Ear. In: Logan Turner's Diseases of the Nose, Throat and Ear, 10th Edition, pp 274-\\n75.\\n2. External Auditory Meatus. In: Scott- Brown's Otolaryngology, JB Booth (ed) Vol 3, 6th Edition, 1997,\\nButterworth-Heinemann, pp 3/6/14-15.\\nMALIGNANT OTITIS EXTERNA\\nExternal otitis in diabetic patients or those who are using immunosuppressive drugs due to\\nPseudomonas aeruginosa infection\\nSalient features\\nInvestigations\\n\\uf0b7\\nOtoscopy shows external canal inflammation and granulation\\n\\uf0b7\\nCranial nerve paralysis or  facial palsy is common\\n\\uf0b7\\nTo exclude diabetes / CT scan temporal bone to rule out osteomyelitis of temporal bone.\\n\\uf0b7\\nSevere pain and swelling around the ear / facial weakness\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 174, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n159\\n\\uf0b7\\nPain, fever and ear discharge\\n\\uf0b7\\nHearing impairment and tinnitus\\n\\uf0b7\\nSymptoms in children include fever, vomiting, diarrhea, sleeplessness, incessant cry and\\nirritability\\nPharmacological treatment\\n\\uf0b7\\nTopical \\nanti-pseudomonal \\nantibacterials \\n(ciprofloxacin, \\ncarbenicillin, \\namikacin,\\ntobramycin, ticarcillin, third generation cephalosporins)\\n\\uf0b7\\nSurgical debridement of devitalised tissue and bone to be done judiciously.\\nACUTE SUPPURATIVE OTITIS MEDIA\\nIt is an acute inflammation of middle ear caused by pyogenic organism. It is common in\\nchildren, associated with upper respiratory infection and exanthematous fevers.\\nSalient features\\nInvestigations\\n\\uf0b7\\nOtoscopy shows congested and bulging tympanic membrane\\n\\uf0b7\\nMucopurulent discharge\\nNon pharmacological treatment\\n\\uf0b7\\nSteam inhalation and to keep the ear clean in case of pus discharge.\\nPharmacological treatment\\n\\uf0b7\\nTab. paracetamol 500 mg SOS\\n\\uf0b7\\nCap. amoxicillin 250-500 mg 8 hourly for 7 days. In complicated cases and children <2'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 174, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Pharmacological treatment\\n\\uf0b7\\nTab. paracetamol 500 mg SOS\\n\\uf0b7\\nCap. amoxicillin 250-500 mg 8 hourly for 7 days. In complicated cases and children <2\\nyears duration of treatment 10 days or Cap. cephalexin 250-500 mg 8 hourly. In children\\n20-40 mg/kg/day in 3 divided doses. Switch antibiotics if no clinical improvement by 3rd\\nday.\\n\\uf0b7\\nXylometazoline HC1 0.1% 1-2 nasal drops in each nostril 1-2 times daily.\\nIn Children (0.05%) 1-2 nasal drops 1-2 times daily or oxymetazoline 0.05% 1-2 nasal\\ndrops in each nostril 2 times daily. In Children (0.01%) 1-2 drops 2 times daily.\\n\\uf0b7\\nRefer to an Otolaryngologist if there is intense pain, bulging of the ear drum or persisting\\nfever despite treatment for myringotomy.\\nPatient education\\n\\uf0b7\\nTreat upper respiratory and sinus infections at the earliest.\\nReferences\\n1. Acute Suppurative Otitis Media and Acute Mastoiditis. In: Scott Brown's Otolaryngology, Vol 3, JB Booth\\n6th Edition, pp 3/9/1-15.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 174, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"References\\n1. Acute Suppurative Otitis Media and Acute Mastoiditis. In: Scott Brown's Otolaryngology, Vol 3, JB Booth\\n6th Edition, pp 3/9/1-15.\\n2. Acute Otitis Media in Adults. In: Logan Turner's Diseases of the Nose, Throat and Ear 10th Edition, pp 280-\\n81.\\n3. Diseases of the Middle Ear Cleft. In: A Synopsis of Otolaryngology, 4th Edition, 91-109.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 175, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n160\\n\\uf0b7\\nEar discharge - Mucopurulent / intermittent / not foul smelling / profuse / not blood\\nstained. Associated with upper respiratory tract infection\\n\\uf0b7\\nHearing loss (conductive) and Tinnitus\\n\\uf0b7\\nThere are two stages- active and inactive (no discharge, only hearing loss)\\n\\uf0b7\\nProteus, Pseudomonas, Klebsiella, E. Coli., Staphylococcus aureus are the most\\ncommon organisms. While anaerobes organisms include Bacteroides fragilis\\n(most\\ncommon) and anaerobic Streptococci.\\nCHRONIC SUPPURATIVE OTITIS MEDIA\\nChronic Suppurative Otitis Media(CSOM)  a long standing infection of middle ear clef,\\ncharacterized by ear discharge and permanent perforation of tympanic membrane. It is\\nclassified as tubo tympanic disease (safe ear) and attico-antral disease (unsafe ear).\\nSalient features\\nInvestigations\\n\\uf0b7\\nOtoscopy shows discharge mucopurulent / mucoid / dry , perforation – central perforation\\n\\uf0b7\\nConductive deafness (tuning fork test) (confirm degree and type of hearing loss)\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 175, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Investigations\\n\\uf0b7\\nOtoscopy shows discharge mucopurulent / mucoid / dry , perforation – central perforation\\n\\uf0b7\\nConductive deafness (tuning fork test) (confirm degree and type of hearing loss)\\n\\uf0b7\\nMiddle ear mucosa - normal in quiescent stage, edematous and velvety in active stage\\n\\uf0b7\\nExamination under microscope, audiogram\\n\\uf0b7\\nPus culture and sensitivity\\n\\uf0b7\\nX-ray mastoids -both ears sclerotic. May be pneumatised with clouding of air cells to\\nassess co-morbid status\\n\\uf0b7\\nHRCT temporal bone which help in (1) establishing cholesteatoma (2) operative planning\\nNon- pharmacological treatment\\n\\uf0b7\\nAural toilet by dry mopping or careful suction.\\nPharmacological treatment\\n\\uf0b7\\nTopical antibiotics like ciprofloxacin HC1 0.3% w/v ear drops 2-3 drops 3-4 times daily\\n\\uf0b7\\nWhen associated with marked inflammation, add prednisolone 0.5% + chloramphenicol\\n5% + lignocaine 2% + acetic acid 2% to be used as 3-4 drops 3-4 times daily.\\n\\uf0b7\\nFor profuse mucopurulent discharge and associated upper respiratory tract infection'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 175, 'source_type': 'Authorotative', 'priority': '1'}, page_content='5% + lignocaine 2% + acetic acid 2% to be used as 3-4 drops 3-4 times daily.\\n\\uf0b7\\nFor profuse mucopurulent discharge and associated upper respiratory tract infection\\n(URTI), Cap. amoxicillin 750-1500 mg in 3 divided doses. In children 20-40 mg/kg in 3\\ndivided doses. The choice of antibiotic depends on the culture and sensitivity report.\\nSurgical treatment\\n\\uf0b7\\nOnce the ear is dry and any local nidus of infection has been treated the ear can be taken\\nup for myringoplasty after assessing the hearing status.\\nPatient education\\n\\uf0b7\\nAvoid water or dust to enter the ear. Explain the patient to take immediate treatment in\\ncase of URTI. Not to instill oil if there is a discharge from the ear or if the patient is\\nknown to have perforation of ear drum.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 176, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"ENT Diseases\\n161\\n\\uf0b7\\nDeafness, sensation of fluid, tinnitus. Earache and ear drum appear to be normal,\\nlusterless retracted or fluid level or air bubbles may be seen behind the drum.\\n\\uf0b7\\nHeadache, nasal obstruction, hawking and postnasal drip. Fever, malaise, congested\\nnasal mucosa, pus in the middle meatus and tender sinuses.\\nReferences\\n1.\\nDiseases of the External Ear. In: Logan Turner's Diseases of the Nose, Throat and ear 10th Edition, pp 271-\\n73.\\n2.\\nManagement of Chronic Suppurative Otitis Media. In: Scott Brown's Otolaryngology', JB Boothy (ed), Vol\\n3, 6th Edition, 1997, pp 3/10/1-11.\\nSEROUS OTITIS MEDIA\\nIt is characterized by the presence of non-purulent fluid in middle ear cleft which may be due\\nto Eustachian tube dysfunction, unresolved acute otitis media or viral infection. It is one stage\\nfurther then Eustachian tube catarrh where fluid having a consistency of glue collects in the\\nmiddle ear producing conductive deafness.\\nSalient features\\nInvestigations\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 176, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"further then Eustachian tube catarrh where fluid having a consistency of glue collects in the\\nmiddle ear producing conductive deafness.\\nSalient features\\nInvestigations\\n\\uf0b7\\nAudiogram reveal conductive deafness\\n\\uf0b7\\nImpedance audiometry show flat type of curve (B curve)\\nPharmacological treatment\\n\\uf0b7\\nCap. amoxycillin 250 mg with clavulanic acid 375 mg, TDS before meals for 21 days.\\n\\uf0b7\\nTab. pseudoephedrine 120 mg 8 hourly. In children 1-2 mg/kg twice daily.\\nSurgical treatment\\n\\uf0b7\\nFor patients not responding to long term pharmacological measures. This include\\nmyringotomy with or without grommet insertion, adenoidectomy, treatment for sinusitis\\nand even mastoidotomy in refractory cases.\\nPatient education\\n\\uf0b7\\nDo not instill oil in the ear.\\nReferences\\n1.\\nManagement of Chronic Otitis Media. In: Scott Brown's Otolaryngology, JB Booth (ed), Vol. 3, 6th\\nEdition, 1997, Butterworth-Heinemann, pp 3/9/1-15.\\nACUTE SINUSITIS\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 176, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"References\\n1.\\nManagement of Chronic Otitis Media. In: Scott Brown's Otolaryngology, JB Booth (ed), Vol. 3, 6th\\nEdition, 1997, Butterworth-Heinemann, pp 3/9/1-15.\\nACUTE SINUSITIS\\nIt is inflammation of paranasal sinuses. Acute maxillary sinusitis is the commonest type of\\nsinusitis while acute ethmoidal sinusitis is more common in infants and children.\\nSalient features\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 177, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n162\\nInvestigations\\n\\uf0b7\\nX ray paranasal sinuses – Water’s view - haziness or opacity /fluid level.\\n\\uf0b7\\nCT-para nasal sinuses in selected cases where WBC, ESR, Positive blood culture confirm\\n\\uf0b7\\nTrans illumination test reveal opaque sinuses\\nNon- pharmacological treatment\\n\\uf0b7\\nSteam inhalation via nose 2-3 times/day for 2-3 days and rest.\\nPharmacological treatment\\n\\uf0b7\\nTab. paracetamol 500 mg 3-4 times a day for 5 days (children 10 kg/dose) or Tab.\\nibuprofen 400 mg - 600 mg 3 times a day for 5 days (children 10 mg/kg/dose.)\\n\\uf0b7\\nCap. amoxicillin 500 mg 8 hourly for 5-7 days (children 50 mg/kg/day).\\nSinusitis of dental origin\\n\\uf0b7\\nCap. amoxicillin 500 mg 3 times a day for 5-7 days.\\n\\uf0b7\\nTab. metronidazole 400 mg 3 times a day for 5-7 days.\\n\\uf0b7\\nTab. bromhexine 8 mg 3 times a day for 7 days.\\nIf nasal obstruction or rhinorrhoea,\\n\\uf0b7\\nNormal saline nasal 1-2 drops in each nostril 2-3 times a day. Or ephedrine 0.75% nasal'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 177, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTab. bromhexine 8 mg 3 times a day for 7 days.\\nIf nasal obstruction or rhinorrhoea,\\n\\uf0b7\\nNormal saline nasal 1-2 drops in each nostril 2-3 times a day. Or ephedrine 0.75% nasal\\ndrops in isotonic saline 1-2 drops in each nostril 2 times a day. In children 0.5% 1-2 drops\\nin each nostril 2 times daily. Or oxymetazoline HCl 0.05% nasal drops. 1-2 drops in each\\nnostril 2 times a day. In children 0.025% 1-2 drops in each nostril 2 times daily.\\n\\uf0b7\\nXylometazoline 0.1% nasal drops 2-3 drops in each nostril 2-3 times a day. In Children\\n0.05% 1-2 drops in each nostril 2 times daily.\\n(Caution: Medicated nasal drops should not be used for more than 7 days).\\nImprovement is seen in symptoms viz. pain tenderness, nasal obstruction and discharge\\nwithin 48-72 hours after initiation of therapy. If there is no desirable response patient should\\nbe referred to an Otolaryngologist.\\nPatient education\\n\\uf0b7\\nTo take full course of systemic antibiotics to avoid the risk of developing antimicrobial\\nresistance.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 177, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"be referred to an Otolaryngologist.\\nPatient education\\n\\uf0b7\\nTo take full course of systemic antibiotics to avoid the risk of developing antimicrobial\\nresistance.\\n\\uf0b7\\nProlonged use of topical decongestants more than a week to be avoided as it can cause\\natrophic rhinitis, anosmia and rhinitis medicamentosa.\\nReferences\\n1.\\nAcute Rhinosinusitis. In: Logan Turner's Diseases of Nose, Throat and Ear. 10th Edition pp 34-6.\\nEPISTAXIS\\nEpistaxis is defined as bleeding through the nose. The common cause in children may be due\\nto nose picking, in adolescents (especially males) due to juvenile nasopharyngeal\\nangiofibroma and hypertension /neoplasm in elderly.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 178, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n163\\n\\uf0b7Sneezing, itching, watery nasal discharge and a feeling of nasal obstruction.  It may be\\nassociated with allergic conjunctivitis and bronchial asthma.\\n\\uf0b7Sneezing, itching watery rhinorrhoea and conjunctivitis are prominent symptoms  in seasonal\\nallergic rhinitis (SAR/Hay fever) while perennial allergic rhinitis (PAR) due  to long standing\\nnasal mucosal congestion with purulent nasal discharge associated with  nasal blockage, post\\nnasal discharge and hyposmia.\\nInvestigations\\n\\uf0b7\\nBaseline investigations including complete hemogram, coagulation profile, blood\\ngrouping and typing\\n\\uf0b7\\nX ray paranasal sinuses and  CT para nasal sinuses – if necessary\\nTreatment\\n\\uf0b7\\nResuscitative measures if clinical parameters suggestive of hemodynamic compromise\\n\\uf0b7\\nCauterization\\n\\uf0b7\\nAnterior and posterior nasal packing\\n\\uf0b7\\nSurgical – endoscopic cautery and ligation of vessels\\nPatient education\\n\\uf0b7\\nAvoid inserting fingers into the nose, especially children.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 178, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nCauterization\\n\\uf0b7\\nAnterior and posterior nasal packing\\n\\uf0b7\\nSurgical – endoscopic cautery and ligation of vessels\\nPatient education\\n\\uf0b7\\nAvoid inserting fingers into the nose, especially children.\\n\\uf0b7\\nAs first aid, explain how to pinch the nose tightly and apply ice pack over the nose, while\\nwaiting for proper medical attention.\\nReferences\\n1.\\nEpistaxis. In: Scott Brown's Otolaryngology, IS MacKay and TR Bull (eds) Vd4, 6th Edition, 1997,\\nLondon: Buttcrworths. pp 4/18/1-19.\\nALLERGIC RHINITIS\\nAllergic rhinitis is an IgE mediated type I hypersensitivity reaction of mucus membrane of\\nnasal cavity sometimes affecting paranasal sinuses due to mucosal continuity.\\nSalient features\\nInvestigations\\n\\uf0b7\\nPeripheral blood eosinophilia\\n\\uf0b7\\nNasal smear – shows eosinophilia\\n\\uf0b7\\nX ray nose and para nasal sinuses\\n\\uf0b7\\nIntranasal provocation test\\n\\uf0b7\\nSpecific IgE antibody test\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoid allergens.\\nPharmacological treatment\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 178, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nX ray nose and para nasal sinuses\\n\\uf0b7\\nIntranasal provocation test\\n\\uf0b7\\nSpecific IgE antibody test\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoid allergens.\\nPharmacological treatment\\n\\uf0b7\\nTab. cetrizine 10-20 mg in a single daily dose for 7 days In children 5 mg od or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 179, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n164\\n\\uf0b7\\nNasal stuffiness, rhinorrhea, sneezing and low grade fever. Nasal obstruction, profuse\\nmucopurulant secretions\\n\\uf0b7\\nSore throat for 1 or 2 days followed by cough and nasal discharge.\\n\\uf0b7\\nTab. chlorpheniramine maleate 4 mg 6-8 hourly for 7 days. (Caution: Not recommended\\nfor children under 1 year)  Or\\n\\uf0b7\\nTab. pheniramine maleate 25-50 mg 8 hourly for 7 days. In children 0.5mg/kg/day\\ndivided in 3 doses. The duration of treatment may need to be extended depending upon\\nthe response of the patient.\\n\\uf0b7\\nIf nasal obstruction and rhinorrhoea, Normal saline nasal drops 1-2 drops in each nostril 2\\ntimes daily or  xylometazoline 0.1% nasal drops 1-2 drops 2-3 times daily for 5-7 days. In\\nchildren 0.05% 1-2 drops 2 times daily. or oxymetazoline 0.5% nasal drops 2-3 drops 2-3\\ntimes daily for 5-7 days. In children 0.025% 1-2 drops 2 times in each nostril\\n\\uf0b7\\nIf the signs and symptoms are persistent, Betamethasone/ hydrocortisone nasal drops 2-3'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 179, 'source_type': 'Authorotative', 'priority': '1'}, page_content='times daily for 5-7 days. In children 0.025% 1-2 drops 2 times in each nostril\\n\\uf0b7\\nIf the signs and symptoms are persistent, Betamethasone/ hydrocortisone nasal drops 2-3\\ntimes/ day. Beclomethasone inhaler (50 mcg/puff) 2 puffs 12 hourly or budesonide (50-\\n100 mcg/puff) 1-2 puffs a day or fluticasone 150 meg/puff 1-2 puffs a day. Or Topical\\nazelastine intranasal spray 2-3 times a day.\\n\\uf0b7\\nIn case of no response to the above treatment, Tab. prednisolone 5-60 mg/day in 3-4\\ndivided doses for 5-7 days or Tab. dexamethasone 0.5-5.0 mg/day in 3-4 divided doses\\nfor 5-7 days. Or Tab. betamethasone 0.5-5.0 mg/day in 3-4 divided doses for 5-7 days.\\nPatient education\\n\\uf0b7\\nThis disease is due to hypersensitivity and there is no cure but symptoms can be controlled\\neffectively by the judicious use of drugs and the patient can lead a normal life.\\n\\uf0b7\\nAvoid prolong use of topical decongestant nasal drops as it can cause atrophic rhinitis,\\nanosmia and rhinitis medicamentosa.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 179, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nAvoid prolong use of topical decongestant nasal drops as it can cause atrophic rhinitis,\\nanosmia and rhinitis medicamentosa.\\n\\uf0b7\\nChlorpheniramine, pheniramine etc. can cause sedation, cognitive impairment. Patient\\nshould avoid tasks requiring alertness and skill. These drugs can also cause dryness of the\\nmouth and urinary hesitancy.\\n\\uf0b7\\nSystemic steroids should not be stopped abruptly. Dose to be tapered off before cessation\\nof therapy.\\n\\uf0b7\\nMedicated nasal drops should not be used for more than seven days.\\nReferences\\n1.\\nMechanism and Treatment of Allergic Rhinitis. In: Scott Brown's Otolaryngology. JB Booth (ed), 6th\\nEdition, 1997. Butterworth’s-Heinemann, pp 4/6/1-16.\\nCOMMON COLD (CORYZA)\\nIt is one of the most common viral infection affecting upper respiratory tract.\\nSalient features\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 180, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n165\\n\\uf0b7\\nSever pain and tenderness over the tip of nose. There may be headache, malaise and\\npyrexia. Examination reveals congestion and swelling of vestibule.\\nNon- pharmacological treatment\\n\\uf0b7\\nSteam inhalation 2-3 times/day\\n\\uf0b7\\nFor nasal obstruction, saline nasal drops 1-2drops in each nostril 2-3 times daily\\nPharmacological treatment\\n\\uf0b7\\nTab. chlorpheniramine 4mg 8 hourly for 5-7 days. (in children 0.35mg/kg/day in 3 equal\\ndoses)  or  Tab. pheniramine 25mg 2-3 times daily for 5-7days ( in children 0.5mg/kg/day\\ndivided in equal doses)  or  Tab. cetirizine dihydrochloride 10mg once a day 5-7days (in\\nchildren 5mg once per day).\\n\\uf0b7\\nIf patient has malaise and fever,\\n\\uf0b7\\nTab. paracetamol 1500mg 3-4 times a day for 2-3 days and then as when required (in\\nchildren 40-60mg/kg/day divided in 4 doses)\\nIf nasal obstruction is severe,\\n\\uf0b7\\nEphedrine 0.75% nasal drop,1-2drops in each nostril 3 times a day for 2-3 days or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 180, 'source_type': 'Authorotative', 'priority': '1'}, page_content='children 40-60mg/kg/day divided in 4 doses)\\nIf nasal obstruction is severe,\\n\\uf0b7\\nEphedrine 0.75% nasal drop,1-2drops in each nostril 3 times a day for 2-3 days or\\noxymetazoline HCL 0.05% nasal drops,1-2drops in each nostril 3 times a day for 2-3\\ndays( in children 0.025% nasal drops,1 drop 2 times daily or  xylometazoline 0.1%, 1-\\n2drops in each nostril 3 times a day for 2-3 days( in children 0.05%, 1-2 drops 2 times\\ndaily)  (Caution: Not recommended in children below 6yrs of age, medicated nasal drops\\nshould not used for more than 7 days)\\nPatient education\\n\\uf0b7\\nThis is a self-limiting viral infection and usually subsides in one week requiring only\\nsymptomatic relief.\\n\\uf0b7\\nAntibiotics have no role.\\n\\uf0b7\\nChlorpheniramine and pheniramine can cause sedation and cognitive impairment,\\ntherefore should be avoided for tasks requiring alertness and skill.\\n\\uf0b7\\nMedicated nasal drops used for longer periods can cause rebound congestion and rhinitis\\nmedicamentosa.\\nReferences\\n1.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 180, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"therefore should be avoided for tasks requiring alertness and skill.\\n\\uf0b7\\nMedicated nasal drops used for longer periods can cause rebound congestion and rhinitis\\nmedicamentosa.\\nReferences\\n1.\\nAcute Rhinosinusitis. In: Logan Turner's Disease of the Nose, Throat and Ear. 10th Edition, PP 34\\nFURUNCULOSIS OF NOSE (VESTIBULITS)\\nFurunculosis is acute infection of hair follicle with Staphylococcus aureus.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nLocal application of moist heat will enhance the localization of infection and promote\\ndrainage.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 181, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n166\\n\\uf0b7\\nThroat pain, difficulty in swallowing.\\n\\uf0b7\\nPyrexia, cervical lymphadenopathy.\\n\\uf0b7\\nInflamed tonsils with exudates\\nPharmacological treatment\\n\\uf0b7\\nCap. amoxicillin 500mg 8hrly for 5-7 days (in children 25-50mg /kg/day in 3 divided\\ndose)  or Cap. amoxicillin 250/500mg plus clavulanic acid 125mg 8 hr for 5-7days\\n\\uf0b7\\nTab ibuprofen 400-600mg 3 times in a day for 5 days (In children 10mg/kg/dose or Tab\\nparacetamol 500 mg 6hrly for 2-3days then as and when required till pain and fever\\nsubsides (in children 10mg/kg/dose 6-8hrly).\\n\\uf0b7\\nUsually improvement in pain, tenderness and inflammation occur within 24-48hr after\\nimitation of treatment, patient should be monitored regularly. However, if there is flaring\\nof infection in the form of spreading facial cellulitis then patient should be hospitalized\\nand shifted to systemic IV antibiotics. If patient is having recurrent furunculosis, then the\\npatient must be investigated for diabetes mellitus.\\nPatient education\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 181, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and shifted to systemic IV antibiotics. If patient is having recurrent furunculosis, then the\\npatient must be investigated for diabetes mellitus.\\nPatient education\\n\\uf0b7\\nDo not fidget with the furuncle as this lies in the dangerous area of the face and cause\\nserious complications.\\n\\uf0b7\\nComplete antibiotic therapy to avoid risk of developing antimicrobial resistance\\nReferences\\n1.\\nDisease of external nose and nasal vestibule. In diseases of ear nose and throat, PL Dhingra’s 2nd edition.\\nACUTE TONSILLITIS\\nThe common cause is viral infection due to adenovirus and Epstein-Barr virus. Secondary\\nbacterial infection due to Group A β haemolytic Streptococci, Haemophilus influenza,\\nStaphylococcus also occurs.\\nSalient features\\nPharmacological treatment\\n•\\nTab. paracetamol 500 mg 3-4 times a day for 5 days (children 10 kg/dose) or Tab.\\nibuprofen 400 mg - 600 mg 3 times a day for 5 days (children 10 mg/kg/dose.)\\n•\\nCap. amoxicillin 500mg TDS for 5 days. Or Tab. erythromycin 500mg QID for 5-7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 181, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ibuprofen 400 mg - 600 mg 3 times a day for 5 days (children 10 mg/kg/dose.)\\n•\\nCap. amoxicillin 500mg TDS for 5 days. Or Tab. erythromycin 500mg QID for 5-7\\nCHRONIC TONSILLITIS\\nChronic inflammation of tonsil starts as an acute inflammation. Minute abscesses get walled\\nby chronic inflammation. It can be chronic parenchymatous or hypertrophic type tonsillitis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 182, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n167\\n\\uf0b7\\nTonsils are uniformly enlarged and congested. Chronic follicular tonsillitis shows beads of\\nwhite discharge on surface of tonsil. Tonsils are small and inflamed, occur in adults,\\nanterior pillars are congested in chronic fibrotic tonsillitis\\nSymptoms\\n\\uf0b7Repeated attacks of sore throat with little remission between attacks\\n\\uf0b7Odynophagia, fever, cough and irritation in throat. Halitosis –foul breath. Thick speech,\\ndifficulty in breathing, swallowing and snoring\\nSigns\\n\\uf0b7\\nHypertrophied tonsils, congestion of anterior pillar, enlarged non-tender jugulodigastric\\nnodes\\n\\uf0b7\\nExtrusion of purulent discharge on pressure over the tonsil with a tongue depressor – Irwin\\nMoore’s sign\\n\\uf0b7\\nBilateral parotid swelling, pain over gland, ear pain\\n\\uf0b7\\nLow-grade fever, arthralgia, malaise, headache\\n\\uf0b7\\nPain, swelling, tenderness, indurations of gland. Erythema of skin and oral mucosa, fever.\\nSalient features\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 182, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nLow-grade fever, arthralgia, malaise, headache\\n\\uf0b7\\nPain, swelling, tenderness, indurations of gland. Erythema of skin and oral mucosa, fever.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nCap. amoxicillin 500mg TDS/ tab. azithromycin 500mg OD for 5-7 days\\n\\uf0b7\\nTab. paracetamol 500mg TDS for 5 days\\n\\uf0b7\\nBed rest\\n\\uf0b7\\nSurgery – tonsillectomy for  recurrent episodes of tonsillitis\\nACUTE PAROTITIS\\nKnown as mumps, caused by paramyxovirus. It usually affects children less than 15 years.\\nthe incubation period –2-3 weeks.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nSupportive measures- bed rest, adequate hydration, antipyretics\\n\\uf0b7\\nPrevention – Measles Mumps Rubella (MMR) vaccine\\nBACTERIAL PAROTITIS\\nMechanical blockage of salivary duct or due to stasis of salivary secretions coupled with\\nsecondary infection results in bacterial parotitis. It is prevalent in debilitated patients.\\nRetrograde migration of intra-oral bacteria contributes to development of acute bacterial'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 182, 'source_type': 'Authorotative', 'priority': '1'}, page_content='secondary infection results in bacterial parotitis. It is prevalent in debilitated patients.\\nRetrograde migration of intra-oral bacteria contributes to development of acute bacterial\\nparotitis. Sialolithiasis is the cause of acute parotitis in non-debilitated patients.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 183, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ENT Diseases\\n168\\nInvestigations\\n\\uf0b7\\nLeucocytosis\\n\\uf0b7\\nMilking of gland for purulent discharge through the duct for culture and sensitivity\\n\\uf0b7\\nPalpation and X- ray for stone\\nNon- pharmacological treatment\\n\\uf0b7\\nAdequate hydration, good oral hygiene\\n\\uf0b7\\nWarm compression and repeated massage of the gland. Stone in the distal duct –\\nexpressed manually or removed after enlarging the duct orifice with a small incision.\\nFailure indicates an abscess, which is confirmed by CT scan or USG.\\nPharmacological treatment\\n\\uf0b7\\nCap. amoxicillin 500mg thrice a day / Tab. amoxicillin with clavulanic acid 625 mg (in\\nadult) TDS for 7 days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 184, 'source_type': 'Authorotative', 'priority': '1'}, page_content='169\\n\\uf0b7\\nA gradually enlarging painless nodule. Very rarely a large upper lid chalazion may press\\non the cornea, induce astigmatism and cause blurred vision. A ‘marginal’ chalazion is\\nsimilar except that it involves a gland of Zeis and is therefore located not in the tarsal\\nplate but on the anterior lid margin.\\n\\uf0b7\\nPatients with meibomian gland disease or rosacea are at increased risk of chalazion\\nformation which may be multiple and/or recurrent.\\n\\uf0b7\\nAcute pain and tenderness over inflamed Zeis gland, seen as a localised painful and\\nhard swelling seen near the lid margin. The lid margin is red and oedematous.\\n\\uf0b7\\nAn abscess may form which points near the base of the lash. The pain subsides after\\nevacuation of the pus.\\nChapter 11\\nEYE DISEASES\\nSTYE (EXTERNAL HORDEOLUM)\\nStye is an acute suppurative inflammation of glands of Zeis due to staphylococci infection\\nand is common in young adults and debilitated persons.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 184, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Stye is an acute suppurative inflammation of glands of Zeis due to staphylococci infection\\nand is common in young adults and debilitated persons.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nDry hot fomentation applied frequently in early stage is useful.\\nPharmacological treatment\\n\\uf0b7\\nEvacuation of the pus by pulling the involved lash or incising the abscess.\\n\\uf0b7\\nAntibiotic eye drops and ointment- to control and prevent spread of infection\\n(fluoroquinolones e.g. moxifloxacin 0.5% eye drops 4 to 6 hourly until infection subsides)\\n\\uf0b7\\nSystemic antibiotics (e.g. Tab. amoxicillin with clavulanic acid 625 mg TDS for 5 days)\\n\\uf0b7\\nFor  pain and inflammation e.g. Tab. ibuprofen 400 mg TDS till inflammation subsides.\\nPatient education\\n\\uf0b7\\nMaintain ocular hygiene to prevent recurrence.\\nCHALAZION\\nA chalazion (meibomian cyst) is a chronic, sterile, granulomatous inflammatory lesion\\ncaused by retained sebaceous secretion leaking from the meibomian or other sebaceous'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 184, 'source_type': 'Authorotative', 'priority': '1'}, page_content='CHALAZION\\nA chalazion (meibomian cyst) is a chronic, sterile, granulomatous inflammatory lesion\\ncaused by retained sebaceous secretion leaking from the meibomian or other sebaceous\\nglands into adjacent stroma. A chalazion secondarily infected is referred as an internal\\nhordeolum.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 185, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n170\\n\\uf0b7\\nCommon symptoms include itching, foreign body sensation, watering of eyes. It can also\\npresent as pharyngoconjunctival fever and acute haemorrhagic conjunctivitis.\\n\\uf0b7\\nFrequently a history of recent upper respiratory tract infection or contact with a patient. It\\noften starts in one eye and involves the fellow eye a few days later.\\n\\uf0b7\\nOn examination, inferior palpebral conjunctival follicles and pinpoint subconjunctival\\nhaemorrhages are observed. The common organism responsible is Adenovirus.\\n\\uf0b7\\nConjunctival cultures/swabs are not needed unless the discharge is excessive or the\\ncondition becomes chronic\\nNon- pharmacological treatment\\n\\uf0b7\\nTreatment may not be required because at least a third of chalazia resolve spontaneously\\nand an internal hordeolum may discharge and disappear. Persistent lesions may be treated\\nas follows:\\n\\uf0b7\\nDry hot fomentation applied frequently in early stage is useful.\\nPharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 185, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and an internal hordeolum may discharge and disappear. Persistent lesions may be treated\\nas follows:\\n\\uf0b7\\nDry hot fomentation applied frequently in early stage is useful.\\nPharmacological treatment\\n\\uf0b7Steroid injection into the lesion is preferable if close to the lacrimal punctum because of the\\nrisk of surgical damage.\\n- Between 0.2 and 2 ml of 5 mg/mL triamcinolone diacetate aqueous suspension diluted with\\nlidocaine (or equivalent) to a concentration of 5 mg/mL is injected through the\\nconjunctiva into the tissue around the lesion with a 30-gauge needle.\\n-\\nThe success rate following one injection is about 80%. In unresponsive cases a second\\ninjection can be given 2 weeks later.\\n\\uf0b7\\nCap. doxycycline (100 mg BD for 7 days) may be required as prophylaxis in patients with\\nrecurrent chalazia, particularly if associated with acne rosacea.\\n\\uf0b7\\nIncision and curettage, in case of large chalazia, if present for more than 3 – 4 months or\\nif cosmetically unacceptable.\\nPatient education\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 185, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIncision and curettage, in case of large chalazia, if present for more than 3 – 4 months or\\nif cosmetically unacceptable.\\nPatient education\\n\\uf0b7\\nRecurrence may occur; common causes are uncorrected refractive error, blepharitis and\\ndiabetes.\\nVIRAL CONJUNCTIVITIS\\nSalient features\\nNon- pharmacological treatment\\nSelf-limiting condition that typically gets worse for the first 4 to 7 days after onset and may\\nnot resolve for 2 to 3 weeks or longer if there is corneal involvement. It is highly contagious,\\nusually for 10 to 12 days from onset as long as the eyes are red (when not on steroids).\\n\\uf0b7\\nUse dark goggles and avoid close contact with other persons for two weeks.\\n\\uf0b7\\nRestrict work and school for patients with significant exposure to others.\\n\\uf0b7\\nFrequent handwashing and cool compresses several times per day.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 186, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n171\\n\\uf0b7\\nThe patient present with marked itching and watery discharge. History of allergy is\\nusually present.\\n\\uf0b7\\nOn examination, conjunctival papillae and edema over eyelids is seen.\\nPharmacological treatment\\n\\uf0b7\\nPreservative-free artificial tears (carboxy methyl cellulose 0.5% eye drops) four to eight\\ntimes per day for 1 to 3 weeks. Use single-use vials to limit tip contamination and spread\\nof disease.\\n\\uf0b7\\nAntihistamine (e.g., epinastine 0.05% BD) if itching is severe. Anti-inflammatory drops\\nlike ketorolac 0.5% may also be used if needed.\\n\\uf0b7\\nIf a membrane / pseudomembrane are present, use a steroid in form of drops with or\\nwithout ointment (e.g. loteprednol 0.5% QID, flurometholone 0.1% ointment QID or\\ndexamethasone 0.3% ointment QID). Steroid treatment is maintained depending upon the\\nresponse and then slowly tapered.\\n\\uf0b7\\nRoutine / unsupervised use of topical antibiotics or steroids should be discouraged.\\nPatient education\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 186, 'source_type': 'Authorotative', 'priority': '1'}, page_content='response and then slowly tapered.\\n\\uf0b7\\nRoutine / unsupervised use of topical antibiotics or steroids should be discouraged.\\nPatient education\\n\\uf0b7\\nPatients should avoid touching their eyes, shaking hands, sharing handkerchiefs, towels\\nwith family members.\\n\\uf0b7\\nPatient’s drops or ointment must not be used by other members of the family.\\nALLERGIC CONJUNCTIVITIS\\nIt occurs as a result of hypersensitivity reaction due exposure to allergic substances.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nCool compresses several times per day and avoid offending agents.\\nPharmacological treatment\\n\\uf0b7\\nTopical anti-inflammatory and anti-histaminic drops, depending on the severity\\n(olopatadine 0.1% OD/BD, nedocromil 2% TDS, or ketotifen 0.025% BD, ketorolac\\n0.5% QID).\\n\\uf0b7\\nIn severe cases, mild topical steroid (e.g., loteprednol 0.2% or fluorometholone 0.1%,\\nQID for 1 to 2 weeks) may have to be added. Steroids are gradually tapered as patient\\nresponds to medications.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 186, 'source_type': 'Authorotative', 'priority': '1'}, page_content='In severe cases, mild topical steroid (e.g., loteprednol 0.2% or fluorometholone 0.1%,\\nQID for 1 to 2 weeks) may have to be added. Steroids are gradually tapered as patient\\nresponds to medications.\\n\\uf0b7\\nPreservative free artificial tears four to eight times per day.\\n\\uf0b7\\nInvestigate for offending agents and avoidance of the same.\\n\\uf0b7\\nOral \\nantihistamine \\n(e.g.,\\ndiphenhydramine\\n25 \\nmg \\nTDS/QID. \\nor\\ncetrizine/\\nlevocetrizine/montelukast/loratadine 10 mg OD) can be helpful in severe cases and in\\ncases with associated systemic allergy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 187, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n172\\nVERNAL / ATOPIC CONJUNCTIVITIS\\nVernal keratoconjunctivitis (VKC) is a recurrent bilateral disorder in which both IgE- and\\ncell-mediated immune mechanisms play important roles. It primarily affects boys and onset is\\ngenerally from about the age of 5 years onwards (mean age 7 years).\\nSalient features\\nTreatment\\n\\uf0b7\\nTreat as for allergic conjunctivitis.\\n\\uf0b7\\nMast cell stabilizer (e.g. sodium chromoglycate QID) or a dual action mast cell stabilizer\\nand antihistamine (e.g., olopatadine 0.1% OD/BD) or ketotifen 0.025%, or azelastine\\n0.05% for 2 to 3 weeks, prophylactically, before the season starts).\\n\\uf0b7\\nIf a shield ulcer is present, add topical steroid (e.g., loteprednol 0.5% or flurometholone\\n0.1%, prednisolone 1%, etc) four to six times per day. Taper steroids over 4 week as\\ncondition of patient improves. Shield ulcers may need to be scraped to remove superficial\\nplaque-like material before re-epithelialization will occur.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 187, 'source_type': 'Authorotative', 'priority': '1'}, page_content='condition of patient improves. Shield ulcers may need to be scraped to remove superficial\\nplaque-like material before re-epithelialization will occur.\\n\\uf0b7\\nTopical antibiotic (e.g., moxifloxacin 0.3% eye drop, tobramycin 1% QID) is given if\\nassociated infection is there or steroids are prescribed\\n\\uf0b7\\nCycloplegic agent (e.g., cyclopentolate 1% BD drops or atropine 1% TDS in form of\\ndrops or ointment) if cornea is involved, when there is much pain due to ciliary spasm.\\n\\uf0b7\\nConsider cyclosporine 0.05% BD if not responding to the preceding treatment. Maximal\\neffect may not be seen for several weeks.\\n\\uf0b7\\nFollow-up should be done every 1 to 3 days in the presence of a shield ulcer; otherwise,\\nevery few weeks. Steroids are tapered slowly as improvement is noted.\\n\\uf0b7\\nAnti-allergy drops are maintained for the duration of the season and are often reinitiate a\\nfew weeks before the next spring.\\n\\uf0b7\\nPatients on topical steroids should be monitored regularly, including IOP monitoring,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 187, 'source_type': 'Authorotative', 'priority': '1'}, page_content='few weeks before the next spring.\\n\\uf0b7\\nPatients on topical steroids should be monitored regularly, including IOP monitoring,\\neven if used only on the skin.\\n\\uf0b7\\nPatients and relatives of children should be strictly instructed not to use or continue\\nsteroids, in any form, without medical advice\\nPatient education\\n\\uf0b7\\nAvoid exposure to substances causing atopy. Maintain hygiene to prevent secondary\\ninfection.\\n\\uf0b7\\nCommon symptoms include marked itching, thick ropy discharge and seasonal\\noccurrence (during spring/summer)\\n\\uf0b7\\nHistory of atopy may be present. Usually seen in young patients, especially boys.\\n\\uf0b7\\nLarge conjunctival papillae seen under the upper eyelid or along the limbus (limbal\\nvernal). Often they are so large as to give a cobble stone appearance.\\n\\uf0b7\\nSuperior corneal “shield” ulcer (a well-delineated, sterile, gray–white infiltrate) maybe\\nseen in some cases.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 188, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n173\\n\\uf0b7\\nThe patient complains of redness, foreign body sensation, mucoid or mucopurulent\\ndischarge. Itching is much less prominent.\\n\\uf0b7\\nOn examination, purulent discharge, conjunctival papillae and chemosis are seen.\\n\\uf0b7\\nIf severe or recurrent, conjunctival swab for routine cultures and sensitivities and\\nimmediate Gram stain to evaluate for gonococcus.\\n\\uf0b7\\nClinical symptoms start within 12 to 24 hours and include severe purulent discharge,\\nswelling of eyelids\\n\\uf0b7\\nOn examination, conjunctival papillae, marked chemosis and preauricular adenopathy is\\nobserved. Examination of entire cornea for peripheral ulcers (especially superiorly) should\\nbe done because of the risk for rapid perforation.\\n\\uf0b7\\nConjunctival scrapings for immediate Gram stain and for culture and sensitivities (e.g.,\\nblood agar and chocolate agar) should be taken.\\nBACTERIAL CONJUNCTIVITIS (NON-GONOCOCCAL)\\nAcute bacterial conjunctivitis is a common and usually self-limiting condition caused by'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 188, 'source_type': 'Authorotative', 'priority': '1'}, page_content='blood agar and chocolate agar) should be taken.\\nBACTERIAL CONJUNCTIVITIS (NON-GONOCOCCAL)\\nAcute bacterial conjunctivitis is a common and usually self-limiting condition caused by\\ndirect eye contact with infected secretions. The most common isolates are S. pneumoniae,\\nS.aureus, H. influenzae and Moraxella catarrhalis.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nPatients should avoid touching their eyes, shaking hands, sharing handkerchiefs, towels,\\netc.\\n\\uf0b7\\nRestrict work and school for patients with significant exposure to others.\\n\\uf0b7\\nFrequent hand washing.\\nPharmacological treatment\\n\\uf0b7\\nUse topical antibiotic therapy [moxifloxacin 0.5% drops QID or more frequent in severe\\ncases] for 5 to 7 days.\\n\\uf0b7\\nH. influenzae conjunctivitis should be treated with oral amoxicillin/clavulanic acid (20 to\\n40 mg/kg/day in three divided doses) because of occasional extra ocular involvement\\n(e.g., otitis media, pneumonia, and meningitis). Antibiotic therapy is adjusted according'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 188, 'source_type': 'Authorotative', 'priority': '1'}, page_content='40 mg/kg/day in three divided doses) because of occasional extra ocular involvement\\n(e.g., otitis media, pneumonia, and meningitis). Antibiotic therapy is adjusted according\\nto culture and sensitivity results.\\n\\uf0b7\\nIf associated with dacryocystitis, systemic antibiotics are necessary.\\nPatient education\\n\\uf0b7\\nFollow up every 2 to 3 days initially, then every 5 to 7 days until resolved.\\n\\uf0b7\\nMaintain ocular hygiene\\nGONOCOCCAL CONJUNCTIVITIS\\nSalient features\\nPharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 189, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n174\\n\\uf0b7\\nComplaints of mild itching and irritation of the eyes and eyelids, purulent or mucoid\\ndischarge from the eyes, photophobia, blurred vision and eye pain are common.\\n\\uf0b7\\nDiseases progresses slowly, and the more painful symptoms may not emerge until\\nadulthood.\\n\\uf0b7\\nPresence of at least two of the following signs: superior tarsal follicles, limbal follicles\\n(Herbert’s pit), typical conjunctival scarring and vascular pannus.\\n\\uf0b7\\nTransmission of the disease occurs vial ocular and nasal secretions (direct spread, indirect\\nvia fomites, coughing/sneezing).\\nInitiated if the Gram stain shows gram negative intracellular diplococci or there is a high\\nsuspicion clinically of gonococcal conjunctivitis.\\n\\uf0b7\\nInj. ceftriaxone 1 g intramuscularly in a single dose.\\n\\uf0b7\\nIf corneal involvement exists, or cannot be excluded because of chemosis and eyelid\\nswelling, hospitalize the patient and treat with Inj. ceftriaxone 1 g intravenously every 12\\nto 24 hours.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 189, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIf corneal involvement exists, or cannot be excluded because of chemosis and eyelid\\nswelling, hospitalize the patient and treat with Inj. ceftriaxone 1 g intravenously every 12\\nto 24 hours.\\n\\uf0b7\\nIn penicillin-allergic patients, consider an oral fluoroquinolone (e.g., Tab. ciprofloxacin\\n500 mg, for 5 days) or a single oral dose of Tab. azithromycin 1 g.\\n\\uf0b7\\nTopical ciprofloxacin ointment QID or fluoroquinolone drops every two hours (e.g.,\\ngatifloxacin, moxifloxacin, or ciprofloxacin).\\n\\uf0b7\\nSaline irrigation QID until the discharge resolves.\\n\\uf0b7\\nTreat for possible chlamydial co-infection (e.g., Tab. azithromycin 1 g single dose or Tab.\\ndoxycycline 100 mg BD for 7 days).\\n\\uf0b7\\nTreat sexual partners with oral antibiotics for both gonorrhea and chlamydia as described\\npreviously.\\nPatient education\\n\\uf0b7\\nThe patient should be followed daily until consistent improvement is noted, and then\\nevery 2 to 3 days until the condition resolves.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 189, 'source_type': 'Authorotative', 'priority': '1'}, page_content='previously.\\nPatient education\\n\\uf0b7\\nThe patient should be followed daily until consistent improvement is noted, and then\\nevery 2 to 3 days until the condition resolves.\\n\\uf0b7\\nThe patient and sexual partners should be evaluated by their medical doctors for other\\nsexually transmitted diseases.\\nTRACHOMA\\nTrachoma is an infectious disease caused by the Chlamydia trachomatis type A, type B, type\\nC bacterium which produces a characteristic roughening of the inner surface of the eyelids. It\\nis also called granular conjunctivitis and Egyptian ophthalmia and is the leading cause of\\ninfectious blindness in the world.\\nSalient features\\nGrading of severity'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 190, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n175\\nMacCallan Classification\\n\\uf0b7\\nStage 1: Superior tarsal follicles, mild superior SPK, and pannus, often proceeded by\\npurulent discharge and tender preauricular nodes.\\n\\uf0b7\\nStage 2: Florid superior tarsal follicular reaction (2a) or papillary hypertrophy (2b)\\nassociated with superior corneal SEIs, pannus, and limbal follicles.\\n\\uf0b7\\nStage 3: Follicles and scarring of superior tarsal conjunctiva.\\n\\uf0b7\\nStage 4: No follicles, extensive conjunctival scarring.\\n\\uf0b7\\nLate complications: Severe dry eyes, trichiasis, entropion, keratitis, corneal scarring,\\nsuperficial fibrovascular pannus, Herbert pits (scarred limbal follicles), corneal bacterial\\nsuperinfection, and ulceration.\\nWorld Health Organization (WHO) Classification\\n\\uf0b7\\nTF (Trachomatous inflammation: follicular): More than five follicles on the upper tarsus.\\n\\uf0b7\\nTI (Trachomatous inflammation: intense): Inflammation with thickening obscuring more\\nthan 50% of the tarsal vessels.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 190, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTI (Trachomatous inflammation: intense): Inflammation with thickening obscuring more\\nthan 50% of the tarsal vessels.\\n\\uf0b7\\nTS (Trachomatous scarring): Cicatrization of tarsal conjunctiva with fibrous white bands.\\n\\uf0b7\\nTT (Trachomatous trichiasis): Trichiasis of at least one eyelash.\\n\\uf0b7\\nCO (Corneal opacity): Corneal opacity involving at least part of the pupillary margin.\\nTreatment\\nThe SAFE strategy for trachoma management supported by the WHO and other agencies\\nencompasses\\nS\\nSurgery for trichiasis,\\nA Antibiotics for active disease,\\nF\\nFacial hygiene and\\nE\\nEnvironmental improvement\\n\\uf0b7\\nAntibiotics should be administered to those affected and to all family members. Single\\nantibiotic course is not always effective in eliminating infection in an individual, and\\ncommunities may need to receive annual treatment to suppress infection.\\n-\\nA single dose of azithromycin (20 mg/kg up to 1g) is the treatment of choice.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 190, 'source_type': 'Authorotative', 'priority': '1'}, page_content='communities may need to receive annual treatment to suppress infection.\\n-\\nA single dose of azithromycin (20 mg/kg up to 1g) is the treatment of choice.\\n-\\nTopical 1% tetracycline ointment is less effective than oral treatment; it should be given\\nfor 6 weeks.\\n\\uf0b7Facial cleanliness is a critical preventative measure.\\n\\uf0b7Environmental improvement such as access to adequate water and sanitation, as well as\\ncontrol of flies, is important.\\n\\uf0b7Surgery is aimed at relieving entropion and trichiasis and maintaining complete lid closure\\nwith bilamellar tarsal rotation.\\nCORNEAL ULCER'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 191, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n176\\n\\uf0b7\\nSource of infection can be exogenous or endogenous (from other ocular structures)\\n\\uf0b7\\nPatient presents with history of trauma to the eye with pain and redness. Concomitant\\nphotophobia, discharge and dimness of vision can also be present.\\n\\uf0b7\\nOn examination, conjunctival and circumcorneal vessels may be engorged and inflamed\\nwith localized epithelium disintegrated and cast off.  Ulcer is saucer shaped, walls project\\nabove the normal corneal surface. Surrounding area shows grey discoloration (cloudiness)\\nsuggestive of the progressive stage of the ulcer-microscopic tissue examination reveals\\nleucocytic infiltration.In severe cases there is pronounced anterior chamber reaction, often\\nwith hypopyon.\\nDefect in the integrity of corneal epithelium along with infiltration of underlying stroma is\\ndefined as corneal ulcer. It can be due to direct corneal trauma, chronic eyelid disease, tear\\nfilm abnormalities, hypoxic trauma from contact lens wear, and deficient nutrition as in'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 191, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"defined as corneal ulcer. It can be due to direct corneal trauma, chronic eyelid disease, tear\\nfilm abnormalities, hypoxic trauma from contact lens wear, and deficient nutrition as in\\nkeratomalacia or neuroparalytic keratitis (Bell's palsy).It is classified as;\\n1. Infective keratitis may be bacterial, fungal or viral.\\n2. Non infective like traumatic (chemical/thermal/radiation), neoplastic or immune mediated\\nBACTERIAL KERATITIS\\nSalient features\\nInvestigations\\n\\uf0b7\\nConjunctival swab and ulcer scrapings can be tested with Gram stain, KOH preparation\\nand culture to determine the etiology.\\n\\uf0b7\\nRoutine investigations like complete blood count, blood sugar, urine examination should\\nbe done. Septic foci should be found.\\nNon- pharmacological treatment\\n\\uf0b7\\nMaintain proper ocular hygiene by cleaning discharge twice a day.\\n\\uf0b7\\nRemoval of contributory factors like trichiasis, foreign body etc.\\n\\uf0b7\\nThe eye can be covered with a pad, unless the discharge is copious. In such case, shield\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 191, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nRemoval of contributory factors like trichiasis, foreign body etc.\\n\\uf0b7\\nThe eye can be covered with a pad, unless the discharge is copious. In such case, shield\\nthe eye with dark goggles.\\n\\uf0b7\\nPrevention and treatment of complications – secondary glaucoma\\nPharmacological treatment\\n\\uf0b7\\nControl of infection with antibiotics-Start with empirical broad spectrum antibiotics,\\nwhich can be changed according to sensitivity report (Table 1).\\nTable 1. Indication and doses of antibacterials in treatment of bacterial corneal ulcer\\nName\\nSpecial\\nIndication\\nDose\\nSystemic\\nSubconjunctival\\nTopical\\nGentamicin\\nGm -ve org. and\\nStaph. species\\n3-5 mg/kg/day I/V or\\nI/M in divided doses\\n20 mg\\n0.3% drops and\\nointment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 192, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n177\\n8 hourly\\nTobramycin Same as\\ngentamicin\\nSame as gentamycin\\n5-20 mg\\n0.3% drops\\nCefazolin\\nGm +ve cocci\\nand Gm -ve rods\\n25-50 mg/kg/day IV\\nor IM divided doses\\n8hrly\\n100 mg\\n5% concentration\\nused as topical drops\\nCeftazidime\\nGm -ve specially\\nPseudomonas\\n1-2 gm IV 8-12\\nhourly\\n100 mg\\nCiprofloxacinBroad spectrum\\nincluding most\\naerobic Gm-ve\\norg., S. aureus\\nand S.\\nepidermidis\\n500 mg orally 12\\nhourly, 200 mg IV\\n12 hourly\\n0.3% drops and\\nointment\\nOfloxacin\\nBroad spectrum\\n200-800 mg/day\\norally 200 mg I/V 12\\nhourly\\n0.3% drops\\nNorfloxacin\\nGm +ve and Gm\\n-ve org. including\\nPseudomonas.\\nNot effective\\nagainst anaerobes\\n400 mg orally 12\\nhourly\\n0.3% drops\\nLomefloxacin Good coverage of\\nGm -ve. Less\\npotent against\\nGm +ve\\n400 mg orally or IV\\n12 hourly\\nInitially 5 drops in\\n20 min or 1 drop\\nevery hour for 6/10\\nhours. Then 1 drop\\n2-3 times a day.\\nSparfloxacin Broad spectrum.\\nGm +ve and Gm\\n-ve org. including\\nanaerobes\\n400 mg orally on\\nday 1, followed by\\n200 mg once a day\\n0.3% drops\\nAmpicillin'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 192, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hours. Then 1 drop\\n2-3 times a day.\\nSparfloxacin Broad spectrum.\\nGm +ve and Gm\\n-ve org. including\\nanaerobes\\n400 mg orally on\\nday 1, followed by\\n200 mg once a day\\n0.3% drops\\nAmpicillin\\nGm +ve org.\\n(except\\npenicillinase\\nproducing Staph.)\\nand some Gm -ve\\norg.\\n500 mg orally 6\\nhourly, 3-6 g/day IV\\nor IM divided doses\\n6 hourly\\n50-100 mg\\nCloxacillin\\nPenicillinase\\n250-500 mg orally, 6'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 193, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n178\\n\\uf0b7\\nCommon organisms are aspergillus, penicillium, fusarium and candida. Risk factors are\\nleukemia and diabetes, pre existing corneal disease like dry eye, vegetative injury and long\\nterm treatment with antibiotic and steroids.\\n\\uf0b7\\nOn examination, definite white ring in the mid periphery of the cornea with healthy cornea\\nbetween the ring and ulcer margin is seen (Immune ring- diagnostic of fungal infection)\\n\\uf0b7\\nPresence of hypopyon is the rule. Higher the hypopyon more ominous the sign and chances\\nof perforation.\\nproducing Staph. hourly\\nCephalexin\\nGm +ve cocci\\nand Gm -ve rods\\n500 mg orally 6\\nhourly\\n\\uf0b7Use atropine 1% eye drops or ointment for controlling iridocyclitis, to relieve ciliary\\nspasm and to prevent synechia formation.\\n\\uf0b7Other measures like scraping and cauterization. If the ulcer progresses in spite of the\\npharmacological treatment, the removal of the necrotic material may be hastened by'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 193, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7Other measures like scraping and cauterization. If the ulcer progresses in spite of the\\npharmacological treatment, the removal of the necrotic material may be hastened by\\nscraping or ulcer may be cauterized with 100% carbolic acid, 10% trichloracetic acid 10%\\nor 5% povidone iodine.\\n\\uf0b7In case of non resolving ulcers, surgical methods like vasculoplasty, conjuctival hooding\\nand patch graft, tectonic penetrating keratoplasty and tarsorraphy can be considered.\\nPatient education\\n\\uf0b7Use dark goggles and avoid close contact with other persons for two weeks.\\n\\uf0b7Restrict work and school for patients with significant exposure to others.\\n\\uf0b7Frequent handwashing\\nFUNGAL KERATITIS\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7\\nUse dark goggles and avoid close contact with other persons for two weeks.\\n\\uf0b7\\nRestrict work and school for patients with significant exposure to others.\\n\\uf0b7\\nFrequent handwashing\\nPharmacological treatment\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 193, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nRestrict work and school for patients with significant exposure to others.\\n\\uf0b7\\nFrequent handwashing\\nPharmacological treatment\\n-\\nTreatment should be instituted promptly with topical antifungal drops, initially every hour\\nduring the day tapered to 4 hrly interval for 3-4 days, then reduced to 4 times a day for at\\nleast 14-21 days or till there is resolution of active stage (Table 2).\\n-\\nSubconjunctival injections also may be used in cases of severe keratitis, or when poor\\ncompliance exists.\\n-\\nAn oral antifungal (eg, ketoconazole, fluconazole 100mg) should be considered for cases\\nof deep stromal infection.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 194, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n179\\n-\\nFluconazole has been shown to penetrate better into the cornea after systemic\\nadministration compared to other azoles and is associated with fewer adverse effects.\\nTable 2. Doses of antifungal drugs used in the treatment of fungal infections\\nDrugs\\nTopical\\nSub conjunctival/oral\\nIntravitreal\\nAmphotericin –B\\n1-10mg/ml drops\\n0.37mg sc\\n5-10µg\\nNatamycin\\n5% drops\\n25µg\\nMiconazole\\n1% drops\\n2% oint\\nKetokonazole\\n1%\\n200-800mg oral/day\\n0.5mg\\nFluconazole\\n0.2%-2%\\n100-200mg  6 hourly\\n0.1mg\\nIntra-cameral\\n\\uf0b7\\nInj. amphotericin-B (5 - 7.5% µg in 0.1ml in 5% dextrose)\\nIntra-corneal\\n\\uf0b7\\nInj. amphotericin-B (5µg in 0.1ml) four to five places around the lesion intrastromaly, not\\nin thin area\\n\\uf0b7\\nInj. voriconazole (50 µg in 0.1% in RL solution)\\nSystemic antifungal\\nOral fluconazole and ketoconazole are absorbed systemically with good levels in the anterior\\nchamber and cornea - therefore they should be considered in the management of   deep fungal\\nkeratitis fungal abscess, endothelial plaque.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 194, 'source_type': 'Authorotative', 'priority': '1'}, page_content='chamber and cornea - therefore they should be considered in the management of   deep fungal\\nkeratitis fungal abscess, endothelial plaque.\\n\\uf0b7\\nCycloplegics are mandatory and antiglaucoma drugs may be added to the treatment\\ndepending on the intraocular pressure etc.\\n\\uf0b7\\nFrequent corneal debridement with a spatula is helpful. It debulks fungal organisms and\\nepithelium, and enhances penetration of the topical antifungal agent\\n\\uf0b7\\nSurgery is considered in those patients who fail to respond to medical treatment and may\\nresult in corneal perforation. The treatment of choice is therapeutic penetrating\\nkeratoplasty.\\nVIRAL KERATITS\\nCommon viruses that cause corneal disease are Herpes simplex virus (HSV), Varicella zoster,\\nEpstein Barr and Adenovirus. Cytomegalovirus can also cause keratitis and is more\\ncommonly associated with AIDS.\\nHERPES SIMPLEX KERATITIS\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 195, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n180\\n\\uf0b7\\nHerpes simplex keratitis occurs in two forms – primary and recurrent\\n\\uf0b7\\nPrimary infection of any of the 3 branches (ophthalmic, maxillary, mandibular) of cranial\\nnerve V leads to latent infection of nerve cells in trigeminal ganglion.\\n\\uf0b7\\nInterneuronal spread of HSV within ganglion allows patients to develop ocular disease\\nwithout ever having had primary ocular HSV infection\\n\\uf0b7\\nRecurrent infection has been thought of as reactivation of virus in the sensory ganglion.\\n\\uf0b7\\nThe disease manifests as vesicular blepharoconjunctivitis occasionally with corneal\\ninvolvement as punctate keratitis.\\n\\uf0b7\\nThe patient presents with irritation, photophobia, reduction in vision (when central cornea is\\naffected) and corneal anaesthesia.\\n\\uf0b7\\nCorneal ulceration and scarring can occasionally be the only sign of recurrent herpetic\\ninfections. Typical branching, linear pattern with feathery edges and terminal bulbs at ends\\nare visualized by fluorescein staining.\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 195, 'source_type': 'Authorotative', 'priority': '1'}, page_content='infections. Typical branching, linear pattern with feathery edges and terminal bulbs at ends\\nare visualized by fluorescein staining.\\nPharmacological treatment\\n\\uf0b7\\nAntiviral drugs\\n-\\nTrifluridine and acyclovir are much more effective in epithelial disease than others.\\n-\\nIdoxuridine and trifluridine are frequently associated with toxic reactions.\\nTable 3. Antiviral drugs used in the treatment of viral keratitis\\nDrug\\nStrength\\nFrequency\\nTrifluridine\\n1% solution\\nEvery 2 hours while awake\\nAcyclovir\\n3% ointment\\n5 times daily\\nIdoxuridine\\n0.1% solution\\nHourly while awake\\nVidarabine\\n3% ointment\\n5 times daily\\n-\\nOral acyclovir may be useful in treatment of severe herpetic eye disease particularly in\\natopic individuals.\\n-\\nFor active treatment 400 mg five times daily in non immunocompromised patients.\\n-\\n800 mg five times daily in compromised and atopic patients.\\n-\\nProphylactic dosage in recurrent disease is 400 mg twice daily.\\n-\\nFamciclovir or valacyclovir may also be used.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 195, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\n800 mg five times daily in compromised and atopic patients.\\n-\\nProphylactic dosage in recurrent disease is 400 mg twice daily.\\n-\\nFamciclovir or valacyclovir may also be used.\\n\\uf0b7\\nTopical corticosteroids accelerate corneal thinning, increasing risk of corneal perforation\\n\\uf0b7\\nEpithelial debridement is an effective way to treat dendritic keratitis before acyclovir.\\nInfected epithelium is easy to remove with tightly wound cotton tip applicator.\\nAdjunctive therapy with topical antiviral accelerates epithelial healing\\n\\uf0b7\\nSurgical management like penetrating keratoplasty is indicated for visual rehabilitation in\\npatients with severe corneal scarring. It should not be undertaken until herpetic disease\\nhas been inactive for many months.\\nGLAUCOMA'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 196, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n181\\n\\uf0b7\\nThe disease is insidious and usually asymptomatic, until it has caused a significant loss\\nof visual field. Patients may experience mild headache, eye ache and visual field defect\\nin late cases.\\n\\uf0b7\\nReading and close work often present increasing difficulties owing to accommodative\\nfailure due to constant pressure on the ciliary muscle and its nerve supply. Therefore,\\npatients usually complain of frequent changes in presbyopic glasses.\\n\\uf0b7\\nOcular examination including slit-lamp biomicroscopy may reveal normal anterior\\nsegment. In late stages pupil reflex becomes sluggish and cornea may show slight haze.\\n\\uf0b7\\nIn the initial stages the IOP may not be raised permanently, but there is an exaggeration\\nof the normal diurnal variation. Therefore, repeated observations of IOP (every 3-4hour),\\nfor 24 hours is required during this stage (Diurnal variation test). Applanation tonometry\\nshould be preferred over Schiotz tonometry.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 196, 'source_type': 'Authorotative', 'priority': '1'}, page_content='for 24 hours is required during this stage (Diurnal variation test). Applanation tonometry\\nshould be preferred over Schiotz tonometry.\\n\\uf0b7\\nGonioscopy reveals open angles. Optic disc changes are typically progressive,\\nasymmetric and present a variety of characteristic clinical patterns. It is essential,\\ntherefore, to record the appearance of the nerve head in such a way that will accurately\\nreveal subtle glaucomatous changes over the course of follow-up period.\\nThe classical triad of increased intraocular pressure (IOP), optic nerve head cupping and\\nvisual field changes are always present and are signs of progress of the disease and bench\\nmark for assessing response to therapy.\\nPRIMARY OPEN ANGLE GLAUCOMA\\nIn open angle glaucoma the structure of the trabecular meshwork appears normal but offers\\nan increased resistance to the outflow of aqueous which results in an elevated ocular pressure.\\nSalient features\\nInvestigations\\n\\uf0b7\\nPerimetry to detect the visual field defects.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 196, 'source_type': 'Authorotative', 'priority': '1'}, page_content='an increased resistance to the outflow of aqueous which results in an elevated ocular pressure.\\nSalient features\\nInvestigations\\n\\uf0b7\\nPerimetry to detect the visual field defects.\\n\\uf0b7\\nNerve fibre layer analysis and disc topography analysis to detect early damage and for\\nprogression analysis.\\nPharmacological treatment\\n\\uf0b7\\nIdentification of target pressure. From the baseline evaluation data a ‘target pressure’\\nshould be identified for each patient. Progression of disease is uncommon if IOP is\\nmaintained at less than 16 to 18 mm of Hg in patients having mild to moderate damage\\nand 10 to 12 mmHg in patients with severe damage.\\n\\uf0b7\\nSingle drug therapy. One topical antiglaucoma drug should be chosen after due\\nconsideration to the patient’s personal and medical factors. If the initial drug chosen is\\nineffective or intolerable, it should be replaced by the drug of second choice.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 197, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n182\\n\\uf0b7\\nCombination therapy. If one drug is not sufficient to control IOP then a combination\\ntherapy with two or more drugs should be tried.\\n\\uf0b7\\nMonitoring of therapy by disc changes, field changes and tonometry is most essential on\\nregular follow-up. In the event of progression of glaucomatous damage, the target\\npressure should be reset at a lower level and any risk factors should be evaluated (Table\\n4).\\nTable 4. Drugs used for treatment of glaucoma\\nTopical agent\\nSide effects\\nBeta-blockers\\n(timolol 0.5%, levobunolol 0.5%,\\nbetaxolol 0.5%-selective)\\nExacerbate asthma and chronic airway disease,\\nhypotension, bradycardia\\nParasympathomimetic\\n(pilocarpine 2%)\\nVisual blurring in young patients, in patient with\\ncataracts, headache due to ciliary spasm\\nSympathomimetic (adrenaline\\n0.5%, dipivefrine 0.1%)\\nRedness, headache, mydriasis\\nAlpha-2 agonist (brimonidine\\n0.2%)\\nRedness, headache, drowsiness, allergic reaction\\nCarbonic anhydrase inhibitors\\n(Systemic –acetazolamide, topical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 197, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Redness, headache, mydriasis\\nAlpha-2 agonist (brimonidine\\n0.2%)\\nRedness, headache, drowsiness, allergic reaction\\nCarbonic anhydrase inhibitors\\n(Systemic –acetazolamide, topical\\n– dorzolamide 2%, brinzolamide\\n1%)\\nStinging, bitter test\\nProstaglandin analogues\\n(latanoprost 0.005%, bimatoprost\\n0.3%, travoprost 0.004% )\\nRedness, aggravation of inflammation, increased\\npigmentation of iris and peri ocular skin, lengthening of\\ncilia, rarely macular edema.\\nHyper osmotic agents 1-1.5g/kg\\nglycerol, mannitol 1-2g/kg\\nMannitol contraindicated in hypertensives and in patient\\nwith pulmonary edema. Glycerol not to be given in\\ndiabetics\\nLaser treatment\\nArgon laser trabeculoplasty (ALT) or selective laser trabeculoplasty (SLT) are indicated in\\npatients intolerant to topical medication, failure of medical therapy or non compliance to\\ntreatment. Since IOP reduction with laser is seldom greater than 30%, an IOP higher than 28\\nmmHg is unlikely to be adequately controlled by laser alone.\\nSurgical treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 197, 'source_type': 'Authorotative', 'priority': '1'}, page_content='treatment. Since IOP reduction with laser is seldom greater than 30%, an IOP higher than 28\\nmmHg is unlikely to be adequately controlled by laser alone.\\nSurgical treatment\\n\\uf0b7\\nUncontrolled glaucoma despite maximal medical therapy and laser trabeculoplasty.\\n\\uf0b7\\nNon-compliance of medical therapy and\\n\\uf0b7\\nIntolerance to medical therapy\\n\\uf0b7\\nEyes with advanced disease i.e., having very high IOP, advanced cupping and advanced\\nfield loss should be treated with filtration surgery as a primary line of management.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 198, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n183\\n\\uf0b7\\nPatient presents acutely (congestive glaucoma) with coloured halos around lights due to\\ncorneal oedema, ocular pain and headache.\\n\\uf0b7\\nThe IOP rise maybe often be so severe as to cause nausea and vomiting and mimic a case of\\nacute abdomen.\\n\\uf0b7\\nPrecipitating factors include watching television or movie in a darken room, reading,\\npharmacological mydriasis or miosis, acute emotional stress and rarely systemic medications\\nlike parasympathetic antagonists or sympathetic agonists (e.g. inhalers, motion sickness\\npatches and cold remedies) and topiramate.\\n\\uf0b7\\nOn examination, IOP is usually very high (> 40 - 50 mmHg) with conjunctival hyperaemia,\\ncorneal edema, unreactive mid dilated vertically oval pupil.\\n\\uf0b7\\nFellow eye generally shows an occludable angle.\\n\\uf0b7\\nTypes of surgeries- trabeculectomy, shunt & valve surgeries, non penetrating glaucoma\\nPatient education\\n\\uf0b7\\nTreatment of glaucoma whether medical or surgical is aimed to decrease further damage'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 198, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTypes of surgeries- trabeculectomy, shunt & valve surgeries, non penetrating glaucoma\\nPatient education\\n\\uf0b7\\nTreatment of glaucoma whether medical or surgical is aimed to decrease further damage\\nto optic nerve. Once damage has occurred, it is irreversible\\nPRIMARY ANGLE-CLOSURE GLAUCOMA\\nThe term ‘angle-closure’ refers to occlusion of the trabecular meshwork by the peripheral iris,\\nobstructing aqueous outflow.\\nI.\\nACUTE ANGLE CLOSURE GLAUCOMA\\nSalient features\\nPharmacological treatment\\nTreatment intensity should be individualized dependent on severity. Hospital admission is\\nusually required in an acute presentation.\\n\\uf0b7\\nThe patient should assume a supine position to encourage the lens to shift posteriorly\\nunder the influence of gravity.\\n\\uf0b7\\nInj. mannitol 20% 1–2 g/kg intravenously over half hour or glycerol 50% 1 g/kg orally,\\nhaving checked for contraindications.\\n\\uf0b7\\nPilocarpine 2–4% one drop to the affected eye, repeated after half an hour, and one drop'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 198, 'source_type': 'Authorotative', 'priority': '1'}, page_content='having checked for contraindications.\\n\\uf0b7\\nPilocarpine 2–4% one drop to the affected eye, repeated after half an hour, and one drop\\nof 1% as prophylaxis into the fellow eye. Some practitioners prefer to omit pilocarpine in\\nan acutely presenting eye with very high IOP until a significant IOP fall has taken place,\\nas the associated ischaemia will compromise the action of pilocarpine on the pupillary\\nsphincter and it may also aggravate the pupillary block.\\n\\uf0b7\\nAn additional oral dose of Tab. acetazolamide 500 mg may be given.\\n\\uf0b7\\nTopical timolol 0.5%, prednisolone 1% or dexamethasone 0.1% to the affected eye,\\nleaving 5 minutes between each instillation.\\n\\uf0b7\\nAnalgesia and an antiemetic may often be required.\\nSubsequent medical treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n184\\n\\uf0b7\\nMany patients with angle-closure maybe asymptomatic, including those with intermittently\\nor chronically elevated IOP.\\n\\uf0b7\\nThey may have intermittent\\nmilder symptoms of blurring (‘smoke-filled room’)\\nunassociated with pain.\\n\\uf0b7Pilocarpine 2% QID to the affected eye and 1% QID to the fellow eye.\\n\\uf0b7Topical steroid (prednisolone 1% or dexamethasone 0.1% QID) if the eye is acutely\\ninflamed.\\n\\uf0b7Any or all of the following should be continued as necessary according to response:\\ntimolol 0.5% BD and oral acetazolamide 250 mg QID may be required.\\nSurgical treatment\\n\\uf0b7Definitive treatment is laser iridotomy or iridoplasty after corneal oedema clears. Topical\\nsteroids and any necessary hypotensives can be continued for at least a week. Surgical\\noptions in resistant cases include surgical peripheral iridectomy, lens extraction,\\ngoniosynechialysis and trabeculectomy.\\nPatient education\\n\\uf0b7\\nDo not ignore headache or chronic ache in the eyes and report to the ophthalmologist if'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content='goniosynechialysis and trabeculectomy.\\nPatient education\\n\\uf0b7\\nDo not ignore headache or chronic ache in the eyes and report to the ophthalmologist if\\ncoloured halos around light appear.\\nII.\\nCHRONIC ACUTE ANGLE CLOSURE GLAUCOMA\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nTimolol 0.5% or betaxolol0.5% eye drops twice a day usually required lifelong.\\nSurgical treatment\\n\\uf0b7\\nLaser or surgical iridotomy is done to eliminate any element of pupillary block in\\naffected as well as fellow eye.\\nIII. LENS INDUCED GLAUCOMA\\nLens induced glaucoma is classified into phacolytic, phacomorphic, phacoanaphylactic\\nglaucoma, lens particle glaucoma and glaucoma due to dislocated lens. In addition to\\nmedically lowering the IOP, the cataractous lens needs to be removed, under steroid cover to\\nsuppress the inflammatory element.\\nANTERIOR UVEITIS\\nIt is the inflammation of the uveal tract i.e. iris, ciliary body and choroid. Inflammation of iris\\nand ciliary body constitutes iridocyclitis and anterior uveitis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 199, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ANTERIOR UVEITIS\\nIt is the inflammation of the uveal tract i.e. iris, ciliary body and choroid. Inflammation of iris\\nand ciliary body constitutes iridocyclitis and anterior uveitis.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 200, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n185\\n\\uf0b7\\nSymptoms of acute uveitis include pain, redness, photophobia, consensual photophobia\\n(pain in the affected eye when a light is shown in the fellow eye), excessive tearing and\\ndecreased vision.\\n\\uf0b7\\nSymptoms of chronic uveitis include decreased vision (from vitreous debris, cystoid\\nmacular edema (CME), or cataract, periods of exacerbations and remissions with few\\nacute symptoms [e.g. juvenile idiopathic (rheumatoid) arthritis].\\n\\uf0b7\\nCells and flare in the anterior chamber, ciliary flush and keratic precipitates (KP) are\\nobserved by slit lamp microscopy.\\n\\uf0b7\\nComplete ocular examination, including an IOP check and a dilated fundus examination.\\nThe vitreous should be evaluated for cells.\\nNon- pharmacological treatment\\n\\uf0b7\\nWear dark glasses\\nPharmacological treatment\\n\\uf0b7\\nCycloplegic e.g., cyclopentolate 1% eye drops BD for mild to moderate inflammation;\\natropine ointment 1% TDS for severe inflammation.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 200, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nWear dark glasses\\nPharmacological treatment\\n\\uf0b7\\nCycloplegic e.g., cyclopentolate 1% eye drops BD for mild to moderate inflammation;\\natropine ointment 1% TDS for severe inflammation.\\n\\uf0b7\\nTopical steroid like prednisolone acetate 1% one drop 1 to 6 hourly, depending on the\\nseverity. Most cases of moderate to severe acute uveitis require 1 to 2 hourly dosing\\ninitially. Consider FML (flurometholone) 1% ophthalmic ointment at night.\\n\\uf0b7\\nIf the anterior uveitis is severe and is not responding to topical steroids, then consider\\nperiocular repository steroids (e.g., triamcinolone 20 to 40 mg subtenon injection).\\n\\uf0b7\\nIf there is no improvement on maximal topical and repository steroids, or if the uveitis is\\nbilateral and severe, consider systemic steroids (Tab. prednisolone 1mg/kg), or\\nimmunosuppressive therapy.\\n\\uf0b7\\nTreat secondary glaucoma with beta blockers, not with pilocarpine or prostaglandin\\nanalogues.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 200, 'source_type': 'Authorotative', 'priority': '1'}, page_content='immunosuppressive therapy.\\n\\uf0b7\\nTreat secondary glaucoma with beta blockers, not with pilocarpine or prostaglandin\\nanalogues.\\n\\uf0b7\\nIf an exact etiology for the anterior uveitis is determined (herpes, tuberculosis, ankylosing\\nspondylitis etc.), then appropriate systemic management is required.\\n\\uf0b7\\nFollow-up is done every 1 to 7 days in the acute phase, depending on the severity and\\nevery 1 to 6 months when stable. At each visit, the anterior chamber reaction and IOP\\nshould be evaluated.\\n\\uf0b7\\nIf the anterior chamber reaction is improving, then the steroid drops can be slowly tapered\\n[usually one drop per day every 3 to 7 days (e.g., QID for 1 week, then TDS for 1 week,\\nthen BD for 1 week)].\\nPatient education\\n\\uf0b7\\nRecurrent nature of the disease which may interfere with vision should be explained and\\npossible complications like cataract and glaucoma should be mentioned.\\n\\uf0b7\\nPossible side effects of long term topical, periocular and systemic corticosteroid therapy\\nshould be explained.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 201, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n186\\n\\uf0b7\\nCommon causes include Streptococcus pneumoniae, Staphylococcus aureus, Streptococcus\\npyogenes and Haemophilus influenzae.\\n\\uf0b7\\nSymptoms include swelling of eyelids, severe pain which is increased by movements of eye\\nor pressure and fever, nausea, vomiting and sometimes loss of vision.\\n\\uf0b7\\nA marked swelling of lids with chemosis of conjunctiva is observed. Restriction of ocular\\nmovements is also seen.\\n\\uf0b7\\nFundus examination may show congestion of retinal veins and signs of papillitis or\\npapilloedema\\n\\uf0b7\\nBacterial cultures should be performed from nasal and conjunctival swabs and blood\\nsamples, X-ray to identify associated sinusitis and orbital ultrasonography to detect intra-\\norbital abscess should be done.\\nORBITAL CELLULITIS\\nOrbital cellulitis refers to an acute infection of the soft tissues of the orbit behind the orbital\\nseptum. The infection can be exogenous (trauma, foreign body), endogenous (septicemia) or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 201, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orbital cellulitis refers to an acute infection of the soft tissues of the orbit behind the orbital\\nseptum. The infection can be exogenous (trauma, foreign body), endogenous (septicemia) or\\nextension of infection from neighbouring structures (paranasal sinuses, teeth, face, eyelids).\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nWarm compresses\\nPharmacological treatment\\n\\uf0b7\\nIntensive antibiotic therapy:\\n-\\nAfter obtaining nasal, conjunctival and blood culture samples, intravenous higher broad\\nspectrum antibiotics should be administered.\\n-\\nTab. amoxicillin and clavulanic acid 625mg TDS should be given OR\\n-\\nInj. cefotaxime 1-2 gm every 12 hours in adults and 100-150 mg/kg in 2 to 3 divided\\ndoses in children are given. Antibacterials are changed according to the culture sensitivity\\nreports and continued till resolution of symptoms.\\n-\\nCiprofloxacin or vancomycin may be used an alternative.\\n\\uf0b7\\nAnalgesic and anti-inflammatory drugs are helpful in controlling pain and fever.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 201, 'source_type': 'Authorotative', 'priority': '1'}, page_content='reports and continued till resolution of symptoms.\\n-\\nCiprofloxacin or vancomycin may be used an alternative.\\n\\uf0b7\\nAnalgesic and anti-inflammatory drugs are helpful in controlling pain and fever.\\n\\uf0b7\\nSurgical intervention is needed when the patient is unresponsive to antibacterials,\\ndecrease in vision and presence of an orbital or subperiosteal abscess.\\nPatient education\\n\\uf0b7\\nAny ear, sinus or dental infection especially in children should be treated promptly\\n\\uf0b7\\nAny patient presenting with unexplained lid edema or cellulitis should be immediately\\nreferred to an ophthalmologist.\\nENDOPHTHALMITIS'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 202, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n187\\n\\uf0b7\\nEtiological agents include Staphylococcus aureus, coagulase negative Staphylococci,\\nStreptococci, Pseudomonas aeruginosa, Hemophilus influenza and fungus like Candida,\\nAspergillus, Histoplasma etc.\\n\\uf0b7\\nHistory of eye surgery, penetrating injury, fever, infection or predisposing systemic diseases\\nleading to metastatic endophthalmitis.\\n\\uf0b7\\nSymptoms include visual loss, pain, discharge, photophobia, lid swelling. Signs include\\nconjunctival congestion, hypopyon, vitrous exudates and loss of red fundus reflex.\\n\\uf0b7\\nSmear of aqueous humour, vitreous humour can be taken for smear and culture testing.\\nAntibiotic susceptibility testing can also be done.\\nIt is an inflammation of the internal coats of the eye along with inflammatory conditions of\\nintraocular cavities, aqueous and vitreous humour, retina and uvea. Endophthalmitis can be\\nendogenous (due to hematogenous spread of infective agents) and exogenous (direct'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 202, 'source_type': 'Authorotative', 'priority': '1'}, page_content='intraocular cavities, aqueous and vitreous humour, retina and uvea. Endophthalmitis can be\\nendogenous (due to hematogenous spread of infective agents) and exogenous (direct\\ninoculation of infecting agents through breach in continuity of ocular coats e.g. post\\ntraumatic).\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nPost operative endophthalmitis\\n-\\nIntravitreal injection of antibiotics - Inj. vancomycin hydrochloride 1 mg in 0.1 ml plus\\nInj. ceftazidime 2 mg in 0.1 ml or Inj. amikacin sulfate 0.4 mg in 0.1 ml.\\n-\\nSubconjunctival Inj. vancomycin 25 mg/0.5 ml plus Inj. ceftazidime 100 mg/0.5 ml plus\\ndexamethasone 0.25 mg/0.5 ml.\\n-\\nVancomycin eye drops 50 mg/ml plus amikacin eye drops 15 mg/ml 1 drop every 6\\nhours.\\n-\\nHomatropine 2% eye drops 3 times a day or atropine 1% eye ointment 2 times a day.\\n-\\nPrednisolone acetate 1% eye drops or dexamethasone or betamethasone 0.1% eye drops\\nevery 6 hours.\\n-\\nTab. prednisolone 1 mg/kg/day in a single morning dose after 24 hours of antibiotic use'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 202, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\nPrednisolone acetate 1% eye drops or dexamethasone or betamethasone 0.1% eye drops\\nevery 6 hours.\\n-\\nTab. prednisolone 1 mg/kg/day in a single morning dose after 24 hours of antibiotic use\\nand continue for 10-14 days 2 times a day for 5-10 days.\\n-\\nParenteral antibiotics are of questionable value and given only as a supportive therapy.\\nSurgical treatment\\nPars plana vitrectomy is indicated if visual acuity is limited to light perception or if there is\\npoor response to above treatment in 30-36 hours.\\n\\uf0b7\\nTraumatic endophthalmitis\\n-\\nHospitalize the patient and give immunization for tetanus.\\n-\\nInj. vancomycin 1 g IV infused over 1 hour, 12 hourly.\\n-\\nInj. gentamicin 2 mg/kg every 12 hour or Inj. ceftazidime 2 g IV every 12 hour or inj.\\nceftriaxone 2 g IV/day.\\n-\\nTopical fortified eye drops, subconjunctival injection and intravitreal injection\\nand cycloplegic drops as in cases of postoperative bacterial endophthalmitis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 203, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n188\\n\\uf0b7\\nSurgery\\n-\\nRepair the ruptured eyeball at the earliest.\\n-\\nPars plana vitrectomy - indications are similar to that of postoperative bacterial\\nendophthalmitis.\\n\\uf0b7\\nTreatment for fungal endophthalmitis\\nExogenous fungal infections may occur postoperatively or secondary to trauma.\\nEndogenous bacterial endophthalmitis should be treated as an emergency treatment.\\n-\\nVitrectomy to debulk the vitreous of fungi.\\n-\\nIntravitreal Inj. amphotericin B 5-10 mcg/0.1 ml or Inj. fluconazole 25 mcg/0.1 ml.\\n-\\nInj. amphotericin B 0.5-1.5 mg/kg/day slow infusion over 2-6 hours. (50 mg vial in\\npowder form and is dissolved in 5% dextrose) for 10-14 days. Or\\n-\\nTab. fluconazole 400 mg loading dose followed by 200 mg daily, total dose should not\\nexceed 600 mg/day. In children 12 mg/kg loading dose followed by 6 mg/kg/day. Or\\n-\\nTab. ketoconazole 200 mg orally 2 times a day or daily. In children above 2 years of age,\\n3.3-6.6 mg/kg/day.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 203, 'source_type': 'Authorotative', 'priority': '1'}, page_content='exceed 600 mg/day. In children 12 mg/kg loading dose followed by 6 mg/kg/day. Or\\n-\\nTab. ketoconazole 200 mg orally 2 times a day or daily. In children above 2 years of age,\\n3.3-6.6 mg/kg/day.\\n-\\nHomatropine 2% eye drops 4 times a day or atropine 1% eye ointment 2\\ntimes a day.\\nPatient education\\n\\uf0b7All patients with open globe injury must contact an ophthalmologist after getting initial\\ntreatment.\\n\\uf0b7Cataract operated cases should never ignore pain, tearing and photophobia and decrease in\\nvision in the operated eye and must consult the ophthalmologist at the earliest.\\nOPTIC NEURITIS\\nOptic neuritis includes inflammatory and demyelinating disorders of the optic nerve like\\npapillitis (inflammation of the optic disc), retrobulbar neuritis (inflammation of retro-ocular\\nportion of optic nerve) and neuroretinitis (when both optic nerve and retina are inflamed).\\nEtiology may be hereditary, systemic bacterial/viral infections, endophthalmitis, orbital'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 203, 'source_type': 'Authorotative', 'priority': '1'}, page_content='portion of optic nerve) and neuroretinitis (when both optic nerve and retina are inflamed).\\nEtiology may be hereditary, systemic bacterial/viral infections, endophthalmitis, orbital\\ncellulitis, demyelinating disorders or idiopathic in nature.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 204, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n189\\n\\uf0b7\\nSudden, progressive and profound visual loss is the hallmark of acute optic neuritis.\\n\\uf0b7\\nDecreased dark adaptation and impairment of colour vision, visual obscuration in bright light\\nand episodic obscuration on physical exertion, hot bath, fatigue etc.\\n\\uf0b7\\nDepth perception, particularly for the moving object may be impaired (Pulfrich’s\\nphenomenon). Patient may complain of mild dull eye ache. It is more marked in patients\\nwith retrobulbar neuritis than with papillitis. Pain is usually aggravated by ocular\\nmovements, especially in upward or downward directions due to attachment of some fibers\\nof superior rectus to the dura mater.\\n\\uf0b7\\nMarked abnormality in papillary responses to light reflex (sluggish or afferent pupil defect).\\n\\uf0b7\\nFundus examination reveals hyperaemia of the disc and blurring of the margins. Disc\\nbecomes oedematous and physiological cup is obliterated. Retinal veins are congested and\\ntortuous. Splinter haemorrhages and fine exudates may be seen on the disc.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 204, 'source_type': 'Authorotative', 'priority': '1'}, page_content='becomes oedematous and physiological cup is obliterated. Retinal veins are congested and\\ntortuous. Splinter haemorrhages and fine exudates may be seen on the disc.\\n\\uf0b7\\nSlit-lamp examination may reveal inflammatory cells in the vitreous. The most common\\nfield defect in optic neuritis is a relative central or centrocaecal scotoma.\\nPharmacological treatment\\n\\uf0b7\\nEfforts should be made to find out and treat the underlying cause. There is no effective\\ntreatment for idiopathic and hereditary optic neuritis and that associated with\\ndemyelinating disorders.\\n\\uf0b7\\nCorticosteroid therapy may shorten the period of visual loss, but will not influence the\\nultimate level of visual recovery in patients with optic neuritis.\\n\\uf0b7\\nOral prednisolone therapy alone is contraindicated in the treatment of acute optic neuritis,\\nsince, it did not improve visual outcome and was associated with a significant increase in\\nthe risk of new attacks of optic neuritis.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 204, 'source_type': 'Authorotative', 'priority': '1'}, page_content='since, it did not improve visual outcome and was associated with a significant increase in\\nthe risk of new attacks of optic neuritis.\\n\\uf0b7\\nIndications for intravenous methylprednisolone in acute optic neuritis patients with a\\nnormal brain MRI scan are:\\n-\\nVisual loss in both eyes simultaneously or subsequently within hours or days of each\\nother.\\n-\\nWhen the only good eye is affected.\\n-\\nWhen the slow progressive visual loss continues to occur.\\n\\uf0b7\\nInj. methylprednisolone 1gm/day (or 15 mg/kg/day) intravenously in 2-4 divided doses\\nfor 3 days followed by Tab. prednisolone 1 mg/kg/day orally for 11 days tapered over the\\nnext week.\\nPatient education\\n\\uf0b7\\nExplain the recurrent nature of the disease and that permanent vision loss can occur.\\n\\uf0b7\\nAvoid factors provoking transient visual obsurations like physical exertion, hot weather,\\nstress, anger etc.\\nDIABETIC RETINOPATHY'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 205, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n190\\n\\uf0b7\\nRhegmatogenous RD is characterized by formation of a tear in the retina. Symptoms include\\nflashes of light, presence of floaters in visual field and loss of central vision, if macula is\\ninvolved. The diagnosis is done by examination of the fundus with indirect ophthalmoscopy.\\nThe retina appears grey wit oscillating folds.\\n\\uf0b7\\nTractional RD is caused by gliotic bands on retina.\\n\\uf0b7\\nExudative RD is caused by collection of serous fluid between neurosensory retina and retinal\\npigment epithelium.\\nIt is the microangiopathy of retinal vasculature occurring in long standing diabetes mellitus\\nclassified as non proliferative and proliferative. It is the sixth leading cause of blindness in\\nthe world. Risk factors include increased duration of diabetes, uncontrolled diabetes,\\nabnormal lipid profile, smoking, renal disease etc.\\nNon- pharmacological treatment\\n\\uf0b7\\nEarly diagnosis, proper diabetic control, regular follow up and fundus examination are'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 205, 'source_type': 'Authorotative', 'priority': '1'}, page_content='abnormal lipid profile, smoking, renal disease etc.\\nNon- pharmacological treatment\\n\\uf0b7\\nEarly diagnosis, proper diabetic control, regular follow up and fundus examination are\\nimportant. In certain cases laser photocoagulation and vitrectomy surgery can help.\\nPharmacological treatment\\n\\uf0b7\\nNo tested or proven pharmacological treatment exists which can delay, prevent or\\ncurdiabetic retinopathy.\\nPatient education\\n\\uf0b7\\nExplain the importance of yearly fundus examination. Laser treatment can prevent\\ndeterioration of vision but cannot correct existing visual defects.\\nRETINAL DETACHMENT\\nRetinal detachment (RD) is the separation of the sensory retina from retinal pigment\\nepithelium. It may be localized or entire retina may be involved. Retinal detachment that\\nincludes the macula results in significant visual loss. The three types are Rhegmatogenous\\nRD, exudative RD and tractional RD.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 205, 'source_type': 'Authorotative', 'priority': '1'}, page_content='includes the macula results in significant visual loss. The three types are Rhegmatogenous\\nRD, exudative RD and tractional RD.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nTreatment of choice is reattachment surgery involving identification of all retinal breaks\\nareas of vitreous or retinal tractions and induction of aspectic chorioretinal inflammation\\naround the breaks to seal them.\\n\\uf0b7\\nEnsuring chorioretinal apposition by approximating choroid/retinal pigment epithelium to\\nneurosensory retina by external tamponade, internal tamponade and drainage of subretinal\\nfluid\\n\\uf0b7\\nAdhesion between retinal pigment epithelium and retina can be achieved by cryotherapy,\\ndiathermy or photocoagulation.\\nPharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 206, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n191\\nNo pharmacological treatment which can prevent or cure rhegmatogenous RD. Exudative RD\\ndue to inflammatory conditions like panuveitis can be treated with systemic corticosteroids as\\ndescribed in treatment of uveitis. The refractory patients can be treated with\\nimmunosuppresants.\\nPatient education\\n\\uf0b7\\nPatients with high myopia, family history of RD, post cataract surgery, past episodes of\\nchorioretinal inflammation should be warned about the premonitory signs of impending\\nRD (sudden onset of floaters, flashes of light and sudden obscuration of one part of visual\\nfield). In such cases, an opthalmologist should be contacted immediately.\\nVITAMIN A DEFICIENCY\\nThe term xerophthalmia is now reserved (by a joint WHO and USAID Committee, 1976) to\\ncover all the ocular manifestations of vitamin A deficiency, including not only the structural\\nchanges affecting the conjunctiva, cornea and occasionally retina, but also the biophysical\\ndisorders of retinal rods and cones functions.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 206, 'source_type': 'Authorotative', 'priority': '1'}, page_content='changes affecting the conjunctiva, cornea and occasionally retina, but also the biophysical\\ndisorders of retinal rods and cones functions.\\nSalient features\\nWHO Classification\\nPrimary signs\\nSecondary signs\\nX1: Conjunctival Xerosis:\\nXN: Night blindness\\nX1A- without Bitot spot\\nXF: Fundal changes\\nX1B- with Bitot spot\\nXS: Corneal scarring\\nX2: Corneal Xerosis\\nX3: Cornel ulceration\\nX3A: < 1/3 of corneal ulceration\\nX3B: > 1/3 of corneal ulceration\\nPharmacological treatment\\n\\uf0b7\\nVitamin A deficient diet is the main reason especially in young growing children of\\ndeveloping countries. It is usually associated with protein energy malnutrition.\\n\\uf0b7\\nIn some cases, decreased absorption of vitamin A due to gastro-intestinal disorders like lipid\\nmalabsorption or chronic alcoholism can occur.\\n\\uf0b7\\nPresentation can be as\\n-\\nNyctalopia- night blindness is the earliest presenting symptom.\\n-\\nConjunctival xerosis\\n-\\nBitot spot: It is a metaplastic keratinisation of conjunctiva.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 206, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPresentation can be as\\n-\\nNyctalopia- night blindness is the earliest presenting symptom.\\n-\\nConjunctival xerosis\\n-\\nBitot spot: It is a metaplastic keratinisation of conjunctiva.\\n-\\nPersistent epithelial defect (usually in chronic alcoholics) and corneal ulcer\\n-\\nKeratomalacia: a diffuse corneal necrosis occurring in severe vitamin A deficiency.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 207, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n192\\n\\uf0b7\\nSevere xerophthalmia is a medical emergency, so treatment should begin as early as\\npossible.\\n\\uf0b7\\nTreatment is aimed at restoring vitamin A level to normal and addressing associated\\nprotein energy malnutrition.\\n-\\nOral vitamin A:\\n0-6 month of age\\n: 50,000 IU (on 0 day, 1st day & after 4 weeks)\\n6-12 month of age\\n: 1 lakh IU (on 0 day, 1st day & after 4 weeks)\\nMore than 1 year of age\\n: 2 lakh IU (on 0 day, 1st day & after 4 weeks)\\n\\uf0b7\\nIntramuscular water soluble vitamin A is given to children with persistent vomiting or\\nsevere malabsorption.\\n\\uf0b7\\nTopical preservative free lubricating eye drops and antibiotic drops (e.g. moxifloxacin\\neye drops 1 to 6 hourly) to prevent secondary infection can be given.\\nPatient education\\n\\uf0b7\\nRegular consumption of Vitamin A rich foods particularly fresh dark green leafy\\nvegetables which constitute very rich and cheap sources.\\n\\uf0b7\\nPregnant women and lactating mothers should also consume Vitamin A rich diet\\nregularly.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 207, 'source_type': 'Authorotative', 'priority': '1'}, page_content='vegetables which constitute very rich and cheap sources.\\n\\uf0b7\\nPregnant women and lactating mothers should also consume Vitamin A rich diet\\nregularly.\\n\\uf0b7\\nBreast feeding including feeding of new born with rich colostrum.\\n\\uf0b7\\nHigh dose universal distribution schedule for prevention of Vitamin A deficiency.\\n-\\nInfants less than 6 months of age – 50,000 IU orally\\n-\\nInfants 6-12 months of age - 100,000 IU orally.\\n-\\nChildren more than 12 months - 200,000 IU orally every 4-6 months till 5 years of age.\\n\\uf0b7\\nMothers - 200,000 IU orally within 8 weeks of delivery.\\nSENILE CATARACT\\nIt is age related opacification of crystalline lens affecting persons of either sex usually above\\nthe age of 50 years. By 70 years, over 90% of the individuals develop senile cataract. The\\ncondition is usually bilateral, but almost always one eye is affected earlier than the other.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 208, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n193\\n\\uf0b7\\nGradual painless progressive diminution of vision in one or both eyes. Symptoms include\\nglare, uniocular diplopia or polyopia, coloured haloes, distortion of images and misty vision\\nand fixed black spots in visual field. Ocular examination reveals greyish white to white\\nlenticular opacity on torch light examination which depends on the stage of cataract.\\nDepending upon the location and maturation of cataract, the visual acuity may range from\\n6/9 to just perception of light.\\n\\uf0b7\\nSlit-lamp examination should be performed with a fully-dilated pupil. The examination\\nreveals complete morphology of opacity (site, size, shape, colour pattern and hardness of the\\nnucleus).\\n\\uf0b7\\nHypermetropia (hyperopia) or long-sightedness is the refractive state of the eye wherein\\nparallel rays of light coming from infinity are focused behind the retina with accommodation\\nbeing at rest. Symptoms include astheopic symptoms (tiredness and watering of eyes, frontal'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 208, 'source_type': 'Authorotative', 'priority': '1'}, page_content='parallel rays of light coming from infinity are focused behind the retina with accommodation\\nbeing at rest. Symptoms include astheopic symptoms (tiredness and watering of eyes, frontal\\nheadache) and defective vision, more for near vision.\\n\\uf0b7\\nMyopia or short-sightedness is a type of refractive error in which parallel rays of light\\ncoming from infinity are focused in front of the retina when accommodation is at rest.\\n\\uf0b7\\nAstigmatism - The optical power of the cornea in different planes is not equal. Parallel rays\\nof light passing through these different planes are brought to different points of focus.\\nSurgical treatment\\nNo medical management can halt the progression of cataract. Surgery in the form of small\\nincision cataract surgery or phacoemulsification is the preferred option.\\nPatient education\\n\\uf0b7\\nDo not wait for maturation of cataract for undergoing lens extraction.\\n\\uf0b7\\nSecondary glaucoma or other complications can develop if total cataract remains\\nunoperated for a long time.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 208, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nDo not wait for maturation of cataract for undergoing lens extraction.\\n\\uf0b7\\nSecondary glaucoma or other complications can develop if total cataract remains\\nunoperated for a long time.\\n\\uf0b7\\nVisual rehabilitation in early post operative period is faster in small incision cataract\\nsurgery.\\nREFRACTIVE ERRORS\\nRefractive errors (ametropia) are the optical defects of eye in which the parallel rays of light\\nentering the eye do not come to focus on the fovea centralis. Ametropia includes myopia,\\nhypermetropia and astigmatism.\\nSalient features\\nSurgical treatment\\n\\uf0b7\\nNo pharmacological treatment is available for ametropia.\\n\\uf0b7\\nAccurate retinoscopy and corrective spectacles or contact lens. Keratorefractive surgery\\nSTRABISMUS (SQUINT)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 209, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n194\\nAny child presenting with strabismus should have the following conditions ruled out:\\n\\uf0b7\\nRefractive error - refraction should be done under full cycloplegia i.e. Atropine Ointment 1%\\n3 times a day for 3 days prior to performing retinoscopy. If any refractive error is present,\\nthat should be fully corrected by spectacles for at least 3-6 months, before performing\\ndefinitive surgical therapy for strabismus.\\n\\uf0b7\\nAny opacity in the media e.g. cataract, corneal opacity, retinoblastoma etc.\\n\\uf0b7\\nAmblyopia element whether induced by strabismus or vice versa should be treated with\\nocclusion therapy or other modality before treating strabismus.\\n\\uf0b7\\nCharacterized by visual symptoms which result from interaction with a computer display\\nor its environment. In most cases, symptoms occur because the visual demands of the\\ntask exceed the visual abilities of the individual to comfortably perform the task.\\n\\uf0b7\\nContributing factors: Decreased blinking reflex, prolonged near focusing efforts,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 209, 'source_type': 'Authorotative', 'priority': '1'}, page_content='task exceed the visual abilities of the individual to comfortably perform the task.\\n\\uf0b7\\nContributing factors: Decreased blinking reflex, prolonged near focusing efforts,\\nrepeated head posture change/fixation in a wrong posture,  Environmental factors of\\ncomputer workstations like contrast and resolution of the display, viewing distances and\\nangles, room lighting, sustained viewing etc.\\n\\uf0b7\\nSymptoms include tiredness of eyes, headache, blurred near and distant vision, dry or\\nirritated eyes, neck pain and/or backaches, diplopia (double vision), difficulty in re-\\nfocusing the eyes. Diagnostic tests include tear film break-up time and Schirmer test.\\nCervical spondylitis, anxiety and migraine are the differential diagnosis.\\nSalient features\\nSurgical treatment\\n\\uf0b7\\nCorrect the refractive error or associated cataract, corneal opacity etc. Fusion exercises\\nfor intermittent exotropia and other orthoptic exercises. Definitive therapy is surgical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 209, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nCorrect the refractive error or associated cataract, corneal opacity etc. Fusion exercises\\nfor intermittent exotropia and other orthoptic exercises. Definitive therapy is surgical\\nrealignment of axis once other associated features have been treated.\\nPatient education\\nFunctional improvement in strabismus is best between 3-5 years of age. It is a misconception\\nthat squint is spontaneously corrected as the child grows.\\nCOMPUTER VISION SYNDROME\\nComputer Vision Syndrome (CVS) is the complex of eye and vision problems related to near\\nwork which are experienced during or related to computer use.\\nSalient features\\nNon- pharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 210, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Eye Diseases\\n195\\n\\uf0b7\\nCounselling regarding the syndrome and work environment modification\\nSteps for relieving computer eye strain\\n-\\nGet a computerized eye exam before start using computer. Repeat once a year.\\n-\\nUse proper lighting. Eliminate exterior light by closing drapes, shades or blinds. Reduce\\ninterior lighting by using lower intensity bulbs and tubes.\\n-\\nMinimize glare: To install an anti-glare screen on your monitor. Paint bright white walls a\\ndarker color with a matt finish.\\n-\\nUpgrade your display. Use LCD monitor instead of a CRT monitor.\\n-\\nAdjust the brightness and contrast of your computer screen.\\n-\\nBlink more often.\\n-\\nExercise your eyes: Follow 20-20-20 rule i.e. after every 20 minutes, look at 20 feet\\ndistance for 20 seconds.\\n-\\nTake frequent breaks - two 15-minute breaks -four additional five-minute \"minibreaks\"\\nthroughout the work day (6-8 hrs).\\n-\\nModify your workstation. Proper posture during computer work. Position computer'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 210, 'source_type': 'Authorotative', 'priority': '1'}, page_content='throughout the work day (6-8 hrs).\\n-\\nModify your workstation. Proper posture during computer work. Position computer\\nscreen 20 to 24 inches from your eyes. The center of your screen should be about 10 to 15\\ndegrees below your eyes. Top of the screen tilted back slightly (10-20 degree) away from\\nthe operator.\\n-\\nConsider customized eyeglasses specific for use during work on a computer screen. Anti-\\nreflective coating in the lenses should be used and avoid contact lens use during computer\\nwork.\\nPharmacological treatment\\n\\uf0b7\\nTear substitute should be considered if symptoms are aggravated during computer work.\\nCommercially available tear substitutes include sodium carboxymethylcellulose and\\nhydroxypropyl methylcellulose.\\nReferences\\n1.\\nKanski, Clinical Ophthalmology 7th edition\\n2.\\nReady reckoner in ophthalmology by AIOS\\n3.\\nWills Eye Manual, The: Office and Emergency Room Diagnosis and Treatment of Eye Disease, 5th Edition\\n4.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 210, 'source_type': 'Authorotative', 'priority': '1'}, page_content='1.\\nKanski, Clinical Ophthalmology 7th edition\\n2.\\nReady reckoner in ophthalmology by AIOS\\n3.\\nWills Eye Manual, The: Office and Emergency Room Diagnosis and Treatment of Eye Disease, 5th Edition\\n4.\\nShields textbook of glaucoma; 6th edition Orbit, Eyelids, and Lacrimal System Section 7 2011-2012 by\\nAmerican Academy of Ophthalmology.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 211, 'source_type': 'Authorotative', 'priority': '1'}, page_content='196\\n\\uf0b7\\nImpetigo (Figure 1) - commonly seen in childhood at muco-cutaneous junctions and presents\\nwith bullae that evolves into yellow or honey colored crusts.\\n\\uf0b7\\nEcthyma (Figure 2) – it is deeper variant of impetigo.-characterised by thick chocolate\\ncolored crust with indurated base that heals with scar.\\n\\uf0b7\\nFolliculitis (Figure 3) – inflammation of the ostium of hair follicle. Commonly affects scalp\\nhair margin, beard and extremities.\\n\\uf0b7\\nBoil/ furuncle (Figure 4) – inflammation of entire hair follicle, perifollicular region and\\nsubcutaneous tissue. Seen as inflammatory indurated nodule associated with fever and\\nmalaise.\\n\\uf0b7\\nCarbuncle (Figure 5) – group of multiple furuncles, commonly seen in diabetics at back of\\nneck, shoulder.\\n\\uf0b7\\nErysipelas (Figure 6) - it involves upper subcutaneous tissue and lymphatic vessels. Skin\\nbecomes tense, erythematous and slightly elevated which later on becomes brown and\\nedematous giving peau d’ orange appearance.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 211, 'source_type': 'Authorotative', 'priority': '1'}, page_content='becomes tense, erythematous and slightly elevated which later on becomes brown and\\nedematous giving peau d’ orange appearance.\\n\\uf0b7\\nCellulitis (Figure 7) - it involves deeper subcutaneous tissue, involves larger area and\\nassociated with fever and malaise\\n\\uf0b7\\nDiagnosis is mainly clinical; if required gram stain and culture-sensitivity.\\nChapter 12\\nSKIN DISEASES\\nBACTERIAL SKIN INFECTIONS\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nGood personal hygiene and proper nutrition.\\n\\uf0b7\\nWash with soap and water, drainage of pus.\\nPharmacological treatment\\n\\uf0b7\\nTopical antibacterial creams like neomycin or silver sulfadiazine or framycetin to be applied\\non the affected sites twice a day for 7-10day\\n\\uf0b7\\nSystemic antibacterial like Tab. azithromycin 500 mg OD for 3-5 days or\\nCap. amoxicillin 250 mg QID/ 500 mg TDS for 7 days or Tab. erythromycin (500 mg QID)\\nfor  5 days.\\nLEPROSY\\nIt is a chronic bacterial infection caused by Mycobacterium leprae that primarily affects skin and\\nperipheral nerves.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 212, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n197\\n\\uf0b7\\nHypopigmented / erythmatous skin lesion with or without loss / impairment of sensation,\\nsweating  and hair (Figure 8)\\n\\uf0b7\\nThickening / tenderness of  peripheral nerves with or without loss / impairment of sensation\\n\\uf0b7\\nSlit skin smear show acid fast bacilli ( M. Leprae)\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical examination of skin and peripheral nerves including sensation.\\n\\uf0b7\\nSlit skin smear and biopsy.\\nPharmacological treatment\\nWHO Classification for treatment purpose (Table 1)\\nPaucibacillary (PB) leprosy - ≤5 skin lesions and/or single nerve involvement, slit skin smear\\nnegative.\\nMultibacillary (MB) leprosy - ≥5 skin lesions and/or more than one nerve involvement, slit\\nskin smear positive.\\nTable 1. Treatment as per NLEP guideline\\nType of\\nleprosy\\nDrugs\\nSupervised\\nSupervised\\nDuration for\\nblister pack\\nMB (adult)\\nDapsone\\n(100mg) daily\\nRifampicin\\n(600mg) monthly\\nClofazimine\\n(300mg) monthly\\n+ 50 mg daily\\n12 months\\nPB (adult)\\nDapsone\\n(100mg) daily\\nRifampicin\\n(600mg) monthly'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 212, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Duration for\\nblister pack\\nMB (adult)\\nDapsone\\n(100mg) daily\\nRifampicin\\n(600mg) monthly\\nClofazimine\\n(300mg) monthly\\n+ 50 mg daily\\n12 months\\nPB (adult)\\nDapsone\\n(100mg) daily\\nRifampicin\\n(600mg) monthly\\n6 months\\nMB (pediatric)\\nDapsone (50mg)\\ndaily\\nRifampicin\\n(450mg) monthly\\nClofazimine\\n(150mg) monthly\\n+ 50 mg alternate\\nday\\n12 months\\nPB (pediatric)\\nDapsone (50mg)\\ndaily\\nRifampicin\\n(450mg) monthly\\n6 months\\nNon- pharmacological treatment\\n\\uf0b7\\nCare of insensitive hands and feet – emollient application, avoidance of trauma, burn,\\ndaily inspection, and rest.\\n\\uf0b7\\nCare of eyes – protective glasses.\\n\\uf0b7\\nProper nutrition.\\n\\uf0b7\\nActive and passive exercises.\\n\\uf0b7\\nIn case of deformity – use correct splints, modula grip aids for household works, MCR\\n(Micro cellular rubber) shoes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 213, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n198\\nLepra reaction\\n\\uf0b7\\nIt is immunologically mediated episodes of acute or chronic inflammation which interrupt\\nthe chronic course of disease affecting skin, nerves, mucous membrane and systemic\\ninvolvement.\\n\\uf0b7\\nType 1 reaction: Characterized by pain, tenderness of pre-existing lesions with or without\\nnew lesions/ peripheral nerves (neuritis).\\n\\uf0b7\\nType 2 reaction: Characterized by sudden appearance of tender nodules or plaques which\\nare evanescent, neuritis, pain and swelling of joints with or without systemic\\ninvolvement.\\nTreatment\\nType 1 reaction\\n\\uf0b7\\nMild reaction- NSAIDS like Tab. paracetamol (500 mg) TDS/Tab. aspirin (375-625 mg)\\nBD\\n\\uf0b7\\nSevere reaction- corticosteroids like Tab.prednisolone (1-2 mg/kg/day) in tapering dose\\n\\uf0b7\\nSurgical decompression of nerves SOS\\nType 2 reaction\\n\\uf0b7\\nMild to moderate reaction- Rest and NSAIDs like Tab. paracetamol (500 mg) TDS\\n/Tab.aspirin (375-625 mg) BD\\n\\uf0b7\\nSevere reaction : As above plus,\\n-\\nCap.clofazimine 300 mg daily.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 213, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Type 2 reaction\\n\\uf0b7\\nMild to moderate reaction- Rest and NSAIDs like Tab. paracetamol (500 mg) TDS\\n/Tab.aspirin (375-625 mg) BD\\n\\uf0b7\\nSevere reaction : As above plus,\\n-\\nCap.clofazimine 300 mg daily.\\n-\\nCorticosteroids (in tapering dose) such as Tab.prednisolone 40 mg daily for 15 days\\nfollowed by 30 mg daily for 15 days, 20 mg daily for 15 days, 15 mg daily for 15\\ndays,10 mg daily for 15 days and 5 mg daily for 15 days.\\n-\\nThalidomide (to be used with caution especially in chronic recurrent and steroid\\ndependent cases at tertiary care centre).\\n\\uf0b7\\nSurveillance / follow up for 2 years and 5 years period for PB and MB cases respectively\\nfor relapse and reactions.\\nPatient education\\n\\uf0b7\\nLeprosy is curable disease. The treatment is widely available and free of charge under\\nNLEP (National leprosy eradication programme).\\n\\uf0b7\\nRisk of developing disease is very low. Children and elderly are more prone.\\n\\uf0b7\\nEarly detection and proper treatment prevents disabilities.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 213, 'source_type': 'Authorotative', 'priority': '1'}, page_content='NLEP (National leprosy eradication programme).\\n\\uf0b7\\nRisk of developing disease is very low. Children and elderly are more prone.\\n\\uf0b7\\nEarly detection and proper treatment prevents disabilities.\\n\\uf0b7\\nDisease can be managed easily.The patient should not suffer any discrimination. Patient\\nshould be encouraged and supported by the family and society so that they are able to live\\na normal life.\\n\\uf0b7\\nExplain the importance of multidrug treatment and patient compliance, ADRs of drugs.\\nAll members of family and close contacts should be examined.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 214, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n199\\n\\uf0b7\\nLupus vulgaris – occurs in high immunity host having granulomatous lesion with marginal\\nactivation, central clearing and atrophy.\\n\\uf0b7\\nScrofuloderma – seen in low immunity host, involvement of skin overlying any internal\\ntuberculous focus such as bone, lymph node and joint.\\n\\uf0b7\\nTuberculosis veruccosa cutis (Figure 9) - occurs in high immunity host with\\nverrucous plaque.\\n\\uf0b7\\nCharacterized by nocturnal itching, excoriated papules, papulo vesicles, burrows on inter\\ndigital clefts of hands, wrist, axillary folds, breasts, periumblical region, medial side of\\nthigh and genitals. Face, palms, soles and scalp involvement in infants\\nCUTANEOUS TUBERCULOSIS\\nIt is caused by mycobacterium tuberculae and has varied manifestations depending on the\\nhost immunity and root of entry.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nCBC, ESR, mantoux test, chest x-ray\\n\\uf0b7\\nSputum AFB and  biopsy\\nNon- pharmacological treatment\\n\\uf0b7\\nProper nutrition\\nPharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 214, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Salient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nCBC, ESR, mantoux test, chest x-ray\\n\\uf0b7\\nSputum AFB and  biopsy\\nNon- pharmacological treatment\\n\\uf0b7\\nProper nutrition\\nPharmacological treatment\\nAccording to the National TB management guidelines, treatment is given in two phases:\\nCategory 1: newly diagnosed cases\\n\\uf0b7\\nInitial phase - 2 HRZE\\n\\uf0b7\\nContinuation phase - 4 HR\\nCategory 2: recurrence, relapse, defaulter\\n\\uf0b7\\nInitial phase : 1HRZES + 2HRZE\\n\\uf0b7\\nContinuation phase: 5HRE\\nH – isoniazid    R- rifampicin  Z- pyrazinamide  E- ethambutol   S-streptomycin\\nPatient education\\n\\uf0b7\\nExplain that it is a curable disease.\\n\\uf0b7\\nCounselling for regular follow up and adherence to treatment. Screening of close contacts\\nfor tuberculosis.\\nSCABIES\\nScabies is caused by arthropod mite (sarcoptes scabiei), transmitted by close personal\\ncontact. Family history is positive.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 215, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n200\\n\\uf0b7\\nPediculosis capitis - localised to scalp, mainly confined to sub-occipital region predominant\\nsymptom is itching,- nits are attached to hair shaft.\\n\\uf0b7\\nPediculosis \\ncorporis\\n–\\ncharacterised \\nby \\nintense \\nitching \\naccompanied \\nby\\nerythematous macules, excoriated papules and scratch marks.\\n\\uf0b7\\nPhthiriasis pubis – itching of pubic region, Peduculli and nits are seen in pubic region, blue\\ngrey macules (maculae caeruleae) are seen in lower abdomen and upper thigh.\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nInspection of mites from scabetic burrows.\\nNon pharmacological treatment\\n\\uf0b7\\nMaintenance of personal hygiene.\\n\\uf0b7\\nDisinfection of bedding and clothing.\\n\\uf0b7\\nAll family members should be treated simultaneously.\\nPharmacological treatment\\n\\uf0b7\\nTab. ivermectin 200 mcg/kg as a single stat dose to be repeated after 2 weeks.\\n\\uf0b7\\nAntihistamines like Tab. cetirizine 10 mg daily\\n\\uf0b7\\nGamma benzene hexachloride (GBHC) lotion 1%. Single overnight application below\\nneck on  entire body surface after a thorough'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 215, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAntihistamines like Tab. cetirizine 10 mg daily\\n\\uf0b7\\nGamma benzene hexachloride (GBHC) lotion 1%. Single overnight application below\\nneck on  entire body surface after a thorough\\nscrub bath, to be washed off next\\nmorning.\\n\\uf0b7\\nFor infants, neonates, children, pregnant and lactating mothers.\\n\\uf0b7\\nPermethrin 5% to be applied\\ngenerously,\\nafter bath, at bedtime,\\ncovering\\nentire\\nsurface of the body below neck (except\\nface).\\n\\uf0b7\\nSystemic and topical antibacterial SOS\\nPEDICULOSIS (LICE INFESTATION)\\n\\uf0b7\\nThree different species namely pediculosis humanus corporis (body louse), pediculosis\\nhumanus capitis (head louse), pediculosis humanus pubis (pubic louse).\\n\\uf0b7\\nTransmission occurs by personal contact, sharing of combs, infected clothing, poor\\npersonal hygiene while transmission of pubic lice is by sexual-contact.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nFinding lice in occipital region in P. capitis, in sieves of clothes in P. corporis and in\\npubic region in phthiriasis pubis.\\nNon- pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 215, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Salient features\\nDiagnosis\\n\\uf0b7\\nFinding lice in occipital region in P. capitis, in sieves of clothes in P. corporis and in\\npubic region in phthiriasis pubis.\\nNon- pharmacological treatment\\n\\uf0b7\\nMaintenance of personal hygiene.\\n\\uf0b7\\nDisinfection of bedding and clothing.\\n\\uf0b7\\nAll the family member should be treated simultaneously.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 216, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n201\\nThree forms seen:\\n\\uf0b7\\nCreeping myiasis – most superficial\\n\\uf0b7\\nFuruncle myiasis – boil like lesion and\\n\\uf0b7\\nWound myiasis\\n\\uf0b7\\nAsymptomatic hypo or hyperpigmented irregular macules with branny scales usually seen on\\nupper trunk. Recurrence is common.\\n\\uf0b7\\nTo shave pubic hair.\\n\\uf0b7\\nTreatment of partner in case of pubic lice infestation.\\nPharmacological treatment\\n\\uf0b7\\nAntihistamines like Tab. cetirizine 10mg daily or Tab. pheniramine maleate 25 mg 3\\ntimes a day for 7 days.\\n\\uf0b7\\nLotion GBHC/ permethrin 1% to be applied on scalp (in head louse infestation) for a\\nperiod of more than 30 minutes to be washed off later.\\nMYIASIS (MAGGOTS)\\nMyiasis is the infestation of the body by fly larvae that feed on body tissues in people with\\npoor hygiene.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nApply liquid paraffin, turpentine oil.\\n\\uf0b7\\nRemove mechanically by forceps.\\n\\uf0b7\\nExplain the patient about personal hygiene and proper care of wound.\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 216, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nApply liquid paraffin, turpentine oil.\\n\\uf0b7\\nRemove mechanically by forceps.\\n\\uf0b7\\nExplain the patient about personal hygiene and proper care of wound.\\nPharmacological treatment\\n\\uf0b7\\nSystemic antihelminthics like Tab. albendazole 400mg stat.\\n\\uf0b7\\nSystemic antibiotics if secondary infection present.\\n\\uf0b7\\nWound management.\\nITYROSPORUM  INFECTIONS\\nMild superficial fungal infection of stratum corneum characterised by scaly hypo or\\nhyperpigmented irregular macules caused by mycelial form of malassezia species (Fig. 10).\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nWood’s lamp – yellowish fluorescence.\\n\\uf0b7\\n10 % KOH mount - non branching mycelia and yeasts giving “banana and grapes”\\nappearance.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 217, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n202\\n\\uf0b7\\nSharply marginated patches with active scaly border and central clearing.\\n\\uf0b7\\nExtremely pruritic condition\\nPharmacological treatment\\n\\uf0b7\\nTopical antifungal cream like – ketoconazole or miconazole or clotrimazole or terbinafine\\n\\uf0b7\\nTopical selenium sulfide 2.5% shampoo or lotion\\n\\uf0b7\\nSystemic antifungals like Cap. fluconazole 400 mg stat\\n\\uf0b7\\nFor recurrence Tab.ketoconazole 400 mg once per month\\nPITYRIASIS CAPITIS (DANDRUFF)\\nMild superficial fungal infection of stratum corneum caused by yeast form of malassezia.\\nSalient features\\n\\uf0b7\\nDiffuse itchy scaly lesions over scalp, eyebrows, eyelashes and naso-labial folds\\nDiagnosis\\n\\uf0b7\\nClinical\\nNon- pharmacological treatment\\n\\uf0b7\\nFrequent hair washes by shampooing with light massage.\\n\\uf0b7\\nAvoid oil and soap application.\\nPharmacological treatment\\n\\uf0b7\\nAntifungal lotions / shampoos that contain antifungals like ketoconazole or econazole,\\nkeratolytics like salicylic acid or coal tar that should be applied 15 min before bath to the\\naffected areas.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 217, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Antifungal lotions / shampoos that contain antifungals like ketoconazole or econazole,\\nkeratolytics like salicylic acid or coal tar that should be applied 15 min before bath to the\\naffected areas.\\n\\uf0b7\\nTopical steroids like betamethasone lotion in combination with antifungal lotion after hair\\nwash.\\nTINEA CRURIS AND CORPORIS\\nTinea cruris is a superficial fungal infection of groin and axilla, also known as dhobi’s itch.\\nTinea corporis involves trunk and extremities. It is more common in obese and diabetics.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and  KOH mount\\nNon- pharmacological treatment\\n\\uf0b7\\nMaintain hygiene and avoid tight clothing.\\nPharmacological treatment\\n\\uf0b7\\nTopical antifungals like– clotrimazole or miconazole or ketoconazole cream to be applied\\ntwice daily.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 218, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n203\\n\\uf0b7\\nGray patch: Circular patches of partial hair loss that are broken off, dull gray and lusterless\\nin appearance\\n\\uf0b7\\nBlack Dot: Multiple, polygonal areas of sparse hair, broken hair follicles are seen as black\\ndots.\\n\\uf0b7\\nKerion: Inflamed, boggy, indurated and tender swelling studded with vesicles and pustules\\n(Figure 11).\\n\\uf0b7\\nFavus: Rare type of tinea capitis presenting with cup shaped scutula around the hair orifice.\\n\\uf0b7\\nCharacterized by involvement of only a few nails, brownish or yellowish streaks,\\nonycholysis and thickend nail plate.\\n\\uf0b7\\nTypes- distal and lateral subungual onychomycosis\\n(Figure 12), white superficial\\nonychomycosis, proximal subungual onychomycosis, total dystrophic onychomycosis.\\n\\uf0b7\\nExtensive cases – in addition to topicals, systemic antifungals like Cap.fluconazole-150\\nmg/ week x 2-4 weeks or Tab. terbinafine (62.5 mg daily for <20 kg weight, 125 mg daily\\nfor 20-40 kg weight, 250 mg daily for >40 kg weight) for 2 weeks.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 218, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mg/ week x 2-4 weeks or Tab. terbinafine (62.5 mg daily for <20 kg weight, 125 mg daily\\nfor 20-40 kg weight, 250 mg daily for >40 kg weight) for 2 weeks.\\n\\uf0b7\\nCap. itraconazole- 200 mg daily for 1 week.\\nTINEA CAPITIS\\nTinea capitis is a dermatophyte infection of the scalp most commonly seen in childhood.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nWood’s lamp: greenish yellow fluorescence\\n\\uf0b7\\nKOH mount and  hair mount\\nNon- pharmacological treatment\\n\\uf0b7\\nNot to share caps and combs.\\n\\uf0b7\\nRemoval of matted crusts.\\nPharmacological treatment\\n\\uf0b7\\nTab. griseofulvin: 15- 25 mg / kg per day with food preferably at night for 4-6 weeks.\\n\\uf0b7\\nTab. fluconazole: 3- 6 mg / kg per day administered for 6 wks.\\n\\uf0b7\\nTab. terbinafine: according to weight of the patient.\\n\\uf0b7\\nCap. itraconazole -5mg/kg/d for 7 days.\\nONYCHOMYCOSIS\\nOnychomycosis is fungal infection of nail.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 219, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n204\\n\\uf0b7\\nNeonatal candidiasis (due to infection acquired during delivery or postnatally) is\\ncharacterized by oral thrush as well as pink–red patches with satellite papules and pustules\\nthat favor the diaper area, other intertriginous sites and the face.\\n\\uf0b7\\nOral candidiasis is characterized by curdy white patches covered by pseudomembrane over\\nthe gums, teeth, cheeks and palate (Figure 13).\\n\\uf0b7\\nFlexural candidiasis (candidal intertrigo) it is characterized by moist erythematous exudates\\ndeep in the folds and gradually develops characteristic fringed erosions. Satellite popular or\\npustular lesions are characteristic.\\n\\uf0b7\\nBalanoposthitis (candida balanitis) is acquired through direct sexual contact with a partner\\nwho \\nhas\\nvulvovaginal \\ncandidiasis\\npresents \\nwith\\nintense \\nerythema \\nwith\\ndesquamation/superficial erosions, maculopapular rash over glans and foreskin is seen a\\nwhite subpreputial discharge, increased skin marking, fissuring of glans and foreskin may be\\nseen.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 219, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with\\ndesquamation/superficial erosions, maculopapular rash over glans and foreskin is seen a\\nwhite subpreputial discharge, increased skin marking, fissuring of glans and foreskin may be\\nseen.\\n\\uf0b7\\nVulvovaginitis: vulvar pruritus, vaginal discharge, dysuria, and dyspareunia physical\\nexamination findings include a vagina and labia that are usually erythematous, a thick curd\\nlike discharge, and a normal cervix upon speculum examination.\\n\\uf0b7\\nMicroscopy- KOH mount.\\n\\uf0b7\\nCulture- sabouraud’s dextrose agar.\\nNon pharmacological treatment\\n\\uf0b7\\nAvoid tight fitting footwear and working in wet areas.\\nPharmacological treatment\\n\\uf0b7\\nTopical antifungal agents like clotrimazole, miconazole or tolnaftate.\\n\\uf0b7\\nOral antifungal agents such as Tab.fluconazole:150-300mg once a week for 6 -12 months\\nor Tab. terbinafine: 250mg daily for 6-12 weeks or Cap. itraconazole 200mg daily for 2-3\\nmonths.\\nCANDIDIASIS\\nCandidiasis is an infection caused by the yeast candida albicans or sometimes other species of\\ncandida.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 219, 'source_type': 'Authorotative', 'priority': '1'}, page_content='months.\\nCANDIDIASIS\\nCandidiasis is an infection caused by the yeast candida albicans or sometimes other species of\\ncandida.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nMicroscopy- demonstration of candida by 10% KOH –yeast cells, mycelia is seen.\\nNon- pharmacological treatment\\n\\uf0b7\\nDaily bath and maintain personal hygiene.\\n\\uf0b7\\nKeep the affected area dry and clean.\\n\\uf0b7\\nControl of diabetes mellitus.\\n\\uf0b7\\nCare of dental prosthesis.\\n\\uf0b7\\nAvoid prolonged use of diaper.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 220, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n205\\n\\uf0b7\\nDiaper dermatitis is characterized by joined patches of erythema and scaling mainly seen on\\nthe convex surfaces, with the skin folds spared.\\n\\uf0b7\\nSigns and symptoms are restricted in most individuals to the area covered by diapers.\\n\\uf0b7\\nDiagnosis is mainly clinical.\\n\\uf0b7\\nMost common form occurring between 1-5 years.\\n\\uf0b7\\nDisease starts with fever and malaise and subsequently small vesicles develop.\\n\\uf0b7\\nVesicular lesions rupture to form shallow ulcers with yellow exudative base and\\nerythematous halo.\\nPharmacological treatment\\nTopical antifungals (1% clotrimazole, 1% ciclopirox, 2% miconazole nitrate etc) creams.\\nClotrimazole vaginal pessaries for vulvovaginal candidiasis.\\nSystemic – Cap.fluconazole 150mg single dose.\\nDIAPER DERMATITIS\\nKnown as napkin dermatitis or diaper rash is a prototypical example of irritant contact\\ndermatitis; caused by overhydration of the skin, maceration, prolonged contact with urine and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 220, 'source_type': 'Authorotative', 'priority': '1'}, page_content='DIAPER DERMATITIS\\nKnown as napkin dermatitis or diaper rash is a prototypical example of irritant contact\\ndermatitis; caused by overhydration of the skin, maceration, prolonged contact with urine and\\nfeces, retained diaper soaps, and topical preparations and often triggered by an episode of\\ndiarrhoea; commonly seen in infants; induced by occlusion of areas covered by impermeable\\ndiapers.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoid impermeable diapers and keep affected skin dry.\\n\\uf0b7\\nMaintain personal hygiene.\\n\\uf0b7\\nAvoid use of topical antiseptics and medicated soaps.\\nPharmacological treatment\\n\\uf0b7\\nZinc oxide paste.\\n\\uf0b7\\nAntifungal (clotrimazole 1% cream; econazole nitrate cream; miconazole 2%) cream after\\nevery diaper change or at least 4 times per day can be applied.\\n\\uf0b7\\nTopical corticosteroids e.g. hydrocortisone 1% can be used for the first 1-2 days.\\nHERPES LABIALIS\\n\\uf0b7\\nIt is an infection of the lip by herpes simplex virus (HSV-1) (Figure 14).\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 220, 'source_type': 'Authorotative', 'priority': '1'}, page_content='HERPES LABIALIS\\n\\uf0b7\\nIt is an infection of the lip by herpes simplex virus (HSV-1) (Figure 14).\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nMicroscopy- Tzanck smear showing multinucleate giant cells.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 221, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n206\\n\\uf0b7\\nGeneralized pruritic vesicular rash, preceded by 2-3 days of fever, chills, headache, malaise,\\nanorexia. Characterized by polymorphic vesicular lesions with central haemorrhagic\\ncrusting, centripetal in arrangement, mainly over trunk\\n\\uf0b7\\nProdromal symptoms fever, malaise, paraesthesia.\\nCharacterized by unilateral radicular\\nsevere pain and grouped vesicular eruption involving dermatome, not crossing the midline.\\nMucous membrane of the affected dermatome is also involved.\\nPharmacological treatment\\n\\uf0b7\\n1% silver sulphadiazine cream.\\n\\uf0b7\\nTab. acyclovir 200 mg 5 times daily for 5/7 days or Tab. famcyclovir 250 mg TDS for 7\\ndays or Tab. valacyclovir 1000 mg BD for 7 days.\\n\\uf0b7\\nTab. paracetamol 500mg TDS for 5 days.\\nPatient education\\n\\uf0b7\\nPatient should avoid contact until all the lesions are crusted.\\nCHICKEN POX\\nIt is a febrile illness characterized by generalized pruritic vesicular rash, caused by varicella'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 221, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patient education\\n\\uf0b7\\nPatient should avoid contact until all the lesions are crusted.\\nCHICKEN POX\\nIt is a febrile illness characterized by generalized pruritic vesicular rash, caused by varicella\\nzoster virus, providing lifelong immunity and is most prevalent in childhood.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and microscopy- Tzanck smear.\\nNon- pharmacological treatment\\n\\uf0b7\\nRest, cold compresses,  tepid baths\\nPharmacological treatment\\n\\uf0b7\\nSymptomatic treatment with rest, analgesics, antibiotics and topical calamine lotion.\\n\\uf0b7\\nIn severe varicella and immune-compromised oral acyclovir: children 20 mg/ kg QID,\\nadults 800 mg 5 times for 10 days.\\nHERPES ZOSTER\\nLocalized disease caused by reactivation of varicella zoster virus lying dormant in sensory\\nganglia (Figure 15).\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and microscopy – Tzanck smear.\\nNon- pharmacological treatment\\n\\uf0b7\\nRest and isolation\\nPharmacological treatment\\n\\uf0b7\\nTopical like calamine lotion till symptoms resolve.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 222, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n207\\n\\uf0b7\\nThe lesions are generally multiple, occur on exposed part.\\n\\uf0b7\\nIt is characterized by shiny, pearly white, hemispherical, umbilicated papule which may\\nshow a central pore (Figure 16).\\n\\uf0b7\\nManifest as common warts, flat warts, filiform warts; depending on the site, palmar and\\nplantar warts. Characterised by asymptomatic skin coloured verrucous papules or plaques.\\n\\uf0b7\\nTab. acyclovir 15-20 mg/kg 5 times daily for 5/7 days or Tab. valacyclovir 1000 mg BD\\nfor 7 days.\\nMOLLUSCUM CONTAGIOSUM\\nIt is a viral infection of the skin caused by molluscum contagiosum virus seen in children.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nExtraction of molluscum body and  biopsy\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoid scratching.\\n\\uf0b7\\nAvoid shared towels, contact sports and communal bathing.\\nPharmacological treatment (at tertiary care centres)\\n\\uf0b7\\nChemical cauterisation by trichloroacetic acid 10-20%, phenol or salicylic acid or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 222, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAvoid shared towels, contact sports and communal bathing.\\nPharmacological treatment (at tertiary care centres)\\n\\uf0b7\\nChemical cauterisation by trichloroacetic acid 10-20%, phenol or salicylic acid or\\npotassium hydroxide 10% solution (to be applied on the lesion with application of liquid\\nparaffin over surrounding area).\\n\\uf0b7\\nSurgical removal by curettage.\\nWART\\nIt is a viral infection of the skin caused by different groups of human papilloma viruses.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and biopsy\\nNon pharmacological treatment\\n\\uf0b7\\nAvoid scratching.\\n\\uf0b7\\nAvoid shared towels, contact sports and communal bathing.\\n\\uf0b7\\nSafe sex practice in case of genital warts.\\nPharmacological treatment\\n\\uf0b7\\nPodophyllotoxin 0.5% solution or 0.15% cream twice daily for 3 days followed by 4 days\\nrest-give for 3 cycles.\\n\\uf0b7\\nCryotherapy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 223, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n208\\n\\uf0b7\\nPeak in 14-17 years in women and 16-19 years in men\\n\\uf0b7\\nCharacterized by comedones (mild), papules (moderate), nodules (severe) over face, back\\nand shoulders (Figure 17).\\n\\uf0b7\\nSequelae are hyperpigmentation, acne excoriee and different types of scars\\n\\uf0b7\\nMiliaria crystalline is characterized by itchy, discrete or confluent transparent thin walled\\nvesicles.\\nMilaiaria rubra is characterized by discrete erythematous macules and papules.\\nMiliaria profunda- characterized by flesh coloured 1-3 mm sized papules.\\n\\uf0b7\\nTrichloroacetic acid application.\\n\\uf0b7\\nPodophyllin 10%- 25%.\\nACNE VULGARIS\\nIt is chronic, self limiting, inflammatory disease of pilosebaceous unit, manifesting generally\\nin adolescence. In addition to pathogens-\\nthe\\np.acnes, hormonal, immunological,\\nenvironmental and genetic factors also play a role.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical.\\n\\uf0b7\\nHormonal assay if severe acne, menstrual irregularity, hirsutism is present.\\nNon- pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 223, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Salient features\\nDiagnosis\\n\\uf0b7\\nClinical.\\n\\uf0b7\\nHormonal assay if severe acne, menstrual irregularity, hirsutism is present.\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoid sugar rich diet, milk, etc.\\n\\uf0b7\\nAvoid use of drugs causing acne like steroid, androgens, halogens.\\n\\uf0b7\\nAvoid use of oils, pomades and cosmetics.\\n\\uf0b7\\nPatient education about premenstrual flare and stress.\\n\\uf0b7\\nWashing or cleaning of face to keep skin dry, shampooing of scalp.\\nPharmacological treatment\\n\\uf0b7\\nMild – benzoyl peroxide (2.5%) cream or azelaic acid 10% cream.\\n\\uf0b7\\nModerate – Topical retinoids like tretinoin 0.025% gel or adapelene 0.1% gel and topical\\nantibacterials clindamycin 1% cream or nadifloxacin 1% cream.\\n\\uf0b7\\nSevere – in addition to topical therapy, systemic antibiotics like Tab. azithromycin 500\\nmg daily for 5 days in a month or Cap. doxycycline 100mg BD or, Tab. minocycline\\n50/100 mg daily or Tab. isotretinoin 0.5-1mg/kg for 3-6 months (tertiary care centre).\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 223, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mg daily for 5 days in a month or Cap. doxycycline 100mg BD or, Tab. minocycline\\n50/100 mg daily or Tab. isotretinoin 0.5-1mg/kg for 3-6 months (tertiary care centre).\\n\\uf0b7\\nHormonal therapy for unresponsive female patients with menstrual irregularity.\\nMILIARIA\\nMiliaria is a common ailment in hot and humid conditions during the summer season.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 224, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n209\\n\\uf0b7\\nLesions are characterized by itching, redness, edema, and papulovesicles in acute stage,\\nedema and scaling in subacute stage and lichenification in chronic stage.\\nDiagnosis\\n\\uf0b7\\nClinical\\nNon- pharmacological treatment\\n\\uf0b7\\nCool baths, aeration.\\n\\uf0b7\\nAvoid heat and occlusion due to tight clothing, oils, creams, cosmetics etc.\\nPharmacological treatment\\n\\uf0b7\\nCalamine lotion and talc.\\n\\uf0b7\\nSystemic antibacterial if infection present.\\nECZEMA\\nEczema is an inflammatory response of the skin to various exogenous and endogenous\\nallergens. Exogenous allergens cause irritant contact dermatitis, allergic contact dermatitis,\\nphotodermatitis and infective dermatitis. The endogenous allergens result into atopic\\ndermatitis, seborrheic dermatitis, nummular eczema, asteatotic eczema, stasis dermatitis.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and skin biopsy.\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoid allergens, cold compresses, emollients.\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 224, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Salient features\\nDiagnosis\\n\\uf0b7\\nClinical and skin biopsy.\\nNon- pharmacological treatment\\n\\uf0b7\\nAvoid allergens, cold compresses, emollients.\\nPharmacological treatment\\n\\uf0b7\\nTopical corticosteroids like betamethasone valerate 0.05 % cream and mometasone\\nfuroate 0.05% cream/ointment.\\n\\uf0b7\\nTopical and /or oral antibacterial in case of secondary infection.\\n\\uf0b7\\nOral antihistaminics like Tab.cetirizine (10mg/day) and Tab. Chlorpheniramine 4mg/day\\n\\uf0b7\\nSevere cases Tab. prednisolone 0.5-1 mg/kg/day.\\n\\uf0b7\\nRegular follow up of the patient.\\nPatient education\\n\\uf0b7\\nExplain about the side effects of local and systemic corticosteroids\\nCONTACT DERMATITIS\\nInflammatory response of skin to an exogenous substance immunologically or none\\nimmunologically mediated (Figure 18). Common allergens are cement (nickel, chromium,\\ncobalt), epoxy resins, rubber, plastics, photographic chemicals, paints, flowers, clothing, shoe\\nmaterials, watches, jewellery, cosmetics (bindi, lipstick, sindoor, hair dyes), topical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 224, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cobalt), epoxy resins, rubber, plastics, photographic chemicals, paints, flowers, clothing, shoe\\nmaterials, watches, jewellery, cosmetics (bindi, lipstick, sindoor, hair dyes), topical\\nmedications (antibacterials, antifungals and antiseptic lotions), plants, fertilizers, insecticides,\\npesticides, soap, detergents, vegetables, toothpaste.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 225, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n210\\n\\uf0b7\\nIrritation, itching, pain. Erythema, papules, vesicles, erosions, scaling and crusts can be seen.\\n\\uf0b7\\nLesions may or may not be confined to the site of contact.\\n\\uf0b7\\nDiagnosis is clinical\\n\\uf0b7\\nA typical lesion is well-defined depigmented patch, which shows depigmented hair without\\nany change in skin texture .\\n\\uf0b7\\nCommon sites are extensors body surfaces such as pre tibial lesion, sides of ankle, knees,\\nelbows and skin overlying the digits, periocular region located generally bilaterally\\nsymmetrical.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nEvaluation of alleged contactants and their avoidance.\\n\\uf0b7\\nWet compresses and soaks for exudative lesions.\\nPharmacological treatment\\n\\uf0b7\\nTopical corticosteroids like betamethasone valerate 0.05 % cream or mometasone furoate\\n0.05% cream/ointment.\\n\\uf0b7\\nTopical and oral antibacterial in case of infection.\\n\\uf0b7\\nOral antihistaminics like Tab.cetrizine (10mg/day) or Tab. chlorpheniramine (4mg/day).\\n\\uf0b7\\nSevere cases Tab. prednisolone 0.5-1 mg/kg/day.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 225, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTopical and oral antibacterial in case of infection.\\n\\uf0b7\\nOral antihistaminics like Tab.cetrizine (10mg/day) or Tab. chlorpheniramine (4mg/day).\\n\\uf0b7\\nSevere cases Tab. prednisolone 0.5-1 mg/kg/day.\\n\\uf0b7\\nRegular follow up.\\nPITYRIASIS ALBA\\nUsually found in children, mostly on face. They present as asymptomatic hypopigmented,\\nmildly scaly lesions, generally over face. Diagnosis is clinical.\\nTreatment\\n\\uf0b7\\nEmollient\\n\\uf0b7\\nTopical steroids:  fluticasone (0.005%) or fluocinolone (0.05%) or mometasone (0.1%) to\\nbe applied till the lesion heal.\\nVITILIGO\\nIt is an acquired primary, progressive melanocytopenia of unknown etiology and\\ncharacterized by asymptomatic depigmented lesions.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\nNon- pharmacological treatment\\n\\uf0b7\\nCounselling and reassurance.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 226, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n211\\n\\uf0b7\\nIt can be acute (less than 6 weeks) or chronic (>6 weeks). Characteristic wheals with or\\nwithout angioedema. Dermatographism may be present.\\n\\uf0b7\\nGood general health and balanced nutritious diet enriched with adequate proteins, vitamin\\nB complex, vitamin E, minerals such as copper, zinc and iron.\\n\\uf0b7\\nAvoid trauma.\\n\\uf0b7\\nAvoid soaps and detergents containing phenolic compound and rubber goods.\\nPharmacological treatment\\n\\uf0b7\\nTopical steroids like mometasone furoate 0.1 % cream, betamethasone valerate 0.05%\\ncream ointment.\\n\\uf0b7\\nTopical calcineurin inhibitors like tacrolimus 0.03% or 0.1% ointment.\\n\\uf0b7\\nPUVA therapy Tab. methoxsalen (0.6mg/kg) or topical psoralens followed by sun\\nexposure.\\nALBINISM\\nAlbinism (from latin albus, \"white\") is a congenital disorder characterized by the complete or\\npartial absence of pigment in the skin, hair and eyes due to absence or defect of  tyrosinase.\\nThere is generalised and diffuse depigmentation of skin with white hair from birth. Diagnosis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 226, 'source_type': 'Authorotative', 'priority': '1'}, page_content='partial absence of pigment in the skin, hair and eyes due to absence or defect of  tyrosinase.\\nThere is generalised and diffuse depigmentation of skin with white hair from birth. Diagnosis\\nis clinical.\\nTreatment\\n\\uf0b7\\nReassurance, patient education, protection from sunlight.\\nMELASMA\\nIt is a pigmentary disorder of the skin characterized by malar hyperpigmentation. It is\\nparticularly common in women, especially during pregnancy and those taking oral\\ncontraceptives or hormone replacement therapy.\\nDiagnosis\\nClinical and woods lamp examination\\nNon- pharmacological treatment\\n\\uf0b7\\nReassurance in pregnancy induced melasma.\\n\\uf0b7\\nAvoid sun exposure and causative factor like hormonal therapy.\\nPharmacological treatment\\n\\uf0b7\\nTopical agents like hydroquinone 2-5% cream or azelaic acid 10-20% cream or glycolic\\nacid 6-12% cream or hydroquinone + tretinoin + steroid (fluticasone, mometasone,\\nfluocinolone).\\n\\uf0b7\\nPhotoprotection.\\nURTICARIA'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 226, 'source_type': 'Authorotative', 'priority': '1'}, page_content='acid 6-12% cream or hydroquinone + tretinoin + steroid (fluticasone, mometasone,\\nfluocinolone).\\n\\uf0b7\\nPhotoprotection.\\nURTICARIA\\nUrticaria is characterized by transient erythematous wheals with burning or stinging\\nsensation. Most common causes are idiopathic, infections, food and drugs.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 227, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n212\\n\\uf0b7\\nChronic plaque psoriasis (Figure 19) is clinically characterized by erythematous scaly\\nplaques with micaceous scaling predominantly over extensor surfaces of body, scalp scaling\\nand nail pitting is seen (when involved). Winter aggravation is a feature.\\n\\uf0b7\\nScalp psoriasis- erythematous scaly plaques on the scalp with itching.\\n\\uf0b7\\nGuttate psoriasis- dew drop like crop of erythematous scaly papules and plaques all over\\nbody. Associated with preceding streptococcal infection.\\n\\uf0b7\\nPsoriatic arthritis- asymmetrical oligoarticular arthritis involving distal interphalangeal joints\\nof fingers and toes.\\nDiagnosis\\n\\uf0b7\\nClinical\\nNon- pharmacological treatment\\n\\uf0b7\\nEradicate the etiological factor if any.\\n\\uf0b7\\nAvoid the food causing urticaria.\\n\\uf0b7\\nCold water sponging and soothing applications.\\n\\uf0b7\\nClearance of airway in case of laryngeal oedema.\\nPharmacological treatment\\n\\uf0b7\\nAcute urticaria with/without angioedema-\\nInj. chlorpheniramine maleate, Inj.\\ndexamethasone IV or IM.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 227, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nClearance of airway in case of laryngeal oedema.\\nPharmacological treatment\\n\\uf0b7\\nAcute urticaria with/without angioedema-\\nInj. chlorpheniramine maleate, Inj.\\ndexamethasone IV or IM.\\n\\uf0b7\\nChronic urticaria with/without angioedema- Tab. levocetrizine 5mg OD and/or Tab.\\nchlorpheniramine maleate 4mg HS.\\n\\uf0b7\\nLaryngopharyngeal edema Inj. epinephrine 0.5 to 1 ml SC and Inj. hydrocortisone 100mg\\nIV immediately.\\nPSORIASIS\\nPsoriasis is characterized by hyperproliferation and abnormal differentiation of epidermal\\nkeratinocytes, lymphocyte infiltration and various endothelial vascular changes in the dermis.\\nIt is a multifactorial condition where both genetic and environmental factors act together.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and skin biopsy.\\nNon- pharmacological treatment\\n\\uf0b7\\nIdentify and avoid triggering factors.\\n\\uf0b7\\nAvoid stress, alcohol and smoking.\\n\\uf0b7\\nAvoid beta blockers and chloroquine.\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 227, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Non- pharmacological treatment\\n\\uf0b7\\nIdentify and avoid triggering factors.\\n\\uf0b7\\nAvoid stress, alcohol and smoking.\\n\\uf0b7\\nAvoid beta blockers and chloroquine.\\nPharmacological treatment\\n\\uf0b7\\nTopical agents( if< 10% BSA is involved) such as emollients- liquid paraffin, vaseline,\\nlight liquid paraffin, white soft paraffin, clobetasol and betamethasone either alone or in\\ncombination and salicylic acid 3-6%.\\n\\uf0b7\\nVitamin D3 analogues- calcitriol, calcipotriol (SOS).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 228, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n213\\n\\uf0b7\\nErythematous to violaceous, flat topped, polygonal papules associated with intense pruritus\\n(Figure 20).\\n\\uf0b7\\nSites- Dorsal surface of the hands, flexor surfaces of the wrists and forearms; anterior aspect\\nof the lower legs, neck and sacral area are also common sites.\\n\\uf0b7\\nAsymptomatic, smooth, well defined round to oval totally bald patch slightly depressed\\nbelow the surface.\\n\\uf0b7\\nParaesthesia or mild erythema may precede. At the margins of the expanding lesion, the\\ncharacteristic ‘exclamation’ mark hair can be found.\\n\\uf0b7\\nSystemic therapy  ( if > 20%  BSA is involved) at tertiary care centre - Tab. methotrexate\\n5-7.5 mg/week or Tab. cyclosporine 100-200 mg/day (SOS) or Tab. acitretin 25 mg/day.\\n\\uf0b7\\nPhototherapy SOS.\\nLICHEN PLANUS\\nIt is an inflammatory autoimmune, papulosquamous disorder affecting skin, nails and/or\\nmucous membranes.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and skin biopsy\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 228, 'source_type': 'Authorotative', 'priority': '1'}, page_content='It is an inflammatory autoimmune, papulosquamous disorder affecting skin, nails and/or\\nmucous membranes.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and skin biopsy\\nPharmacological treatment\\n\\uf0b7\\nMild – topical fluocinonide 0.05% or clobetasol propionate 0.05% cream and calcineurin\\ninhibitors like tacrolimus ointment 0.03%.\\n\\uf0b7\\nModerate or severe cases- Tab. prednisolone 0.5-1 mg/kg) in gradually tapering doses\\nover 6 weeks.\\n\\uf0b7\\nInj. triamcinolone acetonide (0.5-1 mg/kg) per month for 3-6 months.\\n\\uf0b7\\nRetinoids – Tab. acitretin (25-50 mg / day for 6-8 weeks).\\nPatient education\\n\\uf0b7\\nInform the patient that condition is non-infectious, self limiting and recurrence may\\noccur.\\nALOPECIA AREATA\\nIt is a common condition characterized by patchy loss of hair without scarring.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nBiopsy – peribulbar lymphocytic infiltrate in “swarm of bees” pattern.\\nNon- pharmacological treatment\\n\\uf0b7\\nCounselling and reassurance – disease is self limiting.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 229, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n214\\nPharmacological treatment\\n\\uf0b7\\nProcedures is done at tertiary care centres with topical application of  irritants - anthralin,\\nphenol, tazarotene, azelaic acid, tincture iodine or contact sensitizers- squaric acid dibutyl\\nester, diphencyprone or\\n\\uf0b7\\nIntralesional- Triamcinolone acetonide 10 mg/ml 0.2-0.5ml per patch every 3 weeks.\\n\\uf0b7\\nTopical therapy by hydrocortisone acetate ointments or cream 1% or fluticasone\\ndipropionate 0.1% or psoralen or minoxidil.\\nSystemic therapy – for progressive lesions, not responding to topical agents.\\n\\uf0b7\\nSystemic corticosteroids-pulsed therapy in form of monthly Inj. triamcinolone (40mg/ml)\\nor oral mini pulse Tab. prednisolone 40mg two successive days in a week.(duration of the\\ntherapy depends on the response).\\n\\uf0b7\\nSystemic immunomodulators – Tab. cyclosporine(2mg/kg/day)\\n\\uf0b7\\nOral phototherapy (PUVA) (should be given at tertiary centres because it is associated\\nwith side effects and cumulative dose dependent toxicities).\\nPEMPHIGUS VULGARIS'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 229, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nOral phototherapy (PUVA) (should be given at tertiary centres because it is associated\\nwith side effects and cumulative dose dependent toxicities).\\nPEMPHIGUS VULGARIS\\nA group of blistering autoimmune diseases that affect the skin and mucous membranes. It is\\ncharacterised by mucosal involvement, flaccid blister over apparently normal skin (Figure 21)\\nand positive Nikolsky sign.\\nDiagnosis\\n\\uf0b7\\nClinical\\n\\uf0b7\\nTzanck smear to demonstrate acantholysis\\n\\uf0b7\\nBiopsy or anti-desmoglein autoantibodies to confirm\\nNon- pharmacological treatment\\n\\uf0b7\\nHospitalization.\\n\\uf0b7\\nFluid replacement.\\nPharmacological treatment (only at tertiary care centre)\\n\\uf0b7\\nOral: to prevent infection (Tab. azithromycin  500 mg OD for 5 days/ Tab. cotrimoxazole\\n2 BD for 7 days  according to culture sensitivity if there is infection).\\n\\uf0b7\\nIV dexamethasone (1mg/kg -2mg/kg bw).\\nCUTANEOUS ADVERSE DRUG REACTIONS\\nI.\\nMACULOPAPULAR RASH\\nIt is milder form of drug reaction also known as scarletiniform rash or morbilliform rash.\\nDugs'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 229, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIV dexamethasone (1mg/kg -2mg/kg bw).\\nCUTANEOUS ADVERSE DRUG REACTIONS\\nI.\\nMACULOPAPULAR RASH\\nIt is milder form of drug reaction also known as scarletiniform rash or morbilliform rash.\\nDugs\\ncausing maculopapular rash are penicillin, sulfonamides, aspirin, phenytoin,\\nphenylbutazone, tetracycline, digitalis, thiacetazone, quinine, pas, rifampicin, ibuprofen etc.\\nIt is confluent erythematous maculopaplar rash with itching.\\nDiagnosis\\n\\uf0b7\\nClinical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 230, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n215\\n\\uf0b7\\nClassical iris or target lesions (central dusky erythema, purpura or blister middle ring of pale\\nedema with erythematous halo) are present in an acral distribution, may involve palms, dorsa\\nof hands, feet, elbows and knees.\\n\\uf0b7\\nLesions usually fade in one to two weeks.\\n\\uf0b7\\nMucosal lesions- lips palate and gingivae are common sites.\\nPharmacological treatment\\n\\uf0b7\\nStop the causal drug.\\n\\uf0b7\\nTopical calamine lotion and Tab. cetirizine (10 mg/ day).\\nII. ERYTHEMA MULTIFORME\\nA self-limited but potentially recurrent disease characterised by appearance of dull red\\nerythematous maculopapular lesions with a central vesicle and sometimes with a marginal\\nring of vesicle usually acral (hands and feet) distribution. Most common cause is infection\\nwith herpes simplex virus and drugs.\\nCommon drugs causing erythema multiforme are penicillin, sulfonamides, aspirin, phenytoin,\\nphenylbutazone, tetracycline, codeine, digitalis, thiacetazone, quinine, isoniazid, PAS,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 230, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Common drugs causing erythema multiforme are penicillin, sulfonamides, aspirin, phenytoin,\\nphenylbutazone, tetracycline, codeine, digitalis, thiacetazone, quinine, isoniazid, PAS,\\nrifampicin, glucocorticoids, methotrexate, clindamycin, ibuprofen, minoxidil, griseofulvin,\\nstreptomycin, piroxicam, anticholinergic eye drops, perfumes topical like vitamin E,  5-\\nfluorouracil, nitrogen mustard.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and Complete blood count, liver function tests.\\nNon- pharmacological treatment\\n\\uf0b7\\nDiscontinue the causal drug.\\nPharmacological treatment\\n\\uf0b7\\nTopical antiseptics for eroded skin lesions.\\n\\uf0b7\\nAntiseptic and local anaesthetic solutions for oral lesion in case of herpes simplex.\\n\\uf0b7\\nTopical ophthalmic preparations like normal saline or lubricating eye drops for eye\\nlesions.\\n\\uf0b7\\nTab. cetirizine (10 mg) or Tab.chlorpheniramine (4 mg) for 3 or 4 days.\\n\\uf0b7\\nTab. prednisone [0.5–1 mg/kg/day].\\nIII.FIXED DRUG ERUPTION'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 230, 'source_type': 'Authorotative', 'priority': '1'}, page_content='lesions.\\n\\uf0b7\\nTab. cetirizine (10 mg) or Tab.chlorpheniramine (4 mg) for 3 or 4 days.\\n\\uf0b7\\nTab. prednisone [0.5–1 mg/kg/day].\\nIII.FIXED DRUG ERUPTION\\nCharacteristically recur at the same site following the administration of the offending drug or\\noccasionally member of the same group of drugs. Occur in 30 mins to 8 hours after drug\\nadministration. Common drugs include sulfonamides, NSAIDs, tetracycline, dapsone,\\nchlordiazepoxide, barbiturates, ciprofloxacin, phenytoin, codeine, quinine, griseofulvin,\\nmebendazole, metronidazole, ampicillin and antituberculous drugs.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 231, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n216\\n\\uf0b7\\nRound, sharply demarcated erythematous/ hyperpigmented patches are seen, sometimes with\\na central blister or detached epidermis (Figure 22).\\n\\uf0b7\\nSites: lips, face, hands, feet and genitalia.\\n\\uf0b7\\nGeneralised bullous FDE is characterized by multiple, sharply defined, deep red macules and\\nblisters with bilateral symmetrical distribution.\\n\\uf0b7\\nLesions consist of wide spread flat atypical target or purpuric macules distributed centrally\\nwith involvement of at least two mucosal sites.\\n\\uf0b7\\nCutaneous lesions are preceded by fever, arthralgia, malaise, headache, vomiting, diarrhea\\nand myalgia. Mucosae involved are eyes, mouth and genitalia.\\n\\uf0b7\\nIn TEN, confluent erythema is present, the epidermis separates in a set forming raised,\\nflaccid bullae. Pain, burning and tenderness of the skin are marked.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\nNon- pharmacological treatment\\n\\uf0b7\\nStop the offending drug.\\n\\uf0b7\\nEnlist the drugs to be avoided.\\nPharmacological treatment\\n\\uf0b7\\nTopical calamine lotion.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 231, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Salient features\\nDiagnosis\\n\\uf0b7\\nClinical\\nNon- pharmacological treatment\\n\\uf0b7\\nStop the offending drug.\\n\\uf0b7\\nEnlist the drugs to be avoided.\\nPharmacological treatment\\n\\uf0b7\\nTopical calamine lotion.\\n\\uf0b7\\nTab. cetirizine (10 mg/ day) or Tab. chlorpheniramine (4 mg/day).\\n\\uf0b7\\nTab. prednisolone 0.5-1 mg/kg/ day) for generalized bullous FDE.\\nIV.STEVENS JOHNSON SYNDROME/ TOXIC EPIDERMAL NECROLYSIS\\nStevens Johnson Syndrome is an adverse cutaneous drug reactions, characterized by <10%\\nbody surface area of epidermal detachment and mucocutaneous tenderness and erythema\\n(Figure 23). Toxic epidermal necrolysis (TEN) is an adverse cutaneous drug reactions,\\ncharacterized by >30% body surface area of epidermal detachment and mucocutaneous\\ntenderness and erythema.\\nCommon drugs causing SJ Syndrome/TEN are ampicillin, allopurinol, carbamazepine,\\ncotrimoxazole, isoniazid, lamotrigine, nevirapine, NSAIDs, phenobarbitol, phenylbutazone,\\nphytoin, ciprofloxacin, rifampicin, salicylates, tetracyclines, thiacetazone'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 231, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cotrimoxazole, isoniazid, lamotrigine, nevirapine, NSAIDs, phenobarbitol, phenylbutazone,\\nphytoin, ciprofloxacin, rifampicin, salicylates, tetracyclines, thiacetazone\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\nNon- pharmacological treatment\\n\\uf0b7\\nWithdraw offending drug.\\n\\uf0b7\\nOral liquid diet with protein supplements.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 232, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n217\\n\\uf0b7\\nCharacterized by grouped vesicles followed by erosive lesions associated with burning and\\npain. Primary genital herpes-systemic symptoms are prominent and prolonged\\n\\uf0b7\\nRecurrent genital herpes-recurrent episodes are milder lasting only for 5-7 days\\n\\uf0b7\\nPrimary syphilis- characterized by single well defined painless indurated ulcer and enlarged,\\ndiscrete, non tender firm lymphnodes with rubbery consistency.\\n\\uf0b7\\nSecondary syphilis- begins after 2-12 weeks after the primary chancre. Presentation-\\nmacular, papular, pustular, annular, follicular, mucus membrane lesions and lues maligna\\n(Figure 24(a)). Tertiary syphilis-Gummatous lesions of covering structures / viscera,\\nCardiovascular syphilis, Neurosyphilis- Meningeal/ Parenchymatous / Gummatous\\n\\uf0b7\\nOral care: oral hygiene should be maintained with antiseptic mouth washes.\\n\\uf0b7\\nMaintain optimum temperature of 30-32° C.\\nPharmacological treatment (tertiary care centre)\\n\\uf0b7\\nHospitalisation.\\n\\uf0b7\\nManagement of fluid and electrolytes.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 232, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nMaintain optimum temperature of 30-32° C.\\nPharmacological treatment (tertiary care centre)\\n\\uf0b7\\nHospitalisation.\\n\\uf0b7\\nManagement of fluid and electrolytes.\\n\\uf0b7\\nMeasures to prevent secondary infections.\\n\\uf0b7\\nOphthalmic care: saline or antibiotic eye drops\\n\\uf0b7\\nSystemic antibiotics to prevent infection according to culture sensitivity: Macrolides-\\nTab. azithromycin 500mg OD for 3/5days/ Tab.erythromycin 500mg QID for 5/7 days.\\n\\uf0b7\\nTab. prednisolone (1-2 mg/kg/day), parentral (Inj. dexamethasone 8-16mg/day). It should\\nbe started within 72hr   of onset and continued for 3-5days with rapid tapering.\\n\\uf0b7\\nTab. cyclosporine (3-5 mg/kg/day) for two weeks followed by weaning over another two\\nweeks SOS.\\nHERPES GENITALIS\\nHerpes genitalis most commonly caused by HSV 2.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical and Tzank smear and serological- HSV IgM antibody.\\nTreatment (Table 2)\\n\\uf0b7\\nKit 5 by NACO.\\nPatient education\\n\\uf0b7\\nAvoid sexual contact and treatment of the partner.\\nSYPHILLIS'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 232, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Diagnosis\\n\\uf0b7\\nClinical and Tzank smear and serological- HSV IgM antibody.\\nTreatment (Table 2)\\n\\uf0b7\\nKit 5 by NACO.\\nPatient education\\n\\uf0b7\\nAvoid sexual contact and treatment of the partner.\\nSYPHILLIS\\nSyphilis is a systemic disease caused by the spirochete, treponema pallidum.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 233, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n218\\n\\uf0b7\\nMultiple painful, non indurated genital ulceration with painful inguinal lymphaedenopathy\\n(Figure 24(b)).\\n\\uf0b7\\nDiagnosis is mostly clinical and confirmation with gram stain and bacterial culture can be\\ndone.\\n\\uf0b7\\nSmall transient painless papule or herpetiform ulcer develops at the site of inoculation, most\\noften goes unnoticed by the patient.\\n\\uf0b7\\nThe primary ulcer resolves without treatment after 2 to 6 weeks. The second stage of the\\ndisease is known as the inguinal syndrome/ano rectal genital syndrome.\\nDiagnosis\\n\\uf0b7\\nDark field microscopy\\n\\uf0b7\\nDirect fluorescent antibody test for treponema pallidum\\n\\uf0b7\\nNon treponemal test- VDRL, RPR and Treponemal test- FTA-ABS,TPHA,MHA-TP\\nTreatment (Table 2)\\n\\uf0b7\\nKit 3 by NACO\\nPatient education\\n\\uf0b7\\nRegular follow up and serological examination\\n\\uf0b7\\nTreatment of partner\\n\\uf0b7\\nCounseling about safe sex practice\\nCHANCROID\\nChancroid is caused by the small gram-negative rod, Haemophilus Ducreyi.\\nSalient features\\nTreatment (Table 2)\\n\\uf0b7\\nKit 4 by NACO'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 233, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTreatment of partner\\n\\uf0b7\\nCounseling about safe sex practice\\nCHANCROID\\nChancroid is caused by the small gram-negative rod, Haemophilus Ducreyi.\\nSalient features\\nTreatment (Table 2)\\n\\uf0b7\\nKit 4 by NACO\\nLYMPHOGRANULOMA VENERUM\\nLymphogranuloma venereum (LGV) is caused by chlamydia trachomatis serovars l1, l2, or\\nl3.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nClinical\\nTreatment (Table 2)\\n\\uf0b7\\nKit 4 by NACO\\nURETHRAL DISCHARGE\\nCaused by Neisseria gonnorhoe, Chlamydia trachomatis, Mycoplasma and Ureaplasma\\nurealyticum. Manifests as thick whitish-yellow discharge per urethra associated with dysuria.\\nDiagnosis\\n\\uf0b7\\nClinical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 234, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n219\\n\\uf0b7\\nGram stain and Culture\\nTreatment (Table 2)\\n\\uf0b7\\nKit 1 by NACO.\\nNon- pharmacological treatment\\n\\uf0b7\\nEducate and counsel the client and sexual partner regarding sexually transmitted\\ninfection/ reproductive tract infection safer sex practices and importance of taking\\ncomplete treatment.\\n\\uf0b7\\nTreat partner. Advice sexual abstinence or condom use during the course of treatment.\\nProvide condoms, educate about correct and consistent condom use.\\n\\uf0b7\\nRefer all patients to ICTC.\\n\\uf0b7\\nFollow up after 7 days for all sexually transmitted infections; on 3rd, 7th and 14th day for\\nlower abdominal pain and on 7th, 14th and 21st day for inguinal bubo.\\n\\uf0b7\\nIf symptoms persist, re-assess for re-infection and advice prompt reference.\\n\\uf0b7\\nConsider immunization against Hepatitis B.\\nTable 2. Drug kits provided by NACO\\nDERMATOLOGICAL EMERGENCY\\nSevere acute allergic reactions include urticaria, angioedema, anaphylaxis, Steven Johnson'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 234, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nConsider immunization against Hepatitis B.\\nTable 2. Drug kits provided by NACO\\nDERMATOLOGICAL EMERGENCY\\nSevere acute allergic reactions include urticaria, angioedema, anaphylaxis, Steven Johnson\\nSyndrome, toxic epidermal necrolysis, life threatening stings and bites. Life threatening\\ninfections include necrotizing soft tissue infections, fungal and viral infections with\\ncomplications. Severe dermatological conditions include: autoimmune vesiculo bullous\\nKit\\nColor\\nComposition of kit\\nSyndrome/disease\\n1\\nGrey\\nTab. azithromycin 1g stat +\\nTab cefixime 400 mg stat\\nUrethral discharge , cervical\\ndischarge , anorectal discharge,\\npainful scrotal swelling\\n2\\nGreen\\nTab. secnidazole 2g stat +\\nCap. fluconazole 150mg stat\\nVaginal discharge\\n3\\nWhite\\nInj. benzathine penicillin 2.4 mu IM\\nstat + Tab. azithromycin 1g stat\\nGenital ulcerative disease\\n(non herpetic)\\n4\\nBlue\\nCap. doxycycline 100mg BD for 15\\ndays + Tab. azithromycin 1g stat\\nGenital ulcerative disease\\n(non-herpetic)\\n5\\nRed'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 234, 'source_type': 'Authorotative', 'priority': '1'}, page_content='stat + Tab. azithromycin 1g stat\\nGenital ulcerative disease\\n(non herpetic)\\n4\\nBlue\\nCap. doxycycline 100mg BD for 15\\ndays + Tab. azithromycin 1g stat\\nGenital ulcerative disease\\n(non-herpetic)\\n5\\nRed\\nTab. acyclovir 400mg TDS for 7\\ndays\\nGenital ulcerative disease  (herpetic)\\n6\\nYellow\\nTab. cefixime 400mg stat +\\nTab. metronidazole 400mg BD for\\n15 days + Cap. doxycycline 100mg\\nBD for 14 days\\nLower abdominal pain (lap)\\n7\\nBlack\\nCap. doxycycline 100mg BD for 21\\ndays + Tab. azithromycin 1g stat\\nInguinal bubo'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 235, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Skin Diseases\\n220\\ndisorders, collagen vascular disorders, psoriasis- unstable, cutaneous involvement in\\nparaneoplastic disorders and systemic infections.\\nTreatment\\nDermatological emergencies can only be managed at tertiary care centre.\\nNon- pharmacological treatment\\n\\uf0b7\\nTreat the primary cause.\\n\\uf0b7\\nMaintain CAB (circulation, airway and breathing).\\n\\uf0b7\\nCareful monitoring of the vitals.\\n\\uf0b7\\nFluid and electrolyte management.\\n\\uf0b7\\nInput and output chart.\\nPharmacological treatment (only at tertiary centres)\\n\\uf0b7\\nSystemic corticosteroids for autoimmune blistering and collagen vascular disorders (dose\\ndepending on the severity of involvement and taper according to the response on follow\\nup).\\n\\uf0b7\\nAppropriate antibiotics like Tab .azithromycin 500 mg OD for 3/5days/Tab .erythromycin\\n500 mg QID for 5/7 days., antiviral like Tab. acyclovir 400 mg TDS for 7 days ;\\nantifungals like Cap. fluconazole 50-100 mg/day for 7-10 days(depending on severity).\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 235, 'source_type': 'Authorotative', 'priority': '1'}, page_content='500 mg QID for 5/7 days., antiviral like Tab. acyclovir 400 mg TDS for 7 days ;\\nantifungals like Cap. fluconazole 50-100 mg/day for 7-10 days(depending on severity).\\n\\uf0b7\\nImmunosuppressant drugs used with caution and monitoring like cyclophosphamide 1-\\n1.5mg/kg/day, azathioprine 1-2mg/kg/day, cyclosporine (2mg/kg/day).\\n\\uf0b7\\nIV Immunoglobulin and biological agents (rarely used).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 236, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"229\\nChapter 13\\nOBSTETRICS AND GYNECOLOGY\\nNORMAL PREGNANCY\\nIt is a transient physiological state during a woman's reproductive years. However, it requires\\nutmost antenatal care regarding diet, lifestyle and drug therapies to achieve a good foetal\\noutcome with minimal maternal morbidity and mortality.\\nInstruct the woman regarding\\n\\uf0b7\\nDiet\\nCaloric requirements depend on the physical work done by the women. The increased\\nrequirement of 300 cals for the pregnancy state is to be made available by exogenous supply\\nof diet. An ideal pregnancy diet should be light, nutritious, easily digestible and rich in\\nproteins, vitamins and minerals. The diet should consist of at least half-a-liter of milk, plenty\\nof green leafy vegetables (one katori serving in each meal) and fruits as available, in addition\\nto normal Indian diet consisting of a balanced cereals and pulses combination. Foods rich in\\niron like green vegetables, jaggery, and protein rich foods like nuts should be stressed upon.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 236, 'source_type': 'Authorotative', 'priority': '1'}, page_content='to normal Indian diet consisting of a balanced cereals and pulses combination. Foods rich in\\niron like green vegetables, jaggery, and protein rich foods like nuts should be stressed upon.\\nFat consumption can be predominantly of animal source so as to take care of vitamins A & D.\\n\\uf0b7\\nExercise\\nAny exercise, the woman is accustomed to can be continued, but not to the point of fatigue.\\nAntenatal exercises done under medical supervision are useful in pregnancy and labour. No\\nnew exercise should be initiated during pregnancy. Sedentary women should be allowed only\\nwalking. Women with multiple foetuses and complications like heart disease, pregnancy\\ninduced hypertension, intrauterine growth retardation, history of preterm labour, anti partum\\nhemorrhage (APH), threatened abortion should not exercise.\\n\\uf0b7\\nClothing\\nShould be non-constricting.\\n\\uf0b7\\nTravel\\nRoad travel is allowed with safety belt. Traveling in a pressurized aircraft is of no risk, should\\nwalk about every 2 hours.\\n\\uf0b7\\nEmployment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 236, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nClothing\\nShould be non-constricting.\\n\\uf0b7\\nTravel\\nRoad travel is allowed with safety belt. Traveling in a pressurized aircraft is of no risk, should\\nwalk about every 2 hours.\\n\\uf0b7\\nEmployment\\nJobs requiring prolonged standing (>8 hours/day) are associated with a minimum risk of pre-\\nterm delivery.\\n\\uf0b7\\nClinical check up\\nDuring each antenatal visit, BP, weight-gain, oedema feet, cardio-vascular, respiratory and\\nbreast examination symphyseal-fundal height, presentation, foetal heart rate(s), amniotic fluid\\nvolume, inquiry about daily foetal movement charting, and pelvic assessment at 38 weeks. Rh\\nnegative women (with Rh positive husband) need to be monitored on similar lines with\\nadditional testing with Indirect Coomb's test (ICT) at first visit, 28 weeks and 34-36 weeks.\\nImmunoglobulin 300 mcg IM is recommended in ICT negative patients at 28 weeks of\\npregnancy and postpartum 300 mcg IM if baby is Rh positive. ICT positive patients are to be\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 237, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n230\\nmanaged only at centers with facilities for amniocentesis and/or cordocentesis, amniotic fluid\\noptical density estimation and intrauterine foetal transfusions.\\nTab. folic acid 5 mg once daily, at least 3 months before conception, and continue till 12\\nweeks of gestation. Dose of iron (60-100 mg elemental iron) and folic acid (Tab. iron folic\\nacid) once daily and Tab. calcium gluconate 500 mg tablet twice daily from 16 weeks till 3\\nmonths postpartum.\\n\\uf0b7\\nImmunization\\n2 doses of tetanus toxoid 4-6 weeks apart, (MMR vaccines is contraindicated). Rest of the\\nvaccines can be administered, if indicated as in non pregnant state.\\n\\uf0b7\\nInvestigations during pregnancy\\nHaemoglobin, urine (routine and microscopy), blood groups and Rh typing, screen for\\nsyphilis, hepatitis B infection, HIV, cervical cytology, ultrasound for foetal anomalies if\\nindicated, diabetes screening\\nPatient education'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 237, 'source_type': 'Authorotative', 'priority': '1'}, page_content='syphilis, hepatitis B infection, HIV, cervical cytology, ultrasound for foetal anomalies if\\nindicated, diabetes screening\\nPatient education\\n\\uf0b7Advise the woman on how to prepare for delivery, when to go, what to bring and where to\\ngo in emergency. Explain the danger signals when she should report to the health center\\nimmediately, day or night, without waiting such as vaginal bleeding, convulsions, severe\\nheadaches with blurred vision, severe abdominal pain, fast or difficult breathing, escape of\\nfluid from vagina or change in frequency or intensity of foetal movements, persistent\\nvomiting, oliguria. She should go to the health centre as soon as possible if any of the\\nfollowing signs: swelling on face or hands, abdominal pain, fever, dysuria, feels ill.\\n\\uf0b7Explain about black staining of stools due to oral iron, therefore, not to worry about it.Iron\\nand calcium supplements should be taken at different times of the day at least 2 hours\\napart.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 237, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7Explain about black staining of stools due to oral iron, therefore, not to worry about it.Iron\\nand calcium supplements should be taken at different times of the day at least 2 hours\\napart.\\n\\uf0b7Discuss birth spacing after delivery and counsel on the importance of family planning.\\nGive advice on correct and consistent use of condoms for dual protection from sexually\\ntransmitted infections or HIV and pregnancy\\n\\uf0b7Sexual intercourse should be avoided when abortion/pre-term labour threatens, and during\\nlast 4 weeks in any pregnancy.\\n\\uf0b7Bowel: constipation, fissures and haemorrhoids are common during pregnancy and should\\nbe treated with fluids, exercise and bulk laxatives and stool softeners.\\n\\uf0b7Smoking, alcohol and drug abuse are contraindicated. Caffeine is best avoided.\\n\\uf0b7Daily foetal movement charting (DFMC): After 28 weeks, the woman should keep foetal\\nmovement count.\\n\\uf0b7Follow-up visits: every 4 weeks till 28 weeks, every 2 weeks till 36 weeks and weekly\\nthereafter.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 237, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7Daily foetal movement charting (DFMC): After 28 weeks, the woman should keep foetal\\nmovement count.\\n\\uf0b7Follow-up visits: every 4 weeks till 28 weeks, every 2 weeks till 36 weeks and weekly\\nthereafter.\\nNAUSEA AND VOMITING IN EARLY PREGNANCY\\nNausea and vomiting of mild to moderate intensity are especially common complaints in\\nearly pregnancy until about 16 weeks. In few cases it may progress to hyperemesis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 238, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Obstetrics and Gynecology\\n231\\n\\uf0b7Common complaint on rising in the morning but sometimes occurs at other times of the day;\\nvomitus is usually small and clear and doesn't produce any impairment of health or restrict the\\nnormal activities of the pregnant woman.\\n\\uf0b7Severe nausea and persistent vomiting progress to hyperemesis leading to weight loss, ketosis\\nand there may be muscle wasting. There are usually signs of dehydration with postural\\nhypotension and tachycardia.\\n\\uf0b7Diagnosis is by exclusion of medical and surgical causes of vomiting like liver or GIT\\ndisorders, pyelonephritis, diabetes mellitus etc. and molar (and multiple) pregnancy should be\\nruled out in all cases of hyperemesis by ultrasound.\\nSalient features\\nMild and moderate cases\\nNon pharmacological treatment\\n\\uf0b7\\nReassurance and advice to take frequent small, dry carbohydrate rich meals and avoid\\nfatty or spicy foods, especially avoid large volume of drinks in the morning.\\nPharmacological treatment\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 238, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nReassurance and advice to take frequent small, dry carbohydrate rich meals and avoid\\nfatty or spicy foods, especially avoid large volume of drinks in the morning.\\nPharmacological treatment\\n\\uf0b7\\nTab. doxylamine succinate 10 mg + Tab. pyridoxine HC1 10 mg 1-2 tablets at bed time.\\nIf required one more tablet can be added in the morning and afternoon. Or\\n\\uf0b7\\nTab. metoclopramide 10 mg 2-4 times a day in moderately severe cases.\\nHyperemesis gravidium\\nNon pharmacological treatment\\nAdmit all cases in the hospital away from a stressful home environment.\\n\\uf0b7\\nStop oral intake of fluids and nutrition.\\n\\uf0b7\\nSerum electrolytes and urinary ketones to be checked at admission and 6 hourly.\\n\\uf0b7\\nEmotional support, psychiatric referral if required.\\n\\uf0b7\\nRule out multiple or molar pregnancy and liver disorders.\\nPharmacological treatment\\nAdequate and appropriate fluid and electrolyte replacement. Normal saline or Ringer's lactate\\nsolutions are appropriate solutions and KC1 is added as required.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 238, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Pharmacological treatment\\nAdequate and appropriate fluid and electrolyte replacement. Normal saline or Ringer's lactate\\nsolutions are appropriate solutions and KC1 is added as required.\\nIf urinary ketones are present, then 1 liter of 10% dextrose is transfused over 3-4 hours.\\nFor prolonged vomiting\\n\\uf0b7\\nTab. thiamine 25-50 mg 3 times a day (if orally tolerated). If vomiting are not controlled\\nwith fluid and electrolytes replacement in 6 - 8 hours.\\n\\uf0b7\\nInj. metoclopramide 10 mg IV or IM 8 hourly\\n\\uf0b7\\nInj. ranitidine 50-100 mg 6 hourly.\\n\\uf0b7\\nIf not controlled, Inj. promethazine chloride 25-50 mg IM or IV 8 hourly or Inj.\\nchlorpromazine 25-50 mg IM 4-6 hourly.\\n\\uf0b7\\nOnce vomiting is controlled for 24 hours, oral intake is gradually started. If well tolerated\\nthen only IV fluids are omitted. At first dry carbohydrate foods are given in the form of\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 239, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n232\\n\\uf0b7\\nBleeding in first trimester of pregnancy can be due to pregnancy related complications\\nsuch as abortion (threatened/inevitable/ incomplete/missed), ectopic pregnancy and molar\\npregnancy or due to local causes such as trauma, erosion, polyp, infection, premalignant\\nor malignant lesions.\\n\\uf0b7\\nLocal lesions are diagnosed on per speculum examination.\\nsmall meals at frequent intervals. Gradually full diet is introduced. In prolonged and\\nsevere disease, parenteral nutrition may be necessary. Give Tab. metoclopramide 10 mg\\nTDS and Tab. ranitidine 150 mg BD\\n\\uf0b7\\nIf well tolerated for 48 hours, patient can be discharged from the hospital with dietary\\nadvice, reassurance and continue Tab. metoclopramide for 5-7 days or longer depending\\non the response.\\nPatient education\\n\\uf0b7\\nAdjust timing of medication in relation to the time of sickness.\\n\\uf0b7\\nThis is a benign disorder and gets relieved by 14-16 weeks of pregnancy\\nFIRST TRIMESTER BLEEDING\\nSalient features\\nTreatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 239, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAdjust timing of medication in relation to the time of sickness.\\n\\uf0b7\\nThis is a benign disorder and gets relieved by 14-16 weeks of pregnancy\\nFIRST TRIMESTER BLEEDING\\nSalient features\\nTreatment\\n\\uf0b7\\nAbortion can be treated at a primary centre.\\n\\uf0b7\\nMolar and ectopic pregnancy should be treated at a secondary/tertiary centre (Table 1)\\n\\uf0b7\\nCheck Bleeding time, clotting time, CRT in missed abortion\\nSurgical treatment\\n\\uf0b7\\nManual vacuum aspiration or suction evacuation, dilatation and evacuation or only\\nevacuation in all cases of abortion and molar pregnancy except threatened abortion.\\n\\uf0b7\\nLaparotomy/laparoscopic removal of ectopic pregnancy except a few selected cases of\\nunruptured ectopic pregnancy.\\nTable 1. Diagnosis of etiology of first trimester bleeding\\nDiagnosis\\nClinical findings\\nUSG/ HCG\\nThreatened abortion Uterine size = period of gestation\\n(POG) Internal Os closed\\nConsistent with live foetus\\nInevitable abortion\\nUterine size = POG\\nInternal Os open, excessive\\nbleeding and pain'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 239, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Threatened abortion Uterine size = period of gestation\\n(POG) Internal Os closed\\nConsistent with live foetus\\nInevitable abortion\\nUterine size = POG\\nInternal Os open, excessive\\nbleeding and pain\\nCardiac activity + Internal\\nOs dilated\\nIncomplete abortion History of passing products of\\nconception (POC) Uterine size < POG\\nInternal Os open/ closed\\nPOC in uterine cavity\\nMissed abortion\\nUterine size < POG Internal Os closed\\nBrownish discharge +\\nCardiac activity absent'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 240, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Obstetrics and Gynecology\\n233\\nMolar pregnancy\\nHistory of passing vesicles\\n± Uterine size > or = or < than POG\\nInternal Os open/closed\\nHoneycomb appearance\\nhCG levels very high\\nEctopic pregnancy\\nCervical excitation +\\nUnilateral tender fornix,\\nadnexal mass\\nPseudogestational sac\\nempty uterine cavity\\nadenexal  mass, HCG rise\\n<66% in 48 hours\\nPatient education\\n\\uf0b7\\nExact etiology of abortions is not always apparent. Very early abortions are often nature's\\nselection to abort a nonviable, chromosomally abnormal conceptus.\\n\\uf0b7\\nIncreased abortions are seen with increasing parity and maternal age. Recurrent abortions\\n3 or more consecutive abortions should be investigated before planning the next\\npregnancy.\\n\\uf0b7\\nEffective contraception should be initiated soon after abortion as ovulation can occur as\\nearly as 2-3 weeks after an abortion.\\nTHREATENED ABORTION\\nNon- pharmacological treatment\\nBed rest\\nPharmacological treatment\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 240, 'source_type': 'Authorotative', 'priority': '1'}, page_content='early as 2-3 weeks after an abortion.\\nTHREATENED ABORTION\\nNon- pharmacological treatment\\nBed rest\\nPharmacological treatment\\n\\uf0b7\\nInj. pentazocin 15 mg and Inj. promethazine 12.5 mg IM stat for those who have pain and\\nare anxious. If not available Inj. diazepam 10 mg IM or Tab. alprazolam 0.5 mg.\\n\\uf0b7\\nTab. folic acid 5 mg daily.\\n\\uf0b7\\nMonitor for the continuation of pregnancy after confirming cardiac activity by USG.\\n\\uf0b7\\nDischarge the patient 48 hours after bleeding stops.\\n\\uf0b7\\nProgesterone supplementation if serum progesterone < 15 ng/ml only after confirming\\ncardiac activity in cases of spontaneous conception.\\nPatient education\\n\\uf0b7\\nTo report immediately if bleeding recurs or it is more than normal periods.Continue bed\\nrest for at least 2 weeks.\\n\\uf0b7\\nAbstinence till at least two follow-up visits in the next 4 weeks when normal continuation\\nof pregnancy is documented. High fiber diet to be given to avoid constipation.\\n\\uf0b7\\nNeed of follow up after 2 weeks for fetal growth by clinical and/or USG parameters.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 240, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of pregnancy is documented. High fiber diet to be given to avoid constipation.\\n\\uf0b7\\nNeed of follow up after 2 weeks for fetal growth by clinical and/or USG parameters.\\nAfter suction evacuation for abortion\\n\\uf0b7\\nReassurance if no living child.\\n\\uf0b7\\nNeed for contraceptive - can be started immediately after evacuation. Can resume coitus\\nafter 4 weeks if no complications.\\n\\uf0b7\\nWhen to attempt conception - after at least 6 months'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 241, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n234\\n\\uf0b7Fever, tachycardia, abdominal distension and tenderness, pelvic tenderness, and purulent\\nvaginal discharge. In severe cases there may be endotoxic shock and end organ failure.\\n\\uf0b7Complications like injury to viscera like uterus and bowel, internal or external\\nhaemorrhage, peritonitis, disseminated intravascular coagulation, renal failure, hepatic\\nfailure, endotoxic shock and tetanus can occur.\\nSEPTIC ABORTION\\nAny abortion associated with fever and signs of pelvic or generalized sepsis are considered\\nseptic abortion. Most septic abortions result from illegal abortions but sepsis may follow\\nspontaneous and elective abortions\\nSalient features\\nBefore starting antibiotic therapy, high vaginal or cervical swab and blood culture should be\\nobtained.\\nPharmacological treatment\\n\\uf0b7\\nIV fluids for correction of electrolyte imbalance\\n\\uf0b7\\nOxygen by facemask in severe cases. In cases of adult respiratory distress syndrome'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 241, 'source_type': 'Authorotative', 'priority': '1'}, page_content='obtained.\\nPharmacological treatment\\n\\uf0b7\\nIV fluids for correction of electrolyte imbalance\\n\\uf0b7\\nOxygen by facemask in severe cases. In cases of adult respiratory distress syndrome\\nintubation and ventilatory support is required, and hydrotherapy if required.\\n\\uf0b7\\nIf blood pressure is not controlled with fluid replacement, Inj. dopamine infusion in 5%\\nDextrose 2 - 5 mcg/kg/min and dose titrated according to clinical and haemodynamic\\nresponse.\\n\\uf0b7\\nIn case of shock, acidosis is corrected by IV sodium bicarbonate 50-100 mEq in normal\\nsaline.\\n\\uf0b7\\nInj. ampicillin 2 g stat followed by 500 mg IV 6 hourly (after test dose) Or\\n\\uf0b7\\nInj. cefuroxime or ceftazidime 1-2 g IV 2 times a day (after test dose).\\n\\uf0b7\\nInj. gentamicin 1.5mg/kg then 1mg/kg IV 8hourly or Inj. amikacin 250 - 500 mg IV 8\\nhourly.\\n\\uf0b7\\nInj. metronidazole 500mg IV 8hourly or Inj. clindamycin 600 mg IV 6 hourly\\n\\uf0b7\\nContinue antibiotic therapy for 48-72 hours until culture sensitivity results provide an'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 241, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"hourly.\\n\\uf0b7\\nInj. metronidazole 500mg IV 8hourly or Inj. clindamycin 600 mg IV 6 hourly\\n\\uf0b7\\nContinue antibiotic therapy for 48-72 hours until culture sensitivity results provide an\\nindication for changing the initial antibiotic regimens or patient does not respond to\\ntherapy. Monitor pulse, temperature, blood pressure, respiratory rate, urine output, and\\nserum electrolytes. In severe cases, central venous pressure (CVP) and arterial blood gas\\n(ABG) monitoring is required. Therapeutic goals are to maintain systolic BP >90 mmHg,\\nurine output >30 ml/min, arterial PO, >60 mmHg, and CVP 6 - 12 cm of H2O.\\nSurgical treatment\\n\\uf0b7\\nUterine curettage: if patient's condition is stable, within 1 hour of antibiotic therapy,\\nevacuation of the uterus by gentle curettage to remove infected products. If general\\ncondition is low at admission, curettage after 6 -8 hours of antibiotic therapy and treat\\nhypovolaemia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 242, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n235\\n\\uf0b7\\nLaparotomy in case of injury to the uterus, suspected injury to the gut, presence of\\nforeign body in the abdomen as evidenced by X ray or felt through the fornix, peritonitis\\nor  colpotomy in cases of pelvic abscess.\\nECTOPIC PREGNANCY\\nTreatment of ectopic pregnancy should be undertaken at a secondary/tertiary care level set\\nup. Laparoscopic surgery or laparotomy is done in all cases of ectopic pregnancy except in a\\nfew selected cases that are highly compliant and reliable and fulfill the following criteria:\\n\\uf0b7\\nUnruptured ectopic pregnancy in haemodynamically stable patient.\\n\\uf0b7\\nGestational sac size <3.5 cm in greatest diameter.\\n\\uf0b7\\nSerum hCG titer < 10,000 mlU/ml.\\n\\uf0b7\\nGestation <6 weeks.\\n\\uf0b7\\nAbsence of foetal cardiac activity.\\nPharmacological treatment (for unruptured ectopic pregnancy)\\n\\uf0b7\\nObtain pretreatment hCG titers, haemogram, liver and renal function tests.\\n\\uf0b7\\nInj. methotrexate 50 mg/sq meter body surface area IM given on day 1.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 242, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nObtain pretreatment hCG titers, haemogram, liver and renal function tests.\\n\\uf0b7\\nInj. methotrexate 50 mg/sq meter body surface area IM given on day 1.\\n\\uf0b7\\nRepeat hCG titers on day 4 and 7.\\n\\uf0b7\\nIf day 7, hCG titers reflect a drop of at least 15% from maximum levels then weekly hCG\\ntiters till negative.\\n\\uf0b7\\nIf fall <15% or there is rise then repeat Inj. methotrexate.\\nPatient education\\n\\uf0b7\\nResolution of ectopic pregnancy may take up to 6 weeks.\\n\\uf0b7\\n5-10% cases require surgery despite medical therapy.\\n\\uf0b7\\nSigns and symptoms of tubal rupture such as vaginal bleeding, abdominal pain, weakness,\\ndizziness or syncope must be reported promptly.\\n\\uf0b7\\nPatient should refrain from alcohol and folic acid containing vitamins during this period.\\n\\uf0b7\\nSexual intercourse should be avoided during therapy.\\nMEDICAL TERMINATION OF PREGNANCY\\nThe government of India has legalized Medical Termination of Pregnancy (MTP) up to 20\\nweeks of gestation by MTP Act 1971. Under this act, pregnancy can be terminated under'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 242, 'source_type': 'Authorotative', 'priority': '1'}, page_content='The government of India has legalized Medical Termination of Pregnancy (MTP) up to 20\\nweeks of gestation by MTP Act 1971. Under this act, pregnancy can be terminated under\\nfollowing clauses:\\nClauses and requirements\\n1. Damage to the life of the pregnant woman.\\n2. Grave injury to the physical or mental health of the pregnant woman.\\n3. Pregnancy caused by rape.\\n4. Substantial risk, that if the child was born, it would suffer from such physical or mental\\nabnormalities as to be seriously handicapped.\\n5. Failure of any contraceptive method or device.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 243, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n236\\nNecessary consent form as laid down in the Act should be duly filled and signed. Opinion of\\ntwo registered medical practitioners is mandatory for second trimester MTP (>12 weeks).\\nFirst trimester MTP methods\\nMedical methods\\n\\uf0b7\\nIt can be done up to 49 days amenorrhoea after proper counseling and excluding\\ncontraindications.\\n\\uf0b7\\nTab. mifepristone 200-600 mg given on day 1.\\n\\uf0b7\\nOn day 3 Tab. misoprostol 400mcg orally or 800 mcg vaginally in hospital. Woman\\ngenerally aborts in next 4-8 hours and USG on day 14 to confirm complete abortion.\\n\\uf0b7\\nAsked to report if excessive bleeding anytime in between. The procedure should be done\\nonly in centers approved under MTP Act.\\nSurgical method\\n\\uf0b7\\nSuction and evacuation done in all centers approved under MTP Act. Manual Vacuum\\nAspiration (MVA) can be done in all PHCs.\\nPatient education\\n\\uf0b7\\nDetails of the method and small risk of complications should be explained. Medical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 243, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Aspiration (MVA) can be done in all PHCs.\\nPatient education\\n\\uf0b7\\nDetails of the method and small risk of complications should be explained. Medical\\nmethod fails in around 5% cases and these will require surgical curettage.\\n\\uf0b7\\nPatient should be motivated for concurrent contraception and option of all available\\nmethods both temporary and permanent should be discussed.\\nSecond trimester MTP methods\\n\\uf0b7\\nTo be conducted in secondary and tertiary care level. None of the second trimester\\nmethods are 100% safe and effective. That is why many methods both surgical and\\nmedical, are available and being used. For second trimester MTP medical methods are\\npreferred.\\n\\uf0b7\\nMethods are usually combined so as to increase the success rate and to shorten induction\\nabortion interval. Most commonly extra amniotic 0.1% ethacridine lactate 10 ml per week\\nof gestation (maximum 150 ml) with IV oxytocin after 6-24 hours or IM 15 methyl\\nPGF2α. Abortion is induced in 32 – 36 hours with a success rate of 75-80%.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 243, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of gestation (maximum 150 ml) with IV oxytocin after 6-24 hours or IM 15 methyl\\nPGF2α. Abortion is induced in 32 – 36 hours with a success rate of 75-80%.\\n\\uf0b7\\nBetter results if some method for cervical ripening is used 6 - 12 hours before.\\n\\uf0b7\\nIf some method fails switch over to other method or surgical method\\nANEMIA IN PREGNANCY\\nPrevalence of anaemia in pregnancy in India is 80% and severe anaemia is 10-15%. Causes\\nof anaemia in pregnancy are the same as those encountered in the non pregnant state.\\nHowever, iron deficiency anaemia is commonest in pregnancy. In about 40-50% of cases\\nthere is associated folic acid deficiency. Anaemia in pregnancy is defined as haemoglobin\\nconcentration of less than 11 g/dl and haematocrit of less than 33%. It is further classified\\ndepending on Hb levels as mild 10-11 g%, moderate 7-10 g% and severe <7 g%.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 244, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n237\\n\\uf0b7\\nMild to moderate cases- weakness, exhaustion, lassitude, anorexia, glossittis, and\\nstomatitis, while severe cases present with palpitation, dyspnoea, oedema and cardiac\\nfailure.\\n\\uf0b7\\nImportant basic investigations required are haemoglobin, haematocrit, total RBC counts,\\nperipheral smear for type of anaemia and haematological indices, plasma proteins and\\nstool for ova and cyst.\\nSalient features\\nIron deficiency anemia\\nAll cases of severe anaemia to be admitted especially those with features of anoxia or cardiac\\ninsufficiency.\\nNon pharmacological treatment\\n\\uf0b7\\nDiet rich in iron - jaggery, green leafy vegetable, sprouted pulses, meat, cooking food in\\niron utensils.\\n\\uf0b7\\nDiet rich in protein - pulses, lentils, milk and milk products, nuts, eggs and meat.\\nPharmacological treatment\\n\\uf0b7\\nOral iron therapy- ferrous sulfate and ferrous fumarate. Recommended dose is 200 mg\\nelemental iron daily in divided doses. Not to be taken with meals, milk, coffee or tea.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 244, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Pharmacological treatment\\n\\uf0b7\\nOral iron therapy- ferrous sulfate and ferrous fumarate. Recommended dose is 200 mg\\nelemental iron daily in divided doses. Not to be taken with meals, milk, coffee or tea.\\nContinue therapy till blood picture returns to normal and then continue with 100 mg\\nelemental iron for 3 months to build up the stores. Government of India recommends\\nminimum of 100 mg of elemental iron and 5 mg folic acid for 100 days starting at 20\\nweeks (Common side effects are epigastric pain, nausea, vomiting, constipation, and\\ndiarrhoea).\\n\\uf0b7\\nDeworming to be done after first trimester, if necessary. Tab. mebendazole 100 mg 2\\ntimes a day for 3 days or Tab. albendazole 400 mg single dose.\\nMonitoring of response to therapy\\nSubjective improvement of feeling better, weight gain and improved appetite is seen after 1-2\\nweeks. Reticulocyte response observed in 5-10 days (increases to 5-6%) and rise in\\nHb/haematocrit in 2-3 weeks. The concentration is expected to rise at the rate of 0.1-0.25'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 244, 'source_type': 'Authorotative', 'priority': '1'}, page_content='weeks. Reticulocyte response observed in 5-10 days (increases to 5-6%) and rise in\\nHb/haematocrit in 2-3 weeks. The concentration is expected to rise at the rate of 0.1-0.25\\ng/dl/day or 0.8 -1 g/dl/week. If no improvement in 3 weeks, reevaluate for: incorrect\\ndiagnosis, non compliance, defective absorption, continuing loss, associated deficiencies.\\nRole of parenteral therapy is limited as rate of rise of haemoglobin with parenteral iron is\\nsimilar to oral iron preparation.\\nSpecific indications\\nSevere intolerance to oral iron, malabsorption, non compliance and moderate to severe\\nanaemia in advanced pregnancy\\nTotal dose of iron to be given is calculated using following formulae:\\n2.4 X weight in kg X deficit in Hb in gm + 500 mg should be added for pregnancy.\\n(Caution: Oral iron is suspended at least 24 hours prior to therapy to avoid reaction).\\nIntravenous route is to be given after hospitalization.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 245, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n238\\n\\uf0b7\\nPatients may be asymptomatic or may have vomiting, diarrhoea, pallor, hepatosplenomegaly,\\nand polyneuropathy.\\n\\uf0b7\\nDiagnosis: is by MCV > 96.11 mc, MCH > 33 pg and MCHC normal.\\nPeripheral smear\\nmacrocytic \\nanaemia \\nwith \\nhypersegmentation \\nof \\nneutrophils, \\nneutropenia \\nand\\nthrombocytopenia.\\n\\uf0b7\\nInj. iron dextran is diluted in 5% dextrose. Initial infusion is given slowly at 8 drops per\\nmin. for half an hour to watch for reaction, and then increase gradually to 40 drops/min.\\nTotal iron dose is administered in a single sitting. If >2000 mg then only half dose is\\ngiven in one day. Monitor for adverse reactions like rigors, chest pain, and hypotension. If\\npresent stop the infusion.\\n\\uf0b7\\nInj. iron dextran or iron sorbitol complex (available as 50 mg ml) IM after an initial test\\ndose of 0.5 ml intramuscularly, the injections are given daily or on alternate days in doses\\nof 2 ml IM using Z technique. To prevent staining of skin one can pass small amount of'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 245, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dose of 0.5 ml intramuscularly, the injections are given daily or on alternate days in doses\\nof 2 ml IM using Z technique. To prevent staining of skin one can pass small amount of\\nsaline/air down the needle before withdrawing it.\\n\\uf0b7\\nInj. iron sucrose intravenously given in each infusion 200mg of elemental iron in100 ml\\nof 0.9% NaCl infused over 20-30 minutes. No test dose required. Two infusion of each\\n200 mg of elemental iron is recommended twice in a week.\\n(Caution: Emergency drugs to be kept ready for resuscitation in case of anaphylactic\\nreaction).\\nIndications for blood transfusion\\nSevere blood loss, severe anemia beyond 36 weeks of pregnancy or anemia refractory to oral\\nand parental therapy or anemic patient with anoxia or cardiac failure. Management of anemic\\npatients during labour:\\n\\uf0b7\\nPropped up position, oxygen therapy.\\n\\uf0b7\\nSedation and pain relief.\\n\\uf0b7\\nCut short 2nd stage of labour by forceps.\\n\\uf0b7\\nActive management of 3rd stage of labour with Inj. methylergometrine maleate 0.2 mg IV'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 245, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPropped up position, oxygen therapy.\\n\\uf0b7\\nSedation and pain relief.\\n\\uf0b7\\nCut short 2nd stage of labour by forceps.\\n\\uf0b7\\nActive management of 3rd stage of labour with Inj. methylergometrine maleate 0.2 mg IV\\nat the delivery of anterior shoulder or injection oxytocin 10 U IM.\\n\\uf0b7\\nInj. methylergometrine to be avoided in patients of anaemia with cardiac failure.\\n\\uf0b7\\nPacked cell transfusion if necessary and if Hb < 5 g after giving diuretics.\\nMEGALOBLASTIC ANAEMIA IN PREGNANCY\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nTab. folic acid 5 mg daily to be continued for at least 4 weeks in puerperium.\\n\\uf0b7\\nInj. cyanocobalamine 250 mcg intramuscular every month.\\nDimorphic anaemia\\n\\uf0b7\\nBoth iron and folic acid in therapeutic doses.\\nPatient education'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 246, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Obstetrics and Gynecology\\n239\\n\\uf0b7\\nHypertension (blood pressure > 140/90 mmHg recorded at 4-6 hours interval) with\\nproteinuria and/or non-dependant oedema, developing after 20 weeks of gestation in a\\npreviously normotensive nonproteinuric patient.\\n\\uf0b7\\nPre-eclampsia is considered mild if diastolic BP < 100 mmHg, protineuria trace to 1+ with\\nminimal elevation of liver enzymes.\\n\\uf0b7\\nSigns of severe pre eclampsia are: BP > 160/110, 24 hour's urinary proteins >2 g, elevated\\nserum uric acid,   thrombocytopenia (platelet count <50,000/ mm3), microangiopathic\\nhaemolysis, raised liver enzymes, has diastolic BP 110 mmHg and foetal growth retardation.\\n\\uf0b7\\nDietary advice as mentioned earlier.\\n\\uf0b7\\nCommon side effects of therapy should be explained to the patient. Explain to the patient\\nthat stools turn black after oral iron therapy, so no need for concern.\\n\\uf0b7\\nIron supplementation should continue for at least 3 months in postpartum period.\\n\\uf0b7\\nAdequate spacing of at least 3 years between two pregnancies.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 246, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIron supplementation should continue for at least 3 months in postpartum period.\\n\\uf0b7\\nAdequate spacing of at least 3 years between two pregnancies.\\nPREGNANCY INDUCED HYPERTENSION (PIH)\\n\\uf0b7\\nHypertension is diagnosed when diastolic blood pressure is 90 mm Hg or more on two\\nconsecutive readings taken four hours or more apart.\\n\\uf0b7\\nIf hypertension occurs after 20 weeks of gestation, during labour and/or within 48 hours\\nof delivery it is classified as pregnancy induced hypertension.\\n\\uf0b7\\nIf hypertension occurs before 20 wks of gestation, it is classified as chronic hypertension.\\n\\uf0b7\\nDiastolic blood pressure alone is an accurate indicator of hypertension in pregnancy.\\nElevated blood pressure with proteinuria, is defined as pre-eclampsia.\\n\\uf0b7\\nWomen with pregnancy-induced hypertension disorders may progress from mild disease\\nto a more serious condition. The classes of pregnancy-induced hypertension are:\\nhypertension without proteinuria; mild pre-eclampsia; severe pre-eclampsia; eclampsia.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 246, 'source_type': 'Authorotative', 'priority': '1'}, page_content='to a more serious condition. The classes of pregnancy-induced hypertension are:\\nhypertension without proteinuria; mild pre-eclampsia; severe pre-eclampsia; eclampsia.\\n\\uf0b7\\nMild pre-eclampsia often has no symptoms.\\n\\uf0b7\\nIncreasing proteinuria is a sign of worsening pre-eclampsia.\\n\\uf0b7\\nOedema of the feet and lower extremities is not considered a reliable sign of pre-\\neclampsia.\\n\\uf0b7\\nIn pregnancy-induced hypertension, there may be no symptoms and the only sign may be\\nhypertension.\\nPRE-ECLAMPSIA\\nPre-eclampsia is one of the commonest causes of maternal and perinatal morbidity and\\nmortality. It affects around 5-8% of all pregnancies. Pre-eclampsia is principally a syndrome\\nof signs, occurring more frequently in primigravida. When superimposed with convulsions it\\nis termed as eclampsia. Other high risk factors are - multiple pregnancy, hydramnios, and\\nmolar pregnancy.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 247, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n240\\nTreatment\\nHospitalize all cases. Definitive therapy is to terminate pregnancy. The choice between\\nimmediate delivery and expectant management depends on: severity of disease, condition of\\nmother and foetus and period of gestation (POG).\\nMild pre-eclampsia\\nExpectant management: in cases of mild pre-eclampsia without foetal and maternal\\ncompromise, with gestational age less than 37 weeks.\\nNon pharmacological treatment\\n\\uf0b7\\nComplete bed rest preferably in left lateral position and regular diet adequate in proteins\\nand calories with omission of extra table salt.\\nPharmacological treatment\\n\\uf0b7\\nAntihypertensive treatment is started if there is persistent diastolic blood pressure over\\n100 mmHg. Aim of treatment is to achieve a systolic BP about 130 mmHg and diastolic\\nBP around 90 mmHg. Tab. methyldopa 250 mg 8 hourly or 6 hourly (maximum dose 2\\ng/day) or Tab. atenolol 50-100 mg once a day.\\n\\uf0b7\\nIf BP is not controlled in 72 hours with the above, add any of the following:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 247, 'source_type': 'Authorotative', 'priority': '1'}, page_content='g/day) or Tab. atenolol 50-100 mg once a day.\\n\\uf0b7\\nIf BP is not controlled in 72 hours with the above, add any of the following:\\nCap. nifedipine 10 mg 8 hourly or Tab. nifedipine retard 10 mg 12 hourly (maximum 30\\nmg 12 hourly) or Tab. labetalol 100-200 mg 8 hourly (maximum 600 mg 6 hourly).\\n\\uf0b7\\nDaily monitoring of weight gain, BP, urine albumin, urine output.\\n\\uf0b7\\nWeekly lab investigations - haemogram with platelet count, liver and kidney function\\ntests specially serum uric acid, fundoscopy.\\n\\uf0b7\\nFoetal monitoring by clinical and USG growth assessment, daily foetal movement count,\\nnon stress test twice weekly and biophysical score weekly, doppler studies in IUGR.\\n\\uf0b7\\nIn case of mild pregnancy induced hypertension without proteinuria, if after\\nhospitalization BP is controlled with rest without any antihypertensive drug, patient can\\nbe discharged after initial evaluation if no maternal/foetal compromise is detected. It can'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 247, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hospitalization BP is controlled with rest without any antihypertensive drug, patient can\\nbe discharged after initial evaluation if no maternal/foetal compromise is detected. It can\\nbe practiced only in reliable patients who will follow instructions for monitoring as\\nabove, and also will report ominous symptoms immediately (ominous symptoms are\\npersistent severe headache, visual disturbances such as dimness of vision, double vision\\nor blindness, epigastric pain, nausea, vomiting and oliguria).\\nDefinitive management\\nInduction of pregnancy by labour induction/caesarean section in the following conditions:\\n\\uf0b7\\nGestational age 37 weeks, foetal compromise like severe growth retardation,\\noligohydramnios, abnormal non-stress test or biophysical score, maternal compromise\\nlike development of features of severe pre-eclampsia, onset of labour, rupture of\\nmembrane or bleeding.\\nSevere pre-eclampsia\\nTreatment is preferably done in a tertiary care center.\\nNon pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 247, 'source_type': 'Authorotative', 'priority': '1'}, page_content='membrane or bleeding.\\nSevere pre-eclampsia\\nTreatment is preferably done in a tertiary care center.\\nNon pharmacological treatment\\n\\uf0b7\\nObservation in intensive care unit for 24 hours.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 248, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Obstetrics and Gynecology\\n241\\n\\uf0b7\\nAssessment of maternal and foetal conditions. BP monitoring 2-4 hourly, hourly urine\\noutput monitoring, watch for sign and symptoms of impending eclampsia and foetal\\ndistress.\\n\\uf0b7\\nLab Investigations: haemogram with platelet count, liver and kidney function tests,\\nurinary proteins, coagulation profile, fundus examination, obstetric ultrasound with BPS.\\n\\uf0b7\\nIntravenous fluids Ringer's lactate at rate of 60 ml/h (maximum 125 ml/h).\\nPharmacological treatment\\nThe aim of the treatment is gradual lowering of blood pressure so that diastolic BP is\\nmaintained between 90-100 mmHg.\\nImmediate management\\n\\uf0b7\\nTab. nifedipine 10 mg orally can be repeated after 30-60 min. (maximum dose 20 mg 4\\nhourly).\\n(Caution: Side effects- Tachycardia, headache, flushing, and aggravation of angina. Rapid\\nfall in BP can cause foetal distress).\\n\\uf0b7\\nIf BP is not controlled with oral treatment then IV drugs are started with intensive\\nmonitoring.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 248, 'source_type': 'Authorotative', 'priority': '1'}, page_content='fall in BP can cause foetal distress).\\n\\uf0b7\\nIf BP is not controlled with oral treatment then IV drugs are started with intensive\\nmonitoring.\\n\\uf0b7\\nInj. labetalol initial dose is 50 mg slow IV followed by infusion at 60 mg/h, doubling\\nevery 15 min until BP is controlled or maximum dose 220 mg in 24 hours is reached.\\nMaintenance therapy\\n\\uf0b7\\nAfter initial control of acute hypertension, patient is started on maintenance therapy with\\nantihypertensives as described in management of mild pre-eclampsia.\\n\\uf0b7\\nManage with antihypertensives, bed rest and more frequent maternal and foetal\\nmonitoring.\\nDefinitive management is induction of pregnancy\\nPregnancy beyond 34 weeks - stabilize maternal condition and induce pregnancy.\\nPregnancy less than 24 weeks - stabilize maternal condition and induce pregnancy.\\nPatient on expectant management develops following features: uncontrolled hypertension\\ndespite maximum dose of 2 antihypertensive drugs, eclampsia, raised liver enzyme >2 time'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 248, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patient on expectant management develops following features: uncontrolled hypertension\\ndespite maximum dose of 2 antihypertensive drugs, eclampsia, raised liver enzyme >2 time\\nwith right upper quadrant pain and tenderness, pulmonary oedema, platelet < 1 lac/mm1,\\ncreatinine > 1 mg/dl over baseline\\nAfter delivery, intensive monitoring should be continued for 72 hours with prophylactic\\nanticonvulsant continued till 24 hours postpartum. Dose of antihypertensives should be\\ngradually reduced.\\nProphylactic anticonvulsants\\n\\uf0b7\\nRequired in women with severe pre-eclampsia especially in cases with signs and\\nsymptoms of impending eclampsia. Dose is same as for eclampsia.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 249, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n242\\n\\uf0b7\\nLoading dose is magnesium sulfate - 4g IV as 20% solution over 20 minutes and 10 g IM\\nas (50% solution, 10 ml (5 g) in each buttock (total of 14 g) followed by second dose in\\nalternate buttocks every 4 hours.\\n\\uf0b7\\nBefore each dose, monitor for presence of patellar reflex, respiratory rate >16/min and\\nurine output > 25 ml/h. It should be discontinued after 24 hours after BP is lowered.\\n\\uf0b7\\nAfter initial evaluation and stabilization of the patient further management is decided\\ndepending on foetal maturity and maternal response.\\n\\uf0b7\\nExpectant management- Considered if pregnancy is between 24-34 weeks and\\nhypertension controlled with maximum of two drugs, urine output is normal, lab\\ninvestigations are normal and no foetal compromise. Patient should be hospitalized till\\ndelivery.\\nECLAMPSIA\\nSalient features\\nTreatment (to be managed at a tertiary care level)\\nPrinciples of management are control and prevention of recurrence of convulsion and control'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 249, 'source_type': 'Authorotative', 'priority': '1'}, page_content='delivery.\\nECLAMPSIA\\nSalient features\\nTreatment (to be managed at a tertiary care level)\\nPrinciples of management are control and prevention of recurrence of convulsion and control\\nof hypertension. Treat any complication that arise and deliver safely as soon as possible.\\nContinue anticonvulsant therapy 24 h after delivery or last fit whichever is latest.\\nNon pharmacological treatment\\n\\uf0b7\\nPlace the patient in left lateral position in a separate, quiet room.\\n\\uf0b7\\nSecure and maintain airway.\\n\\uf0b7\\nUse mouth gag or airway to prevent tongue biting/tongue falling back.\\n\\uf0b7\\nIntubate if patient is deeply unconscious, poor arterial blood gases, extensive laryngeal\\noedema, and extreme restlessness.\\n\\uf0b7\\nSuction to remove oropharyngeal secretions. Oxygen by face mask.\\n\\uf0b7\\nSet up IV access.\\n\\uf0b7\\nMonitor heart rate and respiration, BP, urine output.\\n\\uf0b7\\nLaboratory investigations: haemogram with platelet count, liver and kidney function tests,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 249, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nSet up IV access.\\n\\uf0b7\\nMonitor heart rate and respiration, BP, urine output.\\n\\uf0b7\\nLaboratory investigations: haemogram with platelet count, liver and kidney function tests,\\nurinary proteins, coagulation profile, serum electrolytes, fundus examination.\\nPharmacological treatment\\n\\uf0b7\\nInj. magnesium sulphate loading dose of 14 g of which, 4 g as 20% solution given slowly\\nIV over 5 -10 minutes and 5 g as 50% solution given deep IM in each buttock (total 10 g\\n\\uf0b7\\nOccurrence of generalized convulsions associated with signs of pre eclampsia during\\npregnancy, labour or within 7 days of delivery and not caused by epilepsy or other\\nconvulsive disorders.\\n\\uf0b7\\nEclampsia occurs antepartum in 46%, intrapartum in 16% and postpartum in 36%\\ncases.\\n\\uf0b7\\nPatient may develop acute left ventricular failure, cerebral haemorrhage, renal cortical\\nnecrosis, DIC, foetal distress, abruptio placentae, foetal death and maternal death.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 250, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n243\\nIM) If fits are not controlled in 15 min, give 2 g magnesium sulfate as 20% solution slow\\nIV.\\n\\uf0b7\\nMaintenance dose 5 g magnesium sulfate as 50% solution deep IM every 4 hours in\\nalternate buttock Or Continuous IV regimen 4 g loading dose over 20 minutes followed\\nby 1 g/h slow continuous IV infusion. (Caution: Side effects are respiratory depression\\nand neuromuscular depression in mothers. Neonatal respiratory and neuromuscular\\ndepression). If respiratory depression occurs, give calcium gluconate 1 g IV as 10% sol. If\\nrespiratory arrest occurs, immediate endotracheal intubation and ventilation is to be done.\\nMonitor: Check for respiratory rate to be more than 16/min, patellar reflex to be present\\nand urine output >25 ml/h before giving magnesium sulfate. Or\\n\\uf0b7\\nInj. phenytoin loading dose of 15-25 mg/kg slow IV not exceeding 25 mg/ min diluted in\\nnormal saline for first 750 mg and then 12.5 mg/min followed by 100 mg IV 8 hourly.\\no'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 250, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nInj. phenytoin loading dose of 15-25 mg/kg slow IV not exceeding 25 mg/ min diluted in\\nnormal saline for first 750 mg and then 12.5 mg/min followed by 100 mg IV 8 hourly.\\no\\nECG tracing to be taken every minute for 10 min during infusion of first 750 mg.\\no\\nFluid management should be closely monitored to prevent complications such as\\npulmonary oedema, left ventricular failure and adult respiratory distress\\nsyndrome.\\n\\uf0b7\\nAntihypertensives: as described in pre-eclampsia. Aim is to gradually lower the BP to\\n140-150/90-100 mm Hg.\\nDefinitive management is termination of pregnancy irrespective of the foetal maturity.\\nTermination is by labour induction and vaginal delivery or caesarean section.\\nIndications of caesarean section are: all deeply unconscious patients unless delivery is\\nimminent, uncooperative patient due to restlessness, if vaginal delivery is unlikely to occur\\nwithin 6-8 hours from the onset of 1st eclamptic seizure or eclamptic seizures are not'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 250, 'source_type': 'Authorotative', 'priority': '1'}, page_content='imminent, uncooperative patient due to restlessness, if vaginal delivery is unlikely to occur\\nwithin 6-8 hours from the onset of 1st eclamptic seizure or eclamptic seizures are not\\ncontrolled in 6-8 hours, and other obstetric indications.\\nCare after delivery\\n\\uf0b7\\nPatients of eclampsia and severe pre-eclampsia need intensive monitoring for at least\\ninitial 72 hours.\\n\\uf0b7\\nContinue anticonvulsant till 24 hours after delivery or fit, whichever occurs later.\\nGradually decrease the dose of antihypertensives.\\n\\uf0b7\\nPatient is discharged after 10-14 days of delivery or earlier if BP controlled without\\nantihypertensives.\\n\\uf0b7\\nFollow up after 6 weeks for reevaluation.\\nPatient education\\n\\uf0b7\\nDelivery is the only definitive treatment. Underlying disease remains till delivery and\\ncomplications can arise despite control of BP on treatment.\\n\\uf0b7\\nSymptoms of severe pre-eclampsia like headache, vomiting, epigastric pain, decreased\\nurine output, blurring of vision should be immediately reported.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 250, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nSymptoms of severe pre-eclampsia like headache, vomiting, epigastric pain, decreased\\nurine output, blurring of vision should be immediately reported.\\n\\uf0b7\\nNeed for prolonged hospitalization.\\n\\uf0b7\\nEarly booking in next pregnancy as there is 25-30% risk of recurrence.\\n\\uf0b7\\nProphylactic measures like low-dose aspirin can be started in early pregnancy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 251, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n244\\n\\uf0b7\\nNeed for reevaluation at 6 weeks postpartum for reclassification and investigations of\\nhypertension and need for long- term antihypertensives. High risk of development of\\nchronic hypertension in later life.\\nPREGNANCY WITH DIABETES\\nPregnancy can be complicated by pre-existing insulin dependent or noninsulin-dependent\\ndiabetes or gestational diabetes. Gestational diabetes is defined as the carbohydrate\\nintolerance of variable severity with onset or first recognition during pregnancy.\\nNormal values - FBS less than 90 mg%, 2 hrs post prandial less than 120 mg%, RBS  less\\nthan 100.  All pregnancies in diabetic females should be managed at a tertiary care center.\\nNon pharmacological treatment\\nDietary advice\\n\\uf0b7\\nTotal daily calorie intake should be 30 Cal/kg.\\n\\uf0b7\\nComplex carbohydrates should provide about 50% of the total calories, which should be\\nwell distributed throughout the day.\\n\\uf0b7\\nMeals should be split in 3 major meals and 3-4 snacks.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 251, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nComplex carbohydrates should provide about 50% of the total calories, which should be\\nwell distributed throughout the day.\\n\\uf0b7\\nMeals should be split in 3 major meals and 3-4 snacks.\\n\\uf0b7\\nHigh fiber diet is beneficial with 30-50 g fibers daily. Total diet should be distributed in 3\\nmajor meals and 3 mid meal snacks.\\nGeneral measures\\n\\uf0b7\\nUltrasound assessment of foetal gestational age is to be done as early as possible.\\n\\uf0b7\\nFoetal congenital anomalies should be ruled out by level II USG scan at 16 - 18 weeks,\\nfoetal echo at 22 weeks.\\n\\uf0b7\\nSerial USG for foetal growth monitoring and biophysical scoring for assessment of foetal\\nwell being after 32 weeks of gestation.\\nPharmacological treatment\\n(I) Antenatal management.\\nInitial evaluation should include blood sugar and fundoscopy.\\n(a) Pre-existing diabetes\\n\\uf0b7\\nOral hypoglycaemic agents are contraindicated during pregnancy. If patient is on oral\\nhypoglycaemics, switch over to insulin therapy as soon as pregnancy is diagnosed.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 251, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(a) Pre-existing diabetes\\n\\uf0b7\\nOral hypoglycaemic agents are contraindicated during pregnancy. If patient is on oral\\nhypoglycaemics, switch over to insulin therapy as soon as pregnancy is diagnosed.\\n\\uf0b7\\nInj. Insulin: 0.6-0.8 U/kg in 1st trimester, 0.7 - 0.9 U/kg in 2nd trimester and 0.8 - 1.2\\nU/kg in 3rd trimester.\\n\\uf0b7\\nUsually a combination of intermediate acting and regular insulin in proportion of 2:1 is\\ngiven. 2/3 of the total requirement is given in the morning before breakfast and 1/3 is\\ngiven at night with regular insulin before dinner and intermediate at bedtime.\\n\\uf0b7\\nDose adjustment is done to maintain blood sugar level between fasting <95 mg% and\\npostprandial between 70 and 120 mg%.\\n\\uf0b7\\nSampling of blood should be done initially fasting, pre and post breakfast, pre and post\\nlunch, pre and post dinner and 2 AM regularly till controlled and then daily monitoring by\\nfasting and postmeal sugars.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 252, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n245\\n\\uf0b7\\nHospitalization is required in cases of excessive vomiting, infections, maternal\\ncomplications like hypertension, retinopathy, nephropathy, foetal compromise like\\nmacrosomia or intra uterine growth retardation (IUGR) or poor diabetic control.\\n(b) Gestational diabetes.\\nGeneral management is same as outlined above.\\n\\uf0b7\\nPatient is reassessed after 1 week. If control not achieved, insulin therapy is started.\\nConfirmation of blood sugar and regular insulin if required may be given before\\nbreakfast, before lunch and before dinner or combination of regular and long acting can\\nbe given before breakfast and dinner. Hypoglycaemia should be avoided.\\n\\uf0b7\\nIf fasting plasma sugar is > 105 mg% insulin is usually required for control. Regular\\ninsulin is adjusted to normalize post breakfast glucose and intermediate for post lunch\\nglucose control. If evening or fasting glucose is elevated, 2nd daily injection is added. If'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 252, 'source_type': 'Authorotative', 'priority': '1'}, page_content='insulin is adjusted to normalize post breakfast glucose and intermediate for post lunch\\nglucose control. If evening or fasting glucose is elevated, 2nd daily injection is added. If\\nboth are elevated, mixture of intermediate and regular insulin before dinner is added. If\\nonly fasting is elevated, add intermediate acting insulin at bedtime. Or\\n\\uf0b7\\nInj. regular insulin 3 times a day before each main meal which can be combined with one\\ndose of intermediate acting insulin at bed time in case there is fasting hyperglycaemia.\\n\\uf0b7\\nApart from routine antenatal monitoring, blood sugar monitoring is required throughout\\npregnancy. Therapeutic goal is to achieve plasma blood sugar levels fasting <95 mg% and\\n2 hour postprandial <120 mg%. When levels are high daily monitoring with insulin dose\\nadjustment is required. Once control is achieved, patient can be managed at home with\\nweekly blood sugar profile.\\n\\uf0b7\\nGlycosylated Hb (HbAlc) to be done in 1st trimester. Value of 9% or above'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 252, 'source_type': 'Authorotative', 'priority': '1'}, page_content='adjustment is required. Once control is achieved, patient can be managed at home with\\nweekly blood sugar profile.\\n\\uf0b7\\nGlycosylated Hb (HbAlc) to be done in 1st trimester. Value of 9% or above\\nindicates poor glycemic control, carries higher risk of congenital malformation; MTP may\\nbe offered after proper evaluation.\\n(II) Management during labour\\n\\uf0b7\\nIn uncomplicated case with good glycaemic control pregnancy can be continued till\\nexpected date of delivery.\\n\\uf0b7\\nIn presence of complications or foetal compromise pregnancy is terminated at 38 weeks\\nor earlier if required.\\n\\uf0b7\\nIf estimated foetal weight is >4 kg, caesarean section is performed.\\n\\uf0b7\\nLabour is managed with intensive monitoring. Blood sugars are monitored 3-4 hourly aim\\nis to keep blood sugars between 100-120 mg%, using the sliding scale method using\\nregular insulin. In the postpartum period, the requirement of insulin is decreased.\\nPatient education\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 252, 'source_type': 'Authorotative', 'priority': '1'}, page_content='is to keep blood sugars between 100-120 mg%, using the sliding scale method using\\nregular insulin. In the postpartum period, the requirement of insulin is decreased.\\nPatient education\\n\\uf0b7\\nIn known diabetics, good blood sugar control should be achieved in preconception period\\nto avoid high risk of congenital anomalies.\\n\\uf0b7\\nStrict adherence to the dietary advice and insulin therapy is essential throughout\\npregnancy. As insulin requirements change throughout pregnancy therefore, frequent\\nblood sugar monitoring is required throughout pregnancy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 253, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n246\\n\\uf0b7\\nAll pregnant women with heart disease should be managed at a tertiary level center\\nwith multidisciplinary approach. Depending on the limitation of physical activity\\npatient is classified into class I to IV of New York Heart Association (NYHA).\\n\\uf0b7\\nSevere or progressive dyspnoea, progressive orthopnoea, paroxysmal nocturnal\\ndyspnoea, haemoptysis, syncope with exertion or chest pain related to effort or\\nemotions. Echocardiography is diagnostic\\n\\uf0b7\\nClinical approach to the pregnant women with heart disease is according to NYHA\\nclass irrespective of the aetiology of the heart disease.\\n\\uf0b7\\nPatient on insulin therapy should be told about symptoms of hypoglycaemia like\\npalpitations, sweating, dizziness, and its management.\\n\\uf0b7\\nIn cases of gestational diabetes, there is risk of recurrence in subsequent pregnancies and\\nlater on risk of frank diabetes is there.\\nContraceptive advice\\nCombined oral contraceptive pills and intrauterine devices are preferably avoided. Barrier'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 253, 'source_type': 'Authorotative', 'priority': '1'}, page_content='later on risk of frank diabetes is there.\\nContraceptive advice\\nCombined oral contraceptive pills and intrauterine devices are preferably avoided. Barrier\\nmethods, progestogen only pills/ implants/injectables or sterilization can be offered.\\nPREGNANCY WITH HEART DISEASE\\nOrganic heart disease in pregnancy is commonly due to rheumatic heart disease or congenital\\nheart disease. Pregnancy with its increased cardiovascular stress is a potential cause for\\nworsening of the existing heart disease.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nNYHA class III and IV patients are to be hospitalized throughout the pregnancy while\\nclass I and II can be managed as outdoor patients with more frequent antenatal visits and\\nadmission at 38 weeks.\\n\\uf0b7\\nRest for 10 hours each night and 1 to 2 hour after each meal. Light housework and\\nwalking without climbing stairs is permitted. No heavy work is allowed.\\n\\uf0b7\\nAvoid high salt intake.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 253, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nRest for 10 hours each night and 1 to 2 hour after each meal. Light housework and\\nwalking without climbing stairs is permitted. No heavy work is allowed.\\n\\uf0b7\\nAvoid high salt intake.\\n\\uf0b7\\nScreen and treat at the earliest for excessive weight gain, abnormal fluid retention,\\nanaemia, pregnancy induced hypertension, infections.\\nPharmacological (in consultation with the cardiologist)\\nIn case of rheumatic heart disease,\\n\\uf0b7\\nInj. benzathine penicillin 1.2 mega units IM 3 weekly.\\n\\uf0b7\\nTreat any infections with appropriate antibiotics.\\n\\uf0b7\\nIn patients with mechanical prosthetic valves, give Inj. heparin throughout pregnancy to\\nmaintain PTT at 1.5 to 2.5 times the normal control.\\n(Caution: Oral anticoagulants are not safe during pregnancy because of risk of congenital\\nanomalies in the foetus. But if required, can be given after first trimester and continued till 4\\nweeks before delivery. However, oral anticoagulants are safe during lactation).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 254, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n247\\nLabour management\\nCaesarean is performed for only obstetrical indications.\\n\\uf0b7\\nPain relief is important during labour. Best option is to give continuous epidural\\nanalgesia. It is contraindicated in women with intra cardiac shunts, aortic stenosis,\\npulmonary hypertension, and hypertrophic cardiomyopathy. Inj. morphine can also be\\ngiven for pain relief.\\n\\uf0b7\\nFluids should be restricted to 75 ml/min. Bolus oxytocin and methyl ergometrine should\\nbe avoided.\\n\\uf0b7\\nAntimicrobial prophylaxis for infective endocarditis required in all patients with cardiac\\nlesions undergoing any operative procedure or in labour.\\n\\uf0b7\\nInj. ampicillin 2 g and Inj. gentamicin 1.5 mg/kg (maximum 120 mg) IV or IM 30 min\\nbefore procedure followed by Cap. ampicillin 1 g IM or IV; or Cap. amoxycillin I g orally\\n6 hours after initial dose.\\n\\uf0b7\\nIf patient is allergic to penicillin Inj. vancomycin 1 g IV (over 1-2 hours) plus Inj.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 254, 'source_type': 'Authorotative', 'priority': '1'}, page_content='6 hours after initial dose.\\n\\uf0b7\\nIf patient is allergic to penicillin Inj. vancomycin 1 g IV (over 1-2 hours) plus Inj.\\ngentamicin 1.5 g/kg (maximum 120 mg). Infusion to be completed within 30 min before\\nprocedure.\\nPatient education\\n\\uf0b7\\nDepending on the type and severity of cardiac lesion maternal risk of pregnancy should\\nbe discussed with the patient ideally before pregnancy\\n\\uf0b7\\nOption of corrective surgery preferably before pregnancy.\\n\\uf0b7\\n2 - 5% risk of congenital heart disease in foetus if mother has congenital heart disease.\\n\\uf0b7\\nContraceptive advice: sterilization after 2 weeks, progestogen only method or barrier\\nmethod. Counsel husband for male sterilization preferably by nonscalpel vasectomy.\\n\\uf0b7\\nIn severe cases option of medical termination of pregnancy if pregnancy <12 weeks.\\nANTEPARTUM HEMORRHAGE (APH)\\nAntepartum haemorrhage is defined as bleeding from genital tract after 20 weeks of\\npregnancy and before completion of second stage of labour. It is a major cause of maternal'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 254, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Antepartum haemorrhage is defined as bleeding from genital tract after 20 weeks of\\npregnancy and before completion of second stage of labour. It is a major cause of maternal\\nmorbidity, mortality and perinatal loss. APH is due to placental cause in as high as 70% cases\\nand in 25-30% of cases cause may remain undetermined.\\nSalient features\\n\\uf0b7\\nClinical presentation varies depending on the severity of blood loss and cause of\\nbleeding\\n\\uf0b7\\nIn mild haemorrhage there may be no maternal or foetal compromise, while massive\\nhaemorrhage can lead to hypovolaemic shock, coagulation failure, renal failure, foetal\\ndistress and may result in maternal and foetal death.\\n\\uf0b7\\nUltrasound is confirmatory for placenta praevia.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 255, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n248\\nClinical presentation and severity of blood loss\\nAcute blood loss\\nClinical findings\\n1000 ml\\nNone\\n1000- 1500 ml\\nOrthostatic blood pressure changes, positive tilt test,\\nPulse Pressure = 30 mmHg, reduced peripheral perfusion,\\nprolong capillary refill time\\n1500-2000 ml\\nCold clammy skin, tachycardia, tachypnoea, hypotension\\n> 2000 ml\\nProfound shock, non-palpable pulse, intrauterine death of the\\nfoetus\\nCauses of bleeding\\nPlacenta praevia\\nAbruptio placentae\\nPainless recurrent bleeding\\nAssociated pain abdomen\\nRelaxed non-tender uterus\\nTense tender uterus\\nFree-floating presenting part\\nFoetal parts not easily palpable\\nAbnormal lie\\nFoetal heart irregular or absent\\nPregnancy induced hypertension\\nTreatment\\nAll patients of APH should be hospitalized in a well equipped center with facilities for blood\\ntransfusion, emergency caesarean section and neonatal care unit.\\n(I)\\nMassive hemorrhage\\nFollowing resuscitative measures are started immediately in massive hemorrhage.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 255, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"transfusion, emergency caesarean section and neonatal care unit.\\n(I)\\nMassive hemorrhage\\nFollowing resuscitative measures are started immediately in massive hemorrhage.\\nSimultaneously prepare the patient for induction of labour by vaginal, caesarean section\\ndepending on the cause of bleeding.\\nNon- pharmacological treatment\\n\\uf0b7\\nEstablish intravenous line (one or two 14/16 gauge cannula\\n\\uf0b7\\nDraw 20 ml blood for cross-match, haemogram, coagulation profile.\\n\\uf0b7\\nStart fluid therapy rapidly as described below.\\n\\uf0b7\\nHead down tilt, keep the patient warm.\\n\\uf0b7\\nOxygen by mask at 8 liters/minute.\\n\\uf0b7\\nEmpty bladder (Foley's catheter for urine output).\\nPharmacological treatment\\n\\uf0b7\\nIV fluids and blood replacement therapy.\\n\\uf0b7\\nDefinitive treatment is induction of labour by caesarean section in cases of placenta\\npraevia and by vaginal/caesarian section in cases of abruptio placentae.\\n(II)\\nMild APH\\nExpectant management\\n\\uf0b7\\nIn a case of placenta praevia without maternal and foetal compromise, expectant\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 255, 'source_type': 'Authorotative', 'priority': '1'}, page_content='praevia and by vaginal/caesarian section in cases of abruptio placentae.\\n(II)\\nMild APH\\nExpectant management\\n\\uf0b7\\nIn a case of placenta praevia without maternal and foetal compromise, expectant\\nmanagement is planned if pregnancy is less than 37 weeks and patient is not having active\\nbleeding and labour pains.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 256, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n249\\n\\uf0b7\\nHospitalize and bed rest with foetal and maternal monitoring.\\n\\uf0b7\\nInj. dexamethasone 12 mg IM 12 hourly for 2 doses should be given for foetal lung\\nmaturity if POG < 35 weeks.\\n\\uf0b7\\nDefinitive treatment is induction of labour in case of following: occurrence of life-\\nthreatening bleeding, pregnancy > 37 weeks, patient is in labour, in all cases of abruptio\\nplacentae, baby is dead, congenitally malformed baby and bleeding recurring or\\npremature rupture of membranes on expectant management leading to maternal or foetal\\ncompromise.\\n\\uf0b7\\nIndications for caesarean section are: major degree placenta praevia, non vertex\\npresentation, case of abruptio placentae with live foetus if cervix is unfavourable (labour\\nis likely to be longer than 6 hours), Failure to progress after amniotomy and oxytocin\\ninfusion and other obstetrical indications for caesarean section.\\n\\uf0b7\\nIndications for vaginal delivery in APH are: Minor degree placenta praevia with vertex'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 256, 'source_type': 'Authorotative', 'priority': '1'}, page_content='infusion and other obstetrical indications for caesarean section.\\n\\uf0b7\\nIndications for vaginal delivery in APH are: Minor degree placenta praevia with vertex\\npresentation and slight bleeding with favourable cervix and abruptio placentae with mild\\nbleeding and no increased uterine tone, foetus is dead or has major congenital\\nmalformation incompatible with life.\\n\\uf0b7\\nFor induction artificial rupture of membranes followed by oxytocin infusion is done.\\nOxytocin infusion is continued in the postpartum period to prevent postpartum\\nhaemorrhage. In abruptio placentae monitoring is done to detect maternal complication\\nearly (pulse, BP, uterine height girth chart, vaginal bleeding, urinary output, BT, CT, clot\\nretraction time).\\nPatient education\\n\\uf0b7\\nAPH irrespective of type and cause results in increased perinatal morbidity and mortality.\\n\\uf0b7\\nIncidence of placental abruption and placenta praevia are both increased with increasing\\nage and parity.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 256, 'source_type': 'Authorotative', 'priority': '1'}, page_content='APH irrespective of type and cause results in increased perinatal morbidity and mortality.\\n\\uf0b7\\nIncidence of placental abruption and placenta praevia are both increased with increasing\\nage and parity.\\n\\uf0b7\\nHypertension, cigarette smoking, cocaine abuse etc. predispose to placental abruption.\\nPREMATURE RUPTURE OF MEMBRANES\\nPrelabour rupture of membranes (PROM) is rupture of the membranes before labor has\\nbegun. PROM can occur either when the fetus is immature (preterm or before 37 weeks) or at\\nterm.\\nGeneral management\\n\\uf0b7\\nConfirm accuracy of calculated gestational age, if possible.\\n\\uf0b7\\nPer speculum examination to assess vaginal discharge (amount, colour, odour) and\\nexclude urinary incontinence.\\nDiagnosis of vaginal discharge (Table 2)\\na) Light bleeding: takes longer than five minutes for a clean pad or cloth to be soaked.\\nb) Determine cause and treat accordingly.\\nConfirm diagnosis\\n\\uf0b7\\nThe typical odour of amniotic fluid confirms the diagnosis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 257, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n250\\n\\uf0b7\\nIf membrane rupture is not recent or when leakage is gradual, confirming the diagnosis\\nmay be difficult:\\n\\uf0b7\\nPlace a vaginal pad over the vulva and examine it (visually and by odour) one hour later.\\n\\uf0b7\\nOn per speculum examination: Fluid may be seen coming from the cervix or forming a\\npool in the posterior fornix; and on coughing; there may a gush of fluid.\\n\\uf0b7\\nIf available, perform tests:\\n- The nitrazine test depends upon the fact that vaginal secretions and urine are acidic while\\namniotic fluid is alkaline.\\n- For the ferning test, spread some fluid on a slide and let it dry. Examine it with a\\nmicroscope. Amniotic fluid crystallizes and may leave a fern-leaf pattern. False\\nnegatives are frequent.\\nTable 2. Clinical presentation of patients with vaginal discharge in pregnancy\\nPresenting symptoms\\nand symptoms & signs\\nPresent symptoms and signs sometimes\\npresent\\nProbable\\ndiagnosis\\nWatery vaginal discharge\\n• Sudden gush or intermittent leaking of fluid'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 257, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Presenting symptoms\\nand symptoms & signs\\nPresent symptoms and signs sometimes\\npresent\\nProbable\\ndiagnosis\\nWatery vaginal discharge\\n• Sudden gush or intermittent leaking of fluid\\nFluid seen at introitus\\n•No contractions within 1 hour\\nPremature\\nrupture of\\nmembranes\\nFoul smelling watery\\ndischarge after 22 weeks\\n• Fever/chills\\n• Abdominal pain\\n• History of loss of fluid\\n• Tender uterus\\n• Rapid fetal heart rate\\n• Light vaginal bleeding\\nAmnionitis\\nFoul smelling\\nvaginal discharge\\n• No history of loss of fluid\\n• Itching, Frothy/curdish discharge\\n• Abdominal pain\\n• Dysuria\\nVaginitis\\nor cervicitis\\nBloody vaginal discharge\\n•Abdominal pain\\nLoss of fetal movements\\n• Heavy, prolonged vaginal bleeding\\nAntepartum\\nhaemorrhage\\nTreatment\\n\\uf0b7\\nIf there is vaginal bleeding with intermittent or constant abdominal pain, suspect abruptio\\nplacentae.\\n\\uf0b7\\nIf there are signs of infection (fever, foul-smelling vaginal discharge), give antibiotics as\\nfor amnionitis\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 257, 'source_type': 'Authorotative', 'priority': '1'}, page_content='placentae.\\n\\uf0b7\\nIf there are signs of infection (fever, foul-smelling vaginal discharge), give antibiotics as\\nfor amnionitis\\n\\uf0b7\\nIf there are no signs of infection and the pregnancy is less than 37 weeks (when fetal\\nlungs are more likely to be immature): give antibiotics to reduce maternal and neonatal\\ninfective morbidity and to delay delivery\\n\\uf0b7\\nPre-labour rupture of membranes'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 258, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n251\\n-\\nTab. erythromycin 250 mg by mouth three times per day for seven days or amoxicillin\\n500 mg by mouth three times per day for seven days;\\n-\\nConsider transfer to the most appropriate service for care of the newborn, if possible\\n-\\nGive corticosteroids to the mother to improve fetal lung maturity: betamethasone 12\\nmg IM, two doses 24 hours apart or Inj.  dexamethasone 6 mg IM, four doses 12\\nhours apart.\\nNote: Corticosteroids should not be used in the presence of frank infection.\\n\\uf0b7\\nInduce labour using oxytocin at 37 weeks and give prophylactic antibiotics to help reduce\\nGroup B streptococcus infection in the neonate, even if the woman received antibiotics\\npreviously: penicillin G 2 million units IV every six hours until delivery; or Inj.\\nampicillin 2 g IV every six hours until delivery.\\n\\uf0b7\\nIf there are palpable contractions and blood-stained mucus discharge, suspect preterm\\nlabour.\\n\\uf0b7\\nIf there are no signs of infection and the pregnancy is 37 weeks or more:\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 258, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIf there are palpable contractions and blood-stained mucus discharge, suspect preterm\\nlabour.\\n\\uf0b7\\nIf there are no signs of infection and the pregnancy is 37 weeks or more:\\n-\\nIf the membranes have been ruptured for more than 18 hours, give prophylactic\\nantiboitics to help reduce Group B streptococcus infection in the neonate.\\n-\\nAssess the cervix\\n-\\nIf the cervix is favourable (soft, thin, partly dilated), induce labour using oxytocin.\\n-\\nIf the cervix is unfavourable (firm, thick, closed), ripen the cervix using\\nprostaglandins and    infuse oxytocin or deliver by caesarean section.\\nAmnionitis\\n\\uf0b7\\nGive a combination of antibiotics until delivery\\n- Inj. ampicillin 2 g IV every six hours; plus gentamicin 5 mg/kg body weight IV every 24\\nhours\\n- If the woman delivers vaginally, discontinue antibiotics postpartum\\n- If the woman has a caesarean section, continue antibiotics and give Inj. metronidazole\\n500 mg IV every eight hours until the woman is fever-free for 48 hours.\\n\\uf0b7\\nAssess the cervix'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 258, 'source_type': 'Authorotative', 'priority': '1'}, page_content='- If the woman has a caesarean section, continue antibiotics and give Inj. metronidazole\\n500 mg IV every eight hours until the woman is fever-free for 48 hours.\\n\\uf0b7\\nAssess the cervix\\n- If the cervix is favorable (soft, thin, partly dilated), induce labour using oxytocin\\n- If the cervix is unfavourable (firm, thick, closed), ripen the cervix using prostaglandins\\nand infuse oxytocin or deliver by caesarean section.\\n\\uf0b7\\nIf metritis is suspected (fever, foul-smelling vaginal discharge), give antibiotics.\\n\\uf0b7\\nIf newborn sepsis is suspected, arrange for a blood culture and antibiotics.\\nPRETERM LABOR\\nOnset of labour pains in pregnant women after 20 weeks and before 37 weeks of gestation\\nassociated with progressive dilatation and effacement of the cervix is known as preterm\\nlabour.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 259, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n252\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nHospitalization with complete bed rest, preferably in a centre with neonatal intensive care\\nunit.\\n\\uf0b7\\nLaboratory investigations: haemogram, urine culture, endocervical swab for culture and\\nsensitivity.\\nPharmacological treatment\\n\\uf0b7\\nInj. pentazocine 15mg + Inj. promethazine 25 mg IM stat and can be repeated 8 hourly.\\n\\uf0b7\\nImmediate tocolysis in pregnancies <35 week\\n\\uf0b7\\nIf membranes are intact and labour is not advanced (cervical dilatation <4 cm), there is no\\nindication for immediate delivery and no contraindication for tocolysis.\\n\\uf0b7\\nInj. isoxsuprine HCl 10 mg IM every 6 hours in case of mild contraction; Intravenous\\ninfusion if strong contractions are established 0.2-0.4 mcg/min in 5% dextrose. Maximum\\ndose is 0.8 mcg/min to be continued at least 2 hours after the contractions cease.\\nFollowed by IM therapy for 24 hours.\\n(Caution: Side effects tachycardia and hypotension, hypokalaemia, neonatal tachycardia,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 259, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Followed by IM therapy for 24 hours.\\n(Caution: Side effects tachycardia and hypotension, hypokalaemia, neonatal tachycardia,\\nhypotension and rarely pulmonary oedema and acute respiratory distress syndrome). Or\\n\\uf0b7\\nInj. ritodrine infusion 3 ampoules (150 mg) in 500 ml of 5% dextrose or ringer lactate at\\n50- 100 mcg/min (5-6 drops/min), increase by 50 mcg every 10 min till contractions\\ncease or side effects appear (maximum dose 350 mcg/min), continue for 12 hour after\\ncontractions stop. This is followed by oral treatment - 10 mg every 2 hours for 24 hours\\nthen 10-20 mg every 4-6 hours. (Contraindications: Poorly controlled diabetes or thyroid\\ndisease, sickle cell disease). Or\\n\\uf0b7\\nCap. Nifedipine 30 mg loading dose followed by 10-20 mg every 4-6 hours.\\n(Caution: Do not administer along with magnesium sulfate; contraindicated in maternal\\nhypotension (< 90/50 mmHg), cardiac disease. Use with caution in renal disease.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 259, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(Caution: Do not administer along with magnesium sulfate; contraindicated in maternal\\nhypotension (< 90/50 mmHg), cardiac disease. Use with caution in renal disease.\\nMaternal side effects include flushing, headache, nausea, dizziness, and hypotension.) Or\\n\\uf0b7\\nInj. magnesium sulfate 4-6 g as 20% solution bolus over 30 minutes followed by infusion\\nof 4-6 g/h. (Contraindicated in patients with myasthenia gravis, cardiac decompensation.\\nUse with caution in renal disease. It can cause flushing, lethargy, headache, muscle\\n\\uf0b7\\nUterine contraction of duration of 30 sec or more at interval of 10 minutes or less\\naccompanied by cervical dilatation and effacement with or without leaking or\\nbleeding per vaginum.\\n\\uf0b7\\nRisk factors include: low socioeconomic status,  heavy manual labour, extremes of\\nage (<20 years and >40 years),  previous history of abortion or preterm delivery,\\ncervical or vaginal infection, multiple gestation or over distended uterus, hypoxic'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 259, 'source_type': 'Authorotative', 'priority': '1'}, page_content='age (<20 years and >40 years),  previous history of abortion or preterm delivery,\\ncervical or vaginal infection, multiple gestation or over distended uterus, hypoxic\\nconditions like anaemia, heart disease, preeclampsia, IUGR, foetal congenital\\nmalformations and antepartum haemorrhage in present pregnancy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 260, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n253\\nweakness, dryness of mouth, nausea and foetal distress, transient non-reactive non-stress\\ntest (NST).\\n\\uf0b7\\nMonitor pulse, BP, and cessation of the uterine contractions. If pulse rate >120/min and\\nBP < 90/50 mmHg stop tocolysis. Monitoring in magnesium sulfate therapy is as outlined\\nin eclampsia. Monitor for onset of chorioamnionitis (fever, tachycardia with uterine\\ntenderness).\\nMaintenance therapy\\n\\uf0b7\\nTab. isoxsuprine orally 10 mg 6 hourly or 20 mg 12 hourly (maximum daily-dose is 40 to\\n80 mg/day) to be continued till 34 weeks of pregnancy (long term therapy is\\ncontroversial).\\n\\uf0b7\\nIn pregnancies at 28 - 34 weeks of maturity, steroids are given for foetal lung maturity.\\n\\uf0b7\\nInj. betamethasone 12 mg IM 2 doses 24 hours apart or  Inj. dexamethasone 6 mg IM four\\ndoses 12 hours apart or 12 mg IM two doses 12 hours apart.\\n(Caution: Contraindicated if clinical or laboratory evidence of chorioamnionitis is\\npresent).\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 260, 'source_type': 'Authorotative', 'priority': '1'}, page_content='doses 12 hours apart or 12 mg IM two doses 12 hours apart.\\n(Caution: Contraindicated if clinical or laboratory evidence of chorioamnionitis is\\npresent).\\n\\uf0b7\\nCap. ampicillin 500 mg or erythromycin 500 mg 4 times a day for 5-7 days, only if\\nPROM is present.\\n\\uf0b7\\nPatient may be discharged after 1 week of tocolysis followed by regular antenatal\\nsurveillance.\\nDelivery\\nIn cases of ineffective tocolysis or with contraindications for tocolysis, labour is allowed to\\nprogress and mode of delivery is decided as per obstetric indications. Careful foetal\\nmonitoring required throughout labour.  If any sign of hypoxia, caesarean section is better but\\nfoetus should have a fairly good chance of survival depending on neonatal care facility.\\nPatient education\\n\\uf0b7\\nRestricted physical activity after discharge.\\n\\uf0b7\\nSexual abstinence till at least 34 weeks of gestation.\\n\\uf0b7\\nExplain the risk of recurrence in subsequent pregnancy. Therefore need for early booking\\nand prophylactic measures in next pregnancy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 260, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nSexual abstinence till at least 34 weeks of gestation.\\n\\uf0b7\\nExplain the risk of recurrence in subsequent pregnancy. Therefore need for early booking\\nand prophylactic measures in next pregnancy.\\nNORMAL LABOUR\\nDiagnosis\\n\\uf0b7\\nPainful uterine contractions after 22 weeks gestation;\\n\\uf0b7\\nPain associated with blood-stained mucus vaginal discharge (show);\\n\\uf0b7\\nWatery vaginal discharge or a sudden gush of water.\\n\\uf0b7\\nCervical dilatation and effacement'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 261, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n254\\nTable 3. Stages of normal labour\\nStages of\\nlabour\\nDefinition\\nDuration\\nFirst stage\\nCervical dilatation\\nNullipara\\nMultipara\\nLatent phase\\nActive phase\\n< 3 cm\\n12h\\n8h\\n> 3 cm\\n6-8 h or rate of cervical\\ndilatation 1 cm/h\\n4-6 h or rate of cervical\\ndilatation 1.5 cm/h\\nSecond stage\\nFull dilatation of cervix to\\nexplusion of foetus\\n1 h\\n30 min\\nThird stage\\nFrom expulsion of foetus\\nto the delivery of placenta\\n15 min\\n15 min\\nManagement of labour\\nWhen the patient reports to the hospital with labour pains, examination should be conducted\\nby a doctor on duty and risk category to be assigned (Table 4).\\nTable 4. Common risk factors during labour\\nMaternal\\nfactors\\nPast reproductive\\nhistory\\nPresent pregnancy\\nAssociated medical/\\nsurgical problem\\nAge < 16, >35\\n>1 abortion\\nBleeding in\\npregnancy\\nHeart disease\\nParity - 0, >5\\nPrevious stillbirth\\nPrematurity, PROM\\nDiabetes\\nObesity\\nPrevious caesarean\\nsection\\nPostmaturity\\nAnaemia\\nHeight < 145 cm Prev  PPH/MRP\\nPIH\\nJaundice\\nPIH, Eclampsia'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 261, 'source_type': 'Authorotative', 'priority': '1'}, page_content='pregnancy\\nHeart disease\\nParity - 0, >5\\nPrevious stillbirth\\nPrematurity, PROM\\nDiabetes\\nObesity\\nPrevious caesarean\\nsection\\nPostmaturity\\nAnaemia\\nHeight < 145 cm Prev  PPH/MRP\\nPIH\\nJaundice\\nPIH, Eclampsia\\nIUGR\\nHypertension\\nIUGR\\nMultiple pregnancy\\nRenal disease\\nCongenital anomaly in\\nbaby\\nMalpresentation\\nThyroid disease\\nPrevious early neonatal\\nMalposition\\nEpilepsy\\nDeath\\nAsthma\\nGeneral examination\\n\\uf0b7\\nRecord height and weight.\\n\\uf0b7\\nPulse rate (PR), blood pressure (BP), respiratory rate (RR), temperature.\\n\\uf0b7\\nLook for pallor, pedal oedema, jaundice and cyanosis.\\n\\uf0b7\\nAuscultate cardiovascular and respiratory system.\\nPer abdomen examination\\n\\uf0b7\\nHeight of the uterus/POG.\\n\\uf0b7\\nPresentation, attitude, palpable foetal head (rule of fifths).\\n\\uf0b7\\nFoetal heart rate.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 262, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n255\\n\\uf0b7\\nUterine contractions - +/-, intensity, duration and frequency per 10 minutes.\\n\\uf0b7\\nAmount of liquor.\\n\\uf0b7\\nSize of the baby/estimated baby weight.\\n\\uf0b7\\nLook for overriding of foetal head over symphysis pubis.\\n\\uf0b7\\nFeatures of obstructed labour and contour of the uterus.\\nPer vaginum examination\\n\\uf0b7\\nObserve aseptic precautions - hand washing and sterile gloves. Note:\\n\\uf0b7\\nCervical dilatation and effacement.\\n\\uf0b7\\nPresentation and station of presenting part.\\n\\uf0b7\\nPosition and degree of flexion (sutures and fontanelle).\\n\\uf0b7\\nStatus of membranes and if leaking present then colour of liquor.\\n\\uf0b7\\nCord prolapse or presentation to be ruled out.\\n\\uf0b7\\nPelvic adequacy and rule out cephalopelvic disproportion (CPD).\\n\\uf0b7\\nVaginal examination should be carried out atleast once every 4 hours during first\\nstage of labour and after rupture of membranes.\\nInvestigations\\n\\uf0b7\\nMinimum investigations required during labour are:\\n\\uf0b7\\nHb, urine albumin and sugar, blood grouping.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 262, 'source_type': 'Authorotative', 'priority': '1'}, page_content='stage of labour and after rupture of membranes.\\nInvestigations\\n\\uf0b7\\nMinimum investigations required during labour are:\\n\\uf0b7\\nHb, urine albumin and sugar, blood grouping.\\n\\uf0b7\\nUrine acetone in prolonged/obstructed labour.\\nASSESSMENT OF PROGRESS OF LABOUR\\n\\uf0b7\\nMeasure changes in cervical effacement and dilatation  during the latent phase\\n\\uf0b7\\nMeasure the rate of cervical dilatation and fetal descent during the active phase\\n\\uf0b7\\nAssess further fetal descent during the second stage.\\n\\uf0b7\\nProgress of the first stage of labour should be plotted on a partograph once the patient\\nenters the active phase of labour.\\nPARTOGRAPH\\nThe WHO partograph has been modified to make it simpler and easier to use. The latent\\nphase has been removed and plotting on the partograph begins in the active phase when the\\ncervix is 4 cm dilated.  Record the following on the partograph:\\nPatient information\\n\\uf0b7\\nName, gravida, para,\\n\\uf0b7\\nHospital number, date and time of admission,\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 262, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cervix is 4 cm dilated.  Record the following on the partograph:\\nPatient information\\n\\uf0b7\\nName, gravida, para,\\n\\uf0b7\\nHospital number, date and time of admission,\\n\\uf0b7\\nTime of ruptured membranes or time elapsed since rupture of membranes (if rupture\\noccurred before charting on the partograph began).\\nFetal heart rate: Record every half hour.\\nAmniotic fluid: Record the colour of amniotic fluid at every vaginal examination:\\n\\uf0b7\\nI: membranes intact;\\n\\uf0b7\\nR: membranes ruptured;'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 263, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n256\\n\\uf0b7\\nC: membranes ruptured, clear fluid;\\n\\uf0b7\\nM: meconium-stained fluid;\\n\\uf0b7\\nB: blood-stained fluid.\\nMoulding:\\n\\uf0b7\\n1: sutures apposed;\\n\\uf0b7\\n2: sutures overlapped but reducible;\\n\\uf0b7\\n3: sutures overlapped and not reducible.\\nCervical dilatation: Assessed at every vaginal examination and marked with a cross (X).\\nBegin plotting on the partograph at 4 cm.\\nAlert line: A line starts at 4 cm of cervical dilatation to the point of expected full dilatation at\\nthe rate of 1 cm per hour.\\nAction line: Parallel and four hours to the right of the alert line.\\nDescent assessed by abdominal palpation: Refers to the part of the head (divided into five\\nparts) palpable above the symphysis pubis; recorded as a circle (O) at every abdominal\\nexamination. At 0/5, the sinciput (S) is at the level of the symphysis pubis.\\nHours: Refers to the time elapsed since onset of active phase of labour .\\nTime: Record actual time.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 263, 'source_type': 'Authorotative', 'priority': '1'}, page_content='examination. At 0/5, the sinciput (S) is at the level of the symphysis pubis.\\nHours: Refers to the time elapsed since onset of active phase of labour .\\nTime: Record actual time.\\nContractions: Chart every half hour; count the number of contractions in a 10-minute time\\nperiod, and their duration in seconds.\\n\\uf0b7\\nLess than 20 seconds:\\n\\uf0b7\\nBetween 20 and 40 seconds:\\n\\uf0b7\\nMore than 40 seconds:\\nOxytocin: Record the amount of oxytocin per volume IV fluids in drops per minute every 30\\nminutes when used.\\nDrugs given: Record any additional drugs given.\\nPulse: Record every 30 minutes and mark with a dot (!).\\nBlood pressure: Record every four hours and mark with arrows.\\nTemperature: Record every two hours.\\nProtein, acetone and volume: Record when urine is passed.\\nPartograph passes to the right of Alert line - reassess and consider criteria for referral; call\\nsenior person, if available.\\nPartograph passes to the right of Action line - refer urgently to hospital unless birth is\\nimminent.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 263, 'source_type': 'Authorotative', 'priority': '1'}, page_content='senior person, if available.\\nPartograph passes to the right of Action line - refer urgently to hospital unless birth is\\nimminent.\\nDrugs and IV fluids if administered are recorded.\\nMaintain intake-output chart\\nSECOND STAGE OF LABOUR\\n\\uf0b7\\nShift the patient to delivery table.\\n\\uf0b7\\nInform the paediatrician. Ensure all delivery equipment and supplies, including newborn\\nresuscitation equipment, are available, and place of delivery is clean and warm (25°C).\\n\\uf0b7\\nPut her in dorsal/squatting position.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 264, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Obstetrics and Gynecology\\n257\\n\\uf0b7\\nObserve universal precautions\\n\\uf0b7\\nClean and drape the parts.\\n\\uf0b7\\nInfiltrate the perineum with local anaesthetic agent if episiotomy is planned.\\n\\uf0b7\\nWoman is encouraged to bear down.\\n\\uf0b7\\nEpisiotomy is given if required\\n\\uf0b7\\nTo control birth of the head, keep the baby's head flexed and gently support the perineum\\nas the head delivers. Suction of the nose and mouth.\\n\\uf0b7\\nAfter external rotation, deliver the shoulders one at a time followed by rest of the foetus.\\n\\uf0b7\\nClamp and cut the umbilical cord.\\n\\uf0b7\\nEnsure establishment of respiration in baby or institute resuscitation if required.\\n\\uf0b7\\nAdministration of oxytocin 5 Units IM at the delivery of the anterior shoulder to prevent\\nPPH.\\nTHIRD STAGE OF LABOUR\\n\\uf0b7\\nRecognize signs of placental separation: Uterus becomes globular and firmer, suprapubic\\nbulge appears, sudden gush of blood and permanent lengthening of cord.\\n\\uf0b7\\nDeliver the placenta by controlled cord traction. As the placenta passes through the\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 264, 'source_type': 'Authorotative', 'priority': '1'}, page_content='bulge appears, sudden gush of blood and permanent lengthening of cord.\\n\\uf0b7\\nDeliver the placenta by controlled cord traction. As the placenta passes through the\\nintroitus, care is taken to prevent the membranes from being torn off and left behind.\\n\\uf0b7\\nExamine the placenta for its completeness and anomalies.\\n\\uf0b7\\nAdminister Inj. oxytocin 5-10 U IM.\\n\\uf0b7\\nActive management of third stage should be done unless contraindicated.\\n\\uf0b7\\nExamine the woman for any tears and repair if any. Stitch the episiotomy. Observe the\\nwoman closely for one hour after delivery, record her PR and BP.\\n\\uf0b7\\nEvaluate the uterus frequently, and inspect the perineum to detect excessive bleeding and\\nhaematoma formation.\\nTransfer from labour room\\n\\uf0b7\\nObserve for 2 hours\\n\\uf0b7\\nCheck the following before transfer: pulse rate, BP, uterus, bleeding pre vaginum, inspect\\nexternal genitalia for condition of stitches and any haematoma, passed urine.\\nEpisiotomy (Incision of the perineum)\\n\\uf0b7\\nNot to be performed routinely.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 264, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"external genitalia for condition of stitches and any haematoma, passed urine.\\nEpisiotomy (Incision of the perineum)\\n\\uf0b7\\nNot to be performed routinely.\\n\\uf0b7\\nApplied selectively for: breech, forceps or vacuum delivery, occiput posterior positions,\\nrigid perineum, scarred perineum, and shoulder dystocia.\\n\\uf0b7\\nClean the area with antiseptic solution.\\n\\uf0b7\\nInfiltrate beneath the vaginal mucosa, beneath the skin and deeply into the perineal\\nmuscle using 10 ml of 0.5 - 1% lignocaine.\\n\\uf0b7\\nCheck at the incision site for effect of local anaesthetics by pinching with a forceps before\\ngiving incision.\\n\\uf0b7\\nPerform episiotomy at crowning. Place two fingers between the baby's head and the\\nperineum and cut 3-4 cm of perineum in mediolateral direction.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 265, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n258\\n\\uf0b7\\nAfter delivery of the baby and placenta, carefully examine for extensions of tears.\\n\\uf0b7\\nRepair the episiotomy with vicryl rapide 2-0 suture (chromic catgut if vicryl is not\\navailable). Close the vaginal mucosa with continuous suture starting 1 cm above the apex.\\nPerineal muscles are approximated using interrupted sutures. Skin is closed with\\nsubcuticular (or interrupted) sutures.\\nCare of episiotomy\\nPerineal hygiene: Clean the area with antiseptic solution after urination and defaecation.\\nAnalgesics are prescribed for allaying pain.\\nRespond to following problems during labour and delivery\\nAssess facilities and expertise available and appropriate timely referral if foetal heart rate <\\n120 or> 160 beats per minute, prolapsed cord, breech presentation, stuck shoulders, multiple\\nbirths\\nFETAL DISTRESS IN LABOR\\nAbnormal fetal heart rate (less than 100 or more than 180 beats per minute) with thick\\nmeconium-stained amniotic fluid.\\nGeneral management\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 265, 'source_type': 'Authorotative', 'priority': '1'}, page_content='births\\nFETAL DISTRESS IN LABOR\\nAbnormal fetal heart rate (less than 100 or more than 180 beats per minute) with thick\\nmeconium-stained amniotic fluid.\\nGeneral management\\n\\uf0b7\\nIf a maternal cause is identified (e.g. maternal fever, drugs), initiate appropriate\\nmanagement.\\n\\uf0b7\\nIf a maternal cause is not identified and the fetal heart rate remains abnormal throughout\\nat least three contractions, perform a vaginal examination to check for explanatory signs\\nof distress:\\n\\uf0b7\\nIf there is bleeding with intermittent or constant pain, suspect abruptio placentae.\\n\\uf0b7\\nIf there are signs of infection (fever, foul-smelling vaginal discharge) give antibiotics as\\nfor amnionitis.\\n\\uf0b7\\nA normal fetal heart rate may slow during a contraction but usually recovers to normal as\\nsoon as the uterus relaxes.\\n\\uf0b7\\nA very slow fetal heart rate in the absence of contractions or persisting after contractions\\nis suggestive of fetal distress.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 265, 'source_type': 'Authorotative', 'priority': '1'}, page_content='soon as the uterus relaxes.\\n\\uf0b7\\nA very slow fetal heart rate in the absence of contractions or persisting after contractions\\nis suggestive of fetal distress.\\n\\uf0b7\\nA rapid fetal heart rate may be a response to maternal fever, drugs causing rapid maternal\\nheart rate (e.g. terbutaline or ritodrine), hypertension or amnionitis. In the absence of a\\nrapid maternal heart rate, a rapid fetal heart rate should be considered a sign of fetal\\ndistress.\\n\\uf0b7\\nIf the cord is below the presenting part or in the vagina, manage as prolapsed cord .\\n\\uf0b7\\nIf fetal heart rate abnormalities persist or there are additional signs of distress (thick\\nmeconium-stained fluid), plan delivery:\\n\\uf0b7\\nIf the cervix is fully dilated and the fetal head is not more than 1/5 above the symphysis\\npubis or the leading bony edge of the fetal head is at 0 station, deliver by vacuum\\nextraction or forceps'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 266, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n259\\n\\uf0b7\\nIf the cervix is not fully dilated or the fetal head is more than 1/5 above the symphysis\\npubis or the leading bony edge of the fetal head is above 0 station, deliver by caesarean\\nsection\\nMECONIUM STAINED LIQUOR\\nMeconium staining of amniotic fluid is seen frequently as the fetus matures and by itself is\\nnot an indicator of fetal distress. A slight degree of meconium without fetal heart rate\\nabnormalities is a warning of the need for vigilance. Thick meconium suggests passage of\\nmeconium in reduced amniotic fluid and may indicate the need for expedited delivery and\\nmanagement of the neonatal upper airway at birth to prevent meconium aspiration. In breech\\npresentation, meconium is passed in labour because of compression of the fetal abdomen.\\nThis is not a sign of distress unless it occurs in early labour\\nManagement\\n\\uf0b7\\nProp up the woman or place her on her left side.\\n\\uf0b7\\nStop oxytocin if it is being administered.\\n\\uf0b7\\nGive oxygen 4–6 L by mask or nasal cannulae.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 266, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Management\\n\\uf0b7\\nProp up the woman or place her on her left side.\\n\\uf0b7\\nStop oxytocin if it is being administered.\\n\\uf0b7\\nGive oxygen 4–6 L by mask or nasal cannulae.\\nAdvice on postpartum care\\n\\uf0b7\\nTo always have someone near her for the first 24 hours to respond to any change in her\\ncondition.\\n\\uf0b7\\nNot to insert anything into the vagina.\\n\\uf0b7\\nTo have adequate rest and sleep.\\n\\uf0b7\\nThe importance of hand washing to prevent infection of the mother and her baby.\\n\\uf0b7\\nTo wash perineum daily and after faecal excretion.\\n\\uf0b7\\nTo avoid sexual intercourse until the perineal wound heals.\\n\\uf0b7\\nCounsel for birth spacing and family planning (for details see section on contraception).\\n\\uf0b7\\nAdvise on routine postpartum care visits- within the first week, preferably within 2-3 days\\nand second visit after 4-6 weeks. Earlier if problems- fever, UTI, perineal infection,\\nhypertension, urinary incontinence, severe anaemia, postpartum blues, HIV positive.\\nCounsel on exclusive breastfeeding\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 266, 'source_type': 'Authorotative', 'priority': '1'}, page_content='hypertension, urinary incontinence, severe anaemia, postpartum blues, HIV positive.\\nCounsel on exclusive breastfeeding\\n\\uf0b7\\nBabies should start breastfeeding within 1 hour of birth. The baby should not be given\\nany other food or drink before breastfeeding.\\n\\uf0b7\\nBabies should be exclusively breastfed for the first 6 months of life.\\n\\uf0b7\\nBreast milk contains exactly the nutrients a baby needs, is easily digested and protects the\\nbaby against infection.\\nINDUCTION AND AUGMENTATION OF LABOUR\\nInduction of labour refers to stimulating the uterus to begin labour. While augmentation of\\nlabour means stimulating the uterus during labour to increase the frequency, duration and\\nstrength of contractions.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 267, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n260\\nA good labour pattern is established when there are three contractions in 10 minutes, each\\nlasting more than 40 seconds. If the membranes are intact, it is recommended practice in both\\ninduction and augmentation of labour to first perform artificial rupture of membranes (ARM).\\nIn some cases, this is all that is needed to induce labour. Membrane rupture, whether\\nspontaneous or artificial, often sets off the following chain of events:\\n- Amniotic fluid is expelled;\\n- Uterine volume is decreased;\\n- Prostaglandins are produced, stimulating labour;\\n- Uterine contractions begin (if the woman is not in labour) or become stronger (if she is\\nalready in labour).\\nArtificial rupture of membranes\\n\\uf0b7\\nNote: In areas where HIV and/or hepatitis are highly prevalent, it is prudent to leave the\\nmembranes intact for as long as possible to reduce perinatal transmission of HIV\\n\\uf0b7\\nMonitor the fetal heart rate.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 267, 'source_type': 'Authorotative', 'priority': '1'}, page_content='membranes intact for as long as possible to reduce perinatal transmission of HIV\\n\\uf0b7\\nMonitor the fetal heart rate.\\n\\uf0b7\\nAsk the woman to lie on her back with her legs bent, feet together and knees apart.\\n\\uf0b7\\nWearing sterile gloves, use one hand to examine the cervix and note the consistency,\\nposition, effacement and dilatation.\\n\\uf0b7\\nUse the other hand to insert an amniotic hook or a Kocher clamp into the vagina.\\n\\uf0b7\\nGuide the clamp or hook towards the membranes along the fingers in the vagina.\\n\\uf0b7\\nPlace two fingers against the membranes and gently rupture the membranes with the\\ninstrument in the other hand. Allow the amniotic fluid to drain slowly around the fingers.\\n\\uf0b7\\nNote the colour of the fluid (clear, greenish, bloody). If thick meconium is present,\\nsuspect fetal distress.\\n\\uf0b7\\nAfter ARM, listen to the fetal heart rate during and after a contraction. If the fetal heart\\nrate is abnormal (less than 100 or more than 180 beats per minute), suspect fetal distress.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 267, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAfter ARM, listen to the fetal heart rate during and after a contraction. If the fetal heart\\nrate is abnormal (less than 100 or more than 180 beats per minute), suspect fetal distress.\\n\\uf0b7\\nIf membranes have been ruptured for 18 hours, give prophylactic antibiotics to help\\nreduce Group B streptococcus infection in the neonate - penicillin G 2 million units IV; ,\\nor  Inj. ampicillin 2 g IV, every six hours until delivery\\n\\uf0b7\\nIf good labour is not established one hour after ARM, begin oxytocin infusion\\n\\uf0b7\\nIf labour is induced because of severe maternal disease (e.g. sepsis or eclampsia), begin\\noxytocin infusion at the same time as ARM.\\nAssessment of the cervix\\n\\uf0b7\\nThe success of induction of labour is related to the condition of the cervix at the start of\\ninduction. To assess the condition of the cervix, a cervical exam is performed and a score\\nis assigned based on the criteria (Table 5):\\n\\uf0b7\\nIf the cervix is favourable (has a score of 6 or more), labour is usually successfully'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 267, 'source_type': 'Authorotative', 'priority': '1'}, page_content='is assigned based on the criteria (Table 5):\\n\\uf0b7\\nIf the cervix is favourable (has a score of 6 or more), labour is usually successfully\\ninduced with oxytocin alone.\\n\\uf0b7\\nIf the cervix is unfavourable (has a score of 5 or less), ripen the cervix using\\nprostaglandins or a Foley catheter before induction.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 268, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n261\\nTable 5. Assessment of cervix for induction of labour\\nRating\\nfactor\\nDilatation\\nLength of\\ncervix\\nConsistency\\nPosition\\nDescent by\\nstation of head\\n0\\nClosed\\nMore than 4\\nFirm\\nposterior\\n-3\\n1\\n1-2\\n3-4\\nAverage\\nMid\\n-2 to -1\\n2\\n3-4\\n1-2\\nSoft\\nAnterior\\n0+1\\n3\\nMore than 5\\nLess than 1\\nSoft\\nAnterior\\n+2\\nOxytocin\\n\\uf0b7\\nUse oxytocin with great caution, as fetal distress can occur from hyperstimulation and,\\nrarely, uterine rupture can occur. Multiparous women are at higher risk for uterine\\nrupture.\\n\\uf0b7\\nThe effective dose of oxytocin varies greatly between women. Cautiously administer\\noxytocin in IV fluids (dextrose or normal saline), gradually increasing the rate of infusion\\nuntil good labour is established (three contractions in 10 minutes, each lasting more than\\n40 seconds). Maintain this rate until delivery. The uterus should relax between\\ncontractions.\\n\\uf0b7\\nMonitor the woman’s pulse, blood pressure and contractions, and check the fetal heart\\nrate.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 268, 'source_type': 'Authorotative', 'priority': '1'}, page_content='40 seconds). Maintain this rate until delivery. The uterus should relax between\\ncontractions.\\n\\uf0b7\\nMonitor the woman’s pulse, blood pressure and contractions, and check the fetal heart\\nrate.\\n\\uf0b7\\nWhen oxytocin infusion results in a good labour pattern, maintain the same rate until\\ndelivery.\\n\\uf0b7\\nCarefully observe women receiving oxytocin.\\n\\uf0b7\\nRecord the following on a partograph every 30 minutes rate of infusion of oxytocin.\\n\\uf0b7\\nLook for fetal heart rate. Listen every 30 minutes, always immediately after contraction.\\nIf the fetal heart rate is less than 100 beats per minute, stop the infusion and manage for\\nfetal distress.\\n\\uf0b7\\nInfuse oxytocin 2.5 units in 500 mL of dextrose (or normal saline) at 10 drops per minute\\nin case of multigravida. In case of primigravida start with 5 unit oxytocin in 500 ml of\\ndextrose.\\n\\uf0b7\\nIncrease the infusion rate by 10 drops per minute every 30 minutes until a good\\ncontraction pattern is established (three contractions in 10 minutes, each lasting more than\\n40 seconds).\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 268, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dextrose.\\n\\uf0b7\\nIncrease the infusion rate by 10 drops per minute every 30 minutes until a good\\ncontraction pattern is established (three contractions in 10 minutes, each lasting more than\\n40 seconds).\\n\\uf0b7\\nMaintain this rate until delivery is completed.\\n\\uf0b7\\nIf hyperstimulation occurs (any contraction lasts longer than 60 seconds) or if there are\\nmore than four contractions in 10 minutes, stop the infusion and relax the uterus using\\ntocolytics:\\n-\\nterbutaline 250 mcg IV slowly over five minutes or\\n-\\nsalbutamol 10 mg in 1 L IV fluids (normal saline or Ringer’s lactate) at 10 drops per\\nminute.\\n• If a good contraction pattern has not been established with the infusion rate at 60 drops per\\nminute:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 269, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n262\\n-\\nIncrease the oxytocin concentration to 5 units in 500 ml of dextrose (or normal saline)\\nand adjust the infusion rate to 30 drops per minute (15 mIU per minute);\\n-\\nIn multigravida and in women with previous caesarean scars, induction has failed; deliver\\nby caesarean section.\\nProstaglandins\\nProstaglandins are highly effective in ripening the cervix during induction of labour.\\n\\uf0b7\\nMonitor the woman’s pulse, blood pressure and contractions, and check the fetal heart\\nrate. Record findings on a partograph.\\n\\uf0b7\\nProstaglandin E2 (PGE2) is available in several forms (3 mg pessary or 2–3 mg gel). The\\nprostaglandin is placed high in the posterior fornix of the vagina and may be repeated\\nafter six hours if required.\\n\\uf0b7\\nDiscontinue use of prostaglandins and begin oxytocin infusion if: membranes rupture;,\\ncervical ripening has been achieved;, good labour has been established;,  or 12 hours have\\npassed.\\nMisoprostol\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 269, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Discontinue use of prostaglandins and begin oxytocin infusion if: membranes rupture;,\\ncervical ripening has been achieved;, good labour has been established;,  or 12 hours have\\npassed.\\nMisoprostol\\n\\uf0b7\\nUse misoprostol to ripen the cervix only in highly selected situations such as severe pre-\\neclampsia or eclampsia when the cervix is unfavourable and safe caesarean section is not\\nimmediately available or the baby is too premature to survive; fetal death in-utero if the\\nwoman has not gone into spontaneous labour after four weeks and platelets are\\ndecreasing.\\n\\uf0b7\\nPlace misoprostol 25 mcg in the posterior fornix of the vagina. Repeat after six hours, if\\nrequired.\\n\\uf0b7\\nIf there is no response after two doses of 25 mcg, increase to 50 mcg every six hours;\\n\\uf0b7\\nDo not use more than 50 mcg at a time and do not exceed four doses (200 mcg).\\n\\uf0b7\\nMonitor uterine contractions and fetal heart rate of all women undergoing induction of\\nlabour with prostaglandins.\\nFoley catheter (mechanical dilation)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 269, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nMonitor uterine contractions and fetal heart rate of all women undergoing induction of\\nlabour with prostaglandins.\\nFoley catheter (mechanical dilation)\\nThe Foley catheter is an effective alternative to prostaglandins for cervical ripening and\\nlabour induction. It should, however, be avoided in women with obvious cervicitis or\\nvaginitis.\\n\\uf0b7\\nGently insert a high-level disinfected or sterile speculum into the vagina.\\n\\uf0b7\\nHold the catheter with a high-level disinfected or sterile forceps and gently introduce it\\nthrough the cervix. Ensure that the inflatable bulb of the catheter is beyond the internal\\nos.\\n\\uf0b7\\nInflate the bulb with 30ml of water. Give traction to rest of the catheter and strap it with\\nthe thigh. Leave the catheter in place until contractions begin, or for at least 12 hours.\\n\\uf0b7\\nDeflate the bulb before removing the catheter and then proceed with oxytocin infusion to\\naugment induction of labour.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 270, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n263\\n\\uf0b7\\nPrimary PPH i.e. bleeding within 24 hours of delivery is commonly due to atonic uterus\\n(90% cases) or cervical/vaginal tears (traumatic PPH). It can also be due to occult uterine\\ninversion, rupture uterus or coagulation defect.\\n\\uf0b7\\nAbnormal bleeding can also occur between 24 hours and 6 weeks of delivery (secondary\\nPPH) due to sepsis, retained placental bits, or placental polyp, choriocarcinoma.\\n\\uf0b7\\nPPH requires prompt and effective management, failing which it may result in\\ncomplications like hypovolaemic shock, coagulation failure, renal failure, hepatic failure,\\nadult respiratory distress syndrome and may also result in maternal death.\\n•\\nMonitor pulse rate, blood pressure, respiratory rate and urine output. While resuscitative\\nmeasures are underway, a thorough clinical examination is made to ascertain the cause of\\nPPH and definitive treatment is planned accordingly.\\nPOSTPARTUM HAEMORRHAGE (PPH)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 270, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"measures are underway, a thorough clinical examination is made to ascertain the cause of\\nPPH and definitive treatment is planned accordingly.\\nPOSTPARTUM HAEMORRHAGE (PPH)\\nPostpartum haemorrhage is excessive blood loss from the genital tract after delivery of the\\nfoetus exceeding 500 ml or affecting the general condition of the mother.\\nSalient features\\nPharmacological treatment\\nIV fluids and blood replacement therapy\\nATONIC PPH\\nPrevention\\nIdentify risk factors and anticipate the problem.\\nActive management (oxytocin 5 units intramuscularly at the birth of anterior shoulder or after\\ndelivery of placenta) should be done in all cases unless contraindicated.\\nNon pharmacological treatment\\nPlacental removal with cord traction if already separated uterine massage and bimanual\\ncompression.\\nPharmacological treatment (Table 6)\\n\\uf0b7\\nOxytocin infusion (10-40 units in 500 ml Ringer's lactate/normal saline at 125 ml/min)\\n\\uf0b7\\nMethyl ergometrine maleate 0.2 mg IV may be repeated IM after 5-10 min. (Caution:\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 270, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nOxytocin infusion (10-40 units in 500 ml Ringer's lactate/normal saline at 125 ml/min)\\n\\uf0b7\\nMethyl ergometrine maleate 0.2 mg IV may be repeated IM after 5-10 min. (Caution:\\nContraindicated in heart disease, hypertension).\\nTable 6. Drugs used in the treatment of post partum haemorrhage\\nDrug\\nDose and Route\\nContinuing Dose\\nMaximum Dose\\nPrecautions and\\nContraindications\\nOxytocin\\nIV: Infuse 20\\nunits in 1 L IV\\nfluids at 60\\ndrops per minute\\nIM:  5-10 units\\nIV: Infuse 20\\nunits in 1 L IV\\nfluids at 40 drops\\nper minute\\nNot more than 3\\nL of IV fluids\\ncontaining\\noxytocin\\nDo not give as an\\nIV bolus\\nErgometrine/\\nIM or IV\\nRepeat 0.2 mg\\nFive doses (Total\\nHigh blood\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 271, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n264\\n\\uf0b7\\nProstaglandins should not be given intravenously. It  may be fatal\\n\\uf0b7\\nIf bleeding is not controlled 15-methyl PGF2A 0.25 mg IM intramyometrial, may be\\nrepeated every 15-90 min up to a maximum of 2 mg. (Caution: Contraindicated in\\nbronchial asthma, epilepsy).\\n\\uf0b7\\nIn patients with bronchial asthma and epilepsy, administer with caution Tab. misopristol\\n600 mcg per rectum.\\nIndication for referral\\nIf patient is still bleeding despite medical therapy and if facilities for transfusion and further\\nmanagement are not available arrange for transfer to a higher center. Intrauterine packing\\nmay be done in the mean time.\\nSurgical treatment\\n\\uf0b7\\nRetained placenta - Manual removal of placenta under general anaesthesia (GA)\\n\\uf0b7\\nCervical/ vaginal tears - Exploration and repair\\n\\uf0b7\\nRupture uterus - Laparotomy with repair/ hysterectomy\\n\\uf0b7\\nUterine inversion - Reposition under GA\\n\\uf0b7\\nAtonic PPH not controlled - Laparotomy with uterine artery ligation with medical measures\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 271, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nRupture uterus - Laparotomy with repair/ hysterectomy\\n\\uf0b7\\nUterine inversion - Reposition under GA\\n\\uf0b7\\nAtonic PPH not controlled - Laparotomy with uterine artery ligation with medical measures\\n\\uf0b7\\nInternal artery ligation/Hysterectomy\\nPatient education\\n\\uf0b7\\nHigher parity and previous atonic PPH predispose to PPH.\\n\\uf0b7\\nHospital delivery is mandatory in women with PPH in a previous pregnancy, grand\\nmultipara, multiple pregnancy, APH and severe anaemia.\\nPREVENTION OF MATERNAL TO CHILD TRANSMISSION\\nTransmission rate during pregnancy 5-10%, during labor and delivery 10-15% and during\\nbreastfeeding   5-20%.\\nRisk factors for vertical transmission\\n\\uf0b7\\nViral load >50000 RNA copies/ml at time of delivery\\n\\uf0b7\\nCD4 count <700/cumm\\n\\uf0b7\\nChorioamnionitis\\n\\uf0b7\\nDuration of ruptured membranes over 4 hrs doubles the risk\\n\\uf0b7\\nIntrapartum haemorrhage\\nMethyl-\\nErgometrine\\n(slowly): 0.2 mg\\nIM after 15\\nminutes. If\\nrequired, give 0.2\\nmg IM or IV\\n(slowly) every\\nfour hours\\n1.0 mg)\\npressure, pre-\\neclampsia, heart\\ndisease\\n15-Methyl'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 271, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Intrapartum haemorrhage\\nMethyl-\\nErgometrine\\n(slowly): 0.2 mg\\nIM after 15\\nminutes. If\\nrequired, give 0.2\\nmg IM or IV\\n(slowly) every\\nfour hours\\n1.0 mg)\\npressure, pre-\\neclampsia, heart\\ndisease\\n15-Methyl\\nProstaglandin F2\\nIM: 0.25 mg\\n0.25 mg every 15\\nminutes\\nEight doses\\n(Total 2 mg)\\nAsthma'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 272, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n265\\n\\uf0b7\\nMode of delivery\\n\\uf0b7\\nInvasive fetal monitoring\\n\\uf0b7\\nBreastfeeding\\nBasic mechanism for mother to child transmission\\n\\uf0b7\\nTransplacental\\n\\uf0b7\\nExposure to maternal blood and vaginal secretion at the time of delivery.\\n\\uf0b7\\nPostnatal exposure to maternal secretions such as breast milk.\\n2006 guidelines recommended that only women with a low CD4 count should receive a\\ncombination of HIV and AIDS drugs to prevent mother-to-child transmission and all HIV-\\npositive mothers were advised to exclusively breastfeed for 6 months and then rapidly wean\\nto avoid transmitting HIV to their infant.\\nNew 2010 guidelines, recommended that all HIV-positive mothers, identified during\\npregnancy, should receive a course of antiretroviral drugs to prevent mother-to-child\\ntransmission. All infants born to HIV-positive mothers should also receive a course of\\nantiretroviral drugs and should be exclusively breastfed for 6 months and complementary fed\\nfor up to a year.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 272, 'source_type': 'Authorotative', 'priority': '1'}, page_content='transmission. All infants born to HIV-positive mothers should also receive a course of\\nantiretroviral drugs and should be exclusively breastfed for 6 months and complementary fed\\nfor up to a year.\\nFour key strategies for preventing mother-to-child transmission\\n1. Keeping women of reproductive age and their partners HIV-negative through\\nreproductive health and HIV prevention services.\\n2. Avoiding unwanted pregnancies among HIV-infected women and women at risk of HIV,\\nthrough family planning and HIV testing and counselling services.\\n3. Ensuring HIV testing of pregnant women and timely access to effective antiretroviral\\ntherapy, both for the health of HIV-infected mothers and for PMTCT, during pregnancy,\\ndelivery and breastfeeding.\\n4. Better integration of HIV care, treatment and support for HIV-infected women and their\\nfamilies.\\nFollowing should be avoided\\n\\uf0b7\\nArtificial rupture of membranes\\n\\uf0b7\\nRoutine use of fetal scalp electrodes for fetal monitoring\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 272, 'source_type': 'Authorotative', 'priority': '1'}, page_content='families.\\nFollowing should be avoided\\n\\uf0b7\\nArtificial rupture of membranes\\n\\uf0b7\\nRoutine use of fetal scalp electrodes for fetal monitoring\\n\\uf0b7\\nOperative delivery with forceps or a vacuum extractor and/or episiotomy\\nCD4 count has to be done.  If CD4 count less than or equal to 350 cells/mm3 start\\nantiretroviral drugs for their own health. CD4 count higher than 350 cells/mm3 – no need of\\nART for mother’s health. But helps in preventing transmission.\\nMothers, when identified in pregnancy as being HIV positive, should begin a triple\\nantiretroviral regimen immediately after being diagnosed, irrespective of their CD4 count.\\nMothers should remain on the same triple antiretroviral regimen throughout pregnancy and\\ncontinuing for life.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 273, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n266\\nInfants born to HIV positive mothers should receive a course of medication for PMTCT.\\nUnder the infant should receive daily NVP or AZT from birth until age 4-6 weeks, regardless\\nof infant feeding method.\\nThree options for PMTCT (Table 7):\\nTable 7. Treatment options for prevention of mother to child transmission of HIV\\nTreatment\\n(for CD4 count <350\\ncells/mm3)\\nProphylaxis\\n( for CD4 count >350\\ncells/mm3)\\nInfant recieves\\nOption A\\nTriple ARVs starting as\\nsoon as diagnosed,\\ncontinued for life\\nAntepartum: AZT\\nstarting as early as 14\\nweeks gestation\\nIntrapartum: at onset of\\nlabour\\n-single-dose NVP and\\nfirst dose of AZT/3TC\\nPostpartum: daily\\nAZT/3TC through 7\\ndays postpartum\\nDaily NVP from birth\\nuntil 1 week after\\ncessation of all\\nbreastfeeding; or, if not\\nbreastfeeding or if\\nmother is on treatment,\\nthrough age 4–6 weeks\\nOption B\\nTriple ARVs starting as\\nsoon as diagnosed,\\ncontinued for life\\nTriple ARVs starting as\\nearly as 14 weeks\\ngestation and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 273, 'source_type': 'Authorotative', 'priority': '1'}, page_content='breastfeeding or if\\nmother is on treatment,\\nthrough age 4–6 weeks\\nOption B\\nTriple ARVs starting as\\nsoon as diagnosed,\\ncontinued for life\\nTriple ARVs starting as\\nearly as 14 weeks\\ngestation and\\ncontinued intrapartum\\nand through childbirth if\\nnot breastfeeding or\\nuntil 1 week after\\ncessation of all\\nbreastfeeding\\nDaily NVP or AZT\\nfrom birth through age\\n4–6 weeks\\nregardless of infant\\nfeeding method\\nOption B+\\nTriple ARVs starting as\\nsoon as diagnosed,\\ncontinued for life\\nTriple ARVs starting as\\nsoon as diagnosed,\\ncontinued for life\\nDaily NVP or AZT\\nfrom birth through age\\n4–6 weeks\\nregardless of infant\\nfeeding method\\nAZT: Zidovudine,  sd-NVP: Single-dose Nevirapine,  NVP: Nevirapine,\\nAZT: Zidovudine,  3TC: Lamivudine\\nVAGINAL DISCHARGE\\nReproductive tract infections (RTI), including sexually transmitted infections (STI), represent\\na major public health problem. Syndromic management of symptomatic individuals is'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 273, 'source_type': 'Authorotative', 'priority': '1'}, page_content='VAGINAL DISCHARGE\\nReproductive tract infections (RTI), including sexually transmitted infections (STI), represent\\na major public health problem. Syndromic management of symptomatic individuals is\\nrecommended.  NACO algorithm for the management of vaginal discharge (Figure 1, Table\\n8):'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 274, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n267\\nFigure 1. NACO algorithm for the management of vaginal discharge\\nTable 8. NACO algorithm for the management of vaginal discharge\\nThere are seven pre-packed colour coded STI/RTI drug kits under NACP for syndromic\\nmanagement of STI/RTI and procured by NACO. These drug kits have been developed based\\non the National Guidelines on Prevention, Management and Control of Reproductive Tract\\nInfections including Sexually Transmitted Infections, Ministry of Health & FW, August\\n2007. Syndromic Case Management Protocol\\nKit No.\\nSyndrome\\nColour\\nContents\\nKit 1\\nCervicitis\\nUrethral Discharge\\nPresumptive treatment\\nGrey\\nT. Azithromycin 1 g (1) and\\nT. Cefixime 400 mg (1)\\nKit 2\\nVaginitis\\nGreen\\nT. Secnidazole 2g (1) and\\nT. Fluconazole 150 mg (1)\\nKit 3\\nGenital Ulcer Disease – Non\\nHerpetic\\nWhite\\nInj. Benzathine Penicillin 2.4 MU (1)\\nand T. Azithromycin 1 g (1)\\nKit 4\\nGenital Ulcer Disease – Non\\nHerpetic (for patients allergic to\\nPenicillin)\\nBlue\\nT. Doxycycline 100 mg (30) and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 274, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Herpetic\\nWhite\\nInj. Benzathine Penicillin 2.4 MU (1)\\nand T. Azithromycin 1 g (1)\\nKit 4\\nGenital Ulcer Disease – Non\\nHerpetic (for patients allergic to\\nPenicillin)\\nBlue\\nT. Doxycycline 100 mg (30) and\\nT. Azithromycin 1 g (1)\\nKit 5\\nGenital Ulcer Disease - Herpetic\\nRed\\nT. Acyclovir 400 mg (21)\\nKit 6\\nLower Abdominal Pain (PID)\\nYellow\\nT. Cefixime 400 mg (1) and\\nT. Doxycycline 100 mg (28) and\\nT. Metronidazole 400 mg (28)\\nKit 7\\nInguinal Bubo\\nBlack\\nT. Doxycycline 100 mg (42) and\\nT. Azithromycin 1 g (1)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 275, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n268\\n\\uf0b7\\nLower abdominal pain, cervical motion tenderness and adenexal tenderness, fever,\\ncervical discharge and leucocytosis.\\n\\uf0b7\\nIn severe cases patient may be toxic with high-grade fever, vomiting, dehydration,\\nand abdominal distension.\\n\\uf0b7\\nLong term sequelae can be infertility, ectopic pregnancy, chronic pelvic pain.\\n\\uf0b7\\nFailure of acute PID to resolve completely results in chronic PID with features of\\nsevere, persistent and progressive pelvic pain, repeated acute exacerbation of PID,\\ntubo-ovarian inflammatory mass, dyspareunia or bilateral ureteral obstruction from\\nligamentous cellulitis.\\nPELVIC INFLAMMATORY DISEASE (PID)\\nPelvic inflammatory disease (PID) results from infection of cervix, uterus, tubes, ovaries\\nand pelvic peritoneum. The disease may have acute or chronic presentation. The\\ncommonest cause is sexually transmitted diseases, however, other causes include post\\nabortal and puerperal sepsis, operative procedures like dilatation and curettage, endometrial'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 275, 'source_type': 'Authorotative', 'priority': '1'}, page_content='commonest cause is sexually transmitted diseases, however, other causes include post\\nabortal and puerperal sepsis, operative procedures like dilatation and curettage, endometrial\\nbiopsy, and insertion of intrauterine device.\\nSalient features\\nInvestigations\\n\\uf0b7\\nHaemogram with ESR, LFT, RFT, serum electrolytes, blood culture, endocervical\\nswab culture, ultrasonography if adenexal mass.\\nTreatment (Acute PID)\\nThe patient can be treated as an outpatient or inpatient depending on the severity of clinical\\nfeatures.\\nI.\\nOutpatient treatment- mild PID\\nEither of the following two regimens can be given:\\nRegimen A\\n\\uf0b7\\nInj. cefoxitin 2 g IM, plus probenecid 1 g orally, as a single dose or Inj. ceftriaxone\\n250 mg IM as a single dose or Inj. ceftizoxime or cefotaxime 500 mg IM as a single\\ndose.\\n\\uf0b7\\nCap. doxycycline 100 mg 2 times a day for 14 days.\\nRegimen B\\n1.\\nTab. ofloxacin 400 mg oral 2 times a day for 4 days.\\n2. Tab. Clindamycin 450 mg oral 4 times a day for 14 days or Tab. metronidazole 400'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 275, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Regimen B\\n1.\\nTab. ofloxacin 400 mg oral 2 times a day for 4 days.\\n2. Tab. Clindamycin 450 mg oral 4 times a day for 14 days or Tab. metronidazole 400\\nmg 2 times a day for 14 days\\nFollow up after 2 - 3 days of initiation of therapy; patient is reevaluated for clinical\\nresponse. If poor response, patient is to be admitted for intravenous antibiotics.\\nII.\\nIndoor treatment- severe illness or nausea and vomiting, HIV positive, unable to\\nfollow or tolerate an outpatient regimen and outpatient therapy failed.\\n\\uf0b7\\nBed Rest. Hydrotherapy, if febrile.\\n\\uf0b7\\nIV fluids in cases of vomiting and dehydration and correction of electrolyte imbalance.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 276, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n269\\nMonitoring\\nClinical condition, vital monitoring, signs and symptoms of pelvic abscess and peritonitis.\\nEither of the following regimens may be instituted at the earliest without waiting for culture\\nreports:\\nRegimen A\\n\\uf0b7\\nInj. cefoxitin 2 g IV every 6 hours or Inj. cefotetan 2 g IV every 12 hours.\\n\\uf0b7\\nInj. doxycycline 100 mg IV or orally every 12 hours.\\n\\uf0b7\\nInj. metronidazole 500 mg IV 8 hourly.\\nRegimen B\\n\\uf0b7\\nInj. clindamycin 900 mg IV every 8 hours.\\n\\uf0b7\\nInj. gentamicin 2 mg/kg IV followed by 1.5 mg/kg every 8 hours.\\n\\uf0b7\\nInj. diclofenac sodium 75 mg deep IM 8 hourly or Inj. paracetamol 500 mg IM SOS.\\n\\uf0b7\\nInj. metronidazole 500 mg IV 8 hourly.\\nInjectable regimen should be continued for at least 48 hours after the patient demonstrates\\nclinical improvement (becomes afebrile, decrease in lower abdomen and pelvic tenderness,\\nimprovement in constitutional symptoms). After this, doxycycline 100 mg 2 times a day'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 276, 'source_type': 'Authorotative', 'priority': '1'}, page_content='clinical improvement (becomes afebrile, decrease in lower abdomen and pelvic tenderness,\\nimprovement in constitutional symptoms). After this, doxycycline 100 mg 2 times a day\\norally or clindamycin 450 mg oral 4 times a day should be continued for total of 14 days.\\nClinical improvement should occur within 3 days of initiation of therapy.  Consider further\\ndiagnostic tests /laparoscopy if symptoms do not improve or worsen. Different procedures\\nmay be required in the following situations:\\n\\uf0b7\\nColpotomy for drainage of midline pelvic abscess\\n\\uf0b7\\nDilatation and evacuation of septic products of conception in post abortal sepsis.\\n\\uf0b7\\nLaparotomy in cases of pyoperitoneum, resistant peritonitis, intestinal obstruction,\\nruptured tubo-ovarian abscess, enlarging pelvic mass despite medical therapy,\\n\\uf0b7\\nLaparoscopy: if diagnosis is uncertain, no response to treatment, to reconfirm the\\ndiagnosis, obtain cultures from cul de sac and fallopian tubes and drain pus if necessary.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 276, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nLaparoscopy: if diagnosis is uncertain, no response to treatment, to reconfirm the\\ndiagnosis, obtain cultures from cul de sac and fallopian tubes and drain pus if necessary.\\nTreatment of the sexual male partner\\nAsymptomatic male partner: Inj. ceftriaxone 125 mg IM followed by oral doxycycline 200\\nmg 2 times a day for 14 days.\\nTreatment (Chronic PID)\\nTreatment is surgical, considering pathological lesion, patient's age, and desire for child\\nbearing. Definitive surgery is total abdominal hysterectomy with bilateral salpingo-\\noophorectomy, but in young females conservative surgery is preferred. Chronic PID can be\\ndue to pelvic tuberculosis.\\nTreatment (Pelvic tuberculosis)\\nPrimary treatment is medical therapy with anti tubercular drugs for 6 months. Daily dose of\\nthe drugs is:\\n\\uf0b7\\nTab. isoniazid 5 mg/kg (maximum 300 mg).\\n\\uf0b7\\nCap. rifampicin 10 mg/kg (maximum 600 mg).\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 277, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n270\\n\\uf0b7\\nSomatic symptoms include feeling of bloating, bodyaches, breast tenderness,\\nheadache, food cravings and poor concentration.\\n\\uf0b7\\nEmotional symptoms include emotional hypersensitivity, depression, irritability,\\nmood swings, anxiety, tension, fear of loss of control and confusion.\\n\\uf0b7\\nDiagnosis is confirmed by excluding the concomitant medical or psychiatric\\ndisorders with which it may be confused (depending on the symptoms).\\n\\uf0b7\\nTab. pyrazinamide 15-30 mg/kg (maximum 2 g).\\n\\uf0b7\\nCap. ethambutol 15-25 mg/kg (maximum 2.5 g).\\nAll 4 drugs are given in the initial phase for 2 months followed by INH and rifampicin for\\n4 months.\\nIndications of surgery are: primary unresponsiveness, persistence or enlargement of\\nadenexal mass after 4 - 6 months of treatment, persistence or recurrence of pelvic pain on\\ntreatment. Definitive surgery is total abdominal hysterectomy with bilateral salpingo-\\noophorectomy.\\nPatient education\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 277, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"treatment. Definitive surgery is total abdominal hysterectomy with bilateral salpingo-\\noophorectomy.\\nPatient education\\n\\uf0b7\\nEmphasize behavioural and contraceptive methods to prevent the acquisition of STDs.\\n\\uf0b7\\nEncourage to complete the antibiotic treatment for the full course i.e. 14 days.\\n\\uf0b7\\nSexual abstinence until complete treatment. Sexual partner of patient diagnosed with\\nPID must be treated to prevent reinfection.\\nPREMENSTRUAL SYNDROME\\nPremenstrual syndrome (PMS) i s a cyclic recurrence of physical, psychological or\\nbehavioural symptoms after ovulation and resolve after the onset of menstruation. It\\nrequires treatment when the symptoms are severe to interfere with the woman's lifestyle,\\nrelationships and occupational functioning.\\nSalient features\\nNon- pharmacological treatment\\nLife-style advice should be offered to all women as first line of treatment.\\n1. Daily charting of symptoms for two months.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 277, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Salient features\\nNon- pharmacological treatment\\nLife-style advice should be offered to all women as first line of treatment.\\n1. Daily charting of symptoms for two months.\\n2. Dietary modifications like: increase complex carbohydrate meals, reduce or eliminate,\\nespecially in the luteal phase - salts, chocolate, caffeine and alcohol; and several small\\nmeals per day.\\n3. Moderate regular aerobic exercise like brisk walk 1-2 miles per day for 4-5 days/week.\\n4. Stress management courses/counseling.\\nPharmacological treatment\\n1. Tab. pyridoxine 100 mg/day for 10-14 days (during luteal phase) (maximum daily dose is\\n150 mg) or Tab. Evening primrose oil 500 mg 3 times a day.\\n2. NSAIDs like mefenamic acid 500 mg 3 times a day for premenstrual dysmenorrhea.\\n3. In case of predominantly physical symptoms (bloatedness, irritability swelling,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 278, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n271\\n\\uf0b7\\nDisturbances of the menstrual cycle, regular and irregular uterine bleeding and\\nalteration in the amount or duration of the menstrual blood loss.\\n\\uf0b7\\nDue to anovulatory cycles but can also occur in the ovulatory cycles. Anovulatory\\ncycles are usual in postmenarche, premenopausal age groups and are usually irregular,\\nvariable in duration and amount of bleeding.\\nweight gain, breast tenderness), Tab. spironolactone 100 mg/day Or Tab. bromocriptine\\n1.25 - 5 mg/day in the luteal phase for mastalgia. (Common side effects are nausea and\\nvomiting. Tablet can be given vaginally if side effects are very severe.)\\n4. If no relief in symptoms with above measures in 2 - 3 cycles and symptoms are\\npredominantly emotional, then the following drugs are used preferably in consultation\\nwith a psychiatrist: Tab. fluoxetine 5-20 mg/day\\n5. In non-responders to the above therapy, ovulation suppression may be beneficial; any'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 278, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with a psychiatrist: Tab. fluoxetine 5-20 mg/day\\n5. In non-responders to the above therapy, ovulation suppression may be beneficial; any\\nof the following can be used: Low dose combined oral contraceptive pills, 1 pill daily\\nfrom 5th to 25th day of the cycle.\\nDYSFUNCTIONAL UTERINE BLEEDING (DUB)\\nDysfunctional uterine bleeding (DUB) is an abnormal uterine bleeding in the absence\\nof organic disease of the genital tract.\\nSalient features\\nTreatment (Acute bleeding-first episode)\\nI. Severe bleeding (hemodynamically unstable patient)\\n\\uf0b7\\nIV line, fluid replacement, blood transfusion, oxygen inhalation and monitoring of vitals.\\n\\uf0b7\\nDilatation and curettage to arrest bleeding except in cases of puberty menorrhagia where\\nmedical management is preferred. IV tranexamic acid can be tried before resorting to\\nsurgical intervention.\\nII. Less severe bleeding (haemodynamically stable patient)\\n\\uf0b7\\nHigh dose progestogen: norethisterone 10 mg 3 times a day until bleeding stops (not >3'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 278, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"surgical intervention.\\nII. Less severe bleeding (haemodynamically stable patient)\\n\\uf0b7\\nHigh dose progestogen: norethisterone 10 mg 3 times a day until bleeding stops (not >3\\ndays) followed by norethisterone 5-10 mg or medroxyprogesterone acetate 10 mg per\\nday for 21 days. Withdrawal bleeding occurs after 2-4 days of stopping the drug and\\nstops in 4-5 days. Or combined oral contraceptive pills (OCs) containing 50 mcg\\nethinyloestradiol 1 pill 2 times a day for 7 - 10 days followed by progestins for 7-10 days,\\nfollowed by withdrawal bleeding.\\nIII. If bleeding is not controlled with progestogens\\nPatient is having heavy bleeding for many days, endometrial curettage yields minimal\\ntissue, or when the patient has been on progestogen medication (OC's or Depot MPA) and\\nthe endometrium is shallow and atrophic.\\nTreatment schedules of high dose oestrogens, depending on the severity of the bleeding the\\nfollowing can be used:\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 278, 'source_type': 'Authorotative', 'priority': '1'}, page_content='the endometrium is shallow and atrophic.\\nTreatment schedules of high dose oestrogens, depending on the severity of the bleeding the\\nfollowing can be used:\\n1. Conjugated oestrogen 25 mg IV every 4 h till bleeding abates or for 12 h. Progestin'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 279, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n272\\ntreatment is started at the same time.\\n2. Oral treatment conjugated oestrogen 1.25 mg or 2 mg oestradiol valerate given\\norally every 4 h for maximum of 24 h followed by single daily dose for 7-10 days.\\nAll treatments must he followed by progestin coverage (10 mg MPA daily) along with\\noestrogen for 7 days.\\nMonitoring\\nClinical monitoring by vital charting and observation of blood loss per vaginum\\nTreatment (Chronic DUB - not actively bleeding)\\n\\uf0b7\\nIron therapy: elemental iron maximum 60 mg 3 times a day\\n\\uf0b7\\nHistopathological diagnosis is must before starting hormonal therapy in all cases except\\npuberty menorrhagia.\\nI. Anovulatory DUB\\n\\uf0b7\\nIf contraception is desired: OCPs for 3 - 6 cycles or norethisterone 5-10 mg.\\n\\uf0b7\\nMedroxyprogesterone acetate (MPA) 10 mg 16-25th day of the cycle for 3-6 cycles.\\n\\uf0b7\\nIn cases of endometrial hyperplasia without atypia on histology norethisterone acetate 5 mg\\nthree times a day or MPA 10 mg twice a day 5-25th day of cycle for 3-9 cycles'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 279, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIn cases of endometrial hyperplasia without atypia on histology norethisterone acetate 5 mg\\nthree times a day or MPA 10 mg twice a day 5-25th day of cycle for 3-9 cycles\\nfollowed by repeat endometrial biopsy.\\n\\uf0b7\\nIf fertility desired: ovulation induction is advised.\\n\\uf0b7\\nLevonorgestrel IUD can be offered after counseling and is beneficial in DUB.\\nII. Ovulatory DUB\\n\\uf0b7\\nNSAIDs: mefenamic acid 500 mg 3 times a day for 3 -5 days during periods. Or\\n\\uf0b7\\nOral combined contraceptive pills if contraception is desired.\\nIf the above treatment is not effective in first cycle patient should be referred for\\ntertiary care. Following treatment can be considered as an alternative to surgery:\\n\\uf0b7\\nTab. danazol 200 mg daily for 3 months.\\n\\uf0b7\\nLevonorgestrel IUCD can be offered after counseling and is beneficial in DUB.\\nFollow up\\nAfter 1, 3, 6 months of therapy. Treatment is stopped after 3-6 months. If symptoms\\nrecur medical treatment is to be continued or surgery can be offered.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 279, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Follow up\\nAfter 1, 3, 6 months of therapy. Treatment is stopped after 3-6 months. If symptoms\\nrecur medical treatment is to be continued or surgery can be offered.\\nSurgical treatment - endometrial curettage\\n\\uf0b7\\nAcute bleeding in haemodynamically unstable patient to quickly control the bleeding.\\n\\uf0b7\\nIn acute episode, if bleeding doesn't decrease significantly in 12-24 hours with\\nmedical treatment, then reevaluation is mandatory and surgical curettage should be\\ndone.\\n\\uf0b7\\nIf age is >35 years - premenstrual dilatation and curettage for endometrial histology is\\na must to rule out endometrial pathology.\\nIf medical therapy is not effective then endometrial ablation or hysterectomy is to be\\nperformed.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 280, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n273\\n\\uf0b7\\nHot flushes, night sweats, palpitations, vaginal dryness, itching, atrophy of the\\nbreast and skin, urethral syndrome, stress incontinence, mood changes like anxiety,\\nirritability, depression, insomnia and joint pains.\\n\\uf0b7\\nDiagnosis is always clinical. However, in doubt, estimate serum FSH levels and\\noestradiol levels may be helpful.\\nPatient education\\n\\uf0b7\\nCommon side effects of high dose oestrogens are: nausea, vomiting, headache,\\ndepression, and fluid retention. Contraindicated in liver disease,\\nhistory of\\nthromboembolic disorder, cardiovascular disease, and oestrogen dependant neoplasm.\\n\\uf0b7\\nCommon side effects of progestogens are depression, fluid retention, fatigue, insomnia,\\ndizziness, nausea, and breast tenderness.\\nMENOPAUSE\\nPermanent cessation of menses for one year is known as menopause. The usual age is\\nbetween 40 to 50 years, mean age being 48 years. Long term consequences due to'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 280, 'source_type': 'Authorotative', 'priority': '1'}, page_content='MENOPAUSE\\nPermanent cessation of menses for one year is known as menopause. The usual age is\\nbetween 40 to 50 years, mean age being 48 years. Long term consequences due to\\ndecreased oestrogens can increase the risk of ischaemic heart disease due to adverse lipid\\nprofile and pathological fractures due to osteoporosis.\\nSalient features\\nNon-pharmacological treatment\\n\\uf0b7\\nBalanced diet with fruits, vegetables, semi-skimmed milk adequate in vitamins and\\nminerals. A reduction or avoidance of smoking and alcohol consumption.\\n\\uf0b7\\nExercise: walking or swimming for 20-30 min every day.\\nPharmacological treatment\\n\\uf0b7\\nTab. calcium 1500 mg daily.\\n\\uf0b7\\nHormone replacement therapy (HRT). Rule out contraindications to HRT\\nlike\\nendometrial/breast cancer, acute phase myocardial infarction,\\nundiagnosed breast\\nlump/abnormal vaginal bleeding and acute liver disease. Hypertension and diabetes if\\npresent should be controlled before HRT is prescribed.\\nOestrogen therapy\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 280, 'source_type': 'Authorotative', 'priority': '1'}, page_content='undiagnosed breast\\nlump/abnormal vaginal bleeding and acute liver disease. Hypertension and diabetes if\\npresent should be controlled before HRT is prescribed.\\nOestrogen therapy\\n\\uf0b7\\nFor hysterectomized patients- conjugated equine oestrogen 0.625 -1.25 mg. or oestriol\\n1-2 mg is given daily 1-25th day every month or daily without any break. If symptoms\\nrecur during drug free period then give continuous therapy. Or\\n\\uf0b7\\nTransdermal oestradiol patch 50 or 100 mcg/day applied twice a week away from breast,\\npreferably on the shaved skin of buttock, thigh or legs (Limiting factor is local skin\\nreactions). Transdermal oestradiol patch is preferred in case of gall bladder disease,\\nhypertriglyceridimea, history of thromboembolism, poorly-controlled hypertension,\\nrecent myocardial infarction, vascular diseases, migraine, chronic hepatic dysfunction,\\nmalabsorption syndrome.\\n\\uf0b7\\nCombined therapy with oestrogens and progestin in women with intact uterus.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 281, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n274\\n\\uf0b7\\nObese women and women taking hormone replacement therapy (HRT), vaginal atrophy,\\nlesions and cracks on the vulva may bleed. Bleeding from the upper reproductive system\\ncan be caused by hormone replacements, endometrial cancer (5-10%), endometrial\\npolyps, cervical cancer, cervical lesions, uterine tumours, ovarian cancer or oestrogen\\nsecreting tumors in other parts of the body.\\n\\uf0b7\\nDiagnosis is confirmed by endometrial or cervical biopsy. Non-invasive tests include saline\\ninfusion sonography (SIS), a refinement of vaginal probe ultrasound. Dilatation and\\ncurettage (D &C) is often necessary for definitive diagnosis.\\ni.\\nOestrogen therapy as above.\\nii. Progestogen-medroxyprogesterone acetate 5 - 10 mg, or dihydrogesterone 10 - 20\\nmg or norethisterone 2.5 mg or 200 ml micronized progesterone is added from 13th to\\n25th days in cyclic sequential regimen and 1st to 12th of every month in continuous\\nsequential regimen.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 281, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"mg or norethisterone 2.5 mg or 200 ml micronized progesterone is added from 13th to\\n25th days in cyclic sequential regimen and 1st to 12th of every month in continuous\\nsequential regimen.\\nIf withdrawal bleeding is not acceptable then give continuous combined treatment (0.625 mg\\nconjugated equine oestrogen + 2.5 mg medroxyprogesterone acetate or 1 mg micronized\\noestrogen + 100 mg micronized progesterone).\\nIf conventional HRT is contraindicated\\n\\uf0b7\\nTab. Tibolone 2.5 mg per day (major side effects are weight gain, oedema, breast tenderness,\\nGIT symptoms and vaginal bleeding).\\n\\uf0b7\\nIn symptomatic elderly women with atrophic vaginitis and other urogenital symptoms who\\ndo not desire long term HRT: Oestriol cream daily application of 0.5 g delivering 0.5 mg of\\noestriol for 3 weeks followed by twice weekly application for 3 - 4 weeks.( Key indicator\\nof response to therapy is improvement in symptoms).\\n\\uf0b7\\nFollow up at 2-3 months then at 6 monthly intervals. Yearly mammography, Pap's smear,\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 281, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"of response to therapy is improvement in symptoms).\\n\\uf0b7\\nFollow up at 2-3 months then at 6 monthly intervals. Yearly mammography, Pap's smear,\\npelvic USG and serum oestradiol are advisable.\\nShort term treatment is advocated for acute symptoms and oestrogen use for long term\\nbenefits is controversial.\\nPatient education\\n\\uf0b7\\nExplain about the side effects of estrogen and progestogens\\n\\uf0b7\\nFollow up visits at 2 - 3 months then at 6 monthly intervals are necessary.\\nPOSTMENOPAUSAL BLEEDING\\nPostmenopausal bleeding (PMB) is bleeding that occurs after menopause has been established\\nfor at least one year. It is different from infrequent, irregular periods that occur around the time\\nof menopause.\\nSalient features\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 282, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n275\\nTreatment\\nTreatment of postmenopausal bleeding according to cause\\nCause\\nTreatment\\nBenign & malignant neoplasm of vulva\\nRefer to higher center or treat cervix, vagina,\\nuterus or ovaries according to cause and\\nfacilities available.\\nIndiscriminate use of oestrogen for HRT\\nStop oestrogen therapy\\nInfections\\nAntibiotics\\nInjuries\\nRepair\\nCoagulation disorder\\nTreat accordingly\\nEndometritis\\nAntibiotics\\nPostmenopausal atrophic vaginitis\\nVaginal oestrogen cream/ointment\\nIndication for referral to a higher level of care\\nUrgent referrals:\\n\\uf0b7\\nPalpable pelvic mass or lesions suspicious of cancer on vulva or vagina or cervix on\\nexamination or on ultrasound.\\n\\uf0b7\\nMore than one or a single heavy episode of PMB in women aged >55 years (not on HRT).\\n\\uf0b7\\nPostcoital bleeding (PCB) in a woman aged >35 years that has persisted for more than 4\\nweeks.\\n\\uf0b7\\nProlonged or unexpected bleeding that persists for more than 4 weeks after stopping\\nHRT.\\nEarly Referral (within 4-6 weeks)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 282, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"weeks.\\n\\uf0b7\\nProlonged or unexpected bleeding that persists for more than 4 weeks after stopping\\nHRT.\\nEarly Referral (within 4-6 weeks)\\nAny other woman with PMB not on HRT who does not satisfy the criteria for `urgent\\nreferral' of postmenopausal bleeding\\n\\uf0b7\\nUnexplained repeated postcoital bleeding.\\nNote - in women over 45 years with persistent abdominal distension or pain, ovarian\\ncancer should be considered and therefore a pelvic examination should be performed. If\\nexcessive bleeding, give hemostatic drugs (oral or intravenous) Postmenopausal bleeding\\nthat is not due to cancer and cannot be controlled by any other treatment usually requires a\\nhysterectomy.\\nEARLY DETECTION OF CANCER\\nScreening for Breast Cancer (ACS Guidelines)\\n\\uf0b7\\nEarly detection of breast cancer in average risk women begins at 20 years and consist of a\\ncombination of clinical breast examination (CBE), counseling to raise awareness of breast\\nsymptoms and regular mammography beginning at age 40.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 282, 'source_type': 'Authorotative', 'priority': '1'}, page_content='combination of clinical breast examination (CBE), counseling to raise awareness of breast\\nsymptoms and regular mammography beginning at age 40.\\n\\uf0b7\\nBetween 20 and 39 years, women should undergo clinical breast examination every 3\\nyears. The average risk women should begin annual mammography at 40years and should\\ncontinue to be screened with mammography. Self examination of breast should also be'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 283, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n276\\nadvised to every woman at 20 years.\\n\\uf0b7\\nSelf breast examination from the age of 20years\\n\\uf0b7\\nClinical examination once in 3 years by a physician\\n\\uf0b7\\nBaseline mammogram from age of 40 years and once in 2 years afterwards\\n\\uf0b7\\nAnnual mammography from the age of 50 years\\n\\uf0b7\\nIn countries with limited resources, mammogram is available for diagnostic purposes not\\nfor screening.\\nScreening for Cervical Cancer\\n\\uf0b7\\nScreening for cervical cancer should be approximately 3 years after the onset of vaginal\\nintercourse, but not later than age of 21 years.\\n\\uf0b7\\nAnnual screening with conventional cytology smears or biennial screening using liquid\\nbased cytology is recommended until the age of 30 years. At or after 30 years, a woman\\nwho has had 3 consecutive, technically satisfying normal/negative cytology results may\\nundergo screening every 2 – 3 years using conventional or liquid based cytology.\\n\\uf0b7\\nAfter 30 years of age, women who have the same history of normal cytology results may'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 283, 'source_type': 'Authorotative', 'priority': '1'}, page_content='undergo screening every 2 – 3 years using conventional or liquid based cytology.\\n\\uf0b7\\nAfter 30 years of age, women who have the same history of normal cytology results may\\nundergo HPV DNA testing with conventional or liquid based cytology every 3\\nyears. Average risk for women aged 70 years and older with an intact cervix may choose\\nto cease cervical cancer screening if they have no abnormal /positive cytology tests within\\nthe 10 year period before the age of 70 years.\\n\\uf0b7\\nWomen who are immune-compromised by organ transplantation, chemotherapy or\\ncorticosteroid treatment or HIV+ should be tested twice during the first year after\\ndiagnosis and annually thereafter.\\n\\uf0b7\\nWomen with a history or absence of CIN 2/3 before as the indication for the\\nhysterectomy, should continue until there is a 10 year history of no abnormal positive\\ncytology tests.\\n\\uf0b7\\nEvery woman at 30 years should undergo Pap smear at least once as it helps in diagnosis\\nof early cervical cancer (ICMR guidelines).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 283, 'source_type': 'Authorotative', 'priority': '1'}, page_content='cytology tests.\\n\\uf0b7\\nEvery woman at 30 years should undergo Pap smear at least once as it helps in diagnosis\\nof early cervical cancer (ICMR guidelines).\\nScreening for cervical cancer\\nAge group- 3 years after sexual activity, not later than 21years.  In countries with limited\\nresources all women around the age of 30 years should have one Pap test.\\nMethod\\n\\uf0b7\\nPap smear (or) VIA (visual inspection after application of 5%acetic acid) in countries\\nwith limited resources.\\nPrecautions - Prior to a pap smear\\n\\uf0b7\\nNot to douche for 48 hours, or use vaginal cream for 1 week, abstain from coitus for 24\\nhours, smear to be done on 7th day after menstrual period\\nTechnique\\n\\uf0b7\\nPAP TEST includes samples from ecto-cervix and endo-cervix\\n\\uf0b7\\nUse bivalved speculum'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 284, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n277\\n\\uf0b7\\nPlace the endocervical brush or cotton tipped swab and roll it firmly\\nagainst the canal\\n\\uf0b7\\nRemove the endocervical brush or cotton tipped swab and place samples on the glass\\nslide\\n\\uf0b7\\nPlace the spatula against the cervix with the longer protrusion in the cervical canal\\n\\uf0b7\\nRotate the spatula 360° firmly against the cervix, scrape the entire transformation zone\\n\\uf0b7\\nPlace the sample immediately from the spatula onto the glass slide and fix it (spray\\nfixative or placing it in a bottle of fixative – 95% ethanol.\\nFollow up - Abnormal smears should be referred for colposcopy and biopsy\\nScreening for Endometrial Cancer\\nWomen at high risk due to known hereditary non polyposis colon cancer (HNPCC)\\nassociated genetic mutation carrier status should consider beginning annual testing for early\\nendometrial cancer detection at an age of 35. The endometrial biopsy is still the most\\ncommon technique used to obtain endometrial tissue.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 284, 'source_type': 'Authorotative', 'priority': '1'}, page_content='endometrial cancer detection at an age of 35. The endometrial biopsy is still the most\\ncommon technique used to obtain endometrial tissue.\\n\\uf0b7\\nWomen at high risk (due to hereditary non-polyposis colon cancer carrier status) should\\nconsider annual testing from the age of 35.\\n\\uf0b7\\nEndometrial biopsy is the most common technique used to obtain endometrial tissue.\\nCONTRACEPTION\\nA method or a system, which allows intercourse and yet prevents conception, is called a\\ncontraceptive method. This contraception may be temporary when the effect lasts only till the\\ncouple uses the method but the fertility returns after the use is discontinued. The permanent\\ncontraceptive methods are surgical and are aimed to achieve sterility after the surgical\\nprocedure.\\nA couple in the reproductive age group, who desires contraception should be provided\\ninformation about all the available methods of contraception and should be counselled and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 284, 'source_type': 'Authorotative', 'priority': '1'}, page_content='procedure.\\nA couple in the reproductive age group, who desires contraception should be provided\\ninformation about all the available methods of contraception and should be counselled and\\nhelped so as to choose a method most suitable for that couple. Various contraceptive\\nmethods available are:\\nI. Temporary methods\\n1. Hormonal contraceptives\\n-\\nCombined oral contraceptive pills.\\n-\\nInjectable hormonal contraceptives (DMPA and NET-EN)\\n-\\nProgesterone only pill [ketodesogestrel]\\n2. Non-hormonal contraceptive pills\\n-\\nCentchroman.\\n3. Intrauterine contraceptive device\\n-\\nCuT 200B.\\n-\\nMultiload 250 and Multiload 375.\\n-\\nCuT 380A\\n-\\nLNG IUCD [mirena]\\n4. Barrier methods'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 285, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n278\\n-\\nMale condoms.\\n-\\nVaginal diaphragms with spermicidal jelly.\\n-\\nContraceptive sponge.\\nII. Permanent methods\\n1. Female sterilization\\n-\\nPostpartum sterilization.\\n-\\nInterval ligation (laparoscopic or minilap ligation).\\n-\\nLigation concurrent with MTP.\\n2. Male sterilization\\n- Vasectomy (traditional or non scalpel).\\nTEMPORARY CONTRACEPTIVE METHODS\\nI. Hormonal contraceptives\\n(i) Combined oral contraceptive pills\\nLow dose combined oral contraceptive pill containing 30 mcg ethinyl oestradiol and a\\nprogestin (0.3 mg Norgestrel or 0.15 mg Norgestrel or 0.15 mg Desogestrel) can be\\nprescribed. One tablet to be taken daily with meals at a consistent time. It should be started\\nduring first seven days of the menstrual cycle or at any other time when it is reasonably\\ncertain that she is not pregnant. If started after first 7 days of menstrual cycle, back up\\nmethod (abstinence or barrier method) should be used for 7 days. Pills should be taken for'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 285, 'source_type': 'Authorotative', 'priority': '1'}, page_content='certain that she is not pregnant. If started after first 7 days of menstrual cycle, back up\\nmethod (abstinence or barrier method) should be used for 7 days. Pills should be taken for\\nthree weeks followed by 1 week of pill-free interval during which placebo tablets are to be\\ntaken if pack contains 28 tablets.\\nIn women >40 years of age very low dose pills containing ethinyl oestradiol 20 mcg and\\ndesogestrel 0.15 mg can be used. After age 50 years, if woman on oral pills, check FSH\\nduring 5 - 7 days of pill free interval. If FSH >30 IU/1 change to HRT regimens.\\nContraindications\\n\\uf0b7\\nCombined oral contraceptive pills are contraindicated in cases with current or history of,\\nthromboembolic disease, cerebrovascular disease, coronary artery disease, complicated\\nvalvular heart disease, acute liver disease., current or past breast cancer., undiagnosed\\nvaginal bleeding, pregnancy, heavy smokers over 35 years of age, migraine with'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 285, 'source_type': 'Authorotative', 'priority': '1'}, page_content='valvular heart disease, acute liver disease., current or past breast cancer., undiagnosed\\nvaginal bleeding, pregnancy, heavy smokers over 35 years of age, migraine with\\nneurological symptoms, diabetes >20 years or with vascular disease, current gall bladder\\ndisease, uncontrolled hypertension (BP > 160/100).\\n\\uf0b7\\nCombined oral contraceptive pills should not be taken during first 6 months postpartum if\\nbreastfeeding and first 3 weeks postpartum in non-breastfeeding females. Pills can be\\nstarted immediately after spontaneous or induced abortion; can be used with caution in\\ncases with controlled hypertension, diabetes, migraine without neurological symptoms,\\nnon-smokers with age more than 35 years of age without any other medical illness.\\nFollow up\\nFirst follow up should be within 3 months and then annually. Follow up involves history,\\nblood pressure, urinalysis, breast examination, liver palpation and pelvic examination.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 286, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n279\\nPatient education\\n\\uf0b7\\nCommon side effects are nausea, vomiting, GI upset, breast changes, weight gain, acne,\\nbreakthrough bleeding, amenorrhoea, rash, vaginal candidiasis. Side effects decrease\\nusually after 2 - 3 months of use.\\n\\uf0b7\\nReport immediately in case of symptoms like chest pain, leg pain, severe headache,\\nsevere stomachache, swelling of one or both legs, visual impairment.\\n\\uf0b7\\nIt is one of the most effective contraceptive methods with failure rate of about 0.1%.\\n\\uf0b7\\nIt has non-contraceptive health benefits like regular periods with less pain and bleeding,\\nimproves premenstrual symptoms, and decreases functional ovarian cysts, pelvic\\ninflammatory disease, ovarian and endometrial cancer, endometriosis.\\n\\uf0b7\\nForgotten pill - if one pill is forgotten, take as soon as remembered and next day take next\\npill and continue the schedule. Use back up method for 7 days.\\n\\uf0b7\\nIf 2 pills are forgotten take 2 pills and next day again take 2 pills, and then continue as per'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 286, 'source_type': 'Authorotative', 'priority': '1'}, page_content='pill and continue the schedule. Use back up method for 7 days.\\n\\uf0b7\\nIf 2 pills are forgotten take 2 pills and next day again take 2 pills, and then continue as per\\nschedule. Use back up method for 7 days.\\n\\uf0b7\\nIf 3 pills are forgotten, this cycle is not protected, use back up method till next cycle and\\nthen restart with new pack.\\n\\uf0b7\\nShould be discontinued at least 4 weeks prior to any planned major surgery.\\n\\uf0b7\\nMedicines like rifampicin, barbiturates, phenytoin, carbamazepine, primidone,\\ngriseofulvin interfere with the effects of oral pills. So use alternative method during their\\nintake.\\n(ii) Injectable hormonal contraceptives\\nHighly effective oestrogen free long acting contraceptive can be given when oestrogens are\\ncontraindicated like sickle cell disease, seizure disorders, age >35 years who smoke;\\nbreastfeeding females after first 6 weeks. In non-breastfeeding females, injections can be\\nsafely given immediately postpartum.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 286, 'source_type': 'Authorotative', 'priority': '1'}, page_content='breastfeeding females after first 6 weeks. In non-breastfeeding females, injections can be\\nsafely given immediately postpartum.\\nDepot medroxy progesterone acetate - 150 mg injection to be given deep IM every three\\nmonths. Next injection can be delayed by 2 weeks Or Norethisterone enanthate - 200 mg\\ninjection to be given deep IM every 2 months. Next injection can be delayed by 1 week.\\nAbsolute contraindications\\n\\uf0b7\\nPregnancy\\n\\uf0b7\\nUnexplained genital bleeding.\\n\\uf0b7\\nSevere coagulation disorder.\\n\\uf0b7\\nPrevious sex steroid induced liver adenoma, active liver disease.\\n\\uf0b7\\nBreast feeding during initial 6 weeks.\\n\\uf0b7\\nCurrent or history of thromboembolic disease, cerebrovascular disease, coronary artery\\ndisease.\\n\\uf0b7\\nCurrent or past breast cancer\\n\\uf0b7\\nDiabetes >20 years or with vascular disease\\n\\uf0b7\\nUncontrolled hypertension (BP > 180/110).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 287, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n280\\nPatient education\\n\\uf0b7\\nCommon side effects are irregular bleeding, breast tenderness, weight gain, depression,\\nheadache, dizziness, abdominal pain.\\n\\uf0b7\\nBeneficial effects and efficacy is same as that of oral contraceptive pills.\\n\\uf0b7\\nFertility return is slightly delayed after discontinuation of use.\\n\\uf0b7\\nDrug interactions are same as with oral hormonal pills.\\nII.Non-hormonal oral contraceptive pills (Centchroman) 30 mg tablet started on first day\\nof periods. Take twice weekly for three months and then continue as once weekly.\\nContraindications\\nPolycystic ovarian disease, cervical intraepithelial neoplasia, severe allergy, recent history\\nof liver disease, and first 6 months of lactation\\nPatient education\\n\\uf0b7\\nIt is a non-steroidal contraceptive pill, has no hormonal effects with failure rate is 1-2%.\\n\\uf0b7\\nDelayed periods can occur in 6% cases. If delay is >15 days, perform urine pregnancy\\ntest.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 287, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIt is a non-steroidal contraceptive pill, has no hormonal effects with failure rate is 1-2%.\\n\\uf0b7\\nDelayed periods can occur in 6% cases. If delay is >15 days, perform urine pregnancy\\ntest.\\n\\uf0b7\\nIf one tablet is missed take as soon as possible and resume scheduled intake. Add back up\\nmethod till next period. If tablet missed for >7 days, start fresh regimen.\\nIII. Intrauterine contraceptive devices (IUCD)\\nAny of the following devices can be inserted inside uterus by trained health personnel. It\\nshould be inserted during or shortly after menstruation and after immediately after\\nspontaneous or induced abortion. After delivery it should be inserted during 4-8 weeks\\npostpartum. It can be inserted within 5 days of unprotected coitus. These devices need to\\nbe changed after the duration of their lifespan.\\nLifespan of intrauterine contraceptive devices (IUCD)\\nCuT 200B\\n3 yrs\\nMultiload 250\\n3 yrs\\nMultiload 375\\n5 yrs\\nCuT 380 A\\n10 yrs'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 287, 'source_type': 'Authorotative', 'priority': '1'}, page_content='be changed after the duration of their lifespan.\\nLifespan of intrauterine contraceptive devices (IUCD)\\nCuT 200B\\n3 yrs\\nMultiload 250\\n3 yrs\\nMultiload 375\\n5 yrs\\nCuT 380 A\\n10 yrs\\nFollow up - first follow up should be after next period to check for complications and to rule\\nout expulsion, after that follow up annually.\\nContraindications\\nPregnancy, postpartum <4 weeks, septic abortion, distorted uterine cavity, uterine fibroids,\\ncurrent or within past 3 months PID or STD, increased risk of STD, HIV positive, AIDS,\\npelvic tuberculosis, unexplained vaginal bleeding, trophoblastic disease, genital tract\\nmalignancy, complicated valvular heart disease.\\nPatient education\\n\\uf0b7\\nCommon side effects are increased menstrual bleeding and dysmenorrhea. These decrease\\nafter initial 2-3 months.\\n\\uf0b7\\nNo protection for STDs.\\n\\uf0b7\\nFailure rates are 0.5 - 3%. Ectopic pregnancy can still occur.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 288, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n281\\n\\uf0b7\\nIUCD may get spontaneously expelled. Therefore monthly palpation of IUCD string is\\nimportant. If not palpable, report immediately.\\n4. Barrier methods\\nThese are cheap, available over the counter, coitus dependant methods. Male condoms,\\nvaginal diaphragm, spermicidal jellies, vaginal sponge can be used.\\nMale condoms\\nAny of the available condoms can be used. For each act of coitus a new condom is to be used.\\nIf during intercourse, condom breaks or if there is spillage or leakage, woman should contact\\na clinician within 72 hours and emergency contraception should be provided to her.\\nContraindication- severe allergy to latex rubber.\\nVaginal diaphragm\\nAvailable in different sizes. Proper size should be checked by a clinician by pelvic\\nexamination. Can be inserted 6 hours prior to intercourse. About a tablespoonful of\\nspermicidal cream or jelly should be placed in the dome of diaphragm prior to insertion;'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 288, 'source_type': 'Authorotative', 'priority': '1'}, page_content='examination. Can be inserted 6 hours prior to intercourse. About a tablespoonful of\\nspermicidal cream or jelly should be placed in the dome of diaphragm prior to insertion;\\nshould be left in place for approximately 6 hours (but not >24 hours) after coitus. Additional\\nspermicide should be placed in vagina before each additional episode of sexual intercourse.\\nAfter removal wash with soap and water, rinse and dry.\\nFollow up. Annually to assess proper fitting of diaphragm.\\nContraceptive sponge\\nContains spermicidal agent Nonoxynol 9. It should be removed at least 6 hours after sexual\\nintercourse. Maximal wear time is 30 hours.\\nPatient education\\n\\uf0b7\\nBarrier methods provide protection against STDs and PID. Only condom has been proven\\nto prevent HIV infection.\\n\\uf0b7\\nOther advantages are prevention of diseases like pelvic inflammatory disease, carcinoma\\ncervix, chronic pelvic pain.\\n\\uf0b7\\nIt can be used soon after delivery.\\n\\uf0b7\\nNo hormonal side effects.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 288, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nOther advantages are prevention of diseases like pelvic inflammatory disease, carcinoma\\ncervix, chronic pelvic pain.\\n\\uf0b7\\nIt can be used soon after delivery.\\n\\uf0b7\\nNo hormonal side effects.\\n\\uf0b7\\nSide effects like vaginal dryness, itching, irritation, allergic reactions can occur.\\n\\uf0b7\\nFailure rates are very high. Typical failure rates are with condoms 14%, diaphragm with\\nspermicidal jelly 20%, highest with sponge 28%.\\nPERMANENT CONTRACEPTIVE METHODS\\nPermanent contraception is provided by sterilization operation in male or female partners.\\n\\uf0b7\\nMale client should be <60 years of age.\\n\\uf0b7\\nFemale client should be >22 years and <45 years of age.\\n\\uf0b7\\nClient must make informed decision voluntarily and must give consent on the consent\\nform for sterilization.\\nI. Female sterilization\\nDone by laparoscopic ligation in interval ligation and first trimester abortions or tubectomy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 289, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n282\\nTiming\\n\\uf0b7\\nInterval sterilization - within 7 days after menstrual period is over.\\n\\uf0b7\\nPostpartum sterilization - after delivery till 7 days but preferably within 48 hours. Later\\non after 6 weeks postpartum.\\n\\uf0b7\\nMTP - concurrently\\n\\uf0b7\\nSpontaneous abortion - concurrently but under antibiotic cover and in the absence of\\ninfection and anaemia.\\nContraindications\\nThere are no absolute contraindications. Relative contraindications are psychiatric disorder,\\nacute febrile illness, jaundice, Hb< 8 g%, chronic systemic disease, malignancy, bleeding\\ndisorder, severe nutritional deficiency. Postpartum sterilization is contraindicated in\\npuerperial sepsis or fever, severe pre-eclampsia/eclampsia, premature rupture of membrane\\n>24 hours, severe APH or PPH, genital tract trauma.\\nPost abortal sterilization is contraindicated in sepsis, fever, haemorrhage, severe trauma,\\nuterine perforation, acute haematometra.\\nFollow-up'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 289, 'source_type': 'Authorotative', 'priority': '1'}, page_content='>24 hours, severe APH or PPH, genital tract trauma.\\nPost abortal sterilization is contraindicated in sepsis, fever, haemorrhage, severe trauma,\\nuterine perforation, acute haematometra.\\nFollow-up\\nFirst follow up should be done seven days after the surgery for wound examination. Second\\nfollow up is recommended after one month or next menstrual period whichever is earlier.\\nSubsequent follow-ups if client develops any complication or has query.\\nII. Male sterilization\\nContraindications\\nThere are no absolute contraindications. Relative contraindications include psychiatric and\\nphysical illness, local genital conditions, including large varicocele, hydrocele, inguinal\\nhernia, filariasis, cryptorchidism, previous scrotal surgery, intra scrotal mass.\\nFollow-up. First follow up after 7 days of surgery for wound examination and stitch removal.\\nSecond follow up after 3 months with semen analysis. Subsequent follow up required in cases\\nof any complication or queries.\\nPatient education\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 289, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Second follow up after 3 months with semen analysis. Subsequent follow up required in cases\\nof any complication or queries.\\nPatient education\\n\\uf0b7\\nIn non scalpal vasectomy stitches are not required.\\n\\uf0b7\\nIt is a safe and simple procedure.\\n\\uf0b7\\nIt is a permanent method to prevent future pregnancies.\\n\\uf0b7\\nIt does not affect sexual pleasure, ability or performance.\\n\\uf0b7\\nIt has a small chance of failure even if performed under optimum circumstances.\\n\\uf0b7\\nAfter vasectomy it is necessary to use a back up contraceptive method either for 20\\nejaculations or for a period of 3 months.\\n\\uf0b7\\nSterilization does not provide protection against reproductive tract infections/ STDs or\\nHIV/AIDS.\\n\\uf0b7\\nFailure rates with female sterilization are < 0.5% and male sterilization < 0.1 %.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 290, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Obstetrics and Gynecology\\n283\\nEmergency contraception\\nMethod used to prevent pregnancy after a likely fertile unprotected act of sexual intercourse;\\ncan be used in cases of condom rupture, rape or other circumstances of unprotected sex.\\nFirst dose should be taken within 72 hours following unprotected sex and second dose 12\\nhours after the first dose. Any of the following can be used:\\nLevonorgestrel 0.75 mg 1 tablet 12 hourly for 2 doses. Or combined oral contraceptive pills\\ncontaining 50 meg ethinyl oestradiol with 0.5 mg norgestrel 2 tablets 12 hourly for 2 doses.\\nOr  Low dose combined oral contraceptive pills containing 30 mcg ethinyl oestradiol with 0.3\\nmg norgestrel 4 tablets 12 hourly for 2 doses.\\nPatient education\\n•\\nSide effects are nausea, vomiting, dizziness, fatigue, headache, lower abdominal pain,\\nbreast tenderness, vaginal bleeding.\\n\\uf0b7\\nIt must be used under medical supervision.\\n\\uf0b7\\nIt decreases risk of pregnancy by 70 - 90%. Earlier it is taken, success is more.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 290, 'source_type': 'Authorotative', 'priority': '1'}, page_content='breast tenderness, vaginal bleeding.\\n\\uf0b7\\nIt must be used under medical supervision.\\n\\uf0b7\\nIt decreases risk of pregnancy by 70 - 90%. Earlier it is taken, success is more.\\n\\uf0b7\\nIf vomiting occurs within 2 hours of the dose, it must be repeated.\\n\\uf0b7\\nThere are no contraindications for emergency contraception.\\n\\uf0b7\\nAfter this use a barrier method for each act of intercourse until next menstrual period.\\n\\uf0b7\\nIf period delayed >5 days, rule out pregnancy.\\n\\uf0b7\\nUse regular contraceptive method.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 291, 'source_type': 'Authorotative', 'priority': '1'}, page_content='284\\nChapter 14\\nPSYCHIATRY DISORDERS\\nIntroduction and General Guidelines\\nThe incidence and prevalence of psychiatric disorders is on a rise in the 21st century. The\\nawareness, regarding the nature of mental illnesses and the need for treatment, and their\\nacceptance is also improving. Although psychopharmacology forms the backbone of\\ntreatment in most psychiatric disorders, certain points need to be especially emphasized while\\nmanaging psychiatric patients:\\n1) The formation of a trusting, confidential, non-judgemental and empathetic doctor - patient\\nrelationship is crucial to the practice of psychiatry.\\n2) Knowing the person as a whole rather than only his symptoms endorses patient\\nimprovement.\\n3) The psychotic patient often loses his judgement and reality perception. Such patients\\noften have to be treated against their will.\\n4) Family has an important role in the causation and management of psychiatric disorders.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 291, 'source_type': 'Authorotative', 'priority': '1'}, page_content='often have to be treated against their will.\\n4) Family has an important role in the causation and management of psychiatric disorders.\\n5) All patients do well with holistic treatment which includes psychopharmacology, other\\nbiological treatments, psychotherapy and rehabilitation.\\n6) Psychiatric treatment often continues for a long period, so compliance is a major issue.\\nSCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS\\nSchizophrenia is a chronic debilitating psychiatric disorder of varied and profoundly\\ndisruptive psychopathology affecting cognition, perception, emotion and other aspects of\\nbehavior. Its usual age of presentation is around 25 yrs and affects all social classes equally.\\nSalient features\\n\\uf0b7\\nThe common symptoms of schizophrenia are false, fixed, firm beliefs (delusion),\\nperceptual abnormalities e.g. hearing of voices while alone (hallucinations).\\n\\uf0b7\\nAbnormalities in speech and behavior as irrelevant speech, talking to self, crying or\\nlaughing for no reason are also prominent.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 291, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nAbnormalities in speech and behavior as irrelevant speech, talking to self, crying or\\nlaughing for no reason are also prominent.\\n\\uf0b7\\nschizophrenia has been divided into following subtypes for the ease of practice.\\n-\\nParanoid schizophrenia- Delusions and hallucinations form predominant features\\nalong with other symptoms.\\n-\\nCatatonic schizophrenia-Characterized by marked psychomotor retardation or\\nagitation.\\n-\\nHebephrenic schizophrenia-Characterized by marked abnormalities of behavior.\\n-\\nResidual schizophrenia Simple schizophrenia\\nNon- pharmacological treatment\\n\\uf0b7\\nCognitive behaviorally oriented psychotherapy - understanding of illness, identification of\\ntarget symptoms, and development of strategies to cope up with these symptoms.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 292, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n285\\n\\uf0b7\\nRehabilitation of the patients in the form of supported employment, individualized job\\ndevelopment, ongoing job support, integration of vocational and mental health services.\\n\\uf0b7\\nSocial skills training, behavior based instructions, corrective feedback, and contingent\\nsocial reinforcement.\\nPharmacological treatment\\n\\uf0b7\\nHospitalization is indicated in suicidal patients, non compliant patients, treatment\\nresistant cases and diagnostically difficult cases (Figure 1).\\n\\uf0b7\\nAntipsychotics (typical and atypical) are the main treatment for such patients (Table 1).\\n\\uf0b7\\nCo-administration of Tab. trihexyphenidyl (2 – 12 mg/day) is recommended with typical\\nantipsychotics.\\n\\uf0b7\\nBenzodiazepines (Inj. lorazepam 2-4 mg, orally, IM or IV preparation) may be co-\\nadministered in uncooperative patients initially.\\n\\uf0b7\\nECT (electro convulsive therapy) - electric shock of 100-120 volts may be given in\\npatients with associated suicidal intention and treatment resistant cases. It is given for 1-3'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 292, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nECT (electro convulsive therapy) - electric shock of 100-120 volts may be given in\\npatients with associated suicidal intention and treatment resistant cases. It is given for 1-3\\nseconds under general anesthesia so that it produces short lasting generalized tonic clonic\\nconvulsions.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 293, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n286\\nTable 1. Dosage schedule and adverse effects of commonly used antipsychotics\\nDrugs\\nEffective dose\\nDosage schedule\\nAdverse effect\\nTypical antipsychotics\\nHaloperidol\\n5 – 20 mg/day,\\navailable as tablets,\\nsyrup, injection and\\ndepot preparation\\n(50 mg/ampoule)\\nStart with 5 mg twice a\\nday or 10 mg HS and\\nincrease the dose by\\n5mg if no response.\\nDepot injection to be\\ngiven once two to three\\nweeks.\\nMore extra-pyramidal side\\neffects viz slowness of\\nmovements, blunted facial\\nexpressions, tremors,\\nrigidity, excessive\\nsalivation, etc.\\nNon specific - sedation,\\nreduction in seizure\\nthreshold, orthostatic\\nhypotension,\\nanticholinergic side effects\\nCVS - cardiac toxicity,\\nsudden death,\\nHematological - leucopenia\\nEndocrinal -\\nhyperprolactinemia\\nSexual - anorgasmia and\\ndecreased libido,\\nGIT - nausea, vomiting,\\nhepatotoxicity\\nTrifluoperazine\\nAvailable as 5mg\\nTab.\\nStart with 5mg/ day and\\ncan \\nbe \\ngradually\\ntitrated \\nupto \\na\\nmaximum \\nof \\n40\\nmg/day\\nFluphenazine\\ndecanoate'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 293, 'source_type': 'Authorotative', 'priority': '1'}, page_content='GIT - nausea, vomiting,\\nhepatotoxicity\\nTrifluoperazine\\nAvailable as 5mg\\nTab.\\nStart with 5mg/ day and\\ncan \\nbe \\ngradually\\ntitrated \\nupto \\na\\nmaximum \\nof \\n40\\nmg/day\\nFluphenazine\\ndecanoate\\nDepot injection\\n5 mg/2ml\\nOnce in 15-20 days\\nZuclopenthixol\\nDepot injection\\n200mg/ml\\nOne ampoule IM once\\nin 2-3 weeks.\\nAtypical antipsychotics\\nRisperidone\\n2-10 mg/day,\\navailable as tablets,\\nsyrup and depot\\npreparation (25\\nmg/ampoule)\\nStart with 2mg once a\\nday or twice a day and\\ntitrate it to 8mg/day\\ngradually. \\nDeport\\ninjection to be given\\ndeep IM once every 15\\ndays\\nLess extra-pyramidal side\\neffects\\nNon specific - dizziness,\\nhyperkinesias, somnolence,\\nanti-cholinergic side effects\\nlike dry mouth,\\nconstipation, delirium\\nGIT - nausea, vomiting.\\nEndocrinal -\\nhyperprolactinemia,\\nhyperglycemia.\\nHematological - leucopenia\\nSexual - erectile\\ndysfunction,\\norgasmic dysfunction\\nGeneral - weight gain\\nOlanzapine\\n5 – 30 mg/day,\\navailable as tablets\\nStart with 5 mg once a\\nday or HS and titrate\\ngradually by 5 mg/day'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 293, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Sexual - erectile\\ndysfunction,\\norgasmic dysfunction\\nGeneral - weight gain\\nOlanzapine\\n5 – 30 mg/day,\\navailable as tablets\\nStart with 5 mg once a\\nday or HS and titrate\\ngradually by 5 mg/day\\nif no improvement.\\nQuetiapine\\nAvailable as 50,\\n100, 200 mg\\ntablets\\nStart with 50mg twice a\\nday and build upto 300-\\n800 mg/ per day\\nClozapine\\n25 – 300 mg/ per\\nday,  available as\\ntablets\\nGet \\ncomplete \\nblood\\ncounts \\ndone \\nbefore\\nstarting clozapine.\\nStart with 25 mg HS or\\n50mg \\nHS \\ngradually\\ntitrate to 500mg.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 294, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n287\\nFigure 1. Treatment guidelines for schizophrenia\\nPatient education\\n\\uf0b7\\nBoth, the patient and the primary caregiver should be explained that although\\nschizophrenia is a chronic illness and requires long term treatment, it can be effectively\\ntreated in most cases.\\n\\uf0b7\\nMild to moderate side effects may develop to medications, but usually tolerance develops\\nto them.\\n\\uf0b7\\nMedicines should not be stopped abruptly.\\n\\uf0b7\\nFamily should be encouraged to take up the responsibility for regular treatment and\\nfollow-up. Family interventions include illness education, crisis intervention, emotional\\nsupport and training for coping skills.\\nOTHER PSYCHOTIC DISORDERS\\nSchizophreniform disorder\\n\\uf0b7\\nClinical features similar to schizophrenia\\n\\uf0b7\\nDiffers from schizophrenia in that duration of symptoms is lesser than 6 months\\n\\uf0b7\\nPharmacological treatment is similar as schizophrenia\\nBrief psychotic disorder\\n\\uf0b7\\nClinical features similar to schizophrenia\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 294, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPharmacological treatment is similar as schizophrenia\\nBrief psychotic disorder\\n\\uf0b7\\nClinical features similar to schizophrenia\\n\\uf0b7\\nDiffers from schizophrenia in that duration of symptoms is less than 1 month\\n\\uf0b7\\nPharmacological treatment is similar to schizophrenia'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 295, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n288\\n\\uf0b7\\nCommon symptoms of depression are (for a minimum period of two weeks):\\n-\\nPersistent sadness of mood and decreased interest in previously pleasurable activities\\n-\\nMore than 5 % weight loss or gain\\n-\\nSleep disturbance – insomnia or hypersomnia\\n-\\nMarked slowing of activity or agitation and easy fatigability\\n-\\nLack of concentration\\n-\\nFeelings of worthlessness, helplessness, hopelessness, guilt and suicidal thoughts /\\nattempts\\n-\\nAnxiety symptoms often coexist\\nDelusional disorder\\n\\uf0b7\\nClinical features - characterized by single or multiple non bizarre (false fixed but feasible\\nbeliefs) delusions of 1 month duration\\n\\uf0b7\\nDiffers from schizophrenia in that duration of delusions is 1 month and functioning and\\nbehavior in other areas of life than delusional one is intact\\n\\uf0b7\\nInsight oriented psychotherapy forms mainstay of treatment whereas Pharmacological\\ntreatment is similar to schizophrenia\\nSchizoaffective disorder\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 295, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nInsight oriented psychotherapy forms mainstay of treatment whereas Pharmacological\\ntreatment is similar to schizophrenia\\nSchizoaffective disorder\\n\\uf0b7\\nSymptoms of schizophrenia are present continuously and features of bipolar affective\\ndisorder overlap\\n\\uf0b7\\nDiffers from schizophrenia by prominence of affective features\\n\\uf0b7\\nPharmacological treatment is with antipsychotics and mood stabilizers as in schizophrenia\\nand bipolar disorder respectively\\nMAJOR DEPRESSIVE DISORDER\\nMajor depressive disorder (MDD), more commonly known as depression, is one of the most\\ncommon psychiatric disorders with lifetime prevalence of about 10-20 %. Incidence in\\nfemales are almost twice that in males.\\nSalient features\\nInvestigations\\n\\uf0b7\\nDiagnosis is based on history and mental state examination (MSE). Test for thyroid\\nfunction can be done to rule out the co morbidity.\\n\\uf0b7\\nInvestigations for associated neurological co-morbidities can be done particularly in\\nelderly patients presenting with depression'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 295, 'source_type': 'Authorotative', 'priority': '1'}, page_content='function can be done to rule out the co morbidity.\\n\\uf0b7\\nInvestigations for associated neurological co-morbidities can be done particularly in\\nelderly patients presenting with depression\\nNon pharmacological treatment\\n\\uf0b7\\nPsychological factors are very important in the causing, maintaining as well as\\nimproving depression. For holistic management of depression, some form of\\npsychotherapy should be co-administered.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 296, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n289\\n\\uf0b7\\nPsychodynamic approach aims at promoting personality change through understanding of\\nmajor conflicts, achieving insight into defenses, ego distortions, providing role model\\npermitting cathartic relief or aggression.\\n\\uf0b7\\nCognitive behavioral approach aims at providing symptomatic relief through alteration of\\ntarget thoughts, identifying cognitive distortions, modifying erroneous assumptions,\\npromoting self control over thinking patterns.\\n\\uf0b7\\nInterpersonal approach aims at providing symptoms relief through solving current\\ninterpersonal problems, reducing stress involving family and work, improving\\ninterpersonal communication skills.\\nSupportive approach with techniques such as catharsis, realistic problem solving is also\\nuseful.\\nPharmacological treatment\\n\\uf0b7\\nHospitalization is needed in severely suicidal patients, treatment resistant cases and non\\ncompliant patients.\\n\\uf0b7\\nSSRIs (selective serotonin reuptake inhibitors) are currently the drug of choice for\\ndepression.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 296, 'source_type': 'Authorotative', 'priority': '1'}, page_content='compliant patients.\\n\\uf0b7\\nSSRIs (selective serotonin reuptake inhibitors) are currently the drug of choice for\\ndepression.\\n-\\nTab. fluoxetine - start with 20 mg/day increase to 40 mg/day, if no response in 4-6\\nweeks\\n-\\nTab. escitalopram - start with 10 mg/day depending on tolerability and gradually\\nincrease upto 30 mg/day\\n-\\nTab. sertraline - start with 25 mg/day or 50 mg/day depending on the severity of\\nsymptoms in 1 HS dosage preferably and gradually increase to maximum of\\n300mg/day\\n\\uf0b7\\nTab. mirtazepine - start with 7.5 mg/day and gradually increase upto maximum 30\\nmg/day.\\n\\uf0b7\\nTricyclic antidepressants like Tab. imipramine for depression with somatic complaints.\\nStart with 25mg twice a day and gradually increase by 25 mg/day to maximum of 300\\nmg/day if no response (should be avoided in patients with heart disease, glaucoma,\\nbenign prostatic enlargement and epilepsy).\\n\\uf0b7\\nAntidepressant action takes about 2-3 weeks and needs to be continued for 6-9 months in'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 296, 'source_type': 'Authorotative', 'priority': '1'}, page_content='benign prostatic enlargement and epilepsy).\\n\\uf0b7\\nAntidepressant action takes about 2-3 weeks and needs to be continued for 6-9 months in\\nfirst episode and for longer period in recurrent depression.\\n\\uf0b7\\nInitially benzodiazepines may need to be co-administered to manage insomnia and\\nanxiety.\\n\\uf0b7\\nIn cases of bipolar depression, there might be a sudden switch to mania in which case\\nanti-depressant should be withdrawn.\\n\\uf0b7\\nECT (Electroconvulsive therapy) is a very safe, effective and economical mode of\\ntreatment and is indicated in severe depression with or without suicidal ideas, retarded\\ndepression and resistant depression.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 297, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n290\\n\\uf0b7\\nIn manic episode, an elevated, expansive or irritable mood is the hallmark. The\\nelevated mood is euphoric and characterized by euphoria, impaired judgement, denial\\nof illness, overtly religious, over familiar behavior, increased talkativeness, increased\\nself esteem, increased psychomotor activities and goal directed activities, increased\\nsexual drive and engaging into high risk behavior.\\n\\uf0b7\\nPatients with depressed mood experience loss of energy and interest, feelings of guilt,\\ndifficulty in concentrating, loss of appetite and thoughts of death or suicide.\\n\\uf0b7\\nOther signs  and symptoms of mood disorders include change in activity level,\\ncognitive abilities, speech and vegetative functions (e.g. sleep, appetite, sexual activity\\nand other biological rhythms).\\n\\uf0b7\\nThese disorders virtually always result in impaired interpersonal, social and\\noccupational aspects of life.\\nPatient education\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 297, 'source_type': 'Authorotative', 'priority': '1'}, page_content='and other biological rhythms).\\n\\uf0b7\\nThese disorders virtually always result in impaired interpersonal, social and\\noccupational aspects of life.\\nPatient education\\n\\uf0b7\\nExplain the nature of illness, consequences of untreated depression, suicidal risk, need for\\nadequate does for adequate duration and other supportive measures.\\n\\uf0b7\\nThe therapeutic response takes time to appear but side effects may appear earlier.\\nCommon side effects of tricyclic antidepressants are dry mouth, constipation, postural\\nhypotension (giddiness), blurred vision,\\nsweating,\\npalpitation, tremors,\\ndelayed\\nmicturition, sedation, etc.\\n\\uf0b7\\nCommon side effects of fluoxetine are agitation, headache, nausea or heartburn, tremors,\\nchanges in sexual performance, blurred vision, dry mouth and loss of appetite.\\nBIPOLAR MOOD DISORDER\\nBipolar mood disorders are characterized by episodes of mania and depression or mania\\nalone with intervening periods of normalcy.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 297, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Bipolar mood disorders are characterized by episodes of mania and depression or mania\\nalone with intervening periods of normalcy.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7\\nPsychoeducation, family therapy and rehabilitation for manic phases\\n\\uf0b7\\nPsychotherapeutic measures same as in unipolar depression for depressive phases.\\nPharmacological treatment (Figure 2, Table 2)\\n\\uf0b7\\nAntipsychotics like risperidone and olanzapine are used as an adjuvant in treatment.\\n\\uf0b7\\nEpisode of depression is to be treated as in major depressive disorder but Tab. lamotrigine\\n25-100 mg is the treatment of choice.\\n\\uf0b7\\nProphylactic treatment: to be given to prevent recurrent episodes: Tab. lithium carbonate\\n900-1500 mg /day in divided doses or Tab. sodium valproate 600- 2000 mg /day in\\ndivided doses or Tab. carbamazepine 600-1200 mg / day in divided doses'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 298, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n291\\nFigure 2. Management of current manic episode\\nTable 2. Dosage schedule of anti-manic drugs\\nDrug treatment of mania :  recommended doses\\nDosage schedule\\nLithium\\n400 mg / per day. Adjusted after 3 –\\n4  days according to plasma\\nlevels\\nStart with 600 to 900 mg/day\\nafter getting baseline\\ninvestigations done\\nSodium valproate\\nAs sodium valproate slow release:\\nDose is 20 – 30 mg/ kg/ day\\nStart with 200mg thrice a day\\nand gradually increase upto\\nthe per kg maximum dose if\\nno or less response\\nOxcarbazepine\\n300mg, build upto 1500 mg\\nHas lesser side effect than\\ncarbamazepine\\nPatient education\\n\\uf0b7\\nEmphasize about recurrent course of illness and not to get too much worried regarding\\nrecurrences.\\n\\uf0b7\\nRelapses can be treated as successfully as the first episode.\\n\\uf0b7\\nWhen on lithium, advice to take plenty of fluids especially during summer; not to restrict\\nsalt.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 299, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n292\\n\\uf0b7\\nDifficulty in initiating sleep, frequent awakenings from sleep, early morning insomnia or\\nnon-restorative sleep.\\n\\uf0b7\\nIn the elderly, the physiological reduction in number of hours of sleep does not amount to\\ninsomnia. If the patient is distressed by decreased sleep, treatment may be given to increase\\nthe duration of sleep.\\n\\uf0b7\\nStressful situation leading to insomnia or the symptoms of the causative illness can be\\nelicited on careful enquiry.\\n\\uf0b7\\nDuration of symptoms may vary from few days to many months or years depending on the\\ncause.\\n\\uf0b7\\nIf fever, vomiting or diarrhea develops while on lithium, reduce the dose of lithium to\\nhalf and contact the physician or the psychiatrist.\\nINSOMNIA\\nInsomnia is one of the commonest complaints in psychiatric, medical and general clinical\\npractice. Common causes include recent stress, psychiatric illnesses like depression and\\nanxiety disorders, pain or substance abuse.\\nSalient features\\nNon pharmacological treatment\\nSleep hygiene\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 299, 'source_type': 'Authorotative', 'priority': '1'}, page_content='practice. Common causes include recent stress, psychiatric illnesses like depression and\\nanxiety disorders, pain or substance abuse.\\nSalient features\\nNon pharmacological treatment\\nSleep hygiene\\n\\uf0b7\\nKeep a regular time for going to bed and arising up; avoid day time naps.\\n\\uf0b7\\nLimit daily in-bed time to the usual amount present before the sleep disturbance\\n\\uf0b7\\nAvoid large meals near bedtime; eat at regular times daily. No stimulant medication or\\nfood beverages (caffeine, nicotine, alcohol, etc.) especially in the evenings.\\n\\uf0b7\\nMild to moderate physical exercise in the morning.\\n\\uf0b7\\nAvoid evening stimulation: substitute radio or relaxed reading for television.\\n\\uf0b7\\nPractice meditation or progressive muscular relaxation.\\n\\uf0b7\\nMaintain comfortable sleeping conditions.\\nTreat the underlying cause. In both primary insomnia (where no cause is identifiable) and\\ninsomnia due to other causes, management includes introducing good sleep hygiene and\\nmedications for short period, if required.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 299, 'source_type': 'Authorotative', 'priority': '1'}, page_content='insomnia due to other causes, management includes introducing good sleep hygiene and\\nmedications for short period, if required.\\nPharmacological treatment\\nIf still sleep is inadequate,\\n\\uf0b7\\nTab. nitrazepam 5-10 mg or Tab. clonazepam 1-2mg or Tab. zopiclone 7.5-15mg or Tab.\\nzolpidem 5-10 mg can be given for 2-6 weeks, ½ to 1 hr before bedtime.\\n\\uf0b7\\nPatients must be cautioned regarding risk of dependence in diazepam and nitrazepam.\\nPatient education\\nFollow sleep hygiene instructions, look for tapering off benzodiazepines in 4-6 weeks'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 300, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n293\\n\\uf0b7\\nGeneralized anxiety or excessive worries along with associated symptoms as shakiness,\\nrestlessness, headaches\\n\\uf0b7\\nBreathlessness, excessive sweating, palpitations and nausea, GI disturbance, sleep\\ndisturbance, irritability, hypervigilance.\\n\\uf0b7\\nDiagnosis is based on history and mental status examination\\n\\uf0b7\\nInvestigations for co-morbidities like\\nhyperthyroidism, hypothyroidism, hypo\\nparathyroidism, pheochromocytoma and nutritional deficiencies should be done to rule\\nout organic causes of anxiety.\\nGENERALIZED ANXIETY DISORDER\\nGeneralized and persistent anxiety that is not restricted to any particular situation or\\nenvironment is an essential feature of this condition. One year prevalence of GAD is 3 to 8%\\nand it is twice as common in women as men.\\nSalient features\\nNon pharmacological treatment\\n3 main psycho-therapeutic approaches are used.\\n\\uf0b7\\nCognitive behavior therapy aims at finding out the cognitive distortions and altering'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 300, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Salient features\\nNon pharmacological treatment\\n3 main psycho-therapeutic approaches are used.\\n\\uf0b7\\nCognitive behavior therapy aims at finding out the cognitive distortions and altering\\nfaulty coping strategies. Major techniques used are relaxation and biofeedback.\\n\\uf0b7\\nSupportive therapy aims at offering reassurance and comfort to the patients.\\n\\uf0b7\\nInsight orientated psychotherapy focuses on uncovering unconscious conflicts and\\nidentifying ego strengths.\\nPharmacological treatment\\n\\uf0b7\\nBenzodiazepines are the drug of choice like diazepam (start from 5mg HS or 10 mg HS),\\nor Tab. clonazepam (start from 0.5 mg HS or TDS depending on the severity of\\nsymptoms), or Tab. lorazepam (start from 2 mg HS increase upto 8 mg maximum).\\n\\uf0b7\\nSSRIs like sertraline, escitalopram or paroxetine (start with Tab. paroxetine 10 mg or 20\\nmg per day upto maximum 50 mg/day) is effective in GAD.\\n\\uf0b7\\nBeta blockers (Tab. propranolol 20 mg BD or sustained release preparation upto 80'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 300, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mg per day upto maximum 50 mg/day) is effective in GAD.\\n\\uf0b7\\nBeta blockers (Tab. propranolol 20 mg BD or sustained release preparation upto 80\\nmg/day in divided doses is used) is used for symptomatic relief.\\nPatient education\\n\\uf0b7\\nIt is a chronic disease though easily treatable, but treatment needs to be taken regularly\\nfor a long time.\\n\\uf0b7\\nDo not stop treatment without consulting your doctor.\\n\\uf0b7\\nThe drugs are quite safe and do not cause any serious side effects even if taken for a long\\ntime.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 301, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n294\\n\\uf0b7\\nRecurrent panic attacks formed an essential feature of panic disorder. Panic attack is\\ncharacterized by intense fear or discomfort reaching a peak within 10 minutes.\\nAssociated with palpitations, sweating, shaking, breathlessness, chest pain, nausea,\\nfainting, feeling of choking, fear of dying or going crazy.\\n\\uf0b7\\nPersistence concern about having more attacks.\\n\\uf0b7\\nChange in behavior related to attacks\\n\\uf0b7\\nWorries about consequences of the attacks\\nPANIC DISORDER\\nAn acute intense attack of anxiety accompanied by feelings of impending doom is known as\\npanic disorder. Life time prevalence of panic disorder is 1 to 4%. Women are 2-3 times more\\nof likely to be affected than men.\\nSalient features\\nNon- pharmacological treatment\\nMain approaches used are cognitive and behavioral therapies which aim at providing psycho\\neducation and correcting cognitive distortions. It also includes educating the patient about\\nrelaxation techniques and respiratory training.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 301, 'source_type': 'Authorotative', 'priority': '1'}, page_content='education and correcting cognitive distortions. It also includes educating the patient about\\nrelaxation techniques and respiratory training.\\n\\uf0b7\\nFamily therapy  includes providing psycho education and support\\n\\uf0b7\\nInsight orientated psychotherapy is focused on helping patients to understand unconscious\\nmeaning of anxiety and resolution of conflicts.\\nPharmacological treatment\\n\\uf0b7\\nSSRIs particularly paroxetine are effective in treating panic disorders. Other SSRIs like\\nescitalopram, citalopram, fluvoxamine and sertraline are also useful.\\n\\uf0b7\\nAlprazolam is the most widely used benzodiazepine (start with 0.25 mg/day 1 HS upto\\nmaximum of 6 mg/day). They are used for providing rapid symptomatic relief.\\n\\uf0b7\\nInj. lorazepam 2mg/ml and diazepam 5ml/ml can be used in patients presenting with\\nacute anxiety.\\n\\uf0b7\\nTri cyclic anti depressants like amitriptyline are also useful\\nPatient education\\n\\uf0b7\\nGeneral reassurance about benign nature of symptoms and possibility of spontaneous\\nrecovery of individual\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 301, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTri cyclic anti depressants like amitriptyline are also useful\\nPatient education\\n\\uf0b7\\nGeneral reassurance about benign nature of symptoms and possibility of spontaneous\\nrecovery of individual\\n\\uf0b7\\nContinuing with breathing exercises.\\nOBSESSIVE COMPULSIVE DISORDER (OCD)\\nIt is characterized by recurrent irrational intrusive thoughts, images or impulses that are ego\\ndystonic i.e. distressing in nature. Life time prevalence in general population is 2-3%. Men\\nand women are equally affected by this disorder.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 302, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n295\\n\\uf0b7\\nRepetitive intrusive thoughts, images or impulses (obsessions) that creates anxiety and\\nmental and physical acts are done to relieve the anxiety (compulsions) are the presenting\\nfeatures of this disorder.\\n\\uf0b7\\nCommonly observed obsessions are\\n-\\nRepetitive thoughts and fear of dirt and contamination or germs\\n-\\nFear that something terrible will happen\\n-\\nForbidden or sexual thoughts and images or impulses.\\n\\uf0b7\\nCommonly observed compulsions are excessive hand washing, bathing, checking, ordering\\nand arranging.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7\\nBehavioral therapy is considered as treatment of choice for OCD. Principle approaches\\nused are exposure and response prevention. Other techniques used are desensitization,\\nthought stopping, flooding, implosion therapy and aversive conditioning.\\n\\uf0b7\\nPsychotherapy in form of Cognitive Behavior Therapy (CBT), psychoanalytical and\\npsychodynamic therapies are also c+onsidered useful in the treatment.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 302, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPsychotherapy in form of Cognitive Behavior Therapy (CBT), psychoanalytical and\\npsychodynamic therapies are also c+onsidered useful in the treatment.\\n\\uf0b7\\nResistant cases can also be treated by ECTs or surgeries.\\nPharmacological treatment\\n\\uf0b7\\nSSRIs like fluoxetine, fluoxamine, paroxetine (start with 10 mg gradually increase to\\n50mg/day), sertraline are agents of choice in treating OCD.\\n\\uf0b7\\nTab. clomipramine is start with 75mg sustained release preparation once daily and\\ndepending on severity of symptoms gradually increase upto 300mg. It is the only\\neffective tricyclic anti-depressant used in treating OCD.\\n\\uf0b7\\nAugmenting agents like sodium valproate, lithium or carbamazepine are added to enhance\\nthe response to treatment.\\n\\uf0b7\\nBenzodiazepines may be used as adjuvant treatment.\\nPatient education\\n\\uf0b7\\nReassure the patient that although disease is distressing and disabling, it is treatable.\\n\\uf0b7\\nThe drug takes about 2 weeks for its therapeutic response to manifest.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 302, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Patient education\\n\\uf0b7\\nReassure the patient that although disease is distressing and disabling, it is treatable.\\n\\uf0b7\\nThe drug takes about 2 weeks for its therapeutic response to manifest.\\n\\uf0b7\\nSide effects may appear before the onset of therapeutic response. Common side effects of\\nclomipramine are dry mouth, constipation, postural hypotension (giddiness), blurred\\nvision, and sedation. Side effects of fluoxetine include gastrointestinal distress, nausea,\\nheadache, nervousness, anorexia, restlessness and sexual side effects. Patient usually\\nadapts to these side effects with time.\\n\\uf0b7\\nAdvice the patient that treatment may continue for a long time. He/she should not leave\\ndrugs without medical advice.\\n\\uf0b7\\nIn case of any untoward effects of drugs, he/she must immediately get in touch with his\\nclinician.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 303, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n296\\n\\uf0b7\\nPhobia is defined as excessive, irrational fear of specific object, circumstance or\\nsituation. Social phobias are characterized by marked and persistent fear of social or\\nperformance situations exposing a person to unfamiliar people or scrutiny by others.\\nWomen are more likely to be affected by phobia than men.\\n\\uf0b7\\nExamples of specific phobias are agoraphobia (fear of open spaces), claustrophobia\\n(fear of closed spaces), acrophobia (fear of heights), etc.\\n\\uf0b7\\nExposure to phobic stimulus provokes immediate anxiety sometimes leading to panic\\nattack. The patient is aware of the irrational nature of fears and avoids the anxiety\\nprovoking stimulus.\\n\\uf0b7\\nCauses marked distress in interpersonal, occupational and social areas of life.\\n\\uf0b7\\nPatient must continue all his regular activities as far as possible.\\n\\uf0b7\\nYoga, meditation, physical exercises are useful measures along with drug therapy.\\nPHOBIC DISORDERS\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 303, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nYoga, meditation, physical exercises are useful measures along with drug therapy.\\nPHOBIC DISORDERS\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nSystematic desensitization is the most commonly used behavioral technique which\\nexposes patient to fearful stimulus in a serially graded manner. Imagined or actual\\nexposure to the phobic stimulus is given as long as the patient can tolerate.\\n\\uf0b7\\nInsight orientated psycho therapy aims at enabling patients to understand the origin of\\nphobia, secondary gains and role of resistance and helps them to seek healthy ways of\\ncoping with phobic stimuli.\\n\\uf0b7\\nHypnosis, supportive therapy and family therapy are useful in treatment of phobias.\\nPharmacological treatment\\nFollowing agents are used most commonly in treating phobias.\\n\\uf0b7\\nSSRIs (e.g. Tab. paroxetine 12.5 -50 mg / day in divided doses)\\n\\uf0b7\\nBenzodiazepines as mentioned above\\nPatient education\\nWith regular treatment, most patients show improvement but treatment needs to be continued'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 303, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nBenzodiazepines as mentioned above\\nPatient education\\nWith regular treatment, most patients show improvement but treatment needs to be continued\\nfor a long time, particularly in childhood onset phobias.\\nPOST-TRAUMATIC STRESS DISORDER (PTSD)\\nExposure to a traumatic event consisting of either a direct personal experience or witnessing\\nan event involving threat of death, serious injury or serious harm can lead to post traumatic\\nstress disorder (PTSD) in 1.3 to 8% of victims.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 304, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n297\\nCommon examples of such traumatic events are physical or sexual abuse, domestic/community\\nviolence, kidnapping, terrorist attacks, accidents or disasters like floods, hurricanes, etc. It is\\ncharacterized by a set of symptoms (for more than 1 month) such as:\\n\\uf0b7\\nRe-experiencing – distressing recollections, flashbacks, imageries of the traumatic event\\n\\uf0b7\\nPersistent avoidance – conscious effort to avoid places, situations, or events that will remind\\nthe person of the traumatic event\\n\\uf0b7\\nHyperarousal – vivid dreams, night terrors, startling responses to even minor stimuli leading\\nto palpitations, sweating, tremors and other anxiety features\\n\\uf0b7\\nSense of detachment from usual social groups and situations, i.e. (emotional numbing is\\nseen)\\n\\uf0b7\\nSleep disturbance, checking for safety and exaggerated startled reactions are also present.\\nIf these symptoms are present for less than 4 weeks it is called Acute Stress Disorder.\\nSalient features\\nNon -pharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 304, 'source_type': 'Authorotative', 'priority': '1'}, page_content='If these symptoms are present for less than 4 weeks it is called Acute Stress Disorder.\\nSalient features\\nNon -pharmacological treatment\\nFocused Cognitive Behavior Therapy is aimed at giving psycho education to the patient\\nregarding the nature of typical emotional and physiological reactions to traumatic events and\\nPTSD. It also includes teaching techniques of muscle relaxation, focused breathing, affective\\nmodulation, thought stopping and cognitive coping techniques to deal with the stress.\\n\\uf0b7\\nGradual exposure: The reminders of traumatic events are gradually introduced.\\n\\uf0b7\\nCrisis Intervention/Psychological Debriefing: It consists of encouraging the patient to\\ndescribe the traumatic event in a supportive environment.\\nIf the symptoms persist for more than a year, they do not improve after many years in one\\nthird of patients; so early intervention and treatment is useful.\\nPharmacological treatment\\n\\uf0b7\\nSSRIs are the agents of choice for treating PTSD, the doses are same as in depression.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 304, 'source_type': 'Authorotative', 'priority': '1'}, page_content='third of patients; so early intervention and treatment is useful.\\nPharmacological treatment\\n\\uf0b7\\nSSRIs are the agents of choice for treating PTSD, the doses are same as in depression.\\nPropranolol has been used to treat PTSD symptomatically.\\nCONVERSION DISORDER\\nIt is a type of somatoform disorder characterized by symptoms or deficits affecting voluntary\\nmotor or sensory functions that is judged to be caused by psychological factors. Illness is\\npreceded by conflicts or stressful situations. It is twice more common in women than men\\nand is more commonly seen in lower socio economic strata of the society.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 305, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n298\\n\\uf0b7\\nParalysis, blindness and mutism are most common symptoms.\\n\\uf0b7\\nParasthesias (altered sensations) and anaesthesias (loss of sensations) especially of the\\nextremities are also seen.\\n\\uf0b7\\nAbnormal movements, gate disturbance, weakness and paralysis are possible motor\\nsymptoms.\\n\\uf0b7\\nDiagnosis is based on history and mental status examination. However conversion\\nepisodes should be differentiated from seizures. Seizures are characterized by\\nrepetitive, involuntary jerky movements or episodes of unresponsiveness associated\\nwith tongue bite, frothing, injuries, fecal or urinary incontinence and amnesia (memory\\nloss) during episodes. Seizures can also occur during sleep and when patient is alone.\\nAbsence of the above features is suggestive of conversion disorder. EEG and other\\ninvestigations can be used to rule out organic cause.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nSpontaneous resolution of symptoms occurs but insight orientated, supportive or'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 305, 'source_type': 'Authorotative', 'priority': '1'}, page_content='investigations can be used to rule out organic cause.\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nSpontaneous resolution of symptoms occurs but insight orientated, supportive or\\nbehavioral therapies can facilitate the same.\\n\\uf0b7\\nHypnosis, psychodynamic and psychoanalytical approaches can also be useful.\\n\\uf0b7\\nBenzodiazepines are used as an adjuvant therapy.\\n\\uf0b7\\nSSRIs can be used if co morbid depression is present.\\nDISSOCIATIVE DISORDERS\\nDissociative disorders are characterized by disruption of integrated functions of\\nconsciousness like memory, identity and perception of environment which can be dissociative\\namnesia, dissociative fugue or dissociative identity disorder\\nDissociative amnesia\\n\\uf0b7\\nCharacterized by disturbances in the ability to recall important personal information,\\nusually traumatic in nature.\\n\\uf0b7\\nThe memory loss is too extensive to be explained by simple forgetfulness. The\\ndisturbances cause socio occupational impairment.\\nDissociative fugue\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 305, 'source_type': 'Authorotative', 'priority': '1'}, page_content='usually traumatic in nature.\\n\\uf0b7\\nThe memory loss is too extensive to be explained by simple forgetfulness. The\\ndisturbances cause socio occupational impairment.\\nDissociative fugue\\n\\uf0b7\\nThe disturbance is characterized by sudden, unexpected travel away from home or\\ncustomary places of work etc with inability to recall the past events along with partial or\\ncomplete assumption of new identity. It causes significant socio occupational impairment.\\nDissociative identity disorder\\n\\uf0b7\\nPresence of two or more personality or identities each with its own pattern of reacting to\\nthe environment.\\n\\uf0b7\\nThese personalities take control of person’s behavior and often are accompanied by\\ninability to recall personal information.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 306, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n299\\n\\uf0b7\\nDependence is characterized by compulsion to drink, tolerance, intoxication,\\nwithdrawal and persistence of drinking inspite of overtly harmful consequences.\\n\\uf0b7\\nAlcohol intoxication is characterized by recent intake of alcohol and behavioral changes\\nlike slurred speech, unsteady gait, incoordination, nystagmus, impairment in attention\\nand memory, etc. In extreme cases it can lead to stupor and coma.\\n\\uf0b7\\nSimple alcohol withdrawal is characterized by abrupt cessation of heavy intake of\\nalcohol and development of symptoms like sweating, palpitations, tremors, nausea,\\nvomiting, insomnia, transient visual/tactile/auditory hallucinations and psychomotor\\nagitation.\\n\\uf0b7\\nWithdrawal may be complicated in the form of seizures, delirium tremens, etc.\\nTreatment\\n\\uf0b7\\nPsychotherapeutic \\ninterventions \\nlike \\npsychoanalytic \\npsychotherapy,\\ncognitive\\npsychotherapy, behavioral therapy and hypnotherapy are the mainstay of treatment.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 306, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\n\\uf0b7\\nPsychotherapeutic \\ninterventions \\nlike \\npsychoanalytic \\npsychotherapy,\\ncognitive\\npsychotherapy, behavioral therapy and hypnotherapy are the mainstay of treatment.\\n\\uf0b7\\nPharmacological treatment-antidepressants and antipsychotics have been used with\\nlimited benefits.\\nALCOHOL USE DISORDER\\nAlcohol use disorder is a common lethal condition that often masquerades as other\\npsychiatric syndromes. At any time, one of three men are drinkers, with a ratio of persisting\\nalcohol intake of approximately 1.3 men to 1.0 women.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nMotivation enhancing, individual, group and family therapy\\nPharmacological treatment\\n\\uf0b7\\nHospitalization is advised to most patients for smooth detoxification and to avoid or\\nmanage withdrawal complications including seizures and delirium tremens as well as\\nmedical co-morbidities.\\n\\uf0b7\\nTab. chlordiazepoxide start from 25mg TDS and may be increased upto 100 mg/day, used\\nonly if liver function tests are normal or\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 306, 'source_type': 'Authorotative', 'priority': '1'}, page_content='medical co-morbidities.\\n\\uf0b7\\nTab. chlordiazepoxide start from 25mg TDS and may be increased upto 100 mg/day, used\\nonly if liver function tests are normal or\\n\\uf0b7\\nTab. lorazepam starting from 2 mg TDS increased upto 8 mg is used, preferred when liver\\nfunctions are compromised or not known.\\n\\uf0b7\\nTab. thiamine supplementation to prevent and treat vitamin deficiency (start from 75 mg\\nBD and can be increased upto 300 mg/day)\\n\\uf0b7\\nInjectable vitamins can be used when signs of severe vitamin deficiency are present.\\n\\uf0b7\\nOnce the patient is stable, the dose should be gradually tapered off (20% per day) over a\\nperiod of 10 to 14 days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 307, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n300\\n\\uf0b7\\nFluid and electrolyte disturbance should be corrected especially if there is vomiting or\\nfever.\\n\\uf0b7\\nSeizures – Rum fits (appearing within 24 hours of abstinence) can be treated with Inj.\\ndiazepam 10 mg or lorazepam 2 mg IV stat especially when seizures are repeated.\\nProphylactic treatment is not recommended for true alcohol withdrawal fits.\\n\\uf0b7\\nDelirium tremens – The patient should be preferably treated in an intensive care unit.\\n\\uf0b7\\nAn intravenous line should be started immediately and thiamine 100 mg IV should be\\nadministered. Thiamine along with multivitamin should be continued parenterally till\\nnormal diet is resumed.\\n\\uf0b7\\nIV dextrose and saline should be given at a rate adequate to replace fluid losses and\\nmaintain blood pressure.\\n\\uf0b7\\nHyperthermia should be managed with cold sponge. Tab. paracetamol 500 mg orally 4\\ntimes a day may be used in absence of any hepatic dysfunction.\\n\\uf0b7\\nInj. diazepam 10 mg should be given slowly IV and should be repeated every 15-20'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 307, 'source_type': 'Authorotative', 'priority': '1'}, page_content='times a day may be used in absence of any hepatic dysfunction.\\n\\uf0b7\\nInj. diazepam 10 mg should be given slowly IV and should be repeated every 15-20\\nminutes till sedation is achieved.\\n\\uf0b7\\nPhysical restraint may be necessary if the patient is combative.\\n\\uf0b7\\nAssociated medical and surgical problems should be simultaneously investigated and\\ntreated appropriately.\\n\\uf0b7\\nTab. disulfiram (250mg to 500mg daily) is used for relapse prevention. Informed consent\\nfor treatment with disulfiram is mandatory before administering it.\\n\\uf0b7\\nInformation about the disulfiram reaction and the potential lethality of the same is\\nexplained.\\nPatient education\\nEducation regarding short-term and long term complications (medical, psychological, social,\\nlegal,etc.) of substance use.\\nOPIOID USE DISORDERS\\nOpioid use disorders consist of physiological, behavioral, cognitive symptoms which indicate\\nrepeated continued use of opioid drugs despite the problems related to it.\\nSalient features\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 307, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Opioid use disorders consist of physiological, behavioral, cognitive symptoms which indicate\\nrepeated continued use of opioid drugs despite the problems related to it.\\nSalient features\\n\\uf0b7\\nOpioid intoxication is characterized by recent opioid intake and development of symptoms as\\ninitial euphoria, later dysphoria, apathy, psychomotor agitation or retardation, impaired\\njudgement, pupillary constrictions with drowsiness, slurred speech, impairment in attention\\nand memory.\\n\\uf0b7\\nThere usually is impaired social or occupational functioning.\\n\\uf0b7\\nOpioid withdrawal is characterized by cessation of heavy prolonged use of opioid and\\ndevelopment of symptoms as dysphoric mood, lacrimation, nausea vomiting, muscle aches,\\ndiarrhoea, yawning, fever, insomnia, pupillary dilatation, piloerection, sweating.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 308, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n301\\nIt is characterized with repetitive and compulsive consumption of ganja, charas, etc.\\n\\uf0b7\\nRecent intake of cannabis followed by development of symptoms as impaired motor co\\nordination, euphoria, anxiety, slowed perception of time, impaired judgement, social\\nwithdrawal, conjunctival congestion, increased appetite, dry mouth, tachycardia etc.\\n\\uf0b7\\nChronic dependence can lead to apathy.\\n\\uf0b7\\nMild cannabis withdrawal is characterized by restlessness, craving for cannabis and\\ndysphoria. Only symptomatic treatment is given for cannabis withdrawal.\\nNon- pharmacological treatment\\n\\uf0b7\\nIndividual counseling, family support and encouraging the patient to join the self help\\ngroups are also important to help him maintain long-term abstinence.\\n\\uf0b7\\nHowever opiate dependence is a highly relapsing disorder, and prolonged inpatient stay in\\nsettings that also provide rehabilitative inputs is usually beneficial.\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 308, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nHowever opiate dependence is a highly relapsing disorder, and prolonged inpatient stay in\\nsettings that also provide rehabilitative inputs is usually beneficial.\\nPharmacological treatment\\n\\uf0b7\\nTab. paracetamol 500 mg and dextropropoxyphen 32.5 mg - start from BD dosage and\\ngradually increase to 2 tablets TDS.\\n\\uf0b7\\nTab. buprenorphine 2 mg and naloxone 0.5 mg – start from 1 tablet BD to maximum of\\nTDS or QID dosages depending on the severity of withdrawal symptoms.\\n\\uf0b7\\nTab. clonidine 50 mcg BD is given for symptomatic management of withdrawal. Careful\\nmonitoring of BP is needed.\\n\\uf0b7\\nNSAIDs are given for muscular pains.\\nLong term (to be treated by a psychiatrist)\\n\\uf0b7\\nTab. naltrexone 50 mg/day orally is used to reduce craving and thereby to help patient\\nmaintain long-term abstinence (who have remained opioid free for at least 7-10 days).\\n\\uf0b7\\nBaseline hepatic functions should be assessed, and to be monitored once a month while\\non naltrexone treatment.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 308, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nBaseline hepatic functions should be assessed, and to be monitored once a month while\\non naltrexone treatment.\\n\\uf0b7\\nThe drug is usually continued for a period of 6 months, however, it may have to be\\nwithdrawn in presence of significant liver disease (i.e. several fold increase in the serum\\nlevels of transaminases).\\nPatient education\\nPatient should be told about nature of illness, course and treatment modalities available\\nthrough individual sessions.\\nCANNABIS USE DISORDERS\\nSalient features\\nPharmacological treatment\\nSymptomatic treatment for nausea, insomnia and anxiety may be given\\nNon- pharmacological treatment\\nMotivation enhancing counseling, individual, family & group counseling'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 309, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n302\\n\\uf0b7\\nBehavioral characteristics include lower intelligence, lack of social smile, poor eye\\ncontact, low level of attachment to caregivers and extreme anxiety when their routine\\nis disturbed.\\n\\uf0b7\\nThere is a notable deficit in interactions with peer group, delay in development of\\nspoken language, repetitive movements like hand or finger flapping, rocking body\\nmovements and head banging.\\n\\uf0b7\\nDiagnosis is based on delayed history and clinical mental status examination (MSE).\\nAUTISTIC DISORDER\\nIt is characterized by qualitative impairment in social interactions, impairment in\\ncommunications and restricted, repetitive and stereotypical patterns of behavior. Its\\nprevalence is 0.08% and is 4 - 5 times more common in boys than girls.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nEducational and behavioral interventions are the treatment of choice.\\n\\uf0b7\\nStructured classroom training in combination with behavioral methods is the most'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 309, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Non- pharmacological treatment\\n\\uf0b7\\nEducational and behavioral interventions are the treatment of choice.\\n\\uf0b7\\nStructured classroom training in combination with behavioral methods is the most\\neffective treatment for many autistic children.\\n\\uf0b7\\nBehavioral therapies to reinforce socially acceptable behaviors and encourage self care\\nskills.\\n\\uf0b7\\nTraining of parents with regards to the concepts and skills of behavioral modification has\\nproved beneficial.\\n\\uf0b7\\nLanguage development is added to facilitate communication.\\nPharmacological treatment\\n\\uf0b7\\nNo medication has proven its efficacy in treatment of core symptoms of autism but\\nsymptomatic treatment for hyperactivity, obsessions, compulsions, aggression and self\\ninjurious behavior can be given by using escitalopram, methylphenidate, haloperidol,\\nrisperidone, olanzapine, quetiapine. Lithium can be used in self injurious behaviors.\\n\\uf0b7\\nGuidelines for Tab. risperidone prescribing with autism spectrum disorders in children\\nand adolescents are as follows:\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 309, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nGuidelines for Tab. risperidone prescribing with autism spectrum disorders in children\\nand adolescents are as follows:\\n-\\nInitiating dose at 0.25 mg per day for patients less than 20 kg and 0.5 mg per day for\\npatients weighing 20 kg or more.\\n-\\nOn day 4, the dose may be increased by 0.25 mg for patients being less than 20 kg or\\nmore and by 0.5 mg for patients above 20 kg.\\n-\\nAssess the response after 2 weeks.\\nATTENTION DEFICIT HYPERACTIVITY DISORDER\\nIt is characterized by a pattern of diminished sustained attention and higher levels of\\nimpulsivity in a child or adolescent than expected for someone of that age and developmental\\nlevel. Age of onset is before 7 years. Incidence of ADHD is 2 to 20%. It is 2-9 times more\\ncommon in boys.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 310, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n303\\n\\uf0b7\\nCommon symptoms include careless mistakes in school work, lack of concentration,\\ninability to follow simple instructions, difficulty in organizing tasks and activities, easily\\ndistractible by external stimulus.\\n\\uf0b7\\nHyperactivity is seen as fidgety hands or feet, frequently leaving seat in classroom, running\\nor climbing excessively in inappropriate situations, talking excessively and blurts out before\\nquestions are completed\\n\\uf0b7\\nDiagnosis is based on through case history and Mental Status Examination (MSE).\\nSalient features\\nNon- pharmacological treatment\\nSocial skills training, behavioral therapy and group therapy for patient and families are\\nconsidered beneficial.\\nPharmacological treatment\\n\\uf0b7\\nDrug of choice is Tab. methylphenidate 5-20mg.\\n\\uf0b7\\nOther agents are atomoxetine, bupropion, venlafaxine, clonidine, guanfacine.\\nMENTAL RETARDATION\\nIt is characterized by deficits in cognitive abilities and in behaviors required for social and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 310, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nOther agents are atomoxetine, bupropion, venlafaxine, clonidine, guanfacine.\\nMENTAL RETARDATION\\nIt is characterized by deficits in cognitive abilities and in behaviors required for social and\\npersonal sufficiency also known as adaptive functioning. An assessment of social adaptation\\nas well as Intelligence Quotient (IQ) is necessary to determine the level of mental retardation.\\nPoint prevalence of mental retardation is 1-3% of population. It is 1.5 times more common\\namong men than among women.\\nClassification of mentally retardation\\nAccording to the degrees of severity, mental retardation has been classified into four groups:\\n\\uf0b7\\nMild Mental Retardation – (IQ Range 50 – 70)\\nThese people can live independently with adequate support and raise their own families.\\nThey can obtain academic skills approximately upto sixth grade.\\n\\uf0b7\\nModerate Mental Retardation – (IQ Range 35 – 50)\\nThese people can acquire language and can communicate adequately during early\\nchildhood.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 310, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nModerate Mental Retardation – (IQ Range 35 – 50)\\nThese people can acquire language and can communicate adequately during early\\nchildhood.\\nThey are academically challenged and are unable to go beyond second to third academic\\nlevel.\\nAs adults they are able to perform semi-skilled work under appropriate supervision.\\n\\uf0b7\\nSevere Mental Retardation (IQ Range 20 – 35)\\nThese people may fail to develop communication skills in childhood but can learn to\\ncount and recognize words critical to functioning. In adulthood, they may adapt well to\\nsupervise living situations and may be able to perform work related tasks under\\nsupervision.\\n\\uf0b7\\nProfound Mental Retardation (IQ Range Below 20)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 311, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n304\\nThey can be taught some self-care skills and can learn to communicate their needs if they\\nare given appropriate training.\\nInvestigations\\n\\uf0b7\\nDetailed history, standardized intellectual assessment and assessment of adaptive\\nfunctions in needed for diagnosing mental retardation.\\n\\uf0b7\\nExamination of physical signs and neurological abnormalities is always necessary to\\nsearch for organic causes of MR.\\n\\uf0b7\\nLaboratory tests – tests like chromosomal analysis, urine and blood testing for metabolic\\ndisorder and neuroimaging are done for ascertaining the cause.\\nNon- pharmacological treatment\\nNo treatment measures are available except for those to control behavioural symptoms.\\nPreventive measures form an important strategy.\\n\\uf0b7\\nPrimary prevention\\nIt is aimed at implementing measures such as to increase the knowledge and awareness\\nabout MR, to ensure and upgrade public health policies and laws to provide optimal'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 311, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPrimary prevention\\nIt is aimed at implementing measures such as to increase the knowledge and awareness\\nabout MR, to ensure and upgrade public health policies and laws to provide optimal\\nhealth care to mother and child, to eradicate known disorders associated with CNS\\ndamage, etc.\\n\\uf0b7\\nSecondary and tertiary prevention\\n-\\nIt is aimed at treating the associated disorder if any to shorten the course of illness\\n(secondary prevention) and to minimize the sequelae or consequent disabilities\\n(tertiary prevention).\\n-\\nSpecialized educational programmes addressing the training & adaptive skills, social\\nskills and vocation should be developed to improve quality of life.\\n-\\nGroup therapy has also been successful.\\n-\\nBehaviour therapy to reinforce desired behaviours and to reduce objectionable\\nbehaviours is considered useful.\\n-\\nCognitive therapies like dispelling false beliefs and relaxation exercises have been\\nrecommended.\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 311, 'source_type': 'Authorotative', 'priority': '1'}, page_content='behaviours is considered useful.\\n-\\nCognitive therapies like dispelling false beliefs and relaxation exercises have been\\nrecommended.\\n-\\nPsychodynamic therapy has been used with patients and families to decrease conflicts\\nabout unrealistic expectations.\\n\\uf0b7\\nFamily Education\\nEducating the family and providing them counseling and supportive help is an important\\naspect of management of MR.\\n\\uf0b7\\nSocial Intervention\\nIt is aimed at improving the quantity and quality of social competence of people with MR.\\nPharmacological treatment\\n\\uf0b7\\nMethylphenidate is used successfully for patients of MR with Attention Deficit\\nHyperactivity Disorder.\\n\\uf0b7\\nAntiepileptic agents like sodium valproate and carbamazepine are used for controlling\\naggressive and self-injurious behaviour.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 312, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n305\\n\\uf0b7\\nAntidepressants are used to treat comorbid depression and antipsychotics like haloperidol,\\nchlorpromazine are used for reducing stereotyped movements.\\n\\uf0b7\\nBeta-blockers like propranolol are used to control explosive rages or anger outbursts.\\n\\uf0b7\\nDevelopment of special schools, supportive groups and NGOs form an essential part of\\nsupportive strategies for people with MR.\\nSUICIDAL PATIENT\\nPatients with suicidal ideation need immediate psychiatric intervention. Suicidal ideation can\\noccur in the background of depression, schizophrenia, adjustment disorders and alcohol and\\nother psychoactive substance abuse. About two thirds of all depressed patients contemplate\\nsuicide, and 10 to 15 percent commit suicide.\\nAssessment of suicidal risk can be done with the help of specific questions\\nWhether the patient often feels sad?\\nWhether the patient has lost all hopes in life?\\nThoughts that it is better to be dead than to face the constant miseries of life.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 312, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Whether the patient often feels sad?\\nWhether the patient has lost all hopes in life?\\nThoughts that it is better to be dead than to face the constant miseries of life.\\nThoughts of causing death to self (suicide plans)\\nRisk factors for predicting the risk of suicide\\n\\uf0b7\\nMale sex, age above 45 years in men and above 55 years in women\\n\\uf0b7\\nSuicidal attempt in past\\n\\uf0b7\\nPresence of psychiatric illness especially schizophrenia and depression, substance abuse\\nor dependence\\n\\uf0b7\\nRecent bereavement, social isolation, family history of suicide, unemployment\\n\\uf0b7\\nPhysical illnesses like malignancy, chronic pain, epilepsy, AIDS and recent will.\\nNon pharmacological treatment\\nTreatment is specifically directed at the cause, if identifiable. The patient should be referred\\nto a psychiatrist immediately after ensuring the following steps:\\n\\uf0b7\\nPatient should not be left alone and be kept under constant observation.\\n\\uf0b7\\nFamily should be explained the seriousness of the problem and actively included in\\nmanagement.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 312, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPatient should not be left alone and be kept under constant observation.\\n\\uf0b7\\nFamily should be explained the seriousness of the problem and actively included in\\nmanagement.\\n\\uf0b7\\nPatient should be offered psychological support and reassurance and not criticized.\\n\\uf0b7\\nNo dangerous or potentially dangerous objects such as knife, blade, sharp edged objects,\\nrope, medication supply, etc. should be available in immediate vicinity of the patient.\\n\\uf0b7\\nSpecific treatment for depression, psychotic disorder or whatever may be the cause\\nshould immediately be started.\\nPatient education\\nFamily should be advised to follow a supportive approach towards the patient and should not\\ncriticize. Suicidal attempt is indicative of distress and needs treatment of the causative illness.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 313, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n306\\nPSYCHOTROPIC DRUGS IN SPECIAL POPULATIONS\\nA. Recommendations for use of psychotropic drugs in renal impairment\\nDrug groups\\nRecommended drugs\\nAntipsychotics\\nHaloperidol, olanzapine\\nAntidepressants\\nCitalopram, sertraline\\nMood stabilizers\\nValproate, carbamazepine, lamotrigine\\nAnxiolytics and hypnotics\\nLorazepam, zopiclone\\nB. Recommendations for use of psychotropic drugs in hepatic impairment\\nDrug groups\\nRecommended drugs\\nAntipsychotics\\nHaloperidol, sulpiride/amisulpiride\\nAntidepressants\\nImipramine, paroxetine, citalopram\\nMood stabilizers\\nLithium\\nAnxiolytics and hypnotics\\nLorazepam, oxazepam, temazepam, zopiclone\\nC. Recommendations for use of psychotropic drugs in pregnancy\\nDrug groups\\nRecommended drugs\\nAntipsychotics\\nChlorpromazine, haloperidol, trifluperazine\\nAntidepressants\\nNortriptyline, amitriptyline, fluoxetine\\nMood stabilizers\\nConsider using anti-psychotics\\nAnxiolytics and hypnotics\\nNon pharmacological measures preferred'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 313, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Antidepressants\\nNortriptyline, amitriptyline, fluoxetine\\nMood stabilizers\\nConsider using anti-psychotics\\nAnxiolytics and hypnotics\\nNon pharmacological measures preferred\\nD. Recommendations for use of psychotropic drugs during breast feeding\\nDrug groups\\nRecommended drugs\\nAntipsychotics\\nSulpiride, olanzapine\\nAntidepressants\\nSertraline, paroxetine, imipramine, nortriptyline\\nMood stabilizers\\nConsider using anti-psychotics\\nAnxiolytics and hypnotics\\nLorazepam, zolpidem'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 314, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Psychiatry Disorders\\n307\\nMANAGEMENT OF WANDERING MENTALLY ILL PATIENT OR A MENTALLY\\nILL PATIENT WITH NO FAMILY MEMBER OR ATTENDANT\\n\\uf0b7\\nMental Health Act, 1987 has provision for hospitalization of the mentally ill patients in\\nmental hospital.\\n\\uf0b7\\nIf one happens to come across a psychiatric patient wandering aimlessly or indulging in\\nsocially disorganized behavior in a public place, one can approach the local police station.\\n\\uf0b7\\nThe in charge of the local police station under whose jurisdiction the place lies, has a duty\\nunder the Act to take the patient to the concerned Metropolitan Magistrate (in\\nmetropolitan cities) or the Sub-Divisional Judicial Magistrate or Chief Judicial Magistrate\\nor any Magistrate of first class (in other cities). The Magistrate can issue a reception order\\nfor admission of the patient to a mental hospital after getting him examined by a medical\\nofficer.\\n\\uf0b7\\nAdmission to mental hospital can also be made on the request of the patient, if the patient'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 314, 'source_type': 'Authorotative', 'priority': '1'}, page_content='for admission of the patient to a mental hospital after getting him examined by a medical\\nofficer.\\n\\uf0b7\\nAdmission to mental hospital can also be made on the request of the patient, if the patient\\nis willing to consent (voluntary admission) or on the request of family members, if they\\nso desire (admission under special circumstances).\\nPERSONALITY DISORDERS\\nA pervasive and enduring pattern of behavior, which begins in early adulthood and which\\ngives colour to person’s attitude behavior is known as personality. Behavioral patterns that\\ndeviate from person’s sociocultural background are known as personality disorders.\\nClusters of personality disorders\\n\\uf0b7\\nCluster A - schizoid, schizotypal, paranoid\\n\\uf0b7\\nCluster B - borderline, histrionic, narcissistic, antisocial\\n\\uf0b7\\nCluster C - avoidant dependent personality, obsessive compulsive personality disorders.\\nTreatment of personality disorders is difficult. Psychotherapies and pharmacological'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 314, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nCluster C - avoidant dependent personality, obsessive compulsive personality disorders.\\nTreatment of personality disorders is difficult. Psychotherapies and pharmacological\\ntreatment for symptomatic management can be used with restricted benefits.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 315, 'source_type': 'Authorotative', 'priority': '1'}, page_content='308\\nChapter 15\\nORTHOPEDIC CONDITIONS\\nOSTEOARTHRITIS\\nOsteoarthritis (OA) of the knee is an end result of the degeneration of articular cartilage.\\nSalient features\\n.\\nNon-pharmacological treatment\\n\\uf0b7\\nWeight reduction (if overweight); cold fomentation for acutely swollen knee, however,\\nhot fomentation may give symptomatic relief to some chronic patients.\\n\\uf0b7\\nSupervised non-traumatic muscle conditioning and rehabilitation regimens e.g. isometric\\nquadriceps strengthening exercise (all vigorous exercises to be avoided in acutely\\nswollen/painful knee).\\n\\uf0b7\\nCompressive bandage or crepe bandage for effusion.\\n\\uf0b7\\nAssistive devices like cane (to be held in the hand contralateral to more painful side),\\nwalker for patients with severe deformities or unsteady gait.\\n\\uf0b7\\nBrace for various instability helps while walking.\\nPharmacological treatment\\n\\uf0b7\\nTopical applications- containing salicylates, capsaicin, nicotinates, menthol, camphor,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 315, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nBrace for various instability helps while walking.\\nPharmacological treatment\\n\\uf0b7\\nTopical applications- containing salicylates, capsaicin, nicotinates, menthol, camphor,\\nNSAlDs in various combinations may provide symptomatic relief. (Caution: Avoid hot\\nfomentation immediately after topical applications). Non-steroidal anti-inflammatory\\ndrugs (NSAIDs) for pharmacological pain palliation. The choice of NSAID depends upon\\ndosing convenience, physician and patients comfort, price and the past experience on its\\nfrequency and severity of side effects as all are equipotent in full therapeutic dose (Avoid\\nintra-articular or oral steroids). Commonly used NSAlDs for OA knee\\ni.\\nAcute painful situation/moderate pain (for initial 7-14 days), preferably take\\nNSAIDs after meals.\\n-\\nTab. paracetamol 500 mg 4-6 hourly (maximum daily dose 4000 mg)\\n-\\nTab. ibuprofen 400 -600 mg 2 or 3 times a day (maximum daily dose 3200 mg)\\n-\\nTab. diclofenac sodium 50 mg 3 times a day or 75 mg 2 times a day (maximum'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 315, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\nTab. ibuprofen 400 -600 mg 2 or 3 times a day (maximum daily dose 3200 mg)\\n-\\nTab. diclofenac sodium 50 mg 3 times a day or 75 mg 2 times a day (maximum\\ndaily dose 200 mg)\\n-\\nTab. aspirin 350 mg 2 tablets 4-6 hourly (maximum daily dose 5000 mg).\\nFor mild to moderate pain/chronic pain control (for 3-6 weeks and then SOS)\\n\\uf0b7\\nPain, stiffness after rest, difficulty in climbing stairs, difficulty in getting up from\\nsquatting position, grating sensations and off and on episodes of flare and swelling.\\n\\uf0b7\\nErythema and palpable warmth are possible but rare. Genu -varum deformity and/or\\nfixed flexion contracture in severe cases.\\n\\uf0b7\\nClassical radiological triad - joint space narrowing, peripheral osteophyte formation\\nand subchondral sclerosis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 316, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orthopedic Conditions\\n309\\n-\\nAll above medicines in reduced frequency of dosages.  Or\\n-\\nTab. diclofenac sodium 100 mg/75 mg sustained release once a day. Or\\n-\\nTab. piroxicam 20 mg once a day.\\n\\uf0b7\\nAll patients do not uniformly respond to a particular NSAID. It is not unusual for several\\ndifferent NSAIDs to be tried before a suitably effective and well-tolerated agent is\\nidentified for a particular patient.\\n\\uf0b7\\nCaution: NSAIDs may cause dose related gastric irritation, nausea, vomiting and\\ndyspepsia; GI ulceration, perforation and haemorrhage and sometime renal toxicity.\\nHowever, one-third remains asymptomatic. NSAIDs can interfere with antihypertensive\\ntherapy due to salt and water retention)\\n\\uf0b7\\nIn case of epigastric burning or nausea or vomiting either discontinue and switch over to\\nsafer NSAID or administer Cap. omeprazole 20 mg half an hour before breakfast, in\\npatients on prolonged therapy with NSAIDs monitor haemoglobin, stool for occult blood'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 316, 'source_type': 'Authorotative', 'priority': '1'}, page_content='safer NSAID or administer Cap. omeprazole 20 mg half an hour before breakfast, in\\npatients on prolonged therapy with NSAIDs monitor haemoglobin, stool for occult blood\\nas these drugs may also cause leucopenia, thrombocytopenia and agranulocytosis.\\n\\uf0b7\\nRefer the patient to an orthopaedic surgeon in case of persistent swelling, presence of\\nconstitutional symptoms or mechanical symptoms like locking or frequent giving away\\nsensations. Surgical intervention may be required for severe deformities, contractures and\\nadvanced disease with intractable pain, severe enough to affect independent performance\\nof activities of daily living, for prolonged periods.\\nPatient education\\n\\uf0b7\\nThere is no curative pharmacological agent for osteoarthritis knee and the disease is\\nirreversible. Non-pharmacological treatment has a major role to play in treatment\\n\\uf0b7\\nTake minimal possible medication that provide symptomatic relief and to wait for 1-2'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 316, 'source_type': 'Authorotative', 'priority': '1'}, page_content='irreversible. Non-pharmacological treatment has a major role to play in treatment\\n\\uf0b7\\nTake minimal possible medication that provide symptomatic relief and to wait for 1-2\\nweeks for drug to show its effect.Topical applications do not penetrate into the joint\\nthrough skin directly.\\n\\uf0b7\\nIntra-articular steroid injections give only temporary relief and risks of repeated intra-\\narticular injections far outweigh its advantages.\\n\\uf0b7\\nTo avoid activities which exacerbate pain like sitting cross legged or squatting on floor.\\n\\uf0b7\\nTo use ramp instead of stairs wherever feasible.Not to do vigorous exercises with acutely\\ninflamed knee.\\n\\uf0b7\\nTo report back if recurrent effusions in knee or systemic symptoms. Former may be\\ncaused by mechanical disorder along with OA knee like loose body or meniscal tear.\\nLater situation could be caused by diseases of knee other than OA\\nReferences\\n1.\\nAcetabular Bone Destruction Related to Non Steroidal Anti-inflammatory Drugs. Lancet 1985; 2:11-14.\\n2.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 316, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Later situation could be caused by diseases of knee other than OA\\nReferences\\n1.\\nAcetabular Bone Destruction Related to Non Steroidal Anti-inflammatory Drugs. Lancet 1985; 2:11-14.\\n2.\\nOsteoarthritis. In: Harrison's Principles of Internal Medicine. Rasper DL, Braunwald E, Fauci AS et al\\n(eds), 16th Edition, 2005, McGraw Hill Company Inc., New York, pp 2036-2047.\\n3.\\nOsteoarthritis. In: Conn's Current Therapy, Robert E Rakel (ed), 1999, WB Saunders Company,\\nPhiledelphia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 317, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orthopedic Conditions\\n310\\n\\uf0b7\\nThe revised criterion of American College of Rheumatology (1987) aids in diagnosis and\\nclassification. Suspect rheumatoid arthritis if:\\n> 3 swollen joints\\n>30 minutes of morning stiffness and involvement of metacarpophalangeal or\\nmetatarsophalangeal joints, symmetric arthritis, rheumatoid nodule\\nRHEUMATOID ARTHRITIS\\nRheumatoid arthritis (RA) is characterized by persistent inflammatory synovitis (usually\\ninvolving small and large peripheral joints in symmetrical fashion) causing cartilage\\ndestruction and bone erosion leading to changes in joint integrity.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nSince the etiology of RA is unknown, therapy remains empirical and palliative, aimed at\\nrelieving the signs and symptoms of the disease.\\n\\uf0b7\\nIn acute pain rest and splint. Otherwise exercises directed at maintaining muscle strength\\nand joint mobility without exacerbating joint inflammation. A variety of orthotic (splints)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 317, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIn acute pain rest and splint. Otherwise exercises directed at maintaining muscle strength\\nand joint mobility without exacerbating joint inflammation. A variety of orthotic (splints)\\nand assistive devices (cane, walker) can be helpful in supporting and aligning deformed\\njoints to reduce pain and improve function.\\nPharmacological treatment\\n\\uf0b7\\nIn acute inflammation any of the NSAIDs as given in section on osteoarthritis may be\\ngiven except paracetamol. The anti-inflammatory action of the NSAIDs may take 2-4\\nweeks to become evident. Evaluation of persistent polyarthritis.\\n\\uf0b7\\nReduced NSAID dosages have to be used in the elderly and in patients with impaired\\nrenal function. Concomitant use of more than one NSAID only increases toxicity, and has\\nno additional benefit. Patient not responding to one NSAID may still show a good\\nresponse to another.\\n\\uf0b7\\nTopical applications- containing salicylates, capsaicin, nicotinates, menthol, camphor and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 317, 'source_type': 'Authorotative', 'priority': '1'}, page_content='no additional benefit. Patient not responding to one NSAID may still show a good\\nresponse to another.\\n\\uf0b7\\nTopical applications- containing salicylates, capsaicin, nicotinates, menthol, camphor and\\nNSAIDs in various combinations may provide symptomatic relief.\\n\\uf0b7\\nRefer to a specialist (physician) at a higher centre. Begin disease modifying antirheumatic\\ndrugs (DMARD) early in the disease. Prediction of response to a particular DMARD is\\nnot possible. It takes 4-6 weeks to show its effect.\\n\\uf0b7\\nTab. methotrexate 7.5 mg to 15 mg every week. Concomitant Tab. folic acid 1\\nmg/day reduces side effects.\\nCaution: Nausea, mouth sores, liver damage, increases in incidence of chest infection,\\nmacrocytic anaemia. Regular monitoring of LFT is required. Avoid alcohol during\\ntherapy\\n\\uf0b7\\nFor patients with severe disease, affecting activities of daily living and\\nnot responding to adequate trial of NSAIDs and DMARD for sufficient\\nduration consider following treatment,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 318, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orthopedic Conditions\\n311\\n\\uf0b7\\nTab. prednisolone 40-60 mg/day for 2-4 weeks. Review periodically and possibly taper\\ndown slowly. If required for a longer duration administer at doses of 5-10 mg/day\\n\\uf0b7\\nIntra-articular corticosteroids: methylprednisolone acetate, 20-80 mg may be needed in\\nselected cases with predominantly monoarticular arthritis of a large joint.\\n\\uf0b7\\nRefer the patient to a higher centre if no response to medical therapy after\\n4-8 \\nweeks, \\nsevere \\nextra-articular \\nsymptoms, \\ndeformities \\nor \\ncontractures\\npresent, patient is crippled/or not able to carry out activities of daily living\\ndespite adequate medical treatment.\\nSurgical treatment\\nSynovectomy in patients with predominantly monoarticular involvement, not responding to\\nconservative therapy, might be helpful. Reconstructive surgery is indicated for disorganized\\njoints.\\nPatient education\\n\\uf0b7\\nThe disease can be controlled but no curative agent is known. There can be remissions\\nand exacerbations.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 318, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"joints.\\nPatient education\\n\\uf0b7\\nThe disease can be controlled but no curative agent is known. There can be remissions\\nand exacerbations.\\n\\uf0b7\\nAt the onset of disease it is difficult to predict the natural history of an individual patient's\\nillness. No characteristic features of patients have emerged that predict responsiveness to\\na particular DMARD.\\n\\uf0b7\\nLife style modification may be required depending on the degree of disability.\\n\\uf0b7\\nRegular mild exercises as prescribed by the doctor helps in prevention of deformity\\nmaintain range of motion of the joints and muscle strength.\\n\\uf0b7\\nMagic drug for rheumatic arthritis might contain steroids. Better to consult a qualified\\ndoctor before taking it.\\nReferences\\n1. Rheumatoid Arthritis. In: Harrison's Principles of Internal Medicine. Kasper DL, Braunwald E, Fauci AS et al\\n(eds), 16th Edition, 2005, McGraw Hill Company Inc., New York, pp 1968-1977\\n2. Rheumatoid Arthritis. In: Conn's Current Therapy. Robert E. Rakel (ed), 1999, WB Saunders Company,\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 318, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"(eds), 16th Edition, 2005, McGraw Hill Company Inc., New York, pp 1968-1977\\n2. Rheumatoid Arthritis. In: Conn's Current Therapy. Robert E. Rakel (ed), 1999, WB Saunders Company,\\nPhiladelphia.\\nCERVICAL AND LUMBAR SPONDYLOSIS\\nIt is a clinical syndrome resulting from degeneration of intervertebral discs and facet joints.\\nSalient features\\n\\uf0b7\\nPain and stiffness with decreased range of movement of gradual onset. Occasional acute\\nflare ups of pain with muscle spasm. Neck pain may radiate to occiput, scapular area and\\ndown to one or both arms (may be associated with paraesthesias).\\n\\uf0b7\\nBack pain is usually diffuse and may radiate up to knees through back of thighs.\\n\\uf0b7\\nRadiological narrowing of one or more intervertebral spaces, spur formation (osteophytes)\\nand subchondral sclerosis are the hallmark.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 319, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orthopedic Conditions\\n312\\nNon- pharmacological treatment\\n\\uf0b7\\nIn acute painful situation rest, moist heat in cold weather and light massage (improves\\ntone, circulation and elasticity) to paraspinal muscles. Cervical traction in the position of\\nmaximum comfort to neck (5-10 pounds) for 10-15 minutes. Ultrasonic exposure on\\npainful trigger points in cervical and shoulder muscles. Inter ferential therapy (IFT) for\\nacute neck and back pain. Removable soft cervical collar/back corset/ back belt for\\nsymptomatic relief.\\n(Caution: No exercises in acute painful situation).\\n\\uf0b7\\nIn chronic pain mobilization and strengthening exercises, moist heat and cervical traction.\\nPharmacological treatment\\nSame as described for osteoarthritis of knee.\\nPatient education\\n\\uf0b7\\nIn cervical spondylosis avoid prolonged desk work, if must, then intermittent rest is\\nrequired and proper writing, typing, sitting posture (avoid low table, use tilt table) and\\ncare of the neck.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 319, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nIn cervical spondylosis avoid prolonged desk work, if must, then intermittent rest is\\nrequired and proper writing, typing, sitting posture (avoid low table, use tilt table) and\\ncare of the neck.\\n\\uf0b7\\nIn lumbar spondylosis explain the patient how to manage weight since extra weight puts\\ngreater stress on the back muscles and to maintain proper body alignment while standing\\nwith feet slightly apart. When standing for long periods, use a small stool to keep one foot\\nup with knee bent. Do not tense up or concentrate on standing up straight, just stand\\nnaturally. Try to avoid carrying heavy bags on shoulders.\\n\\uf0b7\\nCare of back while sitting by using well designed fully adjustable chair to provide plenty\\nof support to the lower back. If chair is uncomfortable use a rolled up towel or small\\npillow to support the back. When sitting for long periods rest your feet on low stool and\\nuse arm rests to support weight of your body. Try not to sit in the same position for long'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 319, 'source_type': 'Authorotative', 'priority': '1'}, page_content='pillow to support the back. When sitting for long periods rest your feet on low stool and\\nuse arm rests to support weight of your body. Try not to sit in the same position for long\\nperiods. If prolonged sitting is must take rest for a minute or two every hour.\\n\\uf0b7\\nTo lift weight cautiously by keeping the back as much upright (vertical) and straight (not\\nhunched over) as one can. Not to bend over at waist to pick up the object, instead squat,\\nget under or next to object not on top of it. Lift with your leg muscles rather than back or\\nabdominal muscles. Hold the object close to your body while lifting and carrying and do\\nnot twist your body.\\n\\uf0b7\\nTo sleep safely on a firm bed. While sleeping supine legs should be supported with\\npillows. Not to sleep on your stomach. Sleeping on your side with knees bent and hips\\ntilted forward is probably the best.\\n\\uf0b7\\nRefer to a higher centre in case of severe pain that disturbs sleep/not responding to'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 319, 'source_type': 'Authorotative', 'priority': '1'}, page_content='tilted forward is probably the best.\\n\\uf0b7\\nRefer to a higher centre in case of severe pain that disturbs sleep/not responding to\\nconservative treatment for more than 2 weeks/associated with severe restriction of neck or\\nback movements or torticollis or sciatic pain or constitutional symptoms/neurological\\nsymptoms with back or neck pain.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 320, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orthopedic Conditions\\n313\\n\\uf0b7\\nMild or grade I sprains- partial tearing of ligament fibers, minimal swelling and no joint\\ninstability.\\n\\uf0b7\\nModerate or grade II sprains - pain, oedema, ecchymosis, joint tenderness with some loss\\nof joint motion but no joint instability.\\n\\uf0b7\\nSevere or grade III sprains- gross instability of the joint with complete tearing of all\\nfibers, marked swelling and severe pain.\\nSPRAINS\\nAn injury to a ligament(s), by sudden unnatural or excessive movement of a joint, is termed\\nis a sprain. Symptoms are pain, swelling, discolouration of the skin, especially bruising and\\nimpaired joint function.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nCheck sensation and circulation distal to the injury. Obtain X-rays of the involved region\\nto rule out a fracture. Stress X-rays may show abnormal opening of the joint in a grade III\\nsprain.\\n\\uf0b7\\nProtection, support and rest.\\n\\uf0b7\\nRestrict the movement of the affected area.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 320, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"to rule out a fracture. Stress X-rays may show abnormal opening of the joint in a grade III\\nsprain.\\n\\uf0b7\\nProtection, support and rest.\\n\\uf0b7\\nRestrict the movement of the affected area.\\n\\uf0b7\\nApply cold compresses immediately (this will help to reduce swelling).\\n\\uf0b7\\nAvoid using ice directly on the skin.\\n\\uf0b7\\nElevation of the limb above the level of the heart- especially at night while sleeping.\\n\\uf0b7\\nIn a grade I sprain, apply a compression bandage for a period of 5-7 days, patient may be\\nallowed to bear weight after a week.\\n\\uf0b7\\nIn a grade II sprain, splintage (slab later on converted to cast) may be used to restrict joint\\nmotion, but the patient has to remain non-weight bearing for 4-6 weeks.\\nPharmacological treatment\\n\\uf0b7\\nTab. ibuprofen 400 mg 3 times a day for 5-7 days. Or Tab. diclofenac sodium 50 mg 3\\ntimes a day for 5-7 days.\\nPatient education\\n\\uf0b7\\nDon't massage or hot fomentation in acute stage; it will increase the swelling.\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 320, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"times a day for 5-7 days.\\nPatient education\\n\\uf0b7\\nDon't massage or hot fomentation in acute stage; it will increase the swelling.\\n\\uf0b7\\nTo give rest to the injured area until the pain subsides (usually 7 to 10 days for mild\\nsprains and 3 to 5 weeks for severe sprains).Avoid activities that cause pain or swelling.\\nPractice moderation in physical activities. If the pain and swelling decreases within 48\\nhours after a sprain, move the affected joint in all directions. To avoid high heeled shoes\\n(for ankle sprains).\\nReference\\n1. Apley's System of Orthopaedics and Fractures, 6th edition, 1982, Butterworths and Co. London.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 321, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orthopedic Conditions\\n314\\nDiagnosis considered if any of the following two criteria are present,\\n\\uf0b7\\nClassic symptom of localized pain, fever (with or without chills and rigours), swelling in\\nthe metaphyseal area, warmth, and limited range of motion of the adjacent joint; pus\\naspirated from the bone; positive bone or blood culture for pyogenic organism;\\nradiographic changes typical of acute osteomyelitis (soft tissue swelling, periosteal\\nreaction, lytic areas in the metaphysis).\\n\\uf0b7\\nThe X-ray changes usually appear 7-10 days after the onset of illness.\\nACUTE PYOGENIC OSTEOMYELITIS\\nAcute osteomyelitis is acute infection of the bone, commonly seen in children less than 10\\nyears of age.\\nSalient features\\nNon- pharmacological treatment\\n\\uf0b7\\nRest, splintage to the part, elevation of the limb and sponging for fever. If aspiration is\\npositive for pus, drain the pus (must be performed by an orthopaedic surgeon) and send\\nfor culture and sensitivity for antibiotics.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 321, 'source_type': 'Authorotative', 'priority': '1'}, page_content='positive for pus, drain the pus (must be performed by an orthopaedic surgeon) and send\\nfor culture and sensitivity for antibiotics.\\n\\uf0b7\\nPostoperative duration of splintage depends upon extent of damage to the bone. Usual\\nduration is 4-6 weeks. Gradually mobilize the limb and permit gradual weight bearing\\nthereafter. In case of extensive destruction, bone might require support for a few months.\\nPharmacological treatment\\nBroad spectrum intravenous antibiotics are started depending upon most likely organism\\npresent. Commonest bacterial pathogen is Staphylococcus aureus (40-80% of cases). The\\nantibiotic later on may be changed depending upon culture report or response to therapy.\\nIntravenous administration of antibiotics is continued till favorable clinical response is\\nachieved, followed by oral antibiotics. Total duration of antibiotic(s) administration ranges\\nfrom 4-6 weeks.\\n\\uf0b7\\nInj. cloxacillin 50-100 mg/kg/day in four divided doses for 1-2 weeks.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 321, 'source_type': 'Authorotative', 'priority': '1'}, page_content='achieved, followed by oral antibiotics. Total duration of antibiotic(s) administration ranges\\nfrom 4-6 weeks.\\n\\uf0b7\\nInj. cloxacillin 50-100 mg/kg/day in four divided doses for 1-2 weeks.\\n\\uf0b7\\nInj. gentamicin 5-7.5 mg/kg/day in 2 divided doses for 1-2 weeks Or Inj. amikacin 15\\nmg/kg/day in 2-3 divided doses if resistant Pseudomonas aeruginosa. Or\\n\\uf0b7\\nInj. ceftriaxone 100 mg/kg/day in 2 divided doses for 1-2 weeks (maximum dose 2 g/day)\\nor\\n\\uf0b7\\nInj. cefotaxime 100-200 mg/kg/day by IV infusion or IM or IV in 2-4 divided doses for 1-\\n2 weeks. Or\\n\\uf0b7\\nIf patient is hypersensitive to penicillins and cephalosporins, Inj. clindamycin 40\\nmg/kg/day in 4 divided doses for 1-2 weeks. Or\\n\\uf0b7\\nIf Methicillin resistant Staph, aureus suspected, Inj. vancomycin by IV infusion 500 mg\\nover at least 60 minutes every 6 hours or 1 g over at least 100 minutes every 12 hours;\\nNeonates upto 1 week 15 mg/kg initially then 10 mg/kg every 12 hours; Infants 1-4'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 321, 'source_type': 'Authorotative', 'priority': '1'}, page_content='over at least 60 minutes every 6 hours or 1 g over at least 100 minutes every 12 hours;\\nNeonates upto 1 week 15 mg/kg initially then 10 mg/kg every 12 hours; Infants 1-4\\nweeks 15 mg/kg initially then 10 mg/kg every 8 hours; Children over 1 month 10 mg/kg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 322, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orthopedic Conditions\\n315\\nevery 6 hours. Alternatively linezolid can be given in appropriate dose.\\n\\uf0b7\\nOral Tab. paracetamol 500 mg for fever.\\n\\uf0b7\\nMonitor therapy by clinical response. Favourable response characterized by decrease in\\nswelling and fever, improvement in general well being and movements of limb, fall in\\nESR and C-Reactive protein (better indicator than ESR because CRP closely follows the\\nclinical response). After 7-10 days of symptoms, repeat the X-ray to assess the extent of\\ndestruction and damage to bone. Oral therapy usually started 1-2 weeks of IV antibiotic\\ntherapy, if response is favourable.\\n\\uf0b7\\nThe choice of oral antibiotic largely depends on culture and sensitivity report. In the\\nabsence of culture report give oral: Syr./Cap. cloxacillin 50-100 mg kg day in 4 divided\\ndoses for 3-4 weeks. Or Syr./Cap. cephalexin 25-50 mg/kg/day in 4 divided doses for 3-4\\nweeks. Or\\n\\uf0b7\\nRefer the patient to an orthopaedic surgeon if aspiration yields pus from bone or acute'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 322, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"doses for 3-4 weeks. Or Syr./Cap. cephalexin 25-50 mg/kg/day in 4 divided doses for 3-4\\nweeks. Or\\n\\uf0b7\\nRefer the patient to an orthopaedic surgeon if aspiration yields pus from bone or acute\\nosteomyelitis suspected in an adult/diabetic/haemodialysis patient/IV drug user/ patient\\nwith orthopaedic implant/immunocompromised host.\\nPatient education\\n\\uf0b7\\nAntibiotic therapy may be required for a few weeks depending upon the response. Plaster\\n(or any other splintage) might be required for prolonged periods. Not to make the child\\nwalk (in case of lower limb bone involvement) unless permitted.\\nReferences\\n1.\\nA Comparative Study of Osteomyelitis and Purulent Arthritis with Special Reference to Aetiology and\\nRecovery. Infection, 1984; 12: 75.\\n2.\\nOsteomyelitis and Suppurative Arthritis. In: Nelson's Textbook of Paediatrics. Berhman, Kliegman, Jenson\\net al (eds), 17th Edition, 2004, W.B. Saundcr Company, Philadelphia, pp 2297-2302.\\n3.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 322, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"2.\\nOsteomyelitis and Suppurative Arthritis. In: Nelson's Textbook of Paediatrics. Berhman, Kliegman, Jenson\\net al (eds), 17th Edition, 2004, W.B. Saundcr Company, Philadelphia, pp 2297-2302.\\n3.\\nBone and Joint Sepsis. In: Lovell and Winter's Paediatric Orthopaedics. Morissy RT, Weinstein SL (eds),\\nVol. 4, 1996, Lippincott - Raven, Philadelphia.\\nACUTE SEPTIC ARTHRITIS\\nIt is inflammation of joint caused by pyogenic microorganisms, usually seen in children <10\\nyears. Hip and knee are the commonest joints to be affected.\\nSalient features\\n\\uf0b7\\nInability to move the affected joint, refusal to walk or limp, hip pain referred to knee\\nacute local signs of inflammation (warm and painful joint with effusion) and clinical\\nsigns of sepsis (fever, malaise).More than two thirds of infant with septic arthritis are\\nafebrile.\\n\\uf0b7\\nNeonates present with pseudo paralysis of extremities, discomfort while changing the\\ndiaper, unhappy or out of sorts but rarely appears to be ill or moribund.Ultrasound\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 322, 'source_type': 'Authorotative', 'priority': '1'}, page_content='afebrile.\\n\\uf0b7\\nNeonates present with pseudo paralysis of extremities, discomfort while changing the\\ndiaper, unhappy or out of sorts but rarely appears to be ill or moribund.Ultrasound\\nexamination of suspected septic hip joint greatly aids in diagnosis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 323, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Orthopedic Conditions\\n316\\nRefer the patient immediately to an orthopaedic surgeon.\\nNon- pharmacological treatment\\n\\uf0b7\\nKeep the joint in position of comfort.\\n\\uf0b7\\nAspiration of the joint for gram staining, culture and sensitivity.\\n\\uf0b7\\nIf aspirate is purulent, drainage of the joint on an emergency basis.\\n\\uf0b7\\nDrain the joint even if the joint aspiration is doubtful in the presence of a strong clinical\\nsuspicion, because the risks of negative arthrotomy are far too less than not draining an\\ninfected joint having pus. The latter situation may be disastrous for the joint resulting in\\nlifelong permanent disability to the patient.\\n\\uf0b7\\nAfter drainage splint the joint with a POP slab or skin traction to relieve pain and prevent\\ncontractures till the patient is a febrile, pain free and the joint is clinically quiescent.\\nIntermittent mobilization is permitted to preserve the range of movement of the joint.\\nPharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 323, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Intermittent mobilization is permitted to preserve the range of movement of the joint.\\nPharmacological treatment\\nThe choice of antibiotics, duration of therapy and monitoring of the therapy are same as\\nmentioned in the section on acute pyogenic osteomyelitis.\\nReferences\\n1.\\nOsteomyelitis and Septic Arthritis. In: Nelson's Textbook of Paediatrics. Berhman, Kliegman, Jenson et al\\n(eds), 17th Edition, 2004, W.B. Saunder Company, Philadelphia, pp 2297-2302.\\n2.\\nBone and Joint Sepsis. In: Lovell and Winter's Paediatric Orthopaedics. Morissy RT, Weinstein SL, Vol. 4,\\n1996, Lippincott Raven, Philadelphia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 324, 'source_type': 'Authorotative', 'priority': '1'}, page_content='317\\nChapter 16\\nSURGERY\\nPRE-OPERATIVE ASSESSMENT AND PREPARATIONS\\nPre operative preparation consists of-\\n\\uf0b7\\nGather and record concisely all relevant information\\n\\uf0b7\\nDevise a plan to minimise risk and maximise the benefit to the patients\\n\\uf0b7\\nConsider possible adverse events and how to deal with them\\n\\uf0b7\\nEnsure that everyone, including the patient, understands the surgical plan.\\nPreoperative assessment of the patient\\nFor achieving the desired optimum result in a surgical patient, apart from evaluating the\\nnature and extent of the diseases and choice of surgery from available options the\\nassessment of the patient to withstand the stress of surgery and anaesthesia is very\\nimportant. The factors that must be considered in preoperative assessment are\\n\\uf0b7\\nThe disease (and its extent) for which the surgery is planned.\\n\\uf0b7\\nThe condition of the patient, organ system.\\n\\uf0b7\\nThe relative urgency of the surgery.\\n\\uf0b7\\nThe type of surgery and its alternatives.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 324, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nThe disease (and its extent) for which the surgery is planned.\\n\\uf0b7\\nThe condition of the patient, organ system.\\n\\uf0b7\\nThe relative urgency of the surgery.\\n\\uf0b7\\nThe type of surgery and its alternatives.\\n\\uf0b7\\nThe relative morbidity and mortality of the disease and the surgical procedure.\\n\\uf0b7\\nAll these factors are interdependent and this assessment is the most fundamental task to\\nbe performed in a surgical patient. Surgeon may at times, need the help of a physician,\\ncardiologist or anesthetist, to take the right decision. The preoperative assessment should\\nalso include discussion on drugs being taken by the patient and documentation of known\\nallergies.\\nInformed consent\\nInformed consent should be taken after a detailed discussion by the surgeon (or his\\nresponsible assistant)with the patient and his close relatives ,informing them about the nature\\nof the procedure planned, benefits expected, risks involved and possible alternatives, giving\\nfull opportunity to them to ask questions and clear doubts.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 324, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of the procedure planned, benefits expected, risks involved and possible alternatives, giving\\nfull opportunity to them to ask questions and clear doubts.\\nPreoperative preparation\\n\\uf0b7\\nRoutine investigations Hb, TLC, DLC, CT, BT, urine routine examination, and in patients\\nover 30 years, chest X-ray and ECG should be done.\\n\\uf0b7\\nSpecial and specific investigations depending upon the nature of the procedure planned\\nand the physical condition of the patient for evaluating fitness for surgery.\\n\\uf0b7\\nLipstick, nail polish and other cosmetics which may mask cyanosis and interfere with\\npulse oximetry should be removed.\\n\\uf0b7\\nDentures, spectacles, contact lenses, artificial limbs, artificial eyes, hearing aid and\\njewellery, cash and mobile phones should be removed before shifting the patient to\\noperation theatre.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 325, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n318\\n\\uf0b7\\nWithholding feeds before surgery depending upon age of the patient and nature of\\nanaesthesia and surgery planned.\\n\\uf0b7\\nBathing, if possible, patient should take a proper bath on the day prior and on the morning\\nof surgery giving special attention to the operative area. Patient should wear only clean\\nhospital clothing.\\n\\uf0b7\\nHair removal should be done as close to the time of surgery as possible. If\\n\\uf0b7\\nThe skin is to be shaved which is best done immediately before surgery. These are best\\nremoved with a clipper or chemical depilator. Shaving results in damage to skin and leads\\nto abrasions that may not be visible and may lead to post operative wound infection.\\n\\uf0b7\\nOne should ask for history of allergic reactions to any chemical solutions.\\n\\uf0b7\\nWhile scrubbing, one should work away from the operative site. Visibly soiled skin\\nshould be washed with soap and water before using surgical scrub. Preanaesthetic\\nmedication as per policy.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 325, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nWhile scrubbing, one should work away from the operative site. Visibly soiled skin\\nshould be washed with soap and water before using surgical scrub. Preanaesthetic\\nmedication as per policy.\\n\\uf0b7\\nSkin preparation for surgery: Preoperative surgical antisepsis aims at blocking infection\\nin to surgical wound and consists of hand washing, gloving along with application of\\nantiseptic to surgical site. Different surgical scrubs available for skin preparation before\\nsurgical procedure include any of the following:\\nPovidone-iodine: It acts by oxidation/substitution of free iodine. Povidone iodine is used as\\na surgical scrub after combining with detergent. It is effective against gram positive bacteria\\nbut weaker against other microorganisms. It has a residual activity and is active in presence\\nof organic substance. It is absorbed through skin. It can be used on mucus membranes.\\nPatient skin sensitivity is occasionally a problem.\\nChlorhexidine gluconate'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 325, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of organic substance. It is absorbed through skin. It can be used on mucus membranes.\\nPatient skin sensitivity is occasionally a problem.\\nChlorhexidine gluconate\\nIt is a broad spectrum antiseptic that is better than povidone-iodine as a bactericidal. This has\\na residual activity that continues to kill microorganisms after application. It is not effective in\\npresence of organic material like soap sand oils, blood and body fluids. It should be avoided\\nin preparation of eye. It may be used alone or in combination with cetrimide.\\nAlcohol (70% ethyl or isopropyl alcohol): It is 95% effective against gram negative and\\ngram positive bacteria, mycobacteria, fungi and viruses. It is not completely effective against\\nspores. All traces of alcohol should be dry before drapes are put. Alcohol is never used on\\nmucus membranes and open wounds as it may causes desiccation.\\n\\uf0b7\\nDrug treatment: e.g. prophylactic antibiotics (see section on antibiotic prophylaxis),'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 325, 'source_type': 'Authorotative', 'priority': '1'}, page_content='mucus membranes and open wounds as it may causes desiccation.\\n\\uf0b7\\nDrug treatment: e.g. prophylactic antibiotics (see section on antibiotic prophylaxis),\\nantihypertensives, IV fluids, anticoagulants, Vitamin K etc. where relevant.\\n\\uf0b7\\nNon drug treatment e.g., rectal washouts, stomach wash, etc. where relevant.\\n\\uf0b7\\nHandling of medicolegal cases: First aid has to be provided in all cases who report in an\\nemergency state. After stabilizing the patient, patient should be properly guided and\\nhelped in shifting to the appropriate centre.\\n\\uf0b7\\nIn case where we treat medicolegal cases, we must send information (in duplicate) to the\\npolice. Prepare a medicolegal report. Preserve and seal clothes etc. Preserve fluid and\\nstain samples where indicated. Respond to information sought by the police. Arrange to'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 326, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Surgery\\n319\\ntake dying declaration, where indicated. Preserve all X-rays and patient records. Respond\\nto court summons. In case of death, handover the body to the police. In case of\\ndischarge/referral, police needs to be informed. Care during transfer. This would depend\\non a number of factors like nature, patient's condition, and reasons for referral, readiness\\nof the referral centre to accept the patient and whether the transfer is an emergency or\\nelective.\\nEmergency transfer\\n\\uf0b7\\nIdentify the degree of emergency.\\n\\uf0b7\\nResuscitative measures to be adopted in serious patients with management of shock,\\noxygen etc.\\n\\uf0b7\\nTransfer in a well equipped ambulance to appropriate referral center with prior intimation\\nand confirmation the readiness at the referral centre.\\n\\uf0b7\\nDoctor or paramedical staff to accompany the sick patient.\\n\\uf0b7\\nReferral slip should contain information on: Condition of the patient when first seen.\\nDiagnosis and resuscitative measures taken. Reasons for referral. Where referred\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 326, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nReferral slip should contain information on: Condition of the patient when first seen.\\nDiagnosis and resuscitative measures taken. Reasons for referral. Where referred\\nPrecautions advised during transportation. Any other information (e.g. any staff or\\nequipment sent along with, any communication given to referral centre or specialist\\nconcerned).\\nPOST-OPERATIVE CARE\\nI.\\nPOSTOPERATIVE PAIN RELIEF\\n\\uf0b7\\nPostoperative pain is associated with all surgical procedures. This varies according to the\\nsurgical procedure. Severe pain can prolong gastrointestinal ileus, urinary retention,\\nimpair respiratory movements producing atelectasis and predisposes to deep vein\\nthrombosis due to immobilization.\\n\\uf0b7\\nVarious methods to alleviate postoperative pain are NSAIDs, opioids (intra muscular,\\ntransdermal or transmucosal), patient controlled analgesia, local infiltration of anaesthetic\\ndrugs, epidural analgesia and intrapleural analgesia. The method used depends upon the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 326, 'source_type': 'Authorotative', 'priority': '1'}, page_content='transdermal or transmucosal), patient controlled analgesia, local infiltration of anaesthetic\\ndrugs, epidural analgesia and intrapleural analgesia. The method used depends upon the\\nsite and the magnitude of surgery done, severity of pain, whether the patient is allowed\\norally, facilities and expertise available. It\\nis necessary to give analgesics by\\nintramuscular or intravenous route in the immediate postoperative period and till the\\npatient is able to accept orally.\\nCommonly used agents are\\n\\uf0b7\\nInj. diclofenac sodium 75 mg 6-8 hourly Or\\n\\uf0b7\\nInj. tramadol (50 mg/ml) IM/IV 4-6 hourly,\\n\\uf0b7\\nInj. pentazocine (30mg/ml) 30-60mg IM/IV repeated 3-4hourly.\\n\\uf0b7\\nInj. morphine (15 mg/ml)10-15mg,can be repeated 4-6 times.\\n\\uf0b7\\nIn tertiary care centers, epidural analgesia, intravenous patient controlled analgesia,\\nintrapleural analgesia can be used under expert care.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 327, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n320\\nWhen patient is able to accept orally,\\n\\uf0b7\\nTab.paracetamol 500mg3-4 times a day. Or\\n\\uf0b7\\nTab.ibuprofen 400-600mg 8 hourly.\\nII. POSTOPERATIVE NAUSEA AND VOMITING\\n\\uf0b7\\nPost operative nausea and vomiting lead to significant morbidity and prolonged\\nhospitalization. It has an incidence of 20-30% after abdominal surgery.\\n\\uf0b7\\nPredisposing\\nfactors\\nare\\ndiabetes\\nmellitus,\\npregnancy,\\ndehydration,\\nelectrolyte\\nimbalance, gastroesophageal reflux,emergency surgery, use of certain anaesthetic drugs\\nand opioids.\\nNon- pharmacological treatment\\nBowel obstruction (mechanical or paralytic ileus) should be ruled out as a cause of vomiting\\nby proper examination and investigations. Nausea and vomiting are managed with bed rest,\\nintravenous fluids, analgesics to relieve postoperative pain, nasogastric decompression\\nPharmacological treatment\\n\\uf0b7\\nInj. metoclopramide (5mg/ml)10 mg IM/IV TDS or SOS. Or\\n\\uf0b7\\nInj. ondansetron (2mg/ml) 4 mg slow IV or IM  OD\\nIII.POSTOPERATIVE PNEUMONIA\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 327, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Pharmacological treatment\\n\\uf0b7\\nInj. metoclopramide (5mg/ml)10 mg IM/IV TDS or SOS. Or\\n\\uf0b7\\nInj. ondansetron (2mg/ml) 4 mg slow IV or IM  OD\\nIII.POSTOPERATIVE PNEUMONIA\\n\\uf0b7\\nPulmonary disorders remain the most frequent postoperative problem and 10- 15% of\\npatients are considered to have clinically significant chest complication after surgery\\nunder general anaesthesia.\\n\\uf0b7\\nFactors predisposing to increased chest complications are smoking, obesity, chronic\\nrestrictive and obstructive lung disease, prolonged general anaesthesia and presence of\\nnasogastric tube. Postoperative pneumonia is caused by pathogens such as Pseudomonas,\\nSerratia, Klebsiella, Proteus and Streptococcus\\nSalient features\\n.\\nPharmacological treatment\\n\\uf0b7Antibiotics: Depending upon sputum culture and sensitivity. Initial treatment  can be\\nstarted with amino glycoside and cephalosporin.\\n\\uf0b7\\nInj. diclofenac 75mg 1M every 6-8 hours.\\n\\uf0b7Chest physiotherapy\\n\\uf0b7\\nNebulized bronchodilators may be used if bronchospasm is present.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 327, 'source_type': 'Authorotative', 'priority': '1'}, page_content='started with amino glycoside and cephalosporin.\\n\\uf0b7\\nInj. diclofenac 75mg 1M every 6-8 hours.\\n\\uf0b7Chest physiotherapy\\n\\uf0b7\\nNebulized bronchodilators may be used if bronchospasm is present.\\nAntibiotic prophylaxis in surgery\\nThe goals of prophylactic administration of antibiotics to surgical patients are to:\\n\\uf0b7\\nReduce the incidence of surgical site infection;\\n\\uf0b7\\nFever, productive cough, dyspnoea, chest pain.\\n\\uf0b7\\nBronchial breathing and presence of rales.\\n\\uf0b7\\nChest X-ray shows area of  consolidation'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 328, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Surgery\\n321\\n\\uf0b7\\nUse antibiotics in a manner that is supported by evidence of effectiveness; minimize the\\neffect of antibiotics on the patient's normal bacterial flora; adverse effects.\\nProphylaxis is uniformly recommended for all clean-contaminated, contaminated and\\ndirty procedures. It is considered optional for most clean procedures, although it may be\\nindicated for certain patients and clean procedures that fulfill specific risk criteria. It is\\nimportant to emphasize that surgical antibiotic prophylaxis is an adjunct to, not a\\nsubstitute for good surgical technique.\\n\\uf0b7\\nAntibiotics prophylaxis should be regarded as one component of an effective policy for\\nthe control of hospital acquired infection in procedure that requires the insertion of\\nimplants or prosthetic devices, the term.\\nSurgical site infection is used to encompass the\\nsurgical wound and the implant. Surgical site infection also encompasses infections\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 328, 'source_type': 'Authorotative', 'priority': '1'}, page_content='implants or prosthetic devices, the term.\\nSurgical site infection is used to encompass the\\nsurgical wound and the implant. Surgical site infection also encompasses infections\\ninvolving the body cavity (e.g. subphrenic abscess), bones, joints, meninges and other\\ntissues involved in the operation. Throughout this guideline the term surgical site\\ninfection (SSl) is used, unless the evidence relates specifically to surgical wound\\ninfection.\\nSURGICAL SITE INFECTION\\nCriteria for defining a surgical site infection (SSI)\\nSuperficial incisional SSI\\n\\uf0b7\\nInfection occurs within 30 day after the operation and infection involves only skin of\\nsubcutaneous tissue of the incision and at least one of the following\\n\\uf0b7\\nPurulent drainage, with or without laboratory confirmation, from the superficial incision\\n\\uf0b7\\nOrganisms isolated from an aseptically obtained culture of fluid or tissue from the\\nsuperficial incision.\\n\\uf0b7\\nAt least one of the following signs or symptoms of infection: Pain or tenderness, localized'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 328, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Organisms isolated from an aseptically obtained culture of fluid or tissue from the\\nsuperficial incision.\\n\\uf0b7\\nAt least one of the following signs or symptoms of infection: Pain or tenderness, localized\\nswelling, redness, heat and superficial incision is deliberately opened by a surgeon,\\nunless, incision is culture-negative\\n\\uf0b7\\nDiagnosis of superficial incisional SSI by the surgeon or attending physician\\nDeep incisional SSI\\n\\uf0b7\\nInfection occurs within 30 days after the operation if no implant is left in place or within\\none year if implant is in place and the infection appears to be related to the operation and\\ninfection involves deep soft tissues (e.g. fascial and muscle layers)of the incision and at\\nleast one of the following\\n\\uf0b7Purulent drainage from the deep incision but not from the organ/space component of the\\nsurgical site.\\n\\uf0b7A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 328, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7Purulent drainage from the deep incision but not from the organ/space component of the\\nsurgical site.\\n\\uf0b7A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the\\npatient has at least one of the following signs or symptoms: fever (>38°C) localized pain\\ntenderness unless site is culture-negative\\n\\uf0b7An abscess or other evidence of infection involving the deep incision is found on direct\\nexamination,during re-operation,or by histopathologyor radiologic examination.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 329, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n322\\n\\uf0b7Diagnosis of deep incisional SSI by a surgeon or attending physician.\\nOrgan/space SSI\\n\\uf0b7\\nInfection occurs within 30 days after the operation if no implant is left in place or within\\none year if implant is in place and the infection appears to be related to the operation and\\ninfection involves any part of the anatomy (e.g. organs or spaces), other than the incision,\\nwhich was opened or manipulated during an operation and at least one of the following\\n\\uf0b7\\nPurulent discharge from a drain that is placed through a stab wound in to the organ/space.\\n\\uf0b7\\nOrganisms isolated from an aseptically obtained culture of fluid or tissue in the\\norgan/space.\\n\\uf0b7\\nAn abscess or other evidence of infection involving the organ/space that is found on\\ndirect examination, during re-operation, or by histopathologic or radiologic examination.\\n\\uf0b7\\nDiagnosis of an organ/space SSI by a surgeon or attending physician.\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 329, 'source_type': 'Authorotative', 'priority': '1'}, page_content='direct examination, during re-operation, or by histopathologic or radiologic examination.\\n\\uf0b7\\nDiagnosis of an organ/space SSI by a surgeon or attending physician.\\nPharmacological treatment\\n\\uf0b7\\nThe antibiotics selected for prophylaxis must cover the common pathogens. Antibiotics\\nelection is influenced by the organism most commonly causing wound. Infection in the\\nspecific procedure and by the relative costs of available agents.\\n\\uf0b7\\nGastrointestinal procedures, oral and intravenous administration of agents with activity\\nagainst gram-negative and anaerobic bacteria are warranted, as well as mechanical\\npreparation of the bowel. Ceftriaxone/cefotaxime provides adequate coverage for most\\nother types of procedures. The antibiotics chosen for prophylaxis can be those used for\\nactive treatment of infection. However, the chosen antibiotics must reflect local disease-\\nspecific information about the common pathogens and their antimicrobial susceptibility.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 329, 'source_type': 'Authorotative', 'priority': '1'}, page_content='active treatment of infection. However, the chosen antibiotics must reflect local disease-\\nspecific information about the common pathogens and their antimicrobial susceptibility.\\nA past history of a serious adverse event should preclude administration of a particular\\nantibiotic like penicillin.\\nTiming and duration of prophylaxis\\n\\uf0b7\\nThe first dose should always be given before the procedure, preferably within 30 minutes\\nbefore incision. Re-administration\\nat one to two half-lives of the antibiotic is\\nrecommended for the duration of the procedure. In general, postoperative administration\\nis not recommended.\\n\\uf0b7\\nThere may be situations where overriding factors alter the normal timing of\\nadministration. For example, during a caesarean section prophylaxis should be delayed\\nuntil the cord is clamped in order to prevent the drug reaching the neonate. When a\\ntourniquet is to be applied the necessary tissue concentration must be achieved prior to its'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 329, 'source_type': 'Authorotative', 'priority': '1'}, page_content='until the cord is clamped in order to prevent the drug reaching the neonate. When a\\ntourniquet is to be applied the necessary tissue concentration must be achieved prior to its\\napplication rather than the time of incision. This probably occurs within10 minutes of\\nadministration of an IV antibiotic injection. Antibiotics should also be administered\\nimmediately after unexpected contamination of the tissues additional doses during the\\noperation.\\nThe individual surgeon should be free to give an extra dose for prolonged operations with\\nmajor   blood loss if they wish. However, there is insufficient evidence to make a general\\nrecommendation. Antibiotic prophylaxis should be confined to the peri operative period.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 330, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n323\\nRoute of administration\\nIntravenous administration of antibiotic prophylaxis immediately before or after induction of\\nanesthesia is the most reliable method for ensuring effective serum antibiotic concentrations\\nat the time of surgery.\\nDose selection\\nA single dose of antibiotic at the therapeutic concentration is sufficient for prophylaxis under\\nmost circumstances. In adults, blood loss of up to1500 ml during surgery or haemodilution up\\nto 15 ml/kg does not require an additional dose of prophylactic agent.\\nIn the event of major intraoperative blood loss (>1500ml) additional doses of prophylactic\\nantibiotic should be given after fluid replacement. Antibiotic prophylaxis in all cardiac\\nsurgeries and interventions is recommended.\\nTable 1. Incidence of surgical site infections (SSI) with various types of surgery\\nType of surgery\\nName of Surgeries\\nSSI\\nrate\\nClean\\nElective, not emergency, non traumatic, primarily closed; no\\nacute inflammation ;  no break in technique; respiratory,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 330, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Type of surgery\\nName of Surgeries\\nSSI\\nrate\\nClean\\nElective, not emergency, non traumatic, primarily closed; no\\nacute inflammation ;  no break in technique; respiratory,\\ngastrointestinal, biliary and genitor urinary  tracts not entered\\n<2\\nClean-\\ncontaminated\\nUrgent or emergency  case that is otherwise  clean; elective\\nopening of  respiratory, gastrointestinal, biliary or genitourinary\\ntract with minimal spillage (e.g. appendectomy) not\\nencountering infected urine or bile; minor technique break\\n<10\\nContaminated\\nNonpurulent inflammation; gross pillage from gastrointestinal\\ntract; entry into biliary or genitourinary  tract in the presence of\\ninfected bile or urine; major break in technique; penetrating\\ntrauma <4hours old; chronic open  wounds to be grafted or\\ncovered\\n~20\\nDirty\\nPurulent inflammation (e.g. abscess);preoperative perforation of\\nrespiratory, gastrointestinal,   biliary  or genitourinary tract;\\npenetrating trauma >4hours old\\n~40'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 331, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n324\\n\\uf0b7\\nPain is unusually severe for the magnitude of procedure and last long. Fever: 101 to\\n102 F with tachycardia is usually present.\\n\\uf0b7\\nLocal examination: Wound is warm to touch and may be swollen and oedematous.\\nRedness of the surrounding area and cellulites is often present.\\n\\uf0b7\\nWound infections are generally evident between 3rd to 6th postoperative days\\nInfection risk factors: Factors associated with increased risk of infection are:\\nSystemic factors: Diabetes, corticosteroid use, obesity, extremes of age, malnutrition, recent\\nsurgery, massive transfusion, multiple (3 or more) preoperative co morbid medical diagnoses\\nLocal factors: foreign body, electrocautery; injection with epinephrine; wound drains; hair\\nremoval with razor; previous irradiation of site.\\nDevelopment of local guidelines\\nIt is advisable to make local surgical site infection prevention protocols be developed by local\\nhospital management.\\nPostoperative wound management\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 331, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Development of local guidelines\\nIt is advisable to make local surgical site infection prevention protocols be developed by local\\nhospital management.\\nPostoperative wound management\\n\\uf0b7\\nMost postoperative wounds are covered with occlusive dressings The occlusive dressing\\n(semi permeable to water vapours and oxygen but impermeable to liquids) consists of a\\nhydrating layer (antibiotic ointments or petroleum jelly), a non-adherent contact layer, an\\nabsorbent and cushioning layer(gauze), and a se-  curing layer like hypo allergic tape.\\nOcclusive dressings should be applied within 2 hours of wounding and left on for at least 24\\nhours for optimal healing to occur for acute wounds. These should never be used on infected\\nwounds. Dressing changes can be performed once or twice daily. If other types of occlusive\\nare used, the timing of the dressing changes will vary between I to 7 days, depending on the\\nwound characteristics.\\nPOSTOPERATIVE WOUND INFECTION\\nWound infections are classified as\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 331, 'source_type': 'Authorotative', 'priority': '1'}, page_content='are used, the timing of the dressing changes will vary between I to 7 days, depending on the\\nwound characteristics.\\nPOSTOPERATIVE WOUND INFECTION\\nWound infections are classified as\\n\\uf0b7\\nMinor e.g. stitch abscess, cellulitis.\\n\\uf0b7\\nMajor e.g. presence of discrete collection of pus in wound.\\n\\uf0b7\\nSuperficial infections are limited to skin and subcutaneous tissue.\\n\\uf0b7\\nDeep infections- involve the areas of wound below the fascia.\\nPostoperative cross infection in wards: Staphylococcus aureus is the most frequently involved\\norganism. Other less common organisms are Enterococci, Pseudomonas, Proteus, E. Coli and\\nKlebsiella.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 332, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n325\\nSuperficial infection\\n\\uf0b7\\nDrainage: Wounds are managed by opening up the incision to provide adequate drainage.\\n\\uf0b7\\nDressing: Daily dressing with povidone-iodine 5% and a wick is placed to prevent premature\\nclosure of the wound.\\n\\uf0b7\\nAnalgesics: Tab. ibuprofen 400mg 3 times a day till pain is there.\\nDeep infections\\n\\uf0b7\\nAntibiotics are given on the basis of pus culture and sensitivity in addition to drainage of\\nwound.\\nPrevention\\nPostoperativewound infection rate can be minimized by adequate skin preparation, bowel\\npreparation, prophylactic antibiotics, meticulous surgical technique\\nWOUND CARE\\nWounds can be classified as acute or chronic and further as arterial, venous trophic, malignant.\\nAcute wounds heal uneventfully within an expected time frame e.g. burns. For the purpose of\\nguidelines, chronic wounds can be defined as an ulcer present at least for 6 weeks.\\nTreatment\\nMeticulous wound care includes adequate cleansing, debridement, oedema control and\\nprevention of ischemia,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 332, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Treatment\\nMeticulous wound care includes adequate cleansing, debridement, oedema control and\\nprevention of ischemia,\\nAcute wounds\\n\\uf0b7The overall objective in caring for wounds that are incompletely clotted is to minimize\\nunnecessary blood loss and to avoid the formation of a hematoma.\\n\\uf0b7Irrigate gently with copious quantities of water or normal saline. Debris and necrotic tissue\\nshould be removed without damaging healthy tissue. Sharp mechanical debridement may be\\nnecessary to expose viable tissue for large areas of fibrinous exudates or eschar. Chemical\\ndebridement is useful for those areas that are difficult to access by sharp debridement.\\nChemical debridement of the wounds may be done using topical antiseptics (chlorhexidine,\\npovidoneiodine, alcohol, hydrogenperoxide, triclosan) and antibacterials (silver sulfadiazine,\\nneomycin, polymyxin, bacitracin, mupirocin).When debridement is complete, dressings can\\nbe applied.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 332, 'source_type': 'Authorotative', 'priority': '1'}, page_content='povidoneiodine, alcohol, hydrogenperoxide, triclosan) and antibacterials (silver sulfadiazine,\\nneomycin, polymyxin, bacitracin, mupirocin).When debridement is complete, dressings can\\nbe applied.\\n\\uf0b7Healing of acute wound is further facilitated by closure. Alternatively,closure can be delayed\\nfor several days to allow infection to clear. Wound healing is impaired by malnutrition,\\noedema, bacterial contamination, ischemia, smoking and immunosuppressant.\\nChronic wounds\\nIdentify and treat the predisposing factors, e.g. diabetes mellitus, peripheral arterial or venous\\ndisease, severe anemia, protein deficiency, rheumatoid arthritis, systemic vasculitis, cushing’s\\nsyndrome and conditions requiring systemic steroid therapy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 333, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n326\\nNon- pharmacological treatment\\n\\uf0b7\\nEncourage daily or twice a day bath, to avoid walking bare foot or with slippers and patient\\nshould been courage to wear shoes and socks.\\n\\uf0b7\\nPatients with leg ulcer to reduce standing or excessive walking. In leg ulcer due to chronic\\nvenous insufficiency or oedema, patients should be advised to wear elastic stockings,\\nelevation of leg and foot end of the bed while a sleep along with some leg exercises to\\nactivate the calf muscle pump.\\nPharmacological treatment\\nIdentify the microorganism and treat accordingly. Tubercular ulcer is treated with anti tubercular\\ndrug (2HRZE+7HR) for at least 9 months.\\nSurgical treatment\\n\\uf0b7\\nSurgical debridement in ulcer associated with necrotic tissue or slough. Clean the wound\\nwith physiological normal saline or tap water only (antiseptics delay wound healing).\\n\\uf0b7\\nDaily dressing: Gauze adhere to the wound bed and it may remove viable tissue from the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 333, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with physiological normal saline or tap water only (antiseptics delay wound healing).\\n\\uf0b7\\nDaily dressing: Gauze adhere to the wound bed and it may remove viable tissue from the\\nwound surface on removal , resulting in delayed wound healing. Some of the commonly used\\ndressings are:\\n\\uf0b7\\nOcclusive (moist ureretentive) dressings (Hydrocolloid gel) in case of clean and shallow\\nulcers without any pus discharge or other features of infection. Occlusive dressings have\\nbarrier properties that enable to prolong the presence of moisture and wound fluid in the\\nwound bed.\\n\\uf0b7\\nCalcium alginate dressing: For bleeding wounds and wounds with a cavity.\\nPatient education\\n\\uf0b7\\nTo prevent ulcer in future, explain about the care of leg ulcers, wearing socks, shoes and\\ncompression stocking.\\n\\uf0b7\\nGood personal hygiene (daily bath) and after bath the healed scar area should be massaged\\nwith an emollient cream such as lanolin or some other oil to keep the scar tissue soft and\\nsupple and prevent further breakdown.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 333, 'source_type': 'Authorotative', 'priority': '1'}, page_content='with an emollient cream such as lanolin or some other oil to keep the scar tissue soft and\\nsupple and prevent further breakdown.\\n\\uf0b7\\nRegular use of calf muscle activating exercises and leg elevation and to avoid prolonged\\nperiod of standing or sitting with legs down. In case of diabetic patients, control of diabetes is\\nnecessary.\\nSTERILIZATION AND DISINFECTION\\nDefinitions\\nSterilization is removal of all viable micro-organisms, vegetative and spores. Disinfection is the\\nremoval of actively dividing vegetative micro-organisms. Antisepsis is the process whereby the\\nrisk of medical cross-infection by micro-organisms is reduced'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 334, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n327\\n\\uf0b7\\nTime of occurrence of wound and its etiology\\n\\uf0b7\\nCo morbidities like diabetes mellitus, anemia, scurvy, jaundice\\n\\uf0b7\\nNumber, site, size, depth active bleeding, discharge, foreign material, associated\\nneurovascular injury, tendon injury, bone fracture and make proper documentation of all\\ninjuries to be done in patient records.\\nMethods of Sterilization\\nI.\\nHeat\\n\\uf0b7\\nDry heat (e.g. incineration, flaming to red hot) is effective but rarely useful. Dry heat\\nrequires temperatures of 160Â°C for at least 60min.\\n\\uf0b7\\nMoist heat (e.g. autoclave heating using pressurized steam 121Â°C at 15lb/in2 for\\n15min) is effective and useful especially in operating theatres.\\nII.\\nIrradiation, Gamma radiation effective for inorganic material   Filtration: Air or fluids can\\nbe sterilized by ultrafine membrane filters but are rarely useful in hospital practice\\nIII.\\nChemical\\n\\uf0b7\\nAcids/alkalis, e.g. bleach. Effective for non-human contact use.;\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 334, 'source_type': 'Authorotative', 'priority': '1'}, page_content='be sterilized by ultrafine membrane filters but are rarely useful in hospital practice\\nIII.\\nChemical\\n\\uf0b7\\nAcids/alkalis, e.g. bleach. Effective for non-human contact use.;\\n\\uf0b7\\nAlcohols/phenols, e.g. ethyl alcohol skin swabs, alcohol solutions  hand  disinfection\\ncarbolic; chloroxylenols (Dettol), phenol (Clearsol )\\n\\uf0b7\\nOxidizers, e.g. povidone-iodine (Betadine) skin disinfection/surgical scrubbing;\\nH2O2 superficial wound cleansing; aldehydes (Cidex) surgical instruments such as\\nendoscopes; Cationic solutions, e.g. Chlorhexidine antiseptic washes.;\\n\\uf0b7\\nOrganic dyes, e.g. Proflavin\\nAntisepsis: Principles of antisepsis include the following.\\n\\uf0b7\\nAlways remove gross contamination with simple soap first.\\n\\uf0b7\\nUse high potency acid/alkali disinfection on inert surfaces.\\n\\uf0b7\\nUse less corrosive oxidizers on delicate inert materials.\\n\\uf0b7\\nUse weak alcohols, oxidizers for skin cleansing.\\nSUTURING OF PRIMARY WOUND\\nSuturing is one of the first and foremost thing any surgeon will perform in his or her career.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 334, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nUse weak alcohols, oxidizers for skin cleansing.\\nSUTURING OF PRIMARY WOUND\\nSuturing is one of the first and foremost thing any surgeon will perform in his or her career.\\nConsider following points while suturing primary wounds.\\nSalient features\\nInvestigations\\n\\uf0b7\\nUsually not required. X-rays of local part are needed if fracture or foreign body is suspected.\\nPharmacological treatment\\n\\uf0b7\\nInj.  tetanus toxoid 0.5 ml IM stat'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 335, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n328\\n\\uf0b7\\nInj.  diclofenac sodium 3 ml (75mg) IM stat\\n\\uf0b7\\nTab. ampicillin 500 mg three times day for  3-5 days\\n\\uf0b7\\nTab. diclofenac 50 mg twice day for  3-5 days\\n\\uf0b7\\nTab. multivitamins/Iron if patient is deficient of any for better healing\\n\\uf0b7\\nControl of Diabetes mellitus, if present\\n\\uf0b7\\nManagement of local wound: if wound is recent(<6 hrs) cleaning followed by suturing is\\ndone. If duration of injury is >6 hrs, and contamination is present, wound is debrided and\\nwound is closed by secondary suturing at a later date when wound is clean.\\n\\uf0b7\\nFor primary suturing: Thorough cleaning of wound by saline/Hydrogen Peroxide/Betadine.\\n\\uf0b7\\nRemoval of any foreign material and control of active bleeding.\\nChoice of suture material\\nThe size of suture material is measured by its width or diameter and is vital to proper wound\\nclosure.\\n\\uf0b7\\n1-0 and 2-0: Used for high stress areas requiring strong retention, i.e. - deep fascia repair\\n\\uf0b7\\n3-0: Used in areas requiring good retention, i.e. - scalp, torso, and hands\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 335, 'source_type': 'Authorotative', 'priority': '1'}, page_content='closure.\\n\\uf0b7\\n1-0 and 2-0: Used for high stress areas requiring strong retention, i.e. - deep fascia repair\\n\\uf0b7\\n3-0: Used in areas requiring good retention, i.e. - scalp, torso, and hands\\n\\uf0b7\\n4-0: Used in areas requiring minimal retention, i.e.  extremities. Is the most common size\\nutilized for superficial wound closure.\\n\\uf0b7\\n5-0: Used for areas involving the face, nose, ears, eyebrows, and eyelids.\\n\\uf0b7\\n6-0: Used on areas requiring little or no retention. Primarily used for cosmetic effects\\nSuture Techniques: Wound layers should be placed in close approximation. Minimal amount of\\ntension across the suture line should be kept. Wound edges should be slightly everted. Equal\\nbites, horizontally and vertically are important for wound position and healing. Debride\\ndevitalized tissue.  Alternate day dressing with antiseptic solution till suture removal\\nSuture removal\\n\\uf0b7\\nDuration will vary according to the location and depth of the wound. However, the average'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 335, 'source_type': 'Authorotative', 'priority': '1'}, page_content='devitalized tissue.  Alternate day dressing with antiseptic solution till suture removal\\nSuture removal\\n\\uf0b7\\nDuration will vary according to the location and depth of the wound. However, the average\\ntime frame is 7-10 days after application. The following general rules can be sued in deciding\\nwhen to remove sutures:\\n\\uf0b7\\nFace: 4-5 days.\\n\\uf0b7\\nBody & scalp: 7 days.\\n\\uf0b7\\nSoles, palms, back or over joints: 10 days\\n\\uf0b7\\nAny suture with pus or signs of infections should be removed immediately. Once MO\\ndetermines that the sutures should be removed, a suture removal kit, consisting of scissors\\nand a pair of tooth forceps is utilized to remove the sutures.\\n\\uf0b7\\nUsing the tooth forceps, grasp the knot and snip the suture below the knot with the scissors as\\nclose as possible to the skin.  Pull the suture line through the tissue and place on a 4x4.  Once\\nall sutures have been removed count the sutures.  The number of sutures needs to match the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 336, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Surgery\\n329\\n\\uf0b7\\nVague periumbilical or sometimes epigastic pain of visceral nature from a dilated appendix\\nwhich migrates to right lower quadrant and becomes somatic in nature from contact of\\nserosa of inflammed appendix against the parietal peritoneum.\\n\\uf0b7\\nPain followed by anorexia,nausea and occasional vomiting, fever in 50% of cases\\n\\uf0b7\\nMcBurney's sign : migratory nature of pain that settels at McBurney's point (one third of\\nthe distence from the anterior superior iliac spine to the umbilicus\\n\\uf0b7\\nRebound tenderness\\n\\uf0b7\\nPerforated appendicitis may present with more severe abdominal pain ,progressing from\\nfocal peritonitis to generalized peritonitis with rebound tenderness, voluntory guarding\\nfollowed by involuntary guarding and finally rigidity.\\nnumber indicated in the patient's health record.\\nACUTE APPENDICITIS\\nIt is inflammation of appendix caused by luminal obstruction due to fecoliths (50%), lymphoid\\nhyperplasia, malignancy or rarely parasitic infection.\\nSalient features\\nDiagnosis\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 336, 'source_type': 'Authorotative', 'priority': '1'}, page_content='ACUTE APPENDICITIS\\nIt is inflammation of appendix caused by luminal obstruction due to fecoliths (50%), lymphoid\\nhyperplasia, malignancy or rarely parasitic infection.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nBlood counts (neutrophillia), USG Abdomen (shows inflamed appendix) CECT Abdomen, if\\nRIF lump is palpable.\\nPharmacological treatment\\n\\uf0b7\\nIn early catarrhal appendicitis, with minimally inflamed appendix patient can be given\\nmedical and conservative management which includes-\\n-\\nTab. ciprofloxacin 500mg BD and  Tab. metronidazole 400 mg TDS or a second generation\\ncephalosporin cefotaxim 1 gm BD\\n\\uf0b7\\nInj.diclofenac  75 mg IM\\n\\uf0b7\\nTab.ranitidine 150 mg BD or Cap. omeprazole 40 mg BD\\nSurgical treatment Appendicectomy by open or laproscopic approch\\nHERNIA\\nI.\\nINGUINAL HERNIA\\nInguinal hernias are the most common hernias world wide. Most commonly seen in men. Several\\nclassifications are available worldwide but none has been prove to be perfect, besides, most'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 336, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Inguinal hernias are the most common hernias world wide. Most commonly seen in men. Several\\nclassifications are available worldwide but none has been prove to be perfect, besides, most\\nsurgeons in the world commonly classify them as being Direct or Indirect inguinal hernias.\\nDirect inguinal hernia is the one which occurs medial to deep epigastric artery, through\\nHesselbach's triangle. Indirect inguinal hernia occurs through deep ring.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 337, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n330\\n\\uf0b7\\nGroin swelling reducible, impulsile, history of strenuous activity, heavy labour, chronic\\ncough, chronic constipation, urinary complains. Examination of swelling is required.\\n\\uf0b7\\nReducible, impulse on coughing present, examination of scrotum and penis\\n\\uf0b7\\nPer rectal examination, systemic examination of chest and abdomen is required.\\n\\uf0b7\\nIn history evaluate nature of primary surgery, Wound complications following primary\\nsurgery, presence of malnutrition and associated comorbidities.\\n\\uf0b7\\nPhysical examination of scar and defect and swelling, reducible impulsile on coughing\\nSalient features\\nInvestigations\\n\\uf0b7\\nDiagnosis of hernia is purely clinical, investigations are required where diagnosis is\\ninconclusive or for evaluation of associated conditions.\\n\\uf0b7\\nUSG- local part for defect. USG- KUB for urinary complains.\\n\\uf0b7\\nS. PSA if prostate is enlarged\\n\\uf0b7\\nProstatic biopsy. Pulmonary function tests for chronic cough\\nPharmacological treatment\\n\\uf0b7\\nTreatment of predisposing factors if present any\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 337, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nS. PSA if prostate is enlarged\\n\\uf0b7\\nProstatic biopsy. Pulmonary function tests for chronic cough\\nPharmacological treatment\\n\\uf0b7\\nTreatment of predisposing factors if present any\\n\\uf0b7\\nTreatment of chronic cough according to cause\\n\\uf0b7\\nTreatment of Chronic constipation\\n\\uf0b7\\nTreatment of BPH if present, pharmacological as well surgical\\nSurgical treatment\\n\\uf0b7\\nHerniotomy, for congenital hernias\\n\\uf0b7\\nHernioplasty for open gold standard for any type of adult hernia at present. Lichtenstein\\ntension free hernioplasty\\n\\uf0b7\\nBy laparoscopic hernioplasty is preferred in small and bilateral hernia.\\n\\uf0b7\\nTEP- Totally Extra peritoneal meshplasty\\n\\uf0b7\\nTAPP- Trans Abdominal Preperitoneal meshplasty\\nII. INCISIONAL HERNIA\\nIncisional hernia is defined as hernia occurring through any previous surgical incision.\\nPredisposing factors are improper techniques of wound closure ,wound infection, wound\\ndehiscence, malnutrition, malignancy\\nSalient feature\\nInvestigations\\nUSG local part for defect, Preoperative investigations'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 337, 'source_type': 'Authorotative', 'priority': '1'}, page_content='dehiscence, malnutrition, malignancy\\nSalient feature\\nInvestigations\\nUSG local part for defect, Preoperative investigations\\nSurgical Treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 338, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Surgery\\n331\\n\\uf0b7Underlay: preperitoneal mesh placement under the defect, preferred route\\n\\uf0b7Inlay: mesh placement thought the defect\\n\\uf0b7Onlay/Overlay: Mesh placement above the defect in muscular plane\\n\\uf0b7Laparoscopic mesh placement under the defect, preferred whenever possible\\nHYDROCOELE\\nHydrocele is an abnormal collection of serous fluid in apart of the proccessus vaginalis, usually\\nthe tunica. Acquired hydrocele are primary or idiopathic, or secondary to testicular disease.\\nCauses includes excessive production of fluid within the sac, e.g. secondary hydrocele, by\\ndefective absorption of fluid, e.g. primary hydrocele, by interference with lymphatic drainage  of\\nscrotal structures, by connection with the peritoneal cavity via a patent processus vaginalis.\\nSalient features\\nSurgical treatment\\nCongenital hydrocele requires herniotomy while acquired hydrocele -jaboulay's procedure or\\nLord's procedure\\nCHOLELITHIASIS\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 338, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Salient features\\nSurgical treatment\\nCongenital hydrocele requires herniotomy while acquired hydrocele -jaboulay's procedure or\\nLord's procedure\\nCHOLELITHIASIS\\nCholelithiasis or gall bladder stones are common problem in our country. It may lead to\\ncholecystitis, cholangitis, choledocholithiasis with obstructive jaundice gall stone pancreatitis.\\nGall stones may be of cholesterol stones, pigment stones, mixed stones\\n\\uf0b7\\nHydroceles are translucent and it is possible to get above swelling. Primary vaginal\\nhydrocele is most common in middle and later life but can also occur in older children.\\nSwelling is painless. The testis may be palpable within a lax hydrocele, but an ultrasound\\nscan is necessary to visualize the testis if the hydrocele sac is tense. Testicular\\nmalignancy is an uncommon cause of hydrocele that can be excluded by ultrasound\\nexamination of the scrotum.\\n\\uf0b7\\nAbout 5% inguinal hernia are associated with a vaginal hydrocele of that side. In\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 338, 'source_type': 'Authorotative', 'priority': '1'}, page_content='malignancy is an uncommon cause of hydrocele that can be excluded by ultrasound\\nexamination of the scrotum.\\n\\uf0b7\\nAbout 5% inguinal hernia are associated with a vaginal hydrocele of that side. In\\ncongenital hydrocele, pressure on it does not always empty it but the hydrocele fluid may\\ndrain into the peritoneal cavity when the child is lying down.\\n\\uf0b7\\nEncysted hydrocele of cord is smooth oval swelling near the spermatic cord, which is\\nliable to be mistaken for an inguinal hernia.\\n\\uf0b7\\nThe swelling moves downwards and becomes less mobile if the testis is pulled gently\\ndownwards.\\n\\uf0b7\\nHydrocele of canal of Nuck is similar condition in female. The cyst lies in relation to the\\nround ligament and is always at least partially within the inguinal canal.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 339, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n332\\n\\uf0b7\\n“Fatty forty flatulent fertile female” is the classical description of cholelithiasis.\\n\\uf0b7\\nRight upper quadrant epigastric pain, dyapepsia, nausea, vomiting.\\n\\uf0b7\\nMurphy’s sign.\\nSalient features\\nInvestigations\\nUltrasound abdomen, total and differential count, liver function test\\nSurgical treatment\\n\\uf0b7\\nDefinitive\\ntreatment\\nis cholecystectomy\\nin symptomatic\\nand asymptomatic patients\\nwith diabetes\\nor  a solitary\\nlarge stone or multiple\\nsmall stones with wide cystic\\nduct or porcelain gall bladder or anxious patients. If the patient comes after 48 hours\\nmanage conservatively\\nand cholecystectomy\\nafter 6-8 weeks.\\n\\uf0b7\\nIn case of acute cholecystitis,\\nempyema gall bladder, and stones in the CBD following\\ntreatment is instituted.\\nPharmacological treatment\\n\\uf0b7\\nMaintenance IV fluids\\n\\uf0b7\\nInj. ciprofloxacin\\n(infusion 100 mg/50 ml) 100 ml IV twice a day and Inj. gentamicin (40\\nmg/ml) 2 ml IV 8 hourly.\\n\\uf0b7\\nIn case anaerobic bacterial infection is suspected or anticipated, give Inj. metronidazole'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 339, 'source_type': 'Authorotative', 'priority': '1'}, page_content='(infusion 100 mg/50 ml) 100 ml IV twice a day and Inj. gentamicin (40\\nmg/ml) 2 ml IV 8 hourly.\\n\\uf0b7\\nIn case anaerobic bacterial infection is suspected or anticipated, give Inj. metronidazole\\n(500 mg/l00 ml) 100 ml IV 8 hourly.\\n\\uf0b7\\nInj. diclofenac sodium (25 mg/ml) 2 -3 ml IM SOS or 6 hourly or Inj. pentazocine (30\\nmg/ml) 1 ml IM SOS.\\n\\uf0b7\\nInj. hyoscine butylbromide (20 mg/ml) 1 ml IV SOS.\\n\\uf0b7\\nIn patients having obstructive jaundice, add Inj. vitamin K (10 mg/ml) 1 ml IM once or\\ntwice a day till prothrombin time reaches to a satisfactory level.\\n\\uf0b7\\nAntibiotics are usually stopped after 5-7 days unless the patient has evidence of persistent\\ninfection or has indwelling tube (e.g., T-tube).\\nPatient education\\n\\uf0b7\\nTo avoid fatty and fried meals for 3 months.\\n\\uf0b7\\nAlthough ambulation is encouraged as early as possible, heavy physical exertion should be\\navoided\\nfor 2 weeks\\n(after laparoscopic cholecystectomy) and\\nfor 3 months after\\nconventional cholecystectomy.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 339, 'source_type': 'Authorotative', 'priority': '1'}, page_content='avoided\\nfor 2 weeks\\n(after laparoscopic cholecystectomy) and\\nfor 3 months after\\nconventional cholecystectomy.\\n\\uf0b7\\nIf T -tube has been placed, it should be removed after 2-3 weeks, after ensuring that the\\nCBD is patent, non dilated and there is free flow of contrast into the duodenum during T-\\ntube cholangiography.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 340, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n333\\n\\uf0b7\\nDisease may be entirely asymptomatic. Abdominal lump in right upper quadrant. Pain\\nmay be characterized as heaviness in abdomen.\\n\\uf0b7\\nObstructive jaundice when daughter cyst may communicate with biliary tree.\\nAnaphylactic shock if cyst ruptures into peritoneal cavity.\\n\\uf0b7\\nJaundice, itching, anorexia, weight loss, clay coloured stools, dark urine\\n\\uf0b7\\nAbdominal lump, abdominal examination, look for palpable mass, liver,\\n\\uf0b7\\nGeneral examination: Jaundice, cachexia\\nHYDATID DISEASE OF LIVER\\nIt is caused by Echinococcus granulosus and Echinococcus multilocularis\\nSalient features\\nClassification by WHO\\n\\uf0b7\\nGroup 1- Active group- cysts larger than 2 cm and often fertile\\n\\uf0b7\\nGroup 2- Transition group- cysts starting to degenerate and entering a transitional stage\\nbecause of host resistance or treatment but mat contain viable protoscolices\\n\\uf0b7\\nGroup 3- Inactive group- degenerated, partially or totally calcified cysts, unlikely to contain\\nviable protoscolices\\nInvestigations\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 340, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nGroup 3- Inactive group- degenerated, partially or totally calcified cysts, unlikely to contain\\nviable protoscolices\\nInvestigations\\n\\uf0b7\\nTC and DC show eosinophillia. ELISA can point toward diagnosis. Ultrasound and CT scan\\nare the investigations of choice. CT scan shown smooth space occupying lesion with several\\nsepta\\nPharmacological treatment\\n\\uf0b7\\nTab. albendazole 400 mg TDS for 28 days repeated for 3 cycles.\\nSurgical treatment\\n\\uf0b7\\nPAIR- Puncture, Aspiration, Injection (of a scolicidal agent), Reaspiration\\n\\uf0b7\\nRadical or partial pericystectomy\\n\\uf0b7\\nHepatic segmentectomy\\n\\uf0b7\\nScolicidal agents used for surgery: hypertonic saline 15%, cetrimide 3%\\nOBSTRUCTIVE JAUNDICE\\nJaundice, also known as hyperbilirubinemia causes increased levels of bilirubin in the\\nextracellular fluid. Concentration of bilirubin in blood is normally below 1.2 mg/dL. A\\nconcentration higher than 2.5 mg/dL (>50µmol/L) leads to jaundice. It can be caused by'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 340, 'source_type': 'Authorotative', 'priority': '1'}, page_content='extracellular fluid. Concentration of bilirubin in blood is normally below 1.2 mg/dL. A\\nconcentration higher than 2.5 mg/dL (>50µmol/L) leads to jaundice. It can be caused by\\ncholedocholithiasis, periampullary mass, billiary atresia, cholangiocarcinoma, Mirizzi syndrome\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 341, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n334\\nInvestigations\\n\\uf0b7\\nS. bilirubin: total, direct, indirect, hyperbilirubinemia with increased direct bilirubin, PT with\\nINR, elevated, SGPT, SGOT- can be normal or elevated, SAP- increased more than 3 folds,\\nCA 19-9, elevated in periampullary cancers\\n\\uf0b7\\nUSG- Abdomen, MRCP, CECT- Abdomen, ERCP\\nNon pharmacological treatment\\nLow fat, high carbohydrate diet\\nPharmacological treatment\\n\\uf0b7\\nIV fluids to maintain hydration and Correction of electrolyte imbalance\\n\\uf0b7\\nInj. vitamin k\\n\\uf0b7\\nFresh frozen plasma  when indicated\\n\\uf0b7\\nProphylactic antibiotics, Inj. cefotaxime 1 gm IV 8 hourly\\nSurgical treatment\\n\\uf0b7\\nERCP with sphincterotomy and stenting, followed by cholecystectomy\\n\\uf0b7\\nFor choledocholithiasis, cholecystectomy with CBD exploration\\n\\uf0b7\\nFor stones not amenable for retrieved by ERCP\\n\\uf0b7\\nWhipple procedure (pancreaticoduodenectomy), for resectable periampullary mass\\n\\uf0b7\\nBypass procedures (hepaticojejunostomy with/without gastrojejunostomy) for unresectable\\nperiampullary mass\\nINTESTINAL OBSTRUCTION\\nCauses\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 341, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nBypass procedures (hepaticojejunostomy with/without gastrojejunostomy) for unresectable\\nperiampullary mass\\nINTESTINAL OBSTRUCTION\\nCauses\\n\\uf0b7\\nIntraluminal-impaction, foreign bodies, bezoars, gall stones\\n\\uf0b7\\nIntramural-stricture, malignancy\\n\\uf0b7\\nExtramural-bands/adhesion, hernia, volvulus intussusecption\\n\\uf0b7\\nA dynamic-paralytic ileus ,mesenteric vascular occlusion ,pseudo obstruction\\nMechanism of obstruction\\nVolvulus, incarceration, obstruction, intussusceptions\\nCauses of strangulation\\n\\uf0a7\\nExternal: hernial orifices, adhesion/bands\\n\\uf0a7\\nInterrupted blood flow: volvulus, intussusceptions\\n\\uf0a7\\nIncreased intraluminal pressure: closed loop obstruction\\n\\uf0a7\\nPrimary: mesenteric infarction'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 342, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n335\\n\\uf0b7\\nAcute-sudden onset severe colicky central abdominal pain, distension, early vomiting,\\nconstipation\\n\\uf0b7\\nAcute on chronic -short history of distension and vomiting against a background of pain\\nand constipation\\n\\uf0b7\\nChronic in large bowel obstruction with lower abdominal colic ,absolute constipation\\nfollowed by distension subacute implies incomplete obstruction\\n\\uf0b7\\nOther manifestation are dehydration, hypokalemia pyrexia, abdominal tenderness,\\nclinical features of strangulation; constant pain, tenderness with rigidity, shock\\n\\uf0b7The patient resides or recently visited an endemic area. Patient presents in 2nd or 3rd\\nweek of illness.\\n\\uf0b7Patients present with high temperature and very toxic, Ross spots, abdominal pain,\\nmalena, diarrhoea, abdominal tenderness and guarding.\\nSalient features\\nInvestigations\\n\\uf0b7X ray abdomen in standing position, shows multiple air fluid levels\\n\\uf0b7Total and differential counts\\n\\uf0b7Ultrasound abdomen\\n\\uf0b7Contrast enhanced ct scan abdomen with pelvis\\nNon surgical treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 342, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7X ray abdomen in standing position, shows multiple air fluid levels\\n\\uf0b7Total and differential counts\\n\\uf0b7Ultrasound abdomen\\n\\uf0b7Contrast enhanced ct scan abdomen with pelvis\\nNon surgical treatment\\n\\uf0b7\\nNasogastric decompression, correction of dehydration, correction of electrolytes imbalance\\nand broad spectrum antibiotics\\nSurgical treatment\\n\\uf0b7\\nExploratory laprotomy with adhesiolysis, resection of non viable intestine or extirpation of\\nobstructing lesion.\\nTYPHOID PERFORATION\\nIt is caused by Salmonella typhi.\\nSalient features\\nInvestigations\\nTC and DC shows relative neutropenia, Widal test, Blood and Stool culture, X ray abdomen\\nstanding shows free gas under diaphragm\\nNon pharmacological treatment\\n\\uf0b7\\nPatient should be admitted to intensive care unit\\n\\uf0b7\\nVigorous resuscitation of fluids'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 343, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n336\\n\\uf0b7\\nWeight loss, chronic cough, malaise, evening rise of temperature with sweating, vague\\nabdominal pain with distension, alternating constipation and diahrrea.\\n\\uf0b7\\nMay present with features of peritonitis with perforation or obstruction. Doughy feel of\\nabdomen.\\n\\uf0b7\\nInj. ceftriaxone 2 gm loading dose followed by 1 gm IV 8 hourly\\n\\uf0b7\\nTab. metronidazol 400 mg IV 8 hourly\\nSurgical treatment\\n\\uf0b7\\nEmergency exploratory laparotomy\\n\\uf0b7\\nCommonest site of perforation is terminal ileum\\n\\uf0b7\\nHaving found a perforation, look for others\\n\\uf0b7\\nIn the very ill patient, look for some type of extoriorisation\\n\\uf0b7\\nClose the peritoneum and leave the wound open for secondary healing\\nSMALL BOWEL TUBERCULOSIS\\nSalient features\\nInvestigations\\n\\uf0b7\\nHemogram shows anemia, raised ESR and CRP, positive sputum culture. Ultrasound of\\nabdomen shows localized collection.\\n\\uf0b7\\nChest X Ray show pulmonary infiltrates.\\n\\uf0b7\\nBarium meal and follow through shows multiple small bowel strictures in ileum and\\nsubhepatic caecum.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 343, 'source_type': 'Authorotative', 'priority': '1'}, page_content='abdomen shows localized collection.\\n\\uf0b7\\nChest X Ray show pulmonary infiltrates.\\n\\uf0b7\\nBarium meal and follow through shows multiple small bowel strictures in ileum and\\nsubhepatic caecum.\\nSurgical treatment\\n\\uf0b7\\nPatient should ideally be treated under combined care of physician and surgeon. Vigorous\\nsupportive and full drug treatment is mandatory in all cases. Symptomatic strictures are\\ntreated by appropriate resections.\\n\\uf0b7\\nAcute intestinal obstruction from distal illeal stricture is treated by thorough resuscitation\\nfollowed by side to side illeo-transverse bypass. Once the patient has recovered with medical\\ntreatment, then the second stage definitive procedure of right hemicolectomy is done.\\n\\uf0b7\\nOne stage resection and anastomosis can be done if the patient’s general condition permits.\\nPerforation is treated by appropriate local resection and anastomosis or exteriorization if the\\ncondition of the patient is very poor, that is later followed by restoration of bowel continuity'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 343, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Perforation is treated by appropriate local resection and anastomosis or exteriorization if the\\ncondition of the patient is very poor, that is later followed by restoration of bowel continuity\\nafter patient is fully recovered of anti-tuberculous therapy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 344, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n337\\n\\uf0b7\\nConstipation, sharp agonizing pain during defecation, bright streaks of blood in stools.\\n\\uf0b7\\nUlcer at the lower end of the anal canal seen when tightly closed puckered anus is\\nstretched apart.\\nANAL FISSURE\\nSalient features\\nPharmacological treatment\\n\\uf0b7Lignocaine jelly or ointment (5%) applied locally 3-4 times a day;\\n\\uf0b7Tab. metronidazole 400 mg for 5 days, twice a day.\\n\\uf0b7Tab ibuprofen 400 mg one tablet 8 hourly\\n\\uf0b7\\nSitz bath (warm water with povidone iodine) twice a day\\n\\uf0b7\\nIsapghula husk 1-2 teaspoon in water one or two times a day for control of constipation and\\nstraining during defecation Or\\n\\uf0b7\\nLiquid paraffin (5-15 ml) at bed time for one month, if no relief with local lignocaine,\\napplication\\nSurgical treatment\\n\\uf0b7\\nAim of therapy is to cause complete relaxation of the anal sphincter that will relieve pain and\\nslowly heal the fissure.\\n\\uf0b7\\nAnal dilation under general anaesthesia.\\n\\uf0b7\\nFissurectomy and sphincterotomy if needed.\\nFISTULA IN ANO'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 344, 'source_type': 'Authorotative', 'priority': '1'}, page_content='slowly heal the fissure.\\n\\uf0b7\\nAnal dilation under general anaesthesia.\\n\\uf0b7\\nFissurectomy and sphincterotomy if needed.\\nFISTULA IN ANO\\nA fistula-in-ano is a hollow tract lined with granulation tissue, connecting a primary opening\\ninside the anal canal to a secondary opening in the perianal skin. Secondary tracts may be\\nmultiple and can extend from the same primary opening. Fistula-in-ano is nearly always caused\\nby a previous anorectal abscess.\\nSalient features\\n\\uf0b7\\nPatients often provide a reliable history of previous pain, swelling, and spontaneous or\\nplanned surgical drainage of an anorectal abscess. Signs and symptoms of fistula-in-ano,\\nin order of prevalence, include the following perianal discharge, pain, swelling, bleeding,\\ndiarrhea, skin excoriation, external opening'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 345, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n338\\n\\uf0b7\\nBleeding per rectum, pruritus ani, something coming out per rectum, constipation.\\n\\uf0b7\\nPer rectal examination and proctoscopy  shows haemmorrhoid with or without bleeding\\npoints at 3,7,11 clock position. Grade I- punctuate bleeding , non protruding. Grade II-\\nprotrudes during straining, reduces spontaneousl. Grade III- protrudes during straining needs\\nto be manually reduced. Grade IV – prolapsed haemorrhoids. No other diagnostic modality\\nneeded  other than proctoscopy\\nInvestigations\\nIn selected cases of high fistula, multiple fistulae, and recurrent fistulae.\\n\\uf0b7\\nFistulography\\n\\uf0b7\\nEndoanal/endorectal ultrasonography\\n\\uf0b7\\nMRI\\n\\uf0b7\\nBarium enema/small bowel series\\n\\uf0b7\\nAnal manometry\\n\\uf0b7\\nExamination under anesthesia\\n\\uf0b7\\nProctosigmoidoscopy/colonoscopy\\nSurgical treatment\\n\\uf0b7\\nTreatment of underlying cause, if any - surgical procedure for eradication of tract\\n\\uf0b7\\nFistulotomy and fistulectomy\\n\\uf0b7\\nMucosal advancement flap\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 345, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nProctosigmoidoscopy/colonoscopy\\nSurgical treatment\\n\\uf0b7\\nTreatment of underlying cause, if any - surgical procedure for eradication of tract\\n\\uf0b7\\nFistulotomy and fistulectomy\\n\\uf0b7\\nMucosal advancement flap\\n\\uf0b7\\nSeton placement – the following conditions - complex fistulas (i.e., high transsphincteric,\\nsuprasphincteric, extrasphincteric) or multiple fistulas\\n\\uf0b7\\nRecurrent fistulas after previous fistulotomy\\n\\uf0b7\\nAnterior fistulas in female patients\\n\\uf0b7\\nPoor preoperative sphincter pressures\\n\\uf0b7\\nPatients with Crohn’s disease or patients who are immunosuppressed\\nPatient education\\n\\uf0b7\\nMost patients can be treated in an ambulatory setting with discharge instructions and close\\nfollow-up care. Sitz baths, analgesics, and stool-bulking agents (eg, bran, psyllium products)\\nare used in follow-up care. Frequent office visits within the first few weeks help to ensure\\nproper healing and wound care.\\nHAEMORRHOIDS\\nHaemorrhoids (commonly called piles) are the dilated tortuous veins occurring in relation to the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 345, 'source_type': 'Authorotative', 'priority': '1'}, page_content='proper healing and wound care.\\nHAEMORRHOIDS\\nHaemorrhoids (commonly called piles) are the dilated tortuous veins occurring in relation to the\\nanus. These can be primary or secondary to carcinoma of rectum, pregnancy, straining at\\nmicturition, or constipation.Classified into external, internal or mixed (externo-internal).\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 346, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n339\\n\\uf0b7\\nMajor factors are neuropathy, vasculopathy, infection.\\n\\uf0b7\\nMinor factors are arch collapse, microcirculatory abnormality, glycosylation of skin\\nproteins, reduced host immunity, altered  blood viscosity and rheological properties,\\nassocioted renal oedema, hypertension induced vessel thickness, increased weight bearing\\ndue to obesity.\\nNon pharmacological treatment\\n\\uf0b7\\nHigh fiber diet\\n\\uf0b7\\nPlenty of fluids\\n\\uf0b7\\nSitz bath-twice a day with lukewarm water\\nPharmacological treatment\\n\\uf0b7Bulk forming laxative (esabgol husk),at bed time to relieve constipation.\\n\\uf0b7Local lignocaine 2% ointment if associated external haemorrhoids\\nSurgical measures\\n\\uf0b7\\nGrade I- conservative management, injection sclerotherapy for bleeding hemmorrhoids.\\n\\uf0b7\\nGrade II- conservative management and band ligation.\\n\\uf0b7\\nGrade III/IV – hemorrhoidectomy.\\nDIABETIC FOOT\\nIt is infection, ulceration and /or gangrene of foot due to diabetes and/or its complication.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 346, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nGrade II- conservative management and band ligation.\\n\\uf0b7\\nGrade III/IV – hemorrhoidectomy.\\nDIABETIC FOOT\\nIt is infection, ulceration and /or gangrene of foot due to diabetes and/or its complication.\\nPrecipitating factors are moisture, trauma -mechanical causes like ill fitting shoes, in growing toe\\nnail, thorn prick, physical, heat, cold and infection.\\nSalient features\\nClinical classification- Maggit's classifacation\\nGrade 0- foot symptoms without ulcer\\nGrade 1-superficial ulcer\\nGrade 2-deep ulcer\\nGrade 3-deep ulcer with bone involvement\\nGrade 4-forefoot gangrene\\nGrade 5-whole  foot gangrene\\nClinical classification of neuropathy\\nCategory 1- no loss of sensation\\nCategory2-loss of sensation\\nCategory 3- loss of sensation with deformity\\nCategory 4- loss of sensation with ulcers\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 347, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n340\\n\\uf0b7\\nAching in the veins at the end of day, after prolong standing, ankle swelling, itching,\\nbleeding, superficial thrombophlebitis, eczema, lipodermatosclerosis and ulceration.\\n\\uf0b7\\nTortuous dilated vein are the in subcutaneous tissue indicative of vericose vein.\\nVaricocities in the thigh are indicative of long saphenous incompetence, whereas\\nvaricosities of back of leg are suggestive of short saphenous incompetence.\\nInvestigations\\nHb, TC, DC, Blood sugar-FBS, PPBS, BUN, S. creatinine, urine-sugar/ketone bodies.\\nLocal X-ray foot, biopsy from the edge off ulcer, pus swab for culture and sensitivity, Doppler to\\njudge vascularity\\nTreatment\\nAccording to grade\\n\\uf0b7\\nGrade 0: No specific treatment, take preventive measures to protect the limbs\\n\\uf0b7\\nGrade 1: Prescribe  special cushioned shoes to protect from pressure sore\\n\\uf0b7\\nGrade 2:  control of sugar, antibiotics according to culture reports, daily dressing and\\ndebridement.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 347, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"\\uf0b7\\nGrade 1: Prescribe  special cushioned shoes to protect from pressure sore\\n\\uf0b7\\nGrade 2:  control of sugar, antibiotics according to culture reports, daily dressing and\\ndebridement.\\n\\uf0b7\\nGrade 3: Apart from the management described above , drainage of abscess or local\\namputation\\n\\uf0b7\\nGrade 4: Patients with forefoot gangrene require amputation\\n\\uf0b7\\nGrade 5: Amputation and rehabilitation\\nVARICOSE VEINS\\nThese are defined as tortuous dilated vein. Affect 5% or more of the adult population.\\nSalient features\\nInvestigations\\nBrodie Trendelenberg test, tourniquet test, Perthe's test, Perthe's test (modified), Schwartz test,\\nPratt's test, Morrissey's cough impulse test, Fegan's method to indicate the sites of perforators,\\npitting oedema, thickening, redness, tenderness at lower part of leg, lipodermatosclerosis\\nNon pharmacological treatment\\nReassurance, elastic compression stockings - 6” elastic compression stockings applied with\\ngraduated pressure, foot end elevation\\nPharmacological treatment\\n\\uf0b7\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 347, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Non pharmacological treatment\\nReassurance, elastic compression stockings - 6” elastic compression stockings applied with\\ngraduated pressure, foot end elevation\\nPharmacological treatment\\n\\uf0b7\\nInjection sclerotherapy\\n\\uf0b7\\nUltrasound guided foam sclerotherapy\\nSurgical treatment\\n\\uf0b7\\nSaphenofemoral junction ligation and greater saphenous stripping with or without\\nincompetent perforator ligation'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 348, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n341\\n\\uf0b7\\nSaphenopopleteal junction ligation and lesser saphenous stripping with or without\\nincompetent perforator ligation\\n\\uf0b7\\nSplit thickness skin grafting for venous ulcers ,if present\\nDEEP VENOUS THROMBOSIS\\nA venous thrombus is the formation of a semisolid coagulum within flowing blood in the venous\\nsystem. Venous thrombosis of the deep veins of the leg is complicated by the immediate risk of\\npulmonary embolus and sudden death.\\nSalient features\\nRisk factors\\nPatient factor: age, obesity, varicose veins, immobility, pregnancy, puerperium, high dose\\noestrogen therapy, previous deep vein thrombosis or pulmonary embolism, thrombophilia\\nDisease or surgical procedure: trauma or surgery of pelvis , hip or lower limb, malignancy\\nespecially pelvic, and abdominal metastatic, heart failure, recent myocardial infarction, paralysis\\nof lower limbs, infection, inflammatory bowel disease, nephrotic syndrome, polycythemia,\\nparaproteinemia, homocystinemia\\nInvestigations'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 348, 'source_type': 'Authorotative', 'priority': '1'}, page_content='of lower limbs, infection, inflammatory bowel disease, nephrotic syndrome, polycythemia,\\nparaproteinemia, homocystinemia\\nInvestigations\\nD-dimer, PT, APTT, duplex ultrasound\\nPharmacological treatment\\n\\uf0b7\\nStart with low molecular weight heparin anticoagulated with warfarin.\\n\\uf0b7\\nWarfarin started at a dose of 10 mg on day one,10mg on day 2, 5mg on day three\\n\\uf0b7\\nPatient taken on day three guides  maintenence dose of warfarin\\n\\uf0b7\\nVenous thrombectomy in severe cases.\\n\\uf0b7\\nVenacaval filters in recurrent and high risk cases.\\nProphylaxis\\nMechanical methods-graduated elastic compression stockings, external pneumatic compression\\nstockings.\\nLow molecular weight heparin\\nCERVICAL LYMPHADENOPATHY\\nAn enlarged cervical lymph node is the commonest cause of lump in the neck. Cervical lymph\\nnodes may become enlarged as a result of inflammation or neoplastic process. Tuberculosisis is\\n\\uf0b7\\nChanges in the vessel wall (endothelial damage), stasis which is diminished blood flow'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 348, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"nodes may become enlarged as a result of inflammation or neoplastic process. Tuberculosisis is\\n\\uf0b7\\nChanges in the vessel wall (endothelial damage), stasis which is diminished blood flow\\nthrough the veins, coagulability of blood (thrombophilia).\\n\\uf0b7\\nPain and swelling in the calf of one of the lower limb, mild pitting oedema of ankle,\\ndilated surface veins, stiff calf and redness over the course of the deep veins, Homan's\\nsign; resistance (not pain) of the calf muscle to forcible dorsiflexion, low grade pyrexia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 349, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n342\\n\\uf0b7\\nDetailed history and examination are essential to pinpoint specific etiology.\\n\\uf0b7\\nMajority of the lymph nodes are reactive to viral infections of upper respiratory tract,\\ntherefore, do not require any treatment.\\none of the commonest causes of cervicallymphadenopathy (Table 2).\\nTable 2. Causes and clinical features of cervical lymphadenopathy\\nCondition\\nCauses\\nClinical features\\nAcute inflammation\\nInfection of the digestive  tract, head\\nand neck or other\\nFever ,sore throat,\\nFirm tender 1-2 cm diameter\\nnodes\\nChronic inflammation\\nTuberculosis, sarcoidosis,\\nHistiocytosis X\\nSwelling in the neck, firm,\\nmatted , fever may or may\\nnot  be present\\nLymphomas\\nHodgkins / Non Hodgkins\\nlymphoma\\nLarge\\npainless\\nrubbery\\nlymph nodes.\\nMetastatic\\nCarcinomas of the upper digestive\\ntract, , skin tumours of the head and\\nneck: squamous cell carcinoma, basal\\ncell carcinoma, melanoma\\nSymptoms related to primary\\ndisease,\\nSalient features\\nPharmacological treatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 349, 'source_type': 'Authorotative', 'priority': '1'}, page_content='tract, , skin tumours of the head and\\nneck: squamous cell carcinoma, basal\\ncell carcinoma, melanoma\\nSymptoms related to primary\\ndisease,\\nSalient features\\nPharmacological treatment\\n\\uf0b7\\nIn case of acute suppurative lymphadenopathy secondary to any focus of bacterial\\ninfection in the drainage area: Cap. cephalexin 250-500 mg every 6 hours for 7 days or Cap.\\namoxicillin250-500 mg every 8 hours for 7 days.\\n\\uf0b7\\nIf lymph nodes persist, perform fine needle aspiration cytology (FNAC) and treat\\naccordingly. If FNAC is non-conclusive take a biopsy from the enlarged lymph node and\\ntreat accordingly.\\n\\uf0b7\\nIn case of chronic lymphadenopathy perform FNAC and treat accordingly. If FNAC is non-\\nconclusive,perform biopsy and treat accordingly.\\nTreatment of tubercular l ymphhadenopathy\\n\\uf0b7\\nStart anti-tubercular therapy\\n\\uf0b7\\nReassess the patient after 6 months. If lymph nodes are either not present or less than 1 cm\\nsize, keep the patient under follow-up and continue treatment. However, if lymph nodes are'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 349, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nReassess the patient after 6 months. If lymph nodes are either not present or less than 1 cm\\nsize, keep the patient under follow-up and continue treatment. However, if lymph nodes are\\npalpable and more than 1 cm, take a biopsy of the node and treat accordingly and consider\\nsecond line antitubercular drugs.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 350, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"Surgery\\n343\\n\\uf0b7\\nThe patient is euthyroid, the nodules are palpable often visible( smooth, firm),painless\\nand moves with swallowing.\\n\\uf0b7\\nTiredness, emotional lability, weight loss, excessive appetite, palpitation, tachycardia, hot\\nmoist palms, exopthalmos, lid lag/retraction, agitation, thyroid goitre and bruit\\nTHYROID NODULE\\n\\uf0b7\\nThe normal thyroid gland is impalpable. The term goitre is used for generalized enlargement\\nof thyroid gland. A discrete swelling in one lobe with no palpable abnormality elsewhere is\\ntermed as isolated or solitary swelling. Discrete swellings with evidence of abnormality\\nelsewhere in the gland is termed as dominant\\n\\uf0b7\\nCause are physiological, puberty, pregnancy, Grave's disease,  multinodular, toxic adenoma,\\nneoplastic, benign, malignant, inflammatory,  autoimmune, chronic lymphocytic thyroiditis,\\nHashimoto's disease, granulomatous, de Quervain 's thyroiditis, fibrosing Riedel's thyroiditis.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 350, 'source_type': 'Authorotative', 'priority': '1'}, page_content=\"neoplastic, benign, malignant, inflammatory,  autoimmune, chronic lymphocytic thyroiditis,\\nHashimoto's disease, granulomatous, de Quervain 's thyroiditis, fibrosing Riedel's thyroiditis.\\nInfective can be acute (bacterial, viral) or chronic (tubercular, syphilitic), other   amyloid\\netiology and iodine deficiency.\\nSalient features\\nInvestigations\\nThyroid function test, autoantibody titre, isotope scan, ultrasonography, FNAC, CT scan, MRI,\\nPET scan, laryngoscopy and core biopsy\\nPrevention and treatment of simple goiter\\n\\uf0b7\\nIodised salt\\n\\uf0b7\\nIn hyperplastic goiter, thyroxine 0.15-0.2mg daily for two months\\n\\uf0b7\\nMultinodular goiter total or subtotal thyroidectomy. after subtotal resection, thyroxine is\\ngiven to suppress TSH secretion\\nSurgical treatment\\n\\uf0b7\\nTotal thyroidectomy = total lobectomy + isthmusectomy\\n\\uf0b7\\nSubtotal thyroidectomy = subtotal lobectomy + isthmusectomy\\n\\uf0b7\\nNear total thyroidectomy = total lobectomy + isthmusectomy + subtotal lobectomy\\n\\uf0b7\\nLobectomy = total lobectomy + isthmusectomy\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 350, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nSubtotal thyroidectomy = subtotal lobectomy + isthmusectomy\\n\\uf0b7\\nNear total thyroidectomy = total lobectomy + isthmusectomy + subtotal lobectomy\\n\\uf0b7\\nLobectomy = total lobectomy + isthmusectomy\\nHYPERTHYROIDISM\\nSalient features\\nInvestigations\\nThyroid function test: normal T4, suppressed TSH, thyroid scan\\nNon pharmacological treatment\\nRest and sedation'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 351, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n344\\n\\uf0b7\\nNoncyclical usually of chest wall origin and more common in peri-menopausal women.\\n\\uf0b7\\nCyclical mastalgia is common in child bearing age.\\n\\uf0b7\\nBenign lumpiness may be bilateral present in upper outer quadrant may confined to one\\nquadrant. Increases before menstrual period.\\n\\uf0b7\\nFibroadenoma presents as benign discreet lump\\nPharmacological treatment\\n\\uf0b7\\nTab. carbimazole  10 mg four times a day, when patient becomes euthyroid and maintenance\\ndose of 5 mg two or three times a day for 6-24 months\\nSurgical treatment\\n\\uf0b7\\nLarge toxic multinoduler goiter - total thyroidectomy\\n\\uf0b7\\nLarge diffuse toxic goiter - Promote elective surgery after a course of treatment with\\nantithyroid drugs and beta blocker. A subtotal thyroidectomy is performed.\\n\\uf0b7\\nToxic solitary nodular goitre /toxic adenoma/autonomous hot nodule- hemithyroidectomy\\n\\uf0b7\\nThyrotoxicosis in pregnancy- subtotal thyroidectomy in mid trimester\\n\\uf0b7\\nHashimoto’s disease/lymphedenoid goiter - total thyroidectomy  or total lobectomy'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 351, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nThyrotoxicosis in pregnancy- subtotal thyroidectomy in mid trimester\\n\\uf0b7\\nHashimoto’s disease/lymphedenoid goiter - total thyroidectomy  or total lobectomy\\nBENIGN BREAST DISEASES\\nIt may be cyclical or noncyclical mastalgia and benign breast lump (fibroadenoma)\\nSalient features\\nInvestigations\\nUltrasound of breast and axilla, mammography for patients above 35 years of age.\\nFNAC may show fibroadenoma or changes of fibroadenosis.\\nNon pharmacological treatment\\n\\uf0b7\\nReassurance\\n\\uf0b7\\nAdequate support\\n\\uf0b7\\nExclusion of caffeine in some patients\\n\\uf0b7\\nEvening primrose oil 1000 mg TDS for 3 months\\n\\uf0b7\\nIf does not respond, Tab. danazol 100 mg OD, can be increased upto TDS after discussing\\nside effects of the drugs to the patient (hirtuism, contraception failure)\\n\\uf0b7\\nFor fibroadenoma, no treatment is required. Excision is done on patient’s will, suspicious\\ncytology or large (>5 cm ) lump\\nBREAST ABSCESS\\nUsually the abscess is superficial but deep ones, when they occur, are more difficult to diagnose\\nand to treat.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 352, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n345\\n\\uf0b7\\nMiddle age female, lump in breast and/or axilla, skin changes over breast, nipple\\ndischarge, weight loss.\\n\\uf0b7\\nExamination of breast as whole with nipple areola complex. Examination of axilla as well\\nas the opposite breast and axilla.\\nPharmacological treatment\\nEarly in the infection, non-surgical measures should be applied\\n\\uf0b7\\nTab. amoxicillin (PO) : 1-2 gm/ d divided in 2-3 doses  for 5 days or\\n\\uf0b7\\nCap. ampicillin (PO) : 2-4 gm/ d divided in 2-3 doses  for 5 days\\n\\uf0b7\\nTab. ibuprofen 400 mg thrice daily.\\nNon pharmacological treatment\\n\\uf0b7\\nApply constricting bandage, stop breast-feeding from this side\\n\\uf0b7\\nExpression of milk with a breast pump to avoid engorgement.\\nSurgical treatment\\n\\uf0b7\\nFor superficial abscess: radial incision.\\n\\uf0b7\\nFor abscess near nipple: peri-alveolar incision.\\n\\uf0b7\\nFor deep abscess: beneath the breast\\n\\uf0b7\\nGentle exploration with finger or Kelly forceps. Abundant lavage with chlorhexidine-\\ncetrimide solution. Insertion of a corrugated drain.\\nCARCINOMA BREAST'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 352, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nFor deep abscess: beneath the breast\\n\\uf0b7\\nGentle exploration with finger or Kelly forceps. Abundant lavage with chlorhexidine-\\ncetrimide solution. Insertion of a corrugated drain.\\nCARCINOMA BREAST\\nCarcinoma of breast is most common malignancy in female population world wide and second\\nmost common in India.\\nSalient features\\nInvestigations\\nMammography, look for the non palpable lesion in same breast as well as base line investigation\\nin opposite breast. FNAC, true cut biopsy, excisional biopsy if mass < 4 cm in size, incisional\\nbiopsy if mass > 4 cm size\\nSurgical treatment\\n\\uf0b7\\nModified radical mastectomy is removal of whole breast tissue with nipple areola complex,\\nskin overlying lump, pectoral fascia and axillary dissection.\\n\\uf0b7\\nFor Stage II B, Stage III A:  Breast conservative surgery along with radiotherapy\\n\\uf0b7\\nLumpectomy/quadrentectomy/wide excision is indicated in solitary lump, tumor size < 4 cm,\\nnot involving nipple areola complex\\n\\uf0b7\\nDCIS for Stage I, Stage II A'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 353, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n346\\nPharmacological treatment\\n\\uf0b7\\nNeo adjuvant chemotherapy: Adjuvant chemotherapy given before surgery for down staging\\nof locally advanced breast cancer, Stage III B\\n\\uf0b7\\nAdjuvant chemotherapy:  Post operative chemotherapy for\\n-\\nall node positive cancers\\n-\\nnode negative cancer, > 1 cm in size\\n-\\nnode negative cancer, > 0.5 cm with adverse prognostic factors\\n-\\n(lymphovascular invasion, high nuclear grade, high histological grade, HER 2/neu over\\nexpression, negative hormone receptor status)\\n\\uf0b7\\nCommonly used regimen for chemotherapy are-\\n-\\nCMF regimen: cyclophosphamide, methotrexate, 5- fluorouracil- 6 cycle, every 21 days\\n-\\nCAF regimen: cyclophosphamide, adriamycin, 5- Fluorouracil 6 cycle, every 21 days\\n-\\nCyclophosphamide: 600 mg/ sqm body area IV\\n-\\n5 Fluorouracil: 600 mg/sqm body area IV\\n-\\nMethotrexate: 40 mg/sqm body area IV\\n-\\nAdriamycin: 50 mg/sqm body area IV\\nHormonal regimen\\nTab. tamoxifen 20 mg orally daily, 5 years given to ER/PR positive patients.\\nRENAL STONES'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 353, 'source_type': 'Authorotative', 'priority': '1'}, page_content='-\\nMethotrexate: 40 mg/sqm body area IV\\n-\\nAdriamycin: 50 mg/sqm body area IV\\nHormonal regimen\\nTab. tamoxifen 20 mg orally daily, 5 years given to ER/PR positive patients.\\nRENAL STONES\\nRenal stones are common in India and are caused because of low fluid intake, high salt\\nconcentrate in water. Vitamin A deficiency, renal infections, inadequate urinary drainage and\\nurinary stasis, prolonged immobilization, hyperparathyroidism are also the common causes.\\nTypes of stone: Oxalate stones, phosphate stones, uric acid stones (radiolucent stones), cystine\\nstones, xanthine stones\\nSalient features\\nInvestigations\\nX ray KUB, ultrasonography of KUB, intravenous urography, CT- IVP\\nPharmacological treatment\\n\\uf0b7\\nInj. diclofenac sodium 3 ml IM stat\\n\\uf0b7\\nInj. dicyclomine 2 ml IM stat\\n\\uf0b7\\nTab. ciprofloxacin 500 mg BD for 5 days\\n\\uf0b7\\nSalient calculus, colicky pain in lumbar region of the affected side, worsened by\\nmovements. hematuria, burning micturition.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 353, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nTab. ciprofloxacin 500 mg BD for 5 days\\n\\uf0b7\\nSalient calculus, colicky pain in lumbar region of the affected side, worsened by\\nmovements. hematuria, burning micturition.\\n\\uf0b7\\nRigidity of lateral abdominal muscles but not the rectus abdominis. Tenderness in lumbar\\nregion'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 354, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Surgery\\n347\\n\\uf0b7\\nIt is also be caused by neurogenic bladder (commonly pelvic splanchic nerve damage,\\ncauda equina syndrome, descending cortical fibers lesion, pontine micturation or storage\\ncenter lesions) or can be iatrogenic in nature (caused by medical treatment/procedure),\\nscarring of the bladder neck (commonly from removal of indwelling catheters or\\ncystoscopy operations) or damage to the bladder\\n\\uf0b7\\nIn the prostate the causes may be BPH, prostate cancer and other pelvic malignancies,\\nprostatitis.\\n\\uf0b7\\nIn urethra- congenital urethral valves , phimosis or pinhole meatus, obstruction in the\\nurethra, for example a stricture (usually caused either by injury or STD), a metastasis or a\\nprecipitated pseudo gout crystal in the urine\\n\\uf0b7\\nSTD lesions (gonorrhoea causes numerous strictures, leading to a \"rosary bead\"\\nappearance, whereas chlamydia usually causes a single stricture)\\n\\uf0b7\\nInability to pass urine, thinning of urinary stream, dribbling of urine, pain in infraumbilical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 354, 'source_type': 'Authorotative', 'priority': '1'}, page_content='appearance, whereas chlamydia usually causes a single stricture)\\n\\uf0b7\\nInability to pass urine, thinning of urinary stream, dribbling of urine, pain in infraumbilical\\nregion or palpable urinary bladder above pubic symphysis is seen.\\n\\uf0b7\\nPotassium citrate 5 ml in 100 ml of water 3-4 times/day\\n\\uf0b7\\nCalculi less than 5 mm can pass spontaneously and require no surgical intervention\\nNon pharmacological treatment\\nHigh fluid intake is advised with avoidance of lithogenic food and beverages\\nSurgical treatment\\nKidney stones\\n\\uf0b7\\nPercutaneus nephrolithotomy (PCNL)\\n\\uf0b7\\nExtracorporeal shockwave lithotripsy (ESWL)\\n\\uf0b7\\nOpen pyelolithotomy\\n\\uf0b7\\nNephrolithotomy\\nUreteric stones\\n\\uf0b7\\nEndoscopic removal by uretero renoscopy, dormia basket, ureteric meaotomy or open\\nureterolithotomy\\nURINARY RETENTION\\nUrinary retention, also known as ischuria, is a lack of ability to urinate. It is a common\\ncomplication of BPH- Benign Prostatic Hyperplasia.\\nSalient features\\nTreatment\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 354, 'source_type': 'Authorotative', 'priority': '1'}, page_content='URINARY RETENTION\\nUrinary retention, also known as ischuria, is a lack of ability to urinate. It is a common\\ncomplication of BPH- Benign Prostatic Hyperplasia.\\nSalient features\\nTreatment\\n\\uf0b7\\nInsertion of a low diameter (10 to 12 French) urinary catheter or\\n\\uf0b7\\nInsertion of Infant Feeding Tube (IFT, 5 to 7 French diameter) or\\n\\uf0b7\\nSuprapubic catheterisation (SPC)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 355, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nSymptoms of acute lower respiratory tract illness (cough with or without\\nexpectoration, shortness of breath, pleuritic chest pain) for less than 1 week\\n\\uf0b7\\nTemperature >37.7ºC, chills with rigors, and/or severe malaise\\n\\uf0b7\\nChest signs- bronchial breath sounds and/or crackles); with no other explanation for\\nthe illness.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 356, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Respiratory Diseases\\n349\\n\\uf0b7\\nAlternatives: ceftriaxone (1–2 g IV OD), cefpodoxime (200 mg orally BD), cefuroxime\\n(500 mg orally BD)] plus macrolide [clarithromycin (500 mg orally BD) or azithromycin\\n(500 mg orally once, then 250 mg OD)] for 10 to 14 days\\nInpatients, Non-ICU\\n\\uf0b7\\nA respiratory fluoroquinolone [levofloxacin (750 mg oral or IV OD), moxifloxacin (400\\nmg oral or IV OD)] for 10 to 14 days\\n\\uf0b7\\nAlternatively beta-lactams [cefotaxime (1–2 g IV TDS), ceftriaxone (1–2 g IV OD),\\nampicillin (1–2 g IV every 4–6 hourly), ertapenem (1 g IV OD in selected patients)] plus\\nmacrolide [oral clarithromycin or azithromycin (as listed above for previously healthy\\npatients) or IV azithromycin (1gm once then 500 mg daily)] – parentally for 5 to 7 days\\nand then after orally for 10 days\\nInpatients, ICU\\n\\uf0b7\\nBeta-lactams [cefotaxime (1–2 g IV TDS), ceftriaxone (2 g IV OD), ampicillin-sulbactam\\n(2 g IV TDS)] for 5 to 7 days plus azithromycin or fluoroquinolone (as listed above for'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 356, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Inpatients, ICU\\n\\uf0b7\\nBeta-lactams [cefotaxime (1–2 g IV TDS), ceftriaxone (2 g IV OD), ampicillin-sulbactam\\n(2 g IV TDS)] for 5 to 7 days plus azithromycin or fluoroquinolone (as listed above for\\ninpatients, non-ICU) for 5 to 7 days and to continue after discharge oral medication for 10\\ndays\\nSpecial concerns\\n\\uf0b7\\nIf Pseudomonas is a considered,\\nAn antipseudomonal beta-lactam [piperacillin/tazobactam (4.5 g IV QID), cefepime (1–2\\ng IV BD), imipenem (500 mg IV QID), meropenem (1 g IV TDS)] plus either\\nciprofloxacin (400 mg IV BD) or levofloxacin (750 mg IV OD) or aminoglycoside\\n[amikacin (15 mg/kg OD) or tobramycin (1.7 mg/kg OD)]\\n\\uf0b7\\nIf CA-MRSA (methicillin resistant Staphylococcus aureus) is a considered - Add\\nlinezolid (600 mg IV BD) or vancomycin (1 g IV BD). Total duration in above situations\\nis 14 days including IV for 5 days and oral medication for remaining period.\\nRecommendations for use of steroids in CAP- They should be used in septic shock or\\nARDS secondary to CAP.\\nMonitoring\\n-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 356, 'source_type': 'Authorotative', 'priority': '1'}, page_content='is 14 days including IV for 5 days and oral medication for remaining period.\\nRecommendations for use of steroids in CAP- They should be used in septic shock or\\nARDS secondary to CAP.\\nMonitoring\\n-\\nAntimicrobial therapy should be changed according to the specific pathogen(s)\\nisolated.\\n-\\nDiagnostic/therapeutic interventions should be done for complications e.g.\\nthoracocentesis, chest tube drainage, etc as required.\\n-\\nIf a patient does not respond to treatment within 48-72 hours, he/she should be\\nevaluated for the cause of non-response including development of complications,\\npresence of atypical pathogens, drug resistance, etc.\\n-\\nNon- invasive ventilation should be used in patients with CAP and acute respiratory\\nfailure.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 357, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Respiratory Diseases\\n350\\nNew or progressive radiological deterioration along with any two below\\n\\uf0b7\\nNew onset of fever, purulent discharge, leukocytosis and decline in oxygenation, purulent\\nsputum, or increased respiratory secretions, dyspnea or tachypnoea\\n\\uf0b7\\nAltered mental status\\n\\uf0b7\\nPatients with Acute respiartory distress syndrome (ARDS) as harboring VAP if sustained\\nincrease in PEEP requirement >2.5 cm H2O after being stable or decreasing or Fraction of\\ninspired oxygen (Fio2)  requirement rise by > 0.15 after being stable or decreasing.\\n\\uf0b7\\nHigh risk for developing HAP/VAP e.g. chronic cardiovascular, pulmonary, renal or liver\\ndisease, diabetes mellitus, CSF leak, asplenia, immunocompromised condition/medication,\\ninfluenza, compromised respiratory function or increased aspiration risk.\\n\\uf0b7\\nBlood should be sent for culture prior to antibiotics. However, appropriate management\\nshould not be delayed in clinically unstable patients for purpose of performing diagnostic\\nsampling.\\nFollow up\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 357, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Blood should be sent for culture prior to antibiotics. However, appropriate management\\nshould not be delayed in clinically unstable patients for purpose of performing diagnostic\\nsampling.\\nFollow up\\n\\uf0b7\\nSwitch to oral from IV therapy if the patient shows improvement in moderate to severe\\nCAP.\\n\\uf0b7\\nPatient can be considered for discharge after they start accepting drugs orally, are\\nafebrile, and hemodynamically stable for a period of at least 48 hr\\nHOSPITAL ACQUIRED PNEUMONIA\\nHospital Acquired Pneumonia (HAP) is an inflammatory condition of lung parenchyma\\ncaused by infectious agents, neither present nor incubating at time of hospital admission. It is\\ndefined as pneumonia developing 48 h after admission to the hospital. It can be caused by a\\nwide range of pathogens including gram negative bacilli such as P.aeruginosa, E.coli,\\nK.pneumoniae and Acinobacter. Ventilator Associated Pneumonia (VAP) is defined as\\npneumonia (new onset of fever) that develops after 48 hour of endotracheal intubation.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 357, 'source_type': 'Authorotative', 'priority': '1'}, page_content='K.pneumoniae and Acinobacter. Ventilator Associated Pneumonia (VAP) is defined as\\npneumonia (new onset of fever) that develops after 48 hour of endotracheal intubation.\\nSalient features\\nPharmacological treatment\\nRisk factors for pneumonia: Age >60 years, male gender, smoking, alcohol intake,\\nunderling disease, inspired O2 >0.50, renal failure/dialysis, chronic obstructive pulmonary\\ndisease, airway instrumentation, aspiration before intubation, tracheostomy, mechanical\\nventilation >2 days, coma, head trauma, continuous enteral feeding, prior antibiotics,\\nnosocomial maxillary sinusitis, repeat intensive care unit admission\\nPatients without risk factors for MDR pathogens (Treatment duration is 10 to 14 days)\\nceftriaxone (2 g IV OD) or moxifloxacin (400 mg IV OD), ciprofloxacin (400 mg IV TDS),\\nor levofloxacin (750 mg IV OD) or ampicillin/sulbactam (3 g IV QID)\\nPatients with risk factors for MDR Pathogens (Treatment duration is 10 to 14 days)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 358, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Respiratory Diseases\\n351\\n1. Beta-lactams:\\nceftazidime (2 g IV TDS) or cefepime (2 g IV BD/TDS)\\nor\\npiperacillin/tazobactam (4.5 g IV QID), imipenem (500 mg IV QID or 1 g IV TDS), or\\nmeropenem (1 g IV TDS) plus\\n2. A second agent active against gram-negative bacteria pathogens: gentamicin or\\ntobramycin (7 mg/kg IV OD) or amikacin (20 mg/kg IV OD) or ciprofloxacin (400 mg IV\\nTDS) or levofloxacin (750 mg IV OD) plus\\n3. An agent active against gram-positive bacteria pathogens: linezolid (600 mg IV BD) or\\nvancomycin (15 mg/kg, up to 1 g IV, BD)\\nFollow up\\n\\uf0b7\\nClinical improvement usually evident within 48–72 h of the initiation of antimicrobial\\ntreatment. Because findings on chest radiography often worsen initially during treatment,\\nthey are less helpful than clinical criteria as an indicator of clinical response in severe\\npneumonia.\\n\\uf0b7\\nSeriously ill patients with pneumonia, often undergo follow-up chest radiography daily, at'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 358, 'source_type': 'Authorotative', 'priority': '1'}, page_content='they are less helpful than clinical criteria as an indicator of clinical response in severe\\npneumonia.\\n\\uf0b7\\nSeriously ill patients with pneumonia, often undergo follow-up chest radiography daily, at\\nleast until they are being weaned off mechanical ventilation. Once a patient has been\\nextubated and is in stable condition, follow-up radiographs may not be necessary for a\\nfew weeks\\nPatient education (to reduce the frequency of nosocomial pneumonia in mechanically\\nventilated patients)\\n\\uf0b7\\nGeneral methods: Aggressive treatment of patient’s underlying disease, Review need and\\navoid antacids and H2 blockers for stress ulcer prophylaxis, keep patient elevated at ≥ 30º,\\nreview nutrition regimen and tube feeding procedures, extubate and remove nasogastric\\ntube as clinically indicated, controlled use of antibiotics.\\n\\uf0b7\\nRespiratory care equipment: Discriminate between equipment with nebulizers and\\nhumidiﬁers ≥48-h circuit changes (tubing and humidiﬁer) for mechanical ventilators with'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 358, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nRespiratory care equipment: Discriminate between equipment with nebulizers and\\nhumidiﬁers ≥48-h circuit changes (tubing and humidiﬁer) for mechanical ventilators with\\nhumidiﬁers; no changes for circuits with heat-moisture exchangers, proper removal of\\nrespiratory tubing condensate and education of staff to prevent washing contaminated\\ncondensate into the patient’s trachea, no transfer of equipment or devices between\\npatients, review use and care of in-line medication nebulizers.\\n\\uf0b7\\nInfection control: Surveillance in the ICU education and awareness programs on\\nnosocomial infection, handwashing and/or barrier precautions, review technique for\\nsuctioning patients; type of catheter used, review method of condensate disposal, use\\neffective methods of disinfection of devices and equipment, consider selective\\ndecontamination of the digestive tract with oral nonabsorbable antibiotics to prevent\\nnosocomial infection.\\nBRONCHIAL ASTHMA'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 358, 'source_type': 'Authorotative', 'priority': '1'}, page_content='decontamination of the digestive tract with oral nonabsorbable antibiotics to prevent\\nnosocomial infection.\\nBRONCHIAL ASTHMA\\nAsthma is a chronic inflammatory disorder of the airways characterized by episode of\\nwheezing, breathlessness, chest tightness and coughing, particularly at night or in the early'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 359, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Respiratory Diseases\\n352\\n\\uf0b7\\nPrecipitating allergens are dust, pollen, fish, nuts, strawberries, cold air, tobacco smoke,\\nviral and bacterial infections, exercise, emotional stress and drugs like NSAIDs, aspirin,\\nbeta-blocker\\n\\uf0b7\\nClassical symptoms include cough, breathlessness, chest tightness and wheezing. Signs\\ninclude tachypnoea, tachycardia, pulsus paradoxus, use of accessory muscles, silent chest\\nmorning. It is associated with widespread but variable airflow obstruction that is often\\nreversible either spontaneously or with treatment.\\nSalient features\\nDiagnosis\\n\\uf0b7\\nWhen asthma is suspected and other disorders have been ruled out (e.g. tumours in adults,\\nforeign body in children; don’t assume the presence of wheeze means asthma), confirm\\nthe diagnosis with pulmonary function tests (PFTs).\\n\\uf0b7\\nPFTs suffice as objective evidence of variable airflow obstruction:\\n-\\nA 12 % or greater improvement in forced expiratory volume (FEV1) in children and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 359, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nPFTs suffice as objective evidence of variable airflow obstruction:\\n-\\nA 12 % or greater improvement in forced expiratory volume (FEV1) in children and\\nadults, and > 200 ml in adults from the baseline 15 minutes after use of an inhaled\\nshort-acting beta2 agonist.\\n-\\nSerial measures of peak expiratory flow (PEF): A > 20% change after administration\\nof a bronchodilator.\\n\\uf0b7\\nWhen there is some probability of asthma and the above tests are non-diagnostic, the\\nfollowing tests may be used to help diagnosis of asthma:\\n-\\nMethacholine challenge\\n-\\nExercise challenge\\n-\\nInhaled corticosteroid trial: appropriate doses of inhaled steroids for 4-6 weeks\\n-\\nRaised value of absolute eosinophil count (>6-8%)\\nNon pharmacological treatment\\n\\uf0b7\\nEvaluate and assess impact and exposure to allergens and irritants in individual patients.\\n\\uf0b7\\nComplete cessation of smoking and avoidance of environmental tobacco smoke is\\nstrongly recommended.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 359, 'source_type': 'Authorotative', 'priority': '1'}, page_content='\\uf0b7\\nEvaluate and assess impact and exposure to allergens and irritants in individual patients.\\n\\uf0b7\\nComplete cessation of smoking and avoidance of environmental tobacco smoke is\\nstrongly recommended.\\n\\uf0b7\\nLifestyle management-refer patients to an asthma education program where available.\\nPharmacological treatment\\n\\uf0b7\\nIf expiratory flows are normal and symptoms are controlled, an inhaled short-acting beta2\\nagonist as needed.\\n\\uf0b7\\nIf rescue beta2 agonist is needed more than 2 times per week (excluding preventative use\\nprior to exercise) or if lung function is abnormal, an inhaled glucocorticosteroid used.\\n\\uf0b7\\nUse of spacer: Technically, the most efficient way to maximize inhaled drug delivery to\\nthe lungs is through a metered dose inhaler (MDI) and spacing device. For adults,\\nhowever, a dry powdered inhaler (DPI) has demonstrated efficacy and is more convenient'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 360, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Respiratory Diseases\\n353\\nfor most people. If using an inhaled corticosteroid MDI, a spacer device, in addition to\\nusual oral hygiene, will minimize the risk of oral thrush.\\nStep wise control of chronic asthma in patients more than 6 years of age (Table 1)\\n\\uf0b7\\nPatient should start treatment at the step most appropriate to the initial severity of their\\nasthma.\\n\\uf0b7\\nAt each step, review medication adherence, inhaler technique, and patient education.\\nReconsider diagnosis if no or poor response to therapy.\\n\\uf0b7\\nIf symptom control is maintained over 3 months, consider stepping down to the least\\nmedication necessary to maintain control.\\nTable 1. Step wise control of chronic asthma in patients more than 6 years of age\\nStep 1\\nInhaled short-acting beta2 agonist (SABA) as required.\\nStep 2\\nAdd inhaled corticosteroid (ICS). In children age 6-11 years, start at a low dose.\\nStep 3\\nAdd inhaled long-acting beta2 agonist (LABA) in combination with an ICS.\\nAssess control of asthma:\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 360, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Step 2\\nAdd inhaled corticosteroid (ICS). In children age 6-11 years, start at a low dose.\\nStep 3\\nAdd inhaled long-acting beta2 agonist (LABA) in combination with an ICS.\\nAssess control of asthma:\\n\\uf0b7\\nGood response to LABA/ICS combination ➞continue\\n\\uf0b7\\nBenefit from LABA/ICS combination but control still inadequate ➞continue\\nLABA and increase steroid dose to high dose ICS\\n\\uf0b7\\nNo response to LABA/ICS combination ➞stop LABA combination and\\ncontinue high dose inhaled steroid and proceed to Step 4\\nStep 4\\nConsider the following:\\n\\uf0b7\\nA short course of oral corticosteroids may be used in adults (i.e. prednisone\\n0.6 mg/kg/day for 5 days) to stabilize the patient\\n\\uf0b7\\nReferring patient for specialist care\\n\\uf0b7\\nAdding a third drug (e.g. leukotriene receptor antagonist, theophylline, or low\\ndose daily oral steroids)\\nTable 2 showing control of asthma\\nCharacteristic\\nControlled\\n(all of the\\nfollowing)\\nPartly controlled\\n(any measure\\npresent in any week)\\nUncontrolled\\nDaytime symptom\\nNone\\n(twice or less/wk)\\nMore than'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 360, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Table 2 showing control of asthma\\nCharacteristic\\nControlled\\n(all of the\\nfollowing)\\nPartly controlled\\n(any measure\\npresent in any week)\\nUncontrolled\\nDaytime symptom\\nNone\\n(twice or less/wk)\\nMore than\\ntwice/week\\nThree or more\\nfeature of\\npartly\\ncontrolled\\nasthma present\\nin any week\\nLimitation of activities\\nNone\\nAny\\nNocturnal symptom\\n/awakening\\nNone\\nAny\\nNeed for reliever/rescue\\ntreatment\\nNone\\n(twice or less/wk)\\nMore than\\ntwice/week\\nLung function\\n(PEF of FEV1)*\\nNormal\\n< 80% predicted or\\npersonal best (if\\nknown)\\nExacerbation\\nNone\\nOne or more/year †\\nOne in any\\nweek‡\\n* Lung function testing is not reliable for children 5 years and younger.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 361, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Respiratory Diseases\\n354\\n† Any exacerbation should prompt review of maintenance treatment to ensure that it is\\nadequate.\\n‡ By definition, an exacerbation in any week makes that an uncontrolled asthma week.\\nTable 3. Drugs and recommended dosage\\nDrugs\\nAdult (mcg per day)\\nChildren (6-11 years) mcg per\\nday\\nLow\\nMedium\\nHigh (Max)\\nLow\\nMedium\\nHigh (Max)\\nBeclomethasone\\ndipropionate pMDI\\n≤ 250\\n251-500\\n> 500 (800)\\n≤ 100\\n101-200b\\n> 200 (200)\\nBudesonide DPI\\n≤ 400\\n401-800\\n> 800 (2400)\\n≤ 200\\n201-400b\\n> 400 (400)\\nCiclesonide pMDI\\n≤ 200\\n201-400\\n> 400 (800)\\n100\\n101-200b\\n> 200 (200)\\nFluticasone\\npriopionate  pMDI\\n≤ 250\\n251-500\\n> 500 (2000)\\n≤ 100\\n101-200b\\n> 200 (400)\\nFluticasone\\nPriopionate DPI\\n≤ 250\\n251-500\\n> 500 (2000)\\n≤ 100\\n101-200b\\n> 200 (400)\\nFollow up\\n\\uf0b7\\nAn action plan to increase therapy when asthma is not controlled and to decrease therapy\\nwhen asthma is well controlled\\n\\uf0b7\\nPeriodically discuss adequacy of asthma control with the patient. Identify and eliminate\\nbarriers to effective control.\\n\\uf0b7'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 361, 'source_type': 'Authorotative', 'priority': '1'}, page_content='when asthma is well controlled\\n\\uf0b7\\nPeriodically discuss adequacy of asthma control with the patient. Identify and eliminate\\nbarriers to effective control.\\n\\uf0b7\\nConsider measuring peak flow at each visit.\\n\\uf0b7\\nEncourage the patient/family to actively manage their illness.\\n\\uf0b7\\nIf a patient is not responding to therapy, and compliance and inhaler technique is\\nappropriate, consider an alternative diagnosis and/or referral for further assessment. .\\nPatient education\\n\\uf0b7\\nProper use of prescribed medication, techniques of administration, what constitutes\\n“control” of asthma and how to monitor control with PEF measurement or symptom\\nmonitoring.\\n\\uf0b7\\nDiscuss strategies to assist patients to stop smoking and refer patients to smoking\\ncessation programs.\\nCHRONIC OBSTRUCTIVE PULMONARY DISEASE\\nChronic Obstructive Pulmonary Disease (COPD) is defined as “A preventable and treatable\\ndisease characterized by persistent airflow limitation that is not fully reversible. The airflow'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 361, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Chronic Obstructive Pulmonary Disease (COPD) is defined as “A preventable and treatable\\ndisease characterized by persistent airflow limitation that is not fully reversible. The airflow\\nlimitation is usually progressive and associated with an abnormal inflammatory response of'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'source': '../data/remedies/standard-treatment-guidelines.pdf', 'file_path': '../data/remedies/standard-treatment-guidelines.pdf', 'total_pages': 431, 'format': 'PDF 1.7', 'title': 'STANDARD TREATMENT GUIDELINES', 'author': 'abc', 'subject': '', 'keywords': '', 'moddate': '2014-01-03T12:44:35+05:30', 'trapped': '', 'modDate': \"D:20140103124435+05'30'\", 'creationDate': \"D:20131116110614+05'30'\", 'page': 362, 'source_type': 'Authorotative', 'priority': '1'}, page_content='Respiratory Diseases\\n355\\n\\uf0b7\\nChronic cough, which may be daily and productive, but can also be intermittent and\\nunproductive. Breathlessness on exertion, initially intermittent and becoming persistent\\n\\uf0b7\\nSputum production: any pattern of sputum production may indicate COPD. Frequent\\nexacerbations of bronchitis\\n\\uf0b7\\nA history of exposure to risk factors, especially tobacco smoke, occupational dusts,\\nhome cooking and biomass fuels.\\nthe lung to noxious particles or gases with some significant extra pulmonary effects that may\\ncontribute to the severity in the individual patient”.\\nSalient features\\nDiagnosis\\nDiagnosis is made by spirometry and severity classified as per GOLD (Guidelines for\\nObstructive Lung Diseases) criteria (Table 4).\\nTable 4. GOLD criteria for severity of COPD\\nGOLD\\nStage\\nSeverity\\nSymptoms\\nSpirometry\\n0\\nAt Risk\\nChronic cough, sputum\\nproduction\\nNormal\\nI\\nMild\\nWith or without chronic\\ncough or sputum production\\nFEV1/FVC <0.7 and FEV1 80%\\npredicted\\nIIA\\nModerate\\nWith or without chronic'),\n",
       " ...]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chunks=split_documents(all_pdf_documents)\n",
    "chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "960d500a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Chunks in Merck DB: 19278\n",
      "Total chunks after merge: 20678\n",
      "✅ New remedies merged into the existing medical index!\n"
     ]
    }
   ],
   "source": [
    "from langchain_community.vectorstores import FAISS\n",
    "from langchain_huggingface import HuggingFaceEmbeddings\n",
    "\n",
    "\n",
    "embeddings = HuggingFaceEmbeddings(model_name=\"all-MiniLM-L6-v2\")\n",
    "\n",
    "#Load existing db\n",
    "existing_db = FAISS.load_local(\n",
    "    \"../arvia_medical_index\", \n",
    "    embeddings, \n",
    "    allow_dangerous_deserialization=True\n",
    ")\n",
    "\n",
    "# Temporary db\n",
    "new_db = FAISS.from_documents(chunks, embeddings)\n",
    "\n",
    "print(f\"Chunks in Merck DB: {len(existing_db.docstore._dict)}\")\n",
    "\n",
    "#mergingg\n",
    "existing_db.merge_from(new_db)\n",
    "\n",
    "print(f\"Total chunks after merge: {len(existing_db.docstore._dict)}\")\n",
    "\n",
    "# save combined\n",
    "existing_db.save_local(\"arvia_medical_index_v2\")\n",
    "\n",
    "print(\"✅ New remedies merged into the existing medical index!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "9e23e09b",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 3/3 [00:00<00:00, 12.54it/s]\n"
     ]
    }
   ],
   "source": [
    "from langchain_community.document_loaders.csv_loader import CSVLoader\n",
    "from langchain_community.document_loaders import DirectoryLoader\n",
    "all_csv_documents = []\n",
    "dir_loader=DirectoryLoader(\n",
    "    \"../data/remedies\",\n",
    "    glob=\"**/*.csv\", \n",
    "    loader_cls= CSVLoader, \n",
    "    use_multithreading=True,\n",
    "    show_progress=True\n",
    "\n",
    ")\n",
    "\n",
    "\n",
    "\n",
    "csv_documents=dir_loader.lazy_load()\n",
    "\n",
    "for doc in dir_loader.lazy_load():   \n",
    "    doc.metadata[\"source_type\"] = \"Remedies\"\n",
    "    doc.metadata[\"priority\"] = \"1\"\n",
    "    all_csv_documents.append(doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "a0cb714a",
   "metadata": {},
   "outputs": [],
   "source": [
    "def split_documents(pdf_documents,chunk_size=1000,chunk_overlap=200):\n",
    "\n",
    "    text_splitter = RecursiveCharacterTextSplitter(\n",
    "        chunk_size=chunk_size,\n",
    "        chunk_overlap=chunk_overlap,\n",
    "        length_function=len,\n",
    "        separators=[\"\\n\\n\", \"\\n\", \" \", \"\"]\n",
    "    )\n",
    "    split_docs = text_splitter.split_documents(pdf_documents)\n",
    "    print(f\"Split {len(pdf_documents)} documents into {len(split_docs)} chunks\")\n",
    "    \n",
    "    # Show example of a chunk\n",
    "    if split_docs:\n",
    "        print(f\"\\nExample chunk:\")\n",
    "        print(f\"Content: {split_docs[0].page_content[:200]}...\")\n",
    "        print(f\"Metadata: {split_docs[0].metadata}\")\n",
    "    \n",
    "    return split_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "fec36f4f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Split 16927 documents into 39977 chunks\n",
      "\n",
      "Example chunk:\n",
      "Content: Name of Item: Ginger(Zingiber officinale Rose)\n",
      "Health Issue: Indigestion\n",
      "Home Remedy: 5 gm. crushed rhizome with salt or jaggery twice daily before meal.\n",
      "Yogasan: https://bostcdn.bostinnovation.com/wh...\n",
      "Metadata: {'source': '../data/remedies/Home Remedies.csv', 'row': 0, 'source_type': 'Remedies', 'priority': '1'}\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 0, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: Ginger(Zingiber officinale Rose)\\nHealth Issue: Indigestion\\nHome Remedy: 5 gm. crushed rhizome with salt or jaggery twice daily before meal.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 1, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: ANAR ( Punica granntum Linn., Dadima)\\nHealth Issue: Indigestion\\nHome Remedy: 10 ml. juice of fruit, 1 gm. black\\x02salt or fried Jira powder with honey or sugar to hold inside m ou th for so m etim e b efo re food.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 2, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: DALCHINI ( Cinnamomum zeylamcum Blume ,Tvak)\\nHealth Issue: Indigestion\\nHome Remedy: 2 gm. powder of bark with water twice a day.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 3, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: DHANIA ( Conundrum sativum Linn., Dhanyaka)\\nHealth Issue: Indigestion\\nHome Remedy: 20 ml. decoction prepared from 5 gm. coarse powder with a pinch of ginger powder thrice a day.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 4, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: JEERA ( Cuminum cyminum Linn., jiraka)\\nHealth Issue: Indigestion\\nHome Remedy: 5-6 gm. powder of fried Jeera and rock-salt with warm water thrice daily.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 5, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: KALIMIRACH ( Piper nigrum Linn., Maricha)\\nHealth Issue: Indigestion\\nHome Remedy: A pinch of powder with a piece of cru sh ed ginger & rock salt should be taken before meal.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 6, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: KARELA (Momordica charantin Linn., Karavellaka)\\nHealth Issue: Indigestion\\nHome Remedy: 5-10 ml. juice of fruit twice daily.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 7, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: LAUNG ( Syzygium aromaticum (L.) Merr & Perry, Lavanga)\\nHealth Issue: Indigestion\\nHome Remedy: 1-2 gm. powder with warm water.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 8, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: NIMBU (Citrus limon Linn., Nimbu)\\nHealth Issue: Indigestion\\nHome Remedy: 5-10 ml. juice with a pinch of salt and pepper before food.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 9, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: PIPPALI (Piper longum Linn., Pippali)\\nHealth Issue: Indigestion\\nHome Remedy: 2gm. powder with guda twice daily before meal.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 10, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: SAUNF (Foeniculum vulgare Mill., Shatapushpa)\\nHealth Issue: Indigestion\\nHome Remedy: 3-5 gm. powder with powder of fried Jeera and rock-salt with warm water thrice daily.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 11, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: TULSI (Ocimum sanctum, Tulasi)\\nHealth Issue: Indigestion\\nHome Remedy: 5-10 ml. juice twice or thrice daily.\\nYogasan: https://bostcdn.bostinnovation.com/which_exercise_helps_gastric_problem.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 12, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: Adrak/ Sonth ( Zingiber officinale Rose., Ardraka/Sunthi)\\nHealth Issue: Headache\\nHome Remedy: Warm paste should be applied over forehead upto 3A times a day.\\nYogasan: https://1.bp.blogspot.com/-uktMMkT15AE/X3Bo5puRT6I/AAAAAAAACYs/4BHdApjjehoHc7VDf16C-gGeplpWyywbQCLcBGAsYHQ/w640-h640/yoga%2Bfor%2Bmigraine.png'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 13, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: DALCHINI ( Cinnamomum zeylamcum Blume ,Tvak)\\nHealth Issue: Headache\\nHome Remedy: To be rubbed w ith w ater on a rough surface & applied to fore head.\\nYogasan: https://1.bp.blogspot.com/-uktMMkT15AE/X3Bo5puRT6I/AAAAAAAACYs/4BHdApjjehoHc7VDf16C-gGeplpWyywbQCLcBGAsYHQ/w640-h640/yoga%2Bfor%2Bmigraine.png'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 14, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: DHANIA ( Conundrum sativum Linn., Dhanyaka)\\nHealth Issue: Fever\\nHome Remedy: 20 ml. decoction from 5 gm. powder with sugar 3-4 times a day.\\nYogasan: https://3989ac5bcbe1edfc864a-0a7f10f87519dba22d2dbc6233a731e5.ssl.cf2.rackcdn.com/yogatogostudio/blog/Yoga_for_Cold_&_Flu.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 15, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: PIPPALI (Piper longum Linn., Pippali)\\nHealth Issue: Fever\\nHome Remedy: 2 gm. powder with honey twice daily.\\nYogasan: https://3989ac5bcbe1edfc864a-0a7f10f87519dba22d2dbc6233a731e5.ssl.cf2.rackcdn.com/yogatogostudio/blog/Yoga_for_Cold_&_Flu.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 16, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: TULSI (Ocimum sanctum, Tulasi)\\nHealth Issue: Fever\\nHome Remedy: 30 ml. decoction from handful of leaves & 5 gm. Dhania thrice a day.\\nYogasan: https://3989ac5bcbe1edfc864a-0a7f10f87519dba22d2dbc6233a731e5.ssl.cf2.rackcdn.com/yogatogostudio/blog/Yoga_for_Cold_&_Flu.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 17, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: Adrak/ Sonth ( Zingiber officinale Rose., Ardraka/Sunthi)\\nHealth Issue: Cold/Cough\\nHome Remedy: 2-5 gm. powder of dry rhizome w ith ja g g e ry th rice a day in divided doses. 10ml. decoction prepared from a piece of ginger every morning prevents recurrent attack of cold.\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 18, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: DHANIA ( Conundrum sativum Linn., Dhanyaka)\\nHealth Issue: Cold/Cough\\nHome Remedy: 20 ml. decoction prepared from 5 gm.coarse powder with sugar and turm eric powder thrice a day. or use of dhania powder as herbal tea every morning prevents cold, cough & problem s related to digestion.\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 19, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: ELAICHI ( Elettarin cnrdnmomum Maton, Ela)\\nHealth Issue: Cold/Cough\\nHome Remedy: 20 ml. decoction prepared from. 5 gm. Dhnnia, 1 gm Methi seeds, little turmeric powder should be taken 2-3 times/day. Little elaichi powder with a tea spoon full of honey 3-4 times day. Even ch ew in g elaichi (Not more than 3 per day) frequently is help full in dry as w ell as p ro d u ctiv e cough.\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 20, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: HALDI {Curcuma longa Linn., Haridra)\\nHealth Issue: Cold/Cough\\nHome Remedy: 2 gm. powder with warm milk and sugar twice a day\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 21, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: JEERA ( Cuminum cyminum Linn., jiraka)\\nHealth Issue: Cold/Cough\\nHome Remedy: Warm decoction of 2 gm. jeera, 5 gm. Dhania, 1 gm. Haldi, 1 gm. Methi powder and little pepper should be taken w ith honey/ sugar with lemon two to three times.Either decoction as m entioned above or chew ing few grains frequently helps in dry as well as productive cough.\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 22, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: LAUNG ( Syzygium aromaticum (L.) Merr & Perry, Lavanga)\\nHealth Issue: Cold/Cough\\nHome Remedy: 1-2 gm. of powder with honey in three divided doses.\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 23, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: PYAJ ( Allium cepa Linn., Palandu)\\nHealth Issue: Cold/Cough\\nHome Remedy: In children the decoction made from a piece should be given with Jaggery thrice daily.\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 24, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: PIPPALI (Piper longum Linn., Pippali)\\nHealth Issue: Cold/Cough\\nHome Remedy: 2 gm. powder with honey thrice a day in divided doses. 10-20 ml. decoction with 2-3 gm powder of Pippali, ginger, black pepper with sugar or honey 2-3 times a day.\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 25, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: TULSI (Ocimum sanctum, Tulasi)\\nHealth Issue: Cold/Cough\\nHome Remedy: 5-10 ml. juice twice or thrice a day with honey.\\nYogasan: https://jivayogalive.com/wp-content/uploads/2019/12/yoga-for-cold-and-dry-cough-CM108-15.jpg'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 26, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Acidity\\nHome Remedy: Take a tiny piece of jaggery (gur) every hour. Just keep it in the mouth and slowly suck it till acidity subsides. Drink coconut water 3-4 times a day. Have a plateful of watermelon (tarbooz) and/or cucumber (kheera) every hour.  Harad juice, 1-2 teaspoon daily after meals is very effective in controlling acidity. The juice can be mixed with an equal amount of amla juice for better results. To take out amla juice , grate an amla and squeeze the pulp through a clean muslin cloth to get juice. Chewing a piece of harad is an age old remedy.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 27, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Acne'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 27, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: coconut water 3-4 times a day. Have a plateful of watermelon (Clean face with cotton wool dipped in rose water 2-3 times a day. Do not use soap. Orange peel is very good in the treatment of acne. Grind the peel with some water to a paste and apply on affected parts. when oranges are not in season, you may use a powder of dried orange peels. For this, when oranges are in season, dry orange peels in shade. Powder finely in a grinder and sift it to make it a very fine powder. Store in an air tight bottle for future use. Mix 1 teaspoon lemon juice in 1 teaspoon finely ground cinnamon (dalchini) powder and apply on affected areas frequently. Sift the cinnamon (dalchini) powder to make it into a very fine powder. Crush a fegarlic (lasan) flakes and apply on the face, once or twice a day. Swallowing 1-2 flakes of ragarlic regularly helps further. Grind some neem leaves with water to a fine paste. Apply on infected area. Make a paste of ½ teaspoon each of sandalwood and turmeric'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 27, 'source_type': 'Remedies', 'priority': '1'}, page_content='a day. Swallowing 1-2 flakes of ragarlic regularly helps further. Grind some neem leaves with water to a fine paste. Apply on infected area. Make a paste of ½ teaspoon each of sandalwood and turmeric (haldi) powder in a little water and apply.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 27, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Anaemia'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: Avoid drinking tea and coffee immediately after meals as the tannin present in these interferes in the absorption of iron from the food.  Take freshly prepared apple juice an hour before meals or just before retiring for the night. For proper absorption of the juice, remember the stomach should be relatively empty when you have the juice and also do not take anything for about half an hour after the juice. Juice of beetroot taken 1-2 times daily is an excellent remedy for anaemia especially for children and teenagers. You may combine apple and beetroot for the juice. Mix 1 tablespoon amla juice with a ripe mashed banana and eat 2-3 times a day. Have a ripe banana with 1 tablespoon honey, 1-2 times a day. Soak 8-10 almonds (badam) and 1 teaspoon rice overnight. Remove outer skin of almonds and grind to a fine paste. Boil with 1½ cups of milk and a pinch of turmeric powder (haldi). Sweeten with sugar and drink for a fedays, once a day. Soak 10-12 currants (munakas) in water'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='of almonds and grind to a fine paste. Boil with 1½ cups of milk and a pinch of turmeric powder (haldi). Sweeten with sugar and drink for a fedays, once a day. Soak 10-12 currants (munakas) in water overnight. Remove seeds and eat them. Have for 2-4 weeks. Have spinach juice of 125 gm spinach everyday, for 2-3 weeks. Foods rich in iron are - honey, almonds, bananas, apricots (khurmani), raisins (kishmish), fenugreek (methi) leaves, fenugreek seeds (methi daana), lettuce or salad leaves, onion, spinach (paalak), grapes, tomatoes, carrots, gooseberry (amla), beetroots (chokunder), apples, pomegranate (anaar). Have plenty of them if you are anaemic.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 29, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Angina Pectoris\\nHome Remedy: Thoroughly mix 2 teaspoons almond oil with 1 teaspoon rose oil. Rub gently on the chest, morning and evening. Boil 1 teaspoon fenugreek seeds (methi dana) in 1½ cups water. Strain and add 2 teaspoon honey. Take twice daily.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 30, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Animal bite\\nHome Remedy: Take ½ teaspoon ground black cumin seeds (shah jeera), twice daily. Ankle - swelling & pain Mix equal quantities of castor oil and lime juice. Massage the affected area with this mixture. Also drink 1 cup warm water mixed with lime juice and honey.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 31, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Appetite loss (Anorexia)'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 31, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: Mix and powder equal quantities of carom seeds (ajwain), fennel seeds (saunf), dried ginger powder (sonth), salt and black cumin seeds (shah jeera).Mix a teaspoon of this } powder and a teaspoon of hot ghee to cooked rice and eat frequently . Take 2 teaspoon of amla juice and mix it with 2 teaspoon honey and 2 teaspoon lime juice. Add 1 cup water and drink on an empty stomach every morning. To take out juice from fresh amla, remove seeds from fresh amla and grind the pulp into a fine paste. Tie it in a muslin cloth and squeeze out the juice. whenever fresh fruits are not available, dried amla can be used. Soak 1 tablespoon of dried amla at night in a cup of water. Strain it the next morning. Add 1/8 teaspoon black pepper powder (kali Mirch) and 2 teaspoon lime juice. Dilute it if necessary with water and drink every morning regularly on an empty stomach. Take ½ teaspoon black pepper powder (kali mirch) and 1 tablespoon jaggery powder (shakkar) mixed together. Kali mirch'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 31, 'source_type': 'Remedies', 'priority': '1'}, page_content='it if necessary with water and drink every morning regularly on an empty stomach. Take ½ teaspoon black pepper powder (kali mirch) and 1 tablespoon jaggery powder (shakkar) mixed together. Kali mirch Cut 1\" piece ginger (adrak) into small pieces. Add 1½ cups of water. Boil. Simmer for 2-3 minutes. Add milk and sugar to taste, and take it frequently like tea.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 31, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Asthma'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: Mix 1 teaspoon honey with ½ teaspoon cinnamon (dalchini) powder and have at night before going to bed. Boil carom seeds (ajwain) in water and inhale the steam. Boil 8-10 flakes of garlic (lasan) in ½ cup of milk. Have this every night. Gives excellent results in early stages of asthma. Add a handful of drumstick leaves (sahijan) to 1 cup water. Boil. Simmer on loflame for 3-4 minutes. Cool and strain. Add salt, pepper and lemon juice to taste. Have every day, once or twice a day. wAn expectorant and a very effective remedy for asthma is prepared by boiling 6 cloves (laung) in 3 tablespoons of water. Take 1 teaspoon of this decoction with a little honey, thrice daily. Mix ¼ teaspoon asafetida (hing), 2 teaspoon honey, ½ teaspoon juice from betel leaf (paan ka patta), ½ teaspoon white onion juice. Have it 2-3 times a day. To take out juice from betel leaf, Clove flowers crush to a paste and squeeze through a clean muslin cloth. For onion juice, grate the onion and squeeze'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='white onion juice. Have it 2-3 times a day. To take out juice from betel leaf, Clove flowers crush to a paste and squeeze through a clean muslin cloth. For onion juice, grate the onion and squeeze through a clean muslin cloth. Mix equal amounts of fresh ginger (adrak) juice, honey & pomegranate (anaar) juice. Take 1 tablespoon, 1-2 times a day. Figs (anjeer) are known to give relief by draining the phlegm (balgam). Take 3-4 dry figs, wash them well with warm water. Soak overnight in a cup of water. Eat them first thing in the morning and also drink the water. Do this for at least 2 months.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 33, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Backache\\nHome Remedy: Rub some ginger paste on the affected area. Apply oil of eucalyptus on it.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 34, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Bad Odour\\nHome Remedy: Use neem twigs as tooth paste. Powder the dried mint (pudina) leaves. Use as toothpowder.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 35, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Baldness\\nHome Remedy: Boil 1 cup mustard oil (sarson ka tel) with 4 tablespoon henna (mehendi) leaves. Filter and bottle. Massage on the bald patches regularly. Grind the remains of tobacco smoked in a hookah and add to boiling mustard oil. Cool and store. Massage on the bald patches regularly. Rub on the scalp 1 teaspoon oil in which raw mangoes have been preserved for over one year. Repeat this treatment frequently. Grind 1 tablespoon liquorice root pieces (mulathi) in 1 cup milk with ¼ teaspoon saffron (kesar). Apply this paste on bald patches at bedtime continuously. Grind fenugreek seeds (methi dana), with water and apply on the head. Leave for at least 40 minutes before washing. Do it every morning for a month. Bed sores w Apply honey on the length and breadth of a banana leaf and lie on it for a few hours. Ensure its contact with the affected parts.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 36, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Bed wetting in children\\nHome Remedy: Give 2 walnut halves (akhrot giri) and 1 teaspoon of kishmish to the child before sleeping for 10-12 days. Belching (dakaar) Grind 2 teaspoon each carom seeds (ajwain) and dried ginger (adrak) into a fine powder. Add a little black salt (kala namak). Take 1 teaspoon of this mixture with 1 cup warm water frequently.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 37, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Blackheads\\nHome Remedy: Mix 1 teaspoon lime juice in 1 teaspoon finely ground cinnamon (dalchini) powder and apply on affected areas frequently. Mix 1 teaspoon each turmeric (haldi) powder and juice of fresh coriander (dhania) leaves and apply daily as a face pack before going to sleep.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 38, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Bladder Stones\\nHome Remedy: Boil 2 figs (anjeer) in 1 cup of water. Drink daily for a month.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 39, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Blood Deficiency'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 39, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: Take 2 teaspoon of amla juice and mix it with two teaspoonfuls each of honey and lime. Add 1 teacup water and drink on an empty stomach every morning. Whenever fresh fruits are not available, dried amla can be used. Soak 1 tablespoon the previous night in a cup of water. (Note: The treatment should continue for at least 120 days to achieve expected results.) Mix 1 tablespoon juice of amla with a ripe mashed banana and eat twice or three times a day. Soak 2 or 3 dried figs (anjeer) in 1 teacup water. Eat them along with milk next morning for a month. Blood pressure _ lowHave juice of 10-15 basil (tulsi) leaves mixed with 1 teaspoon honey. Crush the leaves to a paste and squeeze out the juice through a muslin cloth. blood pressure - high  See \"HIGH BLOOD PRESSURE\" on page 60 Blood sugar w Take 2-3 garlic (lasan) cloves for a few days regularly. Body and Muscles developmentSoak 2 almonds, 5 pista kernels and 1 teaspoon poppy seeds (khuskhus) in 1 cup cow\\'s milk for an hour.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 39, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"sugar w Take 2-3 garlic (lasan) cloves for a few days regularly. Body and Muscles developmentSoak 2 almonds, 5 pista kernels and 1 teaspoon poppy seeds (khuskhus) in 1 cup cow's milk for an hour. Grind. Add some more warm milk. Take daily for 3 months. Body dry itch Grind 1 tablespoon poppy seeds (khuskhus) with 1 teaspoon water. Add 1 teaspoon lime juice. Apply on the affected areas.\"),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 39, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 40, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Body Heat\\nHome Remedy: Add 2 to 3 drops of almonds oil to pomegranate (anaar) juice and drink. Soak 8 to 10 almonds and 1 teaspoon rice overnight. Remove the outer skin. Grind into a fine paste. Mix with some milk and add a pinch of turmeric powder (haldi) and sugar candy (mishri) to taste. Boil and drink. Remove seeds from fresh amla fruits and grind the pulp into a fine paste. Tie it in a muslin cloth and squeeze out the juice. Take 2 teaspoon of this juice and mix it with two teaspoonfuls each honey and lime juice. Add 1 cup water and drink on an empty stomach every morning. Take a tender bel fruit. Grind it with 1 cup milk. Apply on the head and massage well before taking a shower.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 41, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Body Pain\\nHome Remedy: Boil 3 tablespoon powdered nutmeg (jaiphal) in 1 cup sesame oil (til ka tel). Cool and apply on affected parts.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 42, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Boils\\nHome Remedy: Slightly roast a big onion on a naked flame. Mash it and mix in teaspoon each turmeric powder and ghee. Apply and tie a bandage. Mash the garlic (lasan) cloves and apply externally. Ground neem leaves into a paste and apply on affected parts. Apply a paste of ginger (adrak) powder and turmeric (haldi) (1:1) on boils. Grind some black cumin (kala jeera) seeds in a little water and apply the paste on the affected areas. Heat black pepper powder in ½ teaspoon ghee until charred. Use this as an ointment. Take fenugreek leaf (methi patta) paste, heat it and when lukewarm, apply on the affected parts of the body. Soak bread in warm milk and sandwich the mixture in-between the folds of a clean cotton cloth. Apply this poultice to the boil and hold in place with a cotton bandage. This draws the dirt to the surface of the skin and simultaneously bursts the boil.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 43, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Body Swelling\\nHome Remedy: Grind black cumin seeds (shah jeera) with a little hot water and apply on affected parts. Body weak ness w Soak 8 to 10 almonds and 1 teaspoon rice overnight. Remove the outer skin of almonds. Grind into a fine paste. Mix in some milk and a pinch of turmeric powder (haldi). Boil and drink along with sugar candy (mishri) or ordinary sugar to taste. Sprinkle the following on a platter of mango slices : 1 teaspoon honey, a pinch of saffron (kesar), cardamom (chhoti illaichi) and rose water (gulab jal). Take twice daily.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 44, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Breathing problem\\nHome Remedy: Mix 1 teaspoon camphor (kapoor) in ½ cup slightly warmed coconut oil and apply on the chest. Boil 2 tablespoon fennel seeds (saunf) in 1 cup water till it is reduced to half. Filter. Take 1 tablespoon every morning and evening for a few days. Boil 3 tablespoon powdered nutmeg (jaiphal) in 1 cup sesame oil (til ka tel). Cool and apply on affected parts.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 45, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Bronchitis in children\\nHome Remedy: Mix 1 teaspoon oil of garlic (lasan) and 3 teaspoon honey and give a small amount three times a day to the child.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 46, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Burns by hot water\\nHome Remedy: Take the thin buds of banana leaves. Bandage directly on affected areas. Tie the upper part for two days and then lower parts for two more days. burns, scar. Boil 1 cup neem bark (neem ki khal) in 4 cups water. Remove from fire and shake liquid. Apply the emerging froth on the affected area. Repeat several times and for several days.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 47, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Body Burns\\nHome Remedy: Mash a ripe banana and apply on burns. Bandage with betel leaves (pan ka patta). If you have a minor burn, immediately place an ice pack on the burnt area for 10 minutes. Combine 4 teaspoon each of lime juice, coconut oil and rub until the betel leaves mixture turns white. Apply on affected parts. Apply curry leaves (kari patta) as poultices over affected areas. Spread a thin layer of honey over the burn and cover with a dressing. Repeat this regularly every two or three hours till it heals. Burns by fire Immediately apply glycerine on the burnt area. Burn a handful of mango leaves to ashes and apply this on the affected parts.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 48, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Bruises\\nHome Remedy: Slice a raw onion & place over the bruise. Do not apply this to broken skin.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 49, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Cataract At Early Stages\\nHome Remedy: Mix 1 teaspoon rose water (gulab jal) with 1 teaspoon fresh lime juice. Add 10 drops of this to the eyes.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 50, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Chest Congestion\\nHome Remedy: Add to ½ litre of boiling water, 1 teaspoon carom seeds (ajwain) powder along with 1 teaspoon turmeric (haldi) powder. Cool. Take 1 tablespoon of this mixture along with 1 teaspoon honey.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 51, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Chickenpox In Early Stage\\nHome Remedy: Include figs (anjeer) in your diet every day. Children irritability Rub a nutmeg (jaiphal) lightly against a smooth grinding stone in milk and feed children who cry out at night without any apparent reasons.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 52, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Chills\\nHome Remedy: Instead of your regular hot tea or coffee, have a glass of hot water mixed with honey and lemon. Put a teaspoon of honey, lemon juice and a little grated ginger in a glass and add hot water. Stir and drink.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 53, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: High Cholesterol\\nHome Remedy: Finely dice an onion and mix it with 1 cup buttermilk along with ¼ teaspoon black pepper (kali mirch) powder and drink. Regularly intake garlic (lasan) cloves for a few days. Regularly intake coriander (dhania) decoction made by boiling 2 teaspoon dry seed powder in 1 cup water. (Milk and sugar can be added to improve its taste. This could be a welcome substitute for tea or coffee.)\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 54, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Cough\\nHome Remedy: Mix equal amounts of honey and ginger (adrak) juice. For better results warm the mixture a little & then have it. Have 1 teaspoon, 2-3-4 times a day. Three pepper corns (saboot kali mirch) sucked with a pinch of black cumin (shah jeera) and a pinch of salt gives relief. Mix 1 teaspoon pepper powder with 4 teaspoon gur (jaggery). Make small balls. Suck 3-4 balls/tablets during the day. Mix equal amounts of pepper powder and sugar candy (mishri) by weight. Mix enough pure ghee to form small balls. Suck one ball/tablet 3-4 times a day. Avoid - curd, bananas, ice, rice fried and cold foods. 1 teaspoon of basil (tulsi) leaves juice 2-3 times a day for children. Tulsi leaves can be crushed to a paste and the paste squeezed through a clean muslin cloth to get juice. Mix a pinch of turmeric (haldi) with warm 1 cup milk and have at night.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 55, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Constipation In Adults'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 55, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Home Remedy: A healthy stomach is a healthy body'. Many diseases have their roots in the digestive system. Constipation is a very common problem affecting a lot of people. Wrong eating habits, sedentary lifestyle & sluggish intestines are the main reasons. If the stomach is not cleared well, it leads to a lot of problems such as headaches, gas etc. However, use of laxatives should be discouraged as it is habit forming and also harmful in the long run. Here are some tips to relieve you of your problem. (It will take some time but be persistent and you will surely benefit) Take a hot glass of water with 1 teaspoon honey and juice of ½ a lemon first thing in the morning. Drink one litre of water first thing in the morning. Soak 6-8 dates (khajoor) in a cup of water at night. Churn in the mixer in the morning & drink first thing in the morning. Consume approx. 250-300 gms fresh grapes (angoor) every day. When not in season, soak 12-15 raisins (kishmish) in water and have them. Raisins\"),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 55, 'source_type': 'Remedies', 'priority': '1'}, page_content='mixer in the morning & drink first thing in the morning. Consume approx. 250-300 gms fresh grapes (angoor) every day. When not in season, soak 12-15 raisins (kishmish) in water and have them. Raisins should be soaked for 24-48 hours and eaten early in the morning. The water in which they are soaked should also be drunk. Simply eat a few liquorice (mulathi) sticks. One of its many properties is that it is a natural laxative.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 55, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 56, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Constipation for small children\\nHome Remedy: Soak 6-8 raisins (kishmish) in hot water (depending on the age). When cool, crush well and strain. When given routinely even to little infants, it helps to regulate bowel movement (however care should be taken - so as not to give too much otherwise the child will get loose motions.) Consumption of 6-8 apricots (khurmani) a day or 2-3 cucumbers (kheera) a day or 1-2 bananas a day is also very useful. Bulk forming vegetables like carrots, radish, spinach, cabbage or roughage creating things should be consumed. Instead of juice always opt for eating the fruit. Whole wheat flour should be used and processed foods (maida, cheese, confectionery) should be avoided. Taking 2-3 teaspoon of isabgol in milk or warm water either first thing in the morning or at bed time is very beneficial. Mix ½ teaspoon honey to ½ - 1 cup warm water and have it 2-3 times a day.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 57, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Colic in Babies\\nHome Remedy: Boil a teaspoon of fennel seeds (saunf) in a cup of water. Boil for 2-3 minutes and keep it to cool for 15-20 minutes. Strain. Add 1-2 teaspoon to every feed of milk of the baby. It helps cure colic.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 58, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Cold'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 58, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: A lemon a day keeps the cold away. For a bad cold, the juice of two lemons in ½ a litre (2½ cups) of boiling water sweetened with honey, taken at bed time, is a very effective remedy. Have ginger (adrak) tea. Cut ginger (adrak) into 1\" _ 1½\" pieces and boil with a cup of water. Give 8-10 boils. Strain, sweeten with ½ teaspoon sugar and drink hot. A tablespoon of carom seeds (ajwain) crushed and tied up in a muslin cloth can be used for inhalation to relieve congestion/blocked nose. A similar small bundle placed near the pillow of sleeping children relieves congestion. A teaspoon of cumin seeds (jeera) is added to 1 glass of boiling water. Strain and simmer for a few minutes. Let it cool. Drink it 1-2 times a day. If sore throat is also present, add a few small pieces of dry ginger (adrak) to the boiling water. Six pepper corns (saboot kali mirch) finely ground and mixed with a glass of warm water, sweetened with 5-6 batasha (a variation of sugar candy) can be taken for a'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 58, 'source_type': 'Remedies', 'priority': '1'}, page_content='(adrak) to the boiling water. Six pepper corns (saboot kali mirch) finely ground and mixed with a glass of warm water, sweetened with 5-6 batasha (a variation of sugar candy) can be taken for a few nights. In the case of the acute cold in the head, boil 1 tablespoon full pepper powder in a cup of milk along with a pinch of turmeric (haldi) and have once daily for at least 3 days. cold with phlegm (balgam) and slight cough. Take 8-10 tulsi leaves and wash well. To 1 cup of water, add these tulsi leaves, 1-2 cloves of garlic (lasan), ½\" piece ginger, crushed and 4-5 peppercorns (saboot kali mirch). Boil the water and keep simmering on fire till the quantity is reduced to ¼ cup. Cool. Strain. Add 1 teaspoon honey. Drink this every morning.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 58, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 59, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Muscular Cramps\\nHome Remedy: Apply clove oil (laung ka tel) on the affected parts.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 60, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Deafness\\nHome Remedy: Use raw onion juice as ear drops. Put two drops of lukewarm neem oil inside the ear.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 61, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Dandruff\\nHome Remedy: Soak 2 tablespoon fenugreek seeds (methi dana) in water overnight. In the morning grind into a fine paste. Apply all over scalp and leave for ½ an hour. Wash with Shikakai or mild shampoo. Boil a handful of neem leaves in 4 teacups of water. After cooling and filtering use for rinsing hair Dehydration due to diarrhoea Soak half a nutmeg (jaiphal) in 2 cups water for over 2-3 hours. Take 1 teaspoon of this infusion and mix in 1 cup fresh coconut water. Drink twice or thrice a day.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 62, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Dehydration\\nHome Remedy: Add ¼ teaspoon salt, 3 teaspoon brown sugar or ordinary sugar and 2 teaspoon lime juice to 1 cup of water, mix well and drink.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 63, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Diabetes'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 63, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: For diabetes, diet restriction & light exercise like walking is a must as this controls the sugar level. Grape fruit is a splendid thing in the diet of a diabetic. Have 3 fruits at a time, 3 times daily. A tablespoon of amla juice mixed with a cup of fresh bitter gourd (karela ) juice and taken daily for 2 months will reduce blood sugar. Take dry tender leaves of the mango tree in the shade. Powder and preserve them. Half a teaspoon of this powder twice a day in the morning and evening proves beneficial. 3-4 teaspoons juice of bitter gourd (karela), taken every morning on an empty stomach gives good results. Coarsely powder fenugreek seeds (methi dana) and have 1-2 teaspoon in the morning everyday. (Vary dosage according to individual tolerance level). Eating 10 fresh fully grown curry leaves (kari patta) every morning for 3 months is said to prevent diabetes due to heredity factors. Soak 2 teaspoon fenugreek seeds (methi dana) in 1 cup water at night. Drink this water'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 63, 'source_type': 'Remedies', 'priority': '1'}, page_content='grown curry leaves (kari patta) every morning for 3 months is said to prevent diabetes due to heredity factors. Soak 2 teaspoon fenugreek seeds (methi dana) in 1 cup water at night. Drink this water first thing in the morning and preferably eat the seeds too. Chew 8-10 basil (tulsi) leaves in the morning.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 63, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 64, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Guidelines of a Diabetics Diet\\nHome Remedy: Eat plenty of vegetables like lettuce (salaad patta), tomato and fruits. Use the following fruits and vegetables sparingly and with caution: banana, seedless grapes (angoor), cheeku, leechi, custard apple (sharifa), dry fruits, mango, raisins (kishmish), potatoes, jackfruit (kathal), carrots (gajar), peas (mattar), beans, sweet potato (shakarkandi), beetroot (chukandar). Foods rich in fibre should be preferred. Daily intake of calories should be restricted.Use proteins moderately. Milk & nuts intake to be restricted to the minimum whereas have plenty of curds and buttermilk (chhach). Avoid all refined foods & sweets. Drink 8-10 glasses of water daily.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 65, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Depression\\nHome Remedy: Boil ¼ teaspoon powdered cardamom (chhoti illaichi) seeds in thin tea water and drink. Mix 1/8 teaspoon nutmeg (jaiphal) powder with 1 tablespoon freshly extracted amla juice. Take 3 times a day.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 66, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Dental Problems\\nHome Remedy: Turmeric (haldi), burnt, and finely powdered, can be used as toothpowder.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 67, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Delivery Of Babies\\nHome Remedy: Mix 3 teaspoon lime juice, ¼ teaspoon powdered black pepper and 1 teaspoon honey in 1 cup water. Drink for 3 months.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Diarrhoea'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: Combine 1 teaspoon each powdered ginger (adrak), powdered cumin (jeera) and powdered cinnamon (dalchini) with honey and make into a thick paste. Take 1 teaspoon thrice daily. Boil 1 teaspoon cumin seeds (jeera) in a glass of water. Add to this 1 teaspoon fresh juice of coriander leaves (dhania) and a pinch of salt. Drink twice daily after meals for 2-3 days. Mash 1 ripe banana along with a pinch of salt and 1 teaspoon tamarind pulp (imli ka guda). Take twice a day. Drinking a strong cup of unsweetened black tea is very effective for stopping diarrhoea. Peel an apple and shred it. Keep the shredded pieces in a plate for approximately 20 minutes until they turn brown in colour, and then eat them. Slice the tender unripe bel fruit. Sun dry them. Powder the slices. Take 1 teaspoon along with warm water twice a day. Take every night, 3 cloves of garlic (lasan), chopped and boiled in milk. Make a paste of 1 green chilli along with 2 tablespoon lime juice and ½ teaspoon camphor'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='along with warm water twice a day. Take every night, 3 cloves of garlic (lasan), chopped and boiled in milk. Make a paste of 1 green chilli along with 2 tablespoon lime juice and ½ teaspoon camphor (kapur). Take ¼ teaspoon of this paste. 2 or 3 teaspoon coriander seeds (saboot dhania) soaked overnight in water and taken next morning with 1 cup buttermilk (chhach). Boil ¼ teaspoon powdered cardamom (chhoti illaichi) seeds in thin tea water and drink. Mix juice of 15-20 tender curry leaves (curry patta) with 1 teaspoon honey and drink. Apply ginger (adrak) juice around the navel. Insert ¼ teaspoon nutmeg (jaiphal) powder inside a ripe banana and eat.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 69, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Diarrhea due to indigestion of food\\nHome Remedy: Insert ¼ teaspoon nutmeg (jaiphal) powder inside a ripe banana and eat. Dog-bite Take ½ teaspoon powder of black cumin seeds (shah jeera) twice daily.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 70, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Ear Infection\\nHome Remedy: Extract 1 teaspoon juice from mango leaves. Slightly warm and use as ear drops when bearably hot.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 71, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Boils inside Ear\\nHome Remedy: Heat 2 teaspoon mustard oil. Add ½ teaspoon carom (ajwain) seeds and one or two flakes of crushed garlic (lasan). Boil till they turn red. Filter. Use as ear drops.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 72, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: For Ear pain due to boils use the folowing :\\nHome Remedy: Heat 1 teaspoon each of garlic (lasan) and carom seeds (ajwain) in 2 tablespoon gingelly oil (til ka tel) till they turn red in colour. Strain and cool. When cooled to body temperature, put some drops into the ears.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 73, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Eye Aching\\nHome Remedy: Powder equal quantities of liquorice (mulathi) and cumin (jeera). Take ¼ teaspoon every day along with 1 teaspoon honey for a month. Eyes burning w Mash 1 ripe banana along with a little curd and water; take twice a day. Mix equal quantities of fenugreek seed (methi daana) powder along with Shikakai powder for washing hair. Wash frequently. Grind an onion with 1 teaspoon each black pepper and poppy seeds (khuskhus) soaked in ½ cup milk. Apply this paste on the head. Allow it to dry for 15-20 minutes. Wash in warm water. Mix the juice of bottle gourd (karela) and sesame oil (til ka tel) in the ratio of 4:1, and heat till the moisture is evaporated completely. Once cool, use it for massaging the head.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 74, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Exhaustion due to overwork\\nHome Remedy: Boil ¼ teaspoon powdered cardamom (chhoti illaichi) seeds in thin tea water and drink.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 75, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Epilepsy\\nHome Remedy: Apply fresh lime juice on the head. Massage well before showering off.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 76, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name of Item: \\nHealth Issue: Eczema\\nHome Remedy: Rub a nutmeg (jaiphal) against a smooth stone slab with a little water and make a paste. Apply on affected parts. (Note: It is believed by some rural, old fashioned practitioners that instead of water, one's own early morning saliva can be used for better results.) Add 1 teaspoon camphor (kapoor) to 1 teaspoon sandalwood paste and apply on the affected areas.\\nYogasan:\"),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 77, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Eyes Having Dark Circles Around Them\\nHome Remedy: Take one teaspoon tomato juice, ½ teaspoon lemon juice, a pinch of turmeric (haldi) powder & a little gram flour (besan). Make a paste & apply. Leave for 10 minute & wash off. Drink tomato juice with a few mint leaves, little lemon juice & salt w Soak cotton wool in cucumber (kheera) or potato juice & apply around the eyes. You will find a change in 2-3 weeks. Eyes strain due to TV watching Boil ½ teaspoon fennel seeds (saunf) in a cup of water till it is reduced to half. Cool. Use as eye drops (Caution: Beware of contamination).\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 78, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Tired Eyes\\nHome Remedy: Lavender oil offers gentle relief for tired and strained eyes. Add a drop of lavender oil to 500 ml (2½ cups) of water and shake the solution well. Dip two cotton wool pads in the liquid, squeeze out the excess water and place one pad over each eye. If you wear contact lenses, they must be removed beforehand.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 79, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Eyesight Weakness\\nHome Remedy: Mix seeds of cardamom (chhoti illaichi) along with 1 tablespoon honey. Eat every day. Boil 2 tablespoon fenugreek (methi) leaves along with ½ cup moong dal and 10 small onions and eat regularly. Mix equal quantities of fenugreek seeds (methi dana) powder along with Shikakai powder for washing hair. Wash frequently.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 80, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Fainting\\nHome Remedy: A hot poultice of carom seeds (ajwain) used as dry fomentation for hands and feet.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 81, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name of Item: \\nHealth Issue: Fatigue\\nHome Remedy: Take a glass of grapefruit and lemon juice in equal parts to dispel fatigue and general tiredness after a day's work.\\nYogasan:\"),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 82, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Feet Burning\\nHome Remedy: Mash 1 ripe banana along with a little curd and water; take twice a day.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 83, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Feet / Sole Having Cracks\\nHome Remedy: Mix equal quantities of glycerin and lemon juice. Apply every night before going to bed. This mixture can be made and stored in a glass bottle. Massage your feet with castor oil every night (in winters) for 2-3 minutes and then wear socks at night. Grind equal amounts of neem leaves & turmeric (haldi). Apply on affected area. Finely grind a handful of henna (mehendi) leaves. Add 2 tablespoon lemon juice and apply on the feet. Mix the juice of bottle gourd (lauki) and sesame oil (til ka tel) in the ratio 4:1 and heat till all the moisture has evaporated. Bottle and use over cracked skin.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 84, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Feet Smelling\\nHome Remedy: Soak feet in strong tea for 20 minutes every day until the smell disappears. To prepare your footbath, brew two tea bags in 500 ml (2½ cups) of water for 15 minutes and pour the tea into a basin containing two litres of cool water.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 85, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Foot Corns\\nHome Remedy: Tie a fresh slice of lemon over the corn (painful area) and keep it all night. Massage castor oil on the corns every morning and night before sleeping. Massage for 2-3 minutes so that the oil gets absorbed. In 3-4 weeks the corns will disappear. Mash 1-2 cloves (laung) & garlic (lasan) and tie over the corns. Keep overnight.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 86, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name of Item: \\nHealth Issue: Athlete's Foot\\nHome Remedy: Keeping your feet clean and dry is enough to discourage the growth of this fungal infection. Remember, it is infectious and you must keep and wash your shoes, socks and towel separately. To soothe the broken areas of your feet, simply soak them for 10 minutes in a footbath of apple cider vinegar mixed with water.\\nYogasan:\"),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 87, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Flatulence\\nHome Remedy: Soak 3 tablespoon carom (ajwain) seeds in an adequate quantity of lime juice and dry in the shade. When fully dried, powder with a little black salt. Take 1 teaspoon of this mixture twice daily for a few days with a little warm water.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 88, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Fever'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 88, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: Extract 1 teaspoon each juice of tulsi leaves and bel flowers. Add 1 teaspoon honey. Take twice a day. Tea made by boiling 1 teaspoon fenugreek seeds (methi dana), taken twice or thrice a day provides excellent remedy. (A little honey or lemon juice can be added to improve the flavour). Grind a few roots of the mango tree into a fine paste and apply on the palm and soles of the patients. The neem leaf decoction taken with pepper powder lowers temperature. ½ teaspoon ground pepper is mixed in warm water along with 1 teaspoon palm candy (sugar obtained from palm). This drink is taken at bedtime. w Fruit juice taken frequently. Regular intake of a pinch of saffron (kesar). Apply sandalwood paste on the forehead to bring the temperature down. Boil 2 tablespoon fennel seeds (saunf) in 1 teacup water till it is reduced to half. Filter. Take 1 tablespoon every morning and evening for a few days. (This filtrate, when used to wash the eyes frequently, is reported to strengthen the'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 88, 'source_type': 'Remedies', 'priority': '1'}, page_content='in 1 teacup water till it is reduced to half. Filter. Take 1 tablespoon every morning and evening for a few days. (This filtrate, when used to wash the eyes frequently, is reported to strengthen the eye muscles. It is a good cleansing lotion for inflamed eyes.)'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 88, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 89, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Fever of unknown origin\\nHome Remedy: Boil 1 tablespoon tulsi leaves with 1 teaspoon powdered cardamom (chhoti illaichi) in 2 teacups water. Take 1 cup of this decoction with milk and sugar to taste 2 or 3 times a day.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 90, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Feverishness\\nHome Remedy: Mix 1 teacup fresh lemon juice in tender coconut water and drink.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 91, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Gas Problem\\nHome Remedy: Some people are allergic or have intolerance for milk, milk products and wheat, wheat products but go through life without ever realizing this and keep suffering from acute gas trouble. Lactose intolerance (from milk) is being recognized in the west as also gluten intolerance (from wheat). Hence giving up these two things may greatly benefit you. Instead of wheat you can have rice or chapatis of maize, jawar or bajara. w Mix ¼ teaspoon dry ginger powder (sonth) with a pinch of asafoetida (hing).\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 92, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Golden Rules for Gas Patients\\nHome Remedy: Avoid heavy (fried), spicy food. Do not eat very large meals, instead eat small meals. Try to eat a little, every 2 hours, so that the gap between the meals is not too big. Do some exercise. Even a walk will do wonders.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 93, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Gastroenteritis\\nHome Remedy: A decoction of 15-20 tulsi leaves taken along with a pinch of rock salt (kala namak) helps in the cure.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 94, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Giddiness\\nHome Remedy: Soak cumin seeds (jeera) in lime juice overnight. Keep this mixture under the sun till completely dry. Bottle it. Chew ½ teaspoon of this mixture and drink with a glass of warm water.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 95, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Giddiness due to blood pressure\\nHome Remedy: Soak 1 teaspoon each of powdered amla, coriander seeds (saboot dhania) and sandalwood in a cup of water overnight. Strain and drink the next day. Continue for a few days.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 96, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Gouty Pains\\nHome Remedy: Mix mustard oil and rectified alcohol (1 part oil to 40 parts alcohol) and use as a lotion. Make a poultice of ground fenugreek seeds (methi dana); use on the affected part.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 97, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Hair Dullness And Coarseness\\nHome Remedy: Grind fresh fenugreek leaves (methi) to a paste and apply the leaf paste over the scalp before a bath.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 98, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Hair Falling\\nHome Remedy: Take a handful of neem leaves and boil them in 4 cups water. After cooling and filtering, use the decoction for rinsing hair. Mix equal quantities of dried curry leaves (curry patta), lime peel (nimbu ka chilka), Shikakai, fenugreek seeds (methi daana) & green gram (moong saboot) and grind them finely. Store and use as a substitute for soap or shampoo. Apply fenugreek (methi) seeds, ground with some water and the paste on the head. Allow to soak at least for 40 minutes before washing. Use every morning for a month.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 99, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Hair Loss\\nHome Remedy: Apply a little almond oil (badam ka tel) on scalp frequently and massage.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 100, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Hair Greying\\nHome Remedy: Wet a lemon half and rub lemon juice into the scalp well. Wash off after it turns dry. Grind 1 tablespoon each, pulp of amla and lime juice. Massage this into the hair before going to bed. Wash it next morning. Soak shredded ginger (adrak) in honey. Eat a spoonful every morning.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 101, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Hair Thinning\\nHome Remedy: Bathe the hair in 1 cup coconut milk twice or thrice a week for a few months.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 102, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Head heaviness\\nHome Remedy: Grind the fresh amla fruits into a fine paste and apply on affected parts. Grind 2 to 3 cloves (laung) into a fine paste along with ½ teaspoon dried ginger (sonth) and apply on nose, forehead, etc.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 103, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Headache\\nHome Remedy: Roast some ajwain dry on a tawa. Tie it in a muslin bag and sniff frequently. Make a paste of 2-3 powdered cloves (laung) and salt. Apply this paste on the forehead. A paste made of dry ginger (sonth) with a little water or milk when applied to the forehead also gives relief. A ripe apple, after removing the upper rind and the inner hard portion should be taken with a little salt every morning on an empty stomach. Continue for a week. This yields good results even in case of chronic headaches. Mix 1 teaspoon finely ground cinnamon (dalchini) in 1 teaspoon water and apply on the forehead. It is very effective in headache due to exposure to cold air. Crush an onion and apply the paste on the head. Grind 10-15 tulsi leaves with 4 cloves (laung) and 1 teaspoon dried ginger (sonth) into a paste and apply.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 104, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Headache due to exposure to cold air\\nHome Remedy: Mix 1 teaspoon finely ground cinnamon (dalchini) in 1 teaspoon water and apply on the affected parts. Headache on one side w Powder equal quantities of liquorice (mulathi) and cumin (jeera). Take ¼ teaspoon every day along with 1 teaspoon honey for a month. Mix 1 teaspoon each of the following powders and store: camphor (kapoor), nutmeg (jaiphal), cardamom (chhoti illaichi) and cloves (laung). Take 2 pinches with warm water. Heart attack w Take ½ teaspoon garlic (lasan) powder every day.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 105, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Heart burn\\nHome Remedy: Add 1 tablespoon mint (pudina) leaves to 1 cup water. Take twice or thrice a day.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 106, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Heart pain\\nHome Remedy: Boil ½ teaspoon sandalwood powder in 1 cup water. Drink thrice daily.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 107, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Heart palpitation\\nHome Remedy: Boil ¼ teaspoon powdered cardamom (chhoti illaichi) seeds in thin tea water and drink.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 108, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Heart problem\\nHome Remedy: Eat ¼ teaspoon asafetida (hing) along with one large raisin (kishmish) every day. Heart weakness w Regular intake of ripe bananas strengthens the heart.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 109, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Heat exhaustion\\nHome Remedy: Apply some sandalwood oil on the forehead.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 110, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name of Item: \\nHealth Issue: Heat stroke\\nHome Remedy: Have the cooling drink 'panna'. To prepare this, cook unripe or green mangoes in hot ashes. Extract the pulp and mix with water and sugar. You may even pressure cook the mangoes if you cannot make provision for the ashes.\\nYogasan:\"),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 111, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Heels having pain\\nHome Remedy: Mix equal amounts by weight of carom seeds (ajwain), onion seeds (kalaunji) fenugreek seeds (methi daana) and saboot isabgol. Have 1 tablespoon every day first thing in the morning. If you like you can grind them slightly in the mixer - makes it more effective. This treatment takes a couple of months but is a sure shot remedy.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 112, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Hepatitis\\nHome Remedy: 1 to 2 teaspoon fresh juice of coriander (dhania) leaves is mixed in 1 cup buttermilk and taken 2-3 times.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 113, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: Hiccups\\nHome Remedy: Drink ½ glass water, slowly. w Keep a teaspoon of sugar in your month and suck slowly. Swallow ½ teaspoon mustard seeds (sarson) mixed with ½ teaspoon pure ghee. Grind 4 cardamom (chhoti illaichi) well. Boil it in 2½ cups or ½ litre water. When about 1 cup water remains, remove from fire and sieve it through a muslin cloth. Let it cool. When warm, drink a glassful. Works like magic. Suck 2-3 small pieces of fresh ginger (adrak). This helps in hiccups which keep occurring again and again.\\nYogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 114, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name of Item: \\nHealth Issue: High Blood Pressure'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 114, 'source_type': 'Remedies', 'priority': '1'}, page_content='Home Remedy: Restrict salt intake and drink plenty of fluids (at least 8-10 glasses of water daily) Drink curry leaves (curry patta) juice initially 3 times a day (1 glassful) for 1- 2 months and then reduce to only once in the morning. Have it on empty stomach. For taking out juice: fill your mixy with washed curry leaves, add ½3/4 glass water. Churn well and sieve. Add ½ - 1 lemon juice and drink fresh. Have single pod garlic (lasan), one pod first thing every morning or if this is not available, have 1-2 cloves of ordinary garlic (lasan). If you get discomfort with having garlic first thing in the morning, have 2 cloves twice a day - swallow with water any time or with meals. Mix 1 teaspoon honey, 1 teaspoon ginger (adrak) juice, 1 teaspoon cumin (jeera) powder. Have twice a day. Go on an apple diet for a few days. It has a diuretic effect and thus brings down the B.P. Fruits such as mausami, orange, peaches (aaru), plum (aloo bukhara), watermelon (tarbooz) are also beneficial.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 114, 'source_type': 'Remedies', 'priority': '1'}, page_content='on an apple diet for a few days. It has a diuretic effect and thus brings down the B.P. Fruits such as mausami, orange, peaches (aaru), plum (aloo bukhara), watermelon (tarbooz) are also beneficial. Having rice, particularly brown rice as the main staple food is very beneficial. As rice has very low sodium content and low cholesterol, it is a perfect diet for those who have been advised to have low salt diets. Consumption of natural diuretics like coconut water, butter milk, coriander (dhania) juice (make from green coriander in the same way as curry leaves juice) is very beneficial. Last but not the least, rest, relaxation and good sleep are effective in keeping B.P. under control. Drink coriander (dhania) juice made from fresh dhania (same way as curry leaves juices) 3 times a day. If this is not effective, start having fenugreek (methi) juice instead (made from fresh methi) and if this is also not effective, move to curry leaves juice. Drink each juice for 10-12 days at least'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 114, 'source_type': 'Remedies', 'priority': '1'}, page_content='If this is not effective, start having fenugreek (methi) juice instead (made from fresh methi) and if this is also not effective, move to curry leaves juice. Drink each juice for 10-12 days at least before you decide. If it is not working and then move to the next one.'),\n",
       " Document(metadata={'source': '../data/remedies/Home Remedies.csv', 'row': 114, 'source_type': 'Remedies', 'priority': '1'}, page_content='Yogasan:'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 0, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gestational Cholestasis\\nSymptoms: Itchy skin, particularly on the hands and feet\\nTreatments: \\nDisease_Code: D001\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 1, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Injury to Internal Organ\\nSymptoms: Abdominal pain, bleeding, organ dysfunction\\nTreatments: Immediate medical attention, diagnostic tests, surgery (in some cases)\\nDisease_Code: D002\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 2, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Scabies\\nSymptoms: Intense itching, especially at night, small blisters or bumps\\nTreatments: Prescription medications (topical or oral scabicides), washing clothes and bedding in hot water, vacuuming and cleaning home\\nDisease_Code: D003\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 3, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Congenital Glaucoma\\nSymptoms: Cloudy or hazy eyes, excessive tearing, sensitivity to light\\nTreatments: Surgery (e.g., trabeculotomy, goniotomy) to create a new drainage pathway, medications to reduce intraocular pressure\\nDisease_Code: D004\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 4, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Avoidant/Restrictive Food Intake Disorder (ARFID)\\nSymptoms: Avoidance or restriction of certain foods or entire food groups, significant weight loss or failure to gain weight\\nTreatments: Nutritional counseling, psychotherapy (such as cognitive-behavioral therapy or family-based therapy), medical monitoring, exposure therapy, occupational therapy\\nDisease_Code: D005\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 5, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Subdural hemorrhage\\nSymptoms: Headache, confusion, dizziness, nausea or vomiting, seizures, weakness or numbness\\nTreatments: Immediate medical attention, close monitoring of vital signs and neurological status, diagnostic imaging (such as CT or MRI scan), potential surgical intervention (such as craniotomy or burr hole evacuation), medication to manage symptoms\\nDisease_Code: D006\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 6, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Poisoning due to Antidepressants\\nSymptoms: Nausea, vomiting, drowsiness, dizziness, confusion, seizures, changes in heart rate, low blood pressure, respiratory distress\\nTreatments: Seek immediate medical assistance or contact a poison control center, activated charcoal (if indicated), supportive care (maintaining vital signs, airway management), gastric lavage (in certain cases), administration of antidotes (if available and appropriate), monitoring and management of complications\\nDisease_Code: D007\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 7, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Mittelschmerz\\nSymptoms: Lower abdominal pain and discomfort occurring around the time of ovulation\\nTreatments: Pain management (over-the-counter pain relievers, heat therapy), hormonal birth control (if severe or recurrent)\\nDisease_Code: D008\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 8, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cornea Infection\\nSymptoms: Eye redness, pain or discomfort, blurred or decreased vision, increased sensitivity to light\\nTreatments: Antibiotic or antifungal eye drops, oral medications, supportive care, possible corneal transplant (in severe cases)\\nDisease_Code: D009\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 9, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Myopia\\nSymptoms: Blurred distance vision, eyestrain, squinting\\nTreatments: Eyeglasses, contact lenses, refractive surgery (LASIK), orthokeratology (for some cases)\\nDisease_Code: D010\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 10, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Abscess of the Lung\\nSymptoms: Cough with phlegm or pus, chest pain, fever, shortness of breath, fatigue\\nTreatments: Antibiotics, drainage or surgical removal of the abscess, supportive care, management of underlying lung conditions\\nDisease_Code: D011\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 11, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Congenital rubella\\nSymptoms: Developmental delays, intellectual disability, hearing loss, vision problems, heart defects, liver or spleen enlargement, rash at birth\\nTreatments: Supportive care to manage symptoms and complications, early intervention services for developmental delays, educational support, vision and hearing interventions, specialized medical care as needed\\nDisease_Code: D012\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 12, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Intertrigo\\nSymptoms: Red, raw, or inflamed skin in skin folds (such as armpits or groin), itching or burning sensation\\nTreatments: Keeping the affected area clean and dry, applying topical antifungal or antibacterial creams, using barrier creams\\nDisease_Code: D013\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 13, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Insect Bites\\nSymptoms: Red, swollen, itchy bumps\\nTreatments: Topical corticosteroids, oral antihistamines, cold compresses\\nDisease_Code: D014\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 14, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Complex Regional Pain Syndrome\\nSymptoms: Severe and chronic pain, often in the limbs, with associated swelling, changes in skin color or temperature, abnormal sweating, limited range of motion\\nTreatments: Physical therapy (including exercises, stretching, and mirror therapy), pain management techniques (such as medications, nerve blocks, or spinal cord stimulation), sympathetic nerve blocks, psychological support (such as cognitive-behavioral therapy or counseling), occupational therapy, graded motor imagery, transcutaneous electrical nerve stimulation (TENS), patient education and self-management techniques\\nDisease_Code: D015\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 15, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Anxiety\\nSymptoms: Excessive worrying, restlessness, increased heart rate, panic attacks\\nTreatments: Therapy (cognitive-behavioral therapy, psychotherapy), medications (antidepressants, anti-anxiety drugs)\\nDisease_Code: D016\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 16, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gastroesophageal Reflux Disease (GERD)\\nSymptoms: Heartburn, acid reflux, chest pain\\nTreatments: Lifestyle changes, medications (antacids, proton pump inhibitors)\\nDisease_Code: D017\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 17, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Crushing Injury\\nSymptoms: Severe pain, swelling, deformity, bruising, difficulty moving or using the affected area\\nTreatments: Emergency medical attention, immobilization, pain management, surgery (to repair or reconstruct affected tissues), rehabilitation (physical therapy, occupational therapy)\\nDisease_Code: D018\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 18, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cellulitis\\nSymptoms: Redness, Pain, tenderness, Swelling, Skin changes, Lymph node enlargement\\nTreatments: Antibiotics, Warm compresses, immobilization, rest, Pain management\\nDisease_Code: D019\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 19, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Anal Fissure\\nSymptoms: Pain during bowel movements, rectal bleeding\\nTreatments: Stool softeners, fiber supplements, topical ointments, surgical procedures (in severe cases)\\nDisease_Code: D020\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 20, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Neuropathic Pain\\nSymptoms: Shooting or burning pain, tingling or numbness\\nTreatments: Medications (such as antidepressants, anticonvulsants, topical treatments), nerve blocks, spinal cord stimulation, physical therapy, occupational therapy, transcutaneous electrical nerve stimulation (TENS), acupuncture, cognitive-behavioral therapy, relaxation techniques\\nDisease_Code: D021\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 21, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Common Cold\\nSymptoms: cough, sore throat, runny nose, sneezing\\nTreatments: rest, fluids, over-the-counter medication\\nDisease_Code: D022\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 22, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Food Allergy\\nSymptoms: Rash, itching, swelling, difficulty breathing, gastrointestinal symptoms\\nTreatments: Avoidance of allergenic food, antihistamines, epinephrine (in severe cases)\\nDisease_Code: D023\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 23, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pulmonary Fibrosis\\nSymptoms: Shortness of breath, dry cough, fatigue\\nTreatments: Medications (immunosuppressants, antifibrotic drugs), oxygen therapy, lung transplantation\\nDisease_Code: D024\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 24, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hyperosmotic Hyperketotic State\\nSymptoms: Increased blood sugar levels, increased ketone production, excessive thirst, frequent urination, fatigue, confusion, fruity breath odor\\nTreatments: Insulin therapy to regulate blood sugar levels, intravenous fluids to correct dehydration, electrolyte replacement, correction of underlying causes (e.g., diabetes management)\\nDisease_Code: D025\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 25, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Overflow Incontinence\\nSymptoms: Frequent or constant dribbling of urine, inability to completely empty the bladder, weak urine stream\\nTreatments: Bladder training exercises, double voiding, catheterization, medications (alpha-blockers, anticholinergics), surgery (in severe cases), lifestyle modifications\\nDisease_Code: D026\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 26, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Abdominal Injury\\nSymptoms: Abdominal pain, tenderness, bruising, swelling, difficulty breathing, nausea, vomiting, changes in bowel movements, blood in urine or stool\\nTreatments: Immediate medical attention, X-ray, CT scan, ultrasound, stabilization of vital signs, pain management, observation for signs of internal bleeding, potential surgical intervention, wound care\\nDisease_Code: D027\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 27, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hirsutism\\nSymptoms: Excessive hair growth in women\\nTreatments: Medications (anti-androgens, oral contraceptives), hair removal methods, lifestyle changes\\nDisease_Code: D028\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Neuralgia\\nSymptoms: Sharp, shooting pain along the affected nerve\\nTreatments: Medications (pain relievers, anticonvulsants), nerve blocks\\nDisease_Code: D029\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 29, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Warthin tumor\\nSymptoms: Painless lump or swelling, Facial changes\\nTreatments: Surgical excision\\nDisease_Code: D030\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 30, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Presbycusis\\nSymptoms: Gradual hearing loss, difficulty hearing high-pitched sounds, speech sounds muffled or unclear\\nTreatments: Hearing aids, assistive listening devices, cochlear implants (in severe cases), communication strategies, counseling, regular hearing evaluations\\nDisease_Code: D031\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 31, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Opioid Use Disorder\\nSymptoms: Compulsive use of opioids, strong desire or cravings for opioids, inability to control or reduce opioid use, withdrawal symptoms (such as nausea, muscle aches, anxiety) when attempting to stop or reduce use, tolerance to opioids, continued use despite negative consequences (such as legal issues, health problems)\\nTreatments: Medication-assisted treatment (such as methadone, buprenorphine, naltrexone), counseling or therapy (such as cognitive-behavioral therapy, contingency management), support groups (such as Narcotics Anonymous), harm reduction strategies, addressing underlying psychological or social factors, lifestyle changes, ongoing monitoring and support\\nDisease_Code: D032\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Panic disorder\\nSymptoms: Palpitations, Sweating, Trembling, Shortness of breath, Fear of losing control, Dizziness\\nTreatments: Antidepressant medications, Cognitive Behavioral Therapy, Relaxation Techniques\\nDisease_Code: D033\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 33, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Esophageal Cancer\\nSymptoms: Difficulty swallowing, unintentional weight loss, chest pain, hoarseness\\nTreatments: Surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, palliative care, clinical trials\\nDisease_Code: D034\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 34, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Alcohol Intoxication\\nSymptoms: Slurred speech, impaired coordination, confusion\\nTreatments: Supportive care, ensuring hydration, monitoring vital signs, prevention of complications\\nDisease_Code: D035\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 35, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pilonidal Cyst\\nSymptoms: Pain or discomfort in the tailbone area, swelling, redness, drainage of pus or blood, abscess formation\\nTreatments: Warm compresses, pain management, antibiotics (for infection), incision and drainage, surgical removal or excision, wound care, lifestyle modifications to prevent recurrence\\nDisease_Code: D036\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 36, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gestational Diabetes\\nSymptoms: High blood sugar levels during pregnancy\\nTreatments: Blood sugar monitoring, healthy diet modifications, regular exercise, insulin injections (if needed), close monitoring by healthcare provider\\nDisease_Code: D037\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 37, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Drug Withdrawal\\nSymptoms: Anxiety, restlessness, irritability, tremors, sweating, nausea, vomiting, insomnia, drug cravings\\nTreatments: Gradual tapering of the drug under medical supervision, medications to manage withdrawal symptoms (such as benzodiazepines, clonidine, or buprenorphine), behavioral therapy, support groups, counseling, rehabilitation programs\\nDisease_Code: D038\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 38, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fetal Alcohol Syndrome\\nSymptoms: Growth deficiencies, facial abnormalities, developmental delays, intellectual disability\\nTreatments: Early intervention services for developmental delays, educational support, speech and occupational therapy, behavioral interventions, medical management of associated health issues\\nDisease_Code: D039\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 39, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Polycythemia Vera\\nSymptoms: Increased red blood cell count, fatigue, headache, dizziness, itching, enlarged spleen\\nTreatments: Phlebotomy (removal of blood), medication (hydroxyurea, interferon), low-dose aspirin, managing complications (blood thinners, medication for itching)\\nDisease_Code: D040\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 40, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Osteoarthritis\\nSymptoms: Joint pain, stiffness, swelling\\nTreatments: Pain relievers, physical therapy, weight management, assistive devices, surgery (in severe cases)\\nDisease_Code: D041\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 41, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fracture of the Neck\\nSymptoms: Severe neck pain, swelling, tenderness, difficulty moving or turning the head, numbness or weakness in the arms or legs\\nTreatments: Immobilization (cervical collar, brace), pain management, potential surgical intervention (in severe cases)\\nDisease_Code: D042\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 42, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Myoclonus\\nSymptoms: Sudden, brief muscle contractions or jerks, often affecting the arms, legs, or face\\nTreatments: Identifying and treating underlying causes (e.g., medication adjustments, metabolic imbalances), medications (anti-seizure drugs, tranquilizers), physical therapy, supportive care\\nDisease_Code: D043\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 43, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Foreign Body in the Gastrointestinal Tract\\nSymptoms: Abdominal pain or discomfort, difficulty swallowing, choking or gagging, drooling, nausea or vomiting, loss of appetite, chest pain or pressure, respiratory distress, coughing or wheezing, gastrointestinal bleeding, bowel obstruction, perforation of the digestive tract\\nTreatments: Observation and monitoring (for small, smooth, and non-sharp objects that are likely to pass through the digestive tract without complications), endoscopic removal (using a flexible tube with a camera to locate and remove the foreign body), surgical intervention (in cases of severe complications, large or sharp objects, or failed endoscopic removal attempts), supportive care (such as intravenous fluids, pain management, and antibiotics if infection is present), imaging studies (such as X-rays or CT scans) to evaluate the location and extent of the foreign body, consultation with a gastroenterologist or surgeon for appropriate management'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 43, 'source_type': 'Remedies', 'priority': '1'}, page_content='Disease_Code: D044\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 44, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Coronary Atherosclerosis\\nSymptoms: Chest pain or discomfort (angina), shortness of breath, fatigue, irregular heartbeat, dizziness, nausea, sweating, jaw or arm pain (in some cases), heart attack (when a coronary artery becomes completely blocked)\\nTreatments: Lifestyle changes (such as a heart-healthy diet, regular exercise, weight management, smoking cessation), medication (such as aspirin, cholesterol-lowering medications, beta-blockers, calcium channel blockers, nitroglycerin), procedures (such as angioplasty and stenting, coronary artery bypass grafting), cardiac rehabilitation, management of other risk factors (such as high blood pressure, diabetes)\\nDisease_Code: D045\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 45, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypertensive Heart Disease\\nSymptoms: High blood pressure, chest pain or discomfort, shortness of breath, fatigue\\nTreatments: Medications (antihypertensives), lifestyle changes (healthy diet, exercise, stress management), treatment of underlying conditions\\nDisease_Code: D046\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 46, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Mumps\\nSymptoms: Swollen salivary glands (usually parotid), fever, headache, fatigue\\nTreatments: Supportive care, pain relievers, isolation, vaccination (MMR)\\nDisease_Code: D047\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 47, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cholesteatoma\\nSymptoms: Ear pain, hearing loss, ear drainage, dizziness or vertigo, tinnitus\\nTreatments: Surgical removal, antibiotics (for associated infections)\\nDisease_Code: D048\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 48, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Polycystic Kidney Disease\\nSymptoms: Abdominal pain, high blood pressure, kidney cysts\\nTreatments: Symptom management, blood pressure control, dialysis\\nDisease_Code: D049\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 49, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Juvenile Rheumatoid Arthritis\\nSymptoms: Joint pain, swelling, stiffness, limited range of motion, fever, rash\\nTreatments: Medications (NSAIDs, DMARDs), physical therapy, occupational therapy, exercise, assistive devices\\nDisease_Code: D050\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 50, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypospadias\\nSymptoms: Abnormal positioning of the urethral opening on the underside of the penis, penile curvature, spraying of urine, difficulty in urination\\nTreatments: Surgical repair (hypospadias repair surgery), hormone therapy (in some cases), counseling and support for the child and family\\nDisease_Code: D051\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 51, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Parotid stones\\nSymptoms: Swelling, pain, dry mouth, bad taste\\nTreatments: Hydration,Saliva stimulation, Stone removal\\nDisease_Code: D052\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 52, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Achalasia\\nSymptoms: Difficulty swallowing\\nTreatments: Balloon dilation, surgery, medication\\nDisease_Code: D053\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 53, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Rumination Disorder\\nSymptoms: Repeated regurgitation and re-chewing of food\\nTreatments: Behavioral therapy (such as diaphragmatic breathing techniques), biofeedback, addressing any underlying psychological or medical conditions, dietary modifications\\nDisease_Code: D054\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 54, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bronchitis\\nSymptoms: Persistent cough with yellow or green mucus, chest congestion, fatigue\\nTreatments: Rest, fluids, over-the-counter cough suppressants, inhalers (if prescribed), treating underlying cause\\nDisease_Code: D055\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 55, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Balanitis\\nSymptoms: Inflammation of the glans penis (tip of the penis), redness, swelling, pain\\nTreatments: Good hygiene, topical antifungal or antibacterial creams, corticosteroid creams (if severe), treating underlying causes\\nDisease_Code: D056\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 56, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Ectopic Pregnancy\\nSymptoms: Vaginal bleeding, abdominal pain or cramping, shoulder pain (if the fallopian tube ruptures)\\nTreatments: Immediate medical attention, potential medical procedures (such as medication or surgery to remove the ectopic pregnancy), close monitoring, emotional support\\nDisease_Code: D057\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 57, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Atelectasis\\nSymptoms: Difficulty breathing, rapid breathing, chest pain\\nTreatments: Treatment of the underlying cause (such as removal of airway obstruction, treatment of lung infection), deep breathing exercises, coughing techniques, incentive spirometry, chest physiotherapy, bronchodilator medications, supplemental oxygen therapy\\nDisease_Code: D058\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 58, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Anorexia Nervosa\\nSymptoms: Extreme weight loss, fear of gaining weight, distorted body image\\nTreatments: Medical monitoring, nutritional counseling, psychotherapy (such as cognitive-behavioral therapy or family-based therapy), medications (in some cases), hospitalization (for severe cases), support groups\\nDisease_Code: D059\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 59, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypergammaglobulinemia\\nSymptoms: Elevated levels of gamma globulins in the blood, may be asymptomatic or associated with other underlying conditions\\nTreatments: Treatment of underlying cause or associated condition, immunosuppressive therapy (in some cases)\\nDisease_Code: D060\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 60, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pregnancy-Induced Hypertension\\nSymptoms: High blood pressure during pregnancy\\nTreatments: Monitoring blood pressure, lifestyle modifications (such as salt restriction, regular exercise), medication (such as antihypertensive drugs) if necessary, close monitoring by healthcare provider\\nDisease_Code: D061\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 61, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chorioretinitis\\nSymptoms: Eye pain, blurred vision, sensitivity to light\\nTreatments: Antiviral medications, corticosteroids, eye drops\\nDisease_Code: D062\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 62, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Open-Angle Glaucoma\\nSymptoms: Gradual loss of peripheral vision, tunnel vision\\nTreatments: Eye drops to lower intraocular pressure (e.g., prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors), oral medications (e.g., carbonic anhydrase inhibitors), laser trabeculoplasty, surgical procedures (e.g., trabeculectomy, glaucoma drainage implants)\\nDisease_Code: D063\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 63, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cranial Nerve Palsy\\nSymptoms: Depends on the specific cranial nerve involved; symptoms can include vision changes, eye movement abnormalities, facial weakness or paralysis, difficulty swallowing or speaking, loss of sensation in the face or other areas\\nTreatments: Treatment depends on the underlying cause and specific cranial nerve affected. It may include medications (such as corticosteroids or antiviral drugs), physical therapy, speech therapy, occupational therapy, eye exercises, surgery (in some cases), and management of any underlying conditions.\\nDisease_Code: D064\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 64, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Corneal Abrasion\\nSymptoms: Eye pain, redness, foreign body sensation, sensitivity to light\\nTreatments: Eye patching, lubricating eye drops, antibiotic ointments (if infected), avoiding further eye irritation\\nDisease_Code: D065\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 65, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hiatal Hernia\\nSymptoms: Heartburn, chest pain, difficulty swallowing\\nTreatments: Lifestyle changes, medications (antacids, proton pump inhibitors)\\nDisease_Code: D066\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 66, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Type 2 Diabetes\\nSymptoms: increased thirst, frequent urination, fatigue\\nTreatments: insulin, medication, lifestyle change\\nDisease_Code: D067\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 67, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Uterine Fibroids\\nSymptoms: Heavy or prolonged menstrual periods, pelvic pain or pressure, frequent urination, difficulty emptying the bladder, constipation, backache, leg pain, enlarged abdomen or uterus, infertility or recurrent miscarriages (in some cases)\\nTreatments: Watchful waiting (for small or asymptomatic fibroids), medication (such as hormonal birth control, GnRH agonists, progestin-releasing intrauterine devices), minimally invasive procedures (such as uterine artery embolization, myomectomy), hysteroscopic procedures (such as hysteroscopic myomectomy or endometrial ablation), surgical removal of fibroids (such as laparoscopic or robotic-assisted myomectomy, hysterectomy), focused ultrasound ablation, hormonal therapy, alternative approaches (such as acupuncture or herbal remedies)\\nDisease_Code: D068\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Angle-Closure Glaucoma\\nSymptoms: Severe eye pain, headache, blurred vision, halos around lights, nausea and vomiting\\nTreatments: Medications (e.g., oral or intravenous acetazolamide, topical beta blockers, alpha agonists, prostaglandin analogs), laser peripheral iridotomy, surgical procedures (e.g., trabeculectomy, glaucoma drainage implants)\\nDisease_Code: D069\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 69, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Headache\\nSymptoms: Persistent head pain, tension in neck and shoulders\\nTreatments: Pain-relieving medications, relaxation techniques, stress management\\nDisease_Code: D070\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 70, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Acute Kidney Injury\\nSymptoms: Decreased urine output, fluid retention, fatigue\\nTreatments: Treating underlying cause, supportive care, medications to manage complications, dialysis (in severe cases)\\nDisease_Code: D071\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 71, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Scarlet Fever\\nSymptoms: Sore throat, fever, rash (red, sandpaper-like), swollen glands\\nTreatments: Antibiotics (such as penicillin or erythromycin), rest, fluids, symptomatic relief\\nDisease_Code: D072\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 72, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Thoracic Aortic Aneurysm\\nSymptoms: Chest or back pain, shortness of breath, hoarseness, difficulty swallowing\\nTreatments: Regular monitoring and imaging tests to assess aneurysm size and growth, lifestyle modifications (e.g., blood pressure control, avoiding smoking, managing cholesterol levels), medication (e.g., beta-blockers, ACE inhibitors) to manage blood pressure and reduce the risk of rupture, surgical intervention\\nDisease_Code: D073\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 73, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name: Scleroderma\\nSymptoms: Thickening of the skin, Raynaud's phenomenon\\nTreatments: Medications (immunosuppressants), therapy, symptom management\\nDisease_Code: D074\\nContagious: False\\nChronic: True\"),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 74, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bone Spur of the Calcaneus\\nSymptoms: Heel pain, especially when walking or standing, tenderness, swelling, inflammation of the surrounding tissue\\nTreatments: Nonsteroidal anti-inflammatory drugs (NSAIDs), orthotic devices, physical therapy, stretching exercises, shoe modifications, corticosteroid injections, surgical removal (in severe cases)\\nDisease_Code: D075\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 75, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Ethylene glycol poisoning-2\\nSymptoms: Metabolic acidosis, apid breathing, rapid heart rate, confusion, headache, dizziness, seizures\\nTreatments: Blood tests, Supportive Measures, Gastric Decontamination, Antidote Administration, Hemodialysis\\nDisease_Code: D076\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 76, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pica\\nSymptoms: Persistent consumption of non-food substances\\nTreatments: Behavioral therapy, addressing underlying nutritional deficiencies, addressing any medical complications, family support\\nDisease_Code: D077\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 77, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name: Induced Abortion\\nSymptoms: Vaginal bleeding, cramping, abdominal pain, nausea, fatigue, emotional distress\\nTreatments: Medical Abortion: Medication (such as mifepristone and misoprostol) is used to induce abortion, which can be done in the early stages of pregnancy. Surgical Abortion: A healthcare professional performs a procedure to remove the pregnancy, which can involve suction aspiration or dilation and curettage (D&C). It's important to consult with a healthcare professional to discuss the options and determine the most suitable method.\\nDisease_Code: D078\\nContagious: True\\nChronic: True\"),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 78, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Tension Headache\\nSymptoms: Mild to moderate head pain, tightness or pressure sensation on both sides of head\\nTreatments: Over-the-counter pain relievers, relaxation techniques, stress management\\nDisease_Code: D079\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 79, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Tuberculosis\\nSymptoms: cough, weight loss, fever, night sweats\\nTreatments: antibiotics, long-term medication\\nDisease_Code: D080\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 80, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Urethral Valves\\nSymptoms: Difficulty or poor urinary stream, urinary tract infections, urinary frequency or urgency, abdominal distension, poor weight gain\\nTreatments: Surgical intervention (valve ablation or resection), catheterization, medications for symptoms and complications\\nDisease_Code: D081\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 81, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hashimoto Thyroiditis\\nSymptoms: Fatigue, weight gain, constipation, dry skin, depression, muscle aches and stiffness, sensitivity to cold\\nTreatments: Thyroid hormone replacement (levothyroxine), monitoring and management of symptoms\\nDisease_Code: D082\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 82, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Parkinson Disease\\nSymptoms: Tremors, stiffness, slowness of movement\\nTreatments: Medications (levodopa, dopamine agonists), physical therapy, deep brain stimulation\\nDisease_Code: D083\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 83, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cryptorchidism\\nSymptoms: Absence or undescended testicle(s), empty scrotum, smaller or underdeveloped testicle(s), inguinal hernia, abnormal positioning of the testicle(s) (higher in the groin area)\\nTreatments: Observation and monitoring (in cases of mild or transient cryptorchidism), hormone therapy (to stimulate testicular descent), surgical intervention (orchiopexy) to reposition the testicle(s) into the scrotum, if necessary, performed around the age of 6 to 12 months, open or laparoscopic surgery (in cases of high or persistent cryptorchidism), testicular prostheses (in cases of absent or non-functional testicles), regular follow-up visits with a urologist or pediatric surgeon\\nDisease_Code: D084\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 84, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Mucocele\\nSymptoms: Painless fluid-filled swelling in the oral cavity\\nTreatments: Observation, Surgical removal if necessary\\nDisease_Code: D085\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 85, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Empyema\\nSymptoms: Fever, chest pain, productive cough with foul-smelling or bloody sputum\\nTreatments: Antibiotics, drainage (chest tube insertion, thoracentesis), surgical intervention (decortication), supportive care, treatment of underlying cause\\nDisease_Code: D086\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 86, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Abdominal Hernia\\nSymptoms: Visible bulge or swelling, discomfort or pain\\nTreatments: Watchful waiting, hernia truss, surgical repair, lifestyle changes\\nDisease_Code: D087\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 87, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hemarthrosis\\nSymptoms: Joint swelling, pain, warmth, limited range of motion\\nTreatments: RICE method (Rest, Ice, Compression, Elevation), pain management, joint aspiration or drainage (in severe cases)\\nDisease_Code: D088\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 88, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pregnancy-Related Back Pain\\nSymptoms: Lower back pain, discomfort in the pelvic area\\nTreatments: Prenatal exercises (such as stretching and strengthening exercises), good posture, heat or cold therapy, prenatal massages, supportive devices (such as pregnancy belts), physical therapy\\nDisease_Code: D089\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 89, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Muscle Spasm\\nSymptoms: Sudden, involuntary muscle contractions, muscle pain, stiffness, limited range of motion\\nTreatments: Stretching and relaxation exercises, heat or cold therapy, over-the-counter pain relievers, muscle relaxants, physical therapy, lifestyle modifications\\nDisease_Code: D090\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 90, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Diverticulosis\\nSymptoms: Abdominal pain, bloating, changes in bowel movements\\nTreatments: High-fiber diet, medications (pain relievers, antibiotics)\\nDisease_Code: D091\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 91, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dry Skin\\nSymptoms: Dry, flaky skin with itching\\nTreatments: Moisturizing creams or lotions, avoiding hot showers or baths, using mild soaps\\nDisease_Code: D092\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 92, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Alcohol Use Disorder\\nSymptoms: Cravings for alcohol, inability to control or limit alcohol consumption, withdrawal symptoms (such as tremors, anxiety, sweating) when attempting to stop or reduce alcohol use, continued use despite negative consequences (such as relationship problems, health issues), neglecting responsibilities, tolerance to alcohol\\nTreatments: Detoxification (if necessary), counseling or therapy (such as cognitive-behavioral therapy, motivational interviewing), support groups (such as Alcoholics Anonymous), medication (such as disulfiram, naltrexone, acamprosate), addressing underlying psychological or social factors, lifestyle changes, ongoing monitoring and support\\nDisease_Code: D093\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 93, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Muscular Dystrophy\\nSymptoms: Progressive muscle weakness and degeneration, difficulty walking or moving, muscle wasting\\nTreatments: Supportive care, physical therapy, assistive devices, medications for symptom management, gene therapies (in some cases)\\nDisease_Code: D094\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 94, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vaginal Yeast Infection\\nSymptoms: Itching and irritation in the vagina and vulva, redness and swelling of the vulva, white, thick, clumpy vaginal discharge (resembling cottage cheese), burning sensation during urination, pain during sexual intercourse, rash or soreness in the affected area\\nTreatments: Over-the-counter antifungal creams, ointments, or suppositories (such as miconazole, clotrimazole, or terconazole), prescription-strength antifungal medications (in severe or recurrent cases), oral antifungal medications (if recommended by a healthcare professional), topical corticosteroids (for relief of itching and inflammation), maintaining good hygiene practices, avoiding irritants (such as scented products), wearing breathable cotton underwear, avoiding tight-fitting clothing, probiotics (to restore healthy vaginal flora)\\nDisease_Code: D095\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 95, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Osteoporosis\\nSymptoms: Fragile bones, loss of height over time, back pain, fractures\\nTreatments: Calcium and vitamin D supplements, regular exercise, medications to slow bone loss\\nDisease_Code: D096\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 96, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Syndrome of Inappropriate Secretion of ADH (SIADH)\\nSymptoms: Excessively concentrated urine, low blood sodium levels\\nTreatments: Treating underlying cause, fluid restriction, medications to suppress ADH (vasopressin) secretion, addressing electrolyte imbalance\\nDisease_Code: D097\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 97, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Myasthenia Gravis\\nSymptoms: Muscle weakness, fatigue, difficulty speaking\\nTreatments: Medications (acetylcholinesterase inhibitors, immunosuppressants), thymectomy (in some cases)\\nDisease_Code: D098\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 98, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Torticollis\\nSymptoms: Neck pain, stiffness, and abnormal head positioning\\nTreatments: Physical therapy exercises, pain relievers, botulinum toxin injections (in severe cases)\\nDisease_Code: D099\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 99, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Complex Regional Pain Syndrome (CRPS)\\nSymptoms: Intense burning pain, swelling, changes in skin temperature\\nTreatments: Physical therapy, medications, nerve blocks\\nDisease_Code: D100\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 100, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gastroenteritis (Stomach Flu)\\nSymptoms: Nausea, vomiting, diarrhea, abdominal pain or cramps, fever\\nTreatments: Rest, fluids (electrolyte solutions), bland diet, avoiding irritating foods, over-the-counter medications for symptom relief\\nDisease_Code: D101\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 101, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Scleritis\\nSymptoms: Eye redness, severe eye pain, blurred vision\\nTreatments: Steroid eye drops, nonsteroidal anti-inflammatory drugs (NSAIDs), immunosuppressants\\nDisease_Code: D102\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 102, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cirrhosis\\nSymptoms: Fatigue, jaundice, abdominal swelling (ascites), easy bruising and bleeding, confusion, loss of appetite, weight loss\\nTreatments: Treatment aims to manage symptoms, slow down disease progression, and address underlying causes. It may include: lifestyle modifications (e.g., avoiding alcohol, maintaining a healthy diet), medication (e.g., diuretics, lactulose, antiviral drugs), procedures (e.g., paracentesis, transjugular intrahepatic portosystemic shunt), liver transplantation (in severe cases)\\nDisease_Code: D103\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 103, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Lung Contusion\\nSymptoms: Chest pain (sharp or dull), difficulty breathing or shortness of breath, rapid or shallow breathing, coughing up blood or pink-tinged sputum, decreased oxygen levels, wheezing, cyanosis (bluish discoloration of the skin), chest wall bruising, rib fractures (associated injuries)\\nTreatments: Supportive care (including supplemental oxygen, pain management, and respiratory support), monitoring in a hospital setting (to assess lung function and overall stability), treatment of associated injuries (such as rib fractures), management of complications (such as pneumonia or respiratory failure), prevention of further complications (such as deep vein thrombosis or pressure ulcers), respiratory therapy (including breathing exercises and airway clearance techniques), possible use of mechanical ventilation in severe cases\\nDisease_Code: D104\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 104, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Corneal Disorder\\nSymptoms: Blurred or hazy vision, eye pain or discomfort, redness or irritation of the eye, excessive tearing, sensitivity to light (photophobia), foreign body sensation, dryness or excessive tearing, corneal abrasions or ulcers, distorted or irregular corneal shape, vision loss\\nTreatments: Treatment depends on the specific corneal disorder and may include: artificial tears or lubricating eye drops, antibiotic or antifungal eye drops (if infection is present), corticosteroid eye drops or ointments (to reduce inflammation), bandage contact lenses, therapeutic contact lenses, corneal transplantation (in severe cases), refractive surgeries (such as LASIK or PRK) to correct vision, protective eyewear or sunglasses, avoiding irritants or triggers, regular eye examinations and monitoring, lifestyle modifications (such as proper eye hygiene and avoiding eye strain)\\nDisease_Code: D105\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 105, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Mucoepidermoid carcinoma\\nSymptoms: Lump, swelling, Difficulty, pain when swallowing and speaking, Facial weakness, Facial paralysis\\nTreatments: Surgery, Radiation therapy\\nDisease_Code: D106\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 106, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Carpal Tunnel Syndrome\\nSymptoms: Tingling, numbness, and pain in the hand and fingers\\nTreatments: Wrist splints, avoiding repetitive hand movements, applying cold or hot compresses, gentle exercises, ergonomic adjustments\\nDisease_Code: D107\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 107, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Macular Degeneration\\nSymptoms: Blurred or distorted central vision, blind spots\\nTreatments: Vision aids, medications (injections into the eye), laser therapy, photodynamic therapy, surgical intervention\\nDisease_Code: D108\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 108, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Atrophic vaginitis\\nSymptoms: Vaginal dryness, Vaginal burning, frequent urination, urinary tract infections, Painful intercourse\\nTreatments: Vaginal moisturizers, Vaginal estrogen therapy, Lifestyle modifications\\nDisease_Code: D109\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 109, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Osteochondrosis\\nSymptoms: Joint pain, stiffness, swelling, reduced range of motion\\nTreatments: Physical therapy, pain medications, rest, surgery\\nDisease_Code: D110\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 110, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\\nSymptoms: Weakness, numbness, tingling in limbs\\nTreatments: Immunoglobulin therapy, corticosteroids, physical therapy\\nDisease_Code: D111\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 111, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Parasitic Infections\\nSymptoms: Intense itching, visible lice or nits in the affected area\\nTreatments: Prescription medications (topical or oral antiparasitic agents), washing clothes and bedding in hot water\\nDisease_Code: D112\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 112, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Normal Pressure Hydrocephalus\\nSymptoms: Gait disturbances, urinary incontinence, cognitive decline or dementia-like symptoms\\nTreatments: Ventriculoperitoneal shunt placement, medication management for symptoms\\nDisease_Code: D113\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 113, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Kidney Stone\\nSymptoms: Severe pain in the side or back, blood in the urine, frequent urination\\nTreatments: Pain management, increased fluid intake, medication to facilitate stone passage, minimally invasive procedures or surgery\\nDisease_Code: D114\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 114, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pituitary Disorder\\nSymptoms: Various symptoms depending on the specific disorder, including hormonal imbalances\\nTreatments: Treatment depends on the specific pituitary disorder and may involve medications, surgery, hormone replacement therapy\\nDisease_Code: D115\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 115, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name: Pinguecula\\nSymptoms: Yellowish or white growth on the conjunctiva (eye's surface), usually near the cornea\\nTreatments: Artificial tears, lubricating eye drops, sunglasses for UV protection, surgical removal (in severe cases)\\nDisease_Code: D116\\nContagious: False\\nChronic: False\"),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 116, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Influenza (Flu)\\nSymptoms: High fever, body aches, fatigue, cough, sore throat, congestion\\nTreatments: Rest, fluids, over-the-counter medications for symptom relief, antiviral medications (in some cases)\\nDisease_Code: D117\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 117, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cat Scratch Disease\\nSymptoms: Swollen lymph nodes, fever, fatigue, headache, rash\\nTreatments: Antibiotics (azithromycin, doxycycline), pain management, supportive care\\nDisease_Code: D118\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 118, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hyperemesis Gravidarum\\nSymptoms: Severe nausea and vomiting during pregnancy\\nTreatments: Intravenous fluids to prevent dehydration, anti-nausea medications, nutritional support, rest, monitoring for weight loss and electrolyte imbalance\\nDisease_Code: D119\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 119, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Diabetic retinopathy\\nSymptoms: Blurred or distorted vision, floaters, impaired color vision, dark or empty areas in the visual field, vision loss\\nTreatments: Management of blood sugar levels, blood pressure control, cholesterol management, regular eye examinations, laser treatment , intravitreal injections of anti-VEGF medications, vitrectomy\\nDisease_Code: D120\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 120, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Aplastic Anemia\\nSymptoms: Fatigue, pale skin, frequent infections, shortness of breath, rapid or irregular heartbeats, prolonged bleeding or bruising\\nTreatments: Blood transfusions, bone marrow-stimulating medications, immunosuppressive therapy, stem cell transplant (in severe cases), supportive care\\nDisease_Code: D121\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 121, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Wilson Disease\\nSymptoms: Fatigue, abdominal pain or swelling, jaundice, neurological symptoms (tremors, difficulty speaking or walking)\\nTreatments: Medications to remove copper from the body (chelators), dietary changes, liver transplant (in severe cases)\\nDisease_Code: D122\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 122, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Drug Abuse (Barbiturates)\\nSymptoms: Sedation, drowsiness, slurred speech, confusion, respiratory depression\\nTreatments: Medical detoxification, supportive care, counseling, rehabilitation programs\\nDisease_Code: D123\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 123, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Primary Insomnia\\nSymptoms: Difficulty falling asleep or staying asleep, daytime sleepiness, irritability, difficulty concentrating\\nTreatments: Cognitive-behavioral therapy for insomnia (CBT-I), sleep hygiene practices (such as maintaining a regular sleep schedule, creating a comfortable sleep environment), relaxation techniques, stimulus control techniques (such as limiting bed activities to sleep only), sleep restriction therapy, medications for insomnia (such as sedative-hypnotics, melatonin agonists)\\nDisease_Code: D124\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 124, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Mastoiditis\\nSymptoms: Ear pain (particularly behind the ear), swelling and redness of the ear or the area behind the ear, fever, headache, hearing loss or impaired hearing, drainage of fluid or pus from the ear, earache, irritability (in infants and young children), tenderness or pain when touching the area, mastoid bone protrusion or swelling\\nTreatments: Antibiotics (oral or intravenous) to treat the underlying bacterial infection, pain relievers (such as acetaminophen or ibuprofen) for pain and fever, ear drops (if there is drainage from the ear), surgical intervention (in severe or chronic cases), such as mastoidectomy (removal of infected mastoid bone cells) or tympanostomy tube placement (to relieve pressure and drain fluid from the middle ear), supportive care (rest, hydration, warm compresses)\\nDisease_Code: D125\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 125, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Acinic cell carcinoma\\nSymptoms: Lump, swelling, Facial changes\\nTreatments: Surgery, Radiation therapy\\nDisease_Code: D126\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 126, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Arthritis\\nSymptoms: Joint pain, stiffness, swelling\\nTreatments: Medications, physical therapy, surgery (in severe cases)\\nDisease_Code: D127\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 127, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name: Wharton's duct stones\\nSymptoms: Swelling, pain, dry mouth, bad taste\\nTreatments: Hydration,Saliva stimulation, Stone removal\\nDisease_Code: D128\\nContagious: False\\nChronic: False\"),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 128, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pharyngitis\\nSymptoms: Sore throat, difficulty swallowing, swollen lymph nodes\\nTreatments: Rest, pain relievers, throat lozenges, antibiotics (if bacterial infection), symptomatic relief\\nDisease_Code: D129\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 129, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pericarditis\\nSymptoms: Chest pain (sharp and stabbing), worsens with deep breaths or lying down, fever\\nTreatments: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain, colchicine (for recurrent or persistent pericarditis), corticosteroids (in severe cases or when NSAIDs are ineffective), antibiotics (if bacterial infection is present), lifestyle modifications (rest, avoiding strenuous activity), treating underlying causes (if identified), potential pericardiocentesis (fluid drainage)\\nDisease_Code: D130\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 130, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Antihypertensives Poisoning\\nSymptoms: Dizziness, low blood pressure, slow heart rate, nausea, vomiting\\nTreatments: Immediate medical attention, activated charcoal administration, supportive care, specific antidotes\\nDisease_Code: D131\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 131, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypothyroidism\\nSymptoms: Fatigue, weight gain, sensitivity to cold, dry skin, constipation, depression, muscle weakness, elevated cholesterol levels\\nTreatments: Hormone replacement therapy with synthetic thyroid hormone (levothyroxine), regular monitoring of thyroid hormone levels and adjustment of medication dosage, lifestyle modifications (such as healthy diet and regular exercise), management of associated symptoms (such as cholesterol-lowering medications or antidepressants), education and support for long-term management\\nDisease_Code: D132\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 132, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Oral Leukoplakia\\nSymptoms: White patches or plaques in the mouth, often on the tongue or inside of the cheeks, that cannot be scraped off\\nTreatments: Regular monitoring and follow-up, identification and elimination of potential irritants (such as tobacco or alcohol), improving oral hygiene practices, medication (such as topical retinoids or antifungal agents), surgical removal (in some cases), cryotherapy (freezing the patches), laser therapy, lifestyle modifications (such as healthy diet), regular dental check-ups, education and support\\nDisease_Code: D133\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 133, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Seborrheic Dermatitis\\nSymptoms: Red, itchy, and oily patches of skin, dandruff, flaky scalp\\nTreatments: Topical antifungal creams or ointments, medicated shampoos, corticosteroid creams\\nDisease_Code: D134\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 134, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hydrocephalus\\nSymptoms: Headache, nausea, vomiting, cognitive or developmental problems, enlarged head in infants\\nTreatments: Shunt placement (to divert excess cerebrospinal fluid), endoscopic third ventriculostomy, medication (in some cases)\\nDisease_Code: D135\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 135, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Marijuana Abuse\\nSymptoms: Impaired memory and cognition, altered judgment, anxiety\\nTreatments: Behavioral therapy, counseling, support groups, medication, detoxification\\nDisease_Code: D136\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 136, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Otitis Media\\nSymptoms: Ear pain, hearing loss, recurrent ear infections\\nTreatments: Antibiotics, ear drops, surgical intervention (in some cases)\\nDisease_Code: D137\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 137, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pterygium\\nSymptoms: Growth on the conjunctiva (white part of the eye)\\nTreatments: Artificial tears, eye lubricants, surgical removal (in severe cases)\\nDisease_Code: D138\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 138, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hepatic Encephalopathy\\nSymptoms: Confusion, forgetfulness, personality changes, tremors\\nTreatments: Treating underlying liver disease, medications to manage symptoms, dietary modifications\\nDisease_Code: D139\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 139, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Tietze Syndrome\\nSymptoms: Chest pain, swelling and tenderness of the cartilage connecting the ribs to the breastbone\\nTreatments: Nonsteroidal anti-inflammatory drugs (NSAIDs), pain relievers, local heat or ice application, avoiding activities that worsen symptoms, supportive measures (such as wearing loose clothing or using supportive pillows), physical therapy (to improve posture and strengthen muscles), corticosteroid injections (in some cases), stress reduction techniques\\nDisease_Code: D140\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 140, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Nose Disorder\\nSymptoms: Nasal congestion, runny nose, sneezing, facial pain or pressure, loss of smell\\nTreatments: Treatment depends on the underlying cause (such as allergies, sinusitis, or nasal polyps), and may include medications (such as decongestants, antihistamines, nasal sprays), saline nasal irrigation, steam inhalation, allergy management, antibiotics (if bacterial infection is present), surgical intervention (in some cases)\\nDisease_Code: D141\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 141, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Exfoliation Glaucoma\\nSymptoms: Elevated intraocular pressure, visual field loss\\nTreatments: Eye drops to lower intraocular pressure (e.g., prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors), laser trabeculoplasty, surgical procedures (e.g., trabeculectomy, glaucoma drainage implants)\\nDisease_Code: D142\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 142, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Protein Deficiency\\nSymptoms: Muscle wasting, fatigue, weakness, delayed wound healing, swelling of the limbs, hair loss, impaired immunity\\nTreatments: Increasing protein intake through diet (lean meats, fish, dairy, legumes, nuts), protein supplements, nutritional counseling, addressing underlying causes (e.g., malabsorption)\\nDisease_Code: D143\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 143, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Thrombocytopenia\\nSymptoms: Easy bruising, prolonged bleeding from cuts, petechiae (red or purple spots on the skin), nosebleeds, excessive menstrual bleeding\\nTreatments: Treatment of underlying cause, platelet transfusion (if severe), medication (corticosteroids, immunosuppressants), avoiding medications that can worsen platelet counts\\nDisease_Code: D144\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 144, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Alopecia\\nSymptoms: Hair loss or balding, patchy or generalized hair loss\\nTreatments: Topical medications (minoxidil), oral medications (finasteride), steroid injections, hair transplant surgery, wigs or hairpieces\\nDisease_Code: D145\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 145, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Polymyalgia Rheumatica\\nSymptoms: Muscle pain and stiffness, joint pain, fatigue\\nTreatments: Low-dose corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs)\\nDisease_Code: D146\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 146, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bone Cancer\\nSymptoms: Bone pain, fractures, fatigue, unexplained weight loss\\nTreatments: Surgery, chemotherapy, radiation therapy, targeted therapy\\nDisease_Code: D147\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 147, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Preeclampsia\\nSymptoms: High blood pressure, proteinuria, swelling, headaches, visual disturbances\\nTreatments: Bed rest, blood pressure monitoring, frequent prenatal visits, medication (such as antihypertensive drugs), magnesium sulfate (for severe cases), delivery of the baby (in severe cases)\\nDisease_Code: D148\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 148, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypertrophic Obstructive Cardiomyopathy (HOCM)\\nSymptoms: Shortness of breath, especially during physical activity or exertion, chest pain or discomfort, dizziness or lightheadedness, fainting or near-fainting episodes, heart palpitations (rapid or irregular heartbeat), fatigue, swelling in the ankles, feet, or legs'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 148, 'source_type': 'Remedies', 'priority': '1'}, page_content='Treatments: Medications to relieve symptoms and improve heart function (such as beta-blockers, calcium channel blockers, and disopyramide), medications to prevent abnormal heart rhythms (such as anti-arrhythmic drugs), medications to reduce blood clotting (such as aspirin or anticoagulants), implantable cardioverter-defibrillator (ICD) placement (to monitor and correct abnormal heart rhythms), septal myectomy (surgical removal of a portion of the thickened heart muscle), alcohol septal ablation (destruction of excess heart muscle with alcohol injection), lifestyle modifications (such as avoiding strenuous activities, managing stress, and maintaining a healthy weight), regular follow-up visits with a cardiologist\\nDisease_Code: D149\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 149, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Nonalcoholic Liver Disease (NASH)\\nSymptoms: Fatigue, abdominal swelling or pain, enlarged liver, elevated liver enzymes, insulin resistance\\nTreatments: Lifestyle changes (weight loss, healthy diet, regular exercise), management of underlying conditions, medication as needed\\nDisease_Code: D150\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 150, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Amyloidosis\\nSymptoms: Fatigue, weight loss, organ dysfunction\\nTreatments: Treatment depends on the type and extent of organ damage\\nDisease_Code: D151\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 151, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Ethylene glycol poisoning-3\\nSymptoms: Decreased urine output, swelling in the legs and ankles, and signs of fluid overload, Severe kidney damage\\nTreatments: Supportive Measures, Gastric Decontamination, Antidote Administration, Hemodialysis\\nDisease_Code: D152\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fracture of the Rib\\nSymptoms: Chest pain, difficulty breathing, tenderness or swelling over the ribcage\\nTreatments: Pain management, rest, immobilization (splinting or bracing), physical therapy\\nDisease_Code: D153\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Breast Cancer\\nSymptoms: Breast lump, changes in breast size or shape, nipple changes, breast pain\\nTreatments: Surgery (lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, targeted therapy\\nDisease_Code: D154\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 154, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Neuromyelitis Optica\\nSymptoms: Optic neuritis (vision loss, pain with eye movement), transverse myelitis (weakness, numbness, or paralysis of the limbs, loss of bladder or bowel control)\\nTreatments: High-dose corticosteroids, plasma exchange (to remove antibodies from the blood), immunosuppressive therapy (such as azathioprine or rituximab), supportive care to manage symptoms, physical therapy or rehabilitation for functional recovery\\nDisease_Code: D155\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 155, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Eye alignment disorder\\nSymptoms: Double vision, Eye fatigue, Poor depth perception, Head tilting\\nTreatments: Glasses, Patching therapy, Vision therapy, Botox injections, Surgical intervention\\nDisease_Code: D156\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 156, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Meniere Disease\\nSymptoms: Vertigo, hearing loss, tinnitus, ear fullness\\nTreatments: Medications (diuretics, anti-vertigo drugs), lifestyle changes\\nDisease_Code: D157\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 157, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pituitary Adenoma\\nSymptoms: Headaches, vision problems (such as blurred vision or loss of peripheral vision), hormonal imbalances (such as excessive production or deficiency of specific hormones), fatigue, weight gain or loss, menstrual irregularities, infertility, erectile dysfunction, growth abnormalities in children, mood changes, cognitive impairments\\nTreatments: Observation and monitoring (for small, non-secreting tumors that are not causing significant symptoms), medication (to manage hormonal imbalances or reduce tumor size), surgery (transsphenoidal surgery to remove the tumor), radiation therapy (in cases where surgery is not possible or to treat residual or recurrent tumors), targeted therapy (in cases of aggressive or resistant tumors), hormone replacement therapy (if necessary), regular follow-up and monitoring to assess tumor growth and hormone levels, management of associated complications or hormone deficiencies\\nDisease_Code: D158\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 158, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Ischemia of the Bowel\\nSymptoms: Severe abdominal pain, bloody stools, diarrhea, nausea, vomiting, fever, rapid heart rate, low blood pressure\\nTreatments: diagnostic tests, intravenous fluids and medications to stabilize the patient, bowel rest, resection, bypass procedure, potential angioplasty\\nDisease_Code: D159\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 159, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hydrocele of the Testicle\\nSymptoms: Swelling of the scrotum\\nTreatments: Observation, surgical drainage (in some cases)\\nDisease_Code: D160\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 160, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Endometrial Cancer\\nSymptoms: Abnormal vaginal bleeding, pelvic pain or discomfort, changes in bowel or bladder habits\\nTreatments: Surgery (hysterectomy), radiation therapy, chemotherapy, hormone therapy\\nDisease_Code: D161\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 161, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Endometriosis\\nSymptoms: Pelvic pain, painful periods, infertility\\nTreatments: Pain medications, hormonal therapies, surgery\\nDisease_Code: D162\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 162, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hydronephrosis\\nSymptoms: Flank pain, urinary frequency, swelling in the abdomen\\nTreatments: Treating underlying cause, medications, ureteral stent, surgery\\nDisease_Code: D163\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 163, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bell Palsy\\nSymptoms: Facial weakness or paralysis, drooping of the mouth or eyelid\\nTreatments: Corticosteroids, antiviral medications, eye protection, physical therapy\\nDisease_Code: D164\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 164, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Abscess of Nose\\nSymptoms: Pain, swelling, redness, discharge from the nose\\nTreatments: Antibiotics, warm compresses, surgical drainage (in severe cases)\\nDisease_Code: D165\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 165, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bladder Disorder\\nSymptoms: Frequent urination, urgency, pelvic pain\\nTreatments: Medications, bladder training, lifestyle changes\\nDisease_Code: D166\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 166, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Emphysema\\nSymptoms: Shortness of breath, wheezing, chronic cough, chest tightness, fatigue, weight loss\\nTreatments: Smoking cessation (the most important intervention), medications to manage symptoms (such as bronchodilators, inhaled corticosteroids), pulmonary rehabilitation (exercise training, breathing techniques), supplemental oxygen therapy (in advanced cases), vaccination against respiratory infections, avoiding exposure to irritants (such as secondhand smoke or air pollutants), regular monitoring of symptoms and lung function, surgical interventions (such as lung volume reduction surgery or lung transplantation)\\nDisease_Code: D167\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 167, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Extrapyramidal Effect of Drugs\\nSymptoms: Muscle stiffness, tremors, involuntary movements\\nTreatments: Adjusting medication dosage, switching to alternative medications\\nDisease_Code: D168\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 168, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vasculitis\\nSymptoms: Inflammation of blood vessels leading to various symptoms depending on the affected organs, including rash, fever, fatigue, muscle and joint pain, shortness of breath, weight loss\\nTreatments: Treatment depends on the type and severity of vasculitis. It may include corticosteroids, immunosuppressive medications (such as cyclophosphamide or azathioprine), biologic therapies (such as rituximab), disease-specific treatments (such as plasmapheresis for certain types), supportive care to manage symptoms (such as pain relievers or blood pressure medications), monitoring and management of associated complications (such as organ damage or infections)\\nDisease_Code: D169\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 169, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Female Infertility of Unknown Cause\\nSymptoms: Inability to conceive after one year of unprotected intercourse, irregular or absent menstrual cycles, hormonal imbalances, age-related factors, other\\nTreatments: Fertility testing and evaluation (hormone tests, imaging, genetic screening), lifestyle modifications (healthy diet, regular exercise, stress reduction), fertility treatments (assisted reproductive technologies, fertility medications)\\nDisease_Code: D170\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 170, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Syringomyelia\\nSymptoms: Muscle weakness, loss of sensation, chronic pain\\nTreatments: Surgical decompression, draining of syrinx (cyst), physical therapy, pain management techniques\\nDisease_Code: D171\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 171, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Von Hippel-Lindau Disease\\nSymptoms: Hemangioblastomas (tumors in the brain, spinal cord, or other organs), retinal angiomas (abnormal blood vessel growth in the retina), renal cell carcinomas (kidney tumors), pheochromocytomas (adrenal gland tumors), pancreatic cysts/tumors, other tumors or cysts\\nTreatments: Regular monitoring and surveillance to detect and manage tumor growth and associated complications, surgical removal or treatment of tumors if necessary, embolization or radiation therapy for certain tumors, medication or surgery to manage hormonal issues (such as pheochromocytomas), genetic counseling and testing, screening and management for other potential complications (such as kidney function monitoring)\\nDisease_Code: D172\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hemorrhoids\\nSymptoms: Swollen, itchy, or painful veins in the rectal area\\nTreatments: Increasing fiber intake, staying hydrated, avoiding straining during bowel movements, warm sitz baths, topical creams or ointments, over-the-counter pain relievers (after consulting with a healthcare provider)\\nDisease_Code: D173\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 173, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bursitis\\nSymptoms: Joint pain, swelling, tenderness, limited range of motion\\nTreatments: Rest, ice, compression, elevation (RICE therapy), pain relievers, physical therapy, steroid injections\\nDisease_Code: D174\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 174, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cannabis Use Disorder\\nSymptoms: Increased appetite, relaxation, altered perception of time, impaired memory and concentration, bloodshot eyes, anxiety or paranoia (in some individuals), withdrawal symptoms (such as irritability, insomnia) when attempting to stop or reduce cannabis use, continued use despite negative consequences (such as relationship problems, job difficulties)\\nTreatments: Counseling or therapy (such as cognitive-behavioral therapy, motivational interviewing), support groups, addressing underlying psychological or social factors, lifestyle changes, addressing co-occurring mental health conditions, harm reduction strategies, ongoing monitoring and support\\nDisease_Code: D175\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 175, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Heart Block\\nSymptoms: Fatigue, dizziness, fainting, chest pain or discomfort, shortness of breath, irregular heart rhythms\\nTreatments: Medications (such as beta-blockers, calcium channel blockers), pacemaker implantation (in severe cases or symptomatic heart block), underlying condition management\\nDisease_Code: D176\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 176, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hemolytic Anemia\\nSymptoms: Fatigue, weakness, pale skin, shortness of breath, jaundice\\nTreatments: Treatment of underlying cause, blood transfusions, medications (immunosuppressants, corticosteroids), splenectomy (in some cases), supportive care, folic acid or iron supplementation\\nDisease_Code: D177\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 177, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Benzodiazepine Use Disorder\\nSymptoms: Sedation, relaxation, reduced anxiety, drowsiness, poor coordination, memory impairment, withdrawal symptoms (such as rebound anxiety, insomnia, tremors) when attempting to stop or reduce benzodiazepine use, continued use despite negative consequences (such as relationship problems, health risks)\\nTreatments: Gradual tapering off benzodiazepines under medical supervision, counseling or therapy (such as cognitive-behavioral therapy), support groups, addressing underlying psychological or social factors, lifestyle changes, addressing co-occurring mental health conditions, harm reduction strategies, ongoing monitoring and support\\nDisease_Code: D178\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 178, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Mitral Valve Disease\\nSymptoms: Fatigue, shortness of breath, heart palpitations\\nTreatments: Medications, lifestyle changes, surgical repair or replacement of the valve (in severe cases)\\nDisease_Code: D179\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 179, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Varicose Veins\\nSymptoms: Enlarged, swollen veins, often in the legs\\nTreatments: Elevating legs, wearing compression stockings, regular exercise, avoiding prolonged sitting or standing, maintaining a healthy weight\\nDisease_Code: D180\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 180, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Recurrent salivary stones\\nSymptoms: Frequent episodes of stone formation\\nTreatments: Hydration,Saliva stimulation, Stone removal\\nDisease_Code: D181\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 181, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Ocular Hypertension\\nSymptoms: Elevated intraocular pressure without optic nerve damage\\nTreatments: Observation with regular eye exams, use of eye drops to lower intraocular pressure (if necessary)\\nDisease_Code: D182\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 182, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Colonic Polyp\\nSymptoms: Most colonic polyps do not cause symptoms. Some larger polyps or certain types may cause rectal bleeding or changes in bowel habits, such as diarrhea or constipation.\\nTreatments: Polypectomy (removal of polyp during colonoscopy), surveillance colonoscopy (regular monitoring for recurrence or new polyps), lifestyle modifications (healthy diet, regular exercise, smoking cessation), follow-up based on pathology findings\\nDisease_Code: D183\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 183, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Indigestion\\nSymptoms: Abdominal pain, bloating, heartburn, nausea, acidic taste\\nTreatments: Lifestyle changes (e.g., dietary modifications, stress reduction), over-the-counter antacids, medication, therapy\\nDisease_Code: D184\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 184, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Acute Glaucoma\\nSymptoms: Severe eye pain, blurred vision, halos around lights\\nTreatments: Medications (eye drops), laser therapy, surgery (in some cases)\\nDisease_Code: D185\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypoglycemia\\nSymptoms: Shaking, dizziness, confusion, sweating\\nTreatments: Consuming glucose or sugar-containing foods, adjusting medication or insulin dosage\\nDisease_Code: D186\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 186, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Sciatica\\nSymptoms: Sharp pain, tingling, or numbness that radiates from the lower back through the hips and down the leg\\nTreatments: Rest, gentle stretching exercises, warm or cold compresses, prenatal massages, maintaining good posture, avoiding activities that worsen the pain\\nDisease_Code: D187\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 187, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Type 2 Diabetes\\nSymptoms: Fatigue, Increased hunger, Slow healing of wounds\\nTreatments: Oral medications, Insulin therapy (in some cases), Blood sugar monitoring, Exercise\\nDisease_Code: D067\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 188, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cystic Fibrosis\\nSymptoms: Persistent cough with thick mucus, recurrent lung infections, poor growth or weight gain, salty-tasting skin\\nTreatments: Medications (mucus-thinning drugs, bronchodilators), chest physical therapy, enzyme supplements, lung transplant (in severe cases)\\nDisease_Code: D188\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 189, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Insulin Overdose\\nSymptoms: Low blood sugar (hypoglycemia) symptoms (e.g., confusion, sweating)\\nTreatments: Immediate treatment of hypoglycemia, medical assistance, adjusting insulin dosage and regimen\\nDisease_Code: D189\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 190, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Peritonsillar Abscess\\nSymptoms: Severe sore throat, difficulty swallowing, fever, swollen tonsils, voice changes, neck pain or stiffness\\nTreatments: Antibiotics to treat infection, drainage of the abscess (needle aspiration or incision and drainage), pain relievers, warm saltwater gargles, rest, fluids, surgical removal of the tonsils (in chronic or recurrent cases)\\nDisease_Code: D190\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 191, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Leishmaniasis\\nSymptoms: Skin sores, fever, weight loss, enlarged spleen or liver\\nTreatments: Antiparasitic medications, treatment of complications, vector control measures (in endemic areas)\\nDisease_Code: D191\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 192, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pulmonary Congestion\\nSymptoms: Shortness of breath, cough, wheezing, fatigue, chest discomfort or tightness\\nTreatments: Diuretics, medications to manage underlying conditions (e.g., heart failure), oxygen therapy, lifestyle changes\\nDisease_Code: D192\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 193, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Magnesium Deficiency\\nSymptoms: Muscle twitches or cramps, fatigue, weakness, loss of appetite, nausea, vomiting, irritability, mental confusion, irregular heartbeat, tingling or numbness, personality changes, seizures\\nTreatments: Dietary changes (consuming magnesium-rich foods), oral magnesium supplements, intravenous magnesium therapy (in severe cases), addressing underlying causes (e.g., malabsorption), medical supervision and monitoring\\nDisease_Code: D193\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 194, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fracture of the Shoulder\\nSymptoms: Shoulder pain, swelling, limited range of motion\\nTreatments: Immobilization (sling, brace), pain management, physical therapy, surgical intervention (in severe cases)\\nDisease_Code: D194\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 195, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Thrombophlebitis\\nSymptoms: Redness, warmth, swelling, and tenderness along a vein, pain or discomfort, skin discoloration, visible veins, fever\\nTreatments: Medications to manage pain and inflammation, compression stockings or bandages to promote blood flow, elevation of the affected limb, warm compresses, regular movement and exercise, treatment of underlying causes (such as infection or intravenous catheter removal), anticoagulant therapy to prevent clot formation or progression\\nDisease_Code: D195\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 196, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Encephalitis\\nSymptoms: Headache, fever, confusion, seizures, neurological symptoms\\nTreatments: Hospitalization, antiviral medications (if caused by a viral infection), supportive care\\nDisease_Code: D196\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 197, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fat Embolism\\nSymptoms: Respiratory distress, chest pain, confusion, petechial rash (small red or purple spots), neurological symptoms\\nTreatments: Supportive care (oxygen therapy, fluid resuscitation), managing symptoms (pain medication, anticoagulants), treatment of underlying cause if possible\\nDisease_Code: D197\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 198, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cyst of the Eyelid\\nSymptoms: Painful lump or swelling on the eyelid, redness, tenderness\\nTreatments: Warm compresses, good eyelid hygiene, antibiotic ointments (if infected), surgical removal (if necessary)\\nDisease_Code: D198\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 199, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dislocation of the Patella\\nSymptoms: Knee pain, swelling, inability to straighten the leg\\nTreatments: Manual reduction, immobilization, physical therapy\\nDisease_Code: D199\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 200, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Conjunctivitis due to Allergy\\nSymptoms: Redness, itching, watery discharge, swollen eyelids\\nTreatments: Allergen avoidance, antihistamine eye drops, cold compresses, lubricating eye drops\\nDisease_Code: D200\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 201, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Coagulation (Bleeding) Disorder\\nSymptoms: Easy bruising, prolonged bleeding after injury or surgery, excessive bleeding from minor cuts or abrasions, frequent nosebleeds, heavy menstrual bleeding\\nTreatments: Blood transfusions, clotting factor replacement therapy, medications to stimulate clotting, lifestyle modifications, surgery (in some cases)\\nDisease_Code: D201\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 202, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Idiopathic Absence of Menstruation\\nSymptoms: Lack of menstrual periods\\nTreatments: Evaluation to determine underlying cause, hormone therapy\\nDisease_Code: D202\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 203, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Migraine\\nSymptoms: Severe headaches, nausea, sensitivity to light and sound\\nTreatments: Pain-relieving medications, lifestyle changes, preventive medications\\nDisease_Code: D203\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 204, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Temporomandibular Joint Disorder\\nSymptoms: Jaw pain or tenderness, clicking or popping sounds in the jaw joint, difficulty chewing or opening the mouth\\nTreatments: Self-care measures (rest, applying heat or cold, jaw exercises), pain medications, physical therapy, oral splints\\nDisease_Code: D204\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 205, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vitamin A Deficiency\\nSymptoms: Night blindness, dry eyes, dry or rough skin, poor wound healing, weakened immune system\\nTreatments: Vitamin A supplementation, dietary changes to include foods rich in vitamin A\\nDisease_Code: D205\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 206, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Glucocorticoid Deficiency\\nSymptoms: Fatigue, weakness, weight loss, low blood pressure, abdominal pain\\nTreatments: Hormone replacement therapy with glucocorticoid medications\\nDisease_Code: D206\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 207, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Astigmatism\\nSymptoms: Blurred or distorted vision, eye strain, headaches,uneven curvature of cornea\\nTreatments: Eyeglasses, contact lenses, refractive surgery (LASIK, PRK), orthokeratology, toric intraocular lenses\\nDisease_Code: D207\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 208, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Low-Tension Glaucoma\\nSymptoms: Gradual loss of vision, visual field defects\\nTreatments: Eye drops to lower intraocular pressure (e.g., prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors), oral medications (e.g., carbonic anhydrase inhibitors), laser trabeculoplasty, surgical procedures (e.g., trabeculectomy, glaucoma drainage implants)\\nDisease_Code: D208\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 209, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Headache after lumbar puncture\\nSymptoms: throbbing headache\\nTreatments: Epidural blood patch, Conservative measures\\nDisease_Code: D209\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 210, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Flat Feet\\nSymptoms: Foot pain or achiness, difficulty with foot and ankle movement, foot fatigue, swelling\\nTreatments: Supportive footwear, orthotic inserts, physical therapy exercises, pain management, surgery (in severe cases)\\nDisease_Code: D210\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 211, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Carbon Monoxide Poisoning\\nSymptoms: Headache, dizziness, nausea, confusion\\nTreatments: Fresh air, oxygen therapy, immediate medical attention\\nDisease_Code: D211\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 212, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Orbital Cellulitis\\nSymptoms: Eye pain, swelling, redness, vision changes\\nTreatments: Antibiotics, hospitalization (in severe cases), surgical drainage (in some cases)\\nDisease_Code: D212\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 213, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pulmonary Eosinophilia\\nSymptoms: Cough, shortness of breath, wheezing, chest pain, fever, night sweats, fatigue, weight loss, elevated eosinophil count in the blood or sputum\\nTreatments: Identification and treatment of underlying causes (such as parasitic infections, drug reactions, or allergic reactions), corticosteroids (such as prednisone) to reduce inflammation, bronchodilators (such as inhalers) to relieve bronchospasm and improve airflow, antiparasitic medications (if parasitic infection is identified), immunosuppressive medications (in severe cases), avoidance of triggers or allergens (if identified), symptomatic treatment for associated symptoms (such as fever or cough), regular monitoring and follow-up with a healthcare professional\\nDisease_Code: D213\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 214, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Antimicrobial Drugs Poisoning\\nSymptoms: Nausea, vomiting, diarrhea, neurological symptoms\\nTreatments: Immediate medical attention, supportive care, antidote administration\\nDisease_Code: D214\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 215, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Eczema\\nSymptoms: Itchy, red, inflamed skin, rash\\nTreatments: Emollients (moisturizers), topical corticosteroids or immunomodulators, avoiding triggers\\nDisease_Code: D215\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 216, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pneumonia\\nSymptoms: Cough, fever, chest pain, difficulty breathing\\nTreatments: Antibiotics, antiviral medications (if applicable), rest, fluids, symptomatic relief\\nDisease_Code: D216\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 217, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Intestinal Malabsorption\\nSymptoms: Chronic diarrhea, weight loss, abdominal pain or bloating, nutrient deficiencies (vitamins, minerals), fatigue, failure to thrive\\nTreatments: Dietary modifications (specific to the underlying cause), supplementation of deficient nutrients, medications (to manage symptoms or underlying condition), treatment of underlying cause\\nDisease_Code: D217\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 218, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Conductive Hearing Loss\\nSymptoms: Reduced hearing sensitivity, muffled or blocked sound\\nTreatments: Medications, surgical intervention, hearing aids\\nDisease_Code: D218\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 219, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pinworm Infection\\nSymptoms: Itching around the anus or vagina, restless sleep, irritability, anal or vaginal discharge, abdominal pain or discomfort, loss of appetite\\nTreatments: Anthelmintic medication, hygiene measures (handwashing, trimming nails, laundering bedding), treatment for household members\\nDisease_Code: D219\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 220, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Esophageal Varices\\nSymptoms: Swollen blood vessels in the esophagus, vomiting blood, black, tarry stools\\nTreatments: Medications (beta-blockers, vasoconstrictors), endoscopic therapies, band ligation, transjugular intrahepatic portosystemic shunt (TIPS), surgical interventions\\nDisease_Code: D220\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 221, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dermatitis due to Sun Exposure\\nSymptoms: Sunburn-like rash, redness, itching\\nTreatments: Moisturizers, cool compresses, topical corticosteroids\\nDisease_Code: D221\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 222, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gonorrhea\\nSymptoms: Painful urination, abnormal discharge from the genitals, pelvic pain\\nTreatments: Antibiotics (dual therapy with ceftriaxone and azithromycin), safe sexual practices, partner notification\\nDisease_Code: D222\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 223, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Sinusitis\\nSymptoms: Facial pain or pressure, nasal congestion, thick nasal discharge, postnasal drip, cough, fatigue\\nTreatments: Saline nasal irrigation, nasal corticosteroids, antibiotics (in bacterial cases), decongestants, pain relievers, surgery (in severe or chronic cases)\\nDisease_Code: D223\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 224, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Concussion\\nSymptoms: Headache, dizziness, nausea or vomiting, confusion, memory problems, sensitivity to light or noise, mood changes\\nTreatments: Physical and cognitive rest, gradual return to normal activities, symptom management (such as pain relievers or anti-nausea medication), monitoring for complications (such as changes in neurological function), cognitive rehabilitation (if persistent cognitive problems), management of associated symptoms (such as sleep disturbances or mood changes), education and support for recovery, avoiding further head injuries\\nDisease_Code: D224\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 225, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Parathyroid Adenoma\\nSymptoms: Fatigue, weakness, bone pain, frequent urination, kidney stones\\nTreatments: Surgical removal of the adenoma (parathyroidectomy), medications to manage calcium levels\\nDisease_Code: D225\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 226, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Herpangina\\nSymptoms: Sore throat, fever, painful sores or blisters in the mouth and throat, difficulty swallowing, loss of appetite\\nTreatments: Symptomatic relief (pain relievers, throat lozenges, mouth rinses), rest, fluids, maintaining good oral hygiene, avoiding spicy or acidic foods\\nDisease_Code: D226\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 227, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Conversion Disorder\\nSymptoms: Neurological symptoms that cannot be explained by a medical condition or injury, such as paralysis, blindness, seizures, or difficulty speaking\\nTreatments: Psychotherapy (such as cognitive-behavioral therapy or psychodynamic therapy), physical therapy or rehabilitation (to improve physical function and reduce disability), addressing underlying stressors or psychological factors, supportive care and reassurance, potentially medications (such as antidepressants or anti-anxiety medications)\\nDisease_Code: D227\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 228, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Lymphedema\\nSymptoms: Swelling in arms or legs, feeling of heaviness or tightness\\nTreatments: Compression therapy, exercise, lymphatic drainage techniques, surgery (in severe cases)\\nDisease_Code: D228\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 229, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hirschsprung Disease\\nSymptoms: Chronic constipation, abdominal distension, failure to pass meconium (in newborns)\\nTreatments: Surgery to remove the affected part of the colon (pull-through procedure)\\nDisease_Code: D229\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 230, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Rheumatoid Arthritis\\nSymptoms: Joint pain, stiffness, swelling, fatigue, loss of appetite\\nTreatments: Medications (nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs), physical therapy, exercise\\nDisease_Code: D230\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 231, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Turner syndrome\\nSymptoms: Short stature, Gonadal dysgenesis, Webbed neck, Lymphedema\\nTreatments: Growth hormone therapy, Estrogen replacement therapy, Cardiac and renal evaluations\\nDisease_Code: D231\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 232, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Sciatica\\nSymptoms: Pain radiating from the lower back to the leg\\nTreatments: Pain medications, physical therapy, stretching exercises\\nDisease_Code: D187\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 233, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Endophthalmitis\\nSymptoms: Eye pain, redness, swelling, blurred vision, decreased vision, floaters (dark spots or cobwebs in the vision), increased sensitivity to light (photophobia), discharge from the eye, excessive tearing, fever\\nTreatments: Immediate medical attention is required. Treatment may include: intravenous antibiotics or antifungal medications, intravitreal injections (injections of antibiotics or antifungal agents directly into the eye), vitrectomy (surgical removal of the gel-like fluid within the eye), topical or oral medications (to manage pain, inflammation, or infection), frequent follow-up visits with an ophthalmologist, supportive care (such as warm compresses or lubricating eye drops)\\nDisease_Code: D232\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 234, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Myelodysplastic Syndrome\\nSymptoms: Fatigue, frequent infections, easy bruising or bleeding\\nTreatments: Supportive care, blood transfusions, medications, bone marrow transplantation (in some cases)\\nDisease_Code: D233\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 235, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Premature Ventricular Contractions (PVCs)\\nSymptoms: Skipped or extra heartbeats, palpitations, lightheadedness\\nTreatments: Monitoring (in most cases), lifestyle changes, medications (beta-blockers, antiarrhythmics)\\nDisease_Code: D234\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 236, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name: Ludwig's angina\\nSymptoms: Severe swelling of the floor of the mouth, fever, difficulty swallowing, drooling\\nTreatments: Intravenous antibiotics, airway management, surgical drainage\\nDisease_Code: D235\\nContagious: True\\nChronic: False\"),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 237, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cryptococcosis\\nSymptoms: Headache, fever, fatigue, cough, meningitis, pneumonia\\nTreatments: Antifungal medication (e.g., Amphotericin B, Fluconazole), supportive care\\nDisease_Code: D236\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 238, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Diabetic Kidney Disease\\nSymptoms: High blood pressure, increased need to urinate, swelling in the legs and ankles, fatigue, nausea, loss of appetite\\nTreatments: Blood pressure control, blood sugar control, medications to protect the kidneys (such as ACE inhibitors or ARBs), lifestyle modifications (healthy diet, regular exercise, quitting smoking), management of underlying diabetes, treatment of complications (such as dialysis or kidney transplantation in advanced stages)\\nDisease_Code: D237\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 239, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Premenstrual Tension Syndrome\\nSymptoms: Mood swings, bloating, breast tenderness, irritability\\nTreatments: Lifestyle changes, medications (pain relievers, hormonal contraceptives), therapy\\nDisease_Code: D238\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 240, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Drug Abuse (Methamphetamine)\\nSymptoms: Increased energy and alertness, decreased appetite, rapid heartbeat\\nTreatments: Detoxification, counseling, behavioral therapies, support groups, medication-assisted treatment (if applicable)\\nDisease_Code: D239\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 241, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Urge Incontinence\\nSymptoms: Sudden, intense urge to urinate followed by involuntary urine leakage\\nTreatments: Behavioral therapies (bladder training, pelvic floor exercises), medications (anticholinergics, beta-3 agonists), medical devices\\nDisease_Code: D240\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 242, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dengue Fever\\nSymptoms: High fever, severe headache, joint and muscle pain, rash, nausea or vomiting, bleeding tendencies\\nTreatments: Supportive care (hydration, pain relievers, rest), monitoring, medical attention for severe cases (fluid replacement, blood transfusion, hospitalization)\\nDisease_Code: D241\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 243, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Lead Poisoning\\nSymptoms: Fatigue, abdominal pain, joint pain, memory loss or cognitive difficulties, developmental delays (in children), anemia\\nTreatments: Removal of lead source, chelation therapy (in severe cases), supportive care, medication to manage symptoms, addressing complications (such as anemia)\\nDisease_Code: D242\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 244, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Actinic Keratosis\\nSymptoms: Rough, scaly patches on the skin, usually in sun-exposed areas\\nTreatments: Topical medications (e.g., fluorouracil, imiquimod, diclofenac), cryotherapy, curettag\\nDisease_Code: D243\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 245, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Choledocholithiasis\\nSymptoms: Abdominal pain (often in the upper right quadrant), jaundice, dark urine, pale stools, nausea, vomiting, endoscopic retrograde cholangiopancreatography (ERCP) with stone removal, sphincterotomy, Cholecystectomy\\nTreatments: Non-surgical treatment options: Medications to manage pain and discomfort, antibiotics\\nDisease_Code: D244\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 246, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Head and Neck Cancer\\nSymptoms: Persistent sore throat, difficulty swallowing, voice changes, ear pain, neck mass, weight loss\\nTreatments: Treatment depends on the specific type and stage of cancer, and may include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy\\nDisease_Code: D245\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 247, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Name: Sjögren's syndrome\\nSymptoms: Dry mouth and eyes, fatigue, joint pain, dry skin\\nTreatments: Symptomatic relief with artificial tears, saliva substitutes, frequent sips of water, medications to stimulate saliva production, immune-modulating drugs\\nDisease_Code: D246\\nContagious: True\\nChronic: True\"),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 248, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Peritonitis\\nSymptoms: Severe abdominal pain, tenderness, bloating, fever, nausea, vomiting, loss of appetite, increased heart rate\\nTreatments: Intravenous antibiotics to treat the infection, intravenous fluids to restore hydration, drainage or removal of any underlying fluid or abscess, surgery to repair or remove the source of infection\\nDisease_Code: D247\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 249, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Anemia of Chronic Disease\\nSymptoms: Fatigue, weakness, pale skin, shortness of breath, decreased exercise tolerance\\nTreatments: Treating the underlying chronic disease, addressing nutritional deficiencies, blood transfusions (in severe cases)\\nDisease_Code: D248\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 250, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Ovarian Torsion\\nSymptoms: Sudden and severe abdominal or pelvic pain on one side, sharp or stabbing pain, nausea, vomiting, fever, rapid heartbeat, abdominal tenderness, bloating, swelling, pain during intercourse, abnormal bleeding or spotting\\nTreatments: Emergency medical attention (as ovarian torsion is a medical emergency), imaging tests (such as ultrasound or CT scan) to diagnose torsion, surgical intervention (laparoscopic or open surgery) to untwist the ovary and restore blood flow, removal of the ovary (if it is damaged or non-viable), pain management (medications for pain relief)\\nDisease_Code: D249\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 251, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Sciatica\\nSymptoms: Lower back pain, leg pain, numbness or tingling\\nTreatments: Pain relievers, physical therapy, exercise\\nDisease_Code: D187\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 252, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Lupus\\nSymptoms: Joint pain, fatigue, skin rashes\\nTreatments: Medications (anti-inflammatory, immunosuppressants), lifestyle modifications\\nDisease_Code: D250\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 253, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Neonatal Jaundice\\nSymptoms: Yellowing of the skin and eyes, pale stools, dark urine\\nTreatments: Phototherapy, exchange transfusion (in severe cases), monitoring of bilirubin levels, addressing underlying causes (e.g., breastfeeding)\\nDisease_Code: D251\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 254, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gastrointestinal Hemorrhage\\nSymptoms: Abdominal pain, vomiting blood, bloody or black stools\\nTreatments: Blood transfusions, endoscopy, surgery (in severe cases), medications to stop bleeding\\nDisease_Code: D252\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 255, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dislocation of the Ankle\\nSymptoms: Swelling, severe pain, inability to bear weight\\nTreatments: Reduction (realigning the bones), immobilization, rehab\\nDisease_Code: D253\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 256, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vaginal Cyst\\nSymptoms: Small lump or swelling in the vaginal wall, discomfort or pain during intercourse\\nTreatments: Observation (if asymptomatic), warm compresses, sitz baths, surgical removal (if necessary)\\nDisease_Code: D254\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 257, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Orthorexia Nervosa\\nSymptoms: Obsessive focus on \"clean\" eating, healthy food choices\\nTreatments: Psychotherapy (such as cognitive-behavioral therapy or acceptance and commitment therapy), nutrition education, challenging distorted beliefs, addressing underlying issues\\nDisease_Code: D255\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 258, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Urinary Tract Infection (UTI)\\nSymptoms: Frequent urination, burning sensation during urination, cloudy or bloody urine, pelvic pain\\nTreatments: Antibiotics, increased fluid intake, pain relievers\\nDisease_Code: D256\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 259, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Placenta Previa\\nSymptoms: Vaginal bleeding, painless bleeding in the third trimester\\nTreatments: Bed rest, avoiding strenuous activity, frequent prenatal check-ups, potential hospitalization, potential cesarean delivery\\nDisease_Code: D257\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 260, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Acute Pancreatitis\\nSymptoms: Severe upper abdominal pain, nausea, vomiting, fever, rapid pulse, swollen and tender abdomen, jaundice\\nTreatments: Hospitalization, intravenous fluids to restore hydration, pain management, bowel rest, nutritional support, medications to control pain and inflammation\\nDisease_Code: D258\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 261, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gum Disease\\nSymptoms: Swollen, red, tender gums, bleeding gums\\nTreatments: Oral hygiene practices (brushing, flossing), professional dental cleanings, medications, surgical interventions\\nDisease_Code: D259\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 262, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Panic Attack\\nSymptoms: Chest pain, shortness of breath, palpitations\\nTreatments: Breathing exercises, relaxation techniques, therapy\\nDisease_Code: D260\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 263, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Lice\\nSymptoms: Itching and visible presence of lice or nits (eggs) in the hair\\nTreatments: Over-the-counter or prescription medications specifically designed to kill lice (such as pediculicides), manual removal of lice and nits using a fine-toothed comb, washing and drying of infested clothing and bedding at high temperatures, vacuuming of upholstery and household surfaces, disinfection of personal items that cannot be washed or dried, avoiding direct head-to-head contact with infested individuals, education and prevention strategies\\nDisease_Code: D261\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 264, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pyloric stenosis\\nSymptoms: Persistent hunger, Weight loss, Dehydration, Visible peristalsis, Palpable mass, Fussiness\\nTreatments: Ultrasound, Blood tests, Pyloromyotomy\\nDisease_Code: D262\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 265, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pigmentary Glaucoma\\nSymptoms: Blurred vision, halos around lights, eye pain\\nTreatments: Eye drops to lower intraocular pressure (e.g., prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors), laser trabeculoplasty, surgical procedures (e.g., trabeculectomy, glaucoma drainage implants)\\nDisease_Code: D263\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 266, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Abscess\\nSymptoms: Swelling, pain, redness, fever, pus formation\\nTreatments: Antibiotics, surgical drainage\\nDisease_Code: D264\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 267, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Myositis\\nSymptoms: Muscle weakness, pain, inflammation\\nTreatments: Medications (corticosteroids, immunosuppressants), physical therapy\\nDisease_Code: D265\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 268, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Von Willebrand Disease\\nSymptoms: Easy or excessive bruising, prolonged or excessive bleeding from cuts or injuries, frequent nosebleeds, heavy or prolonged menstrual periods, bleeding gums, blood in urine or stool\\nTreatments: Desmopressin (DDAVP) medication, replacement therapy with von Willebrand factor (VWF) concentrate or cryoprecipitate, oral contraceptives (for women with heavy menstrual bleeding), avoiding certain medications, dental care precautions, regular medical follow-up\\nDisease_Code: D266\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 269, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gastroparesis\\nSymptoms: Nausea, vomiting, early satiety, bloating, abdominal pain, poor appetite\\nTreatments: Dietary modifications (small, frequent meals; low-fiber, low-fat diet), medication to promote gastric emptying, managing underlying cause if possible\\nDisease_Code: D267\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 270, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chancroid\\nSymptoms: Painful ulcers or sores on the genital area, swollen lymph nodes in the groin\\nTreatments: Antibiotics (such as azithromycin or ceftriaxone), pain management, warm compresses, good hygiene\\nDisease_Code: D268\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 271, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fungal Infection of the Skin\\nSymptoms: Rash, itching, redness, peeling skin\\nTreatments: Antifungal creams, powders, or oral medications, proper hygiene and skin care\\nDisease_Code: D269\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 272, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Stimulant Use Disorder\\nSymptoms: Increased energy and alertness, euphoria, decreased appetite, increased heart rate and blood pressure, insomnia, restlessness, irritability, paranoia, psychosis (in severe cases)\\nTreatments: Counseling or therapy (such as cognitive-behavioral therapy, motivational interviewing), support groups, medication (if applicable), addressing underlying psychological or social factors, lifestyle changes, addressing co-occurring mental health conditions, harm reduction strategies, ongoing monitoring and support\\nDisease_Code: D270\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 273, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Fatigue Syndrome\\nSymptoms: Extreme fatigue, cognitive difficulties, unrefreshing sleep\\nTreatments: Symptom management (such as medications to address pain, sleep disturbances, and other symptoms), graded exercise therapy, cognitive-behavioral therapy, sleep management techniques, pacing and energy conservation, stress reduction techniques, nutritional support, medications for specific symptoms\\nDisease_Code: D271\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 274, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Threatened Pregnancy\\nSymptoms: Vaginal bleeding, abdominal cramps, pelvic pain\\nTreatments: Bed rest, medications (progesterone), monitoring, avoiding activities that may stress the pregnancy\\nDisease_Code: D272\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 275, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Glaucoma\\nSymptoms: Gradual vision loss, peripheral vision impairment, eye pain or discomfort, halos around lights\\nTreatments: Eye drops (to reduce intraocular pressure), oral medications, laser therapy, surgery (trabeculectomy, implantable devices), regular eye exams\\nDisease_Code: D273\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 276, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Urticaria (Hives)\\nSymptoms: Raised, itchy welts on the skin\\nTreatments: Antihistamines, avoiding triggers, corticosteroids (in severe cases)\\nDisease_Code: D274\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 277, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vitreous Hemorrhage\\nSymptoms: Floaters in vision, blurry vision, eye pain\\nTreatments: Observation, laser treatment, vitrectomy (in severe cases)\\nDisease_Code: D275\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 278, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Binge Eating Disorder\\nSymptoms: Recurrent episodes of binge eating without compensatory behaviors\\nTreatments: Psychotherapy (such as cognitive-behavioral therapy or interpersonal therapy), nutritional counseling, medications (in some cases), support groups\\nDisease_Code: D276\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 279, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypercholesterolemia\\nSymptoms: High levels of cholesterol in the blood, fatty deposits (xanthomas) on the skin or tendons, chest pain or angina, heart attacks, strokes\\nTreatments: Lifestyle modifications (healthy diet, regular exercise, weight management, smoking cessation), medications to lower cholesterol levels (such as statins), regular monitoring of cholesterol levels, management of underlying conditions (such as diabetes or high blood pressure), potential additional treatments (such as bile acid sequestrants or PCSK9 inhibitors)\\nDisease_Code: D277\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 280, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Stress Incontinence\\nSymptoms: Unintentional urine leakage during physical activity\\nTreatments: Pelvic floor exercises, behavioral techniques, surgery (in severe cases)\\nDisease_Code: D278\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 281, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Labyrinthitis\\nSymptoms: Vertigo, dizziness, nausea, hearing loss, ear pain\\nTreatments: Medications (antibiotics, antivirals), vestibular rehabilitation therapy\\nDisease_Code: D279\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 282, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dysthymic Disorder\\nSymptoms: Persistent depressive symptoms (low mood, lack of interest, changes in sleep and appetite), lasting for at least two years\\nTreatments: Psychotherapy (cognitive-behavioral therapy, interpersonal therapy), antidepressant medications\\nDisease_Code: D280\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 283, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Ethylene glycol poisoning-1\\nSymptoms: Nausea, vomiting, abdominal pain, General malaise, weakness, Increased thirst, frequent urination\\nTreatments: Supportive Measures, Gastric Decontamination, Antidote Administration, Hemodialysis\\nDisease_Code: D281\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 284, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Impulse Control Disorder\\nSymptoms: Impulsive behaviors (e.g., gambling, stealing), difficulty resisting urges\\nTreatments: Psychotherapy, medication (in some cases), support groups, behavioral interventions\\nDisease_Code: D282\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 285, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Intracranial Hemorrhage\\nSymptoms: Severe headache, nausea or vomiting, changes in vision, loss of consciousness, seizures\\nTreatments: Emergency medical attention, surgery (if needed), medications to control bleeding and manage symptoms\\nDisease_Code: D283\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 286, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Postpartum Depression\\nSymptoms: Persistent feelings of sadness, emptiness, or hopelessness, frequent crying, irritability, loss of interest or pleasure in activities, difficulty bonding with the baby, changes in appetite or sleep patterns, overwhelming fatigue, feelings of guilt or worthlessness, trouble concentrating or making decisions, thoughts of self-harm or harming the baby\\nTreatments: Psychotherapy (such as cognitive-behavioral therapy or interpersonal therapy), support groups or peer counseling, antidepressant medication (if recommended by a healthcare professional), hormone therapy (in some cases), lifestyle changes (such as exercise, healthy diet, sleep hygiene), involving a partner or family in the care of the baby, social support and understanding from family and friends, regular follow-up and monitoring by healthcare professionals\\nDisease_Code: D284\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 287, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Injury to the Leg\\nSymptoms: Pain, swelling, bruising, difficulty walking\\nTreatments: R.I.C.E. (Rest, Ice, Compression, Elevation), pain medications, physical therapy\\nDisease_Code: D285\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 288, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Stroke\\nSymptoms: Sudden numbness or weakness of the face, arm, or leg (typically on one side of the body), confusion, trouble speaking or understanding, severe headache\\nTreatments: Emergency medical attention, medication (clot-busting drugs, anticoagulants), supportive care, rehabilitation (physical therapy, speech therapy), lifestyle modifications (diet, exercise, smoking cessation), addressing underlying risk factors\\nDisease_Code: D286\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 289, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Huntington Disease\\nSymptoms: Motor, cognitive, and psychiatric symptoms\\nTreatments: Supportive care, medications (to manage symptoms), therapy\\nDisease_Code: D287\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 290, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Mononucleosis\\nSymptoms: Fatigue, sore throat, swollen lymph nodes\\nTreatments: Rest, pain relievers, fluids, symptom management\\nDisease_Code: D288\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 291, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hallucinogen Use Disorder\\nSymptoms: Altered perception of reality, visual or auditory hallucinations, changes in sensory experiences, introspective thoughts, feelings of connection or disconnection, anxiety or paranoia (in some individuals), flashbacks (in some individuals)\\nTreatments: Counseling or therapy (such as cognitive-behavioral therapy, motivational interviewing), support groups, addressing underlying psychological or social factors, harm reduction strategies, ongoing monitoring and support\\nDisease_Code: D289\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 292, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Ependymoma\\nSymptoms: Headaches, nausea, seizures, changes in coordination or balance\\nTreatments: Surgery, radiation therapy, chemotherapy, targeted therapy, rehabilitation\\nDisease_Code: D290\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 293, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Lymphoma\\nSymptoms: Swollen lymph nodes, unexplained weight loss, fatigue\\nTreatments: Chemotherapy, radiation therapy, immunotherapy, targeted therapy\\nDisease_Code: D291\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 294, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Urinary Tract Infection (UTI)\\nSymptoms: Painful urination, frequent urination, pelvic pain, cloudy urine\\nTreatments: Antibiotics safe for pregnancy, increased fluid intake, maintaining good hygiene, urine culture and sensitivity testing to guide antibiotic selection\\nDisease_Code: D256\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 295, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Transient ischemic attack\\nSymptoms: Sudden onset of neurological symptoms that resolve within 24 hours\\nTreatments: Antiplatelet medications, Carotid endarterectomy,  Anticoagulant medications, Lifestyle modifications\\nDisease_Code: D292\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 296, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Normal-Tension Glaucoma\\nSymptoms: Gradual loss of vision, visual field defects\\nTreatments: Eye drops to lower intraocular pressure (e.g., prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors), oral medications (e.g., carbonic anhydrase inhibitors), laser trabeculoplasty, surgical procedures (e.g., trabeculectomy, glaucoma drainage implants)\\nDisease_Code: D293\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 297, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Thyroid Disease\\nSymptoms: Fatigue, weight changes, mood swings, dry skin\\nTreatments: Medications (thyroid hormone replacement, antithyroid drugs), radioactive iodine therapy, surgery (in some cases)\\nDisease_Code: D294\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 298, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bladder Cancer\\nSymptoms: Blood in urine, frequent urination, pelvic pain\\nTreatments: Surgery, chemotherapy, radiation therapy\\nDisease_Code: D295\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 299, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fracture of the Arm\\nSymptoms: Pain, swelling, deformity, limited mobility or difficulty moving the arm, bruising\\nTreatments: Immobilization (cast or splint), pain management, physical therapy, surgery (in complex fractures)\\nDisease_Code: D296\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 300, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Mucocele\\nSymptoms: Painless swelling, usually on the lower lip or floor of the mouth\\nTreatments: Observation, surgical removal if necessary\\nDisease_Code: D085\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 301, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Kidney Failure\\nSymptoms: Decreased urine output, fluid retention, fatigue, shortness of breath, nausea, confusion, chest pain, seizures\\nTreatments: Treatment depends on the underlying cause and may include medications to manage blood pressure and symptoms, dietary modifications (restricting salt, protein, and potassium), dialysis (hemodialysis or peritoneal dialysis) or kidney transplantation (in end-stage kidney failure), treatment of complications, management of fluid and electrolyte balance, lifestyle modifications (exercise, quitting smoking, healthy diet)\\nDisease_Code: D297\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 302, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chagas Disease\\nSymptoms: Fever, fatigue, body aches, heart and digestive problems\\nTreatments: Antiparasitic medications, medications to manage symptoms, supportive care\\nDisease_Code: D298\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 303, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Leukemia\\nSymptoms: Fatigue, pale skin, frequent infections, easy bleeding or bruising\\nTreatments: Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, supportive care\\nDisease_Code: D299\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 304, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vesicoureteral Reflux\\nSymptoms: Frequent urinary tract infections, urinary urgency or frequency, bedwetting (in children), high blood pressure (in severe cases)\\nTreatments: Antibiotics, bladder training exercises, surgical correction (in some cases)\\nDisease_Code: D300\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 305, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Endometriosis\\nSymptoms: Pelvic pain (during menstruation, intercourse, or bowel movements), heavy menstrual bleeding, infertility\\nTreatments: Pain management (such as nonsteroidal anti-inflammatory drugs [NSAIDs], hormonal contraceptives, or progestins), hormone therapy (such as gonadotropin-releasing hormone [GnRH] agonists or oral contraceptives), surgical interventions (such as laparoscopic excision or hysterectomy), fertility treatments (if pregnancy is desired), lifestyle modifications (such as regular exercise, stress management), complementary therapies (such as acupuncture or dietary changes)\\nDisease_Code: D162\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 306, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Psoriasis\\nSymptoms: Red, scaly patches on the skin, itching\\nTreatments: Topical treatments (corticosteroids, salicylic acid), systemic medications (retinoids, immunosuppressants), phototherapy\\nDisease_Code: D301\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 307, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Infection of Open Wound\\nSymptoms: Redness, swelling, warmth, pain or tenderness at the wound site, pus or drainage from the wound, fever, malaise\\nTreatments: Cleaning and irrigation of the wound, antibiotic therapy (oral or intravenous), wound dressings, wound debridement (if necessary), tetanus prophylaxis\\nDisease_Code: D302\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 308, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Anemia\\nSymptoms: Fatigue, weakness, pale skin, shortness of breath\\nTreatments: Iron supplementation, dietary changes (iron-rich foods), managing underlying causes (such as treating iron deficiency or vitamin B12 deficiency), prenatal vitamins\\nDisease_Code: D303\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 309, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Spondylosis\\nSymptoms: Neck or back pain, stiffness, limited range of motion, numbness or weakness in the extremities\\nTreatments: Medications (pain relievers, muscle relaxants), physical therapy, exercise, posture improvement, heat or cold therapy, spinal injections, surgery (in severe cases or if conservative treatments fail)\\nDisease_Code: D304\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 310, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Acute Otitis Media\\nSymptoms: Ear pain, fever, fluid drainage from the ear, hearing loss or muffled hearing in the affected ear\\nTreatments: Antibiotics, pain relievers (e.g., acetaminophen, ibuprofen), warm compresses, ear drops, tympanostomy tubes (in some cases)\\nDisease_Code: D305\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 311, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fracture\\nSymptoms: Pain, Swelling, Bruising, Deformity, Difficulty moving, Loss of function\\nTreatments: Immobilization, Surgery, Rehabilitation\\nDisease_Code: D306\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 312, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Round Ligament Pain\\nSymptoms: Sharp or aching pain in the lower abdomen or groin\\nTreatments: Resting, changing positions slowly, warm compresses, gentle stretching, avoiding sudden movements\\nDisease_Code: D307\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 313, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Autism\\nSymptoms: Challenges with social interaction, communication difficulties, restricted interests or repetitive behaviors\\nTreatments: Behavioral therapy, educational interventions, speech and language therapy, medications for associated symptoms\\nDisease_Code: D308\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 314, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pleomorphic adenoma\\nSymptoms: Painless lump or swelling, Facial changes\\nTreatments: Surgical excision\\nDisease_Code: D309\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 315, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Otosclerosis\\nSymptoms: Hearing loss (gradual and progressive), tinnitus (ringing in the ears), dizziness or balance problems\\nTreatments: Hearing aids, surgical interventions (such as stapedectomy or stapedotomy to replace the affected bone in the middle ear), sodium fluoride therapy (to slow down the progression of the condition), communication strategies and support (such as lip-reading or sign language), regular hearing assessments\\nDisease_Code: D310\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 316, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bulimia Nervosa\\nSymptoms: Recurrent episodes of binge eating followed by purging behaviors\\nTreatments: Psychotherapy (such as cognitive-behavioral therapy or dialectical behavior therapy), nutritional counseling, medications (in some cases), support groups\\nDisease_Code: D311\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 317, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Poisoning due to Analgesics\\nSymptoms: Nausea, vomiting, abdominal pain, liver or kidney damage, dizziness, confusion, respiratory distress\\nTreatments: Immediate medical attention, activated charcoal administration, supportive care, antidote (if available), treatment for complications\\nDisease_Code: D312\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 318, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pseudohypoparathyroidism\\nSymptoms: Hypocalcemia (low calcium levels), tetany (muscle spasms), short stature, rounded face\\nTreatments: Calcium and vitamin D supplementation, management of complications, hormone replacement therapy (if necessary)\\nDisease_Code: D313\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 319, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dermatitis due to Sun Exposure\\nSymptoms: Redness, itching, rash, blistering\\nTreatments: Topical corticosteroids, moisturizers, avoiding sun exposure\\nDisease_Code: D221\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 320, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Anemia due to Malignancy\\nSymptoms: Fatigue, weakness, shortness of breath, pale skin\\nTreatments: Treating underlying malignancy, blood transfusions, medications (erythropoiesis-stimulating agents, iron supplements)\\nDisease_Code: D314\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 321, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hyperhidrosis\\nSymptoms: Excessive sweating (beyond what is necessary for temperature regulation), typically in specific areas (such as palms, soles, underarms), may interfere with daily activities\\nTreatments: Antiperspirants, medications (anticholinergics, beta blockers), iontophoresis, Botox injections, surgical interventions (sympathectomy, sweat gland removal)\\nDisease_Code: D315\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 322, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Otitis Media\\nSymptoms: Ear pain, fever, fluid drainage from the ear\\nTreatments: Antibiotics (if bacterial infection), pain relievers, observation (in some cases)\\nDisease_Code: D316\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 323, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Benign Kidney Cyst\\nSymptoms: Abdominal or flank pain, blood in urine, frequent urination\\nTreatments: Observation, medication (if needed), surgery (in rare cases)\\nDisease_Code: D317\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 324, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pain after an Operation\\nSymptoms: Surgical site pain, discomfort, swelling\\nTreatments: Pain medications, ice packs, rest, wound care\\nDisease_Code: D318\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 325, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Knee Pain\\nSymptoms: Persistent knee pain, stiffness, swelling, limited range of motion\\nTreatments: Pain management, physical therapy, lifestyle modifications, knee braces or supports\\nDisease_Code: D319\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 326, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Volvulus\\nSymptoms: Abdominal pain, nausea, vomiting, bloating, constipation, bloody stool\\nTreatments: Emergency surgery to untwist the affected organ and restore blood flow\\nDisease_Code: D320\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 327, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Scurvy\\nSymptoms: Fatigue, swollen and bleeding gums, joint pain\\nTreatments: Vitamin C supplementation, dietary changes, oral hygiene maintenance\\nDisease_Code: D321\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 328, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Urinary Stones (Kidney Stones)\\nSymptoms: Severe abdominal or back pain, blood in urine, frequent urination, pain during urination\\nTreatments: Pain management, increased fluid intake, medications to help pass the stones, procedures or surgery\\nDisease_Code: D322\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 329, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Injury to the Finger\\nSymptoms: Pain, swelling, bruising, deformity, restricted range of motion, difficulty gripping or using the finger\\nTreatments: RICE method (Rest, Ice, Compression, Elevation), splinting, pain medication, physical therapy, surgery (in severe cases)\\nDisease_Code: D323\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 330, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Retinal Detachment\\nSymptoms: Floaters (spots or cobweb-like shapes in vision), flashes of light, curtain-like shadow over vision, sudden vision loss\\nTreatments: Surgical intervention (pneumatic retinopexy, scleral buckle, vitrectomy), laser therapy, cryotherapy, gas or silicone oil injection, positioning, regular eye exams\\nDisease_Code: D324\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 331, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Rheumatic Fever\\nSymptoms: Joint pain, fever, rash, heart inflammation\\nTreatments: Antibiotics (to treat streptococcal infections), anti-inflammatory medications, medications for heart complications\\nDisease_Code: D325\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 332, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Acute Bronchospasm\\nSymptoms: Wheezing, shortness of breath, chest tightness\\nTreatments: Bronchodilators (inhaled medications), corticosteroids, supplemental oxygen (if needed)\\nDisease_Code: D326\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 333, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vulvodynia\\nSymptoms: Persistent pain or discomfort in the vulva, burning, stinging, rawness, itching\\nTreatments: Topical medications (such as lidocaine or estrogen creams), nerve blocks, physical therapy (including pelvic floor muscle relaxation exercises), cognitive-behavioral therapy (CBT), biofeedback, medications (such as tricyclic antidepressants or anticonvulsants), vulvar care and hygiene practices, stress management techniques, alternative therapies (such as acupuncture or herbal remedies)\\nDisease_Code: D327\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 334, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Other Specified Feeding or Eating Disorder (OSFED)\\nSymptoms: Symptoms that do not meet the full criteria for a specific eating disorder\\nTreatments: Treatment is based on the specific symptoms and can include a combination of psychotherapy, nutritional counseling, medical monitoring, and medications as necessary\\nDisease_Code: D328\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 335, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Anemia due to Chronic Kidney Disease\\nSymptoms: Fatigue, weakness, pale skin\\nTreatments: Erythropoiesis-stimulating agents (ESA), iron supplementation, blood transfusions (in severe cases)\\nDisease_Code: D329\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 336, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pemphigus\\nSymptoms: Painful blisters on the skin and mucous membranes\\nTreatments: Corticosteroids, immunosuppressants, wound care\\nDisease_Code: D330\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 337, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Syphilis\\nSymptoms: Primary stage: painless sores (chancre) at the site of infection, secondary stage: skin rash, fever, swollen lymph nodes, sore throat, latent stage: no symptoms, tertiary stage: severe complications affecting the heart, brain, and other organs\\nTreatments: Antibiotics (usually penicillin), treatment of complications, regular follow-up and testing\\nDisease_Code: D331\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 338, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Omphalitis\\nSymptoms: Redness, swelling, discharge, foul odor around the umbilical area\\nTreatments: Antibiotics, wound care, surgical intervention (in severe cases)\\nDisease_Code: D332\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 339, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Idiopathic Nonmenstrual Bleeding\\nSymptoms: Abnormal vaginal bleeding outside of the menstrual period, unpredictable bleeding episodes, bleeding after sexual intercourse, bleeding after menopause, spotting or light bleeding between periods, prolonged or heavy bleeding\\nTreatments: Evaluation to rule out underlying causes (such as hormonal imbalances, polyps, infections, or uterine abnormalities), hormonal therapy (such as birth control pills, hormone replacement therapy), non-hormonal medications (such as tranexamic acid), dilation and curettage (if necessary to remove excessive tissue or investigate the cause), endometrial ablation (in some cases), hysteroscopy (to examine the uterus), surgery (in rare cases), counseling or support for emotional well-being\\nDisease_Code: D333\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 340, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Myofascial Pain Syndrome\\nSymptoms: Localized muscle pain, trigger points\\nTreatments: Physical therapy, trigger point injections, dry needling, medications (such as pain relievers, muscle relaxants), relaxation techniques, stress management, massage therapy, myofascial release, heat or cold therapy\\nDisease_Code: D334\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 341, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vocal cord polyp\\nSymptoms: Hoarseness, Vocal Changes, Vocal Fatigue\\nTreatments: Voice Rest, Speech Therapy, Surgical Removal\\nDisease_Code: D335\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 342, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Rotator Cuff Injury\\nSymptoms: Shoulder pain, weakness or loss of strength, limited range of motion, shoulder stiffness\\nTreatments: Non-surgical treatment options: Rest, ice or heat therapy, pain medications, physical therapy exercises, Arthroscopic surgery\\nDisease_Code: D336\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 343, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fibromyalgia\\nSymptoms: Widespread musculoskeletal pain, fatigue, sleep disturbances, cognitive difficulties (fibro fog), mood changes\\nTreatments: Multidisciplinary approach: Medications for pain management (such as analgesics, antidepressants, and anticonvulsants), physical therapy, occupational therapy, cognitive-behavioral therapy, relaxation techniques, stress management, exercise programs\\nDisease_Code: D337\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 344, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypercalcemia\\nSymptoms: Fatigue, nausea, excessive thirst, kidney stones\\nTreatments: Treating underlying cause, hydration, medications\\nDisease_Code: D338\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 345, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Secondary Glaucoma\\nSymptoms: Varies depending on the underlying cause\\nTreatments: Treatment of the underlying condition (e.g., medication adjustments, surgery, trauma management, tumor removal, inflammation control)\\nDisease_Code: D339\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 346, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Drug Reaction\\nSymptoms: Rash, itching, swelling, fever, respiratory symptoms\\nTreatments: Discontinuation of the offending drug, supportive care, antihistamines, corticosteroids (in severe cases)\\nDisease_Code: D340\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 347, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Acute Sinusitis\\nSymptoms: Facial pain or pressure, nasal congestion, thick nasal discharge, post-nasal drip, cough, headache, fatigue, fever (in some cases)\\nTreatments: Home remedies (such as nasal saline irrigation, steam inhalation), over-the-counter pain relievers (such as acetaminophen or ibuprofen), nasal decongestants (for short-term use), nasal corticosteroids (to reduce inflammation), plenty of fluids and rest, warm compresses, avoidance of irritants (such as smoke or allergens), prescription antibiotics (if bacterial infection is suspected or confirmed), management of underlying causes (such as allergies or nasal polyps), symptom relief medications (such as cough suppressants or antihistamines)\\nDisease_Code: D341\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 348, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Polycystic Ovarian Syndrome\\nSymptoms: Irregular periods, excessive hair growth, acne, weight gain, ovarian cysts\\nTreatments: Lifestyle changes (diet, exercise, weight management), hormonal contraceptives, fertility treatments (if needed)\\nDisease_Code: D342\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 349, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Complex Regional Pain Syndrome (CRPS)\\nSymptoms: Severe and persistent pain, changes in skin color or temperature, swelling, stiffness\\nTreatments: Medications (such as pain relievers, corticosteroids, anticonvulsants), physical therapy, sympathetic nerve blocks, spinal cord stimulation, occupational therapy, mirror therapy, psychotherapy, graded motor imagery, stress management techniques\\nDisease_Code: D100\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 350, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Optic Neuritis\\nSymptoms: Vision loss or blurry vision, eye pain with eye movement, color vision impairment, flashing lights or floaters\\nTreatments: High-dose intravenous corticosteroids, treatment of underlying cause, symptom management, visual rehabilitation\\nDisease_Code: D343\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 351, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Adrenal Cancer\\nSymptoms: Abdominal or back pain, unexplained weight loss, hormonal imbalances\\nTreatments: Surgery (adrenalectomy), chemotherapy, radiation therapy, targeted therapy, hormone replacement therapy\\nDisease_Code: D344\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 352, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Intracranial Abscess\\nSymptoms: Headache, fever, neurological deficits\\nTreatments: Antibiotics, surgical drainage or removal of the abscess, supportive care\\nDisease_Code: D345\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 353, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Adenoid cystic carcinoma\\nSymptoms: Lump, swelling, Facial numbness, tingling\\nTreatments: Surgery, Radiation therapy\\nDisease_Code: D346\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 354, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fracture of the Patella\\nSymptoms: Severe pain, swelling, bruising, difficulty straightening or bending the knee, deformity\\nTreatments: Immobilization (splint, cast, or brace), pain management, physical therapy, exercises to restore mobility and strength, potential surgical intervention (in severe cases or if displacement is present)\\nDisease_Code: D347\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 355, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Restless Leg Syndrome\\nSymptoms: Uncomfortable sensation in the legs, usually in the evening or at night, urge to move legs for relief\\nTreatments: Lifestyle changes (such as regular exercise, avoiding triggers like caffeine), good sleep hygiene (maintaining a regular sleep schedule), leg massages or stretching exercises, hot or cold packs, medication therapy (such as dopamine agonists, anticonvulsants, opioids), iron supplementation (if iron deficiency is present)\\nDisease_Code: D348\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 356, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Cold Sore\\nSymptoms: Small, painful blisters on the lips or around the mouth\\nTreatments: Antiviral medications (topical or oral), pain relievers, antiviral creams, self-care measures\\nDisease_Code: D349\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 357, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Kidney Disease\\nSymptoms: Fatigue, swelling of the legs or ankles, decreased appetite, difficulty concentrating, increased urination or urine changes, blood in urine, high blood pressure\\nTreatments: Management of underlying conditions (such as diabetes or high blood pressure), lifestyle modifications (such as healthy diet, regular exercise, smoking cessation), medications (such as ACE inhibitors or diuretics), dialysis (in advanced stages), kidney transplant (in end-stage kidney disease), management of associated complications (such as anemia or bone disease), regular monitoring and follow-up with a nephrologist, education and support for self-care\\nDisease_Code: D350\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 358, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Goiter\\nSymptoms: Enlarged thyroid gland in the neck, swelling or visible protrusion, difficulty swallowing or breathing\\nTreatments: Treatment depends on the underlying cause (medication, radioactive iodine therapy, surgery)\\nDisease_Code: D351\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 359, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Type 1 Diabetes\\nSymptoms: Frequent urination, Increased thirst, Weight loss\\nTreatments: Insulin therapy, Blood sugar monitoring, Healthy eating, Regular exercise\\nDisease_Code: D352\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 360, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dislocation of the Elbow\\nSymptoms: Severe pain, visible deformity, swelling, inability to move the elbow, numbness or tingling in the hand/arm\\nTreatments: Closed reduction (realigning the bones without surgery), immobilization (splint or cast), physical therapy, pain management, surgical intervention (in complex or recurrent cases)\\nDisease_Code: D353\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 361, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Rabies\\nSymptoms: Flu-like symptoms (fever, headache, fatigue), anxiety, confusion, hallucinations, difficulty swallowing\\nTreatments: Immediate medical attention (post-exposure prophylaxis), wound care, administration of rabies vaccine and immunoglobulin, supportive care, monitoring and management of symptoms\\nDisease_Code: D354\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 362, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Contact Dermatitis\\nSymptoms: Itchy, red rash caused by contact with irritants or allergens\\nTreatments: Avoiding the trigger, corticosteroid creams or ointments, antihistamines\\nDisease_Code: D355\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 363, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hemophilia\\nSymptoms: Excessive bleeding and bruising, prolonged bleeding from wounds or after dental work or surgery, spontaneous bleeding in joints or muscles\\nTreatments: Replacement therapy with clotting factor concentrates, medications to control bleeding, physical therapy, joint protection measures, genetic counseling and testing for family members\\nDisease_Code: D356\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 364, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Open Wound from Surgical Incision\\nSymptoms: Redness, swelling, discharge from the wound\\nTreatments: Wound care (cleaning, dressing changes), antibiotics (if infection is present), surgical interventions\\nDisease_Code: D357\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 365, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chronic Migraine\\nSymptoms: Recurrent, disabling migraines\\nTreatments: Medications (such as preventive medications, pain relievers, triptans), lifestyle modifications (such as identifying triggers, stress management, regular sleep patterns), relaxation techniques, biofeedback, cognitive-behavioral therapy, nerve blocks, Botox injections, neuromodulation devices, acupuncture\\nDisease_Code: D358\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 366, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hyperkalemia\\nSymptoms: Muscle weakness or fatigue, irregular heartbeat or palpitations, numbness or tingling, nausea or vomiting\\nTreatments: Treatment of underlying cause, medications to reduce potassium levels, dietary modifications, dialysis (in severe cases)\\nDisease_Code: D359\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 367, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Fibromyalgia\\nSymptoms: Widespread musculoskeletal pain, fatigue, sleep disturbances\\nTreatments: Medications (such as pain relievers, antidepressants, anticonvulsants), physical therapy, cognitive-behavioral therapy, stress management techniques, exercise, relaxation techniques, good sleep hygiene\\nDisease_Code: D337\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 368, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Bipolar Disorder\\nSymptoms: Mood swings, manic episodes, depressive episodes\\nTreatments: Medications (mood stabilizers, antipsychotics), therapy\\nDisease_Code: D360\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 369, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Sedatives Poisoning\\nSymptoms: Drowsiness, confusion, slowed breathing\\nTreatments: Immediate medical attention, supportive care, antidote administration\\nDisease_Code: D361\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 370, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Migraine\\nSymptoms: headache, nausea, sensitivity to light, visual disturbances\\nTreatments: pain relief medication, rest, cold compress\\nDisease_Code: D203\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 371, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Plantar Fasciitis\\nSymptoms: Heel pain, tenderness, difficulty walking\\nTreatments: Rest, stretching exercises, orthotic devices, physiotherapy\\nDisease_Code: D362\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 372, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Priapism\\nSymptoms: Persistent, painful erection\\nTreatments: Medical intervention (aspiration, medication, surgery)\\nDisease_Code: D363\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 373, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gestational Hypertension\\nSymptoms: High blood pressure without proteinuria (preeclampsia)\\nTreatments: Monitoring blood pressure, lifestyle modifications (such as salt restriction, regular exercise), medication (such as antihypertensive drugs) if necessary, close monitoring by healthcare provider\\nDisease_Code: D364\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 374, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pyelonephritis\\nSymptoms: Fever, chills, back or flank pain, frequent urination\\nTreatments: Antibiotics (such as fluoroquinolones, cephalosporins, or trimethoprim-sulfamethoxazole) to target the specific bacteria causing the infection, adequate hydration, pain management (such as over-the-counter pain relievers or prescription medications), hospitalization (for severe cases or complications), urine culture to guide antibiotic therapy\\nDisease_Code: D365\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 375, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Drug Abuse (Cocaine)\\nSymptoms: Euphoria, increased energy, dilated pupils, rapid heart rate, high blood pressure, risk of heart attack or stroke\\nTreatments: Medical detoxification, counseling, behavioral therapies, support groups\\nDisease_Code: D366\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 376, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Gout\\nSymptoms: Intense joint pain, swelling, redness\\nTreatments: Medications (nonsteroidal anti-inflammatory drugs, colchicine), lifestyle changes\\nDisease_Code: D367\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 377, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Narcolepsy\\nSymptoms: Excessive daytime sleepiness, sudden loss of muscle tone (cataplexy)\\nTreatments: Stimulant medications, antidepressants, lifestyle modifications, scheduled naps\\nDisease_Code: D368\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 378, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Submandibular stones\\nSymptoms: Swelling, pain, dry mouth, bad taste\\nTreatments: Hydration,Saliva stimulation, Stone removal\\nDisease_Code: D369\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 379, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Dental Caries\\nSymptoms: Toothache, tooth sensitivity, visible pits or holes in the teeth, dark spots on the teeth, bad breath\\nTreatments: Dental fillings, crowns, root canal treatment, tooth extraction (in severe cases), oral hygiene practices (brushing and flossing), regular dental check-ups, fluoride treatments, dietary modifications (reducing sugary and acidic foods and drinks), dental sealants (for prevention), education on proper oral care\\nDisease_Code: D370\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 380, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Vitamin B12 Deficiency\\nSymptoms: Fatigue, weakness, pale skin, shortness of breath, tingling or numbness in the hands and feet, balance problems, sore tongue\\nTreatments: Vitamin B12 supplementation (such as oral supplements or injections), dietary changes to include B12-rich foods (such as meat, fish, eggs, and dairy products), identification and management of underlying causes (such as pernicious anemia or malabsorption disorders), management of associated symptoms or complications (such as nerve pain or balance problems), regular monitoring of B12 levels and treatment adjustment\\nDisease_Code: D371\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 381, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Testicular Cancer\\nSymptoms: Lump or swelling in the testicles, pain or discomfort, changes in testicular size or shape\\nTreatments: Surgery (orchiectomy), chemotherapy, radiation therapy, surveillance (for some cases)\\nDisease_Code: D372\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 382, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Peyronie Disease\\nSymptoms: Curvature of the penis, pain during erections\\nTreatments: Medications, traction therapy, surgery\\nDisease_Code: D373\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 383, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hepatitis due to a Toxin\\nSymptoms: Fatigue, jaundice, abdominal pain, nausea, vomiting\\nTreatments: Supportive care, removal or avoidance of the toxic substance, management of symptoms\\nDisease_Code: D374\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 384, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Foreign Body in the Throat\\nSymptoms: Sensation of a foreign object stuck in the throat, difficulty swallowing or speaking\\nTreatments: Immediate medical attention, removal of the foreign body, evaluation for any complications\\nDisease_Code: D375\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 385, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Stenosis of the Tear Duct\\nSymptoms: Excessive tearing, eye discharge, recurrent eye infections\\nTreatments: Tear duct probing, dilation, surgical correction\\nDisease_Code: D376\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 386, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Lateral Epicondylitis (Tennis Elbow)\\nSymptoms: Pain or tenderness on the outer side of the elbow, weak grip strength, difficulty with forearm movements\\nTreatments: Rest, ice or cold therapy, compression, elbow brace or strap, pain relievers, physical therapy exercises, corticosteroid injections (in severe cases), ergonomic modifications\\nDisease_Code: D377\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 387, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Attention Deficit Hyperactivity Disorder (ADHD)\\nSymptoms: Inattention, hyperactivity, impulsivity\\nTreatments: Behavioral therapy, parent training programs, medication (such as stimulants or non-stimulants), individualized education plans (IEPs) for academic support, accommodations and modifications in school, psychoeducation, counseling\\nDisease_Code: D378\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 388, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Tuberous Sclerosis\\nSymptoms: Benign tumors in various organs, seizures, developmental delays, skin abnormalities\\nTreatments: Medications (anti-seizure, behavioral, etc.), surgery (for tumor removal), therapy (physical, occupational, speech), educational interventions, support services, genetic counseling, monitoring of organ involvement\\nDisease_Code: D379\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 389, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pulmonic Valve Disease\\nSymptoms: Fatigue, shortness of breath, chest pain or discomfort, heart palpitations, fainting or lightheadedness, swollen legs or ankles\\nTreatments: Medications (such as diuretics, beta-blockers, or calcium channel blockers), surgical interventions (such as balloon valvuloplasty or valve replacement), lifestyle modifications (such as regular exercise, heart-healthy diet, smoking cessation), regular follow-up with a cardiologist\\nDisease_Code: D380\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 390, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Pelvic Organ Prolapse\\nSymptoms: Pelvic pressure or heaviness, urinary incontinence, bowel movement difficulties, discomfort or pain during intercourse\\nTreatments: Pelvic floor exercises, pessary use, hormone therapy, surgical repair (in severe cases)\\nDisease_Code: D381\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 391, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Sedative, Hypnotic, or Anxiolytic Use Disorder\\nSymptoms: Sedation, relaxation, reduced anxiety, drowsiness, poor coordination, memory impairment, withdrawal symptoms (such as rebound anxiety, insomnia, tremors) when attempting to stop or reduce use, continued use despite negative consequences (such as relationship problems, health risks)\\nTreatments: Gradual tapering off sedatives, hypnotics, or anxiolytics under medical supervision, counseling or therapy (such as cognitive-behavioral therapy), support groups, addressing underlying psychological or social factors, lifestyle changes, addressing co-occurring mental health conditions, harm reduction strategies, ongoing monitoring and support\\nDisease_Code: D382\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 392, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Atrial Fibrillation\\nSymptoms: Irregular or rapid heartbeat, palpitations, shortness of breath, chest pain or discomfort, dizziness or lightheadedness, fatigue\\nTreatments: Medications (antiarrhythmics, anticoagulants), electrical cardioversion, catheter ablation, lifestyle changes\\nDisease_Code: D383\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 393, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Asthma\\nSymptoms: Recurrent episodes of wheezing, shortness of breath, chest tightness, coughing, especially at night or in response to triggers such as allergens or exercise\\nTreatments: Long-term control medications (such as inhaled corticosteroids, long-acting beta-agonists), quick-relief medications (such as short-acting beta-agonists), avoidance of triggers (such as allergens, smoke), regular monitoring of symptoms and lung function, development of an asthma action plan, proper inhaler technique, regular follow-up with a healthcare provider, emergency medications (such as oral corticosteroids) as needed\\nDisease_Code: D384\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 394, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Edward Syndrome\\nSymptoms: Developmental delays, intellectual disability, distinct facial features (small jaw, low-set ears), heart defects\\nTreatments: Supportive care, addressing associated medical issues, early intervention programs, palliative care\\nDisease_Code: D385\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 395, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: West Nile Virus\\nSymptoms: Fever, headache, body aches, rash\\nTreatments: Supportive care, symptom management, prevention of mosquito bites\\nDisease_Code: D386\\nContagious: True\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 396, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Obesity\\nSymptoms: Excessive body weight, increased risk of chronic conditions\\nTreatments: Antifungal medication eg  Amphotericin B, Fluconazole, supportive care\\nDisease_Code: D387\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 397, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypertension\\nSymptoms: headache, dizziness, blurred vision\\nTreatments: medication, diet change, exercise\\nDisease_Code: D388\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 398, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Sialolithiasis\\nSymptoms: Swelling, pain, tenderness, difficulty eating\\nTreatments: Warm compresses, Saliva stimulation, Sialagogues, Stone removal\\nDisease_Code: D389\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 399, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hyperopia\\nSymptoms: Difficulty seeing objects up close, blurred vision when focusing on near objects\\nTreatments: Eyeglasses, contact lenses, refractive surgery\\nDisease_Code: D390\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 400, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Liver Cancer\\nSymptoms: Abdominal pain, jaundice (yellowing of the skin and eyes), unexplained weight loss, loss of appetite, fatigue, nausea, vomiting\\nTreatments: Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Radiofrequency ablation, Transarterial chemoembolization (TACE), Selective internal radiation therapy (SIRT), Palliative care, Clinical trials\\nDisease_Code: D391\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 401, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Chalazion\\nSymptoms: Painful, red lump or swelling on the eyelid, usually on the upper eyelid, sensitivity to light, blurred vision (if the chalazion affects the line of sight), mild discomfort, tenderness, localized inflammation and swelling\\nTreatments: Warm compresses (to help soften and promote drainage of the blocked oil gland), gentle massage of the affected area, eyelid hygiene (keeping the area clean), over-the-counter lubricating eye drops, topical antibiotic ointments (if there is a risk of infection), corticosteroid injections (for larger or persistent chalazia), surgical drainage or excision (in rare cases or if conservative treatments are ineffective)\\nDisease_Code: D392\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 402, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Hypocalcemia\\nSymptoms: Numbness or tingling in fingers or around the mouth, muscle cramps\\nTreatments: Calcium and vitamin D supplements, treating underlying causes, intravenous calcium (in severe cases)\\nDisease_Code: D393\\nContagious: False\\nChronic: False'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 403, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Viral Warts\\nSymptoms: Small, rough growths on the skin or mucous membranes, typically painless, may appear in clusters or as single lesions\\nTreatments: Topical treatments (salicylic acid, cryotherapy), laser therapy, surgical removal, immune therapy (for persistent or recurrent cases)\\nDisease_Code: D394\\nContagious: False\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/Diseases_Symptoms.csv', 'row': 404, 'source_type': 'Remedies', 'priority': '1'}, page_content='Name: Spondylitis\\nSymptoms: Chronic back pain and stiffness, especially in the morning or after periods of inactivity, limited range of motion in the spine, fatigue, inflammation and pain in other joints (such as hips, shoulders, knees), discomfort or pain in the neck, difficulty maintaining proper posture, tenderness or swelling in affected areas, tingling or numbness in extremities in severe cases\\nTreatments: Medication (such as nonsteroidal anti-inflammatory drugs, corticosteroids, disease-modifying antirheumatic drugs), physical therapy (including stretching and strengthening exercises), heat or cold therapy, posture correction techniques, lifestyle modifications (such as regular exercise, weight management), assistive devices (such as braces or supports), surgical intervention (in rare cases), pain management techniques (such as acupuncture or transcutaneous electrical nerve stimulation)\\nDisease_Code: D395\\nContagious: True\\nChronic: True'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 0, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Lymphocytic Choriomeningitis (LCM)? ?\\nAnswer: LCMV infections can occur after exposure to fresh urine, droppings, saliva, or nesting materials from infected rodents.  Transmission may also occur when these materials are directly introduced into broken skin, the nose, the eyes, or the mouth, or presumably, via the bite of an infected rodent. Person-to-person transmission has not been reported, with the exception of vertical transmission from infected mother to fetus, and rarely, through organ transplantation.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 1, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Lymphocytic Choriomeningitis (LCM) ?\\nAnswer: LCMV is most commonly recognized as causing neurological disease, as its name implies, though infection without symptoms or mild febrile illnesses are more common clinical manifestations. \\n                \\nFor infected persons who do become ill, onset of symptoms usually occurs 8-13 days after exposure to the virus as part of a biphasic febrile illness. This initial phase, which may last as long as a week, typically begins with any or all of the following symptoms: fever, malaise, lack of appetite, muscle aches, headache, nausea, and vomiting. Other symptoms appearing less frequently include sore throat, cough, joint pain, chest pain, testicular pain, and parotid (salivary gland) pain.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 1, 'source_type': 'Remedies', 'priority': '1'}, page_content='Following a few days of recovery, a second phase of illness may occur. Symptoms may consist of meningitis (fever, headache, stiff neck, etc.), encephalitis (drowsiness, confusion, sensory disturbances, and/or motor abnormalities, such as paralysis), or meningoencephalitis (inflammation of both the brain and meninges). LCMV has also been known to cause acute hydrocephalus (increased fluid on the brain), which often requires surgical shunting to relieve increased intracranial pressure. In rare instances, infection results in myelitis (inflammation of the spinal cord) and presents with symptoms such as muscle weakness, paralysis, or changes in body sensation. An association between LCMV infection and myocarditis (inflammation of the heart muscles) has been suggested.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 1, 'source_type': 'Remedies', 'priority': '1'}, page_content='Previous observations show that most patients who develop aseptic meningitis or encephalitis due to LCMV survive. No chronic infection has been described in humans, and after the acute phase of illness, the virus is cleared from the body. However, as in all infections of the central nervous system, particularly encephalitis, temporary or permanent neurological damage is possible. Nerve deafness and arthritis have been reported. \\n                \\nWomen who become infected with LCMV during pregnancy may pass the infection on to the fetus. Infections occurring during the first trimester may result in fetal death and pregnancy termination, while in the second and third trimesters, birth defects can develop. Infants infected In utero can have many serious and permanent birth defects, including vision problems, mental retardation, and hydrocephaly (water on the brain). Pregnant women may recall a flu-like illness during pregnancy, or may not recall any illness.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 1, 'source_type': 'Remedies', 'priority': '1'}, page_content='LCM is usually not fatal. In general, mortality is less than 1%.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 2, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Lymphocytic Choriomeningitis (LCM)? ?\\nAnswer: Individuals of all ages who come into contact with urine, feces, saliva, or blood of wild mice are potentially at risk for infection. Owners of pet mice or hamsters may be at risk for infection if these animals originate from colonies that were contaminated with LCMV, or if their animals are infected from other wild mice. Human fetuses are at risk of acquiring infection vertically from an infected mother. \\n                \\nLaboratory workers who work with the virus or handle infected animals are also at risk. However, this risk can be minimized by utilizing animals from sources that regularly test for the virus, wearing proper protective laboratory gear, and following appropriate safety precautions.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 3, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Lymphocytic Choriomeningitis (LCM) ?\\nAnswer: During the first phase of the disease, the most common laboratory abnormalities are a low white blood cell count (leukopenia) and a low platelet count (thrombocytopenia). Liver enzymes in the serum may also be mildly elevated. After the onset of neurological disease during the second phase, an increase in protein levels, an increase in the number of white blood cells or a decrease in the glucose levels in the cerebrospinal fluid (CSF) is usually found. \\n   \\nLaboratory diagnosis is usually made by detecting IgM and IgG antibodies in the CSF and serum. Virus can be detected by PCR or virus isolation in the CSF at during the acute stage of illness.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 4, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Lymphocytic Choriomeningitis (LCM) ?\\nAnswer: Aseptic meningitis, encephalitis, or meningoencephalitis requires hospitalization and supportive treatment based on severity. Anti-inflammatory drugs, such as corticosteroids, may be considered under specific circumstances. Although studies have shown that ribavirin, a drug used to treat several other viral diseases, is effective against LCMV in vitro, there is no established evidence to support its routine use for treatment of LCM in humans.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 5, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Lymphocytic Choriomeningitis (LCM) ?\\nAnswer: LCMV infection can be prevented by avoiding contact with wild mice and taking precautions when handling pet rodents (i.e. mice, hamsters, or guinea pigs). \\n                \\nRarely, pet rodents may become infected with LCMV from wild rodents. Breeders, pet stores, and pet owners should take measures to prevent infestations of wild rodents. Pet rodents should not come into contact with wild rodents. If you have a pet rodent, wash your hands with soap and water (or waterless alcohol-based hand rubs when soap is not available and hands are not visibly soiled) after handling rodents or their cages and bedding. \\n                \\nIf you have a rodent infestation in and around your home, take the following precautions to reduce the risk of LCMV infection: \\n \\n - Seal up rodent entry holes or gaps with steel wool, lath metal, or caulk. \\n - Trap rats and mice by using an appropriate snap trap.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 5, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Seal up rodent entry holes or gaps with steel wool, lath metal, or caulk. \\n - Trap rats and mice by using an appropriate snap trap. \\n - Clean up rodent food sources and nesting sites and take precautions when cleaning rodent-infected areas: \\n   \\n   - Use cross-ventilation when entering a previously unventilated enclosed room or dwelling prior to cleanup. \\n   - Put on rubber, latex, vinyl or nitrile gloves. \\n   - Do not stir up dust by vacuuming, sweeping, or any other means. \\n   - Thoroughly wet contaminated areas with a bleach solution or household disinfectant. \\n   - Hypochlorite (bleach) solution: Mix 1 and 1/2 cups of household bleach in 1 gallon of water. \\n   - Once everything is wet, take up contaminated materials with damp towel and then mop or sponge the area with bleach solution or household disinfectant. \\n   - Spray dead rodents with disinfectant and then double-bag along with all cleaning materials and throw bag out in an appropriate waste disposal system.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 5, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Spray dead rodents with disinfectant and then double-bag along with all cleaning materials and throw bag out in an appropriate waste disposal system. \\n   - Remove the gloves and thoroughly wash your hands with soap and water (or waterless alcohol-based hand rubs when soap is not available and hands are not visibly soiled).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 5, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"- Remove the gloves and thoroughly wash your hands with soap and water (or waterless alcohol-based hand rubs when soap is not available and hands are not visibly soiled). \\n    \\n \\n                \\nThe geographic distributions of the rodent hosts are widespread both domestically and abroad. However, infrequent recognition and diagnosis, and historic underreporting of LCM, have limited scientists' ability to estimate incidence rates and prevalence of disease among humans. Understanding the epidemiology of LCM and LCMV infections will help to further delineate risk factors for infection and develop effective preventive strategies. Increasing physician awareness will improve disease recognition and reporting, which may lead to better characterization of the natural history and the underlying immunopathological mechanisms of disease, and stimulate future therapeutic research and development.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 6, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Cysticercosis ?\\nAnswer: Cysticercosis is an infection caused by the larvae of the parasite Taenia solium.  This infection occurs after a person swallows tapeworm eggs. The larvae get into tissues such as muscle and brain, and form cysts there (these are called cysticerci). When cysts are found in the brain, the condition is called neurocysticercosis.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 7, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Cysticercosis? ?\\nAnswer: Cysticercosis is an infection caused by the larvae of the tapeworm, Taenia solium. A person with an adult tapeworm, which lives in the person’s gut, sheds eggs in the stool.  The infection with the adult tapeworm is called taeniasis.  A pig then eats the eggs in the stool.  The eggs develop into larvae inside the pig and form cysts (called cysticerci) in the pig's muscles or other tissues. The infection with the cysts is called cysticercosis. Humans who eat undercooked or raw infected pork swallow the cysts in the meat. The larvae then come out of their cysts in the human gut and develop into adult tapeworms, completing the cycle.\\n    \\nPeople get cysticercosis when they swallow eggs that are excreted in the stool of people with the adult tapeworm. This may happen when people\\n    \\n     - Drink water or eat food contaminated with tapeworm eggs\\n     - Put contaminated fingers in their mouth\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 7, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Drink water or eat food contaminated with tapeworm eggs\\n     - Put contaminated fingers in their mouth\\n    \\n    \\nCysticercosis is not spread by eating undercooked meat. However, people get infected with tapeworms (taeniasis) by eating undercooked infected pork. People who have tapeworm infections can infect themselves with the eggs and develop cysticercosis (this is called autoinfection). They can also infect other people if they have poor hygiene and contaminate food or water that other people swallow. People who live with someone who has a tapeworm infection in their intestines have a much higher risk of getting cysticercosis than other people.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 7, 'source_type': 'Remedies', 'priority': '1'}, page_content='Human cysticercosis is found worldwide, especially in areas where pig cysticercosis is common. Both taeniasis and cysticercosis are most often found in rural areas of developing countries with poor sanitation, where pigs roam freely and eat human feces. Taeniasis and cysticercosis are rare among persons who live in countries where pigs are not raised and in countries where pigs do not have contact with human feces. Although uncommon, cysticercosis can occur in people who have never traveled outside of the United States if they are exposed to tapeworm eggs.\\n    \\nMore on: Taeniasis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 8, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Cysticercosis ?\\nAnswer: If you think that you may have cysticercosis, please see your health care provider. Your health care provider will ask you about your symptoms, where you have travelled, and what kinds of foods you eat. The diagnosis of neurocysticercosis usually requires MRI or CT brain scans. Blood tests may be useful to help diagnose an infection, but they may not always be positive in light infections.\\n  \\nIf you have been diagnosed with cysticercosis, you and your family members should be tested for intestinal tapeworm infection. See the taeniasis section for more information on intestinal tapeworm infections.  \\n  \\nMore on: Taeniasis\\n  \\nMore on: Resources for Health Professionals: Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 9, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Cysticercosis ?\\nAnswer: Some people with cysticercosis do not need to be treated. There are medications available to treat cysticercosis for those who do need treatment. Sometimes surgery may be needed. Your doctor will advise you on which treatment is best for you.\\n    \\nMore on: Resources for Health Professionals: Treatment\\n    \\nMore on: Taeniasis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 10, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Cysticercosis ?\\nAnswer: To prevent cysticercosis, the following precautions should be taken:\\n    \\n     - Wash your hands with soap and warm water after using the toilet, changing diapers, and before handling food\\n     - Teach children the importance of washing hands to prevent infection\\n     - Wash and peel all raw vegetables and fruits before eating\\n     - Use good food and water safety practices while traveling in developing countries such as: \\n      \\n       - Drink only bottled or boiled (1 minute) water or carbonated (bubbly) drinks in cans or bottles\\n       - Filter unsafe water through an \"absolute 1 micron or less\" filter AND dissolve iodine tablets in the filtered water; \"absolute 1 micron\" filters can be found in camping and outdoor supply stores\\n      \\n    \\n    \\nMore on: Handwashing\\n    \\nMore on: Food and Water Safety'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 11, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Trichuriasis (also known as Whipworm Infection) ?\\nAnswer: Whipworm (Trichuris trichiura) is an intestinal parasite of humans. The larvae and adult worms live in the intestine of humans and can cause intestinal disease. The name is derived from the worm’s distinctive whip-like shape.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 12, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Trichuriasis (also known as Whipworm Infection)? ?\\nAnswer: Whipworm is a soil-transmitted helminth (STH) and is the third most common roundworm of humans. Whipworm causes an infection called trichuriasis and often occurs in areas where human feces is used as fertilizer or where defecation onto soil happens. The worms are spread from person to person by fecal-oral transmission or through feces-contaminated food.\\n    Geographic Distribution\\nWorldwide, infection occurs more frequently in areas with tropical weather and poor sanitation practices, and among children. In 2002, the estimated number of persons infected with whipworm was 1 billion. Trichuriasis also occurs in the southern United States.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 13, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Trichuriasis (also known as Whipworm Infection) ?\\nAnswer: The standard method for diagnosing the presence of whipworm is by microscopically identifying whipworm eggs in a stool sample. Because eggs may be difficult to find in light infections, a concentration procedure is recommended.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 14, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Trichuriasis (also known as Whipworm Infection) ?\\nAnswer: Anthelminthic medications (drugs that rid the body of parasitic worms), such as albendazole and mebendazole, are the drugs of choice for treatment. Infections are generally treated for 3 days. The recommended medications are effective. Health care providers may decide to repeat a stool exam after treatment. Iron supplements may also be prescribed if the infected person suffers from anemia.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 15, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Trichuriasis (also known as Whipworm Infection) ?\\nAnswer: The best way to prevent whipworm infection is to always:\\n    \\n     - Avoid ingesting soil that may be contaminated with human feces, including where human fecal matter (\"night soil\") or wastewater is used to fertilize crops.\\n     - Wash your hands with soap and warm water before handling food.\\n     - Teach children the importance of washing hands to prevent infection.\\n     - Wash, peel, or cook all raw vegetables and fruits before eating, particularly those that have been grown in soil that has been fertilized with manure.\\n    \\n    \\nMore on: Handwashing\\n    \\nTransmission of infection to others can be prevented by\\n    \\n     - Not defecating outdoors.\\n     - Effective sewage disposal systems.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 16, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: what are marine toxins?\\nAnswer: Marine toxins are naturally occurring chemicals that can contaminate certain seafood. The seafood contaminated with these chemicals frequently looks, smells, and tastes normal. When humans eat such seafood, disease can result.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 17, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: how can these diseases be diagnosed for Marine Toxins ?\\nAnswer: Diagnosis of marine toxin poisoning is generally based on symptoms and a history of recently eating a particular kind of seafood. Laboratory testing for the specific toxin in patient samples is generally not necessary because this requires special techniques and equipment available in only specialized laboratories. If suspect, leftover fish or shellfish are available, they can be tested for the presence of the toxin more easily. Identification of the specific toxin is not usually necessary for treating patients because there is no specific treatment.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 18, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: how can these diseases be treated for Marine Toxins ?\\nAnswer: Other than supportive care there are few specific treatments for ciguatera poisoning, paralytic shellfish poisoning, neurotoxic shellfish poisoning, or amnesic shellfish poisoning. Antihistamines and epinephrine, however, may sometimes be useful in treating the symptoms of scombrotoxic fish poisoning. Intravenous mannitol has been suggested for the treatment of severe ciguatera poisoning.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 19, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: frequency\\nQuestion: how common are these diseases for Marine Toxins ?\\nAnswer: Every year, approximately 30 cases of poisoning by marine toxins are reported in the United States. Because healthcare providers are not required to report these illnesses and because many milder cases are not diagnosed or reported, the actual number of poisonings may be much greater. Toxic seafood poisonings are more common in the summer than winter because dinoflagelates grow well in warmer seasons. It is estimated from cases with available data that one person dies every 4 years from toxic seafood poisonings.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 20, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: what can i do to prevent poisoning by marine toxins?\\nAnswer: General guidelines for safe seafood consumption:'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 21, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: what is the government doing about these diseases for Marine Toxins ?\\nAnswer: Some health departments test shellfish harvested within their jurisdiction to monitor the level of dinoflagellate toxins and asses the risk for contamination. Based on the results of such testing, recreational and commercial seafood harvesting may be prohibited locally during periods of risk. State and federal regulatory agencies monitor reported cases of marine toxin poisoning, and health departments investigate possible outbreaks and devise control measures. The Centers for Disease Control and Prevention (CDC) provides support to investigators as needed.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 22, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: what else can be done to prevent these diseases for Marine Toxins ?\\nAnswer: It is important to notify public health departments about even one person with marine toxin poisoning. Public health departments can then investigate to determine if a restaurant, oyster bed, or fishing area has a problem. This prevents other illnesses. In any food poisoning occurrence, consumers should note foods eaten and freeze any uneaten portions in case they need to be tested. A commercial test has been developed in Hawaii to allow persons to test sport caught fish for ciguatoxins.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 23, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Yellow Fever Vaccination ?\\nAnswer: If you continue to live or travel in yellow fever-endemic areas, you should receive a booster dose of yellow fever vaccine after 10 years.\\n                \\nAfter receiving the vaccine, you should receive an International Certificate of Vaccination (yellow card) that has been validated by the vaccination center. This Certificate becomes valid 10 days after vaccination and lasts for 10 years. You will need this card as proof of vaccination to enter certain countries.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 24, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Schistosomiasis ?\\nAnswer: Schistosomiasis, also known as bilharzia, is a disease caused by parasitic worms. Infection with Schistosoma mansoni, S. haematobium, and S. japonicum causes illness in humans; less commonly, S. mekongi and S. intercalatum can cause disease. Although the worms that cause schistosomiasis are not found in the United States, more than 200 million people are infected worldwide.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 25, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Schistosomiasis? ?\\nAnswer: Schistosomiasis is an important cause of disease in many parts of the world, most commonly in places with poor sanitation. School-age children who live in these areas are often most at risk because they tend to spend time swimming or bathing in water containing infectious cercariae.\\nIf you live in, or travel to, areas where schistosomiasis is found and are exposed to contaminated freshwater, you are at risk.\\n   \\nAreas where human schistosomiasis is found include:\\n   \\n    - Schistosoma mansoni \\n     \\n      - distributed throughout Africa: There is risk of infection in freshwater in southern and sub-Saharan Africa–including the great lakes and rivers as well as smaller bodies of water. Transmission also occurs in the Nile River valley in Sudan and Egypt\\n      - South America: including Brazil, Suriname, Venezuela'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 25, 'source_type': 'Remedies', 'priority': '1'}, page_content='- South America: including Brazil, Suriname, Venezuela\\n      - Caribbean (risk is low): Dominican Republic, Guadeloupe, Martinique, and Saint Lucia.\\n     \\n    - S. haematobium \\n     \\n      - distributed throughout Africa: There is risk of infection in freshwater in southern and sub-Saharan Africa–including the great lakes and rivers as well as smaller bodies of water. Transmission also occurs in the Nile River valley in Egypt and the Mahgreb region of North Africa.\\n      - found in areas of the Middle East\\n     \\n    - S. japonicum \\n     \\n      - found in Indonesia and parts of China and Southeast Asia\\n     \\n    - S. mekongi \\n     \\n      - found in Cambodia and Laos\\n     \\n    - S. intercalatum \\n     \\n      - found in parts of Central and West Africa.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 26, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Schistosomiasis ?\\nAnswer: Stool or urine samples can be examined microscopically for parasite eggs (stool for S. mansoni or S. japonicum eggs and urine for S. haematobium eggs). The eggs tend to be passed intermittently and in small amounts and may not be detected, so it may be necessary to perform a blood (serologic) test.\\n    \\nMore on: Resources for Health Professionals: Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 27, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Schistosomiasis ?\\nAnswer: Safe and effective medication is available for treatment of both urinary and intestinal schistosomiasis. Praziquantel, a prescription medication, is taken for 1-2 days to treat infections caused by all Schistosoma species.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Schistosomiasis ?\\nAnswer: Prevention\\n    \\nNo vaccine is available.\\n    \\nThe best way to prevent schistosomiasis is to take the following steps if you are visiting or live in an area where schistosomiasis is transmitted:\\n    \\n     - Avoid swimming or wading in freshwater when you are in countries in which schistosomiasis occurs. Swimming in the ocean and in chlorinated swimming pools is safe.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Avoid swimming or wading in freshwater when you are in countries in which schistosomiasis occurs. Swimming in the ocean and in chlorinated swimming pools is safe.\\n     - Drink safe water. Although schistosomiasis is not transmitted by swallowing contaminated water, if your mouth or lips come in contact with water containing the parasites, you could become infected. Because water coming directly from canals, lakes, rivers, streams, or springs may be contaminated with a variety of infectious organisms, you should either bring your water to a rolling boil for 1 minute or filter water before drinking it. Bring your water to a rolling boil for at least 1 minute will kill any harmful parasites, bacteria, or viruses present. Iodine treatment alone WILL NOT GUARANTEE that water is safe and free of all parasites.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Water used for bathing should be brought to a rolling boil for 1 minute to kill any cercariae, and then cooled before bathing to avoid scalding. Water held in a storage tank for at least 1 - 2 days should be safe for bathing.\\n     - Vigorous towel drying after an accidental, very brief water exposure may help to prevent the Schistosoma parasite from penetrating the skin. However, do not rely on vigorous towel drying alone to prevent schistosomiasis.\\n    \\n    \\nThose who have had contact with potentially contaminated water overseas should see their health care provider after returning from travel to discuss testing.\\n    \\nMore on: Schistosomiasis in Travelers\\n   \\n  \\n  \\n   Control\\n   \\nIn countries where schistosomiasis causes significant disease, control efforts usually focus on:\\n   \\n    - reducing the number of infections in people and/or\\n    - eliminating the snails that are required to maintain the parasite’s life cycle.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='- reducing the number of infections in people and/or\\n    - eliminating the snails that are required to maintain the parasite’s life cycle.\\n   \\n   \\nFor all species that cause schistosomiasis, improved sanitation could reduce or eliminate transmission of this disease. In some areas with lower transmission levels, elimination of schistosomiasis is considered a \"winnable battle\" by public health officials.\\n   \\nControl measures can include mass drug treatment of entire communities and targeted treatment of school-age children. Some of the problems with control of schistosomiasis include:\\n   \\n    - Chemicals used to eliminate snails in freshwater sources may harm other species of animals in the water and, if treatment is not sustained, the snails may return to those sites afterwards.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 28, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Chemicals used to eliminate snails in freshwater sources may harm other species of animals in the water and, if treatment is not sustained, the snails may return to those sites afterwards.\\n    - For certain species of the parasite, such as S. japonicum, animals such as cows or water buffalo can also be infected. Runoff from pastures (if the cows are infected) can contaminate freshwater sources.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 29, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Lice - Head Lice ?\\nAnswer: The head louse, or Pediculus humanus capitis, is a parasitic insect that can be found on the head, eyebrows, and eyelashes of people. Head lice feed on human blood several times a day and live close to the human scalp. Head lice are not known to spread disease.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 30, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Lice - Head Lice? ?\\nAnswer: In the United States, infestation with head lice (Pediculus humanus capitis) is most common among preschool- and elementary school-age children and their household members and caretakers. Head lice are not known to transmit disease; however, secondary bacterial infection of the skin resulting from scratching can occur with any lice infestation.\\n    \\nGetting head lice is not related to cleanliness of the person or his or her environment.\\n    \\nHead lice are mainly spread by direct contact with the hair of an infested person. The most common way to get head lice is by head-to-head contact with a person who already has head lice. Such contact can be common among children during play at:\\n    \\n     - school,\\n     - home, and\\n     - elsewhere (e.g., sports activities, playgrounds, camp, and slumber parties).\\n    \\n    \\nUncommonly, transmission may occur by:'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 30, 'source_type': 'Remedies', 'priority': '1'}, page_content='- school,\\n     - home, and\\n     - elsewhere (e.g., sports activities, playgrounds, camp, and slumber parties).\\n    \\n    \\nUncommonly, transmission may occur by:\\n    \\n     - wearing clothing, such as hats, scarves, coats, sports uniforms, or hair ribbons worn by an infested person;\\n     - using infested combs, brushes or towels; or\\n     - lying on a bed, couch, pillow, carpet, or stuffed animal that has recently been in contact with an infested person.\\n    \\n    \\nReliable data on how many people get head lice each year in the United States are not available; however, an estimated 6 million to 12 million infestations occur each year in the United States among children 3 to 11 years of age. Some studies suggest that girls get head lice more often than boys, probably due to more frequent head-to-head contact.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 30, 'source_type': 'Remedies', 'priority': '1'}, page_content='In the United States, infestation with head lice is much less common among African-Americans than among persons of other races. The head louse found most frequently in the United States may have claws that are better adapted for grasping the shape and width of some types of hair but not others.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 31, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Lice - Head Lice ?\\nAnswer: Misdiagnosis of head lice infestation is common. The diagnosis of head lice infestation is best made by finding a live nymph or adult louse on the scalp or hair of a person.\\n    \\nBecause adult and nymph lice are very small, move quickly, and avoid light, they may be difficult to find. Use of a fine-toothed louse comb may facilitate identification of live lice.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 31, 'source_type': 'Remedies', 'priority': '1'}, page_content='Because adult and nymph lice are very small, move quickly, and avoid light, they may be difficult to find. Use of a fine-toothed louse comb may facilitate identification of live lice.\\n    \\nIf crawling lice are not seen, finding nits attached firmly within ¼ inch of the base of hair shafts suggests, but does not confirm, the person is infested. Nits frequently are seen on hair behind the ears and near the back of the neck. Nits that are attached more than ¼ inch from the base of the hair shaft are almost always non-viable (hatched or dead). Head lice and nits can be visible with the naked eye, although use of a magnifying lens may be necessary to find crawling lice or to identify a developing nymph inside a viable nit. Nits are often confused with other particles found in hair such as dandruff, hair spray droplets, and dirt particles.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 31, 'source_type': 'Remedies', 'priority': '1'}, page_content='If no nymphs or adults are seen, and the only nits found are more than ¼ inch from the scalp, then the infestation is probably old and no longer active — and does not need to be treated.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Lice - Head Lice ?\\nAnswer: General Guidelines \\n   \\nTreatment for head lice is recommended for persons diagnosed with an active infestation. All household members and other close contacts should be checked; those persons with evidence of an active infestation should be treated. Some experts believe prophylactic treatment is prudent for persons who share the same bed with actively-infested individuals. All infested persons (household members and close contacts) and their bedmates should be treated at the same time.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='Some pediculicides (medicines that kill lice) have an ovicidal effect (kill eggs). For pediculicides that are only weakly ovicidal or not ovicidal, routine retreatment is recommended. For those that are more strongly ovicidal, retreatment is recommended only if live (crawling) lice are still present several days after treatment (see recommendation for each medication). To be most effective, retreatment should occur after all eggs have hatched but before new eggs are produced.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"When treating head lice, supplemental measures can be combined with recommended medicine (pharmacologic treatment); however, such additional (non-pharmacologic) measures generally are not required to eliminate a head lice infestation. For example, hats, scarves, pillow cases, bedding, clothing, and towels worn or used by the infested person in the 2-day period just before treatment is started can be machine washed and dried using the hot water and hot air cycles because lice and eggs are killed by exposure for 5 minutes to temperatures greater than 53.5°C (128.3°F). Items that cannot be laundered may be dry-cleaned or sealed in a plastic bag for two weeks. Items such as hats, grooming aids, and towels that come in contact with the hair of an infested person should not be shared. Vacuuming furniture and floors can remove an infested person's hairs that might have viable nits attached.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='Treatment of the infested person(s): Requires using an Over-the-counter (OTC) or prescription medication. Follow these treatment steps: \\n    \\n    - Before applying treatment, it may be helpful to remove clothing that can become wet or stained during treatment. \\n    - Apply lice medicine, also called pediculicide, according to the instructions contained in the box or printed on the label. If the infested person has very long hair (longer than shoulder length), it may be necessary to use a second bottle. Pay special attention to instructions on the label or in the box regarding how long the medication should be left on the hair and how it should be washed out.\\n \\n       \\n       \\n        \\n       \\n       \\n    - Have the infested person put on clean clothing after treatment.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Have the infested person put on clean clothing after treatment. \\n    - If a few live lice are still found 8–12 hours after treatment, but are moving more slowly than before, do not retreat. The medicine may take longer to kill all the lice. Comb dead and any remaining live lice out of the hair using a fine–toothed nit comb. \\n    - If, after 8–12 hours of treatment, no dead lice are found and lice seem as active as before, the medicine may not be working. Do not retreat until speaking with your health care provider; a different pediculicide may be necessary. If your health care provider recommends a different pediculicide, carefully follow the treatment instructions contained in the box or printed on the label. \\n    - Nit (head lice egg) combs, often found in lice medicine packages, should be used to comb nits and lice from the hair shaft. Many flea combs made for cats and dogs are also effective.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Nit (head lice egg) combs, often found in lice medicine packages, should be used to comb nits and lice from the hair shaft. Many flea combs made for cats and dogs are also effective. \\n    - After each treatment, checking the hair and combing with a nit comb to remove nits and lice every 2–3 days may decrease the chance of self–reinfestation. Continue to check for 2–3 weeks to be sure all lice and nits are gone. Nit removal is not needed when treating with spinosad topical suspension. \\n    - Retreatment is meant to kill any surviving hatched lice before they produce new eggs. For some drugs, retreatment is recommended routinely about a week after the first treatment (7–9 days, depending on the drug) and for others only if crawling lice are seen during this period. Retreatment with lindane shampoo is not recommended.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Supplemental Measures: Head lice do not survive long if they fall off a person and cannot feed. You don't need to spend a lot of time or money on housecleaning activities. Follow these steps to help avoid re–infestation by lice that have recently fallen off the hair or crawled onto clothing or furniture. \\n    \\n    -  \\nMachine wash and dry clothing, bed linens, and other items that the infested person wore or used during the 2 days before treatment using the hot water (130°F) laundry cycle and the high heat drying cycle. Clothing and items that are not washable can be dry–cleaned \\nOR \\nsealed in a plastic bag and stored for 2 weeks.  \\n    - Soak combs and brushes in hot water (at least 130°F) for 5–10 minutes.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='OR \\nsealed in a plastic bag and stored for 2 weeks.  \\n    - Soak combs and brushes in hot water (at least 130°F) for 5–10 minutes. \\n    - Vacuum the floor and furniture, particularly where the infested person sat or lay. However, the risk of getting infested by a louse that has fallen onto a rug or carpet or furniture is very low. Head lice survive less than 1–2 days if they fall off a person and cannot feed; nits cannot hatch and usually die within a week if they are not kept at the same temperature as that found close to the human scalp. Spending much time and money on housecleaning activities is not necessary to avoid reinfestation by lice or nits that may have fallen off the head or crawled onto furniture or clothing. \\n    - Do not use fumigant sprays; they can be toxic if inhaled or absorbed through the skin. \\n    \\n   \\n \\n     \\n   \\nPrevent Reinfestation: \\n   \\nMore on: Prevention & Control \\n   \\n \\n     \\n   Over-the-counter Medications'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='Prevent Reinfestation: \\n   \\nMore on: Prevention & Control \\n   \\n \\n     \\n   Over-the-counter Medications \\n   \\nMany head lice medications are available \"over-the-counter\" without a prescription at a local drug store or pharmacy. Each over-the-counter product approved by the FDA for the treatment of head lice contains one of the following active ingredients. If crawling lice are still seen after a full course of treatment contact your health care provider. \\n    \\n    -  \\nPyrethrins combined with piperonyl butoxide;\\n Brand name products: A–200*, Pronto*, R&C*, Rid*, Triple X*, Licide*'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='-  \\nPyrethrins combined with piperonyl butoxide;\\n Brand name products: A–200*, Pronto*, R&C*, Rid*, Triple X*, Licide* \\nPyrethrins are naturally occurring pyrethroid extracts from the chrysanthemum flower. Pyrethrins are safe and effective when used as directed. Pyrethrins can only kill live lice, not unhatched eggs (nits). A second treatment is recommended 9 to 10 days after the first treatment to kill any newly hatched lice before they can produce new eggs. Pyrethrins generally should not be used by persons who are allergic to chrysanthemums or ragweed. Pyrethrin is approved for use on children 2 years of age and older.  \\n    -  \\nPermethrin lotion, 1%;\\n Brand name product: Nix*.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='-  \\nPermethrin lotion, 1%;\\n Brand name product: Nix*. \\nPermethrin is a synthetic pyrethroid similar to naturally occurring pyrethrins. Permethrin lotion 1% is approved by the FDA for the treatment of head lice. Permethrin is safe and effective when used as directed. Permethrin kills live lice but not unhatched eggs. Permethrin may continue to kill newly hatched lice for several days after treatment. A second treatment often is necessary on day 9 to kill any newly hatched lice before they can produce new eggs. Permethrin is approved for use on children 2 months of age and older.  \\n    \\n   \\n \\n     \\n   Prescription Medications \\n   \\nThe following medications, in alphabetical order, approved by the U.S. Food and Drug Administration (FDA) for the treatment of head lice are available only by prescription. If crawling lice are still seen after a full course of treatment, contact your health care provider. \\n    \\n    -  \\nBenzyl alcohol lotion, 5%;\\n Brand name product: Ulesfia lotion*'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='-  \\nBenzyl alcohol lotion, 5%;\\n Brand name product: Ulesfia lotion* \\nBenzyl alcohol is an aromatic alcohol. Benzyl alcohol lotion, 5% has been approved by the FDA for the treatment of head lice and is considered safe and effective when used as directed. It kills lice but it is not ovicidal(i.e., does not kill lice eggs). A second treatment is needed 9 days after the first treatment to kill any newly hatched lice before they can produce new eggs. Benzyl alcohol lotion is intended for use on persons who are 6 months of age and older and its safety in persons aged more 60 years has not been established. It can be irritating to the skin.  \\n    -  \\nIvermectin lotion, 0.5%;\\n Brand name product: Sklice*'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='-  \\nIvermectin lotion, 0.5%;\\n Brand name product: Sklice* \\nIvermectin lotion, 0.5% was approved by the FDA in 2012 for treatment of head lice in persons 6 months of age and older. It is not ovicidal, but appears to prevent nymphs (newly hatched lice) from surviving. It is effective in most patients when given as a single application on dry hair without nit combing. It should not be used for retreatment without talking to a healthcare provider. \\nGiven as a tablet in mass drug administrations, oral ivermectin has been used extensively and safely for over two decades in many countries to treat filarial worm infections. Although not FDA-approved for the treatment of lice, ivermectin tablets given in a single oral dose of 200 micrograms/kg repeated in 10 days or 400 micrograms/kg repeated in 7 days has been shown effective against head lice. It should not be used in children weighing less than 15 kg or in pregnant women.   \\n    -  \\nSpinosad 0.9% topical suspension;'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='-  \\nSpinosad 0.9% topical suspension;\\n Brand name product: Natroba* \\nSpinosad is derived from soil bacteria. Spinosad topical suspension, 0.9%, was approved by the FDA in 2011. Since it kills live lice as well as unhatched eggs, retreatment is usually not needed. Nit combing is not required. Spinosad topical suspension is approved for the treatment of children 6 months of age and older. It is safe and effective when used as directed. Repeat treatment should be given only if live (crawling) lice are seen 7 days after the first treatment.  \\n    \\n   \\nFor second–line treatment only: \\n    \\n    -  \\nLindane shampoo 1%;\\n Brand name products: None available'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='For second–line treatment only: \\n    \\n    -  \\nLindane shampoo 1%;\\n Brand name products: None available \\nLindane is an organochloride. The American Academy of Pediatrics (AAP) no longer recommends it as a pediculocide. Although lindane shampoo 1% is approved by the FDA for the treatment of head lice, it is not recommended as a first–line treatment. Overuse, misuse, or accidentally swallowing lindane can be toxic to the brain and other parts of the nervous system; its use should be restricted to patients for whom prior treatments have failed or who cannot tolerate other medications that pose less risk. Lindane should not be used to treat premature infants, persons with HIV, a seizure disorder, women who are pregnant or breast–feeding, persons who have very irritated skin or sores where the lindane will be applied, infants, children, the elderly, and persons who weigh less than 110 pounds. Retreatment should be avoided.  \\n    \\n   \\n \\n   \\nWhen treating head lice'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='When treating head lice \\n    \\n    - Do not use extra amounts of any lice medication unless instructed to do so by your physician or pharmacist. The drugs used to treat lice are insecticides and can be dangerous if they are misused or overused. \\n    - All the medications listed above should be kept out of the eyes. If they get onto the eyes, they should be immediately flushed away. \\n    - Do not treat an infested person more than 2–3 times with the same medication if it does not seem to be working. This may be caused by using the medicine incorrectly or by resistance to the medicine. Always seek the advice of your health care provider if this should happen. He/she may recommend an alternative medication. \\n    - Do not use different head lice drugs at the same time unless instructed to do so by your physician or pharmacist.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 32, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Do not use different head lice drugs at the same time unless instructed to do so by your physician or pharmacist. \\n    \\n   \\n \\n   \\n*Use of trade names is for identification purposes only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 33, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Lice - Head Lice ?\\nAnswer: Head lice are spread most commonly by direct head-to-head (hair-to-hair) contact. However, much less frequently they are spread by sharing clothing or belongings onto which lice have crawled or nits attached to shed hairs may have fallen. The risk of getting infested by a louse that has fallen onto a carpet or furniture is very small. Head lice survive less than 1–2 days if they fall off a person and cannot feed; nits cannot hatch and usually die within a week if they are not kept at the same temperature as that found close to the scalp.\\n    \\nThe following are steps that can be taken to help prevent and control the spread of head lice:\\n    \\n     - Avoid head-to-head (hair-to-hair) contact during play and other activities at home, school, and elsewhere (sports activities, playground, slumber parties, camp).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 33, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Avoid head-to-head (hair-to-hair) contact during play and other activities at home, school, and elsewhere (sports activities, playground, slumber parties, camp).\\n     - Do not share clothing such as hats, scarves, coats, sports uniforms, hair ribbons, or barrettes.\\n     - Do not share combs, brushes, or towels. Disinfest combs and brushes used by an infested person by soaking them in hot water (at least 130°F) for 5–10 minutes.\\n     - Do not lie on beds, couches, pillows, carpets, or stuffed animals that have recently been in contact with an infested person.\\n     - Machine wash and dry clothing, bed linens, and other items that an infested person wore or used during the 2 days before treatment using the hot water (130°F) laundry cycle and the high heat drying cycle. Clothing and items that are not washable can be dry-cleaned OR sealed in a plastic bag and stored for 2 weeks.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 33, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Vacuum the floor and furniture, particularly where the infested person sat or lay. However, spending much time and money on housecleaning activities is not necessary to avoid reinfestation by lice or nits that may have fallen off the head or crawled onto furniture or clothing.\\n     - Do not use fumigant sprays or fogs; they are not necessary to control head lice and can be toxic if inhaled or absorbed through the skin.\\n    \\n    \\nTo help control a head lice outbreak in a community, school, or camp, children can be taught to avoid activities that may spread head lice.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 34, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Lice - Body Lice ?\\nAnswer: Body lice are parasitic insects that live on clothing and bedding used by infested persons. Body lice frequently lay their eggs on or near the seams of clothing. Body lice must feed on blood and usually only move to the skin to feed. Body lice exist worldwide and infest people of all races. Body lice infestations can spread rapidly under crowded living conditions where hygiene is poor (the homeless, refugees, victims of war or natural disasters). In the United States, body lice infestations are found only in homeless transient populations who do not have access to bathing and regular changes of clean clothes. Infestation is unlikely to persist on anyone who bathes regularly and who has at least weekly access to freshly laundered clothing and bedding.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 35, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Lice - Body Lice? ?\\nAnswer: Body lice infestation is found worldwide but generally is limited to persons who live under conditions of crowding and poor hygiene who do not have access to regular bathing and changes of clean clothes, such as:\\n    \\n     - the homeless,\\n     - refugees,\\n     - survivors of war or natural disasters.\\n    \\n    \\nInfestations can spread rapidly under such conditions. Body lice infestation can occur in people of all races.\\n    \\nBody lice are spread through direct contact with a person who has body lice or through contact with articles such as clothing, beds, bed linens, or towels that have been in contact with an infested person. However, in the United States, actual infestation with body lice tends to be occur only in homeless, transient persons who do not have access to regular bathing and changes of clean clothes.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 35, 'source_type': 'Remedies', 'priority': '1'}, page_content='Body lice can transmit disease. Epidemics of typhus and louse-borne relapsing fever have been caused by body lice (typically in areas where climate, poverty, and social customs or war and social upheaval prevent regular changes and laundering of clothing).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 36, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Lice - Body Lice ?\\nAnswer: Body lice infestation is diagnosed by finding eggs and crawling lice in the seams of clothing. Sometimes a body louse can be seen crawling or feeding on the skin.\\n    \\nAlthough body lice and nits can be large enough to be seen with the naked eye, a magnifying lens may be necessary to find crawling lice or eggs.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 37, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Lice - Body Lice ?\\nAnswer: A body lice infestation is treated by improving the personal hygiene of the infested person, including assuring a regular (at least weekly) change of clean clothes. Clothing, bedding, and towels used by the infested person should be laundered using hot water (at least 130°F) and machine dried using the hot cycle.\\n    \\nSometimes the infested person also is treated with a pediculicide, a medicine that can kill lice; however, a pediculicide generally is not necessary if hygiene is maintained and items are laundered appropriately at least once a week. A pediculicide should be applied exactly as directed on the bottle or by your physician.\\n    \\nIf you choose to treat, guidelines for the choice of the pediculicide are the same as for head lice.\\n    \\nMore on: Head Lice Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 38, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Lice - Body Lice ?\\nAnswer: Body lice are spread most commonly by direct contact with an infested person or an infested person’s clothing or bedding. Body lice usually infest persons who do not launder and change their clothes regularly.\\n    \\nThe following are steps that can be taken to help prevent and control the spread of body lice:\\n    \\n     - Bathe regularly and change into properly laundered clothes at least once a week; launder infested clothing at least once a week.\\n     - Machine wash and dry infested clothing and bedding using the hot water (at least 130°F) laundry cycle and the high heat drying cycle. Clothing and items that are not washable can be dry-cleaned OR sealed in a plastic bag and stored for 2 weeks.\\n     - Do not share clothing, beds, bedding, and towels used by an infested person.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 38, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Do not share clothing, beds, bedding, and towels used by an infested person.\\n     - Fumigation or dusting with chemical insecticides sometimes is necessary to control and prevent the spread of body lice for certain diseases (epidemic typhus).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 39, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent La Crosse Encephalitis ?\\nAnswer: There is no vaccine against La Crosse encephalitis virus (LACV). Reducing exposure to mosquito bites is the best defense against getting infected with LACV or other mosquito-borne viruses. There are several approaches you and your family can use to prevent and control mosquito-borne diseases. \\n \\n - Use repellent: When outdoors, use insect repellent containing DEET, picaridin, IR3535 or oil of lemon eucalyptus on exposed skin as well as on clothing (mosquitoes will bite through thin cloth). \\n   \\n   - Permethrin is a repellent/insecticide that can be applied to clothing and will provide excellent protection through multiple washes. You can treat clothing yourself (always follow the directions on the package!) or purchase pre-treated clothing. For best protection it is still necessary to apply other repellent to exposed skin.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 39, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"- Wear protective clothing: Wear long sleeves, pants and socks when weather permits. \\n - Avoid peak biting hours: Avoid outdoor activity or use protective measures when mosquitoes are active (Aedes triseriatus mosquitoes are most active during daytime—from dawn until dusk). \\n - Install and repair screens: Have secure, intact screens on windows and doors to keep mosquitoes out.  \\n - Keep mosquitoes from laying eggs near you: Mosquitoes can lay eggs even in small amounts of standing water. While Aedes triseriatus prefers treeholes, it will also lay eggs in artificial containers. You can fill treeholes in/around your yard with soil. Get rid of mosquito breeding sites by emptying standing water from flower pots, buckets, barrels, and tires. Change the water in pet dishes and replace the water in bird baths weekly. Drill holes in tire swings so water drains out. Empty children's wading pools and store on their side after use.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 40, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Toxocariasis (also known as Roundworm Infection) ?\\nAnswer: Frequently Asked Questions (FAQs)\\n    \\n    \\n                \\n    Fact Sheets'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 41, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Toxocariasis (also known as Roundworm Infection)? ?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 41, 'source_type': 'Remedies', 'priority': '1'}, page_content='Answer: Infected dogs and cats shed Toxocara eggs in their feces into the environment. Once in the environment, it takes 2 to 4 weeks for Toxocara larvae to develop and for the eggs to become infectious. Humans or other animals can be infected by accidentally ingesting Toxocara eggs. For example, humans can become infected if they work with dirt and accidentally ingest dirt containing Toxocara eggs. Although rare, people can be infected by eating undercooked or raw meat from an infected animal such as a lamb or rabbit. Because dogs and cats are frequently found where people live, there may be large numbers of infected eggs in the environment. Once in the body, the Toxocara eggs hatch and roundworm larvae can travel in the bloodstream to different parts of the body, including the liver, heart, lungs, brain, muscles, or eyes. Most infected people do not have any symptoms. However, in some people, the Toxocara larvae can cause damage to these tissues and organs. The symptoms of'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 41, 'source_type': 'Remedies', 'priority': '1'}, page_content='liver, heart, lungs, brain, muscles, or eyes. Most infected people do not have any symptoms. However, in some people, the Toxocara larvae can cause damage to these tissues and organs. The symptoms of toxocariasis, the disease caused by these migrating larvae, include fever, coughing, inflammation of the liver, or eye problems.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 41, 'source_type': 'Remedies', 'priority': '1'}, page_content='A U.S. study in 1996 showed that 30% of dogs younger than 6 months deposit Toxocara eggs in their feces; other studies have shown that almost all puppies are born already infected with Toxocara canis. Research also suggests that 25% of all cats are infected with Toxocara cati. Infection rates are higher for dogs and cats that are left outside for more time and allowed to eat other animals. In humans, it has been found that almost 14% of the U.S. population has been infected with Toxocara. Globally, toxocariasis is found in many countries, and prevalence rates can reach as high as 40% or more in parts of the world. There are several factors that have been associated with higher rates of infection with Toxocara. People are more likely to be infected with Toxocara if they own a dog. Children and adolescents under the age of 20 are more likely to test positive for Toxocara infection. This may be because children are more likely to eat dirt and play in outdoor environments, such as'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 41, 'source_type': 'Remedies', 'priority': '1'}, page_content='and adolescents under the age of 20 are more likely to test positive for Toxocara infection. This may be because children are more likely to eat dirt and play in outdoor environments, such as sandboxes, where dog and cat feces can be found. This infection is more common in people living in poverty. Geographic location plays a role as well, because Toxocara is more prevalent in hot, humid regions where eggs are kept viable in the soil.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 42, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Toxocariasis (also known as Roundworm Infection) ?\\nAnswer: If you think you or your child may have toxocariasis, you should see your health care provider to discuss the possibility of infection and, if necessary, to be examined. Toxocariasis can be difficult to diagnose because the symptoms of toxocariasis are similar to the symptoms of other infections. A blood test is available that looks for evidence of infection with Toxocara larvae. In addition to the blood test, diagnosis of toxocariasis includes identifying the presence of typical clinical signs of VT or OT and a history of exposure to cats and dogs.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 43, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Toxocariasis (also known as Roundworm Infection) ?\\nAnswer: Visceral toxocariasis can be treated with antiparasitic drugs such as albendazole or mebendazole. Treatment of ocular toxocariasis is more difficult and usually consists of measures to prevent progressive damage to the eye.\\n    \\nMore on: Resources For Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 44, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Toxocariasis (also known as Roundworm Infection) ?\\nAnswer: Controlling Toxocara infection in dogs and cats will reduce the number of infectious eggs in the environment and reduce the risk of infection for people. Have your veterinarian treat your dogs and cats, especially young animals, regularly for worms. This is especially important if your pets spend time outdoors and may become infected again.\\n    \\nThere are several things that you can do around your home to make you and your pets safer:\\n    \\n     - Clean your pet’s living area at least once a week. Feces should be either buried or bagged and disposed of in the trash. Wash your hands after handling pet waste.\\n     - Do not allow children to play in areas that are soiled with pet or other animal feces and cover sandboxes when not in use to make sure that animals do not get inside and contaminate them.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 44, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Do not allow children to play in areas that are soiled with pet or other animal feces and cover sandboxes when not in use to make sure that animals do not get inside and contaminate them.\\n     - Wash your hands with soap and warm water after playing with your pets or other animals, after outdoor activities, and before handling food.\\n     - Teach children the importance of washing hands to prevent infection.\\n     - Teach children that it is dangerous to eat dirt or soil.\\n    \\n    \\nMore on: Handwashing\\n    \\nToxocara eggs have a strong protective layer which makes the eggs able to survive in the environment for months or even years under the right conditions. Many common disinfectants are not effective against Toxocara eggs but extreme heat has been shown to kill the eggs. Prompt removal of animal feces can help prevent infection since the eggs require 2 to 4 weeks to become infective once they are out of the animal.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 45, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Acanthamoeba - Granulomatous Amebic Encephalitis (GAE); Keratitis ?\\nAnswer: Acanthamoeba is a microscopic, free-living ameba (single-celled living organism) commonly found in the environment that can cause rare, but severe, illness. Acanthamoeba causes three main types of illness involving the eye (Acanthamoeba keratitis), the brain and spinal cord (Granulomatous Encephalitis), and infections that can spread throughout the entire body (disseminated infection).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 46, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Acanthamoeba - Granulomatous Amebic Encephalitis (GAE); Keratitis? ?\\nAnswer: Acanthamoeba keratitis\\n  \\n   \\nAcanthamoeba keratitis is a rare disease that can affect anyone, but is most common in individuals who wear contact lenses. In the United States, an estimated 85% of cases occur in contact lens users. The incidence of the disease in developed countries is approximately one to 33 cases per million contact lens wearers.\\n   \\nFor people who wear contact lenses, certain practices can increase the risk of getting Acanthamoeba keratitis:\\n   \\n    - Storing and handling lenses improperly\\n    - Disinfecting lenses improperly (such as using tap water or topping off solutions when cleaning the lenses or lens case)\\n    - Swimming, using a hot tub, or showering while wearing lenses\\n    - Coming into contact with contaminated water\\n    - Having a history of trauma to the cornea'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 46, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Swimming, using a hot tub, or showering while wearing lenses\\n    - Coming into contact with contaminated water\\n    - Having a history of trauma to the cornea\\n   \\n   \\nContact lens wearers who practice proper lens care and non-contact lens wearers can still develop the infection. For additional information on contact lens care and prevention of Acanthamoeba keratitis visit CDC’s web page on Prevention and Control.\\n   \\nThere have been no reports of Acanthamoeba keratitis being spread from one person to another.\\n   Granulomatous Amebic Encephalitis (GAE)\\n   \\nGranulomatous Amebic Encephalitis (GAE) and disseminated infection are very rare forms of Acanthamoeba infection and primarily affect people with compromised immune systems. While unusual, disseminated infection can also affect healthy children and adults. Conditions that may increase a patient’s risk for GAE and disseminated infection include:\\n   \\n    - AIDS\\n    - Organ/Tissue transplant'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 46, 'source_type': 'Remedies', 'priority': '1'}, page_content='- AIDS\\n    - Organ/Tissue transplant\\n    - Steroids or excessive use of antibiotics\\n    - Diabetes Mellitus\\n    - Cancer\\n    - Disorders in which white blood cells in the lymphatic tissue are over-produced or abnormal\\n    - Disorders in which blood cells or blood clotting mechanisms do not function properly or are abnormal\\n    - Liver cirrhosis\\n    - Lupus'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 47, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Acanthamoeba - Granulomatous Amebic Encephalitis (GAE); Keratitis ?\\nAnswer: Early diagnosis is essential for effective treatment of Acanthamoeba keratitis. The infection is usually diagnosed by an eye specialist based on symptoms, growth of the ameba from a scraping of the eye, and/or seeing the ameba by a process called confocal microscopy.\\n    \\nGranulomatous Amebic Encephalitis (GAE) and disseminated infection are more difficult to diagnose and are often at advanced stages when they are diagnosed. Tests useful in the diagnosis of GAE include brain scans, biopsies, or spinal taps. In disseminated disease, biopsy of the involved sites (e.g. , skin, sinuses) can be useful in diagnosis.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 48, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Acanthamoeba - Granulomatous Amebic Encephalitis (GAE); Keratitis ?\\nAnswer: Early diagnosis is essential for effective treatment of Acanthamoeba keratitis. Several prescription eye medications are available for treatment. However, the infection can be difficult to treat. The best treatment regimen for each patient should be determined by an eye doctor. If you suspect your eye may be infected with Acanthamoeba, see an eye doctor immediately.\\n    \\nSkin infections that are caused by Acanthamoeba but have not spread to the central nervous system can be successfully treated. Because this is a serious infection and the people affected typically have weakened immune systems, early diagnosis offers the best chance at cure.\\n    \\nMost cases of brain and spinal cord infection with Acanthamoeba (Granulomatous Amebic Encephalitis) are fatal.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 49, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Acanthamoeba - Granulomatous Amebic Encephalitis (GAE); Keratitis ?\\nAnswer: Topics'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 50, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Scabies ?\\nAnswer: Scabies is an infestation of the skin by the human itch mite (Sarcoptes scabiei var. hominis). The microscopic scabies mite burrows into the upper layer of the skin where it lives and lays its eggs. The most common symptoms of scabies are intense itching and a pimple-like skin rash. The scabies mite usually is spread by direct, prolonged, skin-to-skin contact with a person who has scabies.\\nScabies is found worldwide and affects people of all races and social classes. Scabies can spread rapidly under crowded conditions where close body and skin contact is frequent. Institutions such as nursing homes, extended-care facilities, and prisons are often sites of scabies outbreaks. Child care facilities also are a common site of scabies infestations.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 51, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Scabies? ?\\nAnswer: Transmission\\n    \\nHuman scabies is caused by an infestation of the skin by the human itch mite (Sarcoptes scabiei var. hominis). The adult female scabies mites burrow into the upper layer of the skin (epidermis) where they live and deposit their eggs. The microscopic scabies mite almost always is passed by direct, prolonged, skin-to-skin contact with a person who already is infested. An infested person can spread scabies even if he or she has no symptoms. Humans are the source of infestation; animals do not spread human scabies.\\n    Persons At Risk\\n    \\nScabies can be passed easily by an infested person to his or her household members and sexual partners. Scabies in adults frequently is sexually acquired.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 51, 'source_type': 'Remedies', 'priority': '1'}, page_content='Persons At Risk\\n    \\nScabies can be passed easily by an infested person to his or her household members and sexual partners. Scabies in adults frequently is sexually acquired.\\n    \\nScabies is a common condition found worldwide; it affects people of all races and social classes. Scabies can spread easily under crowded conditions where close body and skin contact is common. Institutions such as nursing homes, extended-care facilities, and prisons are often sites of scabies outbreaks. Child care facilities also are a common site of scabies infestations.\\n    Crusted (Norwegian) Scabies'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 51, 'source_type': 'Remedies', 'priority': '1'}, page_content='Crusted (Norwegian) Scabies\\n    \\nSome immunocompromised, elderly, disabled, or debilitated persons are at risk for a severe form of scabies called crusted, or Norwegian, scabies. Persons with crusted scabies have thick crusts of skin that contain large numbers of scabies mites and eggs. The mites in crusted scabies are not more virulent than in non-crusted scabies; however, they are much more numerous (up to 2 million per patient). Because they are infested with such large numbers of mites, persons with crusted scabies are very contagious to other persons. In addition to spreading scabies through brief direct skin-to-skin contact, persons with crusted scabies can transmit scabies indirectly by shedding mites that contaminate items such as their clothing, bedding, and furniture. Persons with crusted scabies should receive quick and aggressive medical treatment for their infestation to prevent outbreaks of scabies.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 52, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Scabies ?\\nAnswer: Diagnosis of a scabies infestation usually is made based upon the customary appearance and distribution of the the rash and the presence of burrows.\\n    \\nWhenever possible, the diagnosis of scabies should be confirmed by identifying the mite or mite eggs or fecal matter (scybala). This can be done by carefully removing the mite from the end of its burrow using the tip of a needle or by obtaining a skin scraping to examine under a microscope for mites, eggs, or mite fecal matter (scybala). However, a person can still be infested even if mites, eggs, or fecal matter cannot be found; fewer then 10-15 mites may be present on an infested person who is otherwise healthy.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 53, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Scabies ?\\nAnswer: Suggested General Guidelines \\n  \\n    \\n   \\n  \\nIt is important to remember that the first time a person gets scabies they usually have no symptoms during the first 2 to 6 weeks they are infested; however they can still spread scabies during this time. \\n  \\nTreatment should be given to both the infested person and to household members and sexual contacts, particularly those who have had prolonged direct skin-to-skin contact with the infested person. Both sexual and close personal contacts who have had direct prolonged skin-to-skin contact with an infested person within the preceding month should be examined and treated. All persons should be treated at the same time to prevent reinfestation. Scabies may sometimes be sexually-acquired in adults, but is rarely sexually-acquired in children.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 53, 'source_type': 'Remedies', 'priority': '1'}, page_content='Bedding, clothing, and towels used by infested persons or their household, sexual, and close contacts (as defined above) anytime during the three days before treatment should be decontaminated by washing in hot water and drying in a hot dryer, by dry-cleaning, or by sealing in a plastic bag for at least 72 hours. Scabies mites generally do not survive more than 2 to 3 days away from human skin. \\n  \\nUse of insecticide sprays and fumigants is not recommended. \\n    \\n  Medications Used to Treat Scabies \\n  \\n    \\n   \\n  \\nProducts used to treat scabies are called scabicides because they kill scabies mites; some also kill mite eggs. Scabicides used to treat human scabies are available only with a doctor’s prescription. No “over-the-counter” (non-prescription) products have been tested and approved to treat scabies.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 53, 'source_type': 'Remedies', 'priority': '1'}, page_content='Scabicide should be applied to all areas of the body from the neck down to the feet and toes. In addition, when treating infants and young children, scabicide also should be applied to their entire head and neck because scabies can affect their face, scalp, and neck, as well as the rest of their body. The scabicide should be applied to a clean body and left on for the recommended time before washing it off. Clean clothing should be worn after treatment. \\n  \\nThe instructions contained in the box or printed on the label always should be followed carefully. Always contact a doctor or pharmacist if unsure how to use a particular medicine.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 53, 'source_type': 'Remedies', 'priority': '1'}, page_content='The instructions contained in the box or printed on the label always should be followed carefully. Always contact a doctor or pharmacist if unsure how to use a particular medicine. \\n  \\nBecause the symptoms of scabies are due to a hypersensitivity reaction (allergy) to mites and their feces (scybala), itching still may continue for several weeks after treatment even if all the mites and eggs are killed. If itching still is present more than 2 to 4 weeks after treatment or if new burrows or pimple-like rash lesions continue to appear, retreatment may be necessary. \\n  \\nSkin sores that become infected should be treated with an appropriate antibiotic prescribed by a doctor.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 54, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Scabies ?\\nAnswer: When a person is infested with scabies mites the first time, symptoms may not appear for up to two months after being infested. However, an infested person can transmit scabies, even if they do not have symptoms. Scabies usually is passed by direct, prolonged skin-to-skin contact with an infested person. However, a person with crusted (Norwegian) scabies can spread the infestation by brief skin-to-skin contact or by exposure to bedding, clothing, or even furniture that he/she has used.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 54, 'source_type': 'Remedies', 'priority': '1'}, page_content='Scabies is prevented by avoiding direct skin-to-skin contact with an infested person or with items such as clothing or bedding used by an infested person. Scabies treatment usually is recommended for members of the same household, particularly for those who have had prolonged skin-to-skin contact. All household members and other potentially exposed persons should be treated at the same time as the infested person to prevent possible reexposure and reinfestation. Bedding and clothing worn or used next to the skin anytime during the 3 days before treatment should be machine washed and dried using the hot water and hot dryer cycles or be dry-cleaned. Items that cannot be dry-cleaned or laundered can be disinfested by storing in a closed plastic bag for several days to a week. Scabies mites generally do not survive more than 2 to 3 days away from human skin. Children and adults usually can return to child care, school, or work the day after treatment.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 54, 'source_type': 'Remedies', 'priority': '1'}, page_content='Persons with crusted scabies and their close contacts, including household members, should be treated rapidly and aggressively to avoid outbreaks. Institutional outbreaks can be difficult to control and require a rapid, aggressive, and sustained response.\\n    \\nRooms used by a patient with crusted scabies should be thoroughly cleaned and vacuumed after use. Environmental disinfestation using pesticide sprays or fogs generally is unnecessary and is discouraged.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 55, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Alkhurma Hemorrhagic Fever (AHF)? ?\\nAnswer: Transmission of AHFV is not well understood. AHFV is a zoonotic virus, and its described tick hosts (the soft tick Ornithodoros savignyi and the hard tick Hyalomma dromedari) are widely distributed. People can become infected through a tick bite or when crushing infected ticks. Epidemiologic studies indicate that contact with domestic animals or livestock may increase the risk of human infection. No human-to-human transmission of AHF has been documented. \\n \\nAlthough livestock animals may provide blood meals for ticks, it is thought that they play a minor role in transmitting AHFV to humans. No transmission through non-pasteurized milk has been described, although other tick-borne flaviviruses have been transmitted to humans through this route.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 56, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Alkhurma Hemorrhagic Fever (AHF) ?\\nAnswer: Based on limited information, after an incubation period that could be as short as 2-4 days, the disease presents initially with non-specific flu-like symptoms, including fever, anorexia (loss of appetite), general malaise, diarrhea, and vomiting; a second phase has appeared in some patients, and includes neurologic and hemorrhagic symptoms in severe form. Multi-organ failure precedes fatal outcomes. No repeated or chronic symptoms have been reported following recovery. Evidence suggests that a milder form may exist, where hospitalization is not required. \\n                \\nThrombocytopenia, leukopenia, and elevated liver enzymes are nearly always observed in patients who have been hospitalized.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 57, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Alkhurma Hemorrhagic Fever (AHF)? ?\\nAnswer: Contact with  livestock with tick exposure are risk factors for humans, as is contact with infected ticks, whether through crushing the infected tick with unprotected fingers or by a bite from an infected tick. Slaughtering of animals which may acutely but asymptomatically infected may also be a risk factor, as it is possible that infected animals develop a viremia without obvious clinical signs.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 58, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Alkhurma Hemorrhagic Fever (AHF) ?\\nAnswer: Clinical diagnosis could be difficult due to similarities between AVHF, Crimean-Congo Hemorrhagic fever (CCHF), and Rift Valley fever (RVF), which occur in similar geographic areas. Laboratory diagnosis of AHF can be made in the early stage of the illness by molecular detection by PCR or virus isolation from blood. Later, serologic testing using enzyme-linked immunosorbent serologic assay (ELISA) can be performed.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 59, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Alkhurma Hemorrhagic Fever (AHF) ?\\nAnswer: There is no standard specific treatment for the disease. Patients receive supportive therapy, which consists of balancing the patient’s fluid and electrolytes, maintaining oxygen status and blood pressure, and treatment for any complications. Mortality in hospitalized patients ranges from 1-20%.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 60, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Alkhurma Hemorrhagic Fever (AHF) ?\\nAnswer: Given that no treatment or specific prophylaxis is presently available, prevention and increased awareness of AHFV are the only recommended measures. Complete control of ticks and interruption of the virus life cycle is impractical; in endemic regions, it is important to avoid tick-infested areas and to limit contact with livestock and domestic animals.  \\n                \\nIndividuals should use tick repellants on skin and clothes and check skin for attached ticks, removing them as soon as possible. Tick collars are available for domestic animals, and dipping in acaricides is effective in killing ticks on livestock. People working with animals or animal products in farms or slaughterhouses should avoid unprotected contact with the blood, fluids, or tissues of any potentially infected or viremic animals.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 61, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Taeniasis ?\\nAnswer: Taeniasis in humans is a parasitic infection caused by the tapeworm species Taenia saginata (beef tapeworm), Taenia solium (pork tapeworm), and Taenia asiatica (Asian tapeworm). Humans can become infected with these tapeworms by eating raw or undercooked beef (T. saginata) or pork (T. solium and T. asiatica). People with taeniasis may not know they have a tapeworm infection because symptoms are usually mild or nonexistent.\\n\\nT. solium tapeworm infections can lead to cysticercosis, which is a disease that can cause seizures, so it is important seek treatment.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 62, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Taeniasis? ?\\nAnswer: The tapeworms that cause taeniasis (Taenia saginata, T. solium, and T. asiatica) are found worldwide. Eating raw or undercooked beef or pork is the primary risk factor for acquiring taeniasis. Persons who don't eat raw or undercooked beef or pork are not likely to get taeniasis.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 62, 'source_type': 'Remedies', 'priority': '1'}, page_content='Infections with T. saginata occur wherever contaminated raw beef is eaten, particularly in Eastern Europe, Russia, eastern Africa and Latin America. Taeniasis due to T. saginata is rare in the United States, except in places where cattle and people are concentrated and sanitation is poor, such as around feed lots when cattle can be exposed to human feces. Tapeworm infections due to T. solium are more prevalent in under-developed communities with poor sanitation and where people eat raw or undercooked pork. Higher rates of illness have been seen in people in Latin America, Eastern Europe, sub-Saharan Africa, India, and Asia. Taenia solium taeniasis is seen in the United States, typically among Latin American immigrants. Taenia asiatica is limited to Asia and is seen mostly in the Republic of Korea, China, Taiwan, Indonesia, and Thailand.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 62, 'source_type': 'Remedies', 'priority': '1'}, page_content='A disease called cysticercosis can occur when T. solium tapeworm eggs are ingested. For example, people with poor hygiene who have taeniasis -- with or without symptoms -- will shed tapeworm eggs in their feces and might accidentally contaminate their environment. This can lead to transmission of cysticercosis to themselves or others.\\n    \\nMore on: Cysticercosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 63, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Taeniasis ?\\nAnswer: Diagnosis of Taenia tapeworm infections is made by examination of stool samples; individuals should also be asked if they have passed tapeworm segments. Stool specimens should be collected on three different days and examined in the lab for Taenia eggs using a microscope. Tapeworm eggs can be detected in the stool 2 to 3 months after the tapeworm infection is established.\\n    \\nTapeworm eggs of T. solium can also infect humans, causing cysticercosis. It is important to diagnose and treat all tapeworm infections.\\n    \\nMore on: cysticercosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 64, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Taeniasis ?\\nAnswer: Treatment is available after accurate diagnosis. Your doctor will provide prescription medication, either praziquantel or niclosamide, which is taken by mouth. The medication is also available in a children’s dosage. Work with your health care provider for proper treatment options for you and your family.\\n    \\nMore on: Resources For Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 65, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Taeniasis ?\\nAnswer: One way to prevent taeniasis is to cook meat to safe temperatures. A food thermometer should be used to measure the internal temperature of cooked meat. Do not sample meat until it is cooked. USDA recommends the following for meat preparation.\\n   \\n    - For Whole Cuts of Meat (excluding poultry) \\n     \\n      - Cook to at least 145° F (63° C) as measured with a food thermometer placed in the thickest part of the meat, then allow the meat to rest* for three minutes before carving or consuming.\\n     \\n    - For Ground Meat (excluding poultry) \\n     \\n      - Cook to at least 160° F (71° C); ground meats do not require a rest* time.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 65, 'source_type': 'Remedies', 'priority': '1'}, page_content='- For Ground Meat (excluding poultry) \\n     \\n      - Cook to at least 160° F (71° C); ground meats do not require a rest* time.\\n     \\n   \\n   \\n*According to USDA, \"A \\'rest time\\' is the amount of time the product remains at the final temperature, after it has been removed from a grill, oven, or other heat source. During the three minutes after meat is removed from the heat source, its temperature remains constant or continues to rise, which destroys pathogens.\"\\n   \\nMore on: Fight BAC: Safe Food Handling'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 66, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Baylisascaris infection ?\\nAnswer: Baylisascaris worms are intestinal parasites found in a wide variety of animals. Different species of Baylisascaris are associated with different animal hosts. For example, Baylisascaris procyonis is found in raccoons and Baylisascaris columnaris is an intestinal parasite found in skunks. Cases of Baylisascaris infection in people are not frequently reported, but can be severe. Baylisascaris procyonis is thought to pose the greatest risk to humans because of the often close association of raccoons to human dwellings.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 67, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Baylisascaris infection? ?\\nAnswer: Raccoons are the primary, or definitive, host of Baylisascaris procyonis, a roundworm. Raccoons become infected with Baylisascaris in one of two ways:\\n    \\n     - Young raccoons become infected by eating eggs during foraging, feeding, and grooming.\\n     - Adult raccoons acquire the infection by eating rodents, rabbits, and birds infected with the larvae of Baylisascaris.\\n    \\n    \\nInfected raccoons have been found throughout the United States, mainly in the Midwest, Northeast, Middle Atlantic, and West Coast.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 67, 'source_type': 'Remedies', 'priority': '1'}, page_content='Infected raccoons have been found throughout the United States, mainly in the Midwest, Northeast, Middle Atlantic, and West Coast.\\n    \\nRaccoons are peridomestic animals, which means they live in or around areas where people live. Roundworm eggs are passed in the feces of infected raccoons. Raccoons defecate in communal sites, called latrines. Raccoon latrines are often found at bases of trees, unsealed attics, or on flat surfaces such as logs, tree stumps, rocks, decks, and rooftops. As more raccoons move into populated areas, the number and density of their latrines will increase.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 67, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"While raccoons are the roundworm's primary host, other types of animals can become infected. Birds and small mammals, such as rodents and rabbits, are susceptible to the parasite. Unlike raccoons, these animals sometimes show signs of infection, such as muscle spasms, tremors, and progressive weakness; infection can lead to death. Predator animals, including dogs, may become infected by eating an animal that has been infected with Baylisascaris. In some dogs, Baylisascaris may develop to adult worms and pass eggs in the dogs' feces.\\n    \\nThe worms develop to maturity in the raccoon intestine, where they produce millions of eggs that are passed in the feces. Eggs that are excreted by raccoons are not immediately infectious. These eggs must develop in the environment for 2 to 4 weeks, after which the eggs are able to cause infection. The eggs are resistant to most environmental conditions and with adequate moisture, can survive for years.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 67, 'source_type': 'Remedies', 'priority': '1'}, page_content='Humans become infected by ingesting embryonated (fertile) eggs. Anyone who is exposed to environments where raccoons frequent is potentially at risk. Young children or developmentally disabled persons are at highest risk for infection as they may be more likely to put contaminated fingers, soil, or objects into their mouths.\\n    \\nHunters, trappers, taxidermists, and wildlife handlers may also be at increased risk if they have contact with raccoons or raccoon habitats.\\n    \\nFewer than 25 cases of Baylisascaris disease have been documented in the United States. However, it is possible that some cases are incorrectly diagnosed as other infections or go undiagnosed. Cases that are diagnosed tend to be severe.\\n    \\nCases have been reported in California, Illinois, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, New York, Oregon, and Pennsylvania. As of 2012, there were 16 published human neurological cases in the US; six of the infected persons died.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Baylisascaris infection ?\\nAnswer: If you suspect you have been infected, consult your health care provider immediately. Be sure to tell your health care provider if you have recently been exposed to raccoons or their feces.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='Diagnosis is difficult because symptoms depend on the number of infecting larvae and location in the body. Ocular larva migrans, when the larvae migrate to the eye, can cause sensitivity to light, inflammation of the eye, and blindness. Symptoms of visceral larva migrans, when the larvae travel to organs, depend on which organs are affected. For example, an invasion of the liver may cause hepatomegaly (inflammation and enlargement of the liver), while an invasion of the lung may cause pulmonary symptoms such as cough or chest pain. Larvae rarely end up in the nervous system but the most severe cases are neural larva migrans, when the larvae migrate into the brain and cause it to swell (encephalitis). There is no commercially available test for Baylisascaris infection. A health care provider may test blood, cerebrospinal fluid (CSF), and tissue to determine if an individual is infected. Eye examinations may reveal a migrating larva or lesions and are often the most significant clue to'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='may test blood, cerebrospinal fluid (CSF), and tissue to determine if an individual is infected. Eye examinations may reveal a migrating larva or lesions and are often the most significant clue to infection with Baylisascaris.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 68, 'source_type': 'Remedies', 'priority': '1'}, page_content='Diagnosis often is made by ruling out other infections that cause similar symptoms. Information on diagnosis and testing can be obtained through your local or state health department or CDC.\\n    \\nMore on: Resources for Health Professionals: Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 69, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Baylisascaris infection ?\\nAnswer: No drugs have been shown to be totally effective for the treatment of Baylisascaris infection. Albendazole, a broad spectrum anthelmintic, has been recommended for specific cases.\\n    \\nEarly treatment might reduce serious damage caused by the infection. Should you suspect you may have ingested raccoon feces, seek immediate medical attention.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 70, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Baylisascaris infection ?\\nAnswer: Baylisascaris infection can be prevented by avoiding contact with raccoons and their feces. Washing your hands after working or playing outdoors is good practice for preventing a number of diseases.\\n    \\nDo not keep, feed, or adopt wild animals, including raccoons, as pets. Infection rarely causes symptoms in raccoons, so you cannot tell if a raccoon is infected by observing its behavior. Roundworm eggs passed in the feces of infected raccoons are not visible to the naked eye. Eggs can only be seen using a microscope.\\n    \\n     \\n    \\n    \\nYou may discourage raccoons from living in and around your home or parks by taking these steps:\\n    \\n     - prevent access to food\\n     - keep trash containers tightly closed\\n     - close off access to attics and basements\\n     - keep sandboxes covered when not in use (raccoons may use sandboxes as a latrine)'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 70, 'source_type': 'Remedies', 'priority': '1'}, page_content='- keep trash containers tightly closed\\n     - close off access to attics and basements\\n     - keep sandboxes covered when not in use (raccoons may use sandboxes as a latrine)\\n     - remove fish ponds -- they eat the fish and drink the water\\n     - eliminate water sources\\n     - remove bird feeders\\n     - clear brush so raccoons are not likely to make a den on your property\\n    \\n    \\nStay away from areas and materials that might be contaminated by raccoon feces. Raccoons typically defecate at the base of or in raised forks of trees, or on raised horizontal surfaces such as fallen logs, stumps, or large rocks. Raccoon feces also can be found on woodpiles, decks, rooftops, and in attics, garages, and haylofts. Feces usually are dark and tubular, have a pungent odor (usually worse than dog or cat feces), and often contain undigested seeds or other food items.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 70, 'source_type': 'Remedies', 'priority': '1'}, page_content='If you have found a raccoon latrine near your home, cleaning the area may prevent possible infection. Newly deposited eggs take at least 2-4 weeks to become infective. Prompt removal and destruction of raccoon feces will reduce risk for exposure and possible infection.\\n    \\nMore on: Raccoon Latrine Clean-up [PDF, 111 KB, 1 page]\\n    \\n     \\n    \\n    \\nIf you choose to clean the site yourself, care should be taken to avoid contaminating hands and clothes.\\n    \\n     - Wear disposable gloves to help prevent cross contamination.\\n     - Wear a N95-rated respirator if working in a confined space to prevent accidental ingestion of eggs or other harmful materials.\\n     - Avoid stirring up dust and debris- you can lightly mist the latrine area with a little water from a spray bottle to reduce the amount of dust.\\n     - Wear rubber boots that can be scrubbed or cover your shoes with disposable booties that can be thrown away, so that you do not bring eggs into your household.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 70, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Wear rubber boots that can be scrubbed or cover your shoes with disposable booties that can be thrown away, so that you do not bring eggs into your household.\\n     - Feces and material contaminated with raccoon feces should be removed and burned, buried, or sent to a landfill.\\n     - Most chemicals do not kill roundworm eggs; however, heat kills the eggs instantly.\\n     - Treat feces-soiled decks, patios, and other surfaces with boiling water or a propane torch (please contact your local fire department for regulations and safety practices).\\n    \\n    \\nTo help further reduce the risk of possible infection, wash your hands well with soap and warm running water. Clean/launder your clothes thoroughly with hot water and detergent.\\n    \\nMore on: Handwashing'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 70, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"More on: Handwashing\\n    \\nIf you are cleaning an indoor raccoon latrine and are not able to use a propane torch, use a damp (but not wet) sponge to wipe the area with hot soapy water. Rinse your sponge frequently. After you are finished, flush dirty water down the toilet. Place the sponge in a plastic bag and put the plastic bag in the garbage.\\n    \\nContact your local animal control office for additional assistance.\\n    Dogs\\n    \\nDogs may be infected with adult B. procyonis roundworms, but may not show symptoms. Have all pets de-wormed under a veterinarian's supervision and take precautions to avoid contact with their feces.\\n    Exotic pets\\n    \\nRaccoons and dogs are not the only hosts of Baylisascaris. B. procyonis infection has also been documented in kinkajous. Other animals such as coatis may be susceptible. When wild animals are kept as pets, there can be a risk of disease transmission to humans.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 71, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Babesiosis ?\\nAnswer: Babesiosis is caused by microscopic parasites that infect red blood cells. Most human cases of Babesia infection in the United States are caused by the parasite Babesia microti. Occasional cases caused by other species (types) of Babesia have been detected. Babesia microti is spread in nature by Ixodes scapularis ticks (also called blacklegged ticks or deer ticks). Tickborne transmission is most common in particular regions and seasons: it mainly occurs in parts of the Northeast and upper Midwest; and it usually peaks during the warm months. Babesia infection can range in severity from asymptomatic to life threatening. The infection is both treatable and preventable.\\n    Frequently Asked Questions (FAQs)\\n    \\n    Podcasts'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 72, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Babesiosis? ?\\nAnswer: People can get infected with Babesia parasites in several ways:\\n    \\n     - The main way is through the bite of an infected tick—during outdoor activities in areas where babesiosis is found (see below).\\n     - A less common way is by getting a transfusion from a blood donor who has a Babesia infection but does not have any symptoms. (No tests have been licensed yet for screening blood donors for Babesia.)\\n     - Rare cases of congenital transmission—from an infected mother to her baby (during pregnancy or delivery)—have been reported.\\n    \\n    \\nBabesia parasites are not transmitted from person-to-person like the flu or the common cold.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 72, 'source_type': 'Remedies', 'priority': '1'}, page_content='Babesia parasites are not transmitted from person-to-person like the flu or the common cold.\\n    \\nMany different species (types) of Babesia parasites have been found in animals, only a few of which have been found in people. Babesia microti—which usually infects white-footed mice and other small mammals—is the main species that has been found in people in the United States. Occasional (sporadic) cases of babesiosis caused by other Babesia species have been detected.\\n    \\n     \\n    \\n    \\nBabesia microti is transmitted in nature by Ixodes scapularis ticks (also called blacklegged ticks or deer ticks).\\n    \\n     - Tickborne transmission primarily occurs in the Northeast and upper Midwest, especially in parts of New England, New York state, New Jersey, Wisconsin, and Minnesota.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 72, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Tickborne transmission primarily occurs in the Northeast and upper Midwest, especially in parts of New England, New York state, New Jersey, Wisconsin, and Minnesota.\\n     - The parasite typically is spread by the young nymph stage of the tick, which is most apt to be found (seeking or \"questing\" for a blood meal) during warm months (spring and summer), in areas with woods, brush, or grass.\\n     - Infected people might not recall a tick bite because I. scapularis nymphs are very small (about the size of a poppy seed).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 73, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Babesiosis ?\\nAnswer: In symptomatic people, babesiosis usually is diagnosed by examining blood specimens under a microscope and seeing Babesia parasites inside red blood cells.\\n    \\nTo be sure the diagnosis is correct, your health care provider might have specimens of your blood tested by a specialized reference laboratory (such as at CDC or a health department).\\n    \\nMore on: Resources for Health Professionals: Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 74, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Babesiosis ?\\nAnswer: Effective treatments are available. People who do not have any symptoms or signs of babesiosis usually do not need to be treated.\\n    \\nBefore considering treatment, the first step is to make sure the diagnosis is correct.\\n    \\nFor more information, people should talk to their health care provider.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 75, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Babesiosis ?\\nAnswer: Steps can be taken to reduce the risk for babesiosis and other tickborne infections. The use of prevention measures is especially important for people at increased risk for severe babesiosis (for example, people who do not have a spleen). Avoiding exposure to tick habitats is the best defense.\\n   \\nBabesia microti is spread by Ixodes scapularis ticks, which are mostly found in wooded, brushy, or grassy areas, in certain regions and seasons. No vaccine is available to protect people against babesiosis. However, people who live, work, or travel in tick-infested areas can take simple steps to help protect themselves against tick bites and tickborne infections.\\n   \\n    \\n   \\n   \\nDuring outdoor activities in tick habitats, take precautions to keep ticks off the skin.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 75, 'source_type': 'Remedies', 'priority': '1'}, page_content='During outdoor activities in tick habitats, take precautions to keep ticks off the skin.\\n   \\n    - Walk on cleared trails and stay in the center of the trail, to minimize contact with leaf litter, brush, and overgrown grasses, where ticks are most likely to be found.\\n    - Minimize the amount of exposed skin, by wearing socks, long pants, and a long-sleeved shirt. Tuck the pant legs into the socks, so ticks cannot crawl up the inside of the pants. Wear light-colored clothing, to make it easier to see and remove ticks before they attach to skin.\\n    - Apply repellents to skin and clothing. Follow the instructions on the product label. \\n     \\n      - Products that contain DEET (N,N-diethylmetatoluamide) can be directly applied to exposed skin and to clothing, to help keep ticks away (by repelling them). The product label includes details about how and where to apply the repellent, how often to reapply it, and how to use it safely on children.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 75, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Permethrin products can be applied to clothing/boots (not to skin), actually kill ticks that come in contact with the treated clothing, and usually stay effective through several washings.\\n     \\n   \\n   \\n    \\n   \\n   \\nAfter outdoor activities, conduct daily tick checks and promptly remove any ticks that are found. Thorough, daily tick checks are very important. The I. scapularis nymphs that typically spread B. microti are so small (about the size of a poppy seed) that they are easily overlooked. But they usually must stay attached to a person for more than 36-48 hours to be able to transmit the parasite.\\n   \\n    - Remove ticks from clothing and pets before going indoors.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 75, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Remove ticks from clothing and pets before going indoors.\\n    - Conduct a full-body exam for ticks. Use a hand-held or full-length mirror to view all parts of the body. Be sure to check behind the knees, between the legs (groin/thighs), between the toes, under the arms (armpits), around the waist, inside the belly button, the back of the neck, behind and in the ears, as well as in and around the scalp, hairline, and hair. Remember to check children and pets, too.\\n   \\n   \\nRemove ticks that are attached to the skin as soon as possible, preferably by using pointed (fine-tipped) tweezers. Grab the tick’s mouth parts close to the skin, and slowly pull the tick straight out (with steady outward pressure), until the tick lets go.\\n   \\nMore on: Removing Ticks\\n   \\nMore on: Ticks'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 76, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: what are the signs and symptoms of rabies?\\nAnswer: The first symptoms of rabies may be very similar to those of the flu including general weakness or discomfort, fever, or headache. These symptoms may last for days.\\n                \\nThere may be also discomfort or a prickling or itching sensation at the site of bite, progressing within days to symptoms of cerebral dysfunction, anxiety, confusion, agitation. As the disease progresses, the person may experience delirium, abnormal behavior, hallucinations, and insomnia.\\n                \\nThe acute period of disease typically ends after 2 to 10 days. Once clinical signs of rabies appear, the disease is nearly always fatal, and treatment is typically supportive.\\n                \\nDisease prevention includes administration of both passive antibody, through an injection of human immune globulin and a round of injections with rabies vaccine.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 76, 'source_type': 'Remedies', 'priority': '1'}, page_content='Disease prevention includes administration of both passive antibody, through an injection of human immune globulin and a round of injections with rabies vaccine.\\n                \\nOnce a person begins to exhibit signs of the disease, survival is rare. To date less than 10 documented cases of human survival from clinical rabies have been reported and only two have not had a history of pre- or postexposure prophylaxis.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 77, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: what is the risk for my pet for Rabies ?\\nAnswer: Any animal bitten or scratched by either a wild, carnivorous mammal or a bat that is not available for testing should be regarded as having been exposed to rabies.\\n  \\nUnvaccinated dogs, cats, and ferrets exposed to a rabid animal should be euthanized immediately. If the owner is unwilling to have this done, the animal should be placed in strict isolation for 6 months and vaccinated 1 month before being released.\\n  \\nAnimals with expired vaccinations need to be evaluated on a case-by-case basis. Dogs and cats that are currently vaccinated are kept under observation for 45 days.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 77, 'source_type': 'Remedies', 'priority': '1'}, page_content='Animals with expired vaccinations need to be evaluated on a case-by-case basis. Dogs and cats that are currently vaccinated are kept under observation for 45 days.\\n  \\nSmall mammals such as squirrels, rats, mice, hamsters, guinea pigs, gerbils, chipmunks, rabbits, and hares are almost never found to be infected with rabies and have not been known to cause rabies among humans in the United States. Bites by these animals are usually not considered a risk of rabies unless the animal was sick or behaving in any unusual manner and rabies is widespread in your area.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 77, 'source_type': 'Remedies', 'priority': '1'}, page_content='However, from 1985 through 1994, woodchucks accounted for 86% of the 368 cases of rabies among rodents reported to CDC. Woodchucks or groundhogs (Marmota monax) are the only rodents that may be frequently submitted to state health department because of a suspicion of rabies. In all cases involving rodents, the state or local health department should be consulted before a decision is made to initiate postexposure prophylaxis (PEP).\\n  Is there rabies in my area?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 77, 'source_type': 'Remedies', 'priority': '1'}, page_content='Is there rabies in my area?\\n  \\nEach state collects specific information about rabies, and is the best source for information on rabies in your area. In addition, the CDC publishes rabies surveillance data every year for the United States. The report, entitled Rabies Surveillance in the United States, contains information about the number of cases of rabies reported to CDC during the year, the animals reported rabid, maps showing where cases were reported for wild and domestic animals, and distribution maps showing outbreaks of rabies associated with specific animals.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 78, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: how is rabies diagnosed?\\nAnswer: In animals, rabies is diagnosed using the direct fluorescent antibody (DFA) test, which looks for the presence of rabies virus antigens in brain tissue. In humans, several tests are required.\\n \\nRapid and accurate laboratory diagnosis of rabies in humans and other animals is essential for timely administration of postexposure prophylaxis. Within a few hours, a diagnostic laboratory can determine whether or not an animal is rabid and inform the responsible medical personnel. The laboratory results may save a patient from unnecessary physical and psychological trauma, and financial burdens, if the animal is not rabid.\\n \\nIn addition, laboratory identification of positive rabies cases may aid in defining current epidemiologic patterns of disease and provide appropriate information for the development of rabies control programs.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 78, 'source_type': 'Remedies', 'priority': '1'}, page_content='The nature of rabies disease dictates that laboratory tests be standardized, rapid, sensitive, specific, economical, and reliable.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 79, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: what is botulism?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 79, 'source_type': 'Remedies', 'priority': '1'}, page_content='Answer: Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium Clostridium botulinum and sometimes by strains of Clostridium butyricum and Clostridium baratii. There are five main kinds of botulism. Foodborne botulism is caused by eating foods that contain the botulinum toxin. Wound botulism is caused by toxin produced from a wound infected with Clostridium botulinum. Infant botulism is caused by consuming the spores of the botulinum bacteria, which then grow in the intestines and release toxin. Adult intestinal toxemia (adult intestinal colonization) botulism is a very rare kind of botulism that occurs among adults by the same route as infant botulism. Lastly, iatrogenic botulism can occur from accidental overdose of botulinum toxin. All forms of botulism can be fatal and are considered medical emergencies. Foodborne botulism is a public health emergency because many people can be poisoned by eating a contaminated food.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 80, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: frequency\\nQuestion: how common is botulism?\\nAnswer: In the United States, an average of 145 cases are reported each year.Of these, approximately 15% are foodborne, 65% are infant botulism, and 20% are wound. Adult intestinal colonization and iatrogenic botulism also occur, but rarely. Outbreaks of foodborne botulism involving two or more persons occur most years and are usually caused by home-canned foods. Most wound botulism cases are associated with black-tar heroin injection, especially in California.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 81, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: what are the symptoms of botulism?\\nAnswer: The classic symptoms of botulism include double vision, blurred vision, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, and muscle weakness. Infants with botulism appear lethargic, feed poorly, are constipated, and have a weak cry and poor muscle tone. These are all symptoms of the muscle paralysis caused by the bacterial toxin. If untreated, these symptoms may progress to cause paralysis of the respiratory muscles, arms, legs, and trunk. In foodborne botulism, symptoms generally begin 18 to 36 hours after eating a contaminated food, but they can occur as early as 6 hours or as late as 10 days.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 82, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: exams and tests\\nQuestion: how is botulism diagnosed?\\nAnswer: Physicians may consider the diagnosis if the patient's history and physical examination suggest botulism. However, these clues are usually not enough to allow a diagnosis of botulism. Other diseases such as Guillain-Barré syndrome, stroke, and myasthenia gravis can appear similar to botulism, and special tests may be needed to exclude these other conditions. These tests may include a brain scan, spinal fluid examination, nerve conduction test (electromyography, or EMG), and a tensilon test for myasthenia gravis. Tests for botulinum toxin and for bacteria that cause botulism can be performed at some state health department laboratories and at CDC.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 83, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: how can botulism be treated?\\nAnswer: The respiratory failure and paralysis that occur with severe botulism may require a patient to be on a breathing machine (ventilator) for weeks or months, plus intensive medical and nursing care. The paralysis slowly improves. Botulism can be treated with an antitoxin which blocks the action of toxin circulating in the blood. Antitoxin for infants is available from the California Department of Public Health, and antitoxin for older children and adults is available through CDC.If given before paralysis is complete, antitoxin can prevent worsening and shorten recovery time. Physicians may try to remove contaminated food still in the gut by inducing vomiting or by using enemas. Wounds should be treated, usually surgically, to remove the source of the toxin-producing bacteria followed by administration of appropriate antibiotics. Good supportive care in a hospital is the mainstay of therapy for all forms of botulism.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 84, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: complications\\nQuestion: are there complications from botulism?\\nAnswer: Botulism can result in death due to respiratory failure. However, in the past 50 years the proportion of patients with botulism who die has fallen from about 50% to 3-5%. A patient with severe botulism may require a breathing machine as well as intensive medical and nursing care for several months, and some patients die from infections or other problems related to remaining paralyzed for weeks or months. Patients who survive an episode of botulism poisoning may have fatigue and shortness of breath for years and long-term therapy may be needed to aid recovery.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 85, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: how can botulism be prevented?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 85, 'source_type': 'Remedies', 'priority': '1'}, page_content='Answer: Many cases of botulism are preventable. Foodborne botulism has often been from home-canned foods with low acid content, such as asparagus, green beans, beets and corn and is caused by failure to follow proper canning methods. However, seemingly unlikely or unusual sources are found every decade, with the common problem of improper handling during manufacture, at retail, or by consumers; some examples are chopped garlic in oil, canned cheese sauce, chile peppers, tomatoes, carrot juice, and baked potatoes wrapped in foil. In Alaska, foodborne botulism is caused by fermented fish and other aquatic game foods. Persons who do home canning should follow strict hygienic procedures to reduce contamination of foods, and carefully follow instructions on safe home canning including the use of pressure canners/cookers as recommended through county extension services or from the US Department of Agriculture. Oils infused with garlic or herbs should be refrigerated. Potatoes which have'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 85, 'source_type': 'Remedies', 'priority': '1'}, page_content='of pressure canners/cookers as recommended through county extension services or from the US Department of Agriculture. Oils infused with garlic or herbs should be refrigerated. Potatoes which have been baked while wrapped in aluminum foil should be kept hot until served or refrigerated. Because the botulinum toxin is destroyed by high temperatures, persons who eat home-canned foods should consider boiling the food for 10 minutes before eating it to ensure safety. Wound botulism can be prevented by promptly seeking medical care for infected wounds and by not using injectable street drugs. Most infant botulism cases cannot be prevented because the bacteria that causes this disease is in soil and dust.  The bacteria can be found inside homes on floors, carpet, and countertops even after cleaning.  Honey can contain the bacteria that causes infant botulism so, children less than 12 months old should not be fed honey. Honey is safe for persons 1 year of age and older.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 86, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: what are public health agencies doing to prevent or control botulism?\\nAnswer: Public education about botulism prevention is an ongoing activity. Information about safe canning is widely available for consumers. Persons in state health departments and at CDC are knowledgeable about botulism and available to consult with physicians 24 hours a day. If antitoxin is needed to treat a patient, it can be quickly delivered to a physician anywhere in the country. Suspected outbreaks of botulism are quickly investigated, and if they involve a commercial product, the appropriate control measures are coordinated among public health and regulatory agencies. Physicians should immediately report suspected cases of botulism to their state health department.\\n                \\nFor information and quidelines on canning foods at home: USDA Home Canning Guide'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 87, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Marburg hemorrhagic fever (Marburg HF)? ?\\nAnswer: It is unknown how Marburg virus first transmits from its animal host to humans; however, for the 2 cases in tourists visiting Uganda in 2008, unprotected contact with infected bat feces or aerosols are the most likely routes of infection. \\n  \\nAfter this initial crossover of virus from host animal to humans, transmission occurs through person-to-person contact. This may happen in several ways: direct contact to droplets of body fluids from infected persons, or contact with equipment and other objects contaminated with infectious blood or tissues.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 87, 'source_type': 'Remedies', 'priority': '1'}, page_content='In previous outbreaks, persons who have handled infected non-human primates or have come in direct contact with their fluids or cell cultures have become infected. Spread of the virus between humans has occurred in close environments and direct contacts. A common example is through caregivers in the home or in a hospital (nosocomial transmission).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 88, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Marburg hemorrhagic fever (Marburg HF) ?\\nAnswer: After an incubation period of 5-10 days, symptom onset is sudden and marked by fever, chills, headache, and myalgia. Around the fifth day after the onset of symptoms, a maculopapular rash, most prominent on the trunk (chest, back, stomach), may occur. Nausea, vomiting, chest pain, a sore throat, abdominal pain, and diarrhea may then appear. Symptoms become increasingly severe and can include jaundice, inflammation of the pancreas, severe weight loss, delirium, shock, liver failure, massive hemorrhaging, and multi-organ dysfunction. \\n \\nBecause many of the signs and symptoms of Marburg hemorrhagic fever are similar to those of other infectious diseases such as malaria or typhoid fever, clinical diagnosis of the disease can be difficult, especially if only a single case is involved.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 88, 'source_type': 'Remedies', 'priority': '1'}, page_content='The case-fatality rate for Marburg hemorrhagic fever is between 23-90%. For a complete listing of the case fatality rates for previous outbreaks, please see the History of Outbreaks table'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 89, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Marburg hemorrhagic fever (Marburg HF)? ?\\nAnswer: People who have close contact with African fruit bats, humans patients, or non-human primates infected with Marburg virus are at risk. \\n                \\nHistorically, the people at highest risk include family members and hospital staff who care for patients infected with Marburg virus and have not used proper barrier nursing techniques. Particular occupations, such as veterinarians and laboratory or quarantine facility workers who handle non-human primates from Africa, may also be at increased risk of exposure to Marburg virus. \\n                \\nExposure risk can be higher for travelers visiting endemic regions in Africa, including Uganda and other parts of central Africa, and have contact with fruit bats, or enter caves or mines inhabited by fruit bats.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 90, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Marburg hemorrhagic fever (Marburg HF) ?\\nAnswer: Many of the signs and symptoms of Marburg hemorrhagic fever are similar to those of other more frequent infectious diseases, such as malaria or typhoid fever, making diagnosis of the disease difficult. This is especially true if only a single case is involved. \\n \\nHowever, if a person has the early symptoms of Marburg HF and there is reason to believe that Marburg HF should be considered, the patient should be isolated and public health professionals notified. Samples from the patient can then be collected and tested to confirm infection.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 90, 'source_type': 'Remedies', 'priority': '1'}, page_content='Antigen-capture enzyme-linked immunosorbent assay (ELISA) testing, polymerase chain reaction (PCR), and IgM-capture ELISA can be used to confirm a case of Marburg HF within a few days of symptom onset. Virus isolation may also be performed but should only be done in a high containment laboratory with good laboratory practices. The IgG-capture ELISA is appropriate for testing persons later in the course of disease or after recovery. In deceased patients, immunohistochemistry, virus isolation, or PCR of blood or tissue specimens may be used to diagnose Marburg HF retrospectively.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 91, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: treatment\\nQuestion: What are the treatments for Marburg hemorrhagic fever (Marburg HF) ?\\nAnswer: There is no specific treatment for Marburg hemorrhagic fever. Supportive hospital therapy should be utilized, which includes balancing the patient's fluids and electrolytes, maintaining oxygen status and blood pressure, replacing lost blood and clotting factors, and treatment for any complicating infections. \\n \\nExperimental treatments are validated in non-human primates models, but have never been tried in humans.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 92, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Marburg hemorrhagic fever (Marburg HF) ?\\nAnswer: Preventive measures against Marburg virus infection are not well defined, as transmission from wildlife to humans remains an area of ongoing research. However, avoiding fruit bats, and sick non-human primates in central Africa, is one way to protect against infection. \\n \\nMeasures for prevention of secondary, or person-to-person, transmission are similar to those used for other hemorrhagic fevers. If a patient is either suspected or confirmed to have Marburg hemorrhagic fever, barrier nursing techniques should be used to prevent direct physical contact with the patient. These precautions include wearing of protective gowns, gloves, and masks; placing the infected individual in strict isolation; and sterilization or proper disposal of needles, equipment, and patient excretions.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 92, 'source_type': 'Remedies', 'priority': '1'}, page_content='In conjunction with the World Health Organization, CDC has developed practical, hospital-based guidelines, titled: Infection Control for Viral Haemorrhagic Fevers In the African Health Care Setting. The manual can help health-care facilities recognize cases and prevent further hospital-based disease transmission using locally available materials and few financial resources.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 92, 'source_type': 'Remedies', 'priority': '1'}, page_content='Marburg hemorrhagic fever is a very rare human disease. However, when it occurs, it has the potential to spread to other people, especially health care staff and family members who care for the patient. Therefore, increasing awareness in communities and among health-care providers of the clinical symptoms of patients with Marburg hemorrhagic fever is critical. Better awareness can lead to earlier and stronger precautions against the spread of Marburg virus in both family members and health-care providers. Improving the use of diagnostic tools is another priority. With modern means of transportation that give access even to remote areas, it is possible to obtain rapid testing of samples in disease control centers equipped with Biosafety Level 4 laboratories in order to confirm or rule out Marburg virus infection.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 93, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Leishmaniasis ?\\nAnswer: Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most common forms are cutaneous leishmaniasis, which causes skin sores, and visceral leishmaniasis, which affects several internal organs (usually spleen, liver, and bone marrow).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 94, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Leishmaniasis? ?\\nAnswer: Leishmaniasis is found in people in focal areas of more than 90 countries in the tropics, subtropics, and southern Europe. The ecologic settings range from rain forests to deserts. Leishmaniasis usually is more common in rural than in urban areas, but it is found in the outskirts of some cities. Climate and other environmental changes have the potential to expand the geographic range of the sand fly vectors and the areas in the world where leishmaniasis is found.\\n    \\nLeishmaniasis is found on every continent except Australia and Antarctica.\\n    \\n     - In the Old World (the Eastern Hemisphere), leishmaniasis is found in some parts of Asia, the Middle East, Africa (particularly in the tropical region and North Africa, with some cases elsewhere), and southern Europe. It is not found in Australia or the Pacific islands.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 94, 'source_type': 'Remedies', 'priority': '1'}, page_content='- In the New World (the Western Hemisphere), it is found in some parts of Mexico, Central America, and South America. It is not found in Chile or Uruguay. Occasional cases of cutaneous leishmaniasis have been acquired in Texas and Oklahoma.\\n    \\n    \\nThe number of new cases per year is not known with certainty. For cutaneous leishmaniasis, estimates of the number of cases range from approximately 0.7 million (700,000) to 1.2 million (1,200,000). For visceral leishmaniasis, estimates of the number of cases range from approximately 0.2 million (200,000) to 0.4 million (400,000). The cases of leishmaniasis evaluated in the United States reflect travel and immigration patterns. For example, many of the cases of cutaneous leishmaniasis in U.S. civilian travelers have been acquired in common tourist destinations in Latin America, such as in Costa Rica.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 94, 'source_type': 'Remedies', 'priority': '1'}, page_content='Overall, infection in people is caused by more than 20 species (types) of Leishmania parasites, which are spread by about 30 species of phlebotomine sand flies; particular species of the parasite are spread by particular sand flies. The sand fly vectors generally are the most active during twilight, evening, and night-time hours (from dusk to dawn).\\n    \\nIn many geographic areas where leishmaniasis is found in people, infected people are not needed to maintain the transmission cycle of the parasite in nature; infected animals (such as rodents or dogs), along with sand flies, maintain the cycle. However, in some parts of the world, infected people are needed to maintain the cycle; this type of transmission (human—sand fly—human) is called anthroponotic. In areas with anthroponotic transmission, effective treatment of individual patients can help control the spread of the parasite.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 95, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Leishmaniasis ?\\nAnswer: Various laboratory methods can be used to diagnose leishmaniasis—to detect the parasite as well as to identify the Leishmania species (type). Some of the methods are available only in reference laboratories. In the United States, CDC staff can assist with the testing for leishmaniasis.\\n    \\nTissue specimens—such as from skin sores (for cutaneous leishmaniasis) or from bone marrow (for visceral leishmaniasis)—can be examined for the parasite under a microscope, in special cultures, and in other ways. Blood tests that detect antibody (an immune response) to the parasite can be helpful for cases of visceral leishmaniasis; tests to look for the parasite itself usually also are done.\\n    \\nMore on: Resources for Health Professionals: Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 96, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: treatment\\nQuestion: What are the treatments for Parasites - Leishmaniasis ?\\nAnswer: Before considering treatment, the first step is to make sure the diagnosis is correct.\\n    \\nTreatment decisions should be individualized. Health care providers may consult CDC staff about the relative merits of various approaches. Examples of factors to consider include the form of leishmaniasis, the Leishmania species that caused it, the potential severity of the case, and the patient's underlying health.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 96, 'source_type': 'Remedies', 'priority': '1'}, page_content='The skin sores of cutaneous leishmaniasis usually heal on their own, even without treatment. But this can take months or even years, and the sores can leave ugly scars. Another potential concern applies to some (not all) types of the parasite found in parts of Latin America: certain types might spread from the skin and cause sores in the mucous membranes of the nose (most common location), mouth, or throat (mucosal leishmaniasis). Mucosal leishmaniasis might not be noticed until years after the original sores healed. The best way to prevent mucosal leishmaniasis is to ensure adequate treatment of the cutaneous infection.\\n    \\nIf not treated, severe (advanced) cases of visceral leishmaniasis typically are fatal.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 97, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Leishmaniasis ?\\nAnswer: No vaccines or drugs to prevent infection are available. The best way for travelers to prevent infection is to protect themselves from sand fly bites. To decrease the risk of being bitten, follow these preventive measures:\\n    \\nAvoid outdoor activities, especially from dusk to dawn, when sand flies generally are the most active.\\n    \\nWhen outdoors (or in unprotected quarters):\\n    \\n     - Minimize the amount of exposed (uncovered) skin. To the extent that is tolerable in the climate, wear long-sleeved shirts, long pants, and socks; and tuck your shirt into your pants. (See below about wearing insecticide-treated clothing.)\\n     - Apply insect repellent to exposed skin and under the ends of sleeves and pant legs. Follow the instructions on the label of the repellent. The most effective repellents generally are those that contain the chemical DEET (N,N-diethylmetatoluamide).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 97, 'source_type': 'Remedies', 'priority': '1'}, page_content='When indoors:\\n    \\n     - Stay in well-screened or air-conditioned areas.\\n     - Keep in mind that sand flies are much smaller than mosquitoes and therefore can get through smaller holes.\\n     - Spray living/sleeping areas with an insecticide to kill insects.\\n     - If you are not sleeping in a well-screened or air-conditioned area, use a bed net and tuck it under your mattress. If possible, use a bed net that has been soaked in or sprayed with a pyrethroid-containing insecticide. The same treatment can be applied to screens, curtains, sheets, and clothing (clothing should be retreated after five washings).\\n    \\n    \\nMore on: Insect Bite Prevention'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 98, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Toxoplasmosis (Toxoplasma infection) ?\\nAnswer: A single-celled parasite called Toxoplasma gondii causes a disease known as toxoplasmosis. While the parasite is found throughout the world, more than 60 million people in the United States may be infected with the Toxoplasma parasite. Of those who are infected, very few have symptoms because a healthy person’s immune system usually keeps the parasite from causing illness. However, pregnant women and individuals who have compromised immune systems should be cautious; for them, a Toxoplasma infection could cause serious health problems.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 99, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Toxoplasmosis (Toxoplasma infection)? ?\\nAnswer: Toxoplasmosis is caused by the protozoan parasite Toxoplasma gondii. In the United States it is estimated that 22.5% of the population 12 years and older have been infected with Toxoplasma. In various places throughout the world, it has been shown that up to 95% of some populations have been infected with Toxoplasma. Infection is often highest in areas of the world that have hot, humid climates and lower altitudes. \\n    \\nToxoplasmosis is not passed from person-to-person, except in instances of mother-to-child (congenital) transmission and blood transfusion or organ transplantation. People typically become infected by three principal routes of transmission. \\n         \\n     \\n     \\n       \\n      \\n     \\n    \\n      \\n    Foodborne transmission'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 99, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Foodborne transmission \\n    \\nThe tissue form of the parasite (a microscopic cyst consisting of bradyzoites) can be transmitted to humans by food. People become infected by: \\n     \\n     - Eating undercooked, contaminated meat (especially pork, lamb, and venison) \\n     - Accidental ingestion of undercooked, contaminated meat after handling it and not washing hands thoroughly (Toxoplasma cannot be absorbed through intact skin) \\n     - Eating food that was contaminated by knives, utensils, cutting boards, or other foods that had contact with raw, contaminated meat \\n     \\n    \\n      \\n    Animal-to-human (zoonotic) transmission \\n    \\nCats play an important role in the spread of toxoplasmosis. They become infected by eating infected rodents, birds, or other small animals. The parasite is then passed in the cat's feces in an oocyst form, which is microscopic.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 99, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Kittens and cats can shed millions of oocysts in their feces for as long as 3 weeks after infection. Mature cats are less likely to shed Toxoplasma if they have been previously infected. A Toxoplasma-infected cat that is shedding the parasite in its feces contaminates the litter box. If the cat is allowed outside, it can contaminate the soil or water in the environment as well. \\n     \\n       \\n      \\n     \\n    \\nPeople can accidentally swallow the oocyst form of the parasite. People can be infected by: \\n     \\n     - Accidental ingestion of oocysts after cleaning a cat's litter box when the cat has shed Toxoplasma in its feces \\n     - Accidental ingestion of oocysts after touching or ingesting anything that has come into contact with a cat's feces that contain Toxoplasma \\n     - Accidental ingestion of oocysts in contaminated soil (e.g., not washing hands after gardening or eating unwashed fruits or vegetables from a garden)\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 99, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Accidental ingestion of oocysts in contaminated soil (e.g., not washing hands after gardening or eating unwashed fruits or vegetables from a garden) \\n     - Drinking water contaminated with the Toxoplasma parasite \\n     \\n    \\n      \\n    Mother-to-child (congenital) transmission \\n    \\nA woman who is newly infected with Toxoplasma during pregnancy can pass the infection to her unborn child (congenital infection). The woman may not have symptoms, but there can be severe consequences for the unborn child, such as diseases of the nervous system and eyes. \\n    \\n      \\n    Rare instances of transmission \\n    \\nOrgan transplant recipients can become infected by receiving an organ from a Toxoplasma-positive donor. Rarely, people can also become infected by receiving infected blood via transfusion. Laboratory workers who handle infected blood can also acquire infection through accidental inoculation.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 100, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Toxoplasmosis (Toxoplasma infection) ?\\nAnswer: The diagnosis of toxoplasmosis is typically made by serologic testing. A test that measures immunoglobulin G (IgG) is used to determine if a person has been infected. If it is necessary to try to estimate the time of infection, which is of particular importance for pregnant women, a test which measures immunoglobulin M (IgM) is also used along with other tests such as an avidity test.\\n    \\nDiagnosis can be made by direct observation of the parasite in stained tissue sections, cerebrospinal fluid (CSF), or other biopsy material. These techniques are used less frequently because of the difficulty of obtaining these specimens.\\n    \\nParasites can also be isolated from blood or other body fluids (for example, CSF) but this process can be difficult and requires considerable time.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 100, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Parasites can also be isolated from blood or other body fluids (for example, CSF) but this process can be difficult and requires considerable time.\\n    \\nMolecular techniques that can detect the parasite's DNA in the amniotic fluid can be useful in cases of possible mother-to-child (congenital) transmission.\\n    \\nOcular disease is diagnosed based on the appearance of the lesions in the eye, symptoms, course of disease, and often serologic testing.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 101, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Toxoplasmosis (Toxoplasma infection) ?\\nAnswer: Healthy people (nonpregnant)\\n    \\nMost healthy people recover from toxoplasmosis without treatment. Persons who are ill can be treated with a combination of drugs such as pyrimethamine and sulfadiazine, plus folinic acid.\\n    \\n     \\n    Pregnant women, newborns, and infants\\n    \\nPregnant women, newborns, and infants can be treated, although the parasite is not eliminated completely. The parasites can remain within tissue cells in a less active phase; their location makes it difficult for the medication to completely eliminate them.\\n    \\n     \\n    Persons with ocular disease\\n    \\nPersons with ocular toxoplasmosis are sometimes prescribed medicine to treat active disease by their ophthalmologist. Whether or not medication is recommended depends on the size of the eye lesion, the location, and the characteristics of the lesion (acute active, versus chronic not progressing).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 101, 'source_type': 'Remedies', 'priority': '1'}, page_content='Persons with compromised immune systems\\n    \\nPersons with compromised immune systems need to be treated until they have improvement in their condition. For AIDS patients, continuation of medication for the rest of their lives may be necessary, or for as long as they are immunosuppressed.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 102, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Toxoplasmosis (Toxoplasma infection) ?\\nAnswer: People who are healthy should follow the guidelines below to reduce risk of toxoplasmosis. If you have a weakened immune system, please see guidelines for Immunocompromised Persons.\\n   Reduce Risk from Food\\n   \\nTo prevent risk of toxoplasmosis and other infections from food:\\n   \\n    - Freeze meat for several days at sub-zero (0° F) temperatures before cooking to greatly reduce chance of infection.\\n    - Peel or wash fruits and vegetables thoroughly before eating. \\n     \\n      \\n     \\n    - Wash cutting boards, dishes, counters, utensils, and hands with hot soapy water after contact with raw meat, poultry, seafood, or unwashed fruits or vegetables.\\n   \\n   \\nMore on: Handwashing\\n   \\nThe U.S. Government and the meat industry continue their efforts to reduce T. gondii in meat.\\n   Reduce Risk from the Environment\\n   \\nTo prevent risk of toxoplasmosis from the environment:'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 102, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"The U.S. Government and the meat industry continue their efforts to reduce T. gondii in meat.\\n   Reduce Risk from the Environment\\n   \\nTo prevent risk of toxoplasmosis from the environment:\\n   \\n    - Avoid drinking untreated drinking water.\\n    - Wear gloves when gardening and during any contact with soil or sand because it might be contaminated with cat feces that contain Toxoplasma. Wash hands with soap and warm water after gardening or contact with soil or sand.\\n    - Teach children the importance of washing hands to prevent infection.\\n    - Keep outdoor sandboxes covered. \\n     \\n      \\n     \\n    - Feed cats only canned or dried commercial food or well-cooked table food, not raw or undercooked meats.\\n    - Change the litter box daily if you own a cat. The Toxoplasma parasite does not become infectious until 1 to 5 days after it is shed in a cat's feces. If you are pregnant or immunocompromised:\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 102, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Avoid changing cat litter if possible. If no one else can perform the task, wear disposable gloves and wash your hands with soap and warm water afterwards.\\n      - Keep cats indoors.\\n      - Do not adopt or handle stray cats, especially kittens. Do not get a new cat while you are pregnant.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 103, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Hookworm ?\\nAnswer: Hookworm is an intestinal parasite of humans. The larvae and adult worms live in the small intestine can cause intestinal disease. The two main species of hookworm infecting humans are Ancylostoma duodenale and Necator americanus.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 104, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Hookworm? ?\\nAnswer: Hookworm is a soil-transmitted helminth (STH) and is one of the most common roundworm of humans. Infection is caused by the nematode parasites Necator americanus and Ancylostoma duodenale. Hookworm infections often occur in areas where human feces are used as fertilizer or where defecation onto soil happens.\\n    Geographic Distribution\\n    \\nThe geographic distributions of the hookworm species that are intestinal parasites in human, Ancylostoma duodenale and Necator americanus, are worldwide in areas with warm, moist climates and are widely overlapping. Necator americanus was widespread in the Southeastern United States until the early 20th century.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 105, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Hookworm ?\\nAnswer: The standard method for diagnosing the presence of hookworm is by identifying hookworm eggs in a stool sample using a microscope. Because eggs may be difficult to find in light infections, a concentration procedure is recommended.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 106, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Hookworm ?\\nAnswer: Anthelminthic medications (drugs that rid the body of parasitic worms), such as albendazole and mebendazole, are the drugs of choice for treatment of hookworm infections. Infections are generally treated for 1-3 days. The recommended medications are effective and appear to have few side effects. Iron supplements may also be prescribed if the infected person has anemia.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 107, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Hookworm ?\\nAnswer: The best way to avoid hookworm infection is not to walk barefoot in areas where hookworm is common and where there may be human fecal contamination of the soil. Also, avoid other skin contact with such soil and avoid ingesting it.\\n    \\nInfection can also be prevented by not defecating outdoors and by effective sewage disposal systems.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 108, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - American Trypanosomiasis (also known as Chagas Disease) ?\\nAnswer: Chagas disease is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors that are found only in the Americas (mainly, in rural areas of Latin America where poverty is widespread). Chagas disease (T. cruzi infection) is also referred to as American trypanosomiasis.\\nIt is estimated that as many as 8 million people in Mexico, Central America, and South America have Chagas disease, most of whom do not know they are infected. If untreated, infection is lifelong and can be life threatening.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 108, 'source_type': 'Remedies', 'priority': '1'}, page_content='The impact of Chagas disease is not limited to the rural areas in Latin America in which vectorborne transmission occurs. Large-scale population movements from rural to urban areas of Latin America and to other regions of the world have increased the geographic distribution and changed the epidemiology of Chagas disease. In the United States and in other regions where Chagas disease is now found but is not endemic, control strategies should focus on preventing transmission from blood transfusion, organ transplantation, and mother-to-baby (congenital transmission).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 109, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - American Trypanosomiasis (also known as Chagas Disease)? ?\\nAnswer: Chagas disease, or American trypanosomiasis, is caused by the parasite Trypanosoma cruzi. Infection is most commonly acquired through contact with the feces of an infected triatomine bug (or \"kissing bug\"), a blood-sucking insect that feeds on humans and animals.\\n    \\nInfection can also occur from:\\n    \\n     - mother-to-baby (congenital),\\n     - contaminated blood products (transfusions),\\n     - an organ transplanted from an infected donor,\\n     - laboratory accident, or\\n     - contaminated food or drink (rare)'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 109, 'source_type': 'Remedies', 'priority': '1'}, page_content='- contaminated blood products (transfusions),\\n     - an organ transplanted from an infected donor,\\n     - laboratory accident, or\\n     - contaminated food or drink (rare)\\n    \\n    \\nChagas disease is endemic throughout much of Mexico, Central America, and South America where an estimated 8 million people are infected. The triatomine bug thrives under poor housing conditions (for example, mud walls, thatched roofs), so in endemic countries, people living in rural areas are at greatest risk for acquiring infection. Public health efforts aimed at preventing transmission have decreased the number of newly infected people and completely halted vectorborne transmission in some areas. Infection acquired from blood products, organ transplantation, or congenital transmission continues to pose a threat.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 109, 'source_type': 'Remedies', 'priority': '1'}, page_content='By applying published seroprevalence figures to immigrant populations, CDC estimates that more than 300,000 persons with Trypanosoma cruzi infection live in the United States. Most people with Chagas disease in the United States acquired their infections in endemic countries. Although there are triatomine bugs in the U.S. , only rare vectorborne cases of Chagas disease have been documented.\\n    \\nMore on: Triatomine Bugs'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 110, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: exams and tests\\nQuestion: How to diagnose Parasites - American Trypanosomiasis (also known as Chagas Disease) ?\\nAnswer: The diagnosis of Chagas disease can be made by observation of the parasite in a blood smear by microscopic examination. A thick and thin blood smear are made and stained for visualization of parasites. However, a blood smear works well only in the acute phase of infection when parasites are seen circulating in blood.\\n    \\nDiagnosis of chronic Chagas disease is made after consideration of the patient's clinical findings, as well as by the likelihood of being infected, such as having lived in an endemic country. Diagnosis is generally made by testing with at least two different serologic tests.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 111, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - American Trypanosomiasis (also known as Chagas Disease) ?\\nAnswer: Treatment for Chagas disease is recommended for all people diagnosed with an acute infection, congenital infection, and for those with suppressed immune systems, and for all children with chronic infection. Adults with chronic infection may also benefit from treatment.\\n    \\nFor cardiac or gastrointestinal problems resulting from Chagas disease, symptomatic treatment may be helpful. Patients should consult with their primary health care provider. Some patients may be referred to a specialist, such as a cardiologist, gastroenterologist, or infectious disease specialist.\\n    \\nIn the U.S., medication for Chagas is available only through CDC. Your health care provider can talk with CDC staff about whether and how you should be treated.\\n    \\nMore on: Resources for Health Professionals: Antiparasitic Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 112, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - American Trypanosomiasis (also known as Chagas Disease) ?\\nAnswer: In endemic areas of Mexico, Central America, and South America improved housing and spraying insecticide inside housing to eliminate triatomine bugs has significantly decreased the spread of Chagas disease. Further, screening of blood donations for Chagas is another important public health tool in helping to prevent transfusion-acquired disease. Early detection and treatment of new cases, including mother-to-baby (congenital) cases, will also help reduce the burden of disease.\\n    \\nIn the United States and in other regions where Chagas disease is now found but is not endemic, control strategies are focused on preventing transmission from blood transfusion, organ transplantation, and mother-to-baby.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 113, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Nocardiosis? ?\\nAnswer: The bacteria that cause nocardiosis are commonly found in soil and water.\\n    \\nYou could become sick with nocardiosis if:\\n    \\n     - You inhale (breathe in) the bacteria\\n     - Bacteria gets into an open wound or cut\\n    \\n    \\nIn rare cases, infection can occur during surgical procedures.\\n    \\nFortunately, nocardiosis is not spread person to person, so being around someone who has the disease will not make you sick.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 114, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Nocardiosis? ?\\nAnswer: People with very weak immune (body defense) systems are at risk for getting nocardiosis. \\n    \\nSeveral diseases and circumstances can cause the immune system to be weak. These include:\\n    \\n     - Diabetes\\n     - Cancer\\n     - HIV/AIDS\\n     - Pulmonary alveolar proteinosis (an illness that causes the air sacs of the lungs to become plugged)\\n     - Connective tissue disorder (a disease that affects the tissue that connects and supports different parts of the body)\\n     - Alcoholism\\n     - Having a bone marrow or solid organ transplant\\n     - Taking high doses of drugs called corticosteroids\\n    \\n    \\nIn the United States, it has been estimated that 500-1,000 new cases of nocardiosis infection occur every year. Approximately 60% of nocardiosis cases are associated with pre-existing immune compromise.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 114, 'source_type': 'Remedies', 'priority': '1'}, page_content='In addition, men have a greater risk of getting the infection than women; for every female who gets sick with nocardiosis, there are about 3 males who get the disease.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 115, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Nocardiosis ?\\nAnswer: The symptoms of nocardiosis vary depending on which part of your body is affected.\\n    \\nNocardiosis infection most commonly occurs in the lung. If your lungs are infected, you can experience:\\n    \\n     - Fever\\n     - Weight loss\\n     - Night sweats\\n     - Cough\\n     - Chest pain\\n     - Pneumonia\\n    \\n    \\nWhen lung infections occur, the infection commonly spreads to the brain. If your central nervous system (brain and spinal cord) is infected, you can experience:\\n    \\n     - Headache\\n     - Weakness\\n     - Confusion\\n     - Seizures (sudden, abnormal electrical activity in the brain)\\n    \\n    \\nSkin infections can occur when open wounds or cuts come into contact with contaminated soil. If your skin is affected, you can experience:\\n    \\n     - Ulcers\\n     - Nodules sometimes draining and spreading along lymph nodes'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 116, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Nocardiosis ?\\nAnswer: If you think you might be sick with nocardiosis, talk to your doctor.\\n    \\nHe or she can help find out if you have the disease by performing tests that can identify the bacteria that causes nocardiosis.\\n    \\nTesting may involve taking tissue samples from the part of the body that is infected. Tissue samples may include the:\\n    \\n     - Brain\\n     - Skin\\n     - Lungs (or other parts of the lower airways)\\n     - Mucus from the lower airways'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 117, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Chapare Hemorrhagic Fever (CHHF)? ?\\nAnswer: Like all arenaviruses, Chapare virus has a rodent host as its reservoir. Humans can contract CHHF through contact with an infected rodent. Contact can be direct or through inhalation of aerosolized Chapare virus from the urine or feces of infected rodents. \\n \\nAlthough arenaviruses have been isolated from insects, neither they nor any other intermediary host appear to spread CHHF. \\n \\nPerson-to-person transmission of arenaviruses through aerosolization, although possible, is rare. From the only observed cluster of cases of CHHF, there was no evidence of person-to-person transmission. \\n \\nTransmission, if it can occur with CHHF, is most likely the result of direct contact with an infected person.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 118, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Chapare Hemorrhagic Fever (CHHF) ?\\nAnswer: The symptoms of CHHF, as reported in the only described patient, resemble those of other South American hemorrhagic fevers, such as Argentine HF or Bolivian HF. The incubation period is unknown, but for Argentine hemorrhagic fever (AHF) is 6 to 16 days. \\n   \\nThe CHHF clinical course included: \\n    \\n    - fever \\n    - headache \\n    - articulation and muscle pain \\n    - vomiting \\n    \\n   \\nThese symptoms were followed by deterioration with multiple hemorrhagic signs. The only described CHHF patient died 14 days after onset of symptoms. \\n   \\nSince Arenaviruses may enter the fetus through infection of the mother, and anecdotal evidence suggests that infected pregnant women may suffer miscarriages, it is reasonable to assume that both infection of the fetus and miscarriage may be associated with CHHF infection in the mother.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 119, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Chapare Hemorrhagic Fever (CHHF)? ?\\nAnswer: CHHF occurs in the Cochabamba region of Bolivia. \\nField workers \\n                \\nField workers are at greatest risk because of increased human contact with the reservoir rodent population. Sexual partners of field workers may be at greater risk as well. Laboratory infections have been frequently described with Arenaviruses and Chapare virus can certainly be transmitted to laboratory workers during manipulation of the virus especially during experimental infections of rodents.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 120, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Chapare Hemorrhagic Fever (CHHF) ?\\nAnswer: CHHF virus has been successfully isolated from both blood and serum during the acute febrile phase of illness. Although not undertaken at the time of the initial cluster, virus can certainly be isolated from tissue obtained post-mortem if available. A subsequent complete genomic analysis of Chapare virus facilitated the development of specific molecular detection (RT-PCR) assays. \\n   \\nSerologic diagnosis of CHHF can be made by indirect immunofluorescent assay and ELISA. However, individuals from endemic areas who show fever, dizziness, and myalgia, accompanied by laboratory findings of low white blood cell and platelet counts and excess protein in the urine, should be suspected of having one of the South American hemorrhagic fever viruses. Clinical specimens should be tested using specific assays.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 121, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Chapare Hemorrhagic Fever (CHHF) ?\\nAnswer: Supportive therapy is important in CHHF. This includes: \\n    \\n    - maintenance of hydration \\n    - management of shock \\n    - sedation \\n    - pain relief \\n    - usual precautions for patients with bleeding disorders \\n    - transfusions (when necessary) \\n    \\n   \\nUse of convalescent plasma therapy for treatment of AHF reduces mortality significantly and anecdotal evidence shows that the antiviral drug ribavirin may also hold promise for treating AHF. Ribavirin has also been considered for preventing development of disease in people exposed to other arenaviruses. \\n   Recovery \\n   \\nThe precise mortality of CHHF is unknown and the only described case was fatal.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 121, 'source_type': 'Remedies', 'priority': '1'}, page_content='Recovery \\n   \\nThe precise mortality of CHHF is unknown and the only described case was fatal. \\n   \\nPatients who have suffered from other arenaviruses may continue to excrete virus in urine or semen for weeks after recovery. For this reason, these fluids should be monitored for infectivity, since convalescent patients have the potential to infect others (particularly sexual partners) via these fluids.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 122, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Chapare Hemorrhagic Fever (CHHF) ?\\nAnswer: Although rodent control would be desirable, it will not be a successful strategy for preventing Chapare hemorrhagic fever cases caused by exposures outdoors. \\n   \\nAs for other hemorrhagic fevers, full barrier nursing procedures should be implemented during management of suspected or confirmed CHHF cases.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 123, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: what is yersiniosis for Yersinia ?\\nAnswer: Yersiniosis is an infectious disease caused by a bacterium of the genus Yersinia. In the United States, most human illness is caused by one species, Y. enterocolitica. Infection with Y. enterocolitica can cause a variety of symptoms depending on the age of the person infected. Infection with Y. enterocolitica occurs most often in young children. Common symptoms in children are fever, abdominal pain, and diarrhea, which is often bloody. Symptoms typically develop 4 to 7 days after exposure and may last 1 to 3 weeks or longer. In older children and adults, right-sided abdominal pain and fever may be the predominant symptoms, and may be confused with appendicitis. In a small proportion of cases, complications such as skin rash, joint pains, or spread of bacteria to the bloodstream can occur.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 124, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: frequency\\nQuestion: how common is infection with y. enterocolitica for Yersinia ?\\nAnswer: Y. enterocolitica is a relatively infrequent cause of diarrhea and abdominal pain. Based on data from the Foodborne Diseases Active Surveillance Network (FoodNet), which measures the burden and sources of specific diseases over time, approximately one culture-confirmed Y. enterocolitica infection per 100,000 persons occurs each year. Children are infected more often than adults, and the infection is more common in the winter.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 125, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: how can y. enterocolitica infections be diagnosed for Yersinia ?\\nAnswer: Y. enterocolitica infections are generally diagnosed by detecting the organism in the stools. Many laboratories do not routinely test for Y. enterocolitica,so it is important to notify laboratory personnel when infection with this bacterium is suspected so that special tests can be done. The organism can also be recovered from other sites, including the throat, lymph nodes, joint fluid, urine, bile, and blood.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 126, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: how can y. enterocolitica infections be treated for Yersinia ?\\nAnswer: Uncomplicated cases of diarrhea due to Y. enterocolitica usually resolve on their own without antibiotic treatment. However, in more severe or complicated infections, antibiotics such as aminoglycosides, doxycycline, trimethoprim-sulfamethoxazole, or fluoroquinolones may be useful.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 127, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: what are public health agencies doing to prevent or control yersiniosis for Yersinia ?\\nAnswer: The Centers for Disease Control and Prevention (CDC) monitors the frequency of Y. enterocolitica infections through the foodborne disease active surveillance network (FoodNet). In addition, CDC conducts investigations of outbreaks of yersiniosis to control them and to learn more about how to prevent these infections. CDC has collaborated in an educational campaign to increase public awareness about prevention of Y. enterocolitica infections. The U.S. Food and Drug Administration inspects imported foods and milk pasteurization plants and promotes better food preparation techniques in restaurants and food processing plants. The U.S. Department of Agriculture monitors the health of food animals and is responsible for the quality of slaughtered and processed meat. The U.S. Environmental Protection Agency regulates and monitors the safety of our drinking water supplies.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 128, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Lymphatic Filariasis ?\\nAnswer: Frequently Asked Questions (FAQs)\\n    \\n    Vector Information'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 129, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Lymphatic Filariasis? ?\\nAnswer: There are three different filarial species that can cause lymphatic filariasis in humans. Most of the infections worldwide are caused by Wuchereria bancrofti. In Asia, the disease can also be caused by Brugia malayi and Brugia timori.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 129, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"The infection spreads from person to person by mosquito bites. The adult worm lives in the human lymph vessels, mates, and produces millions of microscopic worms, also known as microfilariae. Microfilariae circulate in the person's blood and infect the mosquito when it bites a person who is infected. Microfilariae grow and develop in the mosquito. When the mosquito bites another person, the larval worms pass from the mosquito into the human skin, and travel to the lymph vessels. They grow into adult worms, a process that takes 6 months or more. An adult worm lives for about 5–7 years. The adult worms mate and release millions of microfilariae into the blood. People with microfilariae in their blood can serve as a source of infection to others.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 129, 'source_type': 'Remedies', 'priority': '1'}, page_content='A wide range of mosquitoes can transmit the parasite, depending on the geographic area. In Africa, the most common vector is Anopheles and in the Americas, it is Culex quinquefasciatus. Aedes and Mansonia can transmit the infection in the Pacific and in Asia.\\n    \\nMany mosquito bites over several months to years are needed to get lymphatic filariasis. People living for a long time in tropical or sub-tropical areas where the disease is common are at the greatest risk for infection. Short-term tourists have a very low risk.\\n    \\nPrograms to eliminate lymphatic filariasis are under way in more than 50 countries. These programs are reducing transmission of the filarial parasites and decreasing the risk of infection for people living in or visiting these communities.\\n    Geographic distribution'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 129, 'source_type': 'Remedies', 'priority': '1'}, page_content='Geographic distribution\\n    \\n     \\n    \\n    \\nLymphatic filariasis affects over 120 million people in 73 countries throughout the tropics and sub-tropics of Asia, Africa, the Western Pacific, and parts of the Caribbean and South America.\\n    \\nIn the Americas, only four countries are currently known to be endemic: Haiti, the Dominican Republic, Guyana and Brazil.\\n    \\nIn the United States, Charleston, South Carolina, was the last known place with lymphatic filariasis. The infection disappeared early in the 20th century. Currently, you cannot get infected in the U.S.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 130, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Lymphatic Filariasis ?\\nAnswer: The standard method for diagnosing active infection is the identification of microfilariae in a blood smear by microscopic examination. The microfilariae that cause lymphatic filariasis circulate in the blood at night (called nocturnal periodicity). Blood collection should be done at night to coincide with the appearance of the microfilariae, and a thick smear should be made and stained with Giemsa or hematoxylin and eosin. For increased sensitivity, concentration techniques can be used.\\n    \\nSerologic techniques provide an alternative to microscopic detection of microfilariae for the diagnosis of lymphatic filariasis. Patients with active filarial infection typically have elevated levels of antifilarial IgG4 in the blood and these can be detected using routine assays.\\n    \\nBecause lymphedema may develop many years after infection, lab tests are most likely to be negative with these patients.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 131, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Lymphatic Filariasis ?\\nAnswer: Patients currently infected with the parasite\\n    \\nDiethylcarbamazine (DEC) is the drug of choice in the United States. The drug kills the microfilaria and some of the adult worms. DEC has been used world-wide for more than 50 years. Because this infection is rare in the U.S., the drug is no longer approved by the Food and Drug Administration (FDA) and cannot be sold in the U.S. Physicians can obtain the medication from CDC after confirmed positive lab results. CDC gives the physicians the choice between 1 or 12-day treatment of DEC (6 mg/kg/day). One day treatment is generally as effective as the 12-day regimen. DEC is generally well tolerated. Side effects are in general limited and depend on the number of microfilariae in the blood. The most common side effects are dizziness, nausea, fever, headache, or pain in muscles or joints.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 131, 'source_type': 'Remedies', 'priority': '1'}, page_content='DEC should not be administered to patients who may also have onchocerciasis as  DEC can worsen onchocercal eye disease.  In patients with loiasis, DEC can cause serious adverse reactions, including encephalopathy and death. The risk and severity of the adverse reactions are related to Loa loa microfilarial density.\\nThe drug ivermectin kills only the microfilariae, but not the adult worm; the adult worm is responsible for the pathology of lymphedema and hydrocele.\\n    \\nSome studies have shown adult worm killing with treatment with doxycycline (200mg/day for 4–6 weeks).  \\n    Patients with clinical symptoms\\n    \\nLymphedema and elephantiasis are not indications for DEC treatment because most people with lymphedema are not actively infected with the filarial parasite.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 131, 'source_type': 'Remedies', 'priority': '1'}, page_content='Lymphedema and elephantiasis are not indications for DEC treatment because most people with lymphedema are not actively infected with the filarial parasite.\\n    \\nTo prevent the lymphedema from getting worse, patients should ask their physician for a referral to a lymphedema therapist so they can be informed about some basic principles of care such as hygiene, exercise and treatment of wounds.\\n    \\nPatients with hydrocele may have evidence of active infection, but typically do not improve clinically following treatment with DEC. The treatment for hydrocele is surgery.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 132, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Lymphatic Filariasis ?\\nAnswer: The best way to prevent lymphatic filariasis is to avoid mosquito bites. The mosquitoes that carry the microscopic worms usually bite between the hours of dusk and dawn. If you live in an area with lymphatic filariasis:\\n   \\n    - at night \\n     \\n      - sleep in an air-conditioned room or\\n      - sleep under a mosquito net\\n     \\n    - between dusk and dawn \\n     \\n      - wear long sleeves and trousers and\\n      - use mosquito repellent on exposed skin.\\n     \\n   \\n   \\nAnother approach to prevention includes giving entire communities medicine that kills the microscopic worms -- and controlling mosquitoes. Annual mass treatment reduces the level of microfilariae in the blood and thus, diminishes transmission of infection. This is the basis of the global campaign to eliminate lymphatic filariasis.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 132, 'source_type': 'Remedies', 'priority': '1'}, page_content='Experts consider that lymphatic filariasis, a neglected tropical disease (NTD), can be eradicated and a global campaign to eliminate lymphatic filariasis as a public health problem is under way. The elimination strategy is based on annual treatment of whole communities with combinations of drugs that kill the microfilariae. As a result of the generous contributions of these drugs by the companies that make them, tens of millions of people are being treated each year. Since these drugs also reduce levels of infection with intestinal worms, benefits of treatment extend beyond lymphatic filariasis. Successful campaigns to eliminate lymphatic filariasis have taken place in China and other countries.\\n   \\nMore on: Insect Bite Prevention'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 133, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Loiasis ?\\nAnswer: Loiasis is an infection caused by the parasitic worm Loa loa.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 134, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Loiasis? ?\\nAnswer: Loa loa parasites are found in West and Central Africa. Ten countries have areas where there are high rates of infection (i.e., where more than 40% of the people who live in that area report that they have had eye worm in the past). An estimated 14.4 million people live in these areas of high rates of infection. Another 15.2 live in areas where 20–40% of people report that they have had eye worm in the past.\\n    \\nMore on: Where Loa Loa is Prevelant [WHO Map]'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 134, 'source_type': 'Remedies', 'priority': '1'}, page_content='More on: Where Loa Loa is Prevelant [WHO Map]\\n    \\nThe people most at risk for loiasis are those who live in the certain rain forests in West and Central Africa. The deerflies that pass the parasite to humans usually bite during the day and are more common during the rainy season. They are attracted by the movement of people and by smoke from wood fires. Rubber plantations are areas where more deerflies may be found. The flies do not typically enter homes, but they might be attracted to homes that are well lit.\\n    \\nTravelers are more likely to become infected if they are in areas where they are bitten by deerflies for many months, though occasionally they get infected even if they are in an affected area for less than 30 days.\\n    \\nYour risk of infection depends on the number of bites received, the number of infected deerflies in the area you visit, and the length of your stay in the area.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 135, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Loiasis ?\\nAnswer: In people who have been bitten by the flies that carry Loa loa in areas where Loa loa is known to exist, the diagnosis can be made in the following ways:\\n  \\n   - Identification of the adult worm by a microbiologist or pathologist after its removal from under the skin or eye\\n   - Identification of an adult worm in the eye by a health care provider\\n   - Identification of the microfilariae on a blood smear made from blood taken from the patient between 10AM and 2PM\\n   - Identification of antibodies against L. loa on specialized blood test'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 135, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Identification of the microfilariae on a blood smear made from blood taken from the patient between 10AM and 2PM\\n   - Identification of antibodies against L. loa on specialized blood test\\n  \\n  \\nDiagnosis of loiasis can be difficult, especially in light infections where there are very few microfilariae in the blood. The specialized blood test is not widely available in the United States. A positive antibody blood test in someone with no symptoms means only that the person was infected sometime in his/her life. It does not mean that the person still has living parasites in his/her body.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 136, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Loiasis ?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 136, 'source_type': 'Remedies', 'priority': '1'}, page_content='Answer: Decisions about treatment of loiasis can be difficult and often require advice from an expert in infectious diseases or tropical medicine. Although surgical removal of adult worms moving under the skin or across the eye can be done to relieve anxiety, loiasis is not cured by surgery alone. There are two medications that can be used to treat the infection and manage the symptoms. The treatment of choice is diethylcarbamazine (DEC), which kills the microfilariae and adult worms. Albendazole is sometimes used in patients who are not cured with multiple DEC treatments. It is thought to kill adult worms. Certain people with heavy infections are at risk of brain inflammation when treated with DEC. This can cause coma or sometimes death. People with heavy infections need to be treated by experienced specialists.  Sometimes, other medical conditions need to be addressed first in order to make it safer to use DEC. Sometimes treatment is not recommended.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 136, 'source_type': 'Remedies', 'priority': '1'}, page_content='More on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 137, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: prevention\\nQuestion: How to prevent Parasites - Loiasis ?\\nAnswer: There are no programs to control or eliminate loiasis in affected areas. Your risk of infection may be less in areas where communities receive regular treatment for onchocerciasis or lymphatic filariasis.\\n    \\nThere are no vaccines that protect you from loiasis. If you are going to be in an area with loiasis for a long period of time, diethylcarbamazine (DEC)—300mg taken once a week—can reduce your risk of infection. Avoiding areas where the deerflies are found, such as muddy, shaded areas along rivers or around wood fires, may also reduce your risk of infection. You may reduce your risk of bites by using insect repellants that contain DEET (N,N-Diethyl-meta-toluamide) and wearing long sleeves and long pants during the day, which is when deerflies bite. Treating your clothes with permethrin may also help. For a description of CDC's information for preventing insect bites, see CDC's Yellow Book.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 137, 'source_type': 'Remedies', 'priority': '1'}, page_content='More on: Insect Bite Prevention'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 138, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Omsk Hemorrhagic Fever (OHF)? ?\\nAnswer: Humans can become infected through tick bites or through contact with the blood, feces, or urine of an infected, sick, or dead animal – most commonly, rodents. Occupational and recreational activities such as hunting or trapping may increase human risk of infection. \\n \\nTransmission may also occur with no direct tick or rodent exposure as OHFV appears to be extremely stable in different environments. It has been isolated from aquatic animals and water and there is even evidence that OHFV can be transmitted through the milk of infected goats or sheep to humans. \\n \\nNo human-to-human transmission of OHFV has been documented but infections due to lab contamination have been described.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 139, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Omsk Hemorrhagic Fever (OHF) ?\\nAnswer: After an incubation period of 3-8 days, the symptoms of OHF begin suddenly with chills, fever, headache, and severe muscle pain with vomiting, gastrointestinal symptoms and bleeding problems occurring 3-4 days after initial symptom onset. Patients may experience abnormally low blood pressure and low platelet, red blood cell, and white blood cell counts.  \\n                \\nAfter 1-2 weeks of symptoms, some patients recover without complication. However, the illness is biphasic for a subset of patients who experience a second wave of symptoms at the beginning of the third week. These symptoms include fever and encephalitis (inflammation of the brain). \\n                \\nThe case fatality rate of OHF is low (0.5% to 3%).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 140, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Omsk Hemorrhagic Fever (OHF)? ?\\nAnswer: In areas where rodent reservoirs and tick species are prevalent, people with recreational or occupational exposure to rural or outdoor settings (e.g., hunters, campers, forest workers, farmers) are potentially at increased risk for OHF by contact with infected ticks and animals. Furthermore, those in Siberia who hunt and trap muskrats specifically are at higher risk for OHF. \\n                \\nExposure may also occur in the laboratory environment.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 141, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Omsk Hemorrhagic Fever (OHF) ?\\nAnswer: OHF virus may be detected in blood samples by virus isolation in cell culture or using molecular techniques such as PCR. Blood samples can also be tested for antibody presence using enzyme-linked immunosorbent seologic assay (ELISA).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 142, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Omsk Hemorrhagic Fever (OHF) ?\\nAnswer: There is no specific treatment for OHF, but supportive therapy is important. Supportive therapy includes the maintenance of hydration and the usual precautions for patients with bleeding disorders. \\n                \\nThough rare, OHF can cause hearing loss, hair loss, and behavioral or psychological difficulties associated with neurological conditions and long term supportive case may be needed.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 143, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Omsk Hemorrhagic Fever (OHF) ?\\nAnswer: There is no vaccine currently available for OHF, but vaccines for tick-borne encephalitis disease (TBE) have been shown to confer some immunity and may be used for high-risk groups. \\n                \\nAdditionally, utilizing insect repellents and wearing protective clothing in areas where ticks are endemic is recommended.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 144, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Enterobiasis (also known as Pinworm Infection) ?\\nAnswer: A pinworm (\"threadworm\") is a small, thin, white roundworm (nematode) called Enterobius vermicularis that sometimes lives in the colon and rectum of humans. Pinworms are about the length of a staple. While an infected person sleeps, female pinworms leave the intestine through the anus and deposit their eggs on the surrounding skin.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 145, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Enterobiasis (also known as Pinworm Infection)? ?\\nAnswer: Risk Factors\\n    \\nThe people most likely to be infected with pinworm are children under 18, people who take care of infected children and people who are institutionalized. In these groups, the prevalence can reach 50%.\\n    \\nPinworm is the most common worm infection in the United States. Humans are the only species that can transfer this parasite. Household pets like dogs and cats cannot become infected with human pinworms. Pinworm eggs can survive in the indoor environment for 2 to 3 weeks.\\n    Epidemiology\\n    \\nPinworm infections are more common within families with school-aged children, in primary caregivers of infected children, and in institutionalized children.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 145, 'source_type': 'Remedies', 'priority': '1'}, page_content='Epidemiology\\n    \\nPinworm infections are more common within families with school-aged children, in primary caregivers of infected children, and in institutionalized children.\\n    \\nA person is infected with pinworms by ingesting pinworm eggs either directly or indirectly. These eggs are deposited around the anus by the worm and can be carried to common surfaces such as hands, toys, bedding, clothing, and toilet seats. By putting anyone’s contaminated hands (including one’s own) around the mouth area or putting one’s mouth on common contaminated surfaces, a person can ingest pinworm eggs and become infected with the pinworm parasite. Since pinworm eggs are so small, it is possible to ingest them while breathing.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 145, 'source_type': 'Remedies', 'priority': '1'}, page_content='Once someone has ingested pinworm eggs, there is an incubation period of 1 to 2 months or longer for the adult gravid female to mature in the small intestine. Once mature, the adult female worm migrates to the colon and lays eggs around the anus at night, when many of their hosts are asleep. People who are infected with pinworm can transfer the parasite to others for as long as there is a female pinworm depositing eggs on the perianal skin. A person can also re-infect themselves, or be re-infected by eggs from another person.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 146, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Enterobiasis (also known as Pinworm Infection) ?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 146, 'source_type': 'Remedies', 'priority': '1'}, page_content='Answer: A person infected with pinworm is often asymptomatic, but itching around the anus is a common symptom. Diagnosis of pinworm can be reached from three simple techniques. The first option is to look for the worms in the perianal reqion 2 to 3 hours after the infected person is asleep. The second option is to touch the perianal skin with transparent tape to collect possible pinworm eggs around the anus first thing in the morning. If a person is infected, the eggs on the tape will be visible under a microscope. The tape method should be conducted on 3 consecutive mornings right after the infected person wakes up and before he/she does any washing. Since anal itching is a common symptom of pinworm, the third option for diagnosis is analyzing samples from under fingernails under a microscope. An infected person who has scratched the anal area may have picked up some pinworm eggs under the nails that could be used for diagnosis.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 146, 'source_type': 'Remedies', 'priority': '1'}, page_content='Since pinworm eggs and worms are often sparse in stool, examining stool samples is not recommended. Serologic tests are not available for diagnosing pinworm infections.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 147, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Enterobiasis (also known as Pinworm Infection) ?\\nAnswer: The medications used for the treatment of pinworm are mebendazole, pyrantel pamoate, and albendazole. All three of these drugs are to be given in 1 dose at first and then another single dose 2 weeks later. Pyrantel pamoate is available without prescription. The medication does not reliably kill pinworm eggs. Therefore, the second dose is to prevent re-infection by adult worms that hatch from any eggs not killed by the first treatment.Health practitioners and parents should weigh the health risks and benefits of these drugs for patients under 2 years of age.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 147, 'source_type': 'Remedies', 'priority': '1'}, page_content='Repeated infections should be treated by the same method as the first infection. In households where more than one member is infected or where repeated, symptomatic infections occur, it is recommended that all household members be treated at the same time. In institutions, mass and simultaneous treatment, repeated in 2 weeks, can be effective.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 148, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Enterobiasis (also known as Pinworm Infection) ?\\nAnswer: Washing your hands with soap and warm water after using the toilet, changing diapers, and before handling food is the most successful way to prevent pinworm infection. In order to stop the spread of pinworm and possible re-infection, people who are infected should bathe every morning to help remove a large amount of the eggs on the skin. Showering is a better method than taking a bath, because showering avoids potentially contaminating the bath water with pinworm eggs. Infected people should not co-bathe with others during their time of infection.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 148, 'source_type': 'Remedies', 'priority': '1'}, page_content='Also, infected people should comply with good hygiene practices such as washing their hands with soap and warm water after using the toilet, changing diapers, and before handling food. They should also cut fingernails regularly, and avoid biting the nails and scratching around the anus. Frequent changing of underclothes and bed linens first thing in the morning is a great way to prevent possible transmission of eggs in the environment and risk of reinfection. These items should not be shaken and carefully placed into a washer and laundered in hot water followed by a hot dryer to kill any eggs that may be there.\\n    \\nIn institutions, day care centers, and schools, control of pinworm can be difficult, but mass drug administration during an outbreak can be successful. Teach children the importance of washing hands to prevent infection.\\n    \\nMore on: Handwashing'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 149, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: how is hps diagnosed and treated for Hantavirus ?\\nAnswer: Diagnosing HPS\\n  \\nDiagnosing HPS in an individual who has only been infected a few days is difficult, because early symptoms such as fever, muscle aches, and fatigue are easily confused with influenza. However, if the individual is experiencing fever and fatigue and has a history of potential rural rodent exposure, together with shortness of breath, would be strongly suggestive of HPS. If the individual is experiencing these symptoms they should see their physician immediately and mention their potential rodent exposure.\\n  Treating HPS'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 149, 'source_type': 'Remedies', 'priority': '1'}, page_content='Treating HPS\\n  \\n    \\n      \\n     \\n   \\n  \\n  \\nThere is no specific treatment, cure, or vaccine for hantavirus infection. However, we do know that if infected individuals are recognized early and receive medical care in an intensive care unit, they may do better. In intensive care, patients are intubated and given oxygen therapy to help them through the period of severe respiratory distress.\\n  \\nThe earlier the patient is brought in to intensive care, the better. If a patient is experiencing full distress, it is less likely the treatment will be effective.\\n  \\nTherefore, if you have been around rodents and have symptoms of fever, deep muscle aches, and severe shortness of breath, see your doctor immediately. Be sure to tell your doctor that you have been around rodents—this will alert your physician to look closely for any rodent-carried disease, such as HPS.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 150, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: what are the symptoms for Hantavirus ?\\nAnswer: Due to the small number of HPS cases, the \"incubation time\" is not positively known. However, on the basis of limited information, it appears that symptoms may develop between 1 and 5 weeks after exposure to fresh urine, droppings, or saliva of infected rodents.\\n  Early Symptoms\\n  \\n    \\n   \\nEarly symptoms include fatigue, fever and muscle aches, especially in the large muscle groups—thighs, hips, back, and sometimes shoulders. These symptoms are universal.\\n   \\nThere may also be headaches, dizziness, chills, and abdominal problems, such as nausea, vomiting, diarrhea, and abdominal pain. About half of all HPS patients experience these symptoms.\\n  \\n  Late Symptoms'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 150, 'source_type': 'Remedies', 'priority': '1'}, page_content='Late Symptoms\\n  \\n    \\n   \\nFour to 10 days after the initial phase of illness, the late symptoms of HPS appear. These include coughing and shortness of breath, with the sensation of, as one survivor put it, a \"...tight band around my chest and a pillow over my face\" as the lungs fill with fluid.\\n  \\n  Is the Disease Fatal?\\n  \\nYes. HPS can be fatal. It has a mortality rate of 38%.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 151, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: prevention\\nQuestion: how can hps be prevented for Hantavirus ?\\nAnswer: Eliminate or minimize contact with rodents in your home, workplace, or campsite. If rodents don't find that where you are is a good place for them to be, then you're less likely to come into contact with them. Seal up holes and gaps in your home or garage. Place traps in and around your home to decrease rodent infestation. Clean up any easy-to-get food.\\n  \\nRecent research results show that many people who became ill with HPS developed the disease after having been in frequent contact with rodents and/or their droppings around a home or a workplace. On the other hand, many people who became ill reported that they had not seen rodents or rodent droppings at all. Therefore, if you live in an area where the carrier rodents are known to live, try to keep your home, vacation place, workplace, or campsite clean.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 151, 'source_type': 'Remedies', 'priority': '1'}, page_content='For more information on how you can prevent rodent infestations, the following information is available on the CDC Rodents site:'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: what is the history of hps for Hantavirus ?\\nAnswer: The \"First\"Outbreak\\n  \\nIn May 1993, an outbreak of an unexplained pulmonary illness occurred in the southwestern United States, in an area shared by Arizona, New Mexico, Colorado and Utah known as \"The Four Corners\". A young, physically fit Navajo man suffering from shortness of breath was rushed to a hospital in New Mexico and died very rapidly.\\n   \\n  \\nWhile reviewing the results of the case, medical personnel discovered that the young man\\'s fiancée had died a few days before after showing similar symptoms, a piece of information that proved key to discovering the disease. As Dr. James Cheek of the Indian Health Service (IHS) noted, \"I think if it hadn\\'t been for that initial pair of people that became sick within a week of each other, we never would have discovered the illness at all\".'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='An investigation combing the entire Four Corners region was launched by the New Mexico Office of Medical Investigations (OMI) to find any other people who had a similar case history. Within a few hours, Dr. Bruce Tempest of IHS, working with OMI, had located five young, healthy people who had all died after acute respiratory failure.\\n  \\nA series of laboratory tests had failed to identify any of the deaths as caused by a known disease, such as bubonic plague. At this point, the CDC Special Pathogens Branch was notified. CDC, the state health departments of New Mexico, Colorado and Utah, the Indian Health Service, the Navajo Nation, and the University of New Mexico all joined together to confront the outbreak.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='During the next few weeks, as additional cases of the disease were reported in the Four Corners area, physicians and other scientific experts worked intensively to narrow down the list of possible causes. The particular mixture of symptoms and clinical findings pointed researchers away from possible causes, such as exposure to a herbicide or a new type of influenza, and toward some type of virus. Samples of tissue from patients who had gotten the disease were sent to CDC for exhaustive analysis. Virologists at CDC used several tests, including new methods to pinpoint virus genes at the molecular level, and were able to link the pulmonary syndrome with a virus, in particular a previously unknown type of hantavirus.\\n  Researchers Launch Investigations to Pin Down the Carrier of the New Virus'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='Researchers knew that all other known hantaviruses were transmitted to people by rodents, such as mice and rats. Therefore, an important part of their mission was to trap as many different species of rodents living in the Four Corners region as possible to find the particular type of rodent that carried the virus. From June through mid-August of 1993, all types of rodents were trapped inside and outside homes where people who had hantavirus pulmonary syndrome had lived, as well as in piñon groves and summer sheep camps where they had worked. Additional rodents were trapped for comparison in and around nearby households as well. Taking a calculated risk, researchers decided not to wear protective clothing or masks during the trapping process. \"We didn\\'t want to go in wearing respirators, scaring...everybody\", John Sarisky, an Indian Health Service environmental disease specialist said. However, when the almost 1,700 rodents trapped were dissected to prepare samples for analysis at CDC,'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='John Sarisky, an Indian Health Service environmental disease specialist said. However, when the almost 1,700 rodents trapped were dissected to prepare samples for analysis at CDC, protective clothing and respirators were worn.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Among rodents trapped, the deer mouse (Peromyscus maniculatus) was found to be the main host to a previously unknown type of hantavirus. Since the deer mouse often lives near people in rural and semi-rural areas—in barns and outbuildings, woodpiles, and inside people's homes—researchers suspected that the deer mouse might be transmitting the virus to humans. About 30% of the deer mice tested showed evidence of infection with hantavirus. Tests also showed that several other types of rodents were infected, although in lesser numbers.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='The next step was to pin down the connection between the infected deer mice and households where people who had gotten the disease lived. Therefore, investigators launched a case-control investigation. They compared \"case\" households, where people who had gotten the disease lived, with nearby \"control\" households. Control households were similar to those where the case-patients lived, except for one factor: no one in the control households had gotten the disease.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='The results? First, investigators trapped more rodents in case households than in control households, so more rodents may have been living in close contact with people in case households. Second, people in case households were more likely than those in control households to do cleaning around the house or to plant in or hand-plow soil outdoors in fields or gardens. However, it was unclear if the risk for contracting HPS was due to performing these tasks, or with entering closed-up rooms or closets to get tools needed for these tasks.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='In November 1993, the specific hantavirus that caused the Four Corners outbreak was isolated. The Special Pathogens Branch at CDC used tissue from a deer mouse that had been trapped near the New Mexico home of a person who had gotten the disease and grew the virus from it in the laboratory. Shortly afterwards and independently, the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) also grew the virus, from a person in New Mexico who had gotten the disease as well as from a mouse trapped in California.\\n   \\n  \\nThe new virus was called Muerto Canyon virus — later changed to Sin Nombre virus (SNV) — and the new disease caused by the virus was named hantavirus pulmonary syndrome, or HPS.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='The new virus was called Muerto Canyon virus — later changed to Sin Nombre virus (SNV) — and the new disease caused by the virus was named hantavirus pulmonary syndrome, or HPS.\\n  \\nThe isolation of the virus in a matter of months was remarkable. This success was based on close cooperation of all the agencies and individuals involved in investigating the outbreak, years of basic research on other hantaviruses that had been conducted at CDC and USAMRIID, and on the continuing development of modern molecular virologic tests. To put the rapid isolation of the Sin Nombre virus in perspective, it took several decades for the first hantavirus discovered, the Hantaan virus, to be isolated.\\n  \\n                \\n  HPS Not Really a New Disease'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='HPS Not Really a New Disease\\n  \\nAs part of the effort to locate the source of the virus, researchers located and examined stored samples of lung tissue from people who had died of unexplained lung disease. Some of these samples showed evidence of previous infection with Sin Nombre virus—indicating that the disease had existed before the \"first\" known outbreak—it simply had not been recognized!\\n  \\nOther early cases of HPS have been discovered by examining samples of tissue belonging to people who had died of unexplained adult respiratory distress syndrome. By this method, the earliest known case of HPS that has been confirmed has been the case of a 38-year-old Utah man in 1959.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='Interestingly, while HPS was not known to the epidemiologic and medical communities, there is evidence that it was recognized elsewhere. The Navajo Indians, a number of whom contracted HPS during the 1993 outbreak, recognize a similar disease in their medical traditions, and actually associate its occurrence with mice. As strikingly, Navajo medical beliefs concur with public health recommendations for preventing the disease.\\n  \\n                \\n  Why Did the Outbreak Occur in the Four Corners Area?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Why Did the Outbreak Occur in the Four Corners Area?\\n  \\nBut why this sudden cluster of cases? The key answer to this question is that, during this period, there were suddenly many more mice than usual. The Four Corners area had been in a drought for several years. Then, in early 1993, heavy snows and rainfall helped drought-stricken plants and animals to revive and grow in larger-than-usual numbers. The area's deer mice had plenty to eat, and as a result they reproduced so rapidly that there were ten times more mice in May 1993 than there had been in May of 1992. With so many mice, it was more likely that mice and humans would come into contact with one another, and thus more likely that the hantavirus carried by the mice would be transmitted to humans.\\n  \\n                \\n  Person-to-Person Spread of HPS Decided Unlikely\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='Person-to-Person Spread of HPS Decided Unlikely\\n  \\n\"Although person-to-person spread [of HPS] has not been documented with any of the other known hantaviruses, we were concerned [during this outbreak] because we were dealing with a new agent\", said Charles Vitek, a CDC medical investigator.\\n  \\nResearchers and clinicians investigating the ongoing outbreak were not the only groups concerned about the disease. Shortly after the first few HPS patients died and it became clear that a new disease was affecting people in the area, and that no one knew how it was transmitted, the news media began extensive reporting on the outbreak. Widespread concern among the public ensued.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Unfortunately, the first victims of the outbreak were Navajo. News reports focused on this fact, and the misperception grew that the unknown disease was somehow linked to Navajos. As a consequence, Navajos found themselves at the center of intense media attention and the objects of the some people's fears.\\n  \\nBy later in the summer of 1993, the media frenzy had quieted somewhat, and the source of the disease was pinpointed. Researchers determined that, like other hantaviruses, the virus that causes HPS is not transmitted from person to person the way other infections, such as the common cold, may be. The exception to this is an outbreak of HPS in Argentina in 1996. Evidence from this outbreak suggests that strains of hantaviruses in South America may be transmissable from person to person.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='To date, no cases of HPS have been reported in the United States in which the virus was transmitted from one person to another. In fact, in a study of health care workers who were exposed to either patients or specimens infected with related types of hantaviruses (which cause a different disease in humans), none of the workers showed evidence of infection or illness.\\n  \\n                \\n  HPS Since the First Outbreak\\n  \\nAfter the initial outbreak, the medical community nationwide was asked to report any cases of illness with symptoms similar to those of HPS that could not be explained by any other cause. As a result, additional cases have been reported.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Since 1993, researchers have discovered that there is not just one hantavirus that causes HPS, but several. In June 1993, a Louisiana bridge inspector who had not traveled to the Four Corners area developed HPS. An investigation was begun. The patient's tissues were tested for the presence of antibodies to hantavirus. The results led to the discovery of another hantavirus, named Bayou virus, which was linked to a carrier, the rice rat (Oryzomys palustris). In late 1993, a 33-year-old Florida man came down with HPS symptoms; he later recovered. This person also had not traveled to the Four Corners area. A similar investigation revealed yet another hantavirus, named the Black Creek Canal virus, and its carrier, the cotton rat (Sigmodon hispidus). Another case occurred in New York. This time, the Sin Nombre-like virus was named New York-1, and the white-footed mouse (Peromyscus leucopus), was implicated as the carrier.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 152, 'source_type': 'Remedies', 'priority': '1'}, page_content='More recently, cases of HPS stemming from related hantaviruses have been documented in Argentina, Brazil, Canada, Chile, Paraguay, and Uruguay, making HPS a pan-hemispheric disease.\\n  \\n                \\n  References\\n  \\nInformation for this page was developed using the CDC video Preventing Hantavirus Disease and resource articles listed in the bibliography.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Q Fever ?\\nAnswer: Q fever can cause acute or chronic illness in humans, who usually acquire infection after contact with infected animals or exposure to contaminated environments. The acute symptoms caused by infection with Coxiella burnetii usually develop within 2-3 weeks of exposure, although as many as half of humans infected withC. burnetii do not show symptoms. \\n \\nThe following is a list of symptoms commonly seen with acute Q fever. However, it is important to note that the combination of symptoms varies greatly from person to person. \\n  \\n  - high fevers (up to 104-105°F)  \\n  - severe headache  \\n  - general malaise  \\n  - myalgia  \\n  - chills and/or sweats  \\n  - non-productive cough  \\n  - nausea  \\n  - vomiting  \\n  - diarrhea  \\n  - abdominal pain  \\n  - chest pain'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='- severe headache  \\n  - general malaise  \\n  - myalgia  \\n  - chills and/or sweats  \\n  - non-productive cough  \\n  - nausea  \\n  - vomiting  \\n  - diarrhea  \\n  - abdominal pain  \\n  - chest pain  \\n  \\n \\nAlthough most persons with acute Q fever infection recover, others may experience serious illness with complications that may include pneumonia, granulomatous hepatitis (inflammation of the liver), myocarditis (inflammation of the heart tissue) and central nervous system complications. Pregnant women who are infected may be at risk for pre-term delivery or miscarriage. The estimated case fatality rate (i.e. the proportion of persons who die as a result of their infection) is low,  at < 2% of hospitalized patients. Treatment with the correct antibiotic may shorten the course of illness for acute Q fever.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='Chronic Q fever is a severe disease occurring in <5% of acutely infected patients. It may present soon (within 6 weeks) after an acute infection, or may manifest years later.  The three groups at highest risk for chronic Q fever are pregnant women, immunosuppressed persons and patients with a pre-existing heart valve defects. Endocarditis is the major form of chronic disease, comprising 60-70% of all reported cases. The estimated case fatality rate in untreated patients with endocarditis is 25-60%. Patients with endocarditis require early diagnosis and long-term antibiotic treatment (at least 18 months) for a successful outcome.   Other forms of chronic Q fever include aortic aneurysms and infections of the bone, liver or reproductive organs, such as the testes in males.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='Coxiella burnetii has the ability to persist for long periods of time in the host after infection. Although the majority of people with acute Q fever recover completely, a post-Q fever fatigue syndrome has been reported to occur in 10-25% of some acute patients. This syndrome is characterized by constant or recurring fatigue, night sweats, severe headaches, photophobia (eye sensitivity to light), pain in muscles and joints, mood changes, and difficulty sleeping.  \\n \\n \\n Physician Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='There are several aspects of Q fever that make it challenging for healthcare providers to diagnose and treat.  The symptoms vary from patient to patient and can be difficult to distinguish from other diseases.  Treatment is more likely to be effective if started in the first three days of symptoms. Diagnostic tests based on the detection of antibodies will frequently appear negative in the first 7-10 days of illness.  For this reason, healthcare providers must use their judgment to treat patients based on clinical suspicion alone. Healthcare providers may find important information in the patient’s history and physical examination that may aid clinical diagnosis. Information such as recent travel to rural or agricultural communities where infected livestock may be present, or employment in high risk occupations such as veterinarians or farmers can be helpful in making the diagnosis.  Chronic Q fever is a risk for anyone with a history of acute Q fever illness, particularly those'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='in high risk occupations such as veterinarians or farmers can be helpful in making the diagnosis.  Chronic Q fever is a risk for anyone with a history of acute Q fever illness, particularly those persons with valvular disease, blood vessel abnormalities, immunosuppressed persons, and women who were pregnant when they became infected.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='The healthcare provider should also look at routine blood tests, such as a complete blood cell count or a chemistry panel. Clues such as a prolonged fever with low platelet count, normal leukocyte count, and elevated liver enzymes are suggestive of acute Q fever infection, but may not be present in all patients.  After a suspect diagnosis is made based on clinical suspicion and treatment has begun, specialized laboratory testing should be used to confirm the diagnosis of Q fever. \\n \\nSuspect diagnosis of Q fever is made based on signs and symptoms and a high index of clinical suspicion.  Diagnosis can later be confirmed using specialized confirmatory laboratory tests. Treatment should never be delayed pending the receipt of laboratory test results, or be withheld on the basis of an initial negative laboratory result. \\n \\n  \\n \\n \\n Laboratory Confirmation'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='Laboratory Confirmation \\n \\nDuring the acute phase of illness, a sample of whole blood can be tested by polymerase chain reaction (PCR) assay to determine if a patient has Q fever. This method is most sensitive in the first week of illness, and rapidly decreases in sensitivity following the administration of appropriate antibiotics. PCR or immunohistochemistry of biopsy specimens has also been used to diagnose Q fever. These tests may be appropriate for endocarditis patients undergoing valve replacement surgery or patients with hepatitis. Although a positive PCR result is helpful, a negative result does not rule out the diagnosis, and treatment should not be withheld due to a negative result. Culture isolation of C. burnetii is only available at specialized laboratories; routine hospital blood cultures cannot detect the organism.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='When a person develops Q fever, their immune system produces antibodies to C. burnetii, with detectable antibody titers usually observed by 7-10 days after illness onset.  It is important to note that a negative test during the first week of illness does not rule out Q fever as a cause of illness. There are two distinct antigenic phases to which humans develop antibody responses. In acute infection, an antibody response to C. burnetii Phase II antigen is predominant and is higher than Phase I antibody response; the reverse is true in chronic infection which is associated with a rising Phase I IgG titer (according to current U.S. case definitions >1:800) that is often much higher than Phase II IgG.  The gold standard serologic test for diagnosis of acute Q fever is the indirect immunofluorescence assay (IFA) using C. burnetii antigen, performed on paired serum samples to demonstrate a significant (four-fold) rise in antibody titers. The first sample should be taken as early in the'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='assay (IFA) using C. burnetii antigen, performed on paired serum samples to demonstrate a significant (four-fold) rise in antibody titers. The first sample should be taken as early in the disease as possible, preferably in the first week of symptoms, and the second sample should be taken 2 to 4 weeks later. In most cases of Q fever, the first IgG IFA titer is typically low, or “negative,” and the second typically shows a significant (four-fold) increase in IgG antibody levels. IgM antibodies usually rise at the same time as IgG near the end of the first week of illness and remain elevated for months or longer.  Also, IgM antibodies are less specific than IgG antibodies and more likely to result in a false positive.  For these reasons, physicians should request both Phase I and Phase II IgG and IgM serologic titers for diagnostic confirmation of acute and chronic Q fever.  Antibodies to C. burnetii may remain elevated for months or longer after the disease has resolved, or may be'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='II IgG and IgM serologic titers for diagnostic confirmation of acute and chronic Q fever.  Antibodies to C. burnetii may remain elevated for months or longer after the disease has resolved, or may be detected in persons who were previously exposed to antigenically related organisms.  Approximately 3% of currently healthy people in the U.S. general population and up to 20% of people in high-risk professions (veterinarians, ranchers, etc.) have elevated antibody titers due to past exposure to C. burnetii. Therefore, if only one sample is tested it can be difficult to interpret the findings.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='Paired samples taken 2-3 weeks apart demonstrating a significant (four-fold) rise in antibody titer provides the best evidence for a correct diagnosis of acute Q fever. Diagnosis of chronic Q fever is confirmed by elevated Phase I IgG antibody (according to current U.S. case definitions >1:800 and higher than Phase II IgG) and an identifiable persistent focus of infection (e.g. endocarditis).  Elevated Phase I titers alone do not confirm a chronic Q fever diagnosis and would not warrant treatment in a clinically normal patient. Because chronic Q fever involves lengthy persistence of the organism in the body, the antibody levels are often quite high and you will not see a rising titer between paired serum specimens. \\n \\nFor more in-depth information about the diagnosis of Q fever, please visit http://www.bt.cdc.gov/agent/qfever/clinicians/diagnosis.asp \\n \\n \\n Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='For more in-depth information about the diagnosis of Q fever, please visit http://www.bt.cdc.gov/agent/qfever/clinicians/diagnosis.asp \\n \\n \\n Treatment \\n \\nDoxycycline is the first line treatment for all adults, and for children with severe illness. Treatment should be initiated immediately whenever Q fever is suspected. \\n \\nUse of antibiotics other than doxycycline or other tetracyclines is associated with a higher risk of severe illness. Doxycycline is most effective at preventing severe complications from developing if it is started early in the course of disease. Therefore, treatment must be based on clinical suspicion alone and should always begin before laboratory results return.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='If the patient is treated within the first 3 days of the disease, fever generally subsides within 72 hours.  In fact, failure to respond to doxycycline suggests that the patient’s condition might not be due to Q fever. Severely ill patients may require longer periods before their fever resolves. Resistance to doxcycline has not been documented.  \\n \\nThere is no role for prophylactic antimicrobial agents in preventing Q fever after a known exposure and prior to symptom onset; attempts at prophylaxis will likely extend the incubation period by several days but will not prevent infection from occurring.  \\n \\nRecommended Dosage for Acute Q fever\\n Doxycycline is the first line treatment for children with severe illness of all ages and adults: \\n  \\n  - Adults: 100 mg every 12 hours  \\n  - Children under 45 kg (100 lbs): 2.2 mg/kg body weight given twice a day'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Adults: 100 mg every 12 hours  \\n  - Children under 45 kg (100 lbs): 2.2 mg/kg body weight given twice a day  \\n  \\n \\nPatients should be treated for at least 3 days after the fever subsides and until there is evidence of clinical improvement. Standard duration of treatment is 2-3 weeks.  \\n \\nRecommended Dosage for Chronic Q fever \\n  \\n  - Adults: Doxycycline 100 mg every 12 hours and hydroxychloroquine 200 mg every 8 hours. \\n  \\n \\nStandard duration of treatment is 18 months. \\n \\n \\n Treating children'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Adults: Doxycycline 100 mg every 12 hours and hydroxychloroquine 200 mg every 8 hours. \\n  \\n \\nStandard duration of treatment is 18 months. \\n \\n \\n Treating children \\n \\nThe use of doxycycline is recommended to treat Q fever in children of all ages who are hospitalized or are severely ill. Unlike older generations of tetracyclines, doxycycline has not been shown to cause staining of permanent teeth, and most experts consider the benefit of doxycycline in treating Q fever in children younger than 8 years of age with severe illness or who are hospitalized greater than the potential risk of dental staining.  Children with mild illness who are less than 8 years of age may be treated with co-trimoxazole, but therapy should be switched to doxycycline if their course of illness worsens. \\n \\n \\n Other Treatments'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 153, 'source_type': 'Remedies', 'priority': '1'}, page_content='Other Treatments \\n \\nIn cases of life threatening allergies to doxycycline and in pregnant patients, physicians may need to consider alternate antibiotics. Treatment of pregnant women diagnosed with acute Q fever with once daily co-trimoxazole throughout pregnancy has been shown to significantly decrease the risk of adverse consequences for the fetus.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 154, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Q Fever ?\\nAnswer: More detailed information on the diagnosis, management, and treatment of Q fever is available in other sections of this web site and in the materials referenced in the section titled “Further Reading”.  \\n How to Contact the Rickettsial Zoonoses Branch at CDC \\n \\nThe general public and healthcare providers should first call 1-800-CDC-INFO (1-800-232-4636) for questions regarding Q fever. If a consultation with a CDC scientist specializing in Q fever is advised, your call will be appropriately forwarded. \\n Case Definitions \\n \\nAs of January 1, 2009, Q fever infections are reported under distinct reporting categories described in the 2009 Q fever surveillance case definition.\\n2009 Q Fever Case Definition \\n Case Report Forms'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 154, 'source_type': 'Remedies', 'priority': '1'}, page_content='2009 Q Fever Case Definition \\n Case Report Forms \\n \\nFor confirmed and probable cases of Q fever that have been identified and reported through the National Notifiable Disease Surveillance System, states are also encouraged to submit additional information using the CDC Case Report Form (CRF). This form collects additional important information that routine electronic reporting does not, such as information on how the diagnosis was made, and whether the patient was hospitalized or died. If a different state-specific form is already used to collect this information, this information may be submitted to CDC in lieu of a CRF. \\n   \\n   \\n    \\n   \\n  \\n How to Submit Specimens to CDC for Q FeverTesting \\n \\nPrivate citizens may not directly submit specimens to CDC for testing. If you feel that diagnostic testing is necessary, consult your healthcare provider or state health department. Laboratory testing is available at many commercial laboratories. \\n State Health Departments'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 154, 'source_type': 'Remedies', 'priority': '1'}, page_content='State Health Departments \\n \\nSpecimens may be submitted to CDC for reference testing for Q fever. To coordinate specimen submission, please call 404-639-1075 during business hours (8:00 - 4:30 ET).  \\n U.S. Healthcare Providers \\n \\nQ fever laboratory testing is available at many commercial laboratories. U.S. healthcare providers should not submit specimens for testing directly to CDC. CDC policy requires that specimens for testing be submitted through or with the approval of the state health department. Please contact your state health department and request assistance with specimen submission and reporting of infection. For general questions about Q fever, please call 1-800-CDC-INFO (1-800-232-4636). If you have questions about a suspect Q fever case, please first consult your state health department. Healthcare providers requiring an epidemiologic or laboratory consultation on Q fever may also call 404-639-1075 during business hours (8:00 - 4:30 ET). Or 770-488-7100 after hours.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 154, 'source_type': 'Remedies', 'priority': '1'}, page_content='Non-U.S. Healthcare Providers \\n \\nNon-U.S. healthcare providers should consult CDC prior to submitting specimens for testing. For general questions about Q fever, please call 1-800-CDC-INFO (1-800-232-4636). If you would like to discuss a suspect Q fever case with CDC, please call 404-639-1075 during business hours (8:00 - 4:30 ET), or 770-488-7100 after hours.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 155, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Q Fever ?\\nAnswer: In the United States, Q fever outbreaks have resulted mainly from occupational exposure involving veterinarians, meat processing plant workers, sheep and dairy workers, livestock farmers, and researchers at facilities housing sheep. Prevention and control efforts should be directed primarily toward these groups and environments. \\n \\nThe following measures should be used in the prevention and control of Q fever: \\n  \\n  - Educate the public on sources of infection.  \\n  - Appropriately dispose of placenta, birth products, fetal membranes, and aborted fetuses at facilities housing sheep and goats.  \\n  - Restrict access to barns and laboratories used in housing potentially infected animals.   \\n  - Use appropriate procedures for bagging, autoclaving, and washing of laboratory clothing.  \\n  - Vaccinate (where possible) individuals engaged in research with pregnant sheep or live C. burnetii.  \\n  - Quarantine imported animals.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 155, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Vaccinate (where possible) individuals engaged in research with pregnant sheep or live C. burnetii.  \\n  - Quarantine imported animals.  \\n  - Ensure that holding facilities for sheep should be located away from populated areas. Animals should be routinely tested for antibodies to C. burnetii, and measures should be implemented to prevent airflow to other occupied areas.  \\n  - Counsel persons at highest risk for developing chronic Q fever, especially persons with pre-existing cardiac valvular disease or individuals with vascular grafts.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 155, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Counsel persons at highest risk for developing chronic Q fever, especially persons with pre-existing cardiac valvular disease or individuals with vascular grafts.  \\n  \\n \\nA vaccine for Q fever has been developed and has successfully protected humans in occupational settings in Australia. However, this vaccine is not commercially available in the United States. Persons wishing to be vaccinated should first have a skin test to determine a history of previous exposure. Individuals who have previously been exposed to C. burnetii should not receive the vaccine because severe reactions, localized to the area of the injected vaccine, may occur. A vaccine for use in animals has also been developed, but it is not available in the United States. \\n Significance for Bioterrorism'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 155, 'source_type': 'Remedies', 'priority': '1'}, page_content='Significance for Bioterrorism \\n \\nCoxiella burnetii is a highly infectious agent that is rather resistant to heat and drying. It can become airborne and inhaled by humans. A single C. burnetii organism may cause disease in a susceptible person. This agent has a past history of being developed for use in biological warfare and is considered a potential terrorist threat.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 156, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Hendra Virus Disease (HeV)? ?\\nAnswer: Transmission of Hendra virus to humans can occur after exposure to body fluids and tissues or excretions of horses infected with Hendra virus. \\n \\nHorses may be infected after exposure to virus in the urine of infected flying foxes. \\n \\nTo date, no human-to-human transmission has been documented.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 157, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Hendra Virus Disease (HeV) ?\\nAnswer: After an incubation of 9-16 days, infection with Hendra virus can lead to respiratory illness with severe flu-like signs and symptoms. In some cases, illness may progress to encephalitis. \\n                \\nAlthough infection with Hendra virus is rare, the case fatality is high: 4/7 (57%).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 158, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Hendra Virus Disease (HeV)? ?\\nAnswer: Australia’s “Flying fox” bats (genus Pteropus) are the natural reservoir of Hendra virus. Serologic evidence for HeV infection have been found in all fours species of Australian flying foxes, but spillover of the virus in horses is limited to coastal and forested regions in Australia (Queensland and New South Wales states)  (see Henipavirus Distribution Map). \\n                \\nPeople at highest risk are those living within the distribution of the flying foxes and with occupational or recreational exposure to horses that have had potential contact with flying foxes in Australia.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 159, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Hendra Virus Disease (HeV) ?\\nAnswer: Laboratory tests that are used to diagnose Hendra virus (HV) and Nipah virus (NV) include detection of antibody by ELISA (IgG and IgM), real time polymerase chain reaction (RT-PCR), and virus isolation attempts.  In most countries, handling Hendra virus needs to be done in high containment laboratories. Laboratory diagnosis of a patient with a clinical history of HV or NV can be made during the acute and convalescent phase of the disease by using a combination of tests including detection of antibody in the serum or the cerebrospinal fluid (CSF), viral RNA detection (RT-PCR) in the serum, CSF, or throat swabs, and virus isolation from the CSF or throat swabs.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 160, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Hendra Virus Disease (HeV) ?\\nAnswer: The drug ribavirin has been shown to be effective against the viruses in vitro, but the clinical usefulness of this drug is uncertain. \\n                \\nA post-exposure therapy with a Nipah/Hendra neutralizing antibody, efficacious in animal models is in human preclinical development stages in Australia.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 161, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Hendra Virus Disease (HeV) ?\\nAnswer: The occurrence of the disease in humans has been associated only with infection of an intermediate species such as horses.  Early recognition of the disease in the intermediate animal host is probably the most crucial means of limiting future human cases.  \\n                \\nHendra virus infection can be prevented by avoiding horses that are ill or may be infected with HeV and using appropriate personal protective equipment when contact is necessary, as in veterinary procedures. \\n                \\nA commercial vaccine has been recently licensed in Australia for horses and could be beneficial for other animal species and eventually humans.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 162, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Zoonotic Hookworm ?\\nAnswer: There are many different species of hookworms, some are human parasites and some are animal parasites. People can be infected by larvae of animal hookworms, usually dog and cat hookworms. The most common result of animal hookworm infection is a skin condition called cutaneous larva migrans.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 163, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Zoonotic Hookworm? ?\\nAnswer: Dog and cat hookworms are found throughout the world, especially in warmer climates. In the United States, zoonotic hookworms are found everywhere but more commonly along the East Coast than the West Coast. Worldwide, zoonotic hookworms are found in tropical and subtropical regions where the parasite is better able to survive because of environmental conditions. However, there is one type of dog and cat hookworm that is more commonly found in cooler climates.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 163, 'source_type': 'Remedies', 'priority': '1'}, page_content='The global burden of zoonotic hookworm in dogs and cats is not known; also, the amount of disease in people caused by these parasites is also unknown. Cutaneous larva migrans (CLM) is most often reported by returning travelers to tropical regions who have had soil and/or sand exposures in places where dogs and cats are likely to have hookworms. However, CLM is likely causing significant problems for the people who live in less developed parts of the world, even though the disease is not reported regularly. In less developed areas of the world, dogs and cats are often free-ranging and have high rates of infection with hookworm which leads to widespread contamination of sand and soil. In a survey of a rural population in Brazil, the prevalence of CLM during the rainy season was 14.9% among children less than 5 years old and 0.7% among adults aged 20 years and older.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 164, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Zoonotic Hookworm ?\\nAnswer: Cutaneous larva migrans (CLM) is a clinical diagnosis based on the presence of the characteristic signs and symptoms, and exposure history to zoonotic hookworm. For example, the diagnosis can be made based on finding red, raised tracks in the skin that are very itchy. This is usually found on the feet or lower part of the legs on persons who have recently traveled to tropical areas and spent time at the beach. There is no blood test for zoonotic hookworm infection. Persons who think they have CLM should consult their health care provider for accurate diagnosis.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 165, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Zoonotic Hookworm ?\\nAnswer: The zoonotic hookworm larvae that cause cutaneous larva migrans (CLM) usually do not survive more than 5 – 6 weeks in the human host. In most patients with CLM, the signs and symptoms resolve without medical treatment. However, treatment may help control symptoms and help prevent secondary bacterial infections. Antiparasitic treatments may be prescribed by your health care provider.\\n    \\nMore on: Resources For Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 166, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Zoonotic Hookworm ?\\nAnswer: Wearing shoes and taking other protective measures to avoid skin contact with sand or soil will prevent infection with zoonotic hookworms. Travelers to tropical and subtropical climates, especially where beach exposures are likely, should be advised to wear shoes and use protective mats or other coverings to prevent direct skin contact with sand or soil. Routine veterinary care of dogs and cats, including regular deworming, will reduce environmental contamination with zoonotic hookworm eggs and larvae. Prompt disposal of animal feces prevents eggs from hatching and contaminating soil -- which makes it important for control of this parasitic infection.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 167, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Chronic Fatigue Syndrome (CFS) ?\\nAnswer: Chronic fatigue syndrome, or CFS, is a devastating and complex disorder. People with CFS have overwhelming fatigue and a host of other symptoms that are not improved by bed rest and that can get worse after physical activity or mental exertion. They often function at a substantially lower level of activity than they were capable of before they became ill.\\n  \\nBesides severe fatigue, other symptoms include muscle pain, impaired memory or mental concentration, insomnia, and post-exertion malaise lasting more than 24 hours. In some cases, CFS can persist for years.\\n  \\nResearchers have not yet identified what causes CFS, and there are no tests to diagnose CFS. Moreover, because many illnesses have fatigue as a symptom, doctors need to take care to rule out other conditions, which may be treatable.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 168, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: causes\\nQuestion: What causes Chronic Fatigue Syndrome (CFS) ?\\nAnswer: Despite a vigorous search, scientists have not yet identified what causes CFS. While a single cause for CFS may yet be identified, another possibility is that CFS has multiple causes. Conditions that have been studied to determine if they cause or trigger the development of CFS include infections, immune disorders, stress, trauma, and toxins.\\n  Infection\\n  \\nVarious types of infections have been studied to determine if they might cause or trigger CFS:\\n  \\n   - Candida albicans, a fungus that causes yeast infections\\n   - Mycoplasma, a cause of atypical pneumonia\\n   - Ross River virus, which causes Ross River Fever, a mosquito-borne tropical disease\\n  \\n  Could One Type of Infection Lead to CFS?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 168, 'source_type': 'Remedies', 'priority': '1'}, page_content='Could One Type of Infection Lead to CFS?\\n  \\nResearchers from around the world have studied if a single type of infection might be the cause of CFS, analyzed the data, and not yet found any association between CFS and infection. Researchers are still analyzing samples from CFS patients using the latest molecular methods to search for previously unknown infections (pathogen discovery). To date, these studies suggest that no one infection or pathogen causes CFS and that the illness may be triggered by a variety of illnesses or conditions. In fact, infection with Epstein-Barr virus, Ross River virus, and Coxiella burnetti will lead to a post-infective condition that meets the criteria for CFS in approximately 10-12% of cases. People who had severe symptoms when they became infected were more likely than those with mild symptoms to later develop CFS symptoms. The possibility remains that there may be a variety of different ways in which patients can develop CFS.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 168, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Immune System and Allergies\\n  \\nStudies have looked to see if changes in a person's immune system might lead to CFS. The findings have been mixed. Similarities in symptoms from immune responses to infection and CFS lead to hypotheses that CFS may be caused by stress or a viral infection, which may lead to the chronic production of cytokines and then to CFS.\\n  \\nAntibodies against normal parts of the body (auto-antibodies) and immune complexes have been seen in some CFS patients. However, no associated tissue damage typical of autoimmune disease has been described in CFS patients. The opportunistic infections or increased risk for cancer observed in persons with immunodeficiency diseases or in immunosuppressed individuals is also not observed in CFS.\\n  \\nT-cell activation markers have been reported to be different between groups of CFS patients and healthy persons, but not all investigators have consistently observed these differences.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 168, 'source_type': 'Remedies', 'priority': '1'}, page_content='T-cell activation markers have been reported to be different between groups of CFS patients and healthy persons, but not all investigators have consistently observed these differences.\\n  \\nAllergic diseases and secondary illnesses such as sinusitis could be one predisposing factor for CFS, but not all CFS patients have allergies. Many patients do, however, report intolerances for certain substances that may be found in foods or over-the-counter medications, such as alcohol.\\n  \\n                \\n  Hypothalamic-Pituitary Adrenal (HPA) Axis\\n  \\nThe central nervous system plays an important role in CFS. Physical or emotional stress, which is commonly reported as a pre-onset condition in CFS patients, alters the activity of the hypothalamic-pituitary-adrenal axis, or HPA axis, leading to altered release of corticotrophin-releasing hormone (CRH), cortisol, and other hormones. These hormones can influence the immune system and many other body systems.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 168, 'source_type': 'Remedies', 'priority': '1'}, page_content='Some CFS patients produce lower levels of cortisol than do healthy people. Similar hormonal abnormalities have also been observed among CFS patients and in persons with related disorders like fibromyalgia. Cortisol suppresses inflammation and cellular immune activation, and reduced levels might relax constraints on inflammatory processes and immune cell activation. Even though CFS patients had lower levels of cortisol than healthy individuals, their cortisol levels were still within the acceptable range of what is considered normal. Therefore, doctors cannot use cortisol levels as a way to diagnose CFS.\\n  \\n                \\n  Abnormally Low Blood Pressure and Lightheadedness (Neurally Mediated Hypotension)'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 168, 'source_type': 'Remedies', 'priority': '1'}, page_content='Disturbances in the autonomic regulation of blood pressure and pulse have been found in CFS patients. This problem with maintaining blood pressure can be diagnosed by using tilt table testing, which involves laying the patient horizontally on a table and then tilting the table upright to 70 degrees for 45 minutes while monitoring blood pressure and heart rate. Persons with neurally mediated hypotension (NMH) or postural orthostatic tachycardia (POTS) will develop lower blood pressure under these conditions, as well as other characteristic symptoms, such as lightheadedness, visual dimming, or a slow response to verbal stimuli. Others may develop an unusually rapid heart rate also associated with the symptoms of the syndrome. Many CFS patients experience lightheadedness or worsened fatigue when they stand for prolonged periods or when in warm places, such as in a hot shower -- all circumstances that are known to trigger NMH or POTS.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 168, 'source_type': 'Remedies', 'priority': '1'}, page_content='NMH and/or POTS share some of the symptoms of CFS. They should be considered in a CFS patients whose symptoms are worsened with changes in position, after eating, following unusual amounts of or inadequate fluid intake, or increases in activity. Not all patients with CFS will have these conditions, however.\\n  \\n                \\n  Nutritional Deficiency\\n  \\nThere is no published scientific evidence that CFS is caused by a nutritional deficiency. While evidence is currently lacking for nutritional defects in CFS patients, it should also be added that a balanced diet can be favorable to better health in general and would be expected to benefit a person with any chronic illness.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 169, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: exams and tests\\nQuestion: How to diagnose Chronic Fatigue Syndrome (CFS) ?\\nAnswer: Diagnostic Challenges\\n  \\nFor doctors, diagnosing chronic fatigue syndrome (CFS) can be complicated by a number of factors:\\n  \\n   - There's no lab test or biomarker for CFS.\\n   - Fatigue and other symptoms of CFS are common to many illnesses.\\n   - For some CFS patients, it may not be obvious to doctors that they are ill.\\n   - The illness has a pattern of remission and relapse.\\n   - Symptoms vary from person to person in type, number, and severity.\\n  \\n  \\nThese factors have contributed to a low diagnosis rate. Of the one to four million Americans who have CFS, less than 20% have been diagnosed.\\n  Exams and Screening Tests for CFS\\n  \\nBecause there is no blood test, brain scan, or other lab test to diagnose CFS, the doctor should first rule out other possible causes.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 169, 'source_type': 'Remedies', 'priority': '1'}, page_content='Exams and Screening Tests for CFS\\n  \\nBecause there is no blood test, brain scan, or other lab test to diagnose CFS, the doctor should first rule out other possible causes.\\n  \\nIf a patient has had 6 or more consecutive months of severe fatigue that is reported to be unrelieved by sufficient bed rest and that is accompanied by nonspecific symptoms, including flu-like symptoms, generalized pain, and memory problems, the doctor should consider the possibility that the patient may have CFS. Further exams and tests are needed before a diagnosis can be made:\\n  \\n   - A detailed medical history will be needed and should include a review of medications that could be causing the fatigue and symptoms\\n   - A thorough physical and mental status examination will also be needed\\n   - A battery of laboratory screening tests will be needed to help identify or rule out other possible causes of the symptoms that could be treated'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 169, 'source_type': 'Remedies', 'priority': '1'}, page_content='- A battery of laboratory screening tests will be needed to help identify or rule out other possible causes of the symptoms that could be treated\\n   - The doctor may also order additional tests to follow up on results of the initial screening tests\\n  \\n  \\nA CFS diagnosis requires that the patient has been fatigued for 6 months or more and has 4 of the 8 symptoms for CFS for 6 months or more. If, however, the patient has been fatigued for 6 months or more but does not have four of the eight symptoms, the diagnosis may be idiopathic fatigue.\\n  \\nThe complete process for diagnosing CFS can be found here.\\n  \\nAdditional information for healthcare professionals on use of tests can be found here.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 170, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: symptoms\\nQuestion: What are the symptoms of Chronic Fatigue Syndrome (CFS) ?\\nAnswer: Chronic fatigue syndrome can be misdiagnosed or overlooked because its symptoms are similar to so many other illnesses. Fatigue, for instance, can be a symptom for hundreds of illnesses. Looking closer at the nature of the symptoms though, can help a doctor distinguish CFS from other illnesses.\\n  Primary Symptoms\\n  \\nAs the name chronic fatigue syndrome suggests, fatigue is one part of this illness. With CFS, however, the fatigue is accompanied by other symptoms. In addition, the fatigue is not the kind you might feel after a particularly busy day or week, after a sleepless night, or after a single stressful event. It's a severe, incapacitating fatigue that isn't improved by bed rest and that is often worsened by physical activity or mental exertion. It's an all-encompassing fatigue that can dramatically reduce a person's activity level and stamina.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 170, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"People with CFS function at a significantly lower level of activity than they were capable of before they became ill. The illness results in a substantial reduction in work-related, personal, social, and educational activities.\\n  \\nThe fatigue of CFS is accompanied by characteristic illness symptoms lasting at least 6 months. These symptoms include:\\n  \\n   - increased malaise (extreme exhaustion and sickness) following physical activity or mental exertion\\n   - problems with sleep\\n   - difficulties with memory and concentration\\n   - persistent muscle pain\\n   - joint pain (without redness or swelling)\\n   - headache\\n   - tender lymph nodes in the neck or armpit\\n   - sore throat\\n  \\n  Other Symptoms\\n  \\nThe symptoms listed above are the symptoms used to diagnose CFS. However, many CFS patients and patients in general may experience other symptoms, including:\\n  \\n   - brain fog (feeling like you're in a mental fog)\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 170, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"- brain fog (feeling like you're in a mental fog)\\n   - difficulty maintaining an upright position, dizziness, balance problems or fainting\\n   - allergies or sensitivities to foods, odors, chemicals, medications, or noise\\n   - irritable bowel\\n   - chills and night sweats\\n   - visual disturbances (sensitivity to light, blurring, eye pain)\\n   - depression or mood problems (irritability, mood swings, anxiety, panic attacks)\\n  \\n  \\nIt's important to tell your health care professional if you're experiencing any of these symptoms. You might have CFS, or you might have another treatable disorder. Only a health care professional can diagnose CFS.\\n  What's the Clinical Course of CFS?\\n  \\nThe severity of CFS varies from patient to patient. Some people can maintain fairly active lives. For most patients, however, CFS significantly limits their work, school, and family activities for periods of time.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 170, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"While symptoms vary from person to person in number, type, and severity, all CFS patients are limited in what they can do to some degree. CDC studies show that CFS can be as disabling as multiple sclerosis, lupus, rheumatoid arthritis, heart disease, end-stage renal disease, chronic obstructive pulmonary disease (COPD), and similar chronic conditions.\\n  \\nCFS often affects patients in cycles: Patients will have periods of illness followed by periods of relative well-being. For some patients, symptoms may diminish or even go into complete remission; however, they often recur at a later point in time. This pattern of remission and relapse makes CFS especially hard for patients to manage. Patients who are in remission may be tempted to overdo activities when they're feeling better, but this overexertion may actually contribute to a relapse.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 170, 'source_type': 'Remedies', 'priority': '1'}, page_content='The percentage of CFS patients who recover is unknown, but there is some evidence to indicate that patients benefit when accompanying conditions are identified and treated and when symptoms are managed. High-quality health care is important.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 171, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: treatment\\nQuestion: What are the treatments for Chronic Fatigue Syndrome (CFS) ?\\nAnswer: Introduction\\n  \\nManaging chronic fatigue syndrome can be as complex as the illness itself. There is no cure, no prescription drugs have been developed specifically for CFS, and symptoms can vary a lot over time. Thus, people with CFS should closely monitor their health and let their doctor know of any changes; and doctors should regularly monitor their patients' conditions and change treatment strategies as needed.\\n  \\nA team approach that involves doctors and patients is one key to successfully managing CFS. Patients and their doctors can work together to create an individualized treatment program that best meets the needs of the patient with CFS. This program should be based on a combination of therapies that address symptoms, coping techniques, and managing normal daily activities.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 171, 'source_type': 'Remedies', 'priority': '1'}, page_content='CFS affects patients in different ways, and the treatment plan should be tailored to address symptoms that are most disruptive or disabling for each patient. Helping the patient get relief from symptoms is the main goal of treatment. However, expecting a patient to return to usual activities should not be the immediate goal because the physical and mental exertion needed to try to reach that goal may aggravate the illness.\\n  \\nBecause CFS is a complicated illness, its management may require input from a variety of medical professionals. Primary care providers can develop effective treatment plans based on their experience in treating other illnesses. Patients benefit when they can work in collaboration with a team of doctors and other health care professionals, who might also include rehabilitation specialists, mental health professionals, and physical or exercise therapists.\\n  Difficulties of Living with CFS'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 171, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Difficulties of Living with CFS\\n  \\nLiving with chronic fatigue syndrome can be difficult. Like other debilitating chronic illnesses, CFS can have a devastating impact on patients' daily lives and require them to make major lifestyle changes to adapt to many new limitations.\\n  \\nCommon difficulties for CFS patients include problems coping with:\\n  \\n   - the changing and unpredictable symptoms\\n   - a decrease in stamina that interferes with activities of daily life\\n   - memory and concentration problems that seriously hurt work or school performance\\n   - loss of independence, livelihood, and economic security\\n   - alterations in relationships with partners, family members, and friends\\n   - worries about raising children\\n  \\n  \\nFeelings of anger, guilt, anxiety, isolation and abandonment are common in CFS patients. While it's OK to have such feelings, unresolved emotions and stress can make symptoms worse, interfere with prescription drug therapies, and make recovery harder.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Rocky Mountain Spotted Fever (RMSF) ?\\nAnswer: The first symptoms of Rocky Mountain spotted fever (RMSF) typically begin 2-14 days after the bite of an infected tick. A tick bite is usually painless and about half of the people who develop RMSF do not remember being bitten. The disease frequently begins as a sudden onset of fever and headache and most people visit a healthcare provider during the first few days of symptoms. Because early symptoms may be non-specific, several visits may occur before the diagnosis of RMSF is made and correct treatment begins. The following is a list of symptoms commonly seen with this disease, however, it is important to note that few people with the disease will develop all symptoms, and the number and combination of symptoms varies greatly from person to person. \\n \\n - Fever  \\n - Rash (occurs 2-5 days after fever, may be absent in some cases; see below) \\n - Headache  \\n - Nausea  \\n - Vomiting'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Fever  \\n - Rash (occurs 2-5 days after fever, may be absent in some cases; see below) \\n - Headache  \\n - Nausea  \\n - Vomiting  \\n - Abdominal pain (may mimic appendicitis or other causes of acute abdominal pain)  \\n - Muscle pain  \\n - Lack of appetite  \\n - Conjunctival injection (red eyes)  \\n \\n                \\nRMSF is a serious illness that can be fatal in the first eight days of symptoms if not treated correctly, even in previously healthy people. The progression of the disease varies greatly. Patients who are treated early may recover quickly on outpatient medication, while those who experience a more severe course may require intravenous antibiotics, prolonged hospitalization or intensive care. \\n                \\n \\nRash'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Rash \\n                \\nWhile most people with RMSF (90%) have some type of rash during the course of illness, some people do not develop the rash until late in the disease process, after treatment should have already begun.  Approximately 10% of RMSF patients never develop a rash. It is important for physicians to consider RMSF if other signs and symptoms support a diagnosis, even if a rash is not present. \\n                \\nA classic case of RMSF involves a rash that first appears 2-5 days after the onset of fever as small, flat, pink, non-itchy spots (macules) on the wrists, forearms, and ankles and spreads to include the trunk and sometimes the palms and soles.  Often the rash varies from this description and people who fail to develop a rash, or develop an atypical rash, are at increased risk of being misdiagnosed.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='The red to purple, spotted (petechial) rash of RMSF is usually not seen until the sixth day or later after onset of symptoms and occurs in 35-60% of patients with the infection. This is a sign of progression to severe disease, and every attempt should be made to begin treatment before petechiae develop. \\n                \\nFigure 1a and 1b: Examples of an early-stage rash in an RMSF patient. \\n \\n  \\n   \\n     \\n    \\n   \\n  \\n  \\n   \\n     \\n    \\n   \\n  \\n \\n \\n   \\n  \\n \\n                \\n  \\n \\n                \\n \\nLong-term Health Problems'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Long-term Health Problems \\n                \\nPatients who had a particularly severe infection requiring prolonged hospitalization may have long-term health problems caused by this disease. Rickettsia rickettsii infects the endothelial cells that line the blood vessels. The damage that occurs in the blood vessels results in a disease process called a \"vasculitis\", and bleeding or clotting in the brain or other vital organs may occur. Loss of fluid from damaged vessels can result in loss of circulation to the extremities and damaged fingers, toes or even limbs may ultimately need to be amputated. Patients who suffer this kind of severe vasculitis in the first two weeks of illness may also be left with permanent long-term health problems such as profound neurological deficits, or damage to internal organs. Those who do not have this kind of vascular damage in the initial stages of the disease typically recover fully within several days to months.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Infection in Children \\n                \\nChildren with RMSF infection may experience nausea, vomiting, and loss of appetite. Children are less likely to report a headache, but more likely to develop an early rash than adults. Other frequently observed signs and symptoms in children with RMSF are abdominal pain, altered mental status, and conjunctival injection. Occasionally, symptoms like cough, sore throat, and diarrhea may be seen, and can lead to misdiagnosis. \\n                \\nFor more in-depth information about signs and symptoms of RMSF, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm \\n                \\n \\nPhysician Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='For more in-depth information about signs and symptoms of RMSF, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm \\n                \\n \\nPhysician Diagnosis \\n                \\nThere are several aspects of RMSF that make it challenging for healthcare providers to diagnose and treat. The symptoms of RMSF vary from patient to patient and can easily resemble other, more common diseases. Treatment for this disease is most effective at preventing death if started in the first five days of symptoms. Diagnostic tests for this disease, especially tests based on the detection of antibodies, will frequently appear negative in the first 7-10 days of illness. Due to the complexities of this disease and the limitations of currently available diagnostic tests, there is no test available at this time that can provide a conclusive result in time to make important decisions about treatment.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='For this reason, healthcare providers must use their judgment to treat patients based on clinical suspicion alone. Healthcare providers may find important information in the patient’s history and physical examination that may aid clinical suspicion. Information such as recent tick bites, exposure to high grass and tick-infested areas, contact with dogs, similar illnesses in family members or pets, or history of recent travel to areas of high incidence can be helpful in making the diagnosis. Also, information about the presence of symptoms such as fever and rash may be helpful. The healthcare provider may also look at routine blood tests, such as a complete blood cell count or a chemistry panel. Clues such as a low platelet count (thrombocytopenia), low sodium levels (hyponatremia), or elevated liver enzyme levels are often helpful predictors of RMSF but may not be present in all patients. After a suspect diagnosis is made on clinical suspicion and treatment has begun, specialized'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='elevated liver enzyme levels are often helpful predictors of RMSF but may not be present in all patients. After a suspect diagnosis is made on clinical suspicion and treatment has begun, specialized laboratory testing should be used to confirm the diagnosis of RMSF.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Laboratory Confirmation'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='R. rickettsii infects the endothelial cells that line blood vessels, and does not circulate in large numbers in the blood unless the patient has progressed to a very severe phase of infection. For this reason, blood specimens (whole blood, serum) are not always useful for detection of the organism through polymerase chain reaction (PCR) or culture. If the patient has a rash, PCR or immunohistochemical (IHC) staining can be performed on a skin biopsy taken from the rash site. This test can often deliver a rapid result. These tests have good sensitivity (70%) when applied to tissue specimens collected during the acute phase of illness and before antibiotic treatment has been started, but a negative result should not be used to guide treatment decisions. PCR, culture, and IHC can also be applied to autopsy specimens (liver, spleen, kidney, etc) collected after a patient dies. Culture of R. rickettsii is only available at specialized laboratories; routine hospital blood cultures cannot'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='to autopsy specimens (liver, spleen, kidney, etc) collected after a patient dies. Culture of R. rickettsii is only available at specialized laboratories; routine hospital blood cultures cannot detect R. rickettsii.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='During RMSF infection, a patient’s immune system develops antibodies to R. rickettsii, with detectable antibody titers usually observed by 7-10 days after illness onset. It is important to note that antibodies are not detectable in the first week of illness in 85% of patients, and a negative test during this time does not rule out RMSF as a cause of illness.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='The gold standard serologic test for diagnosis of RMSF is the indirect immunofluorescence assay (IFA) with R. rickettsii antigen, performed on two paired serum samples to demonstrate a significant (four-fold) rise in antibody titers. The first sample should be taken as early in the disease as possible, preferably in the first week of symptoms, and the second sample should be taken 2 to 4 weeks later. In most RMSF cases, the first IgG IFA titer is typically low or negative, and the second typically shows a significant (fourfold) increase in IgG antibody levels. IgM antibodies usually rise at the same time as IgG near the end of the first week of illness and remain elevated for months or even years. Also, IgM antibodies are less specific than IgG antibodies and more likely to result in a false positive. For these reasons, physicians requesting IgM serologic titers should also request a concurrent IgG titer.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Both IgM and IgG levels may remain elevated for months or longer after the disease has resolved, or may be detected in persons who were previously exposed to antigenically related organisms. Up to 10% of currently healthy people in some areas may have elevated antibody titers due to past exposure to R. rickettsii or similar organisms. Therefore, if only one sample is tested it can be difficult to interpret, whereas two paired samples taken weeks apart demonstrating a significant (four-fold) rise in antibody titer provide the best evidence for a correct diagnosis of RMSF. For more in-depth information about testing, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm \\n                \\n \\nTreatment \\n                \\nDoxycycline is the first line treatment for adults and children of all ages and should be initiated immediately whenever RMSF is suspected.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Treatment \\n                \\nDoxycycline is the first line treatment for adults and children of all ages and should be initiated immediately whenever RMSF is suspected.  \\n                \\nUse of antibiotics other than doxycycline is associated with a higher risk of fatal outcome. Treatment is most effective at preventing death if doxycycline is started in the first 5 days of symptoms. Therefore, treatment must be based on clinical suspicion alone and should always begin before laboratory results return or symptoms of severe disease, such as petechiae, develop.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='If the patient is treated within the first 5 days of the disease, fever generally subsides within 24-72 hours. In fact, failure to respond to doxycycline suggests that the patient’s condition might not be RMSF. Severely ill patients may require longer periods before their fever resolves, especially if they have experienced damage to multiple organ systems. Resistance to doxcycline or relapses in symptoms after the completion of the recommended course of treatment have not been documented. \\n                \\nRecommended Dosage\\nDoxycycline is the first line treatment for adults and children of all ages: \\n \\n - Adults: 100 mg every 12 hours \\n - Children under 45 kg (100 lbs): 2.2 mg/kg body weight given twice a day \\n \\n                \\nPatients should be treated for at least 3 days after the fever subsides and until there is evidence of clinical improvement. Standard duration of treatment is 7-14 days. \\nTreating Children'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Treating Children \\n                \\nThe use of doxycycline to treat suspected RMSF in children is standard practice recommended by both CDC and the AAP Committee on Infectious Diseases. Use of antibiotics other than doxycycline increases the risk of patient death. Unlike older tetracyclines, the recommended dose and duration of medication needed to treat RMSF has not been shown to cause staining of permanent teeth, even when five courses are given before the age of eight. Healthcare providers should use doxycycline as the first-line treatment for suspected Rocky Mountain spotted fever in patients of all ages. \\nOther Treatments'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Other Treatments \\n                \\nIn cases of life threatening allergies to doxycycline and in some pregnant patients for whom the clinical course of RMSF appears mild, chloramphenicol may be considered as an alternative antibiotic. Oral forumulations of chloramphenicol are not available in the United States, and use of this drug carries the potential for other adverse risks, such as aplastic anemia and Grey baby syndrome. Furthermore, the risk for fatal outcome is elevated in patients who are treated with chloramphenicol compared to those treated with doxycycline. Other antibiotics, including broad spectrum antibiotics are not effective against R. rickettsii, and the use of sulfa drugs may worsen infection. \\nProphylaxis (Preventive Treatment)'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='Prophylaxis (Preventive Treatment) \\n                \\nAntibiotic treatment following a tick bite is not recommended as a means to prevent RMSF. There is no evidence this practice is effective, and may simply delay onset of disease. Instead, persons who experience a tick bite should be alert for symptoms suggestive of tickborne illness and consult a physician if fever, rash, or other symptoms of concern develop. \\n                \\nFor more in-depth information about treatment, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm \\n                \\n \\nOther Considerations'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 172, 'source_type': 'Remedies', 'priority': '1'}, page_content='For more in-depth information about treatment, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm \\n                \\n \\nOther Considerations \\n                \\nThe clinical presentation for RMSF can also resemble other tickborne diseases, such as ehrlichiosis and anaplasmosis. Similar to RMSF, these infections respond well to treatment with doxycycline. Healthcare providers should order diagnostic tests for additional agents if the clinical history and geographic association warrant. For more in-depth about other similar tickborne diseases, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 173, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Rocky Mountain Spotted Fever (RMSF) ?\\nAnswer: More detailed information on the diagnosis, management, and treatment of tickborne rickettsial diseases is available in Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever, Ehrlichioses, and Anaplasmosis – United States.\\n*Case definitions have been updated since publication \\nHow to Contact the Rickettsial Zoonoses Branch at CDC \\n                \\nThe general public and healthcare providers should first call 1-800-CDC-INFO (1-800-232-4636) for questions regarding RMSF and other rickettsial diseases. If a consultation with a CDC scientist specializing in rickettsial diseases is advised, your call will be appropriately forwarded. \\nCase Definitions \\n                \\nAs of January 1, 2010, cases of RMSF are reported under a new category called Spotted Fever Rickettsiosis (including Rocky Mountain spotted fever). \\n  \\n \\nCase Report Forms'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 173, 'source_type': 'Remedies', 'priority': '1'}, page_content='As of January 1, 2010, cases of RMSF are reported under a new category called Spotted Fever Rickettsiosis (including Rocky Mountain spotted fever). \\n  \\n \\nCase Report Forms \\n                \\nFor confirmed and probable cases of RMSF that have been identified and reported through the National Notifiable Disease Surveillance System, states are also encouraged to submit additional information using CDC Case Report Forms (CRFs). These forms collect additional important information that routine electronic reporting does not, such as information on how the diagnosis was made, and whether the patient was hospitalized or died. If a different state-specific form is already used to collect this information, this information may be submitted to CDC in lieu of CRFs.  \\n  \\n \\nHow to Submit Specimens to CDC for RMSF Testing'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 173, 'source_type': 'Remedies', 'priority': '1'}, page_content='How to Submit Specimens to CDC for RMSF Testing \\n                \\nPrivate citizens may not directly submit specimens to CDC for testing. If you feel that diagnostic testing is necessary, consult your healthcare provider or state health department. \\nState Health Departments \\n                \\nSpecimens may be submitted to CDC for testing for rickettsial diseases, including RMSF. To coordinate specimen submission, please call 404 639 1075 during business hours (8:00 - 4:30 ET).  \\nU.S. Healthcare Providers'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 173, 'source_type': 'Remedies', 'priority': '1'}, page_content='U.S. Healthcare Providers \\n                \\nU.S. healthcare providers should not submit specimens for testing directly to CDC. CDC policy requires that specimens for testing be submitted through or with the approval of the state health department. Please contact your state health department, who will assist you with specimen submission and reporting of an infected patient. For general questions about RMSF, please call 1-800-CDC-INFO (1-800-232-4636). If you have questions about a suspect RMSF case, please first consult your state health department. Healthcare providers requiring an epidemiologic consultation on rickettsial diseases may also call 404-639-1075 during business hours (8:00 - 4:30 ET). Or 770-488-7100 after hours.  \\nNon-U.S. Healthcare Providers'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 173, 'source_type': 'Remedies', 'priority': '1'}, page_content='Non-U.S. Healthcare Providers \\n                \\nNon-U.S. healthcare providers should consult CDC prior to submitting specimens for testing. For general questions about RMSF, please call 1-800-CDC-INFO (1-800-232-4636). If you would like to discuss a suspect rickettsial case with CDC, please call 404-639-1075 during business hours (8:00 - 4:30 ET), or 770-488-7100 after hours.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 174, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - African Trypanosomiasis (also known as Sleeping Sickness) ?\\nAnswer: Frequently Asked Queestions (FAQs)'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 175, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - African Trypanosomiasis (also known as Sleeping Sickness)? ?\\nAnswer: There are two subspecies of the parasite Trypanosoma brucei that cause disease in humans. The clinical features of the infection depend on the subspecies involved. The two subspecies are found in different regions of Africa. At present, there is no overlap in their geographic distribution.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 175, 'source_type': 'Remedies', 'priority': '1'}, page_content='T. b. rhodesiense (East African sleeping sickness) is found in focal areas of eastern and southeastern Africa. Each year a few hundred cases are reported to the World Health Organization. Over 95% of the cases of human infection occur in Tanzania, Uganda, Malawi, and Zambia. Animals are the primary reservoir of infection. Cattle have been implicated in the spread of the disease to new areas and in local outbreaks. A wild animal reservoir is thought to be responsible for sporadic transmission to hunters and visitors to game parks. Infection of international travelers is rare, but it occasionally occurs. In the U.S., one case per year, on average, is diagnosed. Most cases of sleeping sickness imported into the U.S. have been in travelers who were on safari in East Africa.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 175, 'source_type': 'Remedies', 'priority': '1'}, page_content='T. b. gambiense (West African sleeping sickness) is found predominantly in central Africa and in limited areas of West Africa. Most of the sleeping sickness in Africa is caused by this form of the parasite. Epidemics of sleeping sickness have been a significant public health problem in the past, but the disease is reasonably well-controlled at present, with 7,000-10,000 cases reported annually in recent years. Over 95% of the cases of human infection are found in Democratic Republic of Congo, Angola, Sudan, Central African Republic, Chad, and northern Uganda. Humans are the important reservoir of infection, although the parasite can sometimes be found in domestic animals (e.g., pigs, dogs, goats). Imported infection in the U.S. is extremely rare, and most cases have occurred in African nationals who have immigrated rather than in returning U.S. travelers.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 175, 'source_type': 'Remedies', 'priority': '1'}, page_content='Both forms of sleeping sickness are transmitted by the bite of the tsetse fly (Glossina species). Tsetse flies inhabit rural areas, living in the woodlands and thickets that dot the East African savannah. In central and West Africa, they live in the forests and vegetation along streams. Tsetse flies bite during daylight hours. Both male and female flies can transmit the infection, but even in areas where the disease is endemic, only a very small percentage of flies are infected. Although the vast majority of infections are transmitted by the tsetse fly, other modes of transmission are possible. Occasionally, a pregnant woman can pass the infection to her unborn baby. In theory, the infection can also be transmitted by blood transfusion or sexual contact, but such cases have rarely been documented.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 175, 'source_type': 'Remedies', 'priority': '1'}, page_content='This information is not meant to be used for self-diagnosis or as a substitute for consultation with a health care provider. If you have any questions about the parasites described above or think that you may have a parasitic infection, consult a health care provider.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 176, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - African Trypanosomiasis (also known as Sleeping Sickness) ?\\nAnswer: The diagnosis of African Trypanosomiasis is made through laboratory methods, because the clinical features of infection are not sufficiently specific. The diagnosis rests on finding the parasite in body fluid or tissue by microscopy. The parasite load in T. b. rhodesiense infection is substantially higher than the level in T. b. gambiense infection.\\n    \\nT. b. rhodesiense parasites can easily be found in blood. They can also be found in lymph node fluid or in fluid or biopsy of a chancre. Serologic testing is not widely available and is not used in the diagnosis, since microscopic detection of the parasite is straightforward.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 176, 'source_type': 'Remedies', 'priority': '1'}, page_content='The classic method for diagnosing T. b. gambiense infection is by microscopic examination of lymph node aspirate, usually from a posterior cervical node. It is often difficult to detect T. b. gambiense in blood. Concentration techniques and serial examinations are frequently needed. Serologic testing is available outside the U.S. for T. b. gambiense; however, it normally is used for screening purposes only and the definitive diagnosis rests on microscopic observation of the parasite.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 176, 'source_type': 'Remedies', 'priority': '1'}, page_content='All patients diagnosed with African trypanosomiasis must have their cerebrospinal fluid examined to determine whether there is involvement of the central nervous system, since the choice of treatment drug(s) will depend on the disease stage. The World Health Organization criteria for central nervous system involvement include increased protein in cerebrospinal fluid and a white cell count of more than 5. Trypanosomes can often be observed in cerebrospinal fluid in persons with second stage infection.\\n    \\nMore on: Resources for Health Professionals: Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 177, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - African Trypanosomiasis (also known as Sleeping Sickness) ?\\nAnswer: All persons diagnosed with African Trypanosomiasis should receive treatment. The specific drug and treatment course will depend on the type of infection (T. b. gambiense or T. b. rhodesiense) and the disease stage (i.e. whether the central nervous system has been invaded by the parasite). Pentamidine, which is the recommended drug for first stage T. b. gambiense infection, is widely available in the U.S. The other drugs (suramin, melarsoprol, eflornithine, and nifurtimox) used to treat African trypanosomiasis are available in the U.S. only from the CDC. Physicians can consult with CDC staff for advice on diagnosis and management and to obtain otherwise unavailable treatment drug.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 177, 'source_type': 'Remedies', 'priority': '1'}, page_content='There is no test of cure for African trypanosomiasis. After treatment patients need to have serial examinations of their cerebrospinal fluid for 2 years, so that relapse can be detected if it occurs.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 178, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - African Trypanosomiasis (also known as Sleeping Sickness) ?\\nAnswer: There is no vaccine or drug for prophylaxis against African trypanosomiasis. Preventive measures are aimed at minimizing contact with tsetse flies. Local residents are usually aware of the areas that are heavily infested and they can provide advice about places to avoid. Other helpful measures include:\\n    \\n     - Wear long-sleeved shirts and pants of medium-weight material in neutral colors that blend with the background environment. Tsetse flies are attracted to bright or dark colors, and they can bite through lightweight clothing.\\n     - Inspect vehicles before entering. The flies are attracted to the motion and dust from moving vehicles.\\n     - Avoid bushes. The tsetse fly is less active during the hottest part of the day but will bite if disturbed.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 178, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Avoid bushes. The tsetse fly is less active during the hottest part of the day but will bite if disturbed.\\n     - Use insect repellent. Permethrin-impregnated clothing and insect repellent have not been proved to be particularly effective against tsetse flies, but they will prevent other insect bites that can cause illness.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 178, 'source_type': 'Remedies', 'priority': '1'}, page_content='Control of African trypanosomiasis rests on two strategies: reducing the disease reservoir and controlling the tsetse fly vector. Because humans are the significant disease reservoir for T. b. gambiense, the main control strategy for this subspecies is active case-finding through population screening, followed by treatment of the infected persons that are identified. Tsetse fly traps are sometimes used as an adjunct. Reducing the reservoir of infection is more difficult for T. b. rhodesiense, since there are a variety of animal hosts. Vector control is the primary strategy in use. This is usually done with traps or screens, in combination with insecticides and odors that attract the flies.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 179, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Varicella (Chickenpox) Vaccination ?\\nAnswer: At a Glance \\n \\nVaccine-preventable disease levels are at or near record lows. Even though most infants and toddlers have received all recommended vaccines by age 2, many under-immunized children remain, leaving the potential for outbreaks of disease. Many adolescents and adults are under-immunized as well, missing opportunities to protect themselves against diseases such as Hepatitis B, influenza, and pneumococcal disease. CDC works closely with public health agencies and private partners to improve and sustain immunization coverage and to monitor the safety of vaccines so that this public health success story can be maintained and expanded in the century to come.  \\n  \\n Vaccine Shortages & Delays \\n  \\n   \\n   \\n \\n   \\n  \\n  \\n   \\n   \\nThe latest national information about vaccine supplies and guidance for healthcare providers who are facing vaccine shortages or delays'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 179, 'source_type': 'Remedies', 'priority': '1'}, page_content='The latest national information about vaccine supplies and guidance for healthcare providers who are facing vaccine shortages or delays \\n     \\n    \\n   \\n  \\n  \\n \\n  \\n  \\n  \\n Potential New Vaccines \\n  \\n   \\n   \\n \\n   \\n  \\n  \\n   \\n   \\nResources for finding information on potential vaccines, research and development status, licensure status, etc. \\n       \\n    \\n   \\n  \\n  \\n \\n  \\n  \\n  \\n Vaccines: The Basics \\n  \\n   \\n   \\n \\n   \\n  \\n  \\n   \\n   \\nWithout vaccines, epidemics of many preventable diseases could return, resulting in increased – and unnecessary – illness, disability, and death. \\n          \\n    \\n   \\n  \\n  \\n \\n  \\n  \\n  \\n FAQ about Vaccines & Diseases they Prevent'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 179, 'source_type': 'Remedies', 'priority': '1'}, page_content='FAQ about Vaccines & Diseases they Prevent \\n  \\n   \\n   \\n \\n   \\n  \\n  \\n   \\n          \\n    \\n   \\n  \\n  \\n \\n  \\n  \\n   \\n  \\n                \\n \\n                \\n \\n \\n \\n                \\n  \\n \\n  \\n  \\nImages and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more \\n  \\n  \\n  \\n  This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 180, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Fascioliasis (Fasciola Infection) ?\\nAnswer: Fascioliasis is an infectious disease caused by Fasciola parasites, which are flat worms referred to as liver flukes. The adult (mature) flukes are found in the bile ducts and liver of infected people and animals, such as sheep and cattle. In general, fascioliasis is more common in livestock and other animals than in people.\\nTwo Fasciola species (types) infect people. The main species is Fasciola hepatica, which is also known as \"the common liver fluke\" and \"the sheep liver fluke.\" A related species, Fasciola gigantica, also can infect people.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 181, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Fascioliasis (Fasciola Infection)? ?\\nAnswer: Fascioliasis occurs in many areas of the world and usually is caused by F. hepatica, which is a common liver fluke of sheep and cattle. In general, fascioliasis is more common and widespread in animals than in people. Even so, the number of infected people in the world is thought to exceed 2 million.\\n    \\nFasciola hepatica is found in more than 50 countries, in all continents except Antarctica. It is found in parts of Latin America, the Caribbean, Europe, the Middle East, Africa, Asia, and Oceania. Fasciola gigantica is less widespread. Human cases have been reported in the tropics, in parts of Africa and Asia, and also in Hawaii.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 181, 'source_type': 'Remedies', 'priority': '1'}, page_content='In some areas where fascioliasis is found, human cases are uncommon (sporadic). In other areas, human fascioliasis is very common (hyperendemic). For example, the areas with the highest known rates of human infection are in the Andean highlands of Bolivia and Peru.\\n    \\nSpecial conditions are needed for fascioliasis to be present in an area, and its geographic distribution is very patchy (focal). The eggs passed in the stool of infected mammals have to develop (mature) in a suitable aquatic snail host to be able to infect another mammalian host. Requirements include sufficient moisture and favorable temperatures (above 50°F) that allow the development of miracidia, reproduction of snails, and larval development within the snails. These factors also contribute to both the prevalence and level (intensity) of infection. Prevalence is highest in areas where climatic conditions promote development of cercariae.\\n    \\nMore on: Biology'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 181, 'source_type': 'Remedies', 'priority': '1'}, page_content='More on: Biology\\n    \\nInfective Fasciola larvae (metacercariae) are found in contaminated water, either stuck to (encysted on) water plants or floating in the water, often in marshy areas, ponds, or flooded pastures. People (and animals) typically become infected by eating raw watercress or other contaminated water plants. The plants may be eaten as a snack or in salads or sandwiches. People also can get infected by ingesting contaminated water, such as by drinking it or by eating vegetables that were washed or irrigated with contaminated water. Infection also can result from eating undercooked sheep or goat livers that contain immature forms of the parasite.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 181, 'source_type': 'Remedies', 'priority': '1'}, page_content='The possibility of becoming infected in the United States should be considered, despite the fact that few locally acquired cases have been documented. The prerequisites for the Fasciola life cycle exist in some parts of the United States. In addition, transmission because of imported contaminated produce could occur, as has been documented in Europe.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 182, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"qtype: exams and tests\\nQuestion: How to diagnose Parasites - Fascioliasis (Fasciola Infection) ?\\nAnswer: The standard way to be sure a person is infected with Fasciola is by seeing the parasite. This is usually done by finding Fasciola eggs in stool (fecal) specimens examined under a microscope. More than one specimen may need to be examined to find the parasite. Sometimes eggs are found by examining duodenal contents or bile.\\n    \\nInfected people don't start passing eggs until they have been infected for several months; people don't pass eggs during the acute phase of the infection. Therefore, early on, the infection has to be diagnosed in other ways than by examining stool. Even during the chronic phase of infection, it can be difficult to find eggs in stool specimens from people who have light infections.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 182, 'source_type': 'Remedies', 'priority': '1'}, page_content='Certain types of blood tests can be helpful for diagnosing Fasciola infection, including routine blood work and tests that detect antibodies (an immune response) to the parasite.\\n    \\nMore on: Resources for Health Professionals: Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 183, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Fascioliasis (Fasciola Infection) ?\\nAnswer: The first step is to make sure the diagnosis is correct. For more information, patients should consult their health care provider. Health care providers may consult with CDC staff about the diagnosis and treatment of fascioliasis.\\n    \\nThe drug of choice is triclabendazole. In the United States, this drug is available through CDC, under a special (investigational) protocol. The drug is given by mouth, usually in one or two doses. Most people respond well to the treatment.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 184, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Fascioliasis (Fasciola Infection) ?\\nAnswer: No vaccine is available to protect people against Fasciola infection.\\n    \\nIn some areas of the world where fascioliasis is found (endemic), special control programs are in place or are planned. The types of control measures depend on the setting (such as epidemiologic, ecologic, and cultural factors). Strict control of the growth and sale of watercress and other edible water plants is important.\\n    \\nIndividual people can protect themselves by not eating raw watercress and other water plants, especially from endemic grazing areas. As always, travelers to areas with poor sanitation should avoid food and water that might be contaminated (tainted). Vegetables grown in fields that might have been irrigated with polluted water should be thoroughly cooked, as should viscera from potentially infected animals.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Anaplasmosis ?\\nAnswer: Anaplasmosis is a disease caused by the bacterium Anaplasma phagocytophilium. This pathogen is transmitted to humans by the bite of an infected tick. The black-legged tick (Ixodes scapularis) is the vector of A. phagocytophilum in the northeast and upper midwestern United States. The western black-legged tick (Ixodes pacificus) is the primary vector in Northern California. The first symptoms of anaplasmosis typically begin within 1-2 weeks after the bite of an infected tick. A tick bite is usually painless, and some patients who develop anaplasmosis do not remember being bitten. The following is a list of symptoms commonly seen with this disease. However, it is important to note that few people with the disease will develop all symptoms, and the number and combination of symptoms varies greatly from person to person. \\n  \\n  - Fever \\n  - Headache \\n  - Muscle pain \\n  - Malaise \\n  - Chills'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Fever \\n  - Headache \\n  - Muscle pain \\n  - Malaise \\n  - Chills \\n  - Nausea / Abdominal pain \\n  - Cough \\n  - Confusion \\n  - Rash (rare with anaplasmosis) \\n  \\n \\nAnaplasmosis can be a serious illness that can be fatal if not treated correctly, even in previously healthy people.  Severe clinical presentations may include difficulty breathing, hemorrhage, renal failure or neurological problems. The estimated case fatality rate (i.e., the proportion of persons who die as a result of their infection) is less than 1%. Patients who are treated early may recover quickly on outpatient medication, while those who experience a more severe course may require intravenous antibiotics, prolonged hospitalization or intensive care. \\n \\n \\n Rash \\n \\nRash is rarely reported in patients with anaplasmosis and the presence of a rash may signify that the patient has a coinfection with the pathogen that causes Lyme disease or another tickborne disease, such as Rocky Mountain Spotted Fever .'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Immune-compromised Individuals \\n \\nThe severity of anaplasmosis may depend in part on the immune status of the patient. Persons with compromised immunity caused by immunosuppressive therapies (e.g., corticosteroids, cancer chemotherapy, or longterm immunosuppressive therapy following organ transplant), HIV infection, or splenectomy appear to develop more severe disease, and case-fatality rates for these individuals are characteristically higher than case-fatality rates reported for the general population. \\n \\n \\n Blood Transfusion and Organ Transplant Risks Associated with Anaplasma species'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Because A. phagocytophilum infects the white blood cells and circulates in the blood stream, this pathogen may pose a risk to be transmitted through blood transfusions. Anaplasma phagocytophilum has been shown to survive for more than a week in refrigerated blood. Several cases of anaplasmosis have been reported associated with the transfusion of packed red blood cells donated from asymptomatic or acutely infected donors. Patients who develop anaplasmosis within a month of receiving a blood transfusion or solid organ transplant should be reported to state health officials for prompt investigation. Use of leukoreduced blood products may theoretically decrease the risk of transfusion-associated transmission of these pathogens.  However, the filtration process does not remove all leukocytes or bacteria not associated with leukocytes from leukoreduced blood. Therefore, while this process may reduce the risk of transmission, it does not eliminate it completely. \\n \\n \\n Physician Diagnosis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Physician Diagnosis \\n \\nThere are several aspects of anaplasmosis that make it challenging for healthcare providers to diagnose and treat.  The symptoms vary from patient to patient and can be difficult to distinguish from other diseases.  Treatment is more likely to be effective if started early in the course of disease. Diagnostic tests based on the detection of antibodies will frequently appear negative in the first 7-10 days of illness.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='For this reason, healthcare providers must use their judgment to treat patients based on clinical suspicion alone. Healthcare providers may find important information in the patient’s history and physical examination that may aid clinical diagnosis. Information such as recent tick bites, exposure to areas where ticks are likely to be found, or history of recent travel to areas where anaplasmosis is endemic can be helpful in making the diagnosis.  The healthcare provider should also look at routine blood tests, such as a complete blood cell count or a chemistry panel. Clues such as a low platelet count (thrombocytopenia), low white blood cell count (leukopenia), or elevated liver enzyme levels are helpful predictors of anaplasmosis, but may not be present in all patients.   After a suspect diagnosis is made on clinical suspicion and treatment has begun, specialized laboratory testing should be used to confirm the diagnosis of anaplasmosis.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Laboratory Detection \\n \\nDuring the acute phase of illness, a sample of whole blood can be tested by polymerase chain reaction (PCR) assay to determine if a patient has anaplasmosis. This method is most sensitive in the first week of illness, and rapidly decreases in sensitivity following the administration of appropriate antibiotics. Although a positive PCR result is helpful, a negative result does not completely rule out the diagnosis, and treatment should not be with held due to a negative result.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='During the first week of illness a microscopic examination of blood smears (known as a peripheral blood smear) may reveal morulae (microcolonies of anaplasma) in the cytoplasm of white blood cells in up to 20% of patients.  During A. phagocytophilum infection, morulae are most frequently observed in granulocytes. However, the observance of morulae in a particular cell type cannot conclusively identify the infecting species. Culture isolation of A. phagocytophilum is only available at specialized laboratories; routine hospital blood cultures cannot detect the organism. \\n Figure 1: Morulae detected in a granulocyte on a peripheral blood smear, associated with A. phagocytophilum infection.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Figure 1: Morulae detected in a granulocyte on a peripheral blood smear, associated with A. phagocytophilum infection. \\n  \\n   \\n     \\n    \\n   \\n  \\n \\nWhen a person develops anaplasmosis, their immune system produces antibodies to A. phagocytophilum, with detectable antibody titers usually observed by 7-10 days after illness onset.  It is important to note that a negative test during the first week of illness does not rule out anaplasmosis as a cause of illness.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='The gold standard serologic test for diagnosis of anaplasmosis is the indirect immunofluorescence assay (IFA) using A. phagocytophilum antigen, performed on paired serum samples to demonstrate a significant (four-fold) rise in antibody titers.  The first sample should be taken as early in the disease as possible, preferably in the first week of symptoms, and the second sample should be taken 2 to 4 weeks later. In most cases of anaplasmosis, the first IgG IFA titer is typically low, or “negative,” and the second typically shows a significant (four-fold) increase in IgG antibody levels. IgM antibodies usually rise at the same time as IgG near the end of the first week of illness and remain elevated for months or longer.  Also, IgM antibodies are less specific than IgG antibodies and more likely to result in a false positive.  For these reasons, physicians requesting IgM serologic titers should also request a concurrent IgG titer.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Serologic tests based on enzyme immunoassay (EIA) technology are available from some commercial laboratories. However, EIA tests are qualitative rather than quantitative, meaning they only provide a positive/negative result, and are less useful to measure changes in antibody titers between paired specimens. Furthermore, some EIA assays rely on the evaluation of IgM antibody alone, which may have a higher frequency of false positive results.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Antibodies to A. phagocytophilum may remain elevated for months or longer after the disease has resolved, or may be detected in persons who were previously exposed to antigenically related organisms.  Between 5-10% of currently healthy people in some areas may have elevated antibody titers due to past exposure to A. phagocytophilum or similar organisms. Therefore, if only one sample is tested it can be difficult to interpret, while paired samples taken weeks apart demonstrating a significant (four-fold) rise in antibody titer provides the best evidence for a correct diagnosis of anaplasmosis. \\n \\nFor more in-depth information about the diagnosis of anaplasmosis, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm \\n \\n \\n Treatment \\n \\nDoxycycline is the first line treatment for adults and children of all ages and should be initiated immediately whenever anaplasmosis is suspected.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Treatment \\n \\nDoxycycline is the first line treatment for adults and children of all ages and should be initiated immediately whenever anaplasmosis is suspected.  \\n \\nUse of antibiotics other than doxycycline or other tetracyclines has been associated with a higher risk of fatal outcome for some rickettsial infections. Doxycycline is most effective at preventing severe complications from developing if it is started early in the course of disease. Therefore, treatment must be based on clinical suspicion alone and should always begin before laboratory results return.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='If the patient is treated within the first 5 days of the disease, fever generally subsides within 24-72 hours.  In fact, failure to respond to doxycycline suggests that the patient’s condition might not be due to anaplasmosis. Severely ill patients may require longer periods before their fever resolves. Resistance to doxcycline or relapses in symptoms after the completion of the recommended course have not been documented.  \\n \\nRecommended Dosage\\nDoxycycline is the first line treatment for adults and children of all ages: \\n  \\n  - Adults: 100 mg every 12 hours \\n  - Children under 45 kg (100 lbs): 2.2 mg/kg body weight given twice a day \\n  \\n \\nPatients should be treated for at least 3 days after the fever subsides and until there is evidence of clinical improvement. Standard duration of treatment is 7 to 14 days. Some patients may continue to experience headache, weakness and malaise for weeks after adequate treatment. \\n Treating children'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Treating children \\n \\nThe use of doxycycline to treat suspected anaplasmosis in children is standard practice recommended by both CDC and the AAP Committee on Infectious Diseases. Unlike older generations of tetracyclines, the recommended dose and duration of medication needed to treat anaplasmosis has not been shown to cause staining of permanent teeth, even when five courses are given before the age of eight.  Healthcare providers should use doxycycline as the first-line treatment for suspected anaplasmosis in patients of all ages.  \\n Other Treatments'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='In cases of life threatening allergies to doxycycline and in some pregnant patients for whom the clinical course of anaplasmosis appears mild, physicians may need to consider alternate antibiotics. Although recommended as a second-line therapeutic alternative to treat Rocky Mountain Spotted Fever , chloramphenicol is not recommended for the treatment of anaplasmosis, as studies have shown a lack of efficacy. Rifampin has been used successfully in several pregnant women with anaplasmosis, and studies suggest that this drug appears effective against Anaplasma species. However, rifampin is not effective in treating RMSF, a disease that may be confused with anaplasmosis. Healthcare providers should be cautious when exploring treatments other than doxycycline, which is highly effective in treating both. Other antibiotics, including broad spectrum antibiotics are not considered highly effective against A. phagocytophilum, and the use of sulfa drugs during acute illness may worsen the'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='treating both. Other antibiotics, including broad spectrum antibiotics are not considered highly effective against A. phagocytophilum, and the use of sulfa drugs during acute illness may worsen the severity of infection.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='Prophylaxis (Preventive Treatment) \\n \\nAntibiotic treatment following a tick bite is not recommended as a means to prevent anaplasmosis. There is no evidence this practice is effective, and this may simply delay onset of disease. Instead, persons who experience a tick bite should be alert for symptoms suggestive of tickborne illness and consult a physician if fever, rash, or other symptoms of concern develop.  \\n \\nFor more in-depth information about treatment, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm \\n \\n \\n Other Considerations'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 185, 'source_type': 'Remedies', 'priority': '1'}, page_content='For more in-depth information about treatment, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm \\n \\n \\n Other Considerations \\n \\nThe clinical presentation for anaplasmosis can resemble other tickborne diseases, such as Rocky Mountain Spotted Fever and ehrlichiosis. Similar to anaplasmosis, these infections respond well to treatment with doxycycline. Healthcare providers should order diagnostic tests for additional agents if the clinical history and geographic association warrant. For more in-depth about other similar tickborne diseases, please visit http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5504a1.htm .'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 186, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Anaplasmosis ?\\nAnswer: More detailed information on the diagnosis, management, and treatment of anaplasmosis is available in Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever, Ehrlichioses, and Anaplasmosis – United States.\\n*Case definitions have been updated since publication \\n How to Contact the Rickettsial Zoonoses Branch at CDC \\n \\nThe general public and healthcare providers should first call 1-800-CDC-INFO (1-800-232-4636) for questions regarding RMSF and other rickettsial diseases. If a consultation with a CDC scientist specializing in rickettsial diseases is advised, your call will be appropriately forwarded. \\n Case Definitions \\n \\n2008 Case Definition \\n Case Report Forms'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 186, 'source_type': 'Remedies', 'priority': '1'}, page_content='Case Definitions \\n \\n2008 Case Definition \\n Case Report Forms \\n \\nFor confirmed and probable cases of anaplasmosis that have been identified and reported through the National Notifiable Disease Surveillance System, states are also encouraged to submit additional information using the CDC Case Report Form (CRF). This form collects additional important information that routine electronic reporting does not, such as information on how the diagnosis was made, and whether the patient was hospitalized or died. If a different state-specific form is already used to collect this information, this information may be submitted to CDC in lieu of a CRF. \\n \\n2010 CDC Case Report Form: Tickborne Rickettsial Diseases (2010 version) [PDF – 3 pages] \\n How to Submit Specimens to CDC for RMSF Testing \\n \\nPrivate citizens may not directly submit specimens to CDC for testing. If you feel that diagnostic testing is necessary, consult your healthcare provider or state health department.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 186, 'source_type': 'Remedies', 'priority': '1'}, page_content='Private citizens may not directly submit specimens to CDC for testing. If you feel that diagnostic testing is necessary, consult your healthcare provider or state health department. \\n State Health Departments \\n \\nSpecimens may be submitted to CDC for testing for anaplasmosis. To coordinate specimen submission, please call 404-639-1075 during business hours (8:00 - 4:30 ET). \\n U.S. Healthcare Providers:'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 186, 'source_type': 'Remedies', 'priority': '1'}, page_content='Specimens may be submitted to CDC for testing for anaplasmosis. To coordinate specimen submission, please call 404-639-1075 during business hours (8:00 - 4:30 ET). \\n U.S. Healthcare Providers: \\n \\nU.S. healthcare providers should not submit specimens for testing directly to CDC. CDC policy requires that specimens for testing be submitted through or with the approval of the state health department. Please contact your state health department, who will assist you with specimen submission and reporting of infection. For general questions about anaplasmosis, please call 1-800-CDC-INFO (1-800-232-4636). If you have questions about a suspect ehrlichiosis case, please first consult your state health department. Healthcare providers requiring an epidemiologic or laboratory consultation on anaplasmosis may also call 404-639-1075 during business hours (8:00 - 4:30 ET). Or 770-488-7100 after hours. \\n Non U.S. Healthcare Providers:'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 186, 'source_type': 'Remedies', 'priority': '1'}, page_content='Non U.S. Healthcare Providers: \\n \\nNon-U.S. healthcare providers should consult CDC prior to submitting specimens for testing. For general questions about anaplasmosis, please call 1-800-CDC-INFO (1-800-232-4636). If you would like to discuss a suspect anaplasmosis case with CDC, please call 404-639-1075 during business hours (8:00 - 4:30 ET), or 770-488-7100 after hours.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 187, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Echinococcosis ?\\nAnswer: Frequently Asked Questions (FAQs)\\n    \\nCystic echinococcosis (CE) disease results from being infected with the larval stage of Echinococcus granulosus, a tiny tapeworm (~2-7 millimeters in length) found in dogs (definitive host), sheep, cattle, goats, foxes, and pigs, amongst others (intermediate hosts). Most infections in humans are asymptomatic, but CE, also known as hydatid disease, causes slowly enlarging masses, most commonly in the liver and the lungs. Treatment can involve both medication and surgery.\\n    \\nMore on: Cystic Echinococcosis (CE) FAQs'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 187, 'source_type': 'Remedies', 'priority': '1'}, page_content='More on: Cystic Echinococcosis (CE) FAQs\\n    \\nAlveolar echinococcosis (AE) disease results from being infected with the larval stage of Echinococcus multilocularis, a tiny tapeworm (~1-4 millimeters in length) found in foxes, coyotes, dogs, and cats (definitive hosts). Although human cases are rare, infection in humans causes parasitic tumors to form in the liver, and, less commonly, the lungs, brain, and other organs. If left untreated, infection with AE can be fatal.\\n    \\nMore on: Alveolar Echinococcosis (AE) FAQs'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 188, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Echinococcosis? ?'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 188, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"Answer: Cystic echinococcosis (CE) is caused by infection with the larval stage of Echinococcus granulosus. CE is found in Africa, Europe, Asia, the Middle East, Central and South America, and in rare cases, North America. The parasite is transmitted to dogs when they ingest the organs of other animals that contain hydatid cysts. The cysts develop into adult tapeworms in the dog. Infected dogs shed tapeworm eggs in their feces which contaminate the ground. Sheep, cattle, goats, and pigs ingest tapeworm eggs in the contaminated ground; once ingested, the eggs hatch and develop into cysts in the internal organs. The most common mode of transmission to humans is by the accidental consumption of soil, water, or food that has been contaminated by the fecal matter of an infected dog. Echinococcus eggs that have been deposited in soil can stay viable for up to a year. The disease is most commonly found in people involved in raising sheep, as a result of the sheep's role as an intermediate\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 188, 'source_type': 'Remedies', 'priority': '1'}, page_content=\"eggs that have been deposited in soil can stay viable for up to a year. The disease is most commonly found in people involved in raising sheep, as a result of the sheep's role as an intermediate host of the parasite and the presence of working dogs that are allowed to eat the offal of infected sheep.\"),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 188, 'source_type': 'Remedies', 'priority': '1'}, page_content='Alveolar echinococcosis (AE) is caused by infection with the larval stage of Echinococcus multilocularis. AE is found across the globe and is especially prevalent in the northern latitudes of Europe, Asia, and North America. The adult tapeworm is normally found in foxes, coyotes, and dogs. Infection with the larval stages is transmitted to people through ingestion of food or water contaminated with tapeworm eggs.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 189, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Echinococcosis ?\\nAnswer: The presence of a cyst-like mass in a person with a history of exposure to sheepdogs in an area where E. granulosus is endemic suggests a diagnosis of cystic echinococcosis. Imaging techniques, such as CT scans, ultrasonography, and MRIs, are used to detect cysts. After a cyst has been detected, serologic tests may be used to confirm the diagnosis.\\n    \\nAlveolar echinococcosis is typically found in older people. Imaging techniques such as CT scans are used to visually confirm the parasitic vesicles and cyst-like structures and serologic tests can confirm the parasitic infection.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 190, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Echinococcosis ?\\nAnswer: In the past, surgery was the only treatment for cystic echinococcal cysts. Chemotherapy, cyst puncture, and PAIR (percutaneous aspiration, injection of chemicals and reaspiration) have been used to replace surgery as effective treatments for cystic echinococcosis. However, surgery remains the most effective treatment to remove the cyst and can lead to a complete cure. Some cysts are not causing any symptoms and are inactive; those cysts often go away without any treatment.\\n    \\nThe treatment of alveolar echinococcosis is more difficult than cystic echinococcosis and usually requires radical surgery, long-term chemotherapy, or both.\\n    \\nMore on: Resources for Health Professionals: Treatment'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 191, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Echinococcosis ?\\nAnswer: Cystic echinococcosis is controlled by preventing transmission of the parasite. Prevention measures include limiting the areas where dogs are allowed and preventing animals from consuming meat infected with cysts.\\n    \\n     - Prevent dogs from feeding on the carcasses of infected sheep.\\n     - Control stray dog populations.\\n     - Restrict home slaughter of sheep and other livestock.\\n     - Do not consume any food or water that may have been contaminated by fecal matter from dogs.\\n     - Wash your hands with soap and warm water after handling dogs, and before handling food.\\n     - Teach children the importance of washing hands to prevent infection.\\n    \\n    \\nAlveolar echinococcosis can be prevented by avoiding contact with wild animals such as foxes, coyotes, and dogs and their fecal matter and by limiting the interactions between dogs and rodent populations.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 191, 'source_type': 'Remedies', 'priority': '1'}, page_content='- Do not allow dogs to feed on rodents and other wild animals.\\n     - Avoid contact with wild animals such as foxes, coyotes and stray dogs.\\n     - Do not encourage wild animals to come close to your home or keep them as pets.\\n     - Wash your hands with soap and warm water after handling dogs or cats, and before handling food.\\n     - Teach children the importance of washing hands to prevent infection.\\n    \\n    \\nMore on: Handwashing'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 192, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: information\\nQuestion: What is (are) Parasites - Angiostrongyliasis (also known as Angiostrongylus Infection) ?\\nAnswer: Angiostrongylus cantonensis is a parasitic worm of rats. It is also called the rat lungworm. The adult form of the parasite is found only in rodents. Infected rats pass larvae of the parasite in their feces. Snails and slugs get infected by ingesting the larvae. These larvae mature in snails and slugs but do not become adult worms. The life cycle is completed when rats eat infected snails or slugs and the larvae further mature to become adult worms.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 193, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: susceptibility\\nQuestion: Who is at risk for Parasites - Angiostrongyliasis (also known as Angiostrongylus Infection)? ?\\nAnswer: Angiostrongylus cantonensis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 193, 'source_type': 'Remedies', 'priority': '1'}, page_content='Angiostrongylus cantonensis, also known as the rat lungworm, is a parasitic nematode (worm) that is transmitted between rats and mollusks (such as slugs or snails) in its natural life cycle. Other animals that become infected such as freshwater shrimp, land crabs, frogs, and planarians of the genus Platydemus, are transport hosts that are not required for reproduction of the parasite but might be able to transmit infection to humans if eaten raw or undercooked. Humans are accidental hosts who do not transmit infection to others. Most cases of infection are diagnosed in Southeast Asia and the Pacific Basin, but the parasite has also been found in Australia, some areas of Africa, the Caribbean, Hawaii and Louisiana. Outbreaks of human angiostrongyliasis have involved a few to hundreds of persons; over 2,800 cases have been reported in the literature from approximately 30 countries. It is likely that the parasite has been spread by rats transported on ships and by the introduction of'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 193, 'source_type': 'Remedies', 'priority': '1'}, page_content='persons; over 2,800 cases have been reported in the literature from approximately 30 countries. It is likely that the parasite has been spread by rats transported on ships and by the introduction of mollusks such as the giant African land snail (Achatina fulica). In addition, the semi-slug, Parmarion martensi (native of Southeast Asia)has spread in regions of Hawaii and is found to often be infected with A. cantonensis, and the freshwater snail Pomacea canaliculata (native of South America) has been introduced into Taiwan and China and has been implicated in outbreaks of disease in those countries.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 193, 'source_type': 'Remedies', 'priority': '1'}, page_content='Risk factors for infection with A. cantonensis include the ingestion of raw or undercooked infected snails or slugs; or pieces of snails and slugs accidentally chopped up in vegetables, vegetable juices, or salads; or foods contaminated by the slime of infected snails or slugs. It is possible that ingestion of raw or undercooked transport hosts (freshwater shrimp, land crabs, frogs, etc. ) can result in human infection, though this is less certain. In addition, contamination of the hands during the preparation of uncooked infected snails or slugs could lead to ingestion of the parasite.\\n    \\n     \\n    Angiostrongylus costaricensis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 193, 'source_type': 'Remedies', 'priority': '1'}, page_content='Angiostrongylus costaricensis\\n    \\nAngiostrongylus costaricensis is a parasitic nematode (worm) that resides in rodents and uses mollusks, such as slugs, as an intermediate host. Rats, such as the cotton rat, transmit the larvae through their feces. Slugs then ingest the larvae. Humans are accidental hosts of the parasite. The parasite is not able to complete its life cycle in humans and eventually dies in the abdomen. Human infection principally occurs in Latin America and the Caribbean, with a few cases suspected in the United States and in the Republic of Congo. The organism is also found in animals in the Southern U.S. (Texas).'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 193, 'source_type': 'Remedies', 'priority': '1'}, page_content='Risk factors for infection with A. costaricensis are not well established but are likely to be ingestion of infected slugs or raw vegetables or vegetable juices contaminated with slugs or their slime, which can contain A. costaricensis larvae. The infection of transport hosts, which are not essential to the lifecycle of the parasite, has not been identified and any role in human infection is not known, in contrast to A. cantonensis. Some reports have shown the case rate to be higher in children 6 to 12 years of age, males, and in persons of higher socioeconomic status. There has been one food-related outbreak in Guatemala that affected primarily adults.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 194, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: exams and tests\\nQuestion: How to diagnose Parasites - Angiostrongyliasis (also known as Angiostrongylus Infection) ?\\nAnswer: Angiostrongylus cantonensis\\n    \\nDiagnosing A. cantonensis infections can be difficult, in part because there are no readily available blood tests. Important clues that could lead to the diagnosis of infection are a history of travel to where the parasite is known to be found and ingestion of raw or undercooked snails, slugs, or possibly transport hosts (such as frogs, fresh water shrimp or land crabs) in those areas. A high level of eosinophils, a blood cell that can be elevated in the presence of a parasite, in the blood or in the fluid that surrounds the brain can be another important clue. Persons worried that they might be infected should consult their health care provider.\\n    \\n     \\n    Angiostrongylus costaricensis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 194, 'source_type': 'Remedies', 'priority': '1'}, page_content='Angiostrongylus costaricensis\\n    \\nDiagnosing A. costaricensis infections can be difficult, in part because there are no readily available blood tests. Important clues that could lead to the diagnosis of infection are a history of travel to where the parasite is known to be found and ingestion of raw or undercooked slugs or food contaminated by infected slugs or their slime. A high blood level of eosinophils, a blood cell that can be elevated in the presence of a parasite, can be another important clue. Persons worried that they might be infected should consult their health care provider.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 195, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: treatment\\nQuestion: What are the treatments for Parasites - Angiostrongyliasis (also known as Angiostrongylus Infection) ?\\nAnswer: Angiostrongylus cantonensis\\n    \\nThere is no specific treatment for A. cantonensis infection. There is some evidence that certain supportive treatments may reduce the severity of headache and the duration of symptoms. Persons with symptoms should consult their health care provider for more information.\\n    Angiostrongylus costaricensis\\n    \\nThere is no specific treatment for A. costaricensis infections. Most infections resolve spontaneously though sometime surgical treatment is necessary to removed portions of inflamed intestine. Persons with symptoms should consult their health care provider for more information.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 196, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: prevention\\nQuestion: How to prevent Parasites - Angiostrongyliasis (also known as Angiostrongylus Infection) ?\\nAnswer: Angiostrongylus cantonensis\\n    \\nPrevention of A. cantonensis infections involves educating persons residing in or traveling to areas where the parasite is found about not ingesting raw or undercooked snails and slugs, freshwater shrimp, land crabs, frogs, and monitor lizards, or potentially contaminated vegetables, or vegetable juice. Removing snails, slugs, and rats found near houses and gardens should also help reduce risk. Thoroughly washing hands and utensils after preparing raw snails or slugs is also recommended. Vegetables should be thoroughly washed if eaten raw.\\n    Angiostrongylus costaricensis'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 196, 'source_type': 'Remedies', 'priority': '1'}, page_content='Angiostrongylus costaricensis\\n    \\nPrevention of A. costaricensis infections involves educating persons residing in and traveling to areas where the parasite is known to be found about not ingesting raw or undercooked slugs or potentially contaminated vegetables or vegetable juices. Removing slugs and rats found near houses and gardens should help reduce risk. Thoroughly washing hands and utensils after preparing raw slugs is also recommended. Vegetables should be thoroughly washed if eaten raw.'),\n",
       " Document(metadata={'source': '../data/remedies/train.csv', 'row': 197, 'source_type': 'Remedies', 'priority': '1'}, page_content='qtype: symptoms\\nQuestion: What are the symptoms of Typhoid Fever ?\\nAnswer: Persons with typhoid fever usually have a sustained fever as high as 103° to 104° F (39° to 40° C). They may also feel weak, or have stomach pains, headache, or loss of appetite. In some cases, patients have a rash of flat, rose-colored spots. The only way to know for sure if an illness is typhoid fever is to have samples of stool or blood tested for the presence of Salmonella Typhi.\\n\\nTyphoid fever’s danger doesn’t end when symptoms disappear:'),\n",
       " ...]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csv_chunks=split_documents(all_csv_documents)\n",
    "csv_chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cecb4a06",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Chunks in Merck DB: 20678\n",
      "Total chunks after merge: 60655\n",
      "✅ New remedies merged into the existing medical index!\n"
     ]
    }
   ],
   "source": [
    "from langchain_community.vectorstores import FAISS\n",
    "from langchain_huggingface import HuggingFaceEmbeddings\n",
    "\n",
    "\n",
    "embeddings = HuggingFaceEmbeddings(model_name=\"all-MiniLM-L6-v2\")\n",
    "\n",
    "#Load existing db\n",
    "existing_db = FAISS.load_local(\n",
    "    \"arvia_medical_index_v2\", \n",
    "    embeddings, \n",
    "    allow_dangerous_deserialization=True\n",
    ")\n",
    "\n",
    "# Temporary db\n",
    "new_db = FAISS.from_documents(csv_chunks, embeddings)\n",
    "\n",
    "print(f\"Chunks in Merck DB: {len(existing_db.docstore._dict)}\")\n",
    "\n",
    "#mergingg\n",
    "existing_db.merge_from(new_db)\n",
    "\n",
    "print(f\"Total chunks after merge: {len(existing_db.docstore._dict)}\")\n",
    "\n",
    "# save combined\n",
    "existing_db.save_local(\"arvia_medical_index_v3\")\n",
    "\n",
    "print(\"✅ New remedies merged into the existing medical index!\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.14.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
